Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
1	911928	911928	G	C	exonic	PERM1	.	synonymous SNV	PERM1:NM_001291366:exon3:c.C2226G:p.T742T,PERM1:NM_001291367:exon4:c.C1944G:p.T648T	.	.	.	.	0.06703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	1	911928	chr1:911928	G	C	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	1159252	1159252	C	A	exonic	SDF4	.	nonsynonymous SNV	SDF4:NM_016176:exon3:c.G423T:p.E141D,SDF4:NM_016547:exon3:c.G423T:p.E141D	0.001309827	0.858724277	0.139965896	.	0.10366	0.35502	-0.598810865	18.13517339	109.15684	2.26829	0.074	0.346	T	0.683	0.508	P	0.306	0.519	B	0.000	0.843	D	1.000	0.530	D	1.86	0.494	L	3.05	0.087	T	-0.8	0.221	N	0.391	0.528	-0.914	0.464	T	0.179	0.525	T	0.025	0.480	T	3.092	0.431	22.5	0.988	0.453	0.889	0.487	D	c	-0.298	-0.371	0.038	0.143	0.707	0.730	0	-0.070	0.130	1.032	0.296	-0.009	0.132	1.000	0.715	0.137	0.201	9.532	0.382	EF-hand domain|EF-hand domain pair	.	.	0.5	.	70	1	1159252	chr1:1159252	C	A	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	1225580	1225580	-	CC	intronic	SCNN1D	.	.	.	2.82E-15	0.004782576	0.995217424	.	0.70009	0.14008	1.771089818	96.77990092	880.06096	5.7775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	381	1	1225580	chr1:1225580	T	TCC,TCCCGTGTCTCTGCTCCATTC	66	PASS	DP=381;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	1225580	1225580	-	CCCGTGTCTCTGCTCCATTC	intronic	SCNN1D	.	.	.	2.82E-15	0.004782576	0.995217424	.	0.70009	0.14008	1.771089818	96.77990092	880.06096	5.7775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	381	1	1225580	chr1:1225580	T	TCC,TCCCGTGTCTCTGCTCCATTC	66	PASS	DP=381;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	1431060	1431060	T	C	exonic	ATAD3B	.	nonsynonymous SNV	ATAD3B:NM_001317238:exon14:c.T1672C:p.Y558H,ATAD3B:NM_031921:exon16:c.T1810C:p.Y604H	1.92E-13	0.056353554	0.943646446	.	0.08529	0.12376	2.166192036	98.0301958	6153.92777	16.40046	0.602	0.056	T	0.0	0.026	B	0.0	0.013	B	0.371	0.044	U	1	0.090	N	-0.69	0.019	N	-3.43	0.944	D	-0.05	0.078	N	0.072	0.097	-0.401	0.720	T	0.539	0.830	D	.	.	.	-1.923	0.009	0.001	0.220	0.009	0.006	0.026	N	c	-1.783	-1.863	0.002	0.089	0.707	0.730	0	-2.41	0.061	-1.313	0.028	-1.859	0.006	0.000	0.063	0.000	0.016	2.734	0.049	.	.	.	0.5	149	232	1	1431060	chr1:1431060	T	C	149	PASS	DP=232;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	1452551	1452551	G	A	exonic	ATAD3A	.	nonsynonymous SNV	ATAD3A:NM_018188:exon3:c.G287A:p.R96Q	0.040130598	0.959596763	0.000272639	.	0.3012	0.10317	0.119404819	62.20806794	1511.84536	7.22185	0.491	0.080	T	0.0	0.026	B	0.0	0.013	B	0.000	0.003	N	1	0.090	P	-0.895	0.014	N	-2.18	0.867	D	-0.11	0.087	N	0.08	0.072	-0.919	0.458	T	0.002	0.006	T	.	.	.	-2.157	0.006	0.001	0.618	0.066	0.000	0.002	N	c	-2.249	-2.328	0.999	0.386	0.461	0.090	0	-4.25	0.035	-2.319	0.012	-4.718	0.000	0.000	0.063	0.000	0.016	3.959	0.088	.	.	.	0.5	53	24	1	1452551	chr1:1452551	G	A	53	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	1560911	1560911	C	A	intronic	MIB2	.	.	.	0.000158543	0.998420185	0.001421272	.	0.17639	0.12919	-0.033100763	50.56027365	2011.5952	8.25644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	78	1	1560911	chr1:1560911	C	A	64	PASS	DP=78;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	1560943	1560943	C	T	exonic	MIB2	.	synonymous SNV	MIB2:NM_001170688:exon7:c.C1032T:p.G344G,MIB2:NM_001170689:exon7:c.C687T:p.G229G,MIB2:NM_001170686:exon8:c.C1215T:p.G405G,MIB2:NM_001170687:exon8:c.C1185T:p.G395G,MIB2:NM_080875:exon8:c.C1227T:p.G409G	0.000158543	0.998420185	0.001421272	.	0.17639	0.12919	-0.033100763	50.56027365	2011.5952	8.25644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	1	1560943	chr1:1560943	C	T	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	1571829	1571829	A	G	exonic	CDK11B	.	synonymous SNV	CDK11B:NM_033487:exon16:c.T1164C:p.P388P,CDK11B:NM_033490:exon17:c.T1281C:p.P427P,CDK11B:NM_001291345:exon19:c.T1896C:p.P632P,CDK11B:NM_001787:exon19:c.T1965C:p.P655P,CDK11B:NM_033486:exon19:c.T1926C:p.P642P,CDK11B:NM_033489:exon20:c.T1824C:p.P608P	0.72829444	0.271588478	0.000117082	.	.	0.14135	.	.	147.53387	2.64628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	48	1	1571829	chr1:1571829	A	G	52	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	1643940	1643940	-	T	intronic	CDK11A;CDK11B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	201	1	1643940	chr1:1643940	G	GT	84	PASS	DP=201;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	1647871	1647871	T	C	exonic	CDK11A;CDK11B	.	synonymous SNV	CDK11A:NM_001313896:exon5:c.A372G:p.R124R,CDK11A:NM_001313982:exon5:c.A372G:p.R124R,CDK11A:NM_024011:exon5:c.A402G:p.R134R,CDK11A:NM_033529:exon5:c.A372G:p.R124R,CDK11B:NM_001291345:exon6:c.A372G:p.R124R,CDK11B:NM_001787:exon6:c.A402G:p.R134R,CDK11B:NM_033486:exon6:c.A402G:p.R134R,CDK11B:NM_033489:exon7:c.A300G:p.R100R	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	192	194	1	1647871	chr1:1647871	T	C	192	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	1647893	1647893	-	TTTCTT	exonic	CDK11A;CDK11B	.	nonframeshift insertion	CDK11B:NM_001291345:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313896:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313982:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_001787:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_024011:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11B:NM_033486:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_033529:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_033489:exon6:c.277_278insAAGAAA:p.E92_R93insKE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	177	159	1	1647893	chr1:1647893	C	CTTTCTT	177	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	1688824	1688824	A	-	intronic	NADK	.	.	.	0.00126769	0.990233969	0.008498342	.	0.15314	0.1864	-0.111973265	45.35857514	176.4511	2.88899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	92	1	1688823	chr1:1688823	TA	T	79	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	1843597	1843597	T	-	intergenic	GNB1;CALML6	dist=21041;dist=2669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	69	1	1843596	chr1:1843596	CT	C	64	PASS	DP=69;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	0/1	./.	./.
1	1910301	1910301	C	T	intronic	CFAP74	.	.	.	.	.	.	.	0.12614	0.09843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	98	1	1910301	chr1:1910301	C	T	64	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	1920313	1920313	G	A	intronic	CFAP74	.	.	.	.	.	.	.	0.12614	0.09843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	311	1	1920313	chr1:1920313	G	A	.	PASS	DP=311;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	1920345	1920345	C	T	exonic	CFAP74	.	synonymous SNV	CFAP74:NM_001304360:exon3:c.G135A:p.V45V	.	.	.	.	0.12614	0.09843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	1	1920345	chr1:1920345	C	T	.	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	3421897	3421897	A	G	exonic	MEGF6	.	nonsynonymous SNV	MEGF6:NM_001409:exon17:c.T2063C:p.L688P	4.42E-15	0.994620434	0.005379566	.	0.11042	0.09881	2.072624965	97.81198396	6730.46373	17.39874	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.237	0.158	N	1	0.090	P	-1.3	0.007	N	2.57	0.136	T	5.68	0.000	N	0.032	0.452	-0.927	0.446	T	0.000	0.000	T	.	.	.	-0.904	0.036	0.025	0.046	0.000	0.007	0.029	N	c	-1.324	-1.215	1.000	0.500	0.507	0.198	0	2.53	0.295	1.398	0.339	0.076	0.183	0.004	0.165	0.070	0.176	8.044	0.295	EGF-like domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain|Laminin EGF domain;Laminin EGF domain	.	.	0.5	153	160	1	3421897	chr1:3421897	A	G	153	PASS	DP=160;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	4772583	4772585	CCA	-	exonic	AJAP1	.	nonframeshift deletion	AJAP1:NM_001042478:exon2:c.653_655del:p.T225del,AJAP1:NM_018836:exon2:c.653_655del:p.T225del	0.977592767	0.022386032	2.12E-05	.	0.15431	0.12412	0.418953042	77.06416608	3783.30469	12.04609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	108	1	4772582	chr1:4772582	GCCA	G	56	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	6012757	6012757	C	A	intronic	NPHP4	.	.	.	1.29E-17	0.420064566	0.579935434	DISEASE: Note=Ciliary dysfunction leads to a broad spectrum of disorders, collectively termed ciliopathies. Overlapping clinical features include retinal degeneration, renal cystic disease, skeletal abnormalities, fibrosis of various organ, and a complex range of anatomical and functional defects of the central and peripheral nervous system. The ciliopathy range of diseases includes Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, nephronophtisis, Senior-Loken syndrome, and Jeune asphyxiating thoracic dystrophy among others. Single-locus allelism is insufficient to explain the variable penetrance and expressivity of such disorders, leading to the suggestion that variations across multiple sites of the ciliary proteome, including NPHP4, influence the clinical outcome (PubMed:21258341). {ECO:0000269|PubMed:21258341}.; DISEASE: Senior-Loken syndrome 4 (SLSN4) [MIM:606996]: A renal- retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life. {ECO:0000269|PubMed:12244321, ECO:0000269|PubMed:15776426}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12343	0.16808	0.569383166	81.78815758	1128.55982	6.4092	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	193	1	6012757	chr1:6012757	C	A	.	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	6514592	6514592	A	G	intronic	ESPN	.	.	.	0.002553841	0.982377837	0.015068321	DISEASE: Deafness, autosomal recessive, 36, with or without vestibular involvement (DFNB36) [MIM:609006]: A form of non- syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNB36 is characterized by prelingual, profound hearing loss, and vestibular areflexia in some patients. {ECO:0000269|PubMed:15286153, ECO:0000269|PubMed:15930085}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09981	0.12971	.	.	1569.90563	7.33096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	88	1	6514592	chr1:6514592	A	G	103	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	7861157	7861157	-	T	intronic	PER3	.	.	.	2.19E-10	0.99157171	0.008428289	.	0.17974	.	1.352134556	94.35598018	722.42393	5.33625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	38	1	7861157	chr1:7861157	G	GT	41	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	8424165	8424165	T	G	exonic	RERE	.	nonsynonymous SNV	RERE:NM_001042682:exon5:c.A29C:p.D10A,RERE:NM_001042681:exon15:c.A1691C:p.D564A,RERE:NM_012102:exon16:c.A1691C:p.D564A	0.999995655	4.34E-06	1.54E-16	DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; 	0.87038	0.13942	-2.629516077	0.784383109	607.52718	4.98583	0.009	0.682	D	0.999	0.764	D	0.994	0.807	D	.	.	.	1	0.810	D	1.15	0.294	L	3.46	0.053	T	-2.91	0.630	D	0.83	0.818	-0.908	0.471	T	0.027	0.114	T	0.029	0.513	D	4.919	0.661	25.0	0.981	0.381	0.993	0.938	D	c	0.451	0.509	1.000	0.747	0.719	0.830	0	5.17	0.707	7.448	0.795	1.061	0.807	1.000	0.715	1.000	0.888	14.340	0.660	.	.	.	0.5	197	152	1	8424165	chr1:8424165	T	G	197	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
1	9083026	9083026	C	T	exonic	SLC2A7	.	nonsynonymous SNV	SLC2A7:NM_207420:exon3:c.G262A:p.G88S	2.99E-17	0.000633282	0.999366718	.	0.08611	0.17345	1.692094639	96.42014626	924.8755	5.90621	0.004	0.654	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	0.990	0.411	D	3.465	0.926	M	0.36	0.579	T	-5.29	0.843	D	0.744	0.740	0.017	0.826	D	0.412	0.760	T	0.012	0.299	T	6.084	0.838	28.2	0.998	0.918	0.893	0.494	D	c	0.413	0.224	1.000	0.747	0.526	0.212	0	3.94	0.446	3.066	0.494	0.931	0.441	0.980	0.350	0.114	0.194	14.349	0.661	Major facilitator superfamily domain	.	.	0.5	72	97	1	9083026	chr1:9083026	C	T	72	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	9714247	9714247	A	G	ncRNA_intronic	PIK3CD-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	24	1	9714247	chr1:9714247	A	G	62	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	10697270	10697270	C	A	UTR3	CASZ1	NM_001079843:c.*1729G>T	.	.	0.999938476	6.15E-05	4.86E-13	.	0.71675	0.27528	-2.416721768	1.055673508	1083.53567	6.31123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	235	1	10697270	chr1:10697270	C	A	102	PASS	DP=235;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	11008497	11008497	G	C	exonic	C1orf127	.	synonymous SNV	C1orf127:NM_001170754:exon12:c.C1695G:p.G565G	1.33E-05	0.955388217	0.044598438	.	0.1648	.	0.986521626	90.48124558	1056.79352	6.24152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	19	1	11008497	chr1:11008497	G	C	62	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	11036287	11036287	G	C	exonic	C1orf127	.	nonsynonymous SNV	C1orf127:NM_001170754:exon2:c.C53G:p.P18R	1.33E-05	0.955388217	0.044598438	.	0.1648	.	0.986521626	90.48124558	1056.79352	6.24152	0.035	0.437	D	.	.	.	.	.	.	.	.	.	1	0.216	N	.	.	.	1.44	0.327	T	-2.17	0.490	N	0.103	0.107	-1.024	0.225	T	0.050	0.215	T	0.007	0.179	T	4.095	0.550	23.7	0.997	0.828	0.065	0.124	N	c	-0.464	-0.526	1.000	0.747	0.487	0.094	0	2.82	0.319	1.516	0.352	0.978	0.596	0.014	0.188	0.056	0.168	8.923	0.346	.	.	.	0.5	.	95	1	11036287	chr1:11036287	G	C	.	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	11254843	11254843	T	C	intronic	ANGPTL7;MTOR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	50	1	11254843	chr1:11254843	T	C	104	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	12017050	12017050	C	G	exonic	PLOD1	.	nonsynonymous SNV	PLOD1:NM_000302:exon7:c.C720G:p.I240M,PLOD1:NM_001316320:exon8:c.C861G:p.I287M	2.70E-07	0.995480792	0.004518938	DISEASE: Ehlers-Danlos syndrome 6 (EDS6) [MIM:225400]: A connective tissue disorder characterized by generalized joint hypermobility, hyperextensible skin, atrophic cutaneous scars due to tissue fragility, progressive kyphoscoliosis already present at birth, ocular manifestations, arterial rupture, easy bruising, severe neonatal muscle hypotonia and delayed motor development. {ECO:0000269|PubMed:10686424, ECO:0000269|PubMed:15666309, ECO:0000269|PubMed:15854030, ECO:0000269|PubMed:15979919, ECO:0000269|PubMed:8163671, ECO:0000269|PubMed:9617436}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25274	.	-0.657684922	16.09459778	3458.35803	11.29956	0.001	0.784	D	0.846	0.448	P	0.577	0.507	P	0.000	0.629	D	1.000	0.513	D	2.715	0.797	M	-0.38	0.690	T	-2.51	0.545	D	0.613	0.678	-0.556	0.666	T	0.330	0.698	T	0.066	0.699	D	2.763	0.393	21.2	0.995	0.704	0.609	0.311	D	c	-0.135	-0.258	0.658	0.222	0.707	0.730	0	-0.488	0.114	-0.313	0.081	0.024	0.147	0.286	0.250	0.971	0.463	4.767	0.124	.	.	.	0.5	90	172	1	12017050	chr1:12017050	C	G	90	PASS	DP=172;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	12898378	12898378	C	G	intergenic	PRAMEF11;HNRNPCL1	dist=7114;dist=8852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	245	1	12898378	chr1:12898378	C	G	113	PASS	DP=245;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	12898387	12898387	G	A	intergenic	PRAMEF11;HNRNPCL1	dist=7123;dist=8843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	1	12898387	chr1:12898387	G	A	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	12898654	12898654	A	G	intergenic	PRAMEF11;HNRNPCL1	dist=7390;dist=8576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	150	1	12898654	chr1:12898654	A	G	111	PASS	DP=150;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	12908080	12908080	C	T	exonic	HNRNPCL1;HNRNPCL3;HNRNPCL4	.	synonymous SNV	HNRNPCL3:NM_001146181:exon1:c.G63A:p.G21G,HNRNPCL4:NM_001302551:exon1:c.G63A:p.G21G,HNRNPCL1:NM_001013631:exon2:c.G63A:p.G21G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	200	1	12908080	chr1:12908080	C	T	134	PASS	DP=200;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	12921132	12921132	A	G	exonic	PRAMEF2	.	nonsynonymous SNV	PRAMEF2:NM_023014:exon4:c.A923G:p.E308G	0.00056761	0.708417519	0.291014871	.	0.07552	.	5.208541975	99.84076433	3268.27865	10.91295	0.064	0.365	T	0.38	0.326	B	0.228	0.364	B	0.328	0.041	N	1	0.090	P	1.63	0.419	L	0.79	0.491	T	-1.45	0.356	N	0.091	0.089	-1.097	0.045	T	0.001	0.003	T	.	.	.	1.316	0.222	12.35	0.921	0.209	0.001	0.008	N	c	-1.054	-1.268	0.000	0.012	0.487	0.133	0	-1.65	0.078	-1.150	0.033	0.579	0.285	0.000	0.063	0.008	0.104	1.446	0.022	Leucine-rich repeat domain, L domain-like	.	.	0.5	80	117	1	12921132	chr1:12921132	A	G	80	PASS	DP=117;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	12942138	12942138	C	G	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon3:c.G412C:p.E138Q	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	0.494	0.079	T	0.0	0.026	B	0.0	0.013	B	0.008	0.012	N	1	0.090	P	-0.145	0.044	N	3.35	0.060	T	0.42	0.034	N	0.126	0.193	-0.908	0.471	T	0.000	0.000	T	.	.	.	-2.714	0.002	0.001	0.156	0.004	0.001	0.008	N	c	-1.956	-2.088	0.005	0.107	0.487	0.133	0	-2.4	0.062	-0.634	0.055	-1.273	0.014	0.000	0.063	0.000	0.016	2.286	0.038	.	.	.	0.5	125	79	1	12942138	chr1:12942138	C	G	125	PASS	DP=79;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	12943022	12943022	C	T	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon2:c.G194A:p.R65H	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	.	.	.	0.02	0.170	B	0.009	0.133	B	0.213	0.034	N	1	0.090	N	1.665	0.427	L	.	.	.	.	.	.	0.118	0.153	-0.921	0.455	T	0.025	0.108	T	0.001	0.010	T	0.283	0.121	5.523	0.602	0.062	0.005	0.023	N	c	-1.264	-1.399	0.000	0.012	0.487	0.133	0	0.542	0.163	0.297	0.187	0.529	0.282	0.096	0.225	0.032	0.149	4.846	0.128	.	.	.	0.5	96	189	1	12943022	chr1:12943022	C	T	96	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	12943200	12943200	A	G	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon2:c.T16C:p.W6R	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	0.789	0.032	T	0.0	0.026	B	0.0	0.013	B	0.008	0.012	N	1	0.090	N	-1.55	0.005	N	3.63	0.044	T	2.01	0.004	N	0.151	0.214	-0.956	0.400	T	0.006	0.020	T	.	.	.	-2.243	0.005	0.001	0.154	0.004	0.000	0.001	N	c	-1.633	-1.642	0.000	0.012	0.487	0.133	0	0.538	0.163	-1.922	0.016	-0.986	0.023	0.000	0.063	0.000	0.016	4.042	0.092	.	.	.	0.5	106	136	1	12943200	chr1:12943200	A	G	106	PASS	DP=136;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	13052863	13052863	C	A	intronic	PRAMEF25;PRAMEF26	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	0.135	0.156	-0.974	0.364	T	0.100	0.371	T	.	.	.	-0.267	0.071	0.787	0.933	0.225	0.003	0.015	N	c	-0.773	-1.019	0.000	0.012	0.487	0.133	0	-1.09	0.093	-0.756	0.048	-0.339	0.072	0.000	0.063	0.002	0.062	3.460	0.070	.	.	.	0.5	110	393	1	13052863	chr1:13052863	C	A	110	PASS	DP=393;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	13183578	13183578	G	C	exonic	HNRNPCL2	.	nonsynonymous SNV	HNRNPCL2:NM_001136561:exon2:c.C295G:p.R99G	.	.	.	.	.	.	.	.	.	.	.	.	.	0.927	0.495	P	0.593	0.487	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.385	0.445	.	.	.	.	.	.	.	.	.	-0.206	0.076	1.067	0.496	0.042	0.055	0.112	N	n	-0.273	0.267	0.000	0.055	0.294	0.042	0	0.149	0.141	-0.029	0.122	-0.877	0.028	0.004	0.165	0.004	0.083	6.015	0.187	.	.	.	0.5	99	35	1	13183578	chr1:13183578	G	C	99	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	13414093	13414093	A	G	exonic	PRAMEF10;PRAMEF33	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	338	1	13414093	chr1:13414093	A	G	95	PASS	DP=338;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	14107213	14107213	C	T	exonic	PRDM2	.	nonsynonymous SNV	PRDM2:NM_001007257:exon3:c.C2320T:p.P774S,PRDM2:NM_012231:exon8:c.C2923T:p.P975S,PRDM2:NM_015866:exon8:c.C2923T:p.P975S	0.995040619	0.004959381	1.78E-10	.	0.28355	0.21546	-0.553188106	19.81009672	615.77007	5.0118	0.019	0.501	D	0.098	0.240	B	0.038	0.234	B	0.009	0.305	N	0.850	0.810	D	1.555	0.395	L	4.86	0.016	T	-0.53	0.164	N	0.245	0.299	-0.944	0.419	T	0.006	0.022	T	0.007	0.188	T	1.962	0.297	15.97	0.991	0.512	0.479	0.278	N	c	-0.577	-0.484	1.000	0.434	0.706	0.609	0	3.0	0.336	0.865	0.274	0.038	0.153	0.094	0.225	0.926	0.400	11.450	0.492	.	.	.	0.5	71	88	1	14107213	chr1:14107213	C	T	71	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	15766746	15766746	G	A	intronic	CTRC	.	.	.	5.22E-06	0.4231791	0.57681568	.	0.35475	.	0.016664174	55.21939137	145.59143	2.62957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	92	1	15766746	chr1:15766746	G	A	96	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16094026	16094026	C	A	exonic	FBLIM1	.	nonsynonymous SNV	FBLIM1:NM_001024215:exon3:c.C406A:p.L136M,FBLIM1:NM_017556:exon4:c.C406A:p.L136M,FBLIM1:NM_001350151:exon5:c.C406A:p.L136M	0.00078906	0.928321057	0.070889883	.	0.30445	0.10649	0.510776592	80.23708422	197.45136	3.03792	0.134	0.912	T	0.999	0.764	D	0.998	0.875	D	0.008	0.309	N	1	0.810	D	1.955	0.530	M	0.22	0.608	T	-0.31	0.148	N	0.34	0.401	-0.385	0.725	T	0.358	0.721	T	0.031	0.535	D	3.855	0.520	23.4	0.996	0.733	0.848	0.436	D	c	0.383	0.283	1.000	0.436	0.672	0.522	0	3.81	0.429	0.878	0.276	0.765	0.311	0.998	0.411	0.950	0.426	11.030	0.468	.	.	.	0.5	.	55	1	16094026	chr1:16094026	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	16262553	16262553	C	T	exonic	SPEN	.	nonsynonymous SNV	SPEN:NM_015001:exon11:c.C9818T:p.T3273I	1	3.70E-14	1.69E-35	.	0.87812	0.15972	-2.307490096	1.209011559	1380.73788	6.9638	0.006	0.614	D	0.996	0.670	D	0.931	0.649	D	.	.	.	0.991	0.240	N	2.08	0.576	M	3.05	0.087	T	-1.85	0.433	N	0.247	0.332	-1.045	0.157	T	0.051	0.218	T	0.015	0.350	T	6.043	0.832	28.0	0.996	0.766	0.934	0.580	D	c	0.464	0.469	1.000	0.747	0.732	0.924	0	5.18	0.710	3.790	0.549	0.836	0.341	0.998	0.411	0.782	0.331	17.659	0.880	.	.	.	0.5	.	84	1	16262553	chr1:16262553	C	T	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	16302477	16302477	C	T	splicing	ZBTB17	NM_001287604:exon1:UTR5;NM_001242884:exon1:UTR5;NM_003443:exon1:UTR5;NM_001287603:exon1:UTR5;NM_001324137:exon1:UTR5;NM_001324138:exon1:UTR5	.	.	0.998165365	0.001834626	9.40E-09	.	0.9193	0.14584	-0.688817379	15.20405756	70.88543	1.75315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	132	1	16302477	chr1:16302477	C	T	67	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	16363158	16363158	G	A	intergenic	CLCNKA;CLCNKB	dist=2613;dist=7073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	78	1	16363158	chr1:16363158	G	A	91	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	16451783	16451783	C	T	exonic	EPHA2	.	nonsynonymous SNV	EPHA2:NM_001329090:exon16:c.G2696A:p.G899D,EPHA2:NM_004431:exon17:c.G2858A:p.G953D	0.738294173	0.261704958	8.69E-07	DISEASE: Cataract 6, multiple types (CTRCT6) [MIM:116600]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT6 includes posterior polar and age- related cortical cataracts, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. Age-related cortical cataract is a developmental punctate opacity restricted to the cortex. The cataract is white or cerulean, increases in number with age, but rarely affects vision. {ECO:0000269|PubMed:19005574, ECO:0000269|PubMed:19306328, ECO:0000269|PubMed:19649315}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Overexpressed in several cancer types and promotes malignancy. {ECO:0000269|PubMed:19573808}.; 	0.5483	0.28861	-0.628385276	16.82000472	391.87029	4.16611	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.537	D	1	0.810	D	3.755	0.952	H	-0.23	0.667	T	-5.37	0.849	D	0.683	0.690	0.362	0.885	D	0.573	0.846	D	0.317	0.914	D	7.186	0.945	34	0.998	0.929	0.984	0.818	D	c	0.882	0.802	1.000	0.747	0.672	0.522	0	4.88	0.630	7.818	0.846	0.785	0.317	1.000	0.715	0.958	0.437	17.007	0.862	Sterile alpha motif domain|Sterile alpha motif/pointed domain	.	.	0.5	.	81	1	16451783	chr1:16451783	C	T	.	PASS	DP=81;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	16812113	16812113	G	A	ncRNA_exonic	CROCCP3	.	.	.	.	.	.	.	0.06928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	162	1	16812113	chr1:16812113	G	A	140	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	16890428	16890428	T	A	UTR3	NBPF1	NM_017940:c.*10A>T	.	.	.	.	.	.	.	.	.	.	10963.86792	22.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	336	1	16890428	chr1:16890428	T	A	106	PASS	DP=336;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16910040	16910040	A	G	intronic	NBPF1	.	.	.	.	.	.	.	.	.	.	.	10963.86792	22.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	2016	1	16910040	chr1:16910040	A	G	173	PASS	DP=2016;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16952267	16952267	T	C	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	321	1	16952267	chr1:16952267	T	C	128	PASS	DP=321;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16957374	16957374	C	T	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	135	1	16957374	chr1:16957374	C	T	.	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	16958694	16958694	G	A	intergenic	CROCCP2;MST1P2	dist=1293;dist=13375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	355	1	16958694	chr1:16958694	G	A	.	PASS	DP=355;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16959834	16959834	G	T	intergenic	CROCCP2;MST1P2	dist=2433;dist=12235	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	1078	1	16959834	chr1:16959834	G	T	130	PASS	DP=1078;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16975278	16975278	-	C	ncRNA_exonic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	105	1	16975278	chr1:16975278	A	AC	92	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16975411	16975411	G	C	ncRNA_exonic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	299	1	16975411	chr1:16975411	G	C	114	PASS	DP=299;AN=4	GT	0/1	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	16975787	16975787	C	T	ncRNA_intronic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	200	1	16975787	chr1:16975787	C	T	.	PASS	DP=200;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	17029345	17029345	G	A	ncRNA_exonic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	97	1	17029345	chr1:17029345	G	A	62	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	17034456	17034463	GCGCGCGT	-	ncRNA_exonic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	123	1	17034455	chr1:17034455	CGCGCGCGT	C	150	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	17085030	17085030	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon11:c.G1445A:p.R482H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	795	1	17085030	chr1:17085030	C	T	.	PASS	DP=795;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17086941	17086941	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon4:c.G383A:p.R128H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	480	1	17086941	chr1:17086941	C	T	125	PASS	DP=480;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	17087459	17087459	A	G	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon2:c.T206C:p.M69T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	1675	1	17087459	chr1:17087459	A	G	156	PASS	DP=1675;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17266609	17266609	G	-	intronic	CROCC	.	.	.	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	423	1	17266608	chr1:17266608	TG	T	159	PASS	DP=423;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17266616	17266616	A	G	intronic	CROCC	.	.	.	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	157	400	1	17266616	chr1:17266616	A	G	157	PASS	DP=400;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17662751	17662751	C	G	intronic	PADI4	.	.	.	1.30E-09	0.547876116	0.452123883	DISEASE: Rheumatoid arthritis (RA) [MIM:180300]: An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. {ECO:0000269|PubMed:12833157}. Note=The gene represented in this entry may be involved in disease pathogenesis. The association to rheumatoid arthritis was initially thought to result from increased citrullination of target proteins (PubMed:12833157). However, variants that have been associated to rheumatoid arthritis (Ser-55, Ala-82 and Ala-112) do not affect the catalytic activity or the citrullination activity of PADI4, suggesting that these variants may affect the mRNA stability rather than the protein (PubMed:21245532). {ECO:0000269|PubMed:12833157, ECO:0000269|PubMed:21245532}.; 	0.08126	.	2.230515739	98.17173862	609.89444	4.99213	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	20	1	17662751	chr1:17662751	C	G	53	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	17698725	17698725	C	T	UTR5	PADI6	NM_207421:c.-16C>T	.	.	.	.	.	.	0.06559	0.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	141	1	17698725	chr1:17698725	C	T	78	PASS	DP=141;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	19246151	19246151	G	-	intronic	IFFO2	.	.	.	0.382583916	0.573000165	0.044415918	.	.	.	.	.	254.06335	3.42814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	172	1	19246150	chr1:19246150	AG	A	92	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	19412750	19412750	C	T	exonic	UBR4	.	nonsynonymous SNV	UBR4:NM_020765:exon101:c.G14702A:p.R4901Q	1	2.43E-23	4.94E-62	.	0.25731	0.12662	-7.504914615	0.011795235	2894.47418	10.19251	0.0	0.912	D	0.997	0.689	D	0.968	0.701	D	0.000	0.843	D	1	0.810	D	2.25	0.640	M	1.37	0.342	T	-3.56	0.734	D	0.659	0.703	-0.571	0.660	T	0.256	0.626	T	0.086	0.747	D	8.446	0.958	35	0.999	0.999	0.962	0.679	D	c	0.877	0.858	1.000	0.747	0.707	0.730	0	5.75	0.904	7.568	0.814	0.852	0.362	1.000	0.715	0.993	0.574	18.521	0.909	.	.	.	0.5	.	46	1	19412750	chr1:19412750	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	20414964	20414965	TT	-	intronic	PLA2G5	.	.	.	0.000190275	0.474147037	0.525662688	DISEASE: Fleck retina, familial benign (FRFB) [MIM:228980]: An autosomal recessive condition associated with a distinctive retinal appearance and no apparent visual or electrophysiologic deficits. Affected individuals are asymptomatic, but fundus examination reveals a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but sparing the foveal region. {ECO:0000269|PubMed:22137173}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11251	.	-0.317668748	31.45789101	25.27033	0.82614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	47	20	1	20414963	chr1:20414963	CTT	C	47	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	20662938	20662938	A	G	exonic	VWA5B1	.	nonsynonymous SNV	VWA5B1:NM_001039500:exon13:c.A1901G:p.K634R	.	.	.	.	.	.	.	.	7561.17588	18.64813	0.259	0.166	T	0.013	0.247	B	0.003	0.184	B	0.958	0.082	N	1	0.090	P	1.39	0.351	L	2.53	0.140	T	-0.73	0.206	N	0.021	0.109	-0.902	0.478	T	0.000	0.000	T	.	.	.	-0.662	0.047	0.089	0.874	0.167	0.031	0.080	N	c	-1.133	-1.169	0.004	0.106	0.534	0.214	0	-2.08	0.068	0.106	0.151	1.076	0.850	0.000	0.063	0.270	0.232	4.499	0.112	.	.	.	0.5	72	103	1	20662938	chr1:20662938	A	G	72	PASS	DP=103;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	20671961	20671961	G	A	exonic	VWA5B1	.	nonsynonymous SNV	VWA5B1:NM_001039500:exon17:c.G2639A:p.R880H	.	.	.	.	.	.	.	.	7561.17588	18.64813	0.007	0.721	D	1.0	0.899	D	0.991	0.916	D	0.000	0.559	D	0.070	0.369	P	2.55	0.747	M	3.01	0.091	T	-3.14	0.640	D	0.16	0.341	-0.900	0.481	T	0.000	0.000	T	.	.	.	7.077	0.941	33	0.999	0.996	0.947	0.619	D	c	0.678	0.673	0.524	0.211	0.554	0.246	0	5.28	0.740	5.958	0.698	0.988	0.601	1.000	0.715	0.985	0.512	16.390	0.833	.	.	.	0.5	74	28	1	20671961	chr1:20671961	G	A	74	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	20972061	20972061	G	A	exonic	PINK1	.	nonsynonymous SNV	PINK1:NM_032409:exon5:c.G968A:p.C323Y	4.08E-07	0.587542005	0.412457586	DISEASE: Parkinson disease 6 (PARK6) [MIM:605909]: A neurodegenerative disorder characterized by parkinsonian signs such as rigidity, resting tremor and bradykinesia. A subset of patients manifest additional symptoms including hyperreflexia, autonomic instability, dementia and psychiatric disturbances. Symptoms show diurnal fluctuation and can improve after sleep. {ECO:0000269|PubMed:15087508, ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:15349870, ECO:0000269|PubMed:15505171, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:15955953, ECO:0000269|PubMed:15970950, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16207217, ECO:0000269|PubMed:16257123, ECO:0000269|PubMed:16401616, ECO:0000269|PubMed:16482571, ECO:0000269|PubMed:16632486, ECO:0000269|PubMed:16966503, ECO:0000269|PubMed:17030667, ECO:0000269|PubMed:18286320, ECO:0000269|PubMed:22956510}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14291	0.17629	-0.462894052	23.62585515	2907.56994	10.22981	0.223	0.187	T	0.007	0.161	B	0.006	0.166	B	0.000	0.497	D	1.000	0.489	D	1.095	0.275	L	-0.75	0.733	T	-2.62	0.563	D	0.761	0.755	-0.748	0.581	T	0.267	0.639	T	0.049	0.639	D	1.859	0.284	15.34	0.838	0.144	0.935	0.582	D	c	-0.147	0.067	0.986	0.310	0.707	0.730	0	5.8	0.921	2.416	0.441	1.032	0.654	0.998	0.411	0.999	0.750	15.563	0.759	Protein kinase domain|Protein kinase-like domain	.	.	0.5	.	66	1	20972061	chr1:20972061	G	A	.	PASS	DP=66;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	21799967	21799967	A	T	exonic	NBPF3	.	nonsynonymous SNV	NBPF3:NM_001256417:exon6:c.A619T:p.N207Y,NBPF3:NM_001256416:exon7:c.A829T:p.N277Y,NBPF3:NM_032264:exon7:c.A829T:p.N277Y,NBPF3:NM_001330381:exon11:c.A661T:p.N221Y	1.98E-11	0.378787942	0.621212058	.	0.06699	.	3.60019308	99.52819061	1664.61558	7.53254	0.093	0.682	T	0.999	0.764	D	0.986	0.754	D	.	.	.	1	0.090	N	2.255	0.644	M	3.43	0.055	T	-5.21	0.861	D	0.052	0.494	-1.044	0.162	T	0.034	0.148	T	0.001	0.005	T	1.153	0.205	11.50	0.538	0.049	0.001	0.006	N	c	-0.688	-1.038	0.006	0.111	0.615	0.372	0	-1.8	0.074	-1.030	0.037	-0.882	0.027	0.000	0.063	0.000	0.016	2.840	0.051	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	.	42	1	21799967	chr1:21799967	A	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	22030121	22030121	A	-	intronic	USP48	.	.	.	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	13	1	22030120	chr1:22030120	GA	G	63	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	22304831	22304831	C	A	intronic	CELA3B	.	.	.	2.12E-10	0.035783176	0.964216824	.	0.26327	.	1.732552414	96.59707478	690.96911	5.24243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	170	623	1	22304831	chr1:22304831	C	A	170	PASS	DP=623;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	22922560	22922560	G	A	intronic	EPHA8	.	.	.	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	61	1	22922560	chr1:22922560	G	A	129	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	22928168	22928168	C	A	exonic	EPHA8	.	synonymous SNV	EPHA8:NM_020526:exon17:c.C2952A:p.I984I	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	1	22928168	chr1:22928168	C	A	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	23695969	23695969	G	C	ncRNA_exonic	ZNF436-AS1	.	.	.	.	.	.	.	0.12418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	199	1	23695969	chr1:23695969	G	C	100	PASS	DP=199;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	23966894	23966894	-	AAG	exonic	MDS2	.	nonframeshift insertion	MDS2:NM_001348075:exon7:c.278_279insAAG:p.R95_K96insR	0.042965573	0.662011892	0.295022535	.	0.06917	.	.	.	3048.37206	10.49529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	24	1	23966894	chr1:23966894	T	TAAG	82	PASS	DP=24;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	24022437	24022437	A	G	intronic	RPL11	.	.	.	0.725843321	0.271290852	0.002865827	DISEASE: Diamond-Blackfan anemia 7 (DBA7) [MIM:612562]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:19061985, ECO:0000269|PubMed:19191325}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.91293	.	-0.053113545	49.38664779	5.48246	0.20413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	25	1	24022437	chr1:24022437	A	G	52	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	24120833	24120833	C	-	intronic	LYPLA2	.	.	.	0.979519145	0.020463866	1.70E-05	.	0.20635	0.10011	-0.295622497	32.61972163	4.69509	0.16866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	49	1	24120832	chr1:24120832	AC	A	57	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	24393491	24393491	C	-	intronic	MYOM3	.	.	.	9.28E-28	0.010284505	0.989715495	.	0.13881	0.09984	1.162914409	92.65156877	15097.7948	26.68075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	172	1	24393490	chr1:24393490	GC	G	121	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	24987302	24987302	-	T	intronic	SRRM1	.	.	.	0.999999022	9.78E-07	2.02E-17	.	0.5312	0.11301	-0.929520514	9.683887709	90.5423	2.04787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	228	1	24987302	chr1:24987302	G	GT	64	PASS	DP=228;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	25634235	25634235	G	T	exonic	RHD	.	nonsynonymous SNV	RHD:NM_001282871:exon8:c.G1171T:p.V391F,RHD:NM_001282872:exon8:c.G1171T:p.V391F	0.0060601	0.97290792	0.021031981	.	0.40369	.	3.311471185	99.41613588	1433.80387	7.06993	0.253	0.169	T	0.985	0.592	D	0.488	0.455	P	.	.	.	1	0.090	N	.	.	.	1.84	0.247	T	0.62	0.079	N	0.139	0.162	-1.046	0.156	T	0.057	0.238	T	0.001	0.020	T	-0.167	0.079	1.280	0.988	0.453	0.010	0.038	N	c	-0.564	-0.811	0.000	0.067	0.554	0.283	0	0.996	0.189	-0.266	0.086	0.321	0.271	0.000	0.063	0.041	0.157	5.378	0.154	Ammonium transporter AmtB-like domain|Ammonium/urea transporter	.	.	0.5	110	212	1	25634235	chr1:25634235	G	T	110	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	25717365	25717365	C	G	exonic	RHCE	.	nonsynonymous SNV	RHCE:NM_001330430:exon5:c.G676C:p.A226P,RHCE:NM_020485:exon5:c.G676C:p.A226P,RHCE:NM_138618:exon5:c.G676C:p.A226P	0.861454126	0.138457773	8.81E-05	.	0.18894	0.11913	1.686630123	96.38476056	2200.98585	8.63676	0.066	0.433	T	0.032	0.189	B	0.151	0.326	B	0.040	0.240	N	0.266	0.588	P	.	.	.	1.62	0.282	T	-3.12	0.657	D	0.392	0.483	-1.046	0.156	T	0.000	0.000	T	.	.	.	3.308	0.456	22.9	0.995	0.693	0.216	0.212	N	c	-0.427	-0.396	0.000	0.035	0.516	0.203	0	3.15	0.351	0.742	0.257	0.807	0.329	0.098	0.225	0.961	0.442	8.181	0.303	Ammonium transporter AmtB-like domain|Ammonium/urea transporter	ENSG00000261349.1|ENSG00000183726.6|ENSG00000188672.12|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14	Adipose_Subcutaneous|Artery_Aorta|Cells_Transformed_fibroblasts|Muscle_Skeletal|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Whole_Blood	0.5	54	22	1	25717365	chr1:25717365	C	G	54	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	25747230	25747230	G	C	exonic	RHCE	.	nonsynonymous SNV	RHCE:NM_001330430:exon1:c.C48G:p.C16W,RHCE:NM_020485:exon1:c.C48G:p.C16W,RHCE:NM_138616:exon1:c.C48G:p.C16W,RHCE:NM_138617:exon1:c.C48G:p.C16W,RHCE:NM_138618:exon1:c.C48G:p.C16W	0.861454126	0.138457773	8.81E-05	.	0.18894	0.11913	1.686630123	96.38476056	2200.98585	8.63676	1.0	0.067	T	0.001	0.067	B	0.006	0.112	B	0.624	0.107	N	1	0.090	P	.	.	.	2.26	0.235	T	2.64	0.002	N	0.101	0.429	-0.901	0.479	T	0.000	0.000	T	.	.	.	-1.010	0.032	0.015	0.633	0.070	0.014	0.047	N	c	-1.190	-1.252	1.000	0.441	0.554	0.283	0	0.628	0.168	-0.607	0.057	-0.492	0.052	0.000	0.063	0.157	0.207	3.072	0.058	.	ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000259984.1|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000183726.6|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000261349.1|ENSG00000188672.12|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000117616.13|ENSG00000188672.12|ENSG00000259984.1|ENSG00000261349.1|ENSG00000187010.14|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000187010.14|ENSG00000188672.12|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000261349.1|ENSG00000187010.14|ENSG00000204178.5|ENSG00000188672.12|ENSG00000261349.1|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000188672.12|ENSG00000261349.1|ENSG00000187010.14|ENSG00000224183.1|ENSG00000183726.6|ENSG00000187010.14|ENSG00000259984.1|ENSG00000261349.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Adrenal_Gland|Adrenal_Gland|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Coronary|Artery_Coronary|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Brain_Caudate_basal_ganglia|Brain_Caudate_basal_ganglia|Brain_Cerebellar_Hemisphere|Brain_Cerebellar_Hemisphere|Brain_Cerebellar_Hemisphere|Brain_Cerebellum|Brain_Cortex|Brain_Cortex|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Hippocampus|Brain_Nucleus_accumbens_basal_ganglia|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_EBV-transformed_lymphocytes|Cells_EBV-transformed_lymphocytes|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Heart_Left_Ventricle|Liver|Lung|Lung|Lung|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Pancreas|Pituitary|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Testis|Testis|Testis|Thyroid|Thyroid|Thyroid|Thyroid|Thyroid|Vagina|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood	0.5	101	149	1	25747230	chr1:25747230	G	C	101	PASS	DP=149;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	26310394	26310394	A	G	intronic	PAFAH2	.	.	.	2.69E-07	0.497624678	0.502375053	.	0.13153	.	-0.402212257	26.7338995	141.07833	2.5923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	15	1	26310394	chr1:26310394	A	G	44	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	26349533	26349535	CCT	-	exonic	EXTL1	.	nonframeshift deletion	EXTL1:NM_004455:exon1:c.396_398del:p.L137del	1.18E-12	0.02326237	0.97673763	.	0.19886	0.09359	0.714657953	85.81623024	742.09286	5.41048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	42	1	26349532	chr1:26349532	GCCT	G	45	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	26487940	26487940	A	G	exonic	FAM110D	.	nonsynonymous SNV	FAM110D:NM_024869:exon2:c.A158G:p.H53R	0.550404227	0.396493199	0.053102574	.	0.42842	.	.	.	1309.4018	6.80877	0.531	0.070	T	0.677	0.394	P	0.326	0.402	B	0.070	0.216	U	0.894	0.278	P	1.32	0.331	L	1.08	0.394	T	-1.48	0.362	N	0.096	0.097	-0.947	0.416	T	0.000	0.000	T	.	.	.	1.147	0.205	11.47	0.706	0.091	0.229	0.217	N	c	-0.364	-0.329	1.000	0.747	0.658	0.486	0	4.42	0.526	0.582	0.234	1.005	0.623	0.041	0.208	0.790	0.333	13.078	0.583	.	ENSG00000236782.1|ENSG00000142684.7|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000236782.1|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000142684.7|ENSG00000236782.1|ENSG00000236782.1|ENSG00000142684.7|ENSG00000236782.1|ENSG00000142684.7|ENSG00000236782.1|ENSG00000142684.7|ENSG00000236782.1|ENSG00000142684.7|ENSG00000236782.1|ENSG00000236782.1|ENSG00000142684.7|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000236782.1|ENSG00000142684.7|ENSG00000236782.1|ENSG00000142684.7|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000236782.1|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000142684.7|ENSG00000236782.1|ENSG00000236782.1|ENSG00000236782.1|ENSG00000175087.5|ENSG00000142684.7|ENSG00000142684.7|ENSG00000236782.1|ENSG00000236782.1|ENSG00000142684.7|ENSG00000236782.1|ENSG00000197245.4|ENSG00000142684.7|ENSG00000236782.1|ENSG00000142684.7	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Artery_Tibial|Brain_Caudate_basal_ganglia|Brain_Caudate_basal_ganglia|Brain_Cerebellar_Hemisphere|Brain_Cortex|Brain_Cortex|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Nucleus_accumbens_basal_ganglia|Brain_Nucleus_accumbens_basal_ganglia|Brain_Putamen_basal_ganglia|Brain_Putamen_basal_ganglia|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Colon_Sigmoid|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Lung|Lung|Lung|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Pancreas|Pituitary|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Testis|Thyroid|Thyroid|Thyroid|Whole_Blood|Whole_Blood	0.5	53	25	1	26487940	chr1:26487940	A	G	53	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	26510343	26510343	C	T	intronic	CNKSR1	.	.	.	3.79E-16	0.136331853	0.863668147	.	0.16583	0.10675	0.516238257	80.33734371	811.05923	5.60139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	1	26510343	chr1:26510343	C	T	.	PASS	DP=67;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	26671575	26671575	A	G	exonic	CRYBG2	.	nonsynonymous SNV	CRYBG2:NM_001039775:exon2:c.T1574C:p.F525S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	P	.	.	.	.	.	.	.	.	.	0.042	0.022	.	.	.	.	.	.	.	.	.	-0.331	0.066	0.563	0.341	0.021	0.001	0.007	N	n	-0.405	0.161	0.107	0.165	0.078	0.016	0	-2.25	0.065	-0.405	0.072	-1.200	0.016	0.000	0.063	0.000	0.016	5.118	0.141	Ricin B, lectin domain	ENSG00000130695.9|ENSG00000130695.9|ENSG00000130695.9|ENSG00000130695.9	Esophagus_Gastroesophageal_Junction|Esophagus_Muscularis|Lung|Thyroid	0.5	137	177	1	26671575	chr1:26671575	A	G	137	PASS	DP=177;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	27107159	27107159	G	A	exonic	ARID1A	.	nonsynonymous SNV	ARID1A:NM_006015:exon20:c.G6770A:p.R2257Q,ARID1A:NM_139135:exon20:c.G6119A:p.R2040Q	0.999999997	3.36E-09	9.91E-23	.	0.54895	0.15082	-2.670076378	0.743099788	409.71816	4.24329	0.001	0.784	D	1.0	0.899	D	0.996	0.832	D	0.000	0.843	D	1.000	0.588	D	2.195	0.620	M	0.86	0.468	T	-3.54	0.686	D	0.412	0.936	-0.523	0.678	T	0.277	0.649	T	0.016	0.368	T	4.965	0.668	25.1	0.999	0.994	0.973	0.739	D	c	0.804	0.774	1.0	0.983	0.707	0.730	0	4.6	0.564	9.665	0.979	0.902	0.416	1.000	0.715	1.000	0.888	17.964	0.890	Armadillo-type fold	.	.	0.5	110	51	1	27107159	chr1:27107159	G	A	110	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	27732202	27732202	G	A	UTR3	WASF2	NM_006990:c.*2481C>T;NM_001201404:c.*2617C>T	.	.	0.975317446	0.024677097	5.46E-06	.	0.44161	0.18052	-0.003562597	53.72729417	54.35937	1.47373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	74	1	27732202	chr1:27732202	G	A	60	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	27736326	27736328	GGA	-	exonic	WASF2	.	nonframeshift deletion	WASF2:NM_006990:exon8:c.1197_1199del:p.P400del	0.975317446	0.024677097	5.46E-06	.	0.44161	0.18052	-0.003562597	53.72729417	54.35937	1.47373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	89	1	27736325	chr1:27736325	CGGA	C	62	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	27861282	27861282	C	T	UTR3	AHDC1	NM_001029882:c.*189G>A	.	.	0.999431448	0.000568552	5.41E-10	DISEASE: Mental retardation, autosomal dominant 25 (MRD25) [MIM:615829]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD25 additional features include mild dysmorphism, hypotonia, delayed psychomotor development with absent or poor expressive language, hypoplasia of the corpus callosum, simplified gyral pattern, and delayed myelination. {ECO:0000269|PubMed:24791903}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09286	.	-1.095046929	6.97688134	544.59826	4.74752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	1	27861282	chr1:27861282	C	T	.	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	28224050	28224050	G	A	intronic	RPA2	.	.	.	0.888461679	0.111293635	0.000244687	.	0.88914	0.39065	0.25917371	70.05779665	155.28434	2.72208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	15	1	28224050	chr1:28224050	G	A	.	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	29189597	29189597	C	T	exonic	OPRD1	.	synonymous SNV	OPRD1:NM_000911:exon3:c.C921T:p.G307G	0.109062189	0.776662875	0.114274936	.	0.38858	0.34596	-0.139478553	43.29440906	296.04535	3.67407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	135	1	29189597	chr1:29189597	C	T	128	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	31192650	31192650	T	G	ncRNA_intronic	MATN1-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	35	1	31192650	chr1:31192650	T	G	51	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	35227362	35227362	C	G	exonic	GJB4	.	nonsynonymous SNV	GJB4:NM_153212:exon2:c.C507G:p.C169W	1.96E-06	0.077683308	0.922314728	DISEASE: Erythrokeratodermia variabilis (EKV) [MIM:133200]: A genodermatosis characterized by the appearance of two independent skin lesions: transient figurate erythematous patches and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. {ECO:0000269|PubMed:11017804}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18667	0.11084	0.644875971	84.10002359	1814.33582	7.85361	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1.000	0.588	D	3.88	0.961	H	-4.61	0.979	D	-10.41	0.990	D	0.349	0.410	0.148	0.850	D	0.670	0.886	D	.	.	.	5.321	0.720	25.8	0.994	0.643	0.892	0.492	D	c	0.647	0.523	1.000	0.451	0.554	0.283	0	2.84	0.321	2.774	0.471	0.068	0.175	1.000	0.715	0.156	0.207	4.611	0.117	Connexin, N-terminal|Connexin, conserved site|Gap junction protein, cysteine-rich domain	.	.	0.5	41	17	1	35227362	chr1:35227362	C	G	41	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	37958235	37958235	G	A	UTR3	MEAF6	NM_022756:c.*1465C>T;NM_001270876:c.*1135C>T;NM_001270875:c.*1465C>T	.	.	0.730388139	0.269048652	0.000563209	DISEASE: Note=A chromosomal aberration involving MEAF6 may be a cause of endometrial stromal tumors. Translocation t(1;6)(p34;p21) with PHF1. {ECO:0000269|PubMed:22761769}.; 	0.18507	0.10264	-0.09720619	46.20193442	5.77712	0.21811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	112	1	37958235	chr1:37958235	G	A	64	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	37958245	37958245	T	-	UTR3	MEAF6	NM_022756:c.*1455delA;NM_001270876:c.*1125delA;NM_001270875:c.*1455delA	.	.	0.730388139	0.269048652	0.000563209	DISEASE: Note=A chromosomal aberration involving MEAF6 may be a cause of endometrial stromal tumors. Translocation t(1;6)(p34;p21) with PHF1. {ECO:0000269|PubMed:22761769}.; 	0.18507	0.10264	-0.09720619	46.20193442	5.77712	0.21811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	110	1	37958244	chr1:37958244	GT	G	61	PASS	DP=110;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	38304425	38304425	C	T	exonic	MTF1	.	synonymous SNV	MTF1:NM_005955:exon4:c.G651A:p.L217L	0.991394717	0.0086052	8.29E-08	.	0.88579	0.09665	7.61E-05	53.98089172	88.53093	2.01737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	1	38304425	chr1:38304425	C	T	.	PASS	DP=95;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	38462470	38462470	G	A	UTR3	FHL3	NM_004468:c.*607C>T;NM_001243878:c.*607C>T	.	.	0.534417266	0.462285973	0.003296761	.	0.29794	0.11106	0.284856336	71.40835103	213.429	3.15204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	1	38462470	chr1:38462470	G	A	.	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	38462985	38462987	GGC	-	UTR3	FHL3	NM_004468:c.*92_*90delGCC;NM_001243878:c.*92_*90delGCC	.	.	0.534417266	0.462285973	0.003296761	.	0.29794	0.11106	0.284856336	71.40835103	213.429	3.15204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	86	1	38462984	chr1:38462984	TGGC	T	42	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	39763275	39763275	A	C	intronic	MACF1	.	.	.	1	6.80E-31	4.02E-81	.	0.41854	.	-3.915490887	0.206416608	6684.15405	17.31418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	49	1	39763275	chr1:39763275	A	C	76	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	40432399	40432399	C	A	intronic	MFSD2A	.	.	.	0.91767122	0.082324192	4.59E-06	DISEASE: Microcephaly 15, primary, autosomal recessive (MCPH15) [MIM:616486]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. {ECO:0000269|PubMed:26005865, ECO:0000269|PubMed:26005868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08021	0.09539	-0.492218069	22.35786742	78.73994	1.87316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	60	1	40432399	chr1:40432399	C	A	75	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	40734058	40734058	A	G	intronic	ZMPSTE24	.	.	.	1.25E-07	0.572048078	0.427951797	DISEASE: Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612]: A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, joint contractures, and generalized lipodystrophy with loss of subcutaneous fat from the extremities, face, neck and trunk. {ECO:0000269|PubMed:12913070, ECO:0000269|PubMed:17152860, ECO:0000269|PubMed:18435794, ECO:0000269|PubMed:20814950}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]: Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance. {ECO:0000269|PubMed:15317753}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14921	0.33283	-0.648365105	16.35999056	30.24713	0.96505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	12	1	40734058	chr1:40734058	A	G	56	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	43352369	43352369	G	C	ncRNA_exonic	LOC339539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	98	1	43352369	chr1:43352369	G	C	95	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	43888327	43888327	C	-	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	879	1	43888326	chr1:43888326	AC	A	78	PASS	DP=879;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	43888342	43888342	C	-	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	501	1	43888341	chr1:43888341	AC	A	102	PASS	DP=501;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	43888419	43888419	C	G	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	695	1	43888419	chr1:43888419	C	G	117	PASS	DP=695;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	43888432	43888432	C	G	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	607	1	43888432	chr1:43888432	C	G	81	PASS	DP=607;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	44072066	44072066	C	T	exonic	PTPRF	.	synonymous SNV	PTPRF:NM_001329140:exon17:c.C2727T:p.P909P,PTPRF:NM_001329139:exon18:c.C2754T:p.P918P,PTPRF:NM_130440:exon19:c.C3612T:p.P1204P,PTPRF:NM_001329137:exon20:c.C2772T:p.P924P,PTPRF:NM_002840:exon20:c.C3639T:p.P1213P,PTPRF:NM_001329138:exon21:c.C2784T:p.P928P	0.999998379	1.62E-06	5.73E-19	DISEASE: Aplasia or hypoplasia of the breasts and/or nipples 2 (BNAH2) [MIM:616001]: A group of congenital deformities encompassing total absence of breasts and nipple (amastia), absence of the nipple (athelia), and absence of the mammary gland (amazia). {ECO:0000269|PubMed:24781087}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30877	0.14232	-3.924965486	0.20051899	258.69725	3.45757	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	201	1	44072066	chr1:44072066	C	T	78	PASS	DP=201;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	44131262	44131262	-	A	intronic	KDM4A	.	.	.	0.999993865	6.13E-06	1.77E-15	.	0.18092	0.10689	-0.020150552	52.25288983	135.04266	2.52863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	20	1	44131262	chr1:44131262	T	TA	41	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	44570083	44570083	C	G	intergenic	SLC6A9;KLF17	dist=72919;dist=14439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	32	1	44570083	chr1:44570083	C	G	53	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	44570092	44570092	A	C	intergenic	SLC6A9;KLF17	dist=72928;dist=14430	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	29	1	44570092	chr1:44570092	A	C	56	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	45981386	45981386	T	A	exonic	PRDX1	.	nonsynonymous SNV	PRDX1:NM_001202431:exon3:c.A200T:p.K67M,PRDX1:NM_002574:exon3:c.A200T:p.K67M,PRDX1:NM_181696:exon3:c.A200T:p.K67M,PRDX1:NM_181697:exon3:c.A200T:p.K67M	1.44E-07	0.06218816	0.937811696	.	0.84286	0.73165	-0.251530012	35.42108988	22.33675	0.75	0.001	0.784	D	0.391	0.328	B	0.393	0.425	B	0.000	0.843	D	1.000	0.810	D	3.55	0.934	H	1.35	0.346	T	-3.33	0.671	D	0.471	0.522	-0.700	0.605	T	0.186	0.536	T	0.028	0.507	D	5.765	0.788	27.0	0.994	0.636	0.906	0.517	D	c	0.413	0.472	1.000	0.747	0.672	0.522	0	5.9	0.949	2.323	0.432	1.056	0.757	1.000	0.715	1.000	0.888	11.373	0.488	Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant|Thioredoxin-like fold	.	.	0.5	.	43	1	45981386	chr1:45981386	T	A	.	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	45981387	45981387	T	A	exonic	PRDX1	.	stopgain	PRDX1:NM_001202431:exon3:c.A199T:p.K67X,PRDX1:NM_002574:exon3:c.A199T:p.K67X,PRDX1:NM_181696:exon3:c.A199T:p.K67X,PRDX1:NM_181697:exon3:c.A199T:p.K67X	1.44E-07	0.06218816	0.937811696	.	0.84286	0.73165	-0.251530012	35.42108988	22.33675	0.75	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.475	0.975	37	0.995	0.669	0.901	0.507	D	c	0.868	0.758	1.000	0.747	0.672	0.522	0	5.9	0.949	3.821	0.552	1.056	0.757	1.000	0.715	1.000	0.888	16.325	0.827	Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant|Thioredoxin-like fold	.	.	0.5	.	43	1	45981387	chr1:45981387	T	A	.	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	47338888	47338888	C	A	ncRNA_intronic	CYP4Z2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	146	52	1	47338888	chr1:47338888	C	A	146	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/1	./.
1	47611598	47611598	T	C	exonic	CYP4A22	.	nonsynonymous SNV	CYP4A22:NM_001308102:exon8:c.T989C:p.L330P,CYP4A22:NM_001010969:exon10:c.T1283C:p.L428P	1.42E-08	0.583397923	0.416602062	.	0.28066	0.18241	3.202967632	99.35126209	9392.57383	20.982	1.0	0.010	T	0.001	0.067	B	0.004	0.093	B	0.000	0.843	N	0.002	0.441	P	-4.48	0.000	N	1.64	0.278	T	6.14	0.000	N	0.093	0.210	-0.934	0.435	T	0.000	0.000	T	.	.	.	-0.500	0.055	0.220	0.846	0.149	0.003	0.014	N	c	-1.616	-1.389	0.000	0.035	0.497	0.185	0	0.642	0.169	4.201	0.580	-0.213	0.100	1.000	0.715	0.015	0.124	5.799	0.175	.	ENSG00000162365.7|ENSG00000162365.7	Adipose_Subcutaneous|Nerve_Tibial	0.5	43	14	1	47611598	chr1:47611598	T	C	43	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	48231682	48231682	C	T	exonic	TRABD2B	.	synonymous SNV	TRABD2B:NM_001194986:exon7:c.G1446A:p.Q482Q	0.370916244	0.480003521	0.149080235	.	.	.	.	.	725.47613	5.34688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	85	1	48231682	chr1:48231682	C	T	70	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	49201967	49201967	T	-	exonic	BEND5	.	frameshift deletion	BEND5:NM_001349793:exon4:c.545delA:p.K182Rfs*14,BEND5:NM_001302082:exon5:c.545delA:p.K182Rfs*14,BEND5:NM_024603:exon5:c.1052delA:p.K351Rfs*14,BEND5:NM_001349794:exon6:c.545delA:p.K182Rfs*14,BEND5:NM_001349795:exon7:c.797delA:p.K266Rfs*14	0.114990689	0.857716612	0.027292699	.	0.62579	0.11262	-0.271755481	34.31823543	38.21221	1.13413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	51	1	49201966	chr1:49201966	CT	C	44	PASS	DP=51;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	50666911	50666911	G	A	UTR3	ELAVL4	NM_001324208:c.*61G>A;NM_001144777:c.*61G>A;NM_001144776:c.*61G>A;NM_001144775:c.*61G>A;NM_021952:c.*61G>A;NM_001324212:c.*61G>A;NM_001324209:c.*61G>A;NM_001144774:c.*61G>A;NM_001324214:c.*61G>A;NM_001324213:c.*61G>A;NM_001294348:c.*61G>A;NM_001324215:c.*61G>A	.	.	0.976912762	0.023064415	2.28E-05	.	0.68875	0.15149	-0.095386216	46.48502005	19.6708	0.67387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	1	50666911	chr1:50666911	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	52879584	52879584	A	G	exonic	PRPF38A	.	nonsynonymous SNV	PRPF38A:NM_032864:exon6:c.A643G:p.R215G	0.996467619	0.003532335	4.65E-08	.	0.0439	0.10543	-0.207437529	38.2814343	7.72909	0.28518	0.073	0.348	T	0.029	0.185	B	0.026	0.195	B	0.000	0.843	D	1.000	0.506	D	0.55	0.145	N	0.98	0.421	T	-1.36	0.338	N	0.541	0.579	-1.087	0.060	T	0.069	0.282	T	0.019	0.416	T	2.800	0.397	21.4	0.991	0.518	0.885	0.482	D	c	-0.427	-0.267	0.047	0.147	0.707	0.730	0	1.49	0.219	2.415	0.440	0.242	0.267	1.000	0.715	0.960	0.441	14.090	0.644	Pre-mRNA-splicing factor 38, C-terminal	.	.	0.5	93	148	1	52879584	chr1:52879584	A	G	93	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	53308644	53308644	A	C	exonic	ZYG11A	.	nonsynonymous SNV	ZYG11A:NM_001004339:exon1:c.A89C:p.Q30P	.	.	.	.	0.11936	.	0.837848571	88.22835574	323.85912	3.82518	0.006	0.614	D	0.911	0.484	P	0.461	0.446	P	0.199	0.166	U	1	0.810	D	2.095	0.583	M	0.89	0.456	T	-1.43	0.352	N	0.626	0.650	-1.062	0.114	T	0.091	0.348	T	0.041	0.598	D	5.178	0.699	25.5	0.991	0.531	0.671	0.331	D	c	0.116	0.130	1.000	0.747	0.564	0.319	0	4.03	0.459	1.125	0.307	0.939	0.529	1.000	0.715	0.987	0.523	9.272	0.367	.	.	.	0.5	.	65	1	53308644	chr1:53308644	A	C	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	53527948	53527948	T	G	exonic	PODN	.	synonymous SNV	PODN:NM_153703:exon1:c.T57G:p.P19P	5.20E-07	0.853425189	0.146574291	.	0.2183	0.10789	0.027580343	55.8091531	1753.94189	7.72811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	210	1	53527948	chr1:53527948	T	G	102	PASS	DP=210;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	54831116	54831116	G	A	intronic	SSBP3	.	.	.	0.999756196	0.000243804	3.40E-10	.	0.15537	0.08395	-0.648365105	16.35999056	29.52993	0.94347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	1	54831116	chr1:54831116	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	55129405	55129405	G	T	ncRNA_intronic	MROH7-TTC4	.	.	.	.	.	.	.	.	.	.	.	6.75121	0.24928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	1	55129405	chr1:55129405	G	T	.	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	55277556	55277556	G	A	exonic	LEXM	.	synonymous SNV	LEXM:NM_001110533:exon5:c.G570A:p.E190E,LEXM:NM_152607:exon5:c.G570A:p.E190E	.	.	.	.	0.07116	0.08588	1.798708763	96.91554612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	1	55277556	chr1:55277556	G	A	.	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	62175139	62175139	-	T	intronic	TM2D1	.	.	.	0.042061483	0.929476013	0.028462504	.	0.34406	0.09894	.	.	115.6404	2.33925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	91	1	62175139	chr1:62175139	A	AT	88	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	65693067	65693067	-	T	UTR3	AK4	NM_203464:c.*1207_*1208insT;NM_001005353:c.*1207_*1208insT;NM_013410:c.*1207_*1208insT;NM_001330616:c.*1207_*1208insT	.	.	0.236133361	0.731312413	0.032554226	.	0.41612	0.13186	-0.075159878	47.78839349	1542.50701	7.28675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	28	1	65693067	chr1:65693067	A	AT	40	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	67154855	67154881	CCACTCCTTTGGTTCCTTGCAGAAGTA	-	exonic	SGIP1	.	nonframeshift deletion	SGIP1:NM_001308203:exon13:c.743_769del:p.L251_P259del,SGIP1:NM_001350218:exon14:c.767_793del:p.L259_P267del,SGIP1:NM_001350217:exon16:c.1352_1378del:p.L454_P462del,SGIP1:NM_032291:exon16:c.1340_1366del:p.L450_P458del	0.999651093	0.000348907	6.74E-12	.	0.55441	0.08704	-1.083859071	7.195093182	3375.22155	11.12347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.48	22	1	67154854	chr1:67154854	GCCACTCCTTTGGTTCCTTGCAGAAGTA	G	11.48	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	68628198	68628198	A	G	ncRNA_intronic	GNG12-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	18	1	68628198	chr1:68628198	A	G	54	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	70385153	70385153	C	T	ncRNA_exonic	PIN1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	183	1	70385153	chr1:70385153	C	T	.	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	70504364	70504364	C	A	exonic	LRRC7	.	nonsynonymous SNV	LRRC7:NM_020794:exon19:c.C2743A:p.R915S,LRRC7:NM_001350216:exon21:c.C2860A:p.R954S,LRRC7:NM_001330635:exon22:c.C2758A:p.R920S	0.999998533	1.47E-06	1.10E-17	.	0.42578	0.12755	-1.368693559	4.482189196	157.64981	2.74333	0.046	0.506	D	0.312	0.311	B	0.14	0.321	B	0.005	0.334	N	0.981	0.403	D	0.695	0.181	N	1.24	0.367	T	-0.55	0.168	N	0.663	0.747	-1.089	0.057	T	0.045	0.195	T	0.008	0.217	T	2.963	0.416	22.1	0.993	0.596	0.925	0.555	D	c	-0.078	0.089	0.993	0.329	0.487	0.133	0	5.67	0.876	3.398	0.521	0.892	0.403	1.000	0.715	0.986	0.517	18.749	0.917	.	.	.	0.5	76	44	1	70504364	chr1:70504364	C	A	76	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	70877188	70877188	G	T	exonic	CTH	.	nonsynonymous SNV	CTH:NM_001190463:exon1:c.G90T:p.E30D,CTH:NM_001902:exon1:c.G90T:p.E30D,CTH:NM_153742:exon1:c.G90T:p.E30D	4.09E-05	0.955744395	0.044214725	DISEASE: Cystathioninuria (CSTNU) [MIM:219500]: Autosomal recessive phenotype characterized by abnormal accumulation of plasma cystathionine, leading to increased urinary excretion. {ECO:0000269|PubMed:12574942}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24604	.	0.194852702	67.03231894	1258.99689	6.6911	0.902	0.024	T	0.041	0.200	B	0.074	0.267	B	0.000	0.843	D	1	0.810	D	-0.66	0.021	N	-0.44	0.808	T	-1.54	0.389	N	0.299	0.369	-0.944	0.420	T	0.075	0.301	T	0.024	0.475	T	0.842	0.174	9.720	0.853	0.153	0.909	0.522	D	c	-0.780	-0.540	1.000	0.747	0.442	0.072	0	3.39	0.378	2.628	0.459	0.108	0.203	1.000	0.715	0.209	0.219	5.791	0.175	Pyridoxal phosphate-dependent transferase, major region, subdomain 1	.	.	0.5	81	194	1	70877188	chr1:70877188	G	T	81	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	71352072	71352072	C	-	intronic	PTGER3	.	.	.	0.787642829	0.210975836	0.001381335	.	0.32291	0.24187	0.128714042	63.19886766	53.0037	1.44545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	33	1	71352071	chr1:71352071	TC	T	88	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	74575212	74575212	-	T	exonic	LRRIQ3	.	frameshift insertion	LRRIQ3:NM_001105659:exon5:c.732dupA:p.Q245Tfs*6,LRRIQ3:NM_001322315:exon5:c.732dupA:p.Q245Tfs*6	3.22E-15	0.005170825	0.994829175	.	0.06919	.	1.379742765	94.60368011	1020.69778	6.14814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	25	1	74575212	chr1:74575212	G	GT	51	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	74901656	74901656	C	T	intronic	FPGT-TNNI3K;TNNI3K	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	1	74901656	chr1:74901656	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	75038228	75038228	A	C	exonic	ERICH3	.	nonsynonymous SNV	ERICH3:NM_001002912:exon14:c.T3166G:p.L1056V	.	.	.	.	0.15022	.	2.043117123	97.75300778	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-1.59	0.004	N	2.83	0.108	T	0.78	0.019	N	0.015	0.002	-0.900	0.480	T	0.003	0.010	T	.	.	.	-1.961	0.008	0.001	0.044	0.000	0.001	0.005	N	c	-1.321	-1.249	0.000	0.035	0.549	0.223	0	2.51	0.293	0.067	0.143	-0.095	0.117	0.000	0.063	0.014	0.122	7.414	0.260	.	.	.	0.5	101	20	1	75038228	chr1:75038228	A	C	101	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
1	78444691	78444691	T	C	UTR5	FUBP1	NM_003902:c.-3A>G;NM_001303433:c.-3A>G	.	.	0.999972831	2.72E-05	1.62E-12	.	0.60917	0.16996	-0.291981272	33.20358575	48.41037	1.35624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	46	1	78444691	chr1:78444691	T	C	63	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	83920300	83920300	-	C	ncRNA_intronic	LINC01712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	11	1	83920300	chr1:83920300	A	AC	42	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	84355735	84355748	AGAACTTCAAGGAT	-	intronic	TTLL7	.	.	.	0.268072469	0.731927454	7.64E-08	.	0.20746	0.09426	-0.754958418	13.57631517	77.26727	1.8459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	130	35	1	84355734	chr1:84355734	AAGAACTTCAAGGAT	A	130	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/1	./.
1	84956162	84956162	T	-	intronic	RPF1	.	.	.	9.48E-07	0.528911426	0.471087626	.	0.17412	0.10595	0.997633954	90.65227648	2647.98942	9.65398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	9	1	84956161	chr1:84956161	CT	C	42	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	85014531	85014531	G	A	exonic	SPATA1	.	nonsynonymous SNV	SPATA1:NM_001310156:exon11:c.G1075A:p.V359I	.	.	.	.	0.10403	0.10073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	1	85014531	chr1:85014531	G	A	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	86488534	86488534	A	T	exonic	COL24A1	.	synonymous SNV	COL24A1:NM_001349955:exon16:c.T30A:p.P10P,COL24A1:NM_152890:exon16:c.T2130A:p.P710P	1.06E-25	0.975699922	0.024300078	.	0.15994	0.11186	0.79541165	87.41448455	9574.81397	21.18138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	186	1	86488534	chr1:86488534	A	T	85	PASS	DP=186;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	86905932	86905932	C	A	exonic	CLCA2	.	nonsynonymous SNV	CLCA2:NM_006536:exon8:c.C1305A:p.S435R	1.91E-20	0.003028911	0.996971089	.	0.17798	0.15716	-0.036738982	50.53668318	3264.55081	10.90748	0.411	0.101	T	0.063	0.219	B	0.021	0.181	B	0.000	0.559	D	0.893	0.278	N	1.405	0.356	L	2.67	0.125	T	-0.4	0.138	N	0.23	0.282	-0.942	0.423	T	0.008	0.027	T	0.008	0.204	T	4.118	0.552	23.8	0.979	0.363	0.755	0.367	D	c	-0.375	-0.214	0.027	0.138	0.487	0.133	0	3.79	0.426	0.439	0.211	0.935	0.490	0.945	0.326	0.806	0.338	7.314	0.255	von Willebrand factor, type A	.	.	0.5	58	45	1	86905932	chr1:86905932	C	A	58	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	89448623	89448623	A	G	exonic	RBMXL1	.	nonsynonymous SNV	RBMXL1:NM_019610:exon2:c.T887C:p.L296P,RBMXL1:NM_001162536:exon3:c.T887C:p.L296P	0.119596956	0.87492457	0.005478474	.	0.20063	.	0.72761005	86.08162302	80.60629	1.89749	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.843	N	1	0.810	D	-2.25	0.001	N	-0.57	0.713	T	5.66	0.000	N	0.031	0.012	-0.930	0.441	T	0.018	0.077	T	.	.	.	0.656	0.157	8.539	0.812	0.131	0.042	0.096	N	c	-1.211	-0.979	0.999	0.384	0.707	0.730	0	0.914	0.184	5.108	0.642	-0.395	0.063	1.000	0.715	0.400	0.254	6.535	0.214	.	.	.	0.5	54	16	1	89448623	chr1:89448623	A	G	54	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	89655964	89655964	G	C	exonic	GBP4	.	nonsynonymous SNV	GBP4:NM_052941:exon7:c.C954G:p.I318M	1.42E-09	0.347776877	0.652223122	.	0.06048	.	1.758248793	96.72682236	364.12153	4.03932	0.0	0.912	D	0.996	0.670	D	0.969	0.703	D	0.000	0.843	D	1.000	0.090	N	4.12	0.975	H	3.47	0.052	T	-2.89	0.606	D	0.632	0.650	-1.019	0.241	T	0.043	0.183	T	0.003	0.075	T	3.396	0.466	23.0	0.994	0.632	0.829	0.417	D	c	0.407	0.180	0.932	0.270	0.707	0.730	0	3.41	0.380	3.533	0.531	0.966	0.591	1.000	0.715	0.003	0.074	5.015	0.136	Guanylate-binding protein, C-terminal	.	.	0.5	77	74	1	89655964	chr1:89655964	G	C	77	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	92457938	92457938	T	-	intronic	BRDT	.	.	.	2.47E-06	0.999058891	0.000938637	.	0.14403	0.30507	0.782621089	87.25524888	2880.26845	10.16474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	56	1	92457937	chr1:92457937	CT	C	51	PASS	DP=56;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	92475035	92475035	C	T	intronic	BRDT	.	.	.	2.47E-06	0.999058891	0.000938637	.	0.14403	0.30507	0.782621089	87.25524888	2880.26845	10.16474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	1	92475035	chr1:92475035	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	93646207	93646207	T	C	UTR5	TMED5	NM_016040:c.-408A>G;NM_001167830:c.-408A>G	.	.	0.002437131	0.775974615	0.221588254	.	0.24303	0.09726	0.082802743	60.09082331	5163.447	14.78411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	48	1	93646207	chr1:93646207	T	C	64	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	93704794	93704794	T	-	intronic	CCDC18	.	.	.	.	.	.	.	0.10485	0.09565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	22	1	93704793	chr1:93704793	CT	C	67	PASS	DP=22;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	94474328	94474328	T	C	exonic	ABCA4	.	synonymous SNV	ABCA4:NM_000350:exon41:c.A5814G:p.L1938L	1.27E-28	0.894718807	0.105281193	DISEASE: Fundus flavimaculatus (FFM) [MIM:248200]: Autosomal recessive retinal disorder very similar to Stargardt disease. In contrast to Stargardt disease, FFM is characterized by later onset and slowly progressive course. {ECO:0000269|PubMed:11379881, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:9781034}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:19028736, ECO:0000269|PubMed:9295268}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 3 (CORD3) [MIM:604116]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958761, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:11527935}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 19 (RP19) [MIM:601718]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP19 is characterized by choroidal atrophy. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09923	0.38763	0.736662821	86.30573248	3827.03692	12.16874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	12	1	94474328	chr1:94474328	T	C	43	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	94544157	94544157	T	C	exonic	ABCA4	.	nonsynonymous SNV	ABCA4:NM_000350:exon10:c.A1345G:p.N449D	1.27E-28	0.894718807	0.105281193	DISEASE: Fundus flavimaculatus (FFM) [MIM:248200]: Autosomal recessive retinal disorder very similar to Stargardt disease. In contrast to Stargardt disease, FFM is characterized by later onset and slowly progressive course. {ECO:0000269|PubMed:11379881, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:9781034}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:19028736, ECO:0000269|PubMed:9295268}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 3 (CORD3) [MIM:604116]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958761, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:11527935}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 19 (RP19) [MIM:601718]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP19 is characterized by choroidal atrophy. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09923	0.38763	0.736662821	86.30573248	3827.03692	12.16874	1.0	0.010	T	0.02	0.195	B	0.011	0.201	B	0.344	0.139	N	0.651	0.329	D	0.96	0.240	L	-1.92	0.848	D	-0.61	0.181	N	0.175	0.213	-1.056	0.127	T	0.125	0.430	T	0.057	0.668	D	0.650	0.156	8.499	0.634	0.070	0.867	0.457	D	c	-0.711	-0.536	0.780	0.238	0.554	0.283	0	0.265	0.148	0.472	0.217	0.961	0.567	0.996	0.391	1.000	0.888	5.991	0.186	.	.	.	0.5	.	80	1	94544157	chr1:94544157	T	C	.	PASS	DP=80;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	95332814	95332814	C	T	intronic	SLC44A3	.	.	.	1.82E-24	1.29E-05	0.999987063	.	0.10119	0.09355	-0.020150552	52.25288983	122.98894	2.41486	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	1	95332814	chr1:95332814	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	98186380	98186380	C	A	UTR3	DPYD	NM_001160301:c.*64G>T	.	.	4.19E-09	0.996985954	0.003014042	.	0.29965	0.38628	1.431149089	95.02241095	1997.46528	8.23273	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	1	98186380	chr1:98186380	C	A	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	99127459	99127459	T	C	exonic	SNX7	.	nonsynonymous SNV	SNX7:NM_015976:exon1:c.T172C:p.F58L,SNX7:NM_152238:exon1:c.T172C:p.F58L	0.028838862	0.960436827	0.010724311	.	0.29144	0.08752	0.018483465	55.44939844	558.45821	4.79951	0.069	0.355	T	0.956	0.527	P	0.899	0.620	P	.	.	.	1.000	0.810	D	1.795	0.474	L	2.23	0.299	T	-1.69	0.402	N	0.306	0.366	-1.103	0.038	T	0.049	0.209	T	0.113	0.793	D	3.390	0.466	23.0	0.993	0.571	0.609	0.311	D	c	-0.031	0.083	1.000	0.747	0.442	0.072	0	4.57	0.557	2.216	0.423	0.884	0.388	1.000	0.715	1.000	0.888	11.410	0.490	Phox homologous domain	.	.	0.5	101	124	1	99127459	chr1:99127459	T	C	101	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	100358035	100358035	C	G	exonic	AGL	.	stopgain	AGL:NM_000028:exon24:c.C3131G:p.S1044X,AGL:NM_000642:exon24:c.C3131G:p.S1044X,AGL:NM_000643:exon24:c.C3131G:p.S1044X,AGL:NM_000644:exon24:c.C3131G:p.S1044X,AGL:NM_000646:exon24:c.C3083G:p.S1028X	2.31E-15	0.999885179	0.000114821	DISEASE: Glycogen storage disease 3 (GSD3) [MIM:232400]: A metabolic disorder associated with an accumulation of abnormal glycogen with short outer chains. It is clinically characterized by hepatomegaly, hypoglycemia, short stature, and variable myopathy. Glycogen storage disease type 3 includes different forms: GSD type 3A patients lack glycogen debrancher enzyme activity in both liver and muscle, while GSD type 3B patients are enzyme-deficient in liver only. In rare cases, selective loss of only 1 of the 2 debranching activities, glucosidase or transferase, results in GSD type 3C or type 3D, respectively. {ECO:0000269|PubMed:10571954}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44349	0.24792	1.859295831	97.15734843	3139.05955	10.6731	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.699	0.993	43	0.996	0.729	0.984	0.823	D	c	1.117	0.954	1.000	0.747	0.732	0.924	0	5.2	0.716	7.280	0.778	0.883	0.387	1.000	0.715	0.954	0.431	19.102	0.932	.	.	.	0.5	101	79	1	100358035	chr1:100358035	C	G	101	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	100671699	100671699	G	-	intronic	DBT	.	.	.	0.000147622	0.964498843	0.035353535	DISEASE: Note=Patients with primary biliary cirrhosis (PBC) show autoantibodies against the E2 component of branched-chain alpha- keto acid dehydrogenase complex. PBC is a chronic, progressive cholestatic liver disease characterized by the presence of antimitochondrial autoantibodies in patients serum. It manifests with inflammatory obliteration of intra-hepatic bile duct, leading to liver cell damage and cirrhosis. {ECO:0000269|PubMed:2908870, ECO:0000269|PubMed:7543435, ECO:0000269|PubMed:9141421}.; DISEASE: Maple syrup urine disease 2 (MSUD2) [MIM:248600]: A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated. {ECO:0000269|PubMed:1847055, ECO:0000269|PubMed:9621512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.39075	0.32097	0.817616644	87.95116773	173.95713	2.87132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	18	1	100671698	chr1:100671698	AG	A	58	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	101487364	101487364	G	A	intronic	DPH5	.	.	.	0.001899435	0.904856554	0.093244011	.	0.5481	0.10207	0.3032669	72.009908	87.8002	2.00115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	1	101487364	chr1:101487364	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	103354985	103354985	A	-	intronic	COL11A1	.	.	.	0.999980608	1.94E-05	6.79E-22	DISEASE: Stickler syndrome 2 (STL2) [MIM:604841]: An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:8872475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall syndrome (MRSHS) [MIM:154780]: An autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. {ECO:0000269|PubMed:10486316}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 1 (FBCG1) [MIM:228520]: A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. {ECO:0000269|PubMed:21035103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35429	0.34658	-0.360177779	28.64472753	7076.86232	18.07025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	63	1	103354984	chr1:103354984	GA	G	42	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	103355033	103355033	G	A	exonic	COL11A1	.	nonsynonymous SNV	COL11A1:NM_080630:exon57:c.C4094T:p.S1365F,COL11A1:NM_001190709:exon58:c.C4325T:p.S1442F,COL11A1:NM_001854:exon59:c.C4442T:p.S1481F,COL11A1:NM_080629:exon59:c.C4478T:p.S1493F	0.999980608	1.94E-05	6.79E-22	DISEASE: Stickler syndrome 2 (STL2) [MIM:604841]: An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:8872475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall syndrome (MRSHS) [MIM:154780]: An autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. {ECO:0000269|PubMed:10486316}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 1 (FBCG1) [MIM:228520]: A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. {ECO:0000269|PubMed:21035103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35429	0.34658	-0.360177779	28.64472753	7076.86232	18.07025	0.11	0.295	T	0.036	0.337	B	0.047	0.363	B	0.002	0.367	N	0.999	0.466	D	1.09	0.274	L	-3.22	0.934	D	-2.94	0.640	D	0.376	0.437	-0.051	0.812	T	0.494	0.808	T	0.069	0.708	D	2.773	0.394	21.2	0.979	0.365	0.983	0.814	D	c	0.080	0.274	0.994	0.336	0.706	0.609	0	5.46	0.799	6.902	0.753	1.048	0.713	1.000	0.715	0.992	0.562	13.591	0.613	.	.	.	0.5	39	58	1	103355033	chr1:103355033	G	A	39	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	103355050	103355050	G	A	exonic	COL11A1	.	synonymous SNV	COL11A1:NM_080630:exon57:c.C4077T:p.L1359L,COL11A1:NM_001190709:exon58:c.C4308T:p.L1436L,COL11A1:NM_001854:exon59:c.C4425T:p.L1475L,COL11A1:NM_080629:exon59:c.C4461T:p.L1487L	0.999980608	1.94E-05	6.79E-22	DISEASE: Stickler syndrome 2 (STL2) [MIM:604841]: An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:8872475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall syndrome (MRSHS) [MIM:154780]: An autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. {ECO:0000269|PubMed:10486316}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 1 (FBCG1) [MIM:228520]: A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. {ECO:0000269|PubMed:21035103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35429	0.34658	-0.360177779	28.64472753	7076.86232	18.07025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	1	103355050	chr1:103355050	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	103404616	103404616	C	A	exonic	COL11A1	.	nonsynonymous SNV	COL11A1:NM_080630:exon42:c.G3065T:p.G1022V,COL11A1:NM_001190709:exon43:c.G3296T:p.G1099V,COL11A1:NM_001854:exon44:c.G3413T:p.G1138V,COL11A1:NM_080629:exon44:c.G3449T:p.G1150V	0.999980608	1.94E-05	6.79E-22	DISEASE: Stickler syndrome 2 (STL2) [MIM:604841]: An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:8872475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall syndrome (MRSHS) [MIM:154780]: An autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. {ECO:0000269|PubMed:10486316}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 1 (FBCG1) [MIM:228520]: A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. {ECO:0000269|PubMed:21035103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35429	0.34658	-0.360177779	28.64472753	7076.86232	18.07025	0.014	0.531	D	1.0	0.899	D	0.998	0.971	D	0.000	0.843	D	1	0.810	D	4.18	0.978	H	-6.29	0.996	D	-7.76	0.971	D	0.981	0.993	0.951	0.964	D	0.993	0.998	D	0.858	0.989	D	5.614	0.765	26.6	0.991	0.516	0.993	0.940	D	c	1.040	0.934	1.000	0.747	0.706	0.609	0	5.28	0.740	7.689	0.833	0.892	0.403	1.000	0.715	0.979	0.486	19.269	0.940	.	.	.	0.5	.	42	1	103404616	chr1:103404616	C	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	104203042	104203042	C	T	exonic	AMY1A;AMY1B;AMY1C	.	synonymous SNV	AMY1B:NM_001008218:exon7:c.C939T:p.N313N,AMY1C:NM_001008219:exon7:c.C939T:p.N313N,AMY1A:NM_001008221:exon7:c.C939T:p.N313N,AMY1C:NM_001346780:exon7:c.C939T:p.N313N,AMY1A:NM_004038:exon7:c.C939T:p.N313N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	400	1	104203042	chr1:104203042	C	T	127	PASS	DP=400;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	108878690	108878690	C	T	intergenic	NBPF4;NBPF6	dist=91987;dist=114214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	1	108878690	chr1:108878690	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	109812064	109812064	C	G	exonic	CELSR2	.	nonsynonymous SNV	CELSR2:NM_001408:exon21:c.C6831G:p.I2277M	0.9999992	8.00E-07	3.48E-23	.	0.2169	0.14994	-1.813160269	2.176220807	1933.01574	8.0888	0.011	0.555	D	0.589	0.371	P	0.766	0.548	P	.	.	.	0.990	0.242	N	1.585	0.400	L	2.75	0.116	T	-1.78	0.420	N	0.098	0.100	-0.966	0.381	T	0.017	0.071	T	0.010	0.256	T	4.255	0.570	23.9	0.992	0.542	0.490	0.281	N	c	-0.127	-0.138	0.997	0.352	0.696	0.567	0	2.5	0.292	0.461	0.215	0.935	0.490	0.994	0.380	0.998	0.697	7.066	0.242	GAIN domain, N-terminal	.	.	0.5	76	102	1	109812064	chr1:109812064	C	G	76	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	109816029	109816029	G	A	intronic	CELSR2	.	.	.	0.9999992	8.00E-07	3.48E-23	.	0.2169	0.14994	-1.813160269	2.176220807	1933.01574	8.0888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	148	1	109816029	chr1:109816029	G	A	.	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	110129282	110129282	G	T	intronic	GNAI3	.	.	.	0.038811278	0.954295997	0.006892725	DISEASE: Auriculocondylar syndrome 1 (ARCND1) [MIM:602483]: An autosomal dominant craniofacial malformation syndrome characterized by variable mandibular anomalies, including mild to severe micrognathia, temporomandibular joint ankylosis, cleft palate, and a characteristic ear malformation that consists of separation of the lobule from the external ear, giving the appearance of a question mark (question-mark ear). Other frequently described features include prominent cheeks, cupped and posteriorly rotated ears, preauricular tags, and microstomia. {ECO:0000269|PubMed:22560091}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6315	0.15588	-0.251530012	35.42108988	23.17555	0.77382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	198	1	110129282	chr1:110129282	G	T	113	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	110173005	110173005	C	T	exonic	AMPD2	.	nonsynonymous SNV	AMPD2:NM_203404:exon14:c.C1939T:p.P647S,AMPD2:NM_001308170:exon15:c.C2071T:p.P691S,AMPD2:NM_001257361:exon16:c.C1942T:p.P648S,AMPD2:NM_004037:exon16:c.C2296T:p.P766S,AMPD2:NM_139156:exon16:c.C2053T:p.P685S,AMPD2:NM_001257360:exon17:c.C2296T:p.P766S	0.008542497	0.991346093	0.00011141	DISEASE: Spastic paraplegia 63, autosomal recessive (SPG63) [MIM:615686]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:24482476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23763	0.21683	-1.462333834	3.786270347	1844.00657	7.9205	0.0	0.912	D	1.0	0.899	D	0.999	0.971	D	0.000	0.843	D	1	0.810	D	3.905	0.962	H	-4.51	0.977	D	-6.6	0.956	D	0.73	0.933	0.459	0.900	D	0.587	0.852	D	0.612	0.966	D	6.600	0.907	31	0.999	0.986	0.926	0.558	D	c	0.629	0.609	1.000	0.747	0.752	0.988	0	4.65	0.575	7.855	0.852	0.934	0.450	1.000	0.715	0.998	0.697	17.320	0.871	Adenosine/AMP deaminase domain|Metal-dependent hydrolase	.	.	0.5	.	82	1	110173005	chr1:110173005	C	T	.	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	110257506	110257506	G	C	intronic	GSTM5	.	.	.	0.000214167	0.736990281	0.262795552	.	0.04393	.	0.905808022	89.4373673	506.91274	4.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	82	1	110257506	chr1:110257506	G	C	.	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	110257814	110257814	G	C	exonic	GSTM5	.	nonsynonymous SNV	GSTM5:NM_000851:exon7:c.G519C:p.K173N	0.000214167	0.736990281	0.262795552	.	0.04393	.	0.905808022	89.4373673	506.91274	4.62021	0.145	0.313	T	0.0	0.067	B	0.012	0.149	B	0.047	0.233	U	1.000	0.194	N	2.685	0.788	M	4.55	0.020	T	-2.05	0.545	N	0.052	0.111	-0.943	0.421	T	0.003	0.011	T	.	.	.	-0.413	0.061	0.360	0.849	0.150	0.111	0.162	N	c	-0.989	-1.078	0.003	0.095	0.615	0.372	0	-0.563	0.111	0.400	0.205	-2.819	0.002	0.219	0.243	0.000	0.016	4.434	0.109	Glutathione S-transferase, C-terminal|Glutathione S-transferase, C-terminal-like	.	.	0.5	67	94	1	110257814	chr1:110257814	G	C	67	PASS	DP=94;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	111026677	111026677	C	A	ncRNA_intronic	CYMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	283	1	111026677	chr1:111026677	C	A	108	PASS	DP=283;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	111896013	111896013	C	T	downstream	PIFO	dist=374	.	.	7.55E-05	0.513249739	0.486674787	.	0.05344	.	0.3032669	72.009908	286.96298	3.62929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	22	1	111896013	chr1:111896013	C	T	50	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	112303170	112303170	G	A	exonic	DDX20	.	nonsynonymous SNV	DDX20:NM_007204:exon4:c.G640A:p.D214N	4.19E-07	0.819148759	0.180850822	.	0.1837	0.27351	1.734373503	96.61476763	3458.89491	11.30256	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.42	0.987	H	3.19	0.074	T	-4.76	0.803	D	0.291	0.353	-0.395	0.722	T	0.144	0.467	T	0.118	0.799	D	6.625	0.909	32	0.999	0.993	0.994	0.960	D	c	1.153	1.040	1.000	0.747	0.722	0.854	0	5.49	0.809	9.459	0.968	0.902	0.416	1.000	0.715	1.000	0.888	18.956	0.926	ATP-dependent RNA helicase DEAD-box, conserved site|DEAD/DEAH box helicase domain|Helicase superfamily 1/2, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	22	1	112303170	chr1:112303170	G	A	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	112998640	112998640	A	C	exonic	CTTNBP2NL	.	nonsynonymous SNV	CTTNBP2NL:NM_018704:exon6:c.A526C:p.K176Q	0.141381252	0.854550662	0.004068086	.	0.23525	0.10978	-0.067881249	48.69072895	134.44599	2.52148	0.103	0.301	T	0.999	0.764	D	0.985	0.749	D	0.000	0.843	D	1	0.810	D	1.925	0.515	L	0.52	0.553	T	-3.33	0.662	D	0.641	0.657	-0.644	0.630	T	0.237	0.605	T	0.015	0.350	T	4.243	0.568	23.9	0.994	0.624	0.987	0.856	D	c	0.766	0.781	1.000	0.747	0.707	0.730	0	6.07	0.987	7.130	0.767	1.199	0.960	1.000	0.715	1.000	0.888	16.290	0.825	Cortactin-binding protein-2, N-terminal	.	.	0.5	128	93	1	112998640	chr1:112998640	A	C	128	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	114025434	114025434	-	T	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	370	1	114025434	chr1:114025434	C	CT	99	PASS	DP=370;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
1	114524905	114524905	C	G	downstream	OLFML3	dist=29	.	.	0.000588287	0.899372738	0.100038975	.	0.66863	0.10981	0.064394823	58.84642604	80.4714	1.89543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	71	1	114524905	chr1:114524905	C	G	110	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	115399860	115399861	TT	-	exonic	SYCP1	.	frameshift deletion	SYCP1:NM_001282541:exon4:c.201_202del:p.L68Tfs*3,SYCP1:NM_001282542:exon4:c.201_202del:p.L68Tfs*3,SYCP1:NM_003176:exon4:c.201_202del:p.L68Tfs*3	0.949997702	0.050002296	2.17E-09	.	0.08531	.	0.246221394	69.56829441	212.38101	3.14424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	41	1	115399859	chr1:115399859	CTT	C	62	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	116202162	116202162	A	G	intronic	VANGL1	.	.	.	0.533615186	0.465704188	0.000680626	DISEASE: Sacral defect with anterior meningocele (SDAM) [MIM:600145]: Form of caudal dysgenesis. It is present at birth and becomes symptomatic later in life, usually because of obstructive labor in females, chronic constipation, or meningitis. Inheritance is autosomal dominant. {ECO:0000269|PubMed:17409324}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1456	0.12678	-0.242430445	36.22906346	1019.35056	6.14174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	37	1	116202162	chr1:116202162	A	G	66	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	117078514	117078514	A	C	intronic	CD58	.	.	.	0.299199171	0.681299599	0.019501229	.	0.16155	0.20638	0.61555716	83.13871196	82.3264	1.92612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	52	1	117078514	chr1:117078514	A	C	56	PASS	DP=52;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	117078556	117078556	G	A	intronic	CD58	.	.	.	0.299199171	0.681299599	0.019501229	.	0.16155	0.20638	0.61555716	83.13871196	82.3264	1.92612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	1	117078556	chr1:117078556	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	117078597	117078597	G	A	exonic	CD58	.	synonymous SNV	CD58:NM_001144822:exon3:c.C618T:p.I206I,CD58:NM_001779:exon3:c.C618T:p.I206I	0.299199171	0.681299599	0.019501229	.	0.16155	0.20638	0.61555716	83.13871196	82.3264	1.92612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	1	117078597	chr1:117078597	G	A	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	118166754	118166754	G	A	UTR3	FAM46C	NM_017709:c.*88G>A	.	.	0.523539098	0.459890812	0.01657009	.	0.56632	0.11049	-0.113792788	45.25831564	50.1058	1.38975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	1	118166754	chr1:118166754	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	120612041	120612046	CCGCCG	-	UTR5	NOTCH2	NM_024408:c.-21_-26delCGGCGG;NM_001200001:c.-21_-26delCGGCGG	.	.	0.999999993	6.75E-09	4.50E-24	DISEASE: Alagille syndrome 2 (ALGS2) [MIM:610205]: A form of Alagille syndrome, an autosomal dominant multisystem disorder. It is clinically defined by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems. {ECO:0000269|PubMed:16773578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hajdu-Cheney syndrome (HJCYS) [MIM:102500]: A rare skeletal disorder characterized by the association of facial anomalies, acro-osteolysis, general osteoporosis, insufficient ossification of the skull, and periodontal disease (premature loss of permanent teeth). Other features include cleft palate, congenital heart defects, polycystic kidneys, orthopedic problems and anomalies of the genitalia, intestines and eyes. {ECO:0000269|PubMed:21378985, ECO:0000269|PubMed:21378989}. Note=The disease is caused by mutations affecting the gene represented in this entry. NOTCH2 mutations associated with Hajdu- Cheney syndrome cluster to the last coding exon of the gene. This suggests that the mutant mRNA products may escape nonsense- mediated decay and the resulting truncated NOTCH2 proteins act in a gain-of-function manner.; 	0.95316	0.43816	-1.819260363	2.14673272	449.73773	4.40739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	56	1	120612040	chr1:120612040	TCCGCCG	T,TCCG	41	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	120612044	120612046	CCG	-	UTR5	NOTCH2	NM_024408:c.-24_-26delCGG;NM_001200001:c.-24_-26delCGG	.	.	0.999999993	6.75E-09	4.50E-24	DISEASE: Alagille syndrome 2 (ALGS2) [MIM:610205]: A form of Alagille syndrome, an autosomal dominant multisystem disorder. It is clinically defined by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems. {ECO:0000269|PubMed:16773578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hajdu-Cheney syndrome (HJCYS) [MIM:102500]: A rare skeletal disorder characterized by the association of facial anomalies, acro-osteolysis, general osteoporosis, insufficient ossification of the skull, and periodontal disease (premature loss of permanent teeth). Other features include cleft palate, congenital heart defects, polycystic kidneys, orthopedic problems and anomalies of the genitalia, intestines and eyes. {ECO:0000269|PubMed:21378985, ECO:0000269|PubMed:21378989}. Note=The disease is caused by mutations affecting the gene represented in this entry. NOTCH2 mutations associated with Hajdu- Cheney syndrome cluster to the last coding exon of the gene. This suggests that the mutant mRNA products may escape nonsense- mediated decay and the resulting truncated NOTCH2 proteins act in a gain-of-function manner.; 	0.95316	0.43816	-1.819260363	2.14673272	449.73773	4.40739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	56	1	120612040	chr1:120612040	TCCGCCG	T,TCCG	41	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	121103631	121103631	-	T	ncRNA_exonic	SRGAP2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	291	1	121103631	chr1:121103631	C	CT	106	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	142825055	142825055	C	A	intergenic	ANKRD20A12P;LOC102723769	dist=111450;dist=309548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	1016	1	142825055	chr1:142825055	C	A	165	PASS	DP=1016;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	143195951	143195951	G	T	ncRNA_intronic	LOC102723769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	1	143195951	chr1:143195951	G	T	.	PASS	DP=85;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	143210293	143210293	T	C	intergenic	LOC102723769;MIR6077	dist=8054;dist=462628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	115	1	143210293	chr1:143210293	T	C	138	PASS	DP=115;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	143237559	143237559	C	T	intergenic	LOC102723769;MIR6077	dist=35320;dist=435362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	127	1	143237559	chr1:143237559	C	T	109	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	143237562	143237562	T	A	intergenic	LOC102723769;MIR6077	dist=35323;dist=435359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	126	1	143237562	chr1:143237562	T	A	107	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	143239358	143239358	C	T	intergenic	LOC102723769;MIR6077	dist=37119;dist=433563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	213	1	143239358	chr1:143239358	C	T	130	PASS	DP=213;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	143378854	143378854	G	A	intergenic	LOC102723769;MIR6077	dist=176615;dist=294067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	174	463	1	143378854	chr1:143378854	G	A	174	PASS	DP=463;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	143391793	143391793	G	T	intergenic	LOC102723769;MIR6077	dist=189554;dist=281128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	1585	1	143391793	chr1:143391793	G	T	124	PASS	DP=1585;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	143392481	143392481	C	A	intergenic	LOC102723769;MIR6077	dist=190242;dist=280440	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	672	1	143392481	chr1:143392481	C	A	155	PASS	DP=672;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	143400876	143400876	C	A	intergenic	LOC102723769;MIR6077	dist=198637;dist=272045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	269	1	143400876	chr1:143400876	C	A	114	PASS	DP=269;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	144811965	144811965	C	G	intronic	NBPF19;NBPF20;NBPF8;NBPF9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	338	1	144811965	chr1:144811965	C	G	104	PASS	DP=338;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	144813824	144813824	G	C	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	411	1	144813824	chr1:144813824	G	C	130	PASS	DP=411;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	144828556	144828556	G	C	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	176	1	144828556	chr1:144828556	G	C	130	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	144854698	144854698	C	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	205	1	144854698	chr1:144854698	C	A	.	PASS	DP=205;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	130	731	1	144856817	chr1:144856817	T	C	130	PASS	DP=731;AN=6	GT	0/1	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.
1	144879592	144879592	A	T	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	175	1	144879592	chr1:144879592	A	T	119	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	144994902	144994902	G	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	148	1	144994902	chr1:144994902	G	A	112	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	145074975	145074975	G	A	intronic	NBPF19;NBPF20;NBPF9;PDE4DIP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	138	1	145074975	chr1:145074975	G	A	99	PASS	DP=138;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	145281613	145281613	C	A	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.C543A:p.S181R	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	0.879	0.571	P	0.55	0.621	P	.	.	.	0.999	0.212	N	0.475	0.132	N	1.16	0.381	T	.	.	.	0.366	0.427	-1.068	0.099	T	0.055	0.233	T	.	.	.	3.420	0.469	23.0	0.990	0.502	0.417	0.265	N	c	-0.438	-0.609	1.000	0.747	0.675	0.547	0	0.902	0.183	-0.466	0.067	0.622	0.289	0.000	0.063	0.679	0.305	6.588	0.217	.	.	.	0.5	89	86	1	145281613	chr1:145281613	C	A	89	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	145281633	145281633	C	A	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.C563A:p.P188H	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	0.998	0.899	D	0.912	0.701	D	.	.	.	0.910	0.364	D	2.59	0.760	M	2.86	0.105	T	.	.	.	0.513	0.556	-1.112	0.029	T	0.051	0.217	T	.	.	.	5.957	0.818	27.7	0.995	0.677	0.969	0.712	D	c	0.519	0.389	1.0	0.983	0.675	0.547	0	2.87	0.324	7.735	0.838	0.622	0.289	1.000	0.715	0.990	0.544	11.536	0.497	EGF-like domain	.	.	0.5	85	85	1	145281633	chr1:145281633	C	A	85	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	145281656	145281656	A	T	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.A586T:p.T196S	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	0.998	0.764	D	0.987	0.759	D	.	.	.	0.985	0.247	N	1.315	0.329	L	-0.19	0.659	T	.	.	.	0.3	0.360	0.007	0.824	D	0.739	0.911	D	.	.	.	3.920	0.528	23.5	0.992	0.544	0.974	0.740	D	c	0.504	0.409	1.000	0.747	0.675	0.547	0	2.87	0.324	9.118	0.936	0.785	0.317	1.000	0.715	0.992	0.562	9.174	0.361	EGF-like domain	.	.	0.5	117	284	1	145281656	chr1:145281656	A	T	117	PASS	DP=284;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	145290398	145290398	G	A	ncRNA_intronic	NBPF25P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	270	1	145290398	chr1:145290398	G	A	131	PASS	DP=270;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	145542815	145542815	A	-	UTR3	ITGA10	NM_001303041:c.*537delA;NM_001303040:c.*537delA;NM_003637:c.*537delA	.	.	8.55E-11	0.999944355	5.56E-05	.	0.53865	0.16452	1.274975588	93.67185657	1717.62595	7.64081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	28	1	145542814	chr1:145542814	GA	G	42	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	146420082	146420082	T	G	exonic	NBPF12;NBPF20	.	nonsynonymous SNV	NBPF12:NM_001278141:exon25:c.T2730G:p.C910W,NBPF20:NM_001278267:exon100:c.T11052G:p.C3684W	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	P	2.015	0.552	M	.	.	.	.	.	.	0.229	0.317	-0.958	0.396	T	0.011	0.040	T	.	.	.	1.893	0.288	15.55	0.967	0.303	0.004	0.021	N	c	-0.773	-1.018	0.000	0.012	0.693	0.558	0	-1.04	0.095	0.049	0.139	0.458	0.278	0.001	0.137	0.003	0.074	3.410	0.069	Neuroblastoma breakpoint family (NBPF) domain	ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2|ENSG00000244371.2	Adipose_Subcutaneous|Artery_Tibial|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Lung|Nerve_Tibial|Pancreas|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid	0.5	84	116	1	146420082	chr1:146420082	T	G	84	PASS	DP=116;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	146420119	146420119	T	C	exonic	NBPF12;NBPF20	.	nonsynonymous SNV	NBPF12:NM_001278141:exon25:c.T2767C:p.S923P,NBPF20:NM_001278267:exon100:c.T11089C:p.S3697P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.001	0.002	T	.	.	.	.	.	.	.	.	c	-1.171	-1.403	0.000	0.012	0.693	0.558	0	-1.45	0.083	0.885	0.277	0.095	0.197	0.970	0.340	0.532	0.276	4.744	0.123	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	115	567	1	146420119	chr1:146420119	T	C	115	PASS	DP=567;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	146737572	146737572	-	T	intronic	CHD1L;NBPF19	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	121	1	146737572	chr1:146737572	A	AT	67	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	147091501	147091501	C	-	exonic	BCL9	.	frameshift deletion	BCL9:NM_004326:exon8:c.1540delC:p.P516Lfs*4	0.831846217	0.168152551	1.23E-06	.	0.80794	0.11906	-1.626115313	2.878037273	2074.08236	8.39078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	234	1	147091500	chr1:147091500	AC	A	69	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	148004649	148004649	C	G	exonic	NBPF26	.	nonsynonymous SNV	NBPF26:NM_001351372:exon30:c.G3910C:p.E1304Q	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	228	1	148004649	chr1:148004649	C	G	106	PASS	DP=228;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	148009507	148009507	C	T	intronic	NBPF19;NBPF26	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	120	1	148009507	chr1:148009507	C	T	96	PASS	DP=120;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	148252019	148252019	G	C	exonic	NBPF14;NBPF9	.	nonsynonymous SNV	NBPF9:NM_001277444:exon25:c.C3192G:p.D1064E,NBPF14:NM_015383:exon66:c.C8316G:p.D2772E	.	.	.	.	.	.	.	.	.	.	.	.	.	0.795	0.520	P	0.739	0.573	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.164	0.198	-1.067	0.100	T	0.022	0.094	T	0.001	0.014	T	2.112	0.315	16.93	0.973	0.330	0.006	0.026	N	c	-0.547	-0.839	0.023	0.135	0.706	0.609	0	0.109	0.138	0.337	0.194	0.494	0.279	0.001	0.137	0.001	0.043	.	.	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	74	107	1	148252019	chr1:148252019	G	C	74	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	148890217	148890217	G	A	ncRNA_exonic	LOC101927429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	131	1	148890217	chr1:148890217	G	A	87	PASS	DP=131;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	149676264	149676264	T	C	ncRNA_intronic	LOC101929798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	979	1	149676264	chr1:149676264	T	C	130	PASS	DP=979;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	149784994	149784994	C	T	exonic	HIST2H3D	.	synonymous SNV	HIST2H3D:NM_001123375:exon1:c.G243A:p.T81T	0.49893728	0.427580174	0.073482546	.	.	.	0.035072054	56.2514744	6.52563	0.24176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	295	1	149784994	chr1:149784994	C	T	.	PASS	DP=295;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	149859345	149859345	G	A	exonic	HIST2H2AB	.	nonsynonymous SNV	HIST2H2AB:NM_175065:exon1:c.C122T:p.A41V	0.216215034	0.647861978	0.135922988	.	0.94267	0.1705	-0.119252484	44.53880632	2.43929	0.08861	0.0	0.912	D	1.0	0.899	D	0.981	0.736	D	0.000	0.629	D	1	0.810	D	4.095	0.974	H	-0.53	0.708	T	-3.31	0.659	D	0.515	0.558	0.359	0.885	D	0.583	0.850	D	0.049	0.636	D	3.844	0.519	23.4	0.994	0.649	0.910	0.524	D	c	0.944	0.841	1.0	0.983	0.025	0.001	3	5.27	0.737	6.768	0.746	1.036	0.656	1.000	0.715	0.985	0.512	12.482	0.550	Histone H2A/H2B/H3|Histone-fold	.	.	0.5	122	508	1	149859345	chr1:149859345	G	A	122	PASS	DP=508;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	150526044	150526044	G	C	exonic	ADAMTSL4	.	nonsynonymous SNV	ADAMTSL4:NM_001288607:exon6:c.G577C:p.A193P,ADAMTSL4:NM_001288608:exon6:c.G577C:p.A193P,ADAMTSL4:NM_019032:exon6:c.G577C:p.A193P,ADAMTSL4:NM_025008:exon6:c.G577C:p.A193P	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	0.703	0.076	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-0.205	0.041	N	0.23	0.631	T	1.43	0.011	N	0.012	0.003	-1.058	0.123	T	0.031	0.132	T	.	.	.	-1.198	0.025	0.007	0.673	0.081	0.006	0.026	N	c	-1.688	-1.744	1.000	0.747	0.660	0.495	0	-4.57	0.032	-1.171	0.032	-1.198	0.016	0.000	0.063	0.007	0.100	3.170	0.061	.	ENSG00000143452.11|ENSG00000259357.1|ENSG00000163131.6|ENSG00000259357.1|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143452.11|ENSG00000143369.10|ENSG00000259357.1|ENSG00000163131.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000237781.2|ENSG00000143382.9|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143457.6|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000259357.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Tibial|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Thyroid|Thyroid|Whole_Blood	0.5	174	195	1	150526044	chr1:150526044	G	C	174	PASS	DP=195;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	150526093	150526093	G	-	exonic	ADAMTSL4	.	frameshift deletion	ADAMTSL4:NM_001288607:exon6:c.626delG:p.S209Tfs*22,ADAMTSL4:NM_001288608:exon6:c.626delG:p.S209Tfs*22,ADAMTSL4:NM_019032:exon6:c.626delG:p.S209Tfs*22,ADAMTSL4:NM_025008:exon6:c.626delG:p.S209Tfs*22	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.09	174	1	150526092	chr1:150526092	AG	A	10.09	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	150530506	150530506	G	-	exonic	ADAMTSL4	.	frameshift deletion	ADAMTSL4:NM_019032:exon14:c.2263delG:p.G757Vfs*61,ADAMTSL4:NM_025008:exon14:c.2263delG:p.G757Vfs*61,ADAMTSL4:NM_001288607:exon15:c.2146delG:p.G718Vfs*61,ADAMTSL4:NM_001288608:exon15:c.2332delG:p.G780Vfs*61	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	1523	1	150530505	chr1:150530505	TG	T	99	PASS	DP=1523;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
1	150849068	150849068	-	C	UTR5	ARNT	NM_001668:c.-26_-25insG;NM_001350225:c.-18145_-18144insG;NM_001350224:c.-18135_-18134insG;NM_001350226:c.-18145_-18144insG;NM_001197325:c.-26_-25insG;NM_178427:c.-26_-25insG;NM_001286036:c.-26_-25insG;NM_001286035:c.-18135_-18134insG	.	.	0.976348195	0.023651796	8.24E-09	.	0.28663	0.22862	-0.534490515	20.70063694	99.66528	2.16216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	63	1	150849068	chr1:150849068	G	GC	60	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	151022895	151022895	-	T	intronic	C1orf56	.	.	.	0.001317284	0.650219074	0.348463642	.	0.07271	0.07189	0.327131069	73.27199811	200.14551	3.05763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	56	1	151022895	chr1:151022895	A	AT	53	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	151171498	151171498	C	G	exonic	PIP5K1A	.	nonsynonymous SNV	PIP5K1A:NM_001135636:exon1:c.C26G:p.S9W,PIP5K1A:NM_001135637:exon1:c.C26G:p.S9W,PIP5K1A:NM_001135638:exon1:c.C26G:p.S9W,PIP5K1A:NM_001330689:exon1:c.C26G:p.S9W,PIP5K1A:NM_003557:exon1:c.C26G:p.S9W	0.014586299	0.985162174	0.000251527	.	0.12043	0.12792	-0.514264485	21.41424864	69.18119	1.72333	0.003	0.784	D	0.969	0.571	D	0.57	0.480	P	0.575	0.055	U	0.981	0.398	D	0.69	0.170	N	1.58	0.346	T	-2.2	0.908	N	0.413	0.520	-1.067	0.100	T	0.070	0.286	T	0.030	0.527	D	4.247	0.569	23.9	0.855	0.154	0.741	0.360	D	c	0.235	0.221	1.000	0.747	0.442	0.072	0	4.59	0.561	3.318	0.514	0.935	0.490	1.000	0.715	0.165	0.209	12.781	0.567	.	.	.	0.5	126	488	1	151171498	chr1:151171498	C	G	126	PASS	DP=488;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	152128618	152128689	GTAGTGGGAACTCTGGCCTTGTCTGTCTGTCTGACCATAATGATAACTCTGGTCTTGTCTGTCCGTCTGACC	-	exonic	RPTN	.	nonframeshift deletion	RPTN:NM_001122965:exon3:c.886_957del:p.G296_Y319del	3.18E-18	0.004475026	0.995524974	.	0.09608	.	1.243805243	93.41825902	382.87927	4.1263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	393	1	152128617	chr1:152128617	TGTAGTGGGAACTCTGGCCTTGTCTGTCTGTCTGACCATAATGATAACTCTGGTCTTGTCTGTCCGTCTGACC	T	76	PASS	DP=393;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	152277345	152277345	C	T	exonic	FLG	.	synonymous SNV	FLG:NM_002016:exon3:c.G10017A:p.Q3339Q	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	193	1	152277345	chr1:152277345	C	T	94	PASS	DP=193;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	152800062	152800062	T	C	exonic	LCE1A	.	synonymous SNV	LCE1A:NM_178348:exon1:c.T114C:p.P38P	0.000409834	0.234194562	0.765395605	.	0.25431	.	0.03689118	56.64071715	25.22558	0.8248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	170	1	152800062	chr1:152800062	T	C	71	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	153516163	153516163	A	-	UTR3	S100A4	NM_019554:c.*72delT;NM_002961:c.*72delT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	741	1	153516162	chr1:153516162	GA	G,GAA	71	PASS	DP=741;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	153516163	153516163	-	A	UTR3	S100A4	NM_019554:c.*71_*72insT;NM_002961:c.*71_*72insT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	741	1	153516162	chr1:153516162	GA	G,GAA	71	PASS	DP=741;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	153897055	153897055	T	-	intergenic	GATAD2B;DENND4B	dist=1604;dist=4922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	459	1	153897054	chr1:153897054	AT	A,ATT	60	PASS	DP=459;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	153897055	153897055	-	T	intergenic	GATAD2B;DENND4B	dist=1604;dist=4922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	459	1	153897054	chr1:153897054	AT	A,ATT	60	PASS	DP=459;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	153920564	153920564	A	G	UTR3	CRTC2	NM_181715:c.*21T>C	.	.	0.996361791	0.003638199	1.01E-08	.	0.25674	0.23695	-0.690637458	15.12149092	1834.62554	7.89581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	51	1	153920564	chr1:153920564	A	G	118	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	154963016	154963016	G	C	intronic	FLAD1	.	.	.	0.091793511	0.906439743	0.001766745	.	0.11392	0.23178	-1.043396569	7.71408351	87.62766	1.99904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	26	1	154963016	chr1:154963016	G	C	42	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	155106615	155106615	G	A	UTR3	EFNA1	NM_004428:c.*72G>A;NM_182685:c.*72G>A	.	.	0.872063428	0.126248046	0.001688526	.	0.11427	0.20761	0.25917371	70.05779665	2215.21898	8.66769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	102	1	155106615	chr1:155106615	G	A	75	PASS	DP=102;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	155146419	155146419	G	-	UTR5	TRIM46	NM_001282378:c.-1998del-;NM_025058:c.-24del-;NM_001256600:c.-675del-;NM_001282379:c.-24del-;NM_001256599:c.-1449del-	.	.	0.998652125	0.00134787	4.43E-09	.	0.59864	0.14106	-0.843147538	11.2762444	131.25378	2.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	60	1	155146418	chr1:155146418	AG	A	42	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	155307999	155307999	-	T	exonic	ASH1L	.	frameshift insertion	ASH1L:NM_018489:exon27:c.8683dupA:p.T2895Nfs*3	1	1.66E-13	1.32E-34	.	0.35554	.	-1.798985783	2.223401746	588.79734	4.92053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	510	1	155307999	chr1:155307999	G	GT	82	PASS	DP=510;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	155402991	155402991	G	A	ncRNA_exonic	POU5F1P4	.	.	.	.	.	.	.	0.49402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	356	1	155402991	chr1:155402991	G	A	.	PASS	DP=356;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	155720557	155720557	T	-	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	315	1	155720556	chr1:155720556	CT	C,CTT	98	PASS	DP=315;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	155720557	155720557	-	T	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	315	1	155720556	chr1:155720556	CT	C,CTT	98	PASS	DP=315;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	155942022	155942022	C	T	intronic	ARHGEF2	.	.	.	0.999993235	6.76E-06	4.54E-16	.	0.22628	0.11124	-0.93133804	9.613116301	94.75814	2.09761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	296	1	155942022	chr1:155942022	C	T	.	PASS	DP=296;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	156012038	156012038	G	A	intronic	UBQLN4	.	.	.	0.99752242	0.002477484	9.67E-08	.	0.27058	0.13363	0.062575634	58.74026893	4087.61153	12.68896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	282	1	156012038	chr1:156012038	G	A	.	PASS	DP=282;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	156248057	156248057	T	C	intronic	SMG5	.	.	.	0.998179753	0.001820247	1.55E-11	.	0.2395	0.1262	-1.015898037	8.144609578	170.50384	2.84858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	45	1	156248057	chr1:156248057	T	C	51	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	156436092	156436092	-	A	UTR3	MEF2D	NM_001271629:c.*1344_*1345insT;NM_005920:c.*1344_*1345insT	.	.	0.998547093	0.00145288	2.63E-08	.	0.86578	0.19297	-0.624497208	17.16206653	24.10793	0.7919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	144	1	156436092	chr1:156436092	C	CA	68	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	156552913	156552913	G	T	exonic	TTC24	.	nonsynonymous SNV	TTC24:NM_001105669:exon3:c.G990T:p.K330N	6.58E-05	0.723355769	0.276578427	.	0.129	.	0.841481379	88.35810333	4269.00298	12.99213	0.172	0.226	T	0.837	0.444	P	0.233	0.367	B	0.918	0.085	N	1.000	0.090	N	0.405	0.124	N	-1.06	0.768	T	-0.88	0.238	N	0.142	0.166	-0.968	0.377	T	0.018	0.077	T	0.017	0.383	T	1.960	0.296	15.96	0.990	0.494	0.586	0.304	D	c	-0.398	-0.425	1.000	0.473	0.497	0.185	0	-0.371	0.118	0.577	0.233	-0.774	0.033	1.000	0.715	0.143	0.203	4.581	0.116	Tetratricopeptide repeat-containing domain|Tetratricopeptide-like helical domain	.	.	0.5	75	160	1	156552913	chr1:156552913	G	T	75	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	158368974	158368974	A	G	exonic	OR10T2	.	nonsynonymous SNV	OR10T2:NM_001004475:exon1:c.T283C:p.F95L	0.063110527	0.724960969	0.211928504	.	0.16058	.	2.065168262	97.79429111	5428.19223	15.19737	0.715	0.040	T	0.092	0.237	B	0.05	0.239	B	0.001	0.402	U	1	0.090	P	0.81	0.209	L	6.66	0.005	T	-1.04	0.273	N	0.205	0.251	-0.826	0.536	T	0.001	0.002	T	.	.	.	-0.983	0.033	0.017	0.403	0.028	0.128	0.173	N	c	-0.690	-0.677	0.997	0.348	0.487	0.133	0	4.56	0.555	0.920	0.281	1.006	0.624	0.009	0.180	0.466	0.265	13.035	0.581	GPCR, rhodopsin-like, 7TM	.	.	0.5	42	6	1	158368974	chr1:158368974	A	G	42	PASS	DP=6;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
1	158637829	158637829	C	T	exonic	SPTA1	.	synonymous SNV	SPTA1:NM_003126:exon15:c.G1857A:p.R619R	5.85E-05	0.99994147	3.90E-16	DISEASE: Elliptocytosis 2 (EL2) [MIM:130600]: A Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:1541680, ECO:0000269|PubMed:1638030, ECO:0000269|PubMed:1679439, ECO:0000269|PubMed:1878597, ECO:0000269|PubMed:2384601, ECO:0000269|PubMed:2568861, ECO:0000269|PubMed:2568862, ECO:0000269|PubMed:2794061, ECO:0000269|PubMed:7772539, ECO:0000269|PubMed:8018926, ECO:0000269|PubMed:8193371, ECO:0000269|PubMed:8364215}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary pyropoikilocytosis (HPP) [MIM:266140]: Autosomal recessive hematologic disorder characterized by hemolytic anemia, microspherocytosis, poikilocytosis, and an unusual thermal sensitivity of red cells. {ECO:0000269|PubMed:1878597}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 3 (SPH3) [MIM:270970]: Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. SPH3 is characterized by severe hemolytic anemia. Inheritance is autosomal recessive. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20565	0.08686	4.849637631	99.79358339	7837.04606	19.05718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	1	158637829	chr1:158637829	C	T	.	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	159032487	159032487	T	-	exonic	AIM2	.	frameshift deletion	AIM2:NM_001348247:exon5:c.712delA:p.T238delinsHREVKRTNSSQLV,AIM2:NM_004833:exon6:c.1027delA:p.T343delinsHREVKRTNSSQLV	9.01E-08	0.089843818	0.910156092	.	0.0693	0.09293	0.038710339	56.92380278	212.89479	3.1502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	217	1	159032486	chr1:159032486	GT	G,GTT	82	PASS	DP=217;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/2	./.
1	159032487	159032487	-	T	exonic	AIM2	.	frameshift insertion	AIM2:NM_001348247:exon5:c.711dupA:p.T238delinsNIEK,AIM2:NM_004833:exon6:c.1026dupA:p.T343delinsNIEK	9.01E-08	0.089843818	0.910156092	.	0.0693	0.09293	0.038710339	56.92380278	212.89479	3.1502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	217	1	159032486	chr1:159032486	GT	G,GTT	82	PASS	DP=217;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/2	./.
1	160109408	160109408	-	C	intronic	ATP1A2	.	.	.	0.600219587	0.399780278	1.34E-07	DISEASE: Migraine, familial hemiplegic, 2 (FHM2) [MIM:602481]: A subtype of migraine with aura associated with hemiparesis in some families. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. Migraine with aura is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking. {ECO:0000269|PubMed:12539047, ECO:0000269|PubMed:12953268, ECO:0000269|PubMed:21352219, ECO:0000269|PubMed:23838748, ECO:0000269|PubMed:23918834}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alternating hemiplegia of childhood 1 (AHC1) [MIM:104290]: A rare syndrome of episodic hemi- or quadriplegia lasting minutes to days. Most cases are accompanied by dystonic posturing, choreoathetoid movements, nystagmus, other ocular motor abnormalities, autonomic disturbances, and progressive cognitive impairment. It is typically distinguished from familial hemiplegic migraine by infantile onset and high prevalence of associated neurological deficits that become increasingly obvious with age. {ECO:0000269|PubMed:15174025}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53654	0.22867	-1.374132436	4.429110639	48.50463	1.35867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	66	1	160109408	chr1:160109408	A	AC	43	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	161102192	161102192	C	T	UTR5	DEDD	NM_001039712:c.-7940G>A	.	.	0.86950321	0.130127431	0.00036936	.	0.4811	0.13398	-0.05129383	49.75819769	50.2724	1.39373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	80	1	161102192	chr1:161102192	C	T	.	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	161580116	161580116	G	T	intergenic	HSPA7;FCGR3B	dist=1775;dist=12872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	198	1	161580116	chr1:161580116	G	T	79	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	161595981	161595981	C	T	exonic	FCGR3B	.	synonymous SNV	FCGR3B:NM_001244753:exon4:c.G639A:p.G213G,FCGR3B:NM_001271035:exon4:c.G636A:p.G212G,FCGR3B:NM_001271036:exon4:c.G480A:p.G160G,FCGR3B:NM_000570:exon5:c.G531A:p.G177G	3.30E-05	0.35412722	0.645839759	.	0.00848	0.09063	-0.115612493	45.12856806	161.44959	2.77603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	133	1	161595981	chr1:161595981	C	T	.	PASS	DP=133;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	162729685	162729685	G	T	exonic	DDR2	.	synonymous SNV	DDR2:NM_006182:exon8:c.G771T:p.V257V,DDR2:NM_001014796:exon9:c.G771T:p.V257V	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	1	162729685	chr1:162729685	G	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	162748361	162748361	C	T	intronic	DDR2	.	.	.	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	47	1	162748361	chr1:162748361	C	T	71	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	162773396	162773396	G	A	intronic	HSD17B7	.	.	.	0.001754508	0.896172411	0.102073081	.	.	.	0.016664174	55.21939137	643.08042	5.09426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	91	1	162773396	chr1:162773396	G	A	71	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	164326647	164326647	G	A	intergenic	LOC100422212;PBX1	dist=933666;dist=201950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	82	1	164326647	chr1:164326647	G	A	79	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	165721440	165721440	-	A	intronic	TMCO1	.	.	.	9.55E-07	0.530626517	0.469372527	.	0.21693	0.11262	0.057118534	57.99716914	266.50685	3.50211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	289	1	165721440	chr1:165721440	T	TA	91	PASS	DP=289;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	167190252	167190252	C	-	intronic	POU2F1	.	.	.	0.913950638	0.086048322	1.04E-06	.	0.97789	0.41629	-0.334253673	30.70299599	100.87731	2.1746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	77	1	167190251	chr1:167190251	GC	G	57	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	167893778	167893778	-	A	intronic	MPC2	.	.	.	0.449429467	0.522427122	0.028143411	.	0.22019	0.09609	0.501689326	79.7888653	143.21224	2.60927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	386	1	167893778	chr1:167893778	G	GA	92	PASS	DP=386;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
1	167906503	167906503	A	G	intronic	DCAF6	.	.	.	0.996908923	0.003091077	1.14E-11	.	0.53934	0.13231	-0.242430445	36.22906346	1387.38336	6.97264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	92	1	167906503	chr1:167906503	A	G	71	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	168066292	168066292	C	T	exonic	GPR161	.	nonsynonymous SNV	GPR161:NM_001267613:exon2:c.G319A:p.E107K,GPR161:NM_001267614:exon2:c.G211A:p.E71K,GPR161:NM_001349635:exon2:c.G157A:p.E53K,GPR161:NM_001267611:exon3:c.G604A:p.E202K,GPR161:NM_001267612:exon3:c.G157A:p.E53K,GPR161:NM_001349633:exon3:c.G553A:p.E185K,GPR161:NM_001267609:exon4:c.G613A:p.E205K,GPR161:NM_001267610:exon4:c.G553A:p.E185K,GPR161:NM_001349632:exon5:c.G553A:p.E185K,GPR161:NM_001349634:exon5:c.G553A:p.E185K,GPR161:NM_153832:exon5:c.G553A:p.E185K	0.02957929	0.960088859	0.010331851	.	0.15614	0.15387	-0.800872469	12.33191791	94.16225	2.08754	0.034	0.443	D	0.452	0.481	B	0.164	0.412	B	0.000	0.629	D	1.000	0.588	D	2.265	0.646	M	1.23	0.369	T	-1.67	0.457	N	0.513	0.572	-0.892	0.488	T	0.082	0.323	T	0.013	0.327	T	3.440	0.471	23.0	0.999	0.941	0.970	0.717	D	c	0.410	0.475	1.000	0.747	0.706	0.609	0	5.07	0.680	5.927	0.696	0.935	0.490	1.000	0.715	0.969	0.458	14.859	0.699	GPCR, rhodopsin-like, 7TM	.	.	0.5	103	153	1	168066292	chr1:168066292	C	T	103	PASS	DP=153;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	168201088	168201088	G	A	exonic	SFT2D2	.	stopgain	SFT2D2:NM_199344:exon3:c.G167A:p.W56X	0.003949651	0.855531759	0.140518591	.	0.10989	.	-0.229483771	36.86010852	10.43983	0.37986	.	.	.	.	.	.	.	.	.	0.003	0.350	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.245	0.973	37	0.991	0.519	0.879	0.473	D	c	0.950	0.769	1.000	0.747	0.706	0.609	0	5.57	0.840	4.828	0.622	0.953	0.551	1.000	0.715	0.994	0.587	16.471	0.839	.	.	.	0.5	110	246	1	168201088	chr1:168201088	G	A	110	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	168549282	168549282	-	T	intronic	XCL1	.	.	.	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	342	1	168549282	chr1:168549282	G	GT	87	PASS	DP=342;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	168550446	168550446	T	C	exonic	XCL1	.	synonymous SNV	XCL1:NM_002995:exon3:c.T333C:p.T111T	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	57	1	168550446	chr1:168550446	T	C	71	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	169101312	169101312	C	T	UTR3	ATP1B1	NM_001677:c.*519C>T	.	.	0.995564605	0.004434995	4.00E-07	.	0.38527	0.24812	-0.449946534	24.00330267	4.44425	0.16128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	125	1	169101312	chr1:169101312	C	T	64	PASS	DP=125;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	175116147	175116148	CA	-	exonic	TNN	.	frameshift deletion	TNN:NM_022093:exon19:c.3840_3841del:p.S1280Rfs*154	5.19E-15	0.506715096	0.493284904	.	0.17043	.	1.51017302	95.42934654	5625.2664	15.52544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	84	1	175116146	chr1:175116146	GCA	G,GA	72	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	175116147	175116147	C	-	exonic	TNN	.	frameshift deletion	TNN:NM_022093:exon19:c.3840delC:p.S1280Rfs*12	5.19E-15	0.506715096	0.493284904	.	0.17043	.	1.51017302	95.42934654	5625.2664	15.52544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	84	1	175116146	chr1:175116146	GCA	G,GA	72	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	176681114	176681114	C	T	exonic	PAPPA2	.	synonymous SNV	PAPPA2:NM_020318:exon12:c.C3795T:p.L1265L	0.001250054	0.998749823	1.23E-07	.	0.37518	0.11692	-1.49019634	3.615239443	422.84473	4.29432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	1	176681114	chr1:176681114	C	T	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	177001937	177001937	G	A	exonic	ASTN1	.	synonymous SNV	ASTN1:NM_001286164:exon3:c.C520T:p.L174L,ASTN1:NM_004319:exon3:c.C520T:p.L174L,ASTN1:NM_207108:exon3:c.C520T:p.L174L	0.999415997	0.000584003	9.68E-13	.	0.12514	0.11666	-1.095046929	6.97688134	570.07336	4.84399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	84	1	177001937	chr1:177001937	G	A	72	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	177113303	177113303	C	T	intronic	ASTN1	.	.	.	0.999415997	0.000584003	9.68E-13	.	0.12514	0.11666	-1.095046929	6.97688134	570.07336	4.84399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	16	1	177113303	chr1:177113303	C	T	50	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	179054692	179054692	T	G	intronic	TOR3A	.	.	.	2.47E-08	0.081099893	0.918900082	.	0.06192	0.09551	-0.490397599	22.50530786	76.75897	1.83877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	52	1	179054692	chr1:179054692	T	G	78	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	179271949	179271949	T	-	intronic	SOAT1	.	.	.	1.67E-05	0.96658748	0.03339587	.	0.09058	0.50106	-0.286522835	33.47487615	1212.8663	6.5907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	18	1	179271948	chr1:179271948	AT	A	53	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	180404392	180404392	T	-	intronic	ACBD6	.	.	.	0.064959259	0.920160983	0.014879758	.	0.46704	0.10684	-0.427900189	25.14744043	16.07879	0.56883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	406	1	180404391	chr1:180404391	AT	A,ATT	92	PASS	DP=406;AN=6	GT	./.	./.	0/1	0/2	./.	./.	./.	./.	0/1	./.	./.
1	180404392	180404392	-	T	intronic	ACBD6	.	.	.	0.064959259	0.920160983	0.014879758	.	0.46704	0.10684	-0.427900189	25.14744043	16.07879	0.56883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	406	1	180404391	chr1:180404391	AT	A,ATT	92	PASS	DP=406;AN=6	GT	./.	./.	0/1	0/2	./.	./.	./.	./.	0/1	./.	./.
1	181768572	181768572	G	A	UTR3	CACNA1E	NM_001205293:c.*602G>A;NM_001205294:c.*602G>A;NM_000721:c.*602G>A	.	.	1	6.60E-14	1.68E-33	.	0.53292	0.32174	-2.708891704	0.713611701	325.12803	3.83322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	1	181768572	chr1:181768572	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	182569235	182569235	A	G	UTR3	RGS16	NM_002928:c.*192T>C	.	.	0.009002649	0.806646881	0.18435047	.	0.18324	0.13041	0.371224249	75.12384996	41.89157	1.22032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	1	182569235	chr1:182569235	A	G	.	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	186089252	186089252	G	T	exonic	HMCN1	.	nonsynonymous SNV	HMCN1:NM_031935:exon80:c.G12204T:p.L4068F	2.19E-18	1	6.42E-24	.	0.11657	0.21661	-3.689691478	0.247699929	8270.20936	19.62945	0.303	0.143	T	1.0	0.899	D	0.998	0.875	D	0.000	0.537	D	1.000	0.537	D	0.36	0.120	N	-0.23	0.667	T	-2.27	0.506	N	0.37	0.431	-0.669	0.619	T	0.238	0.606	T	0.032	0.542	D	4.125	0.553	23.8	0.998	0.882	0.937	0.586	D	c	0.287	0.289	0.001	0.082	0.638	0.428	0	2.97	0.333	2.643	0.460	0.089	0.194	1.000	0.715	0.993	0.574	5.862	0.179	Immunoglobulin I-set|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	105	149	1	186089252	chr1:186089252	G	T	105	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	196709736	196709736	-	T	intronic	CFH	.	.	.	0.999630968	0.000369032	3.16E-13	DISEASE: Complement factor H deficiency (CFHD) [MIM:609814]: A disorder that can manifest as several different phenotypes, including asymptomatic, recurrent bacterial infections, and renal failure. Laboratory features usually include decreased serum levels of factor H, complement component C3, and a decrease in other terminal complement components, indicating activation of the alternative complement pathway. It is associated with a number of renal diseases with variable clinical presentation and progression, including membranoproliferative glomerulonephritis and atypical hemolytic uremic syndrome. {ECO:0000269|PubMed:10803850, ECO:0000269|PubMed:11158219, ECO:0000269|PubMed:11170895, ECO:0000269|PubMed:11170896, ECO:0000269|PubMed:12020532, ECO:0000269|PubMed:14978182, ECO:0000269|PubMed:16612335, ECO:0000269|PubMed:9312129}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemolytic uremic syndrome atypical 1 (AHUS1) [MIM:235400]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269|PubMed:10577907, ECO:0000269|PubMed:10762557, ECO:0000269|PubMed:11851332, ECO:0000269|PubMed:12960213, ECO:0000269|PubMed:14583443, ECO:0000269|PubMed:14978182, ECO:0000269|PubMed:20513133, ECO:0000269|PubMed:9551389}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype.; DISEASE: Macular degeneration, age-related, 4 (ARMD4) [MIM:610698]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:22019782}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.10048	0.13588	0.519883383	80.37272942	1002.72313	6.09993	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	9	1	196709736	chr1:196709736	C	CT	62	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0
1	198264408	198264408	A	-	intronic	NEK7	.	.	.	0.707657761	0.29219643	0.000145809	.	0.24935	0.11215	-0.029247611	51.40363293	55.39612	1.49342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	73	1	198264407	chr1:198264407	CA	C	54	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	198717397	198717397	G	A	intronic	PTPRC	.	.	.	0.999941156	5.88E-05	3.61E-15	DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive (T(-)B()NK() SCID) [MIM:608971]: A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. {ECO:0000269|PubMed:11145714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis (MS) [MIM:126200]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:11101853}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; 	0.17677	0.67006	0.231457213	68.57159707	71.3304	1.75714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	1	198717397	chr1:198717397	G	A	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	200143152	200143152	C	G	exonic	NR5A2	.	synonymous SNV	NR5A2:NM_001276464:exon7:c.C1224G:p.A408A,NR5A2:NM_003822:exon7:c.C1302G:p.A434A,NR5A2:NM_205860:exon8:c.C1440G:p.A480A	0.959085111	0.040914105	7.84E-07	.	0.92242	0.40488	-0.291981272	33.20358575	139.12538	2.57057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	99	1	200143152	chr1:200143152	C	G	69	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	200375406	200375406	-	T	UTR3	ZNF281	NM_001281294:c.*739_*740insA;NM_001281293:c.*739_*740insA;NM_012482:c.*739_*740insA	.	.	0.95167159	0.04829939	2.90E-05	.	0.94229	0.26731	-0.400392389	26.85185185	55.86461	1.50094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.68	81	1	200375406	chr1:200375406	C	CT	11.68	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	200939424	200939498	AGGCCACACATCCCCAGACAGGCAGCAGGGCTGGACAGCTGAGGGTGAAGAGATTCCTAGGCTGAATCCAGGGTG	-	UTR3	KIF21B	NM_001252102:c.*3225_*3151delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT;NM_001252103:c.*3225_*3151delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT;NM_017596:c.*3799_*3725delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT;NM_001252100:c.*3799_*3725delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT	.	.	0.99941409	0.00058591	3.31E-16	.	0.7728	0.1193	-2.914589271	0.577966502	413.35583	4.25806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.1	23	1	200939423	chr1:200939423	CAGGCCACACATCCCCAGACAGGCAGCAGGGCTGGACAGCTGAGGGTGAAGAGATTCCTAGGCTGAATCCAGGGTG	C	13.1	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	201178768	201178768	A	G	exonic	IGFN1	.	nonsynonymous SNV	IGFN1:NM_001164586:exon12:c.A4747G:p.S1583G	2.50E-18	0.007485788	0.992514212	.	0.12425	0.10243	6.487063031	99.87615004	12297.47943	23.82839	0.621	0.053	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	-1.03	0.764	T	0.67	0.023	N	0.016	0.013	-1.014	0.258	T	0.146	0.471	T	0.069	0.706	D	-2.098	0.007	0.001	0.770	0.113	0.001	0.004	N	c	-1.686	-1.819	0.000	0.035	0.487	0.133	0	-1.87	0.073	-1.095	0.034	-3.069	0.001	0.000	0.063	0.000	0.016	0.803	0.010	.	.	.	0.5	157	480	1	201178768	chr1:201178768	A	G	157	PASS	DP=480;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	201178984	201178984	G	A	exonic	IGFN1	.	nonsynonymous SNV	IGFN1:NM_001164586:exon12:c.G4963A:p.G1655S	2.50E-18	0.007485788	0.992514212	.	0.12425	0.10243	6.487063031	99.87615004	12297.47943	23.82839	0.016	0.518	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	-2.97	0.920	D	-0.61	0.181	N	0.042	0.022	-0.619	0.641	T	0.419	0.765	T	.	.	.	0.205	0.114	4.733	0.981	0.379	0.045	0.100	N	c	-0.942	-1.104	0.000	0.029	0.487	0.133	0	-2.16	0.066	0.171	0.164	0.670	0.294	0.000	0.063	0.005	0.090	4.275	0.102	.	.	.	0.5	115	692	1	201178984	chr1:201178984	G	A	115	PASS	DP=692;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	202527984	202527984	G	T	intronic	PPP1R12B	.	.	.	0.124454642	0.875545286	7.20E-08	.	0.39842	0.10794	-0.857930839	10.95187544	214.85888	3.16168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	120	1	202527984	chr1:202527984	G	T	91	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	203278553	203278553	G	C	UTR3	BTG2	NM_006763:c.*1987G>C	.	.	0.048978487	0.685197566	0.265823946	.	0.59042	0.1111	-0.207437529	38.2814343	44.13231	1.26674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	45	1	203278553	chr1:203278553	G	C	56	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	204124976	204124976	G	A	exonic	REN	.	nonsynonymous SNV	REN:NM_000537:exon9:c.C1031T:p.T344M	0.006604139	0.989476399	0.003919462	DISEASE: Renal tubular dysgenesis (RTD) [MIM:267430]: Autosomal recessive severe disorder of renal tubular development characterized by persistent fetal anuria and perinatal death, probably due to pulmonary hypoplasia from early-onset oligohydramnios (the Potter phenotype). {ECO:0000269|PubMed:16116425}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial juvenile hyperuricemic nephropathy 2 (HNFJ2) [MIM:613092]: A renal disease characterized by juvenile onset of hyperuricemia, slowly progressive renal failure and anemia. {ECO:0000269|PubMed:19664745}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09012	0.89087	-0.402212257	26.7338995	42.28384	1.23092	0.01	0.564	D	1.0	0.899	D	0.987	0.759	D	0.000	0.504	D	0.999	0.465	D	3.485	0.928	M	0.27	0.592	T	-3.03	0.627	D	0.281	0.340	0.099	0.842	D	0.486	0.804	T	0.062	0.686	D	5.810	0.795	27.2	0.999	0.963	0.925	0.556	D	c	0.474	0.285	1.000	0.747	0.497	0.185	0	3.32	0.370	1.506	0.351	0.902	0.416	0.089	0.223	0.818	0.342	11.616	0.502	Aspartic peptidase domain|Peptidase family A1 domain	.	.	0.5	65	106	1	204124976	chr1:204124976	G	A	65	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	204168378	204168378	A	-	exonic	GOLT1A	.	frameshift deletion	GOLT1A:NM_198447:exon4:c.305delT:p.F102Sfs*35	0.038757883	0.838243926	0.122998191	.	0.11431	0.59876	-0.339715008	30.06605331	18.54855	0.64184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	206	1	204168377	chr1:204168377	GA	G	61	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	204192704	204192704	G	A	exonic	PLEKHA6	.	nonsynonymous SNV	PLEKHA6:NM_014935:exon22:c.C3041T:p.A1014V	0.98196907	0.018030926	4.22E-09	.	0.21929	0.11756	-1.207107349	5.726586459	192.56504	3.00941	0.427	0.096	T	0.997	0.689	D	0.97	0.706	D	0.079	0.210	N	0.979	0.395	D	0.315	0.103	N	3.0	0.092	T	0.74	0.023	N	0.406	0.464	-0.932	0.438	T	0.034	0.145	T	0.024	0.475	T	5.616	0.765	26.6	0.999	0.955	0.853	0.441	D	c	0.338	0.397	1.000	0.747	0.706	0.609	0	4.72	0.591	4.590	0.605	1.048	0.713	1.000	0.715	1.000	0.888	15.846	0.786	.	.	.	0.5	.	66	1	204192704	chr1:204192704	G	A	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	204192747	204192747	G	A	intronic	PLEKHA6	.	.	.	0.98196907	0.018030926	4.22E-09	.	0.21929	0.11756	-1.207107349	5.726586459	192.56504	3.00941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	200	1	204192747	chr1:204192747	G	A	58	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	205028152	205028152	-	C	intronic	CNTN2	.	.	.	0.129621135	0.870378534	3.31E-07	DISEASE: Epilepsy, familial adult myoclonic, 5 (FAME5) [MIM:615400]: A form of cortical myoclonic tremor with epilepsy, a syndrome characterized by cortical myoclonus and variable occurrence of epileptic seizures. Usually, myoclonic tremor is the presenting symptom, characterized by tremulous finger movements and myoclonic jerks of the limbs increased by action and posture. In a minority of patients, seizures are the presenting symptom; both complex partial as well as generalized tonic clonic seizures are described. Some patients exhibit mild cognitive impairment. {ECO:0000269|PubMed:23518707}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.39019	0.18821	-0.189246284	39.30761972	2533.66697	9.38949	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	33	1	205028152	chr1:205028152	A	AC	126	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0
1	205496983	205496983	G	A	exonic	CDK18	.	nonsynonymous SNV	CDK18:NM_002596:exon9:c.G791A:p.R264Q,CDK18:NM_212502:exon9:c.G791A:p.R264Q,CDK18:NM_212503:exon9:c.G881A:p.R294Q	7.16E-08	0.692723341	0.307276588	.	0.32808	0.13832	0.198490371	67.30360934	867.92025	5.73904	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.145	0.976	H	-0.12	0.646	T	-3.85	0.723	D	0.985	0.988	0.535	0.910	D	0.597	0.856	D	0.597	0.965	D	7.683	0.954	35	1.000	1.000	0.985	0.835	D	c	1.043	0.936	1.000	0.747	0.626	0.397	0	4.95	0.648	9.921	0.988	1.047	0.674	1.000	0.715	0.955	0.433	16.746	0.853	Protein kinase domain|Protein kinase-like domain;Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	84	179	1	205496983	chr1:205496983	G	A	84	PASS	DP=179;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	205719177	205719177	C	-	UTR5	NUCKS1	NM_022731:c.-76delG	.	.	0.979237658	0.020744772	1.76E-05	.	0.90068	0.13281	-0.119252484	44.53880632	4.59039	0.16497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	943	1	205719176	chr1:205719176	AC	A	128	PASS	DP=943;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	205901802	205901802	C	T	intronic	SLC26A9	.	.	.	0.002985459	0.996911146	0.000103395	.	0.17926	0.11651	-0.143334748	42.35079028	424.02635	4.30029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	63	1	205901802	chr1:205901802	C	T	71	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	206566861	206566861	A	-	ncRNA_intronic	SRGAP2D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	30	1	206566860	chr1:206566860	TA	T	77	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	207787733	207787733	-	T	intronic	CR1	.	.	.	9.34E-08	0.999999848	5.90E-08	.	0.0878	.	.	.	3621.79634	11.67146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	262	1	207787733	chr1:207787733	C	CT	55	PASS	DP=262;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	207888640	207888640	-	T	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	469	1	207888640	chr1:207888640	C	CT	78	PASS	DP=469;AN=6	GT	./.	0/1	./.	./.	./.	./.	./.	./.	0/1	0/1	./.
1	207930564	207930564	-	T	intronic	CD46	.	.	.	0.000191603	0.974855327	0.02495307	DISEASE: Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269|PubMed:16386793, ECO:0000269|PubMed:16621965, ECO:0000269|PubMed:20513133}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype. Patients with CD46 mutations seem to have an overall better prognosis compared to patients carrying CFH mutations.; 	0.10479	0.17659	0.439181676	77.69521113	55.53796	1.49781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	121	1	207930564	chr1:207930564	C	CT	65	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	209880509	209880509	A	-	ncRNA_intronic	LOC101930114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	42	1	209880508	chr1:209880508	GA	G	119	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	209936964	209936964	-	CA	intronic	TRAF3IP3	.	.	.	1.38E-06	0.989497509	0.010501115	.	0.25181	0.12101	0.286674996	71.49681529	267.89298	3.51107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	52	1	209936964	chr1:209936964	T	TCA	116	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	214503489	214503489	T	G	intronic	SMYD2	.	.	.	0.005368937	0.989356107	0.005274956	.	0.23384	0.10894	0.352813824	74.49280491	200.10993	3.05629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	110	1	214503489	chr1:214503489	T	G	78	PASS	DP=110;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	215256701	215256701	A	-	UTR5	KCNK2	NM_001017425:c.-28del-	.	.	0.339842885	0.657147273	0.003009842	.	0.12841	.	-0.449946534	24.00330267	31.8264	1.00181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	124	1	215256700	chr1:215256700	CA	C	78	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	215972220	215972220	C	A	intronic	USH2A	.	.	.	3.68E-43	0.999989236	1.08E-05	DISEASE: Usher syndrome 2A (USH2A) [MIM:276901]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:10729113, ECO:0000269|PubMed:10738000, ECO:0000269|PubMed:10909849, ECO:0000269|PubMed:11311042, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12525556, ECO:0000269|PubMed:14970843, ECO:0000269|PubMed:15015129, ECO:0000269|PubMed:15025721, ECO:0000269|PubMed:15241801, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:17085681, ECO:0000269|PubMed:17405132, ECO:0000269|PubMed:18273898, ECO:0000269|PubMed:18452394, ECO:0000269|PubMed:19683999, ECO:0000269|PubMed:19737284, ECO:0000269|PubMed:20309401, ECO:0000269|PubMed:20440071, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21593743, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22004887, ECO:0000269|PubMed:23737954, ECO:0000269|PubMed:9624053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 39 (RP39) [MIM:613809]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10775529, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12427073, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:16098008, ECO:0000269|PubMed:17296898, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:24227914}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15836	.	4.179636958	99.70511913	6401.91635	16.71188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	84	1	215972220	chr1:215972220	C	A	103	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	217784432	217784432	C	-	intronic	GPATCH2	.	.	.	9.66E-05	0.986025695	0.013877705	.	0.35805	.	0.108486928	61.90728946	309.35921	3.7445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	382	1	217784431	chr1:217784431	AC	A	92	PASS	DP=382;AN=6	GT	./.	./.	0/1	./.	./.	./.	./.	0/1	./.	0/1	./.
1	219347141	219347141	G	T	upstream	LYPLAL1;LYPLAL1-AS1	dist=32	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	85	1	219347141	chr1:219347141	G	T	82	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	219575920	219575920	C	T	intergenic	LYPLAL1;LOC102723886	dist=189713;dist=32580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	1	219575920	chr1:219575920	C	T	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	219575961	219575961	C	T	intergenic	LYPLAL1;LOC102723886	dist=189754;dist=32539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	1	219575961	chr1:219575961	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	220101104	220101104	G	A	ncRNA_intronic	RNU5F-1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	1	220101104	chr1:220101104	G	A	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	223168205	223168205	-	T	intronic	DISP1	.	.	.	4.23E-06	0.997859918	0.002135849	.	0.16068	0.11183	0.369203982	74.77589054	4506.07665	13.48325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	225	1	223168205	chr1:223168205	C	CT	72	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	223962513	223962513	-	T	intronic	CAPN2	.	.	.	1.62E-11	0.793333331	0.206666669	.	0.2116	0.29838	0.7164803	85.82802548	3510.65552	11.43339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	192	1	223962513	chr1:223962513	C	CT	65	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	227786186	227786186	T	A	intronic	ZNF678	.	.	.	4.67E-07	0.222084042	0.777915492	.	0.19605	.	.	.	258.61102	3.45659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	1	227786186	chr1:227786186	T	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	228248893	228248893	C	T	UTR3	WNT3A	NM_033131:c.*1727C>T	.	.	0.777794121	0.220637276	0.001568603	.	0.14918	0.58479	-0.205617011	38.57631517	18.81775	0.64982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	154	1	228248893	chr1:228248893	C	T	84	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	228335908	228335908	G	T	intronic	GUK1	.	.	.	0.00010002	0.573762218	0.426137762	.	0.61935	0.39826	-0.957024976	9.088228356	85.40721	1.97028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	109	1	228335908	chr1:228335908	G	T	.	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	228597036	228597036	C	-	intronic	TRIM17	.	.	.	2.40E-05	0.744751518	0.255224452	.	0.10342	0.18426	-0.21856543	37.66218448	129.33213	2.47962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	837	1	228597035	chr1:228597035	TC	T	79	PASS	DP=837;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	230800215	230800216	AA	-	intronic	COG2	.	.	.	0.000167565	0.999566074	0.000266361	.	0.14368	0.25108	-0.33061537	30.82094834	941.66479	5.94881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	18	1	230800214	chr1:230800214	TAA	T	58	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	230974299	230974299	G	A	UTR3	C1orf198	NM_001136495:c.*1299C>T;NM_001136494:c.*1299C>T;NM_032800:c.*1299C>T	.	.	0.027375276	0.921047694	0.05157703	.	0.23574	.	0.194852702	67.03231894	31.69042	0.99734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	80	1	230974299	chr1:230974299	G	A	64	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	231408091	231408091	A	G	exonic	GNPAT	.	nonsynonymous SNV	GNPAT:NM_001316350:exon10:c.A1373G:p.D458G,GNPAT:NM_014236:exon11:c.A1556G:p.D519G	0.291272733	0.708689868	3.74E-05	DISEASE: Rhizomelic chondrodysplasia punctata 2 (RCDP2) [MIM:222765]: A disease characterized by rhizomelic shortening of femur and humerus, vertebral disorders, cataract, cutaneous lesions and severe mental retardation. {ECO:0000269|PubMed:11152660, ECO:0000269|PubMed:21990100, ECO:0000269|PubMed:9536089}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.52109	0.26501	-0.200157416	39.11299835	1060.52275	6.249	0.109	0.292	T	0.075	0.227	B	0.034	0.212	B	0.037	0.244	N	0.998	0.224	P	2.16	0.606	M	-0.11	0.645	T	-2.45	0.535	N	0.168	0.280	-1.082	0.070	T	0.000	0.000	T	.	.	.	2.255	0.332	17.87	0.974	0.330	0.485	0.280	N	c	-0.612	-0.584	1.000	0.747	0.731	0.878	0	-0.263	0.123	1.924	0.395	1.194	0.916	0.806	0.296	0.794	0.334	9.158	0.360	.	ENSG00000116906.7|ENSG00000116906.7|ENSG00000116906.7	Artery_Tibial|Nerve_Tibial|Skin_Sun_Exposed_Lower_leg	0.5	41	14	1	231408091	chr1:231408091	A	G	41	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	232098999	232098999	-	T	ncRNA_intronic	TSNAX-DISC1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	13	1	232098999	chr1:232098999	A	AT	42	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	235311773	235311773	A	-	intronic	RBM34	.	.	.	7.95E-09	0.270393494	0.729606498	.	0.5887	.	-0.844966979	11.1759849	50.60593	1.40016	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	210	1	235311772	chr1:235311772	GA	G	79	PASS	DP=210;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	236724605	236724605	G	T	intronic	HEATR1	.	.	.	0.999999993	6.78E-09	9.22E-25	.	0.09748	0.08985	2.322745612	98.36635999	19763.61088	30.12571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	118	1	236724605	chr1:236724605	G	T	152	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	236899900	236899900	C	-	exonic	ACTN2	.	frameshift deletion	ACTN2:NM_001278344:exon10:c.91delC:p.P32Lfs*11	0.999811916	0.000188084	7.39E-12	DISEASE: Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:20022194, ECO:0000269|PubMed:25173926}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:14567970, ECO:0000269|PubMed:25224718}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.77327	0.39885	-1.723336008	2.465204058	447.74179	4.40066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	79	1	236899899	chr1:236899899	TC	T	152	PASS	DP=79;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	237167584	237167584	T	C	exonic	MT1HL1	.	nonsynonymous SNV	MT1HL1:NM_001276687:exon1:c.A89G:p.K30R	0.020062126	0.511088562	0.468849312	.	.	.	.	.	93.79969	2.08288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.192	0.235	.	.	.	.	.	.	0.001	0.004	T	1.077	0.197	11.09	0.740	0.102	0.211	0.211	N	n	0.595	-0.059	0.022	0.134	0.263	0.038	0	0.991	0.188	0.671	0.247	0.368	0.274	0.999	0.424	0.428	0.259	4.242	0.100	Metallothionein domain|Metallothionein domain, vertebrate|TNFR/NGFR cysteine-rich region	.	.	0.5	102	109	1	237167584	chr1:237167584	T	C	102	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	237850692	237850692	C	T	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	1	237850692	chr1:237850692	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	237924231	237924231	T	-	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	10	1	237924230	chr1:237924230	GT	G	41	PASS	DP=10;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	237969493	237969493	-	T	exonic	RYR2	.	frameshift insertion	RYR2:NM_001035:exon99:c.14209dupT:p.A4740Cfs*55	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	236	1	237969493	chr1:237969493	C	CT	71	PASS	DP=236;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	237982282	237982282	-	A	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	175	1	237982282	chr1:237982282	G	GA	69	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	240775299	240775299	C	A	ncRNA_intronic	MIR1273E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	1	240775299	chr1:240775299	C	A	.	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	242383170	242383170	-	AC	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	54	1	242383170	chr1:242383170	T	TAC	118	PASS	DP=54;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	242540222	242540222	G	A	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	1	242540222	chr1:242540222	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	242540223	242540223	G	T	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	38	1	242540223	chr1:242540223	G	T	71	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
1	243218249	243218249	A	T	intergenic	PLD5;LINC01347	dist=530251;dist=1367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	1	243218249	chr1:243218249	A	T	.	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	243328887	243328887	G	T	exonic	CEP170	.	stopgain	CEP170:NM_001042404:exon12:c.C2081A:p.S694X,CEP170:NM_001042405:exon12:c.C2081A:p.S694X,CEP170:NM_014812:exon13:c.C2375A:p.S792X	.	.	.	.	0.51507	0.12994	-0.26629572	34.81953291	653.42753	5.12884	.	.	.	.	.	.	.	.	.	0.816	0.092	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.821	0.956	35	0.989	0.478	0.750	0.364	D	c	0.442	0.135	0.001	0.082	0.732	0.924	0	0.747	0.174	2.208	0.422	0.140	0.223	0.509	0.268	0.491	0.269	6.963	0.236	.	.	.	0.5	65	80	1	243328887	chr1:243328887	G	T	65	PASS	DP=80;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	243594955	243594955	-	T	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	305	1	243594954	chr1:243594954	AT	ATT,A,ATTT	93	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	243594955	243594955	T	-	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	305	1	243594954	chr1:243594954	AT	ATT,A,ATTT	93	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	243594955	243594955	-	TT	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	305	1	243594954	chr1:243594954	AT	ATT,A,ATTT	93	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	243736308	243736308	G	A	exonic	AKT3	.	nonsynonymous SNV	AKT3:NM_005465:exon8:c.C739T:p.R247C,AKT3:NM_181690:exon8:c.C739T:p.R247C,AKT3:NM_001206729:exon9:c.C739T:p.R247C	0.999585399	0.0004146	1.24E-09	DISEASE: Note=AKT3 is a key modulator of several tumors like melanoma, glioma and ovarian cancer. Active AKT3 increases progressively during melanoma tumor progression with highest levels present in advanced-stage metastatic melanomas. Promotes melanoma tumorigenesis by decreasing apoptosis. Plays a key role in the genesis of ovarian cancers through modulation of G2/M phase transition. With AKT2, plays a pivotal role in the biology of glioblastoma.; DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223, ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.51738	0.24974	-0.251530012	35.42108988	6.85051	0.25446	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	1.385	0.346	L	-0.2	0.661	T	-7.48	0.950	D	0.905	0.906	-0.389	0.724	T	0.345	0.710	T	0.037	0.574	D	7.311	0.948	34	0.999	0.999	0.930	0.568	D	c	0.799	0.828	1.000	0.747	0.706	0.609	0	5.87	0.942	7.996	0.879	1.048	0.713	1.000	0.715	1.000	0.888	14.980	0.708	Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	.	32	1	243736308	chr1:243736308	G	A	.	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	245017680	245017680	C	T	UTR3	HNRNPU	NM_004501:c.*72G>A;NM_031844:c.*72G>A	.	.	0.999903323	9.67E-05	7.22E-12	.	0.51398	0.38821	-0.60427181	17.74593064	41.32875	1.20799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	286	1	245017680	chr1:245017680	C	T	91	PASS	DP=286;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	247241850	247241850	G	C	ncRNA_intronic	ZNF670-ZNF695	.	.	.	.	.	.	.	0.07638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	455	1	247241850	chr1:247241850	G	C	109	PASS	DP=455;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	248112554	248112554	T	C	exonic	OR2L8	.	nonsynonymous SNV	OR2L8:NM_001001963:exon1:c.T395C:p.L132P	0.17916862	0.766561924	0.054269456	.	0.05102	0.09448	2.396009417	98.49020996	223.42356	3.23122	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.405	0.131	N	1	0.090	N	-1.51	0.005	N	5.99	0.006	T	7.42	0.000	N	0.136	0.157	-0.991	0.324	T	0.001	0.002	T	0.000	0.001	T	-2.726	0.002	0.001	0.371	0.024	0.001	0.007	N	c	-2.527	-2.516	0.001	0.076	0.487	0.133	0	-3.28	0.047	-7.320	0.000	-5.127	0.000	0.000	0.063	0.000	0.016	2.974	0.055	GPCR, rhodopsin-like, 7TM	.	.	0.5	100	71	1	248112554	chr1:248112554	T	C	100	PASS	DP=71;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	248224216	248224216	C	T	exonic	OR2L3	.	nonsynonymous SNV	OR2L3:NM_001004687:exon1:c.C233T:p.P78L	6.39E-05	0.283107845	0.716828238	.	0.04593	0.09315	1.128108522	92.19155461	2290.45899	8.85807	0.004	0.654	D	0.969	0.548	D	0.883	0.609	P	0.007	0.315	U	1e-37	0.810	P	3.75	0.951	H	4.6	0.019	T	-9.35	0.983	D	0.299	0.359	-0.993	0.320	T	0.000	0.000	T	.	.	.	5.460	0.741	26.1	0.995	0.697	0.866	0.456	D	c	0.370	0.158	0.556	0.214	0.487	0.133	0	2.05	0.257	3.362	0.518	0.498	0.280	0.985	0.357	0.004	0.083	11.965	0.521	GPCR, rhodopsin-like, 7TM	.	.	0.5	77	96	1	248224216	chr1:248224216	C	T	77	PASS	DP=96;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	248224489	248224489	A	G	exonic	OR2L3	.	nonsynonymous SNV	OR2L3:NM_001004687:exon1:c.A506G:p.Q169R	6.39E-05	0.283107845	0.716828238	.	0.04593	0.09315	1.128108522	92.19155461	2290.45899	8.85807	0.692	0.043	T	0.0	0.026	B	0.002	0.063	B	0.540	0.053	N	1	0.090	P	-1.23	0.008	N	1.26	0.363	T	1.25	0.010	N	0.036	0.016	-0.982	0.347	T	0.000	0.000	T	.	.	.	-4.554	0.000	0.001	0.237	0.010	0.000	0.004	N	c	-2.905	-2.917	0.062	0.153	0.487	0.133	0	-4.11	0.036	-2.003	0.015	-4.200	0.000	0.000	0.063	0.000	0.016	7.548	0.268	GPCR, rhodopsin-like, 7TM	.	.	0.5	56	12	1	248224489	chr1:248224489	A	G	56	PASS	DP=12;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	248224754	248224754	T	C	exonic	OR2L3	.	synonymous SNV	OR2L3:NM_001004687:exon1:c.T771C:p.T257T	6.39E-05	0.283107845	0.716828238	.	0.04593	0.09315	1.128108522	92.19155461	2290.45899	8.85807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	114	1	248224754	chr1:248224754	T	C	108	PASS	DP=114;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	248436857	248436857	C	T	exonic	OR2T33	.	nonsynonymous SNV	OR2T33:NM_001004695:exon1:c.G260A:p.S87N	0.016492203	0.706716697	0.2767911	.	0.10124	0.09346	1.219937511	93.19414956	662.98621	5.16078	0.399	0.105	T	0.0	0.026	B	0.0	0.013	B	0.481	0.122	N	1	0.090	N	0.1	0.085	N	4.08	0.030	T	0.88	0.017	N	0.039	0.023	-0.925	0.449	T	0.000	0.000	T	.	.	.	-1.390	0.020	0.003	0.413	0.029	0.002	0.009	N	c	-1.759	-1.873	0.000	0.063	0.487	0.133	0	-5.39	0.024	-2.295	0.012	-0.142	0.109	0.000	0.063	0.001	0.043	1.568	0.024	GPCR, rhodopsin-like, 7TM	.	.	0.5	118	570	1	248436857	chr1:248436857	C	T	118	PASS	DP=570;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	249142462	249142462	G	A	exonic	ZNF672	.	nonsynonymous SNV	ZNF672:NM_024836:exon4:c.G989A:p.R330Q	0.000127541	0.626900007	0.372972452	.	0.31122	.	.	.	21.60164	0.72631	0.952	0.021	T	0.629	0.383	P	0.08	0.274	B	0.646	0.106	U	1.000	0.182	N	0.15	0.089	N	1.23	0.369	T	1.86	0.005	N	0.19	0.232	-1.055	0.131	T	0.035	0.151	T	0.009	0.234	T	1.861	0.284	15.35	0.945	0.244	0.278	0.232	N	c	-0.594	-0.597	1.000	0.413	0.672	0.522	0	0.971	0.187	-1.519	0.023	0.017	0.142	0.000	0.063	0.989	0.536	3.722	0.079	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	70	537	1	249142462	chr1:249142462	G	A	70	PASS	DP=537;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	1500507	1500507	G	T	exonic	TPO	.	stopgain	TPO:NM_175722:exon11:c.G1837T:p.G613X,TPO:NM_001206745:exon12:c.G2185T:p.G729X,TPO:NM_175719:exon12:c.G2185T:p.G729X,TPO:NM_175721:exon12:c.G2356T:p.G786X,TPO:NM_000547:exon13:c.G2356T:p.G786X,TPO:NM_001206744:exon13:c.G2356T:p.G786X	1.36E-07	0.988057948	0.011941916	DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA can cause Graves' disease.; DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A disorder due to defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:10084596, ECO:0000269|PubMed:10468986, ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:11415848, ECO:0000269|PubMed:11874711, ECO:0000269|PubMed:11916616, ECO:0000269|PubMed:12213873, ECO:0000269|PubMed:12490071, ECO:0000269|PubMed:12843174, ECO:0000269|PubMed:12864797, ECO:0000269|PubMed:12938097, ECO:0000269|PubMed:16284446, ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:7550241, ECO:0000269|PubMed:9024270, ECO:0000269|PubMed:9924196}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18628	0.48162	-0.14151689	42.36258552	2837.88244	10.06894	.	.	.	.	.	.	.	.	.	0.043	0.238	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.455	0.983	39	0.992	0.537	0.808	0.401	D	c	0.767	0.513	0.998	0.359	0.581	0.326	0	4.2	0.486	3.523	0.530	0.902	0.416	0.994	0.380	0.007	0.100	14.183	0.650	Sushi/SCR/CCP domain	.	.	0.5	.	67	2	1500507	chr2:1500507	G	T	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	1680706	1680706	G	A	exonic	PXDN	.	stopgain	PXDN:NM_012293:exon8:c.C841T:p.R281X	2.04E-05	0.999934089	4.56E-05	DISEASE: Corneal opacification with other ocular anomalies (COPOA) [MIM:269400]: An ocular disease characterized by sclerocornea associated with other ocular anomalies, such as cataract, microcornea, microphthalmia, and anterior segment dysgenesis. Sclerocornea is a primary anomaly in which scleralization of a peripheral part of the cornea, or the entire corneal tissue, occurs. In the peripheral type of sclerocornea, the affected area is vascularized with regular arcades of superficial scleral vessels. In total sclerocornea, the entire cornea is opaque and vascularized. {ECO:0000269|PubMed:21907015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44329	0.10322	-1.512251235	3.479594244	529.85594	4.69745	.	.	.	.	.	.	.	.	.	0.000	0.523	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.930	0.979	38	0.998	0.927	0.846	0.434	D	c	0.767	0.620	1.000	0.747	0.707	0.730	0	4.77	0.603	3.258	0.510	1.027	0.646	1.000	0.715	1.000	0.888	13.662	0.617	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	63	2	1680706	chr2:1680706	G	A	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	1893021	1893021	C	G	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon16:c.G2512C:p.D838H,MYT1L:NM_001329845:exon16:c.G2512C:p.D838H,MYT1L:NM_001329846:exon16:c.G2506C:p.D836H,MYT1L:NM_001329847:exon16:c.G2506C:p.D836H,MYT1L:NM_001329848:exon16:c.G2506C:p.D836H,MYT1L:NM_001329849:exon16:c.G2506C:p.D836H,MYT1L:NM_001329851:exon16:c.G2512C:p.D838H,MYT1L:NM_001329852:exon16:c.G2506C:p.D836H,MYT1L:NM_015025:exon16:c.G2506C:p.D836H,MYT1L:NM_001329844:exon17:c.G2512C:p.D838H	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.652	0.395	P	0.382	0.421	B	0.005	0.328	N	0.997	0.433	D	0.695	0.181	N	0.73	0.507	T	-1.15	0.295	N	0.245	0.355	-0.960	0.392	T	0.094	0.356	T	0.010	0.259	T	4.432	0.593	24.2	0.995	0.687	0.994	0.953	D	c	0.194	0.324	1.000	0.747	0.487	0.133	0	5.01	0.663	5.405	0.659	0.807	0.329	1.000	0.715	0.137	0.201	18.279	0.900	Myelin transcription factor 1	.	.	0.5	67	40	2	1893021	chr2:1893021	C	G	67	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	1983507	1983507	T	C	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon6:c.A43G:p.K15E,MYT1L:NM_001329845:exon6:c.A43G:p.K15E,MYT1L:NM_001329846:exon6:c.A43G:p.K15E,MYT1L:NM_001329847:exon6:c.A43G:p.K15E,MYT1L:NM_001329848:exon6:c.A43G:p.K15E,MYT1L:NM_001329849:exon6:c.A43G:p.K15E,MYT1L:NM_001329851:exon6:c.A43G:p.K15E,MYT1L:NM_001329852:exon6:c.A43G:p.K15E,MYT1L:NM_015025:exon6:c.A43G:p.K15E,MYT1L:NM_001329844:exon7:c.A43G:p.K15E	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.956	0.559	P	0.899	0.676	P	0.000	0.843	D	1.000	0.537	D	2.625	0.771	M	0.02	0.623	T	-2.59	0.558	D	0.792	0.782	-0.299	0.750	T	0.360	0.722	T	0.029	0.519	D	4.511	0.604	24.3	0.996	0.723	0.965	0.695	D	c	0.634	0.634	1.000	0.517	0.487	0.133	0	5.1	0.688	6.281	0.725	0.913	0.425	1.000	0.715	1.000	0.888	15.192	0.726	.	.	.	0.5	.	101	2	1983507	chr2:1983507	T	C	.	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	3488595	3488595	G	C	intergenic	TRAPPC12;ADI1	dist=5253;dist=13095	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	175	2	3488595	chr2:3488595	G	C	73	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	9593028	9593028	T	-	intronic	CPSF3	.	.	.	3.46E-05	0.99741028	0.002555149	.	0.16707	.	-0.558357437	19.54470394	35.81924	1.07713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	48	2	9593027	chr2:9593027	AT	A	51	PASS	DP=48;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
2	10095020	10095020	-	T	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	310	2	10095020	chr2:10095020	G	GT	87	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	10139226	10139226	C	-	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	55	2	10139225	chr2:10139225	AC	A	65	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	10560259	10560259	C	T	exonic	HPCAL1	.	stopgain	HPCAL1:NM_001258357:exon3:c.C376T:p.Q126X,HPCAL1:NM_001258358:exon3:c.C376T:p.Q126X,HPCAL1:NM_001258359:exon3:c.C376T:p.Q126X,HPCAL1:NM_002149:exon3:c.C376T:p.Q126X,HPCAL1:NM_134421:exon4:c.C376T:p.Q126X	0.779954229	0.212962413	0.007083358	.	0.2282	0.13477	-0.073340031	48.11866006	9.80626	0.35955	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.391	0.983	39	0.998	0.871	0.962	0.678	D	c	0.807	0.664	1.000	0.747	0.706	0.609	0	4.65	0.575	6.064	0.706	0.852	0.362	1.000	0.715	0.999	0.750	17.885	0.887	EF-hand domain|EF-hand domain pair	.	.	0.5	.	53	2	10560259	chr2:10560259	C	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	10560278	10560278	C	T	intronic	HPCAL1	.	.	.	0.779954229	0.212962413	0.007083358	.	0.2282	0.13477	-0.073340031	48.11866006	9.80626	0.35955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	2	10560278	chr2:10560278	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	12164729	12164729	A	T	ncRNA_intronic	MIR3681HG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	120	2	12164729	chr2:12164729	A	T	.	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	13554948	13554948	G	T	intergenic	LOC100506474;LINC00276	dist=407810;dist=814050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	47	2	13554948	chr2:13554948	G	T	42	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	14778252	14778252	C	A	UTR3	FAM84A	NM_145175:c.*3270C>A	.	.	0.087816303	0.762868639	0.149315058	.	0.15023	0.08134	-0.075159878	47.78839349	16.9347	0.59676	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	2	14778252	chr2:14778252	C	A	.	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	15536509	15536509	-	A	intronic	NBAS	.	.	.	1.89E-25	0.999906723	9.33E-05	DISEASE: Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]: A form of infantile liver failure syndrome, a life-threatening disorder of hepatic function that manifests with acute liver failure in the first few months of life. Clinical features include anemia, renal tubulopathy, developmental delay, seizures, failure to thrive, and liver steatosis and fibrosis. {ECO:0000269|PubMed:26073778}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=NBAS mutations have been found in a multisystem disease affecting the liver, eye, immune system, connective tissue, and bone. Clinical manifestations include a progeroid appearance, short stature, slender bones, epiphyseal dysplasia with multiple phalangeal pseudo-epiphyses, cervical instability, myelopathy, elevated transaminases, hypogammaglobulinemia, reduced natural killer cells, Pelger-Huet anomaly of granulocytes, and in some cases retinal dystrophy and optic atrophy. {ECO:0000269|PubMed:26286438}.; 	.	.	-0.224542487	37.33191791	2659.86206	9.69933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	57	2	15536509	chr2:15536509	G	GA	79	PASS	DP=57;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	20240668	20240668	C	A	exonic	LAPTM4A	.	synonymous SNV	LAPTM4A:NM_014713:exon2:c.G216T:p.S72S	0.50380241	0.492021029	0.004176561	.	0.43282	0.10804	-0.139478553	43.29440906	119.75939	2.38284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	21	2	20240668	chr2:20240668	C	A	88	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
2	23698397	23698397	C	-	intronic	KLHL29	.	.	.	.	.	.	.	0.74488	.	-0.53631094	20.53550366	164.66985	2.80262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	25	2	23698396	chr2:23698396	AC	A	58	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	23792485	23792485	-	T	intronic	KLHL29	.	.	.	.	.	.	.	0.74488	.	-0.53631094	20.53550366	164.66985	2.80262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	41	2	23792485	chr2:23792485	A	AT	109	PASS	DP=41;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	23916368	23916368	G	A	exonic	KLHL29	.	stopgain	KLHL29:NM_052920:exon8:c.G1512A:p.W504X	.	.	.	.	0.74488	.	-0.53631094	20.53550366	164.66985	2.80262	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.568	0.984	39	0.996	0.732	0.967	0.705	D	c	1.229	1.082	1.000	0.747	0.672	0.522	0	5.24	0.728	9.928	0.988	1.048	0.713	1.000	0.715	1.000	0.888	19.215	0.937	BTB/Kelch-associated	.	.	0.5	.	42	2	23916368	chr2:23916368	G	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	24413298	24413298	A	G	exonic	FAM228A	.	nonsynonymous SNV	FAM228A:NM_001040710:exon6:c.A419G:p.Y140C	0.00040974	0.638638547	0.360951713	.	.	.	0.193034296	66.82000472	.	.	0.828	0.162	T	0.0	0.026	B	0.0	0.013	B	0.018	0.277	N	1	0.090	P	-1.4	0.006	N	0.82	0.481	T	2.49	0.002	N	0.06	0.150	-0.979	0.352	T	0.000	0.000	T	.	.	.	-1.115	0.028	0.009	0.530	0.048	0.001	0.005	N	c	-1.417	-1.460	0.000	0.054	0.487	0.133	0	-1.3	0.087	-0.655	0.054	-1.526	0.010	0.000	0.063	0.000	0.016	4.287	0.102	.	ENSG00000186453.8|ENSG00000266118.1|ENSG00000186453.8|ENSG00000242628.1|ENSG00000219626.4|ENSG00000186453.8|ENSG00000266118.1|ENSG00000266118.1|ENSG00000266118.1|ENSG00000266118.1|ENSG00000266118.1|ENSG00000266118.1|ENSG00000186453.8|ENSG00000186453.8|ENSG00000186453.8|ENSG00000186453.8|ENSG00000242628.1|ENSG00000266118.1|ENSG00000219626.4|ENSG00000186453.8|ENSG00000223754.1|ENSG00000186453.8|ENSG00000266118.1|ENSG00000219626.4|ENSG00000186453.8|ENSG00000232642.1|ENSG00000242628.1|ENSG00000266118.1|ENSG00000186453.8|ENSG00000242628.1|ENSG00000198399.10|ENSG00000219626.4|ENSG00000115129.9	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Tibial|Brain_Cerebellar_Hemisphere|Brain_Cerebellum|Brain_Cortex|Brain_Frontal_Cortex_BA9|Breast_Mammary_Tissue|Colon_Sigmoid|Esophagus_Gastroesophageal_Junction|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Lung|Nerve_Tibial|Nerve_Tibial|Testis|Testis|Testis|Testis|Thyroid|Thyroid|Thyroid|Thyroid|Whole_Blood	0.5	41	14	2	24413298	chr2:24413298	A	G	41	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	24507685	24507685	G	T	exonic	ITSN2	.	nonsynonymous SNV	ITSN2:NM_001348185:exon17:c.C1891A:p.Q631K,ITSN2:NM_006277:exon17:c.C1891A:p.Q631K,ITSN2:NM_147152:exon17:c.C1891A:p.Q631K,ITSN2:NM_001348181:exon18:c.C1849A:p.Q617K	0.024433691	0.975566309	5.52E-13	.	0.30109	0.18256	-0.512707122	21.42014626	4780.84117	14.02023	0.211	0.419	T	0.4	0.330	B	0.225	0.363	B	.	.	.	0.851	0.810	D	0.345	0.112	N	0.29	0.589	T	-0.51	0.160	N	0.556	0.591	-0.788	0.559	T	0.211	0.572	T	0.019	0.412	T	2.771	0.394	21.2	0.977	0.346	0.870	0.461	D	c	0.261	0.397	1.000	0.500	0.476	0.093	0	5.5	0.813	6.493	0.734	1.048	0.713	1.000	0.715	1.000	0.888	19.784	0.964	.	.	.	0.5	.	30	2	24507685	chr2:24507685	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	24507738	24507738	C	T	intronic	ITSN2	.	.	.	0.024433691	0.975566309	5.52E-13	.	0.30109	0.18256	-0.512707122	21.42014626	4780.84117	14.02023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	2	24507738	chr2:24507738	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	25497908	25497908	G	A	exonic	DNMT3A	.	nonsynonymous SNV	DNMT3A:NM_022552:exon6:c.C541T:p.R181C,DNMT3A:NM_175629:exon6:c.C541T:p.R181C	7.73E-45	8.72E-11	1	DISEASE: Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]: An overgrowth syndrome characterized by a distinctive facial appearance, tall stature and intellectual disability. Facial gestalt is characterized by a round face, heavy horizontal eyebrows and narrow palpebral fissures. Less common features include atrial septal defects, seizures, umbilical hernia, and scoliosis. {ECO:0000269|PubMed:24614070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88689	0.41514	-1.131590109	6.481481481	41.83604	1.21826	0.0	0.912	D	1.0	0.899	D	0.973	0.713	D	0.000	0.629	D	1	0.810	D	0.55	0.145	N	-4.25	0.971	D	-3.97	0.736	D	0.825	0.813	1.034	0.978	D	0.895	0.965	D	0.572	0.961	D	6.239	0.861	28.8	0.999	0.967	0.941	0.599	D	c	0.685	0.719	1.000	0.747	0.722	0.854	0	5.24	0.728	9.119	0.936	0.948	0.535	1.000	0.715	1.000	0.888	16.329	0.828	.	.	.	0.5	.	117	2	25497908	chr2:25497908	G	A	.	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	27529135	27529135	G	A	exonic	TRIM54	.	synonymous SNV	TRIM54:NM_187841:exon7:c.G921A:p.E307E,TRIM54:NM_032546:exon8:c.G1047A:p.E349E	8.25E-07	0.297899937	0.702099238	.	0.13331	0.13638	-0.756778259	13.44656759	59.43838	1.56351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	124	2	27529135	chr2:27529135	G	A	86	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	27597143	27597143	G	A	intronic	SNX17	.	.	.	0.686180301	0.313783013	3.67E-05	.	0.44161	0.1167	0.042348793	57.31304553	118.60339	2.3698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	77	2	27597143	chr2:27597143	G	A	70	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	27665361	27665361	C	G	intronic	KRTCAP3	.	.	.	0.044523534	0.850930012	0.104546453	.	0.21532	.	0.148941568	64.31941496	58.73938	1.55429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	63	2	27665361	chr2:27665361	C	G	76	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	27693830	27693830	C	G	exonic	IFT172	.	nonsynonymous SNV	IFT172:NM_015662:exon16:c.G1657C:p.E553Q	2.29E-18	0.999993369	6.63E-06	DISEASE: Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]: A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. {ECO:0000269|PubMed:24140113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 71 (RP71) [MIM:616394]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:25168386}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25302	0.16159	-1.955181094	1.857749469	367.466	4.05229	0.005	0.632	D	0.374	0.414	B	0.334	0.476	B	0.000	0.843	D	1.000	0.537	D	1.545	0.392	L	1.64	0.278	T	-1.88	0.439	N	0.115	0.126	-1.002	0.294	T	0.116	0.409	T	0.012	0.311	T	4.410	0.590	24.1	0.997	0.785	0.992	0.921	D	c	0.452	0.538	1.000	0.747	0.706	0.609	0	5.36	0.765	7.209	0.773	0.847	0.346	1.000	0.715	0.997	0.653	17.646	0.880	WD40/YVTN repeat-like-containing domain	.	.	0.5	56	57	2	27693830	chr2:27693830	C	G	56	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	27878243	27878266	GGTGAAGCTTCAACCTCCAGGTTA	-	exonic	SUPT7L	.	nonframeshift deletion	SUPT7L:NM_001282732:exon4:c.543_566del:p.N182_P189del,SUPT7L:NM_001282729:exon5:c.948_971del:p.N317_P324del,SUPT7L:NM_001282730:exon5:c.942_965del:p.N315_P322del,SUPT7L:NM_001282731:exon5:c.942_965del:p.N315_P322del,SUPT7L:NM_014860:exon5:c.948_971del:p.N317_P324del	0.833193339	0.166095092	0.000711569	.	0.12986	0.28788	-0.137658575	43.57159707	44.29914	1.27031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	49	2	27878242	chr2:27878242	TGGTGAAGCTTCAACCTCCAGGTTA	T	58	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	29004734	29004734	-	T	intronic	PPP1CB	.	.	.	0.997194974	0.002804895	1.31E-07	.	0.75832	.	-0.09720619	46.20193442	2.60658	0.09519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	331	2	29004734	chr2:29004734	A	AT	88	PASS	DP=331;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	30482653	30482653	C	G	UTR3	LBH	NM_030915:c.*2166C>G	.	.	0.300590032	0.622552463	0.076857505	.	0.1442	.	-0.007201372	53.19061099	187.45852	2.97403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	18	2	30482653	chr2:30482653	C	G	40	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	32515614	32515614	G	T	exonic	YIPF4	.	stopgain	YIPF4:NM_032312:exon2:c.G142T:p.E48X	0.019788591	0.902081655	0.078129753	.	0.25391	0.10849	0.369407109	74.95281906	43.18158	1.24746	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.498	0.975	37	0.996	0.729	0.981	0.792	D	c	0.897	0.760	1.000	0.747	0.706	0.609	0	4.48	0.538	9.020	0.931	0.953	0.551	1.000	0.715	1.000	0.888	15.872	0.788	.	.	.	0.5	.	33	2	32515614	chr2:32515614	G	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	32733267	32733267	C	A	exonic	BIRC6	.	synonymous SNV	BIRC6:NM_016252:exon51:c.C9921A:p.T3307T	1	4.09E-15	2.21E-43	.	0.23071	0.09582	-4.329772159	0.106157113	518.6518	4.65379	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	2	32733267	chr2:32733267	C	A	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	36776617	36776617	T	-	UTR3	CRIM1	NM_016441:c.*773delT	.	.	0.977883079	0.022116914	6.98E-09	.	0.26394	.	-1.100469982	6.929700401	649.0811	5.11079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	159	2	36776616	chr2:36776616	CT	C	133	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	37276876	37276876	C	T	exonic	HEATR5B	.	synonymous SNV	HEATR5B:NM_019024:exon18:c.G2616A:p.A872A	8.10E-10	0.999999998	7.48E-10	.	0.25312	.	-2.513844451	0.914130691	1161.22267	6.48464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	2	37276876	chr2:37276876	C	T	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	37276980	37276980	C	G	exonic	HEATR5B	.	nonsynonymous SNV	HEATR5B:NM_019024:exon18:c.G2512C:p.A838P	8.10E-10	0.999999998	7.48E-10	.	0.25312	.	-2.513844451	0.914130691	1161.22267	6.48464	0.011	0.555	D	0.998	0.715	D	0.976	0.719	D	0.000	0.843	D	1	0.810	D	2.52	0.738	M	3.1	0.083	T	-3.2	0.647	D	0.879	0.916	-1.169	0.005	T	0.066	0.274	T	0.031	0.530	D	4.839	0.650	24.8	0.998	0.866	0.990	0.891	D	c	0.719	0.706	1.000	0.747	0.719	0.830	0	5.19	0.713	7.333	0.783	0.802	0.324	1.000	0.715	0.994	0.587	18.694	0.915	Armadillo-like helical|Armadillo-type fold	.	.	0.5	.	34	2	37276980	chr2:37276980	C	G	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	39234343	39234343	A	-	intronic	SOS1	.	.	.	0.999999895	1.05E-07	1.77E-20	DISEASE: Noonan syndrome 4 (NS4) [MIM:610733]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Some patients with NS4 have polyarticular villonodular synovitis. {ECO:0000269|PubMed:17143282, ECO:0000269|PubMed:17143285, ECO:0000269|PubMed:19020799, ECO:0000269|PubMed:19438935, ECO:0000269|PubMed:19953625, ECO:0000269|PubMed:20673819, ECO:0000269|PubMed:20683980, ECO:0000269|PubMed:21387466}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72054	0.38414	-0.995664936	8.539749941	106.78667	2.24216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	240	2	39234342	chr2:39234342	TA	T	67	PASS	DP=240;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	39964136	39964137	TG	-	exonic	THUMPD2	.	frameshift deletion	THUMPD2:NM_001321479:exon9:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321469:exon10:c.971_972del:p.T324Rfs*1,THUMPD2:NM_001321470:exon10:c.923_924del:p.T308Rfs*1,THUMPD2:NM_025264:exon10:c.1250_1251del:p.T417Rfs*1,THUMPD2:NM_001321477:exon11:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321478:exon11:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321480:exon11:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321481:exon11:c.548_549del:p.T183Rfs*1	1.94E-08	0.241386498	0.758613483	.	0.10863	0.098	-0.578583623	18.71903751	235.39647	3.31568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	56	2	39964135	chr2:39964135	CTG	C	43	PASS	DP=56;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	44445605	44445605	T	-	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	178	2	44445604	chr2:44445604	GT	G,GTT	107	PASS	DP=178;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
2	44445605	44445605	-	T	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	178	2	44445604	chr2:44445604	GT	G,GTT	107	PASS	DP=178;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
2	44559598	44559598	C	A	exonic	PREPL	.	nonsynonymous SNV	PREPL:NM_001042385:exon7:c.G1167T:p.K389N,PREPL:NM_001171613:exon8:c.G1086T:p.K362N,PREPL:NM_001171617:exon8:c.G1086T:p.K362N,PREPL:NM_006036:exon8:c.G1353T:p.K451N,PREPL:NM_001171603:exon9:c.G1353T:p.K451N,PREPL:NM_001171606:exon9:c.G1353T:p.K451N	2.43E-11	0.240558654	0.759441346	.	0.37424	0.10892	-0.835882558	11.47676339	281.52127	3.59257	0.005	0.632	D	0.996	0.670	D	0.99	0.774	D	0.000	0.463	D	1.000	0.810	D	1.955	0.530	M	.	.	.	-1.65	0.500	N	0.193	0.246	-0.291	0.752	T	0.394	0.748	T	0.016	0.371	T	4.514	0.604	24.3	0.998	0.924	0.937	0.587	D	c	0.516	0.477	0.631	0.220	0.732	0.924	0	4.67	0.579	3.472	0.526	0.935	0.490	1.000	0.715	0.996	0.625	14.182	0.650	Alpha/Beta hydrolase fold;Alpha/Beta hydrolase fold|Peptidase S9A, N-terminal domain;Peptidase S9A, N-terminal domain	.	.	0.5	.	27	2	44559598	chr2:44559598	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	47389401	47389401	T	A	intronic	CALM2	.	.	.	0.856387219	0.141331344	0.002281437	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:23040497}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Long QT syndrome 14 (LQT14) [MIM:616247]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24076290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Long QT syndrome 15 (LQT15) [MIM:616249]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24917665}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69728	0.32162	0.12325821	62.38499646	8.57012	0.31396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	2	47389401	chr2:47389401	T	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	47600581	47600581	-	T	intronic	EPCAM	.	.	.	7.50E-07	0.479893423	0.520105827	DISEASE: Diarrhea 5, with tufting enteropathy, congenital (DIAR5) [MIM:613217]: An intractable diarrhea of infancy characterized by villous atrophy and absence of inflammation, with intestinal epithelial cell dysplasia manifesting as focal epithelial tufts in the duodenum and jejunum. {ECO:0000269|PubMed:18572020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary non-polyposis colorectal cancer 8 (HNPCC8) [MIM:613244]: An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. {ECO:0000269|PubMed:19098912}. Note=The disease is caused by mutations affecting the gene represented in this entry. HNPCC8 results from heterozygous deletion of 3-prime exons of EPCAM and intergenic regions directly upstream of MSH2, resulting in transcriptional read-through and epigenetic silencing of MSH2 in tissues expressing EPCAM.; 	0.61487	0.29457	0.373041938	75.29488087	2850.98345	10.10064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	13	2	47600581	chr2:47600581	A	AT	39	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	48807976	48807976	T	C	exonic	STON1;STON1-GTF2A1L	.	synonymous SNV	STON1-GTF2A1L:NM_001198594:exon1:c.T204C:p.D68D,STON1-GTF2A1L:NM_001198593:exon2:c.T204C:p.D68D,STON1:NM_006873:exon2:c.T204C:p.D68D,STON1-GTF2A1L:NM_172311:exon2:c.T204C:p.D68D,STON1:NM_001198595:exon3:c.T204C:p.D68D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	12	2	48807976	chr2:48807976	T	C	54	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	48941191	48941191	T	A	exonic	LHCGR	.	nonsynonymous SNV	LHCGR:NM_000233:exon7:c.A539T:p.K180I	2.80E-08	0.490421431	0.509578541	DISEASE: Luteinizing hormone resistance (LHR) [MIM:238320]: An autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias. {ECO:0000269|PubMed:12050206, ECO:0000269|PubMed:15372531, ECO:0000269|PubMed:15472221, ECO:0000269|PubMed:19551906, ECO:0000269|PubMed:7719343, ECO:0000269|PubMed:8559204, ECO:0000269|PubMed:9215288, ECO:0000269|PubMed:9514160, ECO:0000269|PubMed:9626144, ECO:0000269|PubMed:9626653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13036	0.42555	0.356452144	74.62845011	1328.76039	6.85266	0.034	0.574	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	D	1.000	0.810	D	0.995	0.252	L	-1.57	0.819	D	-3.84	0.823	D	0.829	0.831	0.180	0.856	D	0.618	0.865	D	0.274	0.900	D	4.738	0.635	24.7	0.995	0.706	0.939	0.593	D	c	0.638	0.645	1.000	0.489	0.487	0.133	0	5.52	0.821	5.074	0.640	1.061	0.807	1.000	0.715	0.994	0.587	14.976	0.708	Leucine-rich repeat domain, L domain-like	.	.	0.5	127	87	2	48941191	chr2:48941191	T	A	127	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	54586126	54586126	A	C	exonic	C2orf73	.	nonsynonymous SNV	C2orf73:NM_001100396:exon4:c.A419C:p.E140A	0.000860168	0.557463099	0.441676733	.	.	.	0.617373774	83.25076669	1022.80392	6.14997	0.06	0.395	T	0.763	0.417	P	0.173	0.338	B	0.007	0.316	N	0.956	0.379	D	2.505	0.732	M	1.25	0.365	T	-2.27	0.506	N	0.268	0.452	-0.961	0.390	T	0.068	0.280	T	0.013	0.324	T	3.502	0.479	23.1	0.990	0.493	0.591	0.306	D	c	0.118	0.144	0.030	0.139	0.497	0.185	0	4.3	0.504	2.228	0.424	1.199	0.960	0.526	0.269	0.816	0.342	3.720	0.079	.	.	.	0.5	48	84	2	54586126	chr2:54586126	A	C	48	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	55193935	55194035	GGATGAGAAGAAAGATGGGAAAATGGCCTGCTGTTGTTGTCATGGGCTGGCCATAGGCTTTGCAGCCTGGAGCTGAGCTTGGGTTTGGAGAAAAGCCCTAG	-	intronic	EML6	.	.	.	0.443032449	0.455367432	0.10160012	.	.	.	-0.613589782	17.49823071	281.49654	3.59206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	40	2	55193934	chr2:55193934	TGGATGAGAAGAAAGATGGGAAAATGGCCTGCTGTTGTTGTCATGGGCTGGCCATAGGCTTTGCAGCCTGGAGCTGAGCTTGGGTTTGGAGAAAAGCCCTAG	T	50	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	55863360	55863360	-	A	UTR3	PNPT1	NM_033109:c.*11_*12insT	.	.	0.908266843	0.091733155	2.06E-09	DISEASE: Combined oxidative phosphorylation deficiency 13 (COXPD13) [MIM:614932]: A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased. {ECO:0000269|PubMed:23084291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 70 (DFNB70) [MIM:614934]: A form of non-syndromic deafness characterized by severe, bilateral hearing impairment with prelingual onset, resulting in inability to acquire normal speech. {ECO:0000269|PubMed:23084290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2306	0.0952	0.135991087	63.61759849	3768.17005	12.01066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	29	2	55863360	chr2:55863360	T	TA	40	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	56611386	56611386	-	T	intronic	CCDC85A	.	.	.	0.001735205	0.894912275	0.10335252	.	0.11972	0.09438	0.040529541	57.15380986	1143.32157	6.44627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	82	2	56611386	chr2:56611386	C	CT	86	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	58359058	58359131	AACAAAGTACAAATTTTCAAGTATTTCATCATGTACTGCACCAGGTCTGAAGGGATACATTAAAGGGAGCTAAC	-	exonic	VRK2	.	nonframeshift deletion	VRK2:NM_001288839:exon8:c.438_443del:p.K146_T147del,VRK2:NM_001130480:exon9:c.792_797del:p.K264_T265del,VRK2:NM_001130481:exon9:c.792_797del:p.K264_T265del,VRK2:NM_001130482:exon9:c.723_728del:p.K241_T242del,VRK2:NM_001130483:exon9:c.792_797del:p.K264_T265del,VRK2:NM_006296:exon9:c.792_797del:p.K264_T265del,VRK2:NM_001288836:exon10:c.438_443del:p.K146_T147del,VRK2:NM_001288838:exon11:c.792_797del:p.K264_T265del,VRK2:NM_001288837:exon12:c.792_797del:p.K264_T265del	1.22E-08	0.549410088	0.450589899	.	0.13255	0.0962	0.066214104	58.95848077	3255.28139	10.86391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	18	2	58359057	chr2:58359057	AAACAAAGTACAAATTTTCAAGTATTTCATCATGTACTGCACCAGGTCTGAAGGGATACATTAAAGGGAGCTAAC	A	58	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	60687371	60687371	G	A	UTR3	BCL11A	NM_022893:c.*168C>T	.	.	0.828999685	0.170844975	0.00015534	DISEASE: Note=Chromosomal aberrations involving BCL11A may be a cause of lymphoid malignancies. Translocation t(2;14)(p13;q32.3) causes BCL11A deregulation and amplification. {ECO:0000269|PubMed:11719382}.; 	0.66876	0.16967	-1.155457828	6.168907761	22.77118	0.7611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	2	60687371	chr2:60687371	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	61411443	61411443	G	C	intronic	AHSA2	.	.	.	5.61E-06	0.140152678	0.859841708	.	0.05809	.	-0.339715008	30.06605331	275.26294	3.55364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	73	2	61411443	chr2:61411443	G	C	118	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
2	61644004	61644076	CACAGTGGAAGCCCTCATGAGTGCAGGGCCAGCCACTTGTCCAGAGGGCCATGAATGGCGACATACTTGACCC	-	intronic	USP34	.	.	.	1	4.84E-19	7.26E-51	.	0.83824	0.09517	-3.59020415	0.300778485	689.89772	5.23798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	61	2	61644003	chr2:61644003	GCACAGTGGAAGCCCTCATGAGTGCAGGGCCAGCCACTTGTCCAGAGGGCCATGAATGGCGACATACTTGACCC	G	41	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	64112707	64112707	T	-	intronic	UGP2	.	.	.	0.001020131	0.947456118	0.051523751	.	0.97124	0.39898	-0.979072682	8.752064166	24.54236	0.80685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	45	2	64112706	chr2:64112706	CT	C	65	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	65231063	65231063	-	T	intronic	SLC1A4	.	.	.	0.242897704	0.750367908	0.006734388	.	0.12708	0.17318	-0.111973265	45.35857514	749.9076	5.43136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	20	2	65231063	chr2:65231063	G	GT	41	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	65300138	65300138	G	T	intronic	CEP68	.	.	.	0.371622602	0.626025199	0.002352199	.	0.05976	0.09504	0.718303761	85.85161595	1991.18812	8.21944	0.018	0.506	D	0.0	0.026	B	0.001	0.040	B	.	.	.	1	0.090	N	.	.	.	1.85	0.245	T	-0.62	0.183	N	0.021	0.005	-0.986	0.335	T	0.034	0.146	T	0.003	0.081	T	-0.092	0.085	1.788	0.936	0.229	0.195	0.205	N	c	-1.120	-1.186	0.999	0.394	0.461	0.090	0	-0.517	0.113	-0.739	0.049	-0.918	0.026	0.000	0.063	0.000	0.016	8.567	0.325	.	.	.	0.5	.	36	2	65300138	chr2:65300138	G	T	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	68357928	68357928	T	-	UTR3	WDR92	NM_138458:c.*442delA	.	.	0.805659459	0.194119638	0.000220902	.	.	.	0.084621747	60.31493277	1268.45257	6.71084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	91	2	68357927	chr2:68357927	CT	C	55	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	69472576	69472576	G	A	exonic	ANTXR1	.	nonsynonymous SNV	ANTXR1:NM_032208:exon18:c.G1654A:p.A552T	0.985283203	0.014716734	6.25E-08	DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:18931684}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: GAPO syndrome (GAPO) [MIM:230740]: A disease characterized by growth retardation, alopecia, failure of tooth eruption, and progressive optic atrophy in some patients. {ECO:0000269|PubMed:23602711}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.51987	0.13588	-0.909290275	10.03184713	205.61691	3.09642	0.009	0.574	D	0.001	0.067	B	0.003	0.080	B	0.048	0.232	N	0.890	0.359	D	.	.	.	1.25	0.365	T	-1.05	0.275	N	0.261	0.318	-1.016	0.252	T	0.089	0.343	T	0.030	0.526	D	3.906	0.526	23.5	0.850	0.151	0.926	0.558	D	c	-0.086	0.034	1.000	0.747	0.615	0.372	0	4.43	0.528	5.323	0.654	0.902	0.416	1.000	0.715	0.984	0.507	14.883	0.701	.	.	.	0.5	.	142	2	69472576	chr2:69472576	G	A	.	PASS	DP=142;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	70166207	70166207	-	T	UTR3	MXD1	NM_002357:c.*791_*792insT;NM_001202513:c.*791_*792insT;NM_001202514:c.*791_*792insT	.	.	0.388108481	0.601963686	0.009927833	.	0.9375	0.13242	-0.317668748	31.45789101	29.2168	0.93438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	20	2	70166207	chr2:70166207	A	AT	42	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	70463168	70463168	-	A	intronic	TIA1	.	.	.	0.832581092	0.167412892	6.02E-06	DISEASE: Welander distal myopathy (WDM) [MIM:604454]: An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement. {ECO:0000269|PubMed:23348830, ECO:0000269|PubMed:23401021}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90768	0.26333	0.238945317	69.20853975	83.28929	1.94032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	169	2	70463168	chr2:70463168	T	TA	79	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	71209708	71209708	T	A	exonic	ANKRD53	.	nonsynonymous SNV	ANKRD53:NM_001115116:exon5:c.T784A:p.F262I,ANKRD53:NM_024933:exon5:c.T784A:p.F262I	0.000455608	0.867354929	0.132189463	.	0.06661	0.09362	1.26585432	93.59518754	1459.41609	7.12227	0.1	0.390	T	1.0	0.899	D	0.998	0.875	D	0.002	0.366	N	0.984	0.408	D	0.18	0.091	N	-0.11	0.706	T	-1.19	0.342	N	0.67	0.680	-0.280	0.756	T	0.335	0.702	T	0.036	0.572	D	5.365	0.727	25.9	0.992	0.539	0.898	0.502	D	c	0.426	0.478	1.000	0.747	0.554	0.283	0	5.57	0.840	1.972	0.399	0.964	0.580	1.000	0.715	0.995	0.604	13.988	0.637	Ankyrin repeat-containing domain	.	.	0.5	.	63	2	71209708	chr2:71209708	T	A	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	71265235	71265235	G	T	intergenic	OR7E91P;NAGK	dist=8175;dist=30173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	2	71265235	chr2:71265235	G	T	.	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	71658541	71658541	C	T	exonic	ZNF638	.	nonsynonymous SNV	ZNF638:NM_001014972:exon26:c.C5735T:p.A1912V,ZNF638:NM_001252612:exon26:c.C5735T:p.A1912V,ZNF638:NM_001252613:exon26:c.C5735T:p.A1912V,ZNF638:NM_014497:exon26:c.C5735T:p.A1912V	0.99995995	4.01E-05	5.79E-17	.	0.53078	0.09373	-1.600473032	3.01958009	4929.35469	14.30986	0.484	0.081	T	0.017	0.163	B	0.003	0.080	B	0.163	0.031	N	1	0.090	P	1.1	0.281	L	1.47	0.320	T	0.1	0.058	N	0.003	0.000	-1.049	0.147	T	0.001	0.002	T	.	.	.	3.047	0.426	22.4	0.978	0.357	0.237	0.219	N	c	-0.755	-0.678	0.158	0.175	0.707	0.730	0	1.86	0.244	1.021	0.294	-0.375	0.066	0.520	0.269	0.111	0.193	4.368	0.106	.	ENSG00000205847.5	Esophagus_Mucosa	0.5	164	194	2	71658541	chr2:71658541	C	T	164	PASS	DP=194;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	71896341	71896341	G	A	intronic	DYSF	.	.	.	1.00E-15	0.999999362	6.38E-07	DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.26}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18661	0.30664	-1.309065031	4.853739089	1760.18248	7.74393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	49	2	71896341	chr2:71896341	G	A	72	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	73496111	73496111	G	A	exonic	FBXO41	.	synonymous SNV	FBXO41:NM_001080410:exon1:c.C648T:p.D216D	0.951773201	0.048220951	5.85E-06	.	0.30259	0.1115	.	.	1132.93967	6.42282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	2	73496111	chr2:73496111	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	74303470	74303470	C	T	intronic	TET3	.	.	.	0.999942651	5.73E-05	1.00E-11	.	0.85759	0.1031	-1.512251235	3.479594244	432.06015	4.33811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	2	74303470	chr2:74303470	C	T	.	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	74668346	74668346	T	A	intronic	RTKN	.	.	.	0.000149538	0.992324331	0.007526131	.	0.1644	0.10277	-0.841329384	11.36470866	111.05692	2.29721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	279	2	74668346	chr2:74668346	T	A	127	PASS	DP=279;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	74687410	74687410	C	-	exonic	WBP1	.	frameshift deletion	WBP1:NM_012477:exon4:c.412delC:p.P140Lfs*8	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	779	2	74687409	chr2:74687409	AC	A	105	PASS	DP=779;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	74687542	74687542	-	C	exonic	WBP1	.	frameshift insertion	WBP1:NM_012477:exon4:c.545dupC:p.H185Sfs*4	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	1009	2	74687542	chr2:74687542	G	GC	79	PASS	DP=1009;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	74763924	74763924	C	-	exonic	LOXL3	.	frameshift deletion	LOXL3:NM_032603:exon5:c.824delG:p.G275Afs*4	5.65E-08	0.991443691	0.008556252	.	0.36983	0.16108	0.003714825	54.06935598	1582.47535	7.35746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	41	2	74763923	chr2:74763923	GC	G	44	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	74906846	74906846	C	-	exonic	SEMA4F	.	frameshift deletion	SEMA4F:NM_001271661:exon10:c.1358delC:p.R455Gfs*8,SEMA4F:NM_001271662:exon13:c.1724delC:p.R577Gfs*8,SEMA4F:NM_004263:exon14:c.1823delC:p.R610Gfs*8	6.74E-10	0.857591603	0.142408397	.	0.0811	0.09449	-1.061810361	7.519462137	110.21044	2.28329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	417	2	74906845	chr2:74906845	AC	A	76	PASS	DP=417;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	79364374	79364374	C	G	ncRNA_exonic	REG1CP	.	.	.	.	.	.	.	.	0.21173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	17	2	79364374	chr2:79364374	C	G	40	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	87169455	87169455	-	CGGCCTCGACCTGGCGGGGCGG	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	328	2	87169455	chr2:87169455	A	ACGGCCTCGACCTGGCGGGGCGG	130	PASS	DP=328;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	87211799	87211799	A	G	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	370	2	87211799	chr2:87211799	A	G	106	PASS	DP=370;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	87211809	87211809	C	A	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	414	2	87211809	chr2:87211809	C	A	83	PASS	DP=414;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	87355912	87355912	C	T	intergenic	LOC285074;MIR4771-2	dist=52376;dist=65997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	166	2	87355912	chr2:87355912	C	T	131	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	87408300	87408300	G	A	intergenic	LOC285074;MIR4771-2	dist=104764;dist=13609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	90	2	87408300	chr2:87408300	G	A	90	PASS	DP=90;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89278489	89278489	A	C	intergenic	MIR4436A;NONE	dist=166521;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	203	2	89278489	chr2:89278489	A	C	115	PASS	DP=203;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89292182	89292182	A	G	intergenic	MIR4436A;NONE	dist=180214;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	75	2	89292182	chr2:89292182	A	G	105	PASS	DP=75;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89292401	89292401	T	C	intergenic	MIR4436A;NONE	dist=180433;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	111	2	89292401	chr2:89292401	T	C	87	PASS	DP=111;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89309542	89309542	T	G	intergenic	MIR4436A;NONE	dist=197574;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	86	2	89309542	chr2:89309542	T	G	94	PASS	DP=86;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89309554	89309554	T	A	intergenic	MIR4436A;NONE	dist=197586;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	86	2	89309554	chr2:89309554	T	A	84	PASS	DP=86;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89309762	89309762	T	G	intergenic	MIR4436A;NONE	dist=197794;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	76	2	89309762	chr2:89309762	T	G	114	PASS	DP=76;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	89326797	89326886	GGATGCATCATAGATGAGGAGCCTGGGAGCCTGGCCAGGTTTCTGTTGGTACCAGGCTAAGTAGCTGCTAACACTCTGACTGGCCCTGCA	-	intergenic	MIR4436A;NONE	dist=214829;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	47	2	89326796	chr2:89326796	TGGATGCATCATAGATGAGGAGCCTGGGAGCCTGGCCAGGTTTCTGTTGGTACCAGGCTAAGTAGCTGCTAACACTCTGACTGGCCCTGCA	T	54	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	89339848	89339848	C	G	intergenic	MIR4436A;NONE	dist=227880;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	192	2	89339848	chr2:89339848	C	G	88	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	89346026	89346026	G	-	intergenic	MIR4436A;NONE	dist=234058;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	42	2	89346025	chr2:89346025	AG	A	41	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	90077766	90077766	C	G	intergenic	MIR4436A;LOC654342	dist=965798;dist=1746943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	371	2	90077766	chr2:90077766	C	G	130	PASS	DP=371;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	90121985	90121985	A	G	intergenic	MIR4436A;LOC654342	dist=1010017;dist=1702724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	67	2	90121985	chr2:90121985	A	G	99	PASS	DP=67;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	90211702	90211702	C	A	intergenic	MIR4436A;LOC654342	dist=1099734;dist=1613007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	362	2	90211702	chr2:90211702	C	A	118	PASS	DP=362;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	90259965	90259965	T	C	intergenic	MIR4436A;LOC654342	dist=1147997;dist=1564744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	27	2	90259965	chr2:90259965	T	C	55	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	91777719	91777719	G	A	intergenic	NONE;LOC654342	dist=NONE;dist=46990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	239	2	91777719	chr2:91777719	G	A	75	PASS	DP=239;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	91795525	91795525	G	T	intergenic	NONE;LOC654342	dist=NONE;dist=29184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	1071	2	91795525	chr2:91795525	G	T	109	PASS	DP=1071;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	91800851	91800851	T	C	intergenic	NONE;LOC654342	dist=NONE;dist=23858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	569	2	91800851	chr2:91800851	T	C	103	PASS	DP=569;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	95940557	95940557	A	T	exonic	PROM2	.	nonsynonymous SNV	PROM2:NM_001165977:exon1:c.A224T:p.Q75L,PROM2:NM_001165978:exon1:c.A224T:p.Q75L,PROM2:NM_144707:exon1:c.A224T:p.Q75L	7.90E-08	0.994662578	0.005337343	.	0.12478	0.0927	-0.369255208	28.25548478	1092.43407	6.32455	0.002	0.721	D	0.999	0.764	D	0.984	0.745	D	0.001	0.428	D	1.000	0.495	D	2.93	0.848	M	0.81	0.485	T	-5.55	0.862	D	0.527	0.674	-0.634	0.634	T	0.268	0.640	T	0.173	0.850	D	4.590	0.615	24.4	0.993	0.575	0.707	0.344	D	c	0.400	0.310	1.000	0.747	0.609	0.351	0	4.94	0.645	2.723	0.467	1.028	0.649	0.998	0.411	0.909	0.387	10.981	0.465	.	.	.	0.5	.	71	2	95940557	chr2:95940557	A	T	.	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	96147352	96147352	G	A	exonic	TRIM43B	.	synonymous SNV	TRIM43B:NM_001164464:exon3:c.C498T:p.F166F	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	92	2	96147352	chr2:96147352	G	A	106	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
2	96457946	96457946	T	C	intergenic	TRIM43;LINC00342	dist=192427;dist=14854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	221	2	96457946	chr2:96457946	T	C	173	PASS	DP=221;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	96504594	96504594	C	T	intergenic	LINC00342;ANKRD36C	dist=11865;dist=10702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	64	2	96504594	chr2:96504594	C	T	64	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	96517502	96517502	A	C	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon87:c.T6351G:p.I2117M	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.038	0.427	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	1.27	0.361	T	0.01	0.069	N	0.067	0.112	-1.027	0.214	T	0.037	0.162	T	.	.	.	-0.910	0.035	0.025	0.253	0.012	0.004	0.021	N	c	-1.567	-1.743	0.000	0.044	0.651	0.465	0	-3.59	0.043	-0.643	0.055	-1.236	0.015	0.000	0.063	0.000	0.016	0.308	0.003	Ankyrin repeat-containing domain	.	.	0.5	85	57	2	96517502	chr2:96517502	A	C	85	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	96521280	96521280	T	G	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon84:c.A5827C:p.I1943L	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.119	0.280	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	2.54	0.139	T	-0.89	0.240	N	0.077	0.068	-0.967	0.377	T	0.013	0.048	T	.	.	.	-0.120	0.083	1.583	0.702	0.089	0.017	0.053	N	c	-1.017	-1.184	0.000	0.035	0.707	0.730	0	-2.62	0.058	-0.723	0.050	-0.461	0.055	0.000	0.063	0.016	0.126	0.732	0.009	.	.	.	0.5	121	489	2	96521280	chr2:96521280	T	G	121	PASS	DP=489;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	96606914	96606914	C	-	exonic	ANKRD36C	.	frameshift deletion	ANKRD36C:NM_001310154:exon20:c.1525delG:p.A509Qfs*14	.	.	.	.	.	.	.	.	2676.37542	9.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	182	2	96606913	chr2:96606913	GC	G	51	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	96617102	96617102	C	T	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon15:c.G1258A:p.E420K	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.356	0.120	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	2.18	0.189	T	-0.23	0.107	N	0.084	0.246	-0.990	0.327	T	0.025	0.109	T	.	.	.	-0.620	0.049	0.112	0.589	0.059	0.000	0.002	N	c	-1.003	-1.160	0.000	0.038	0.581	0.330	0	0.406	0.155	0.404	0.206	-0.320	0.077	0.064	0.217	0.001	0.043	3.230	0.063	.	.	.	0.5	91	186	2	96617102	chr2:96617102	C	T	91	PASS	DP=186;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	96697823	96697823	G	A	exonic	GPAT2	.	synonymous SNV	GPAT2:NM_001321525:exon3:c.C135T:p.P45P,GPAT2:NM_001321526:exon3:c.C135T:p.P45P,GPAT2:NM_001321527:exon3:c.C135T:p.P45P,GPAT2:NM_001321528:exon3:c.C135T:p.P45P,GPAT2:NM_001321529:exon3:c.C135T:p.P45P,GPAT2:NM_001321530:exon3:c.C135T:p.P45P,GPAT2:NM_207328:exon3:c.C135T:p.P45P,GPAT2:NM_001321531:exon4:c.C135T:p.P45P	0.0016123	0.992339401	0.006048299	.	.	.	.	.	151.08322	2.68731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	395	2	96697823	chr2:96697823	G	A	161	PASS	DP=395;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	97711806	97711806	A	G	intergenic	FAM178B;FAHD2B	dist=59505;dist=37517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	33	2	97711806	chr2:97711806	A	G	62	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	97827782	97827782	T	C	intronic	ANKRD36	.	.	.	2.12E-19	0.086362931	0.913637069	.	.	.	.	.	4272.72254	12.99655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	2	97827782	chr2:97827782	T	C	.	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	98205924	98205924	C	G	intronic	ANKRD36B	.	.	.	.	.	.	.	0.28221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	491	2	98205924	chr2:98205924	C	G	105	PASS	DP=491;AN=4	GT	0/1	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	98872571	98872571	T	-	intronic	VWA3B	.	.	.	3.27E-18	0.596776822	0.403223178	DISEASE: Note=Defects in VWA3B may be a cause of cerebellar ataxia with intellectual disability. {ECO:0000269|PubMed:26157035}.; 	0.09166	.	1.322735566	94.07879217	1748.74917	7.72022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	281	2	98872570	chr2:98872570	CT	C	110	PASS	DP=281;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	100218010	100218010	C	T	exonic	AFF3	.	nonsynonymous SNV	AFF3:NM_001025108:exon13:c.G1333A:p.G445S,AFF3:NM_002285:exon13:c.G1258A:p.G420S	0.998912591	0.001087409	4.40E-12	.	0.81091	0.1261	-1.455091209	3.886529842	210.2759	3.13007	0.919	0.023	T	0.004	0.112	B	0.004	0.093	B	0.832	0.091	N	0.700	0.334	D	-0.215	0.040	N	-0.0	0.626	T	-0.6	0.178	N	0.153	0.230	-0.898	0.482	T	0.070	0.286	T	0.029	0.518	D	1.237	0.214	11.94	0.909	0.195	0.110	0.161	N	c	-1.248	-1.118	1.000	0.428	0.554	0.246	0	-5.37	0.025	-0.234	0.090	-0.505	0.051	0.950	0.328	0.993	0.574	12.972	0.577	.	.	.	0.5	59	76	2	100218010	chr2:100218010	C	T	59	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	101098726	101098726	-	T	intronic	NMS	.	.	.	2.78E-10	0.041912109	0.958087891	.	0.0817	0.1288	0.25917371	70.05779665	1820.09065	7.86854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	42	2	101098726	chr2:101098726	C	CT	52	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	101437601	101437601	C	G	intronic	NPAS2	.	.	.	0.990888562	0.009111438	7.90E-10	.	0.21897	0.22837	-0.506987379	21.76810569	5079.47281	14.59455	.	.	.	0.005	0.119	B	0.003	0.080	B	.	.	.	1	0.090	P	.	.	.	0.78	0.494	T	.	.	.	0.089	0.086	-0.993	0.318	T	0.000	0.000	T	.	.	.	0.932	0.183	10.26	0.684	0.084	0.123	0.170	N	c	-0.944	-0.949	1.000	0.747	0.437	0.062	0	2.43	0.287	0.288	0.186	0.852	0.362	0.003	0.159	0.015	0.124	7.284	0.253	.	ENSG00000170485.12	Skin_Sun_Exposed_Lower_leg	0.5	190	179	2	101437601	chr2:101437601	C	G	190	PASS	DP=179;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	101640087	101640087	T	-	intronic	TBC1D8	.	.	.	5.26E-07	0.999927627	7.18E-05	.	0.16485	0.13045	-1.006844617	8.209483369	2278.58196	8.83254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	260	2	101640086	chr2:101640086	GT	G,GTT	59	PASS	DP=260;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
2	101640087	101640087	-	T	intronic	TBC1D8	.	.	.	5.26E-07	0.999927627	7.18E-05	.	0.16485	0.13045	-1.006844617	8.209483369	2278.58196	8.83254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	260	2	101640086	chr2:101640086	GT	G,GTT	59	PASS	DP=260;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
2	102315057	102315057	A	G	intronic	MAP4K4	.	.	.	0.999998979	1.02E-06	2.24E-17	.	0.51487	0.22596	-1.442099697	3.951403633	72.59332	1.77682	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	15	2	102315057	chr2:102315057	A	G	43	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	103343382	103343382	G	A	exonic	MFSD9	.	synonymous SNV	MFSD9:NM_001322080:exon4:c.C166T:p.L56L,MFSD9:NM_001322081:exon4:c.C166T:p.L56L,MFSD9:NM_032718:exon4:c.C349T:p.L117L	7.72E-06	0.501855498	0.498136782	.	0.10254	.	0.380318343	75.63104506	710.21598	5.29472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	2	103343382	chr2:103343382	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	103343394	103343394	G	A	exonic	MFSD9	.	synonymous SNV	MFSD9:NM_001322080:exon4:c.C154T:p.L52L,MFSD9:NM_001322081:exon4:c.C154T:p.L52L,MFSD9:NM_032718:exon4:c.C337T:p.L113L	7.72E-06	0.501855498	0.498136782	.	0.10254	.	0.380318343	75.63104506	710.21598	5.29472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	2	103343394	chr2:103343394	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	105892143	105892143	C	T	exonic	TGFBRAP1	.	synonymous SNV	TGFBRAP1:NM_001142621:exon8:c.G1539A:p.V513V,TGFBRAP1:NM_001328646:exon8:c.G1539A:p.V513V,TGFBRAP1:NM_004257:exon8:c.G1539A:p.V513V	0.129423466	0.870378795	0.000197739	.	0.07447	0.23492	-1.03794674	7.832035858	126.08397	2.44361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	2	105892143	chr2:105892143	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	106498259	106498259	G	T	exonic	NCK2	.	nonsynonymous SNV	NCK2:NM_001004720:exon3:c.G702T:p.W234C,NCK2:NM_003581:exon4:c.G702T:p.W234C	0.702843118	0.293520718	0.003636164	.	0.24804	0.25902	-0.714505427	14.4019816	20.00595	0.68218	0.0	0.912	D	0.987	0.600	D	0.928	0.645	D	0.000	0.843	D	1	0.810	D	2.795	0.818	M	-5.51	0.992	D	-12.07	0.996	D	0.973	0.974	1.076	0.988	D	0.980	0.994	D	0.619	0.967	D	6.609	0.908	32	0.993	0.588	0.966	0.698	D	c	0.960	0.915	1.000	0.747	0.707	0.730	0	5.51	0.817	9.536	0.971	0.974	0.594	1.000	0.715	0.993	0.574	19.782	0.964	SH2 domain|SH3 domain	.	.	0.5	130	208	2	106498259	chr2:106498259	G	T	130	PASS	DP=208;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	106994488	106994488	G	C	intergenic	UXS1;PLGLA	dist=183693;dist=4082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	118	2	106994488	chr2:106994488	G	C	76	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	106994545	106994545	C	T	intergenic	UXS1;PLGLA	dist=183750;dist=4025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	122	2	106994545	chr2:106994545	C	T	64	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	107032238	107032238	A	G	intronic	RGPD3	.	.	.	.	.	.	.	.	.	.	.	3258.22851	10.87204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	38	2	107032238	chr2:107032238	A	G	74	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	109239403	109239403	G	C	intronic	LIMS1	.	.	.	0.347565207	0.649601345	0.002833447	.	0.85268	0.14897	.	.	138.63474	2.56496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	67	2	109239403	chr2:109239403	G	C	44	PASS	DP=67;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	109356988	109356988	G	C	exonic	RANBP2	.	nonsynonymous SNV	RANBP2:NM_006267:exon7:c.G826C:p.D276H	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	0.004	0.654	D	0.996	0.670	D	0.831	0.578	P	.	.	.	0.951	0.377	D	2.645	0.776	M	1.53	0.304	T	-3.05	0.629	D	0.485	0.623	-0.912	0.466	T	0.126	0.432	T	0.016	0.378	T	3.831	0.517	23.4	0.994	0.618	0.996	0.976	D	c	0.721	0.716	0.972	0.293	0.707	0.730	0	4.79	0.608	9.401	0.966	1.038	0.658	1.000	0.715	1.000	0.888	11.696	0.506	Tetratricopeptide-like helical domain	.	.	0.5	143	373	2	109356988	chr2:109356988	G	C	143	PASS	DP=373;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	109374849	109374849	-	T	intronic	RANBP2	.	.	.	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	335	2	109374849	chr2:109374849	A	AT	78	PASS	DP=335;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	109404474	109404474	-	T	intronic	CCDC138	.	.	.	1.08E-05	0.986815955	0.013173211	.	0.15822	.	-0.464712395	23.5727766	2253.24012	8.76685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	49	2	109404474	chr2:109404474	C	CT	65	PASS	DP=49;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	109960809	109960809	G	T	intronic	SH3RF3	.	.	.	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.231	0.074	0.945	0.713	0.093	0.095	0.150	N	n	-0.099	-0.182	1.000	0.473	0.054	0.004	0	0.474	0.159	1.163	0.312	0.635	0.291	0.004	0.165	0.015	0.124	5.12	0.141	.	.	.	0.5	97	225	2	109960809	chr2:109960809	G	T	97	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	110036009	110036009	G	T	exonic	SH3RF3	.	synonymous SNV	SH3RF3:NM_001099289:exon5:c.G1314T:p.S438S	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	2	110036009	chr2:110036009	G	T	.	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	111644331	111644331	A	G	intronic	ACOXL	.	.	.	6.28E-10	0.400098611	0.599901388	.	0.07205	0.07959	1.86668643	97.19863175	3441.02377	11.26674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	56	2	111644331	chr2:111644331	A	G	71	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	112526866	112526866	G	A	UTR3	ANAPC1	NM_022662:c.*2C>T	.	.	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	55	2	112526866	chr2:112526866	G	A	52	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	113138326	113138326	C	T	intronic	RGPD5;RGPD8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	2	113138326	chr2:113138326	C	T	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	114400755	114400755	-	T	UTR3	RABL2A	NM_001306158:c.*1049_*1050insT;NM_013412:c.*1049_*1050insT;NM_001306161:c.*1049_*1050insT	.	.	0.940339178	0.059419131	0.000241691	.	.	0.09824	0.283038099	71.26680821	604.99814	4.97813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	404	2	114400755	chr2:114400755	C	CT	95	PASS	DP=404;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	114500277	114500277	A	-	exonic	SLC35F5	.	frameshift deletion	SLC35F5:NM_001330314:exon7:c.724delT:p.C242Afs*21,SLC35F5:NM_001330315:exon7:c.742delT:p.C248Afs*21,SLC35F5:NM_001330316:exon7:c.742delT:p.C248Afs*20,SLC35F5:NM_001330317:exon7:c.724delT:p.C242Afs*3,SLC35F5:NM_025181:exon7:c.742delT:p.C248Afs*21	0.001215718	0.996927948	0.001856334	.	0.26269	0.09982	0.062575634	58.74026893	105.3262	2.22212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	47	8	2	114500276	chr2:114500276	CA	C	47	PASS	DP=8;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	119599910	119599910	C	A	UTR3	EN1	NM_001426:c.*604G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	2	119599910	chr2:119599910	C	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	119599911	119599911	C	A	UTR3	EN1	NM_001426:c.*603G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	2	119599911	chr2:119599911	C	A	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	120714402	120714404	TTT	-	intronic	PTPN4	.	.	.	0.999997516	2.48E-06	3.96E-17	.	0.18506	0.12354	-0.021969881	52.14673272	429.77615	4.32968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.35	98	2	120714401	chr2:120714401	CTTT	C,CT,CTTTT	10.35	PASS	DP=98;AN=2	GT	././.	0/1/.	././.	././.	././.	././.	././.	././.	././.	././.	././.
2	120714403	120714404	TT	-	intronic	PTPN4	.	.	.	0.999997516	2.48E-06	3.96E-17	.	0.18506	0.12354	-0.021969881	52.14673272	429.77615	4.32968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.35	98	2	120714401	chr2:120714401	CTTT	C,CT,CTTTT	10.35	PASS	DP=98;AN=2	GT	././.	0/1/.	././.	././.	././.	././.	././.	././.	././.	././.	././.
2	120714404	120714404	-	T	intronic	PTPN4	.	.	.	0.999997516	2.48E-06	3.96E-17	.	0.18506	0.12354	-0.021969881	52.14673272	429.77615	4.32968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.35	98	2	120714401	chr2:120714401	CTTT	C,CT,CTTTT	10.35	PASS	DP=98;AN=2	GT	././.	0/1/.	././.	././.	././.	././.	././.	././.	././.	././.	././.
2	120831655	120831655	T	-	intronic	EPB41L5	.	.	.	0.022933841	0.977065093	1.07E-06	.	0.19351	0.09111	0.04598748	57.47817882	253.06645	3.42227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	17	2	120831654	chr2:120831654	CT	C	44	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	120857746	120857747	TA	-	intronic	EPB41L5	.	.	.	0.022933841	0.977065093	1.07E-06	.	0.19351	0.09111	0.04598748	57.47817882	253.06645	3.42227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	138	37	2	120857745	chr2:120857745	GTA	G	138	PASS	DP=37;AN=2	GT	./.	1/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	120980428	120980428	G	C	exonic	TMEM185B	.	nonsynonymous SNV	TMEM185B:NM_024121:exon1:c.C125G:p.A42G	0.493451137	0.430599693	0.07594917	.	.	.	.	.	50.82318	1.40476	0.175	0.224	T	0.102	0.243	B	0.137	0.317	B	.	.	.	0.000	0.588	P	1.79	0.469	L	1.8	0.253	T	-1.69	0.402	N	0.515	0.558	.	.	.	.	.	.	.	.	.	3.602	0.490	23.2	0.997	0.776	0.976	0.756	D	n	1.793	1.061	1.000	0.747	0.733	0.969	0	2.9	0.327	9.126	0.937	1.048	0.713	1.000	0.715	0.999	0.750	9.636	0.388	.	ENSG00000226479.3|ENSG00000115109.9|ENSG00000226479.3|ENSG00000226479.3|ENSG00000226479.3|ENSG00000226479.3|ENSG00000226479.3|ENSG00000226479.3|ENSG00000226479.3|ENSG00000144118.9|ENSG00000226479.3	Adipose_Subcutaneous|Adrenal_Gland|Artery_Aorta|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Muscle_Skeletal|Testis|Testis	0.5	61	23	2	120980428	chr2:120980428	G	C	61	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	122006480	122006480	C	T	intronic	TFCP2L1	.	.	.	0.999192587	0.000807412	1.27E-09	.	0.12962	0.10362	-0.400392389	26.85185185	222.44013	3.22468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	195	2	122006480	chr2:122006480	C	T	65	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	125191997	125191997	A	C	intronic	CNTNAP5	.	.	.	0.097272924	0.902726965	1.10E-07	.	0.28988	0.10318	-0.986602472	8.645907054	325.79675	3.83698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	13	2	125191997	chr2:125191997	A	C	44	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	128370201	128370201	G	T	intronic	MYO7B	.	.	.	6.38E-16	0.999852793	0.000147207	.	0.11748	.	1.019668216	90.92356688	5040.89055	14.51846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	74	2	128370201	chr2:128370201	G	T	76	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	128462192	128462192	A	-	UTR3	WDR33	NM_018383:c.*1705delT	.	.	0.999997733	2.27E-06	2.62E-19	.	0.17172	0.11281	-0.813834387	12.05472989	577.17958	4.87117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	32	2	128462191	chr2:128462191	TA	T	51	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	130951848	130951848	T	C	exonic	TUBA3E	.	synonymous SNV	TUBA3E:NM_207312:exon4:c.A567G:p.L189L	0.001205278	0.846489817	0.152304904	.	0.51437	0.17173	0.378498378	75.58386412	520.54799	4.65963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	154	2	130951848	chr2:130951848	T	C	124	PASS	DP=154;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	131414196	131414196	A	T	exonic	POTEJ	.	synonymous SNV	POTEJ:NM_001277083:exon15:c.A1863T:p.L621L	.	.	.	.	.	.	.	.	1579.22659	7.35384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	2	131414196	chr2:131414196	A	T	.	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	131827434	131827434	T	-	intronic	FAM168B	.	.	.	0.043771494	0.849524038	0.106704469	.	.	.	-0.185391282	39.67916962	20.93895	0.70903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	43	2	131827433	chr2:131827433	CT	C	79	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	131883311	131883311	-	T	intronic	PLEKHB2	.	.	.	3.54E-06	0.573002701	0.426993762	.	0.16785	.	-0.427900189	25.14744043	21.94762	0.73814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	54	2	131883311	chr2:131883311	A	AT	53	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	131947396	131947396	T	-	intergenic	PLEKHB2;POTEE	dist=39971;dist=28528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	312	2	131947395	chr2:131947395	AT	A	82	PASS	DP=312;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	131976061	131976061	G	T	exonic	POTEE	.	nonsynonymous SNV	POTEE:NM_001083538:exon1:c.G86T:p.C29F	.	.	.	.	.	.	.	.	513.98926	4.63955	0.12	0.279	T	0.676	0.394	P	0.308	0.396	B	.	.	.	1	0.090	N	0.55	0.145	N	-0.97	0.757	T	-0.37	0.132	N	0.421	0.478	-0.900	0.480	T	0.209	0.569	T	0.030	0.525	D	-0.368	0.064	0.461	0.652	0.075	0.010	0.039	N	c	-0.930	-1.136	0.000	0.012	0.554	0.246	0	0.1	0.138	0.059	0.141	0.303	0.270	0.004	0.165	0.007	0.100	.	.	.	.	.	0.5	.	109	2	131976061	chr2:131976061	G	T	.	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	132014501	132014501	G	T	intronic	POTEE	.	.	.	.	.	.	.	.	.	.	.	513.98926	4.63955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	173	2	132014501	chr2:132014501	G	T	.	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	132121350	132121350	G	C	UTR5	WTH3DI	NM_001077637:c.-57C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	168	2	132121350	chr2:132121350	G	C	124	PASS	DP=168;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	132366964	132366964	T	C	ncRNA_exonic	POTEKP	.	.	.	.	.	.	.	.	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	305	2	132366964	chr2:132366964	T	C	141	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	132384704	132384704	T	C	downstream	POTEKP	dist=702	.	.	.	.	.	.	.	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	717	2	132384704	chr2:132384704	T	C	137	PASS	DP=717;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	132860647	132860647	C	T	intergenic	LINC01945;ANKRD30BL	dist=65174;dist=44517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	121	2	132860647	chr2:132860647	C	T	86	PASS	DP=121;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	133426045	133426045	G	T	exonic	LYPD1	.	nonsynonymous SNV	LYPD1:NM_144586:exon2:c.C118A:p.P40T,LYPD1:NM_001321234:exon3:c.C166A:p.P56T	0.000238591	0.313658655	0.686102754	.	0.21654	.	0.3032669	72.009908	18.3074	0.63566	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1.000	0.810	D	2.045	0.562	M	-1.48	0.812	T	-2.85	0.600	D	0.724	0.723	0.127	0.847	D	0.525	0.823	D	0.092	0.758	D	5.793	0.792	27.1	0.998	0.897	0.972	0.733	D	c	0.730	0.775	1.0	0.983	0.652	0.477	0	5.43	0.789	8.986	0.930	1.048	0.713	1.000	0.715	0.999	0.750	17.605	0.879	Ly-6 antigen / uPA receptor -like	.	.	0.5	.	40	2	133426045	chr2:133426045	G	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	136552282	136552282	G	A	exonic	LCT	.	synonymous SNV	LCT:NM_002299:exon14:c.C5040T:p.F1680F	0.064255017	0.935744974	8.95E-09	DISEASE: Congenital lactase deficiency (COLACD) [MIM:223000]: Autosomal recessive, rare and severe gastrointestinal disorder. It is characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas. An almost total lack of LCT activity is found in jejunal biopsy material of patients with congenital lactase deficiency. Opposite to congenital lactase deficiency, also known as lactose intolerance, is the most common enzyme deficiency worldwide. It is caused by developmental down- regulation of lactase activity during childhood or early adulthood. The decline of lactase activity is a normal physiological phenomenon; however, the majority of Northern Europeans have the ability to maintain lactase activity and digest lactose throughout life (lactase persistence). The down-regulation of lactase activity operates at the transcriptional level and it is associated with a noncoding variation in the MCM6 gene, located in the upstream vicinity of LCT. {ECO:0000269|PubMed:16400612}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10638	0.66554	-1.335817967	4.659117716	3628.57927	11.68781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	2	136552282	chr2:136552282	G	A	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	136872414	136872414	-	A	UTR3	CXCR4	NM_001348059:c.*24_*25insT;NM_001348056:c.*24_*25insT;NM_003467:c.*24_*25insT;NM_001348060:c.*24_*25insT;NM_001008540:c.*24_*25insT	.	.	0.42745098	0.539796705	0.032752315	DISEASE: WHIM syndrome (WHIMS) [MIM:193670]: Immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. {ECO:0000269|PubMed:12692554}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90261	0.79193	-0.295622497	32.61972163	7.8354	0.28802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	25	2	136872414	chr2:136872414	T	TA	39	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
2	144008050	144008050	C	G	intronic	ARHGAP15	.	.	.	5.25E-06	0.964756522	0.035238224	.	0.77364	0.12676	-0.624497208	17.16206653	736.83485	5.38892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	34	2	144008050	chr2:144008050	C	G	41	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	145027394	145027394	-	A	intronic	GTDC1	.	.	.	2.41E-10	0.07320236	0.92679764	.	0.15283	0.07494	-0.176292081	40.56381222	263.31779	3.48127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.17	40	2	145027394	chr2:145027394	T	TA	19.17	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	145277696	145277696	C	T	ncRNA_intronic	ZEB2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	14	2	145277696	chr2:145277696	C	T	.	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	145277718	145277718	C	T	ncRNA_intronic	ZEB2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	13	2	145277718	chr2:145277718	C	T	.	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	152695179	152695179	T	-	UTR3	CACNB4	NM_001320722:c.*454delA;NM_001145798:c.*454delA;NM_000726:c.*454delA;NM_001330115:c.*454delA;NM_001330116:c.*454delA;NM_001330114:c.*454delA;NM_001330113:c.*454delA;NM_001330117:c.*454delA;NM_001330118:c.*454delA;NM_001005747:c.*454delA;NM_001005746:c.*454delA	.	.	0.011363582	0.988273668	0.00036275	DISEASE: Juvenile myoclonic epilepsy 6 (EJM6) [MIM:607682]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Episodic ataxia 5 (EA5) [MIM:613855]: A disorder characterized by episodes of vertigo and ataxia that last for several hours. Interictal examination show spontaneous downbeat and gaze-evoked nystagmus, mild dysarthria and truncal ataxia. {ECO:0000269|PubMed:10762541}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19944	0.13941	0.082802743	60.09082331	22.57919	0.75555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	23	2	152695178	chr2:152695178	GT	G	43	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	153476208	153476208	G	A	exonic	FMNL2	.	nonsynonymous SNV	FMNL2:NM_052905:exon15:c.G1813A:p.V605M	0.996999397	0.003000603	5.23E-11	.	0.37448	.	0.135991087	63.61759849	191.04411	2.99833	0.054	0.386	T	0.99	0.615	D	0.969	0.703	D	0.000	0.523	D	1	0.810	D	2.615	0.767	M	0.93	0.441	T	-0.71	0.202	N	0.683	0.690	-0.864	0.510	T	0.150	0.478	T	0.034	0.558	D	5.015	0.675	25.2	0.998	0.910	0.998	0.995	D	c	0.337	0.465	1.000	0.747	0.707	0.730	0	5.12	0.693	9.309	0.953	0.940	0.530	1.000	0.715	0.994	0.587	18.611	0.912	.	.	.	0.5	.	29	2	153476208	chr2:153476208	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	157186619	157186619	G	T	exonic	NR4A2	.	stopgain	NR4A2:NM_006186:exon3:c.C80A:p.S27X	0.991432866	0.008565133	2.00E-06	.	0.64744	0.60715	-0.626318434	17.03231894	29.24717	0.93603	.	.	.	.	.	.	.	.	.	0.010	0.301	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.397	0.967	36	0.990	0.491	0.958	0.660	D	c	0.937	0.824	1.000	0.747	0.549	0.223	0	5.43	0.789	6.401	0.730	1.048	0.713	1.000	0.715	1.000	0.888	19.013	0.928	.	.	.	0.5	116	247	2	157186619	chr2:157186619	G	T	116	PASS	DP=247;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	160086692	160086692	A	G	exonic	TANC1	.	synonymous SNV	TANC1:NM_001350062:exon24:c.A4152G:p.T1384T,TANC1:NM_001350063:exon25:c.A4386G:p.T1462T,TANC1:NM_001350064:exon27:c.A4734G:p.T1578T,TANC1:NM_033394:exon27:c.A4755G:p.T1585T,TANC1:NM_001350065:exon28:c.A4734G:p.T1578T	0.140685896	0.859314101	2.36E-09	.	0.2207	0.09998	-1.262475058	5.266572305	1280.16491	6.73695	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	42	2	160086692	chr2:160086692	A	G	62	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	162274729	162274729	C	A	exonic	TBR1	.	nonsynonymous SNV	TBR1:NM_006593:exon3:c.C865A:p.H289N	0.993588037	0.006410977	9.85E-07	.	0.93213	0.38022	-0.405853867	26.23260203	93.16795	2.07643	0.0	0.912	D	0.998	0.715	D	0.997	0.850	D	0.000	0.629	D	1	0.810	D	3.825	0.957	H	-3.22	0.934	D	-6.13	0.902	D	0.531	0.718	1.079	0.989	D	0.934	0.978	D	0.470	0.947	D	4.217	0.565	23.9	0.992	0.537	0.993	0.944	D	c	1.035	0.937	1.000	0.747	0.598	0.340	0	5.07	0.680	7.860	0.853	0.932	0.445	1.000	0.715	1.000	0.888	18.612	0.912	Transcription factor, T-box, conserved site|p53-like transcription factor, DNA-binding	.	.	0.5	.	26	2	162274729	chr2:162274729	C	A	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	162890134	162890134	G	C	exonic	DPP4	.	nonsynonymous SNV	DPP4:NM_001935:exon10:c.C804G:p.F268L	4.06E-10	0.983161288	0.016838711	.	0.31053	0.64989	-0.973616687	8.8995046	165.27236	2.81237	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.002	0.383	N	0.980	0.396	D	-1.215	0.008	N	2.1	0.200	T	2.09	0.004	N	0.206	0.253	-0.968	0.375	T	0.011	0.040	T	0.003	0.079	T	1.357	0.227	12.57	0.750	0.105	0.752	0.365	D	c	-0.799	-0.545	0.767	0.236	0.615	0.372	0	1.29	0.206	0.388	0.203	1.048	0.713	0.999	0.424	1.000	0.888	4.229	0.100	Dipeptidylpeptidase IV, N-terminal domain	.	.	0.5	79	64	2	162890134	chr2:162890134	G	C	79	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	163045690	163045690	-	A	intronic	FAP	.	.	.	3.27E-11	0.974918303	0.025081697	.	0.37525	0.24378	-1.105907904	6.86482661	161.12606	2.77308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	134	2	163045690	chr2:163045690	G	GA	53	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	165365287	165365287	-	T	exonic	GRB14	.	frameshift insertion	GRB14:NM_001303422:exon6:c.630dupA:p.H211Tfs*5,GRB14:NM_004490:exon7:c.891dupA:p.H298Tfs*5	0.096601217	0.903069559	0.000329224	.	0.8157	0.1643	-0.178111357	40.44585987	4317.13537	13.08149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	214	2	165365287	chr2:165365287	G	GT	64	PASS	DP=214;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	165630224	165630224	C	T	intronic	COBLL1	.	.	.	0.012197364	0.987736419	6.62E-05	.	0.60988	0.08604	0.409650696	76.53927813	2197.61027	8.6319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	2	165630224	chr2:165630224	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	166810161	166810161	-	CCCGCTCA	intronic	TTC21B	.	.	.	3.39E-22	0.098887146	0.901112854	DISEASE: Note=Ciliary dysfunction leads to a broad spectrum of disorders, collectively termed ciliopathies. Overlapping clinical features include retinal degeneration, renal cystic disease, skeletal abnormalities, fibrosis of various organ, and a complex range of anatomical and functional defects of the central and peripheral nervous system. The ciliopathy range of diseases includes Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, nephronophtisis, Senior-Loken syndrome, and Jeune asphyxiating thoracic dystrophy among others. TTC21B is causally associated with diverse ciliopathies, and also acts as a modifier gene across the ciliopathy spectrum. TTC21B mutations interact in trans with mutations in other ciliopathy-causing genes and contribute to disease manifestation and severity.; DISEASE: Nephronophthisis 12 (NPHP12) [MIM:613820]: An autosomal recessive disorder resulting in end-stage renal disease. It is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. Some patients manifest extra-renal features including retinal, skeletal and central nervous system defects. {ECO:0000269|PubMed:21258341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short-rib thoracic dysplasia 4 with or without polydactyly (SRTD4) [MIM:613819]: A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. {ECO:0000269|PubMed:21258341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bardet-Biedl syndrome (BBS) [MIM:209900]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:21258341}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 11 (JBTS11) [MIM:613820]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:21258341, ECO:0000269|PubMed:22425360}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.13531	0.09894	0.619029743	83.25666431	820.66154	5.62646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	33	2	166810161	chr2:166810161	G	GCCCGCTCA	66	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	169984066	169984066	C	A	UTR3	LRP2	NM_004525:c.*1107G>T	.	.	1	1.49E-12	3.66E-46	.	0.64775	0.54233	3.324377969	99.4220335	2032.71856	8.29976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	2	169984066	chr2:169984066	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	171608612	171608612	G	A	ncRNA_intronic	LOC101926913	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	2	171608612	chr2:171608612	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	171793186	171793186	G	T	intronic	GORASP2	.	.	.	0.89106444	0.108888812	4.67E-05	.	0.30609	0.14799	-0.26993514	34.59542345	529.4287	4.69614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	30	2	171793186	chr2:171793186	G	T	39	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	173341108	173341108	C	T	intronic	ITGA6	.	.	.	0.009913603	0.990086247	1.50E-07	DISEASE: Epidermolysis bullosa letalis, with pyloric atresia (EB- PA) [MIM:226730]: An autosomal recessive, frequently lethal, epidermolysis bullosa with variable involvement of skin, nails, mucosa, and with variable effects on the digestive system. It is characterized by mucocutaneous fragility, aplasia cutis congenita, and gastrointestinal atresia, which most commonly affects the pylorus. Pyloric atresia is a primary manifestation rather than a scarring process secondary to epidermolysis bullosa. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.61813	0.48979	0.249861693	69.66265629	3306.75309	10.97922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	43	2	173341108	chr2:173341108	C	T	60	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	175199798	175199798	C	T	upstream	SP9	dist=23	.	.	0.498147938	0.428018312	0.07383375	.	.	.	.	.	26.65009	0.86255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	280	2	175199798	chr2:175199798	C	T	114	PASS	DP=280;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	176965470	176965470	G	T	exonic	HOXD12	.	nonsynonymous SNV	HOXD12:NM_021193:exon2:c.G795T:p.Q265H	0.003345917	0.610026817	0.386627266	.	0.8886	0.19255	0.395088462	76.15003539	604.16052	4.97604	0.242	0.176	T	0.126	0.253	B	0.041	0.226	B	0.000	0.559	D	0.993	0.810	D	1.06	0.271	L	-3.25	0.935	D	-1.16	0.297	N	0.435	0.490	-0.329	0.742	T	0.587	0.852	D	0.064	0.693	D	2.791	0.396	21.3	0.991	0.526	0.903	0.511	D	c	-0.349	-0.215	0.941	0.274	0.598	0.340	0	1.68	0.231	1.051	0.298	-0.189	0.103	1.000	0.715	0.975	0.474	8.264	0.308	.	.	.	0.5	.	91	2	176965470	chr2:176965470	G	T	.	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	178988920	178988920	A	-	exonic	RBM45	.	frameshift deletion	RBM45:NM_152945:exon8:c.1135delA:p.A382Lfs*6	0.000125349	0.990228317	0.009646334	.	0.1004	0.11409	-0.271755481	34.31823543	44.33184	1.2715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	308	2	178988919	chr2:178988919	CA	C	95	PASS	DP=308;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	179347386	179347386	C	T	ncRNA_intronic	MIR548N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	33	2	179347386	chr2:179347386	C	T	58	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	179557235	179557235	G	T	exonic	TTN	.	nonsynonymous SNV	TTN:NM_133378:exon117:c.C27935A:p.P9312Q,TTN:NM_001256850:exon118:c.C30716A:p.P10239Q,TTN:NM_001267550:exon120:c.C31667A:p.P10556Q	1.21E-32	1	5.79E-127	DISEASE: Hereditary myopathy with early respiratory failure (HMERF) [MIM:603689]: Autosomal dominant, adult-onset myopathy with early respiratory muscle involvement. {ECO:0000269|PubMed:15802564}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 9 (CMH9) [MIM:613765]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10462489}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11788824, ECO:0000269|PubMed:11846417, ECO:0000269|PubMed:16465475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tardive tibial muscular dystrophy (TMD) [MIM:600334]: Autosomal dominant, late-onset distal myopathy. Muscle weakness and atrophy are usually confined to the anterior compartment of the lower leg, in particular the tibialis anterior muscle. Clinical symptoms usually occur at age 35-45 years or much later. {ECO:0000269|PubMed:12145747, ECO:0000269|PubMed:12891679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Limb-girdle muscular dystrophy 2J (LGMD2J) [MIM:608807]: An autosomal recessive degenerative myopathy characterized by progressive weakness of the pelvic and shoulder girdle muscles. Severe disability is observed within 20 years of onset. {ECO:0000269|PubMed:12145747}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Early-onset myopathy with fatal cardiomyopathy (EOMFC) [MIM:611705]: Early-onset myopathies are inherited muscle disorders that manifest typically from birth or infancy with hypotonia, muscle weakness, and delayed motor development. EOMFC is a titinopathy that, in contrast with the previously described examples, involves both heart and skeletal muscle, has a congenital onset, and is purely recessive. This phenotype is due to homozygous out-of-frame TTN deletions, which lead to a total absence of titin's C-terminal end from striated muscles and to secondary CAPN3 depletion. {ECO:0000269|PubMed:17444505}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40699	0.38418	2.169883458	98.04199104	74772.86558	42.91324	0.009	0.721	D	0.948	0.604	P	0.694	0.610	P	.	.	.	1	0.810	D	.	.	.	-0.27	0.674	T	-3.33	0.832	D	0.265	0.335	0.050	0.833	D	0.474	0.798	T	0.050	0.643	D	1.876	0.286	15.44	0.974	0.334	0.952	0.636	D	c	0.550	0.477	0.609	0.218	0.487	0.133	0	4.54	0.551	4.643	0.608	0.948	0.535	1.000	0.715	0.672	0.303	13.348	0.599	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	76	151	2	179557235	chr2:179557235	G	T	76	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	182775403	182775403	-	T	intronic	SSFA2	.	.	.	7.68E-05	0.999757987	0.000165174	.	0.16545	0.10002	0.235100429	68.59518754	2237.71105	8.72526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	439	2	182775402	chr2:182775402	GT	GTT,G	120	PASS	DP=439;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	182775403	182775403	T	-	intronic	SSFA2	.	.	.	7.68E-05	0.999757987	0.000165174	.	0.16545	0.10002	0.235100429	68.59518754	2237.71105	8.72526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	439	2	182775402	chr2:182775402	GT	GTT,G	120	PASS	DP=439;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	183841601	183841601	C	G	intronic	NCKAP1	.	.	.	0.999999991	9.29E-09	5.84E-21	.	0.53149	0.18619	-1.199555187	5.761972163	23.37723	0.77966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	2	183841601	chr2:183841601	C	G	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	186629349	186629349	G	A	intronic	FSIP2	.	.	.	3.22E-08	0.999967049	3.29E-05	.	0.05212	0.07622	.	.	5663.99441	15.56525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	75	2	186629349	chr2:186629349	G	A	124	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	187709406	187709406	A	-	intronic	ZSWIM2	.	.	.	5.14E-10	0.363952929	0.63604707	.	0.12176	0.09356	2.311417714	98.35456476	1579.85177	7.35626	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	75	2	187709405	chr2:187709405	TA	T	59	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	187713713	187713713	G	T	exonic	ZSWIM2	.	nonsynonymous SNV	ZSWIM2:NM_182521:exon1:c.C145A:p.P49T	5.14E-10	0.363952929	0.63604707	.	0.12176	0.09356	2.311417714	98.35456476	1579.85177	7.35626	0.137	0.259	T	0.01	0.144	B	0.005	0.104	B	0.042	0.239	N	0.925	0.272	N	2.175	0.612	M	1.89	0.237	T	-0.73	0.206	N	0.439	0.494	-1.047	0.151	T	0.041	0.177	T	0.013	0.317	T	3.032	0.425	22.3	0.962	0.284	0.615	0.312	D	c	-0.275	-0.112	1.000	0.747	0.437	0.062	0	4.02	0.458	2.871	0.479	0.952	0.539	1.000	0.715	0.829	0.346	9.679	0.390	.	.	.	0.5	.	97	2	187713713	chr2:187713713	G	T	.	PASS	DP=97;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	190323402	190323402	C	T	intronic	WDR75	.	.	.	0.566494634	0.433504487	8.79E-07	.	0.42701	0.10537	-1.219785504	5.602736494	110.68114	2.29156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	2	190323402	chr2:190323402	C	T	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	190925148	190925148	C	A	exonic	MSTN	.	nonsynonymous SNV	MSTN:NM_005259:exon2:c.G387T:p.M129I	0.812914736	0.186112611	0.000972653	DISEASE: Muscle hypertrophy (MSLHP) [MIM:614160]: A condition characterized by increased muscle bulk and strength. Affected individuals are exceptionally strong. {ECO:0000269|PubMed:15215484}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83937	0.74393	0.663285274	84.55414013	913.77022	5.87603	0.271	0.160	T	0.0	0.026	B	0.0	0.013	B	0.001	0.407	D	0.830	0.287	N	0	0.065	N	-0.1	0.643	T	0.39	0.035	N	0.159	0.191	-1.014	0.256	T	0.104	0.382	T	0.017	0.383	T	0.556	0.147	7.847	0.856	0.154	0.207	0.209	N	c	-0.737	-0.579	0.991	0.323	0.487	0.133	0	4.89	0.632	0.051	0.139	0.059	0.165	0.029	0.202	0.947	0.422	6.745	0.225	Transforming growth factor-beta, N-terminal	.	.	0.5	.	38	2	190925148	chr2:190925148	C	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	192818559	192818560	CA	-	exonic	TMEFF2	.	stopgain	TMEFF2:NM_001305134:exon9:c.873_874del:p.C291fs*0,TMEFF2:NM_016192:exon9:c.873_874del:p.C291fs*0	0.386319162	0.61325271	0.000428128	.	0.36998	0.26214	-0.139478553	43.29440906	116.63956	2.34915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	61	2	192818558	chr2:192818558	TCA	T	56	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	196891589	196891589	C	T	exonic	DNAH7	.	nonsynonymous SNV	DNAH7:NM_018897:exon7:c.G562A:p.V188I	1.04E-47	0.815068072	0.184931928	.	0.23862	0.10363	5.09315636	99.81717386	6415.17778	16.77483	1.0	0.096	T	0.027	0.182	B	0.019	0.176	B	0.000	0.523	D	1.000	0.513	D	1.035	0.257	L	2.2	0.186	T	-0.04	0.140	N	0.328	0.471	-1.074	0.085	T	0.038	0.165	T	0.004	0.088	T	1.570	0.250	13.69	0.997	0.773	0.789	0.387	D	c	-0.416	-0.236	1.000	0.415	0.487	0.133	0	5.92	0.955	1.692	0.371	0.935	0.490	0.951	0.329	0.208	0.219	19.912	0.970	.	.	.	0.5	81	201	2	196891589	chr2:196891589	C	T	81	PASS	DP=201;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	197649613	197649613	-	T	exonic	GTF3C3	.	frameshift insertion	GTF3C3:NM_001206774:exon8:c.1081dupA:p.T361Nfs*10,GTF3C3:NM_012086:exon8:c.1081dupA:p.T361Nfs*10	5.36E-06	0.999685126	0.000309515	.	0.34288	0.24605	-0.422438699	25.64284029	26.74564	0.86554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	329	2	197649613	chr2:197649613	G	GT	77	PASS	DP=329;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	197786924	197786924	A	G	intronic	PGAP1	.	.	.	0.008785882	0.991209738	4.38E-06	DISEASE: Mental retardation, autosomal recessive 42 (MRT42) [MIM:615802]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:24784135}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24265	.	-0.666770504	15.86459071	57.58899	1.53274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	53	2	197786924	chr2:197786924	A	G	95	PASS	DP=53;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	198362018	198362018	T	C	exonic	HSPD1	.	synonymous SNV	HSPD1:NM_002156:exon3:c.A273G:p.K91K,HSPD1:NM_199440:exon3:c.A273G:p.K91K	0.985208244	0.01479021	1.55E-06	DISEASE: Spastic paraplegia 13, autosomal dominant (SPG13) [MIM:605280]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:11898127}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukodystrophy, hypomyelinating, 4 (HLD4) [MIM:612233]: A severe autosomal recessive hypomyelinating leukodystrophy. Clinically characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, neurologic regression, motor impairment, profound mental retardation. Death usually occurs within the first two decades of life. {ECO:0000269|PubMed:18571143}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9786	0.9809	-0.203796826	38.81811748	89.54005	2.03508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	15	2	198362018	chr2:198362018	T	C	82	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
2	202700456	202700456	C	T	exonic	CDK15	.	nonsynonymous SNV	CDK15:NM_001261435:exon8:c.C821T:p.A274V,CDK15:NM_001261436:exon8:c.C821T:p.A274V,CDK15:NM_139158:exon8:c.C668T:p.A223V	5.06E-13	0.02716957	0.97283043	.	0.16207	0.08286	-0.023789244	52.09365416	171.90123	2.85972	0.001	0.784	D	0.992	0.629	D	0.939	0.657	D	0.000	0.629	D	1.000	0.588	D	1.355	0.339	L	-0.2	0.661	T	-3.08	0.633	D	0.652	0.666	-0.345	0.737	T	0.366	0.727	T	0.043	0.611	D	7.235	0.946	34	0.999	0.983	0.973	0.736	D	c	0.686	0.714	1.000	0.747	0.497	0.185	0	5.62	0.857	6.105	0.710	0.935	0.490	1.000	0.715	1.000	0.888	20.02	0.975	Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	52	90	2	202700456	chr2:202700456	C	T	52	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	202978199	202978199	T	-	ncRNA_intronic	LOC729224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	346	2	202978198	chr2:202978198	GT	G,GTTT	117	PASS	DP=346;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	202978199	202978199	-	TT	ncRNA_intronic	LOC729224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	346	2	202978198	chr2:202978198	GT	G,GTTT	117	PASS	DP=346;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	203142655	203142655	T	-	intronic	NOP58	.	.	.	0.509478886	0.490487322	3.38E-05	.	.	.	-0.47017169	23.25430526	30.9563	0.97894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	19	2	203142654	chr2:203142654	CT	C	59	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	203676526	203676526	A	-	intronic	ICA1L	.	.	.	0.442027586	0.557692446	0.000279968	.	0.12377	.	0.373041938	75.29488087	125.08262	2.43349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	18	2	203676525	chr2:203676525	CA	C	56	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	204137443	204137443	C	T	exonic	CYP20A1	.	synonymous SNV	CYP20A1:NM_177538:exon6:c.C651T:p.N217N	7.41E-10	0.250664384	0.749335615	.	0.17142	0.20477	0.264628794	70.5178108	4123.36118	12.75546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	2	204137443	chr2:204137443	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	204350859	204350859	G	A	intronic	RAPH1	.	.	.	0.957851233	0.042148732	3.46E-08	.	0.25984	0.27016	-2.607452819	0.807973579	124.99766	2.43194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	63	2	204350859	chr2:204350859	G	A	39	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	204354507	204354507	C	T	exonic	RAPH1	.	nonsynonymous SNV	RAPH1:NM_001329728:exon4:c.G532A:p.D178N,RAPH1:NM_203365:exon4:c.G532A:p.D178N,RAPH1:NM_213589:exon4:c.G532A:p.D178N	0.957851233	0.042148732	3.46E-08	.	0.25984	0.27016	-2.607452819	0.807973579	124.99766	2.43194	0.206	0.682	T	0.804	0.432	P	0.173	0.396	B	0.011	0.299	N	1.000	0.499	D	1.25	0.319	L	0.96	0.460	T	-1.6	0.416	N	0.047	0.043	-0.976	0.360	T	0.113	0.404	T	0.008	0.207	T	2.994	0.420	22.2	0.998	0.882	0.936	0.583	D	c	0.129	0.220	1.000	0.747	0.707	0.730	0	5.33	0.756	2.720	0.467	0.852	0.362	1.000	0.715	0.965	0.450	19.022	0.929	.	.	.	0.5	42	11	2	204354507	chr2:204354507	C	T	42	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	205989177	205989177	A	-	exonic	PARD3B	.	frameshift deletion	PARD3B:NM_001302769:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_057177:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_152526:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_205863:exon9:c.1292delA:p.D431Afs*5	8.65E-08	0.999805592	0.000194321	.	0.48627	0.09509	0.126687467	62.75064874	840.37721	5.67705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	41	2	205989176	chr2:205989176	GA	G	82	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	206631554	206631554	T	-	intronic	NRP2	.	.	.	0.00171165	0.998241695	4.67E-05	.	0.30972	0.15109	-1.080231599	7.277659825	168.69076	2.83534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	16	2	206631553	chr2:206631553	AT	A	39	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	210368990	210368990	-	A	intronic	MAP2	.	.	.	0.999983365	1.66E-05	9.93E-14	.	0.28644	0.25532	-1.313764723	4.824251003	424.49113	4.30507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	15	2	210368990	chr2:210368990	T	TA	69	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	210737613	210737613	G	T	exonic	UNC80	.	synonymous SNV	UNC80:NM_032504:exon23:c.G3765T:p.R1255R,UNC80:NM_182587:exon23:c.G3750T:p.R1250R	0.139839111	0.85601101	0.00414988	.	0.61288	.	0.992010122	90.49893843	987.20517	6.05851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	2	210737613	chr2:210737613	G	T	.	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	215851354	215851354	C	T	exonic	ABCA12	.	nonsynonymous SNV	ABCA12:NM_015657:exon20:c.G3121A:p.V1041I,ABCA12:NM_173076:exon28:c.G4075A:p.V1359I	2.02E-07	0.999999798	2.70E-13	DISEASE: Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:12915478, ECO:0000269|PubMed:17508018, ECO:0000269|PubMed:18284401, ECO:0000269|PubMed:19262603, ECO:0000269|PubMed:22257947}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis, congenital, autosomal recessive 4B (ARCI4B) [MIM:242500]: A rare, very severe form of congenital ichthyosis, in which the neonate is born with a thick covering of armor-like scales. The skin dries out to form hard diamond-shaped plaques separated by fissures, resembling 'armor plating'. The normal facial features are severely affected, with distortion of the lips (eclabion), eyelids (ectropion), ears, and nostrils. Affected babies are often born prematurely and rarely survive the perinatal period. Babies who survive into infancy and beyond develop skin changes resembling severe non-bullous congenital ichthyosiform erythroderma. {ECO:0000269|PubMed:15756637, ECO:0000269|PubMed:16675967, ECO:0000269|PubMed:16902423}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16262	0.15786	-0.299763455	32.26586459	2992.15591	10.38229	0.413	0.100	T	0.0	0.067	B	0.001	0.093	B	0.358	0.137	N	0.999	0.213	N	0.225	0.096	N	-3.24	0.935	D	-0.7	0.199	N	0.061	0.077	-0.509	0.683	T	0.545	0.833	D	0.032	0.539	D	2.069	0.310	16.65	0.968	0.308	0.210	0.210	N	c	-0.677	-0.544	0.001	0.081	0.693	0.558	0	1.25	0.204	0.583	0.234	-0.170	0.106	0.415	0.261	0.862	0.360	7.885	0.286	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	27	2	215851354	chr2:215851354	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	216241244	216241244	T	A	exonic	FN1	.	nonsynonymous SNV	FN1:NM_001306131:exon34:c.A5321T:p.D1774V,FN1:NM_001306132:exon34:c.A5321T:p.D1774V,FN1:NM_212474:exon34:c.A5321T:p.D1774V,FN1:NM_212476:exon34:c.A5321T:p.D1774V,FN1:NM_001306130:exon35:c.A5594T:p.D1865V,FN1:NM_002026:exon35:c.A5591T:p.D1864V,FN1:NM_212478:exon35:c.A5591T:p.D1864V,FN1:NM_001306129:exon36:c.A5864T:p.D1955V,FN1:NM_212482:exon36:c.A5864T:p.D1955V	0.064441538	0.935558462	2.07E-16	DISEASE: Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]: Genetically heterogeneous autosomal dominant disorder characterized clinically by proteinuria, microscopic hematuria, and hypertension that leads to end-stage renal failure in the second to fifth decade of life. {ECO:0000269|PubMed:18268355}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.92203	0.99216	-2.323170444	1.18542109	825.54252	5.63214	0.001	0.912	D	0.996	0.689	D	0.998	0.875	D	0.001	0.432	D	1	0.810	D	2.43	0.707	M	0.4	0.573	T	-5.66	0.912	D	0.731	0.739	-0.140	0.792	T	0.395	0.748	T	0.094	0.762	D	6.174	0.852	28.6	0.994	0.640	0.969	0.714	D	c	0.654	0.648	1.000	0.747	0.732	0.924	0	5.91	0.952	6.255	0.722	1.061	0.807	1.000	0.715	0.837	0.349	16.348	0.829	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	115	216	2	216241244	chr2:216241244	T	A	115	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	217541463	217541463	G	A	UTR3	IGFBP5	NM_000599:c.*11C>T	.	.	0.85997835	0.137886185	0.002135465	.	0.65909	0.31908	.	.	128.68174	2.47216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	2	217541463	chr2:217541463	G	A	.	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	218706857	218706857	T	C	intronic	TNS1	.	.	.	0.924939889	0.075060111	5.03E-11	.	0.49253	0.15564	1.585596299	95.81269167	8076.56687	19.41076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	28	2	218706857	chr2:218706857	T	C	55	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	218723107	218723107	G	C	intronic	TNS1	.	.	.	0.924939889	0.075060111	5.03E-11	.	0.49253	0.15564	1.585596299	95.81269167	8076.56687	19.41076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	197	2	218723107	chr2:218723107	G	C	140	PASS	DP=197;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	219134766	219134766	G	-	exonic	AAMP	.	frameshift deletion	AAMP:NM_001087:exon1:c.44delC:p.P15Hfs*4,AAMP:NM_001302545:exon1:c.44delC:p.P15Hfs*4	0.531201269	0.468105025	0.000693706	.	0.49551	0.1223	0.040529541	57.15380986	343.13644	3.92709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	61	2	219134765	chr2:219134765	TG	T	42	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	219745839	219745839	T	C	intronic	WNT10A	.	.	.	0.010169289	0.943911812	0.045918899	DISEASE: Note=Defects in WNT10A may be a cause of hypohidrotic/anhidrotic ectodermal dysplasia, a disorder characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. Most patients carrying WNT10A mutations present with sweating anomalies. However, comparison with cases harboring mutations in the ectodysplasin pathway identifies some phenotypic differences. Dermatological features (anomalies of hair and sweat glands) are less severe in patients carrying WNT10A mutations and facial dysmorphism can be absent. The dental phenotype consists in microdontia, whereas teeth agenesis is more frequent in patients carrying mutations in the ectodysplasin pathway. {ECO:0000269|PubMed:20979233}.; DISEASE: Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]: A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. {ECO:0000269|PubMed:17847007, ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]: A rare ectodermal dysplasia, characterized chiefly by cysts of the eyelid margins, palmoplantar keratoderma, hypodontia, hypotrichosis and nail dystrophy. Multiple eyelid apocrine hidrocystomas are the hallmark of this condition, although they usually appear in adulthood. The concomitant presence of eccrine syringofibroadenoma in most patients and of other adnexal skin tumors in some affected subjects indicates that Schopf-Schulz- Passarge syndrome is a genodermatosis with skin appendage neoplasms. {ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tooth agenesis selective 4 (STHAG4) [MIM:150400]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). In STHAG4, the upper lateral incisors are absent or peg-shaped. {ECO:0000269|PubMed:21484994, ECO:0000269|PubMed:22581971}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24339	0.20297	.	.	263.26685	3.48077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	58	2	219745839	chr2:219745839	T	C	89	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	219826587	219826587	G	T	UTR3	CDK5R2	NM_003936:c.*941G>T	.	.	.	.	.	.	0.44177	0.11161	.	.	35.94	1.07912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	2	219826587	chr2:219826587	G	T	.	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	220173905	220173905	C	T	intronic	PTPRN	.	.	.	0.021748201	0.978223608	2.82E-05	DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8144912, ECO:0000269|PubMed:8641276}.; 	0.5043	0.3225	-1.392555112	4.269874971	262.5746	3.47632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	246	2	220173905	chr2:220173905	C	T	85	PASS	DP=246;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	224620103	224620213	ACTGTCTTTCTCTTGGTAGTTTTATAGTAATTATATAATATAAAGAAAACACAATGACTATTTTAGCCTAGGCCCATGGAAGATGTCCCTAAAATCCCTCAAATTTACCCC	-	UTR3	AP1S3	NM_001039569:c.*3329_*3219delGGGGTAAATTTGAGGGATTTTAGGGACATCTTCCATGGGCCTAGGCTAAAATAGTCATTGTGTTTTCTTTATATTATATAATTACTATAAAACTACCAAGAGAAAGACAGT	.	.	0.167450177	0.771753753	0.06079607	.	0.14506	0.10315	1.302692676	93.93724935	140.64371	2.58746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	318	2	224620102	chr2:224620102	TACTGTCTTTCTCTTGGTAGTTTTATAGTAATTATATAATATAAAGAAAACACAATGACTATTTTAGCCTAGGCCCATGGAAGATGTCCCTAAAATCCCTCAAATTTACCCC	T	58	PASS	DP=318;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	225422591	225422591	G	C	intronic	CUL3	.	.	.	0.974063405	0.025936543	5.11E-08	DISEASE: Pseudohypoaldosteronism 2E (PHA2E) [MIM:614496]: An autosomal dominant disorder characterized by severe hypertension, hyperkalemia, hyperchloremia, hyperchloremic metabolic acidosis, and correction of physiologic abnormalities by thiazide diuretics. {ECO:0000269|PubMed:22266938}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25175	0.18619	-0.139478553	43.29440906	1361.02638	6.92534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	76	2	225422591	chr2:225422591	G	C	111	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	225781324	225781324	C	T	intronic	DOCK10	.	.	.	0.02919253	0.97080747	2.09E-12	.	0.22785	0.12287	-1.065786145	7.377919321	3131.37113	10.65498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	2	225781324	chr2:225781324	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	226265720	226265722	TGG	-	UTR5	NYAP2	NM_020864:c.-7877_-7875del-	.	.	0.906196258	0.093772035	3.17E-05	.	.	.	-0.020150552	52.25288983	158.7708	2.75169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	158	73	2	226265719	chr2:226265719	CTGG	C	158	PASS	DP=73;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	228109625	228109625	-	TG	ncRNA_intronic	LOC654841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	74	2	228109625	chr2:228109625	T	TTG	51	PASS	DP=74;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	228735140	228735140	T	C	upstream	DAW1	dist=952	.	.	0.000785948	0.982644868	0.016569184	.	0.08054	0.09429	0.440999548	77.79547063	1957.37654	8.14493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	12	2	228735140	chr2:228735140	T	C	45	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	228735186	228735186	T	C	upstream	DAW1	dist=906	.	.	0.000785948	0.982644868	0.016569184	.	0.08054	0.09429	0.440999548	77.79547063	1957.37654	8.14493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	19	2	228735186	chr2:228735186	T	C	45	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	230931295	230931295	C	T	intronic	SLC16A14	.	.	.	0.215983364	0.775382473	0.008634163	.	0.12329	0.10389	-0.490397599	22.50530786	65.9738	1.67277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	2	230931295	chr2:230931295	C	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	232321394	232321394	T	A	exonic	NCL	.	nonsynonymous SNV	NCL:NM_005381:exon11:c.A1653T:p.R551S	0.999106738	0.000893261	3.29E-10	.	0.98769	0.73546	-0.686998355	15.26893135	112.77476	2.30967	0.001	0.784	D	1.0	0.899	D	0.997	0.850	D	0.000	0.843	D	1	0.810	D	2.785	0.815	M	-1.22	0.924	T	-4.15	0.761	D	0.819	0.816	0.699	0.932	D	0.821	0.940	D	0.415	0.937	D	6.355	0.878	29.4	0.998	0.851	0.971	0.726	D	c	0.470	0.427	1.000	0.747	0.722	0.854	0	4.44	0.530	1.319	0.330	1.058	0.762	0.981	0.351	1.000	0.888	8.095	0.298	Nucleotide-binding alpha-beta plait domain|RNA recognition motif domain;Nucleotide-binding alpha-beta plait domain|RNA recognition motif domain|RNA recognition motif domain, eukaryote	.	.	0.5	.	29	2	232321394	chr2:232321394	T	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	232577559	232577559	T	C	exonic	PTMA	.	stoploss	PTMA:NM_001099285:exon5:c.T334C:p.X112Q,PTMA:NM_002823:exon5:c.T331C:p.X111Q	0.377491926	0.576544202	0.045963872	.	.	.	-0.009020804	52.8544468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.417	0.352	18.93	0.684	0.084	0.932	0.572	D	c	0.982	0.806	1.000	0.747	0.140	0.025	0	4.63	0.570	4.562	0.603	1.040	0.660	1.000	0.715	1.000	0.888	13.544	0.610	.	.	.	0.5	100	604	2	232577559	chr2:232577559	T	C	100	PASS	DP=604;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
2	232673465	232673465	C	T	UTR3	COPS7B	NM_001282949:c.*1110C>T;NM_001282951:c.*1110C>T;NM_022730:c.*1110C>T;NM_001282952:c.*1110C>T;NM_001282950:c.*1136C>T;NM_001308381:c.*1136C>T	.	.	0.207502332	0.783128198	0.00936947	.	0.49504	0.08191	-0.117432389	44.89266336	59.3707	1.56192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	2	232673465	chr2:232673465	C	T	.	PASS	DP=87;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	233245026	233245026	G	A	exonic	ALPP	.	nonsynonymous SNV	ALPP:NM_001632:exon6:c.G788A:p.R263H	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	0.877	0.026	T	0.007	0.131	B	0.001	0.040	B	0.991	0.079	N	1	0.090	P	-1	0.012	N	-4.04	0.965	D	0.35	0.038	N	0.093	0.092	-0.828	0.535	T	0.002	0.006	T	.	.	.	0.356	0.128	6.224	0.762	0.110	0.008	0.032	N	c	-1.491	-1.418	0.004	0.106	0.497	0.185	0	-0.177	0.126	0.494	0.220	-0.025	0.128	0.000	0.063	0.021	0.135	7.139	0.246	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain	ENSG00000244280.1|ENSG00000244280.1	Testis|Thyroid	0.5	.	294	2	233245026	chr2:233245026	G	A	.	PASS	DP=294;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	233246153	233246153	C	T	intronic	ALPP	.	.	.	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	98	2	233246153	chr2:233246153	C	T	81	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	233413825	233413825	G	A	exonic	TIGD1	.	synonymous SNV	TIGD1:NM_145702:exon1:c.C768T:p.P256P	.	.	.	.	.	.	.	.	119.93261	2.38592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	144	2	233413825	chr2:233413825	G	A	67	PASS	DP=144;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	233791834	233791834	C	A	exonic	NGEF	.	nonsynonymous SNV	NGEF:NM_001114090:exon2:c.G170T:p.S57I,NGEF:NM_019850:exon4:c.G446T:p.S149I	0.949825525	0.050173168	1.31E-06	.	0.30052	0.12355	-0.33061537	30.82094834	85.46834	1.97133	0.007	0.599	D	0.838	0.568	P	0.205	0.503	B	0.001	0.416	D	0.907	0.292	N	0.975	0.246	L	-0.48	0.719	T	-2.58	0.556	D	0.333	0.419	-0.608	0.645	T	0.252	0.622	T	0.027	0.500	D	4.233	0.567	23.9	0.993	0.571	0.895	0.497	D	c	0.292	0.360	1.000	0.747	0.598	0.340	0	4.84	0.620	1.994	0.401	0.935	0.490	1.000	0.715	1.000	0.888	10.72	0.450	.	.	.	0.5	74	127	2	233791834	chr2:233791834	C	A	74	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	234094429	234094429	G	A	intronic	INPP5D	.	.	.	0.167430841	0.832564139	5.02E-06	.	.	0.1054	.	.	1963.99989	8.16671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	2	234094429	chr2:234094429	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	234394236	234394236	-	T	exonic	USP40	.	frameshift insertion	USP40:NM_018218:exon29:c.3477dupA:p.Q1160Tfs*19	1.74E-14	0.764370206	0.235629794	.	0.06046	0.09101	0.501484965	79.67681057	7072.32994	18.02774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	2	234394236	chr2:234394236	G	GT	41	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	234656517	234656517	T	C	intronic	UGT1A10;UGT1A3;UGT1A4;UGT1A5;UGT1A6;UGT1A7;UGT1A8;UGT1A9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	125	2	234656517	chr2:234656517	T	C	70	PASS	DP=125;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	234669144	234669144	G	A	exonic	UGT1A1	.	nonsynonymous SNV	UGT1A1:NM_000463:exon1:c.G211A:p.G71R	2.94E-09	0.085606144	0.914393853	DISEASE: Gilbert syndrome (GILBS) [MIM:143500]: Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:12139570, ECO:0000269|PubMed:7715297, ECO:0000269|PubMed:9627603}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Transient familial neonatal hyperbilirubinemia (HBLRTFN) [MIM:237900]: A condition characterized by excessive concentration of bilirubin in the blood, which may lead to jaundice. Breast milk jaundice is a common problem in nursing infants. {ECO:0000269|PubMed:11061796}. Note=The disease may be caused by mutations affecting the gene represented in this entry. The defect has been ascribed to various breast milk substances, but the component or combination of components that is responsible remains unclear. Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk. One or more components in the milk may trigger the jaundice in infants who have such mutations. Mutations are identical to those detected in patients with Gilbert syndrome, a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia.; DISEASE: Crigler-Najjar syndrome 1 (CN1) [MIM:218800]: Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life. CN1 inheritance is autosomal recessive. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:15712364, ECO:0000269|PubMed:1634050, ECO:0000269|PubMed:17229650, ECO:0000269|PubMed:19830808, ECO:0000269|PubMed:23992562, ECO:0000269|PubMed:7906695, ECO:0000269|PubMed:7989045, ECO:0000269|PubMed:7989595, ECO:0000269|PubMed:8226884}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Crigler-Najjar syndrome 2 (CN2) [MIM:606785]: Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage. Phenobarbital, which induces the partially deficient glucuronyl transferase, can diminish the jaundice. CN2 inheritance is autosomal dominant. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:11370628, ECO:0000269|PubMed:12402338, ECO:0000269|PubMed:15712364, ECO:0000269|PubMed:17229650, ECO:0000269|PubMed:19830808, ECO:0000269|PubMed:23099197, ECO:0000269|PubMed:23992562, ECO:0000269|PubMed:7989595, ECO:0000269|PubMed:8276413, ECO:0000269|PubMed:8280139, ECO:0000269|PubMed:8706880, ECO:0000269|PubMed:9621515, ECO:0000269|PubMed:9639672}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.58091	-0.556537043	19.72753008	185.91297	2.96084	0.04	0.421	D	0.127	0.581	B	0.183	0.497	B	.	.	.	0.599	0.309	P	1.39	0.351	L	0.09	0.615	T	-1.77	0.486	N	0.097	0.100	-1.081	0.071	T	0.001	0.002	T	.	.	.	4.055	0.545	23.7	0.997	0.801	0.339	0.247	N	c	-0.077	-0.054	1.000	0.500	0.487	0.133	0	5.14	0.699	3.900	0.558	1.048	0.713	0.572	0.273	0.951	0.427	7.612	0.271	.	.	.	0.5	40	6	2	234669144	chr2:234669144	G	A	40	PASS	DP=6;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
2	238274611	238274627	CTTCTGGGCCACAAAAA	-	exonic	COL6A3	.	frameshift deletion	COL6A3:NM_057166:exon9:c.3731_3747del:p.V1244Gfs*45,COL6A3:NM_057167:exon11:c.4934_4950del:p.V1645Gfs*45,COL6A3:NM_004369:exon12:c.5552_5568del:p.V1851Gfs*45	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	82	2	238274610	chr2:238274610	CCTTCTGGGCCACAAAAA	C	65	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	238275344	238275344	G	-	exonic	COL6A3	.	frameshift deletion	COL6A3:NM_057166:exon8:c.3665delC:p.T1222Mfs*10,COL6A3:NM_057167:exon10:c.4868delC:p.T1623Mfs*10,COL6A3:NM_004369:exon11:c.5486delC:p.T1829Mfs*10	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.79	35	2	238275343	chr2:238275343	AG	A	25.79	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	238632159	238632159	-	T	intronic	LRRFIP1	.	.	.	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.52	45	2	238632159	chr2:238632159	G	GT	12.52	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	238672174	238672174	G	A	exonic	LRRFIP1	.	synonymous SNV	LRRFIP1:NM_001137553:exon8:c.G1650A:p.K550K,LRRFIP1:NM_004735:exon10:c.G1746A:p.K582K,LRRFIP1:NM_001137552:exon11:c.G1818A:p.K606K	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	21	2	238672174	chr2:238672174	G	A	58	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	240900608	240900608	G	-	intronic	NDUFA10	.	.	.	0.00138794	0.964065844	0.034546216	.	0.0669	0.10997	0.060756528	58.52795471	1093.05276	6.32741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	54	2	240900607	chr2:240900607	TG	T	54	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	241622318	241622318	C	A	upstream	AQP12B	dist=1	.	.	0.004358648	0.431917163	0.563724189	.	0.16011	.	.	.	3743.83383	11.95806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	299	2	241622318	chr2:241622318	C	A	121	PASS	DP=299;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	241808308	241808308	-	C	exonic	AGXT	.	frameshift insertion	AGXT:NM_000030:exon1:c.26dupC:p.K12Qfs*155	0.003594369	0.9539627	0.042442931	DISEASE: Hyperoxaluria primary 1 (HP1) [MIM:259900]: An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease. {ECO:0000269|PubMed:10394939, ECO:0000269|PubMed:10453743, ECO:0000269|PubMed:10541294, ECO:0000269|PubMed:10862087, ECO:0000269|PubMed:12559847, ECO:0000269|PubMed:1301173, ECO:0000269|PubMed:1349575, ECO:0000269|PubMed:15253729, ECO:0000269|PubMed:15849466, ECO:0000269|PubMed:15961946, ECO:0000269|PubMed:15963748, ECO:0000269|PubMed:16971151, ECO:0000269|PubMed:1703535, ECO:0000269|PubMed:17495019, ECO:0000269|PubMed:2039493, ECO:0000269|PubMed:23229545, ECO:0000269|PubMed:24055001, ECO:0000269|PubMed:24934730, ECO:0000269|PubMed:26149463, ECO:0000269|PubMed:8101040, ECO:0000269|PubMed:9192270, ECO:0000269|PubMed:9604803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59321	0.59981	0.644875971	84.10002359	526.88786	4.68568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	818	2	241808307	chr2:241808307	AC	ACC,A	86	PASS	DP=818;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	241808308	241808308	C	-	exonic	AGXT	.	frameshift deletion	AGXT:NM_000030:exon1:c.26delC:p.K12Rfs*33	0.003594369	0.9539627	0.042442931	DISEASE: Hyperoxaluria primary 1 (HP1) [MIM:259900]: An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease. {ECO:0000269|PubMed:10394939, ECO:0000269|PubMed:10453743, ECO:0000269|PubMed:10541294, ECO:0000269|PubMed:10862087, ECO:0000269|PubMed:12559847, ECO:0000269|PubMed:1301173, ECO:0000269|PubMed:1349575, ECO:0000269|PubMed:15253729, ECO:0000269|PubMed:15849466, ECO:0000269|PubMed:15961946, ECO:0000269|PubMed:15963748, ECO:0000269|PubMed:16971151, ECO:0000269|PubMed:1703535, ECO:0000269|PubMed:17495019, ECO:0000269|PubMed:2039493, ECO:0000269|PubMed:23229545, ECO:0000269|PubMed:24055001, ECO:0000269|PubMed:24934730, ECO:0000269|PubMed:26149463, ECO:0000269|PubMed:8101040, ECO:0000269|PubMed:9192270, ECO:0000269|PubMed:9604803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59321	0.59981	0.644875971	84.10002359	526.88786	4.68568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	818	2	241808307	chr2:241808307	AC	ACC,A	86	PASS	DP=818;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	241973240	241973240	C	T	exonic	SNED1	.	nonsynonymous SNV	SNED1:NM_001080437:exon3:c.C590T:p.T197I	0.98376281	0.01623719	1.33E-10	.	0.22403	0.13286	-1.379925048	4.364236848	4194.17391	12.86144	0.02	0.496	D	0.58	0.369	P	0.272	0.382	B	.	.	.	0.950	0.265	N	2.535	0.741	M	-0.74	0.732	T	-0.88	0.238	N	0.222	0.272	-0.579	0.657	T	0.330	0.698	T	0.119	0.800	D	4.400	0.589	24.1	0.998	0.850	0.636	0.319	D	c	0.062	0.038	0.935	0.272	0.646	0.450	0	3.53	0.394	1.624	0.364	0.852	0.362	0.999	0.424	0.513	0.273	2.452	0.042	NIDO domain	.	.	0.5	50	94	2	241973240	chr2:241973240	C	T	50	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	241979571	241979571	C	T	exonic	SNED1	.	synonymous SNV	SNED1:NM_001080437:exon7:c.C1125T:p.C375C	0.98376281	0.01623719	1.33E-10	.	0.22403	0.13286	-1.379925048	4.364236848	4194.17391	12.86144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	132	2	241979571	chr2:241979571	C	T	69	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	242140634	242140671	CAGCTTCCTCCAAACCTTCTGCACCGTTCACATGCCCA	-	intronic	ANO7	.	.	.	1.87E-30	1.93E-05	0.999980702	.	0.10367	0.1057	0.268088483	70.58858221	3536.57926	11.4675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	220	2	242140633	chr2:242140633	GCAGCTTCCTCCAAACCTTCTGCACCGTTCACATGCCCA	G	76	PASS	DP=220;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	242263784	242263784	A	C	intronic	SEPT2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	2	242263784	chr2:242263784	A	C	.	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	242612999	242613000	AT	-	UTR3	ATG4B	NM_013325:c.*1320_*1321delAT;NM_178326:c.*1379_*1380delAT	.	.	0.988495913	0.011499968	4.12E-06	.	.	0.10738	0.284856336	71.40835103	488.90283	4.55127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	38	2	242612998	chr2:242612998	CAT	C	70	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
2	242794725	242794725	C	G	intronic	PDCD1	.	.	.	0.017954048	0.894121848	0.087924104	DISEASE: Systemic lupus erythematosus 2 (SLEB2) [MIM:605218]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:12402038}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.14221	0.27803	-0.314027422	31.9297004	885.9353	5.79855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	2	242794725	chr2:242794725	C	G	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	243052762	243052762	T	C	ncRNA_intronic	LINC01881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	150	2	243052762	chr2:243052762	T	C	96	PASS	DP=150;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	369955	369955	T	A	exonic	CHL1	.	synonymous SNV	CHL1:NM_001253388:exon3:c.T303A:p.S101S,CHL1:NM_001253387:exon5:c.T303A:p.S101S,CHL1:NM_006614:exon5:c.T303A:p.S101S	2.05E-06	0.999947701	5.02E-05	.	0.39224	0.09664	-0.158112528	41.92026421	1165.89885	6.49553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	3	369955	chr3:369955	T	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	1339632	1339633	GC	-	exonic	CNTN6	.	frameshift deletion	CNTN6:NM_001289081:exon6:c.502_503del:p.A168Kfs*19,CNTN6:NM_001289080:exon7:c.718_719del:p.A240Kfs*19,CNTN6:NM_014461:exon7:c.718_719del:p.A240Kfs*19,CNTN6:NM_001349352:exon8:c.718_719del:p.A240Kfs*19,CNTN6:NM_001349353:exon8:c.718_719del:p.A240Kfs*19,CNTN6:NM_001349354:exon8:c.718_719del:p.A240Kfs*19,CNTN6:NM_001349355:exon8:c.718_719del:p.A240Kfs*19,CNTN6:NM_001349350:exon9:c.718_719del:p.A240Kfs*19,CNTN6:NM_001349351:exon9:c.718_719del:p.A240Kfs*19	3.59E-22	0.004010738	0.995989262	.	0.44656	0.13084	-0.918644703	9.807737674	343.14195	3.92764	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	36.72	15	3	1339631	chr3:1339631	TGC	T	36.72	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	4534940	4534940	G	-	upstream	ITPR1;ITPR1-AS1	dist=92	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	136	3	4534939	chr3:4534939	CG	C	110	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	4738994	4738994	T	A	intronic	ITPR1	.	.	.	1	5.90E-12	3.24E-32	DISEASE: Spinocerebellar ataxia 15 (SCA15) [MIM:606658]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory. {ECO:0000269|PubMed:17590087, ECO:0000269|PubMed:18579805}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinocerebellar ataxia 29 (SCA29) [MIM:117360]: An autosomal dominant, congenital spinocerebellar ataxia characterized by early motor delay, hypotonia and mild cognitive delay. Affected individuals develop a very slowly progressive or non-progressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor. {ECO:0000269|PubMed:22986007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48957	0.4536	-3.352519381	0.401037981	228.28209	3.26405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	123	3	4738994	chr3:4738994	T	A	50	PASS	DP=123;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	7315446	7315446	T	G	intronic	GRM7	.	.	.	0.999169069	0.00083093	1.36E-09	.	0.68439	0.09371	-1.616692429	2.937013447	1262.73334	6.70044	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	20	3	7315446	chr3:7315446	T	G	71	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	7620433	7620433	C	G	exonic	GRM7	.	nonsynonymous SNV	GRM7:NM_000844:exon8:c.C1840G:p.R614G,GRM7:NM_181874:exon8:c.C1840G:p.R614G	0.999169069	0.00083093	1.36E-09	.	0.68439	0.09371	-1.616692429	2.937013447	1262.73334	6.70044	0.002	0.721	D	0.953	0.764	P	0.852	0.850	P	0.000	0.843	D	1	0.810	D	3.42	0.921	M	-2.51	0.893	D	-4.83	0.809	D	0.982	0.985	0.854	0.951	D	0.856	0.952	D	0.337	0.919	D	6.731	0.919	32	0.999	0.975	0.960	0.667	D	c	0.797	0.758	1.000	0.747	0.554	0.246	0	5.93	0.959	2.671	0.463	0.935	0.490	0.993	0.376	1.000	0.888	18.918	0.925	GPCR family 3, C-terminal	.	.	0.5	79	54	3	7620433	chr3:7620433	C	G	79	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	9439598	9439598	G	A	UTR5	SETD5	NM_001292043:c.-36914G>A;NM_001080517:c.-31025G>A;NM_001349451:c.-36914G>A	.	.	0.999999564	4.36E-07	2.82E-18	DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.46735	0.10674	-0.791786324	12.59731069	500.45582	4.59199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	3	9439598	chr3:9439598	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	9489334	9489334	-	TTTC	intronic	SETD5	.	.	.	0.999999564	4.36E-07	2.82E-18	DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.46735	0.10674	-0.791786324	12.59731069	500.45582	4.59199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	16	3	9489334	chr3:9489334	A	ATTTC	50	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	9730571	9730571	G	-	intronic	MTMR14	.	.	.	0.002939821	0.99695446	0.000105719	.	0.30998	0.11304	-0.911109353	9.961075725	98.92051	2.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	102	3	9730570	chr3:9730570	TG	T	91	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	9771206	9771206	G	T	exonic	CPNE9	.	unknown	UNKNOWN	0.001032103	0.998871292	9.66E-05	.	0.25543	.	0.084621747	60.31493277	44.06764	1.26466	0.002	0.721	D	0.999	0.764	D	0.98	0.732	D	0.000	0.843	U	1	0.810	D	3.585	0.937	H	3.26	0.067	T	-6.11	0.900	D	0.935	0.929	-0.783	0.562	T	0.112	0.402	T	0.081	0.737	D	6.948	0.934	33	0.994	0.637	0.995	0.965	D	c	0.977	0.896	1.000	0.747	0.626	0.397	0	4.99	0.658	9.589	0.974	0.953	0.551	1.000	0.715	1.000	0.888	17.894	0.887	Copine|von Willebrand factor, type A	.	.	0.5	.	30	3	9771206	chr3:9771206	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	9786078	9786078	C	-	exonic	BRPF1	.	frameshift deletion	BRPF1:NM_001003694:exon9:c.2806delC:p.Q938Sfs*4,BRPF1:NM_001319050:exon9:c.2785delC:p.Q931Sfs*4,BRPF1:NM_004634:exon9:c.2788delC:p.Q932Sfs*4	0.999626031	0.000373969	7.98E-12	.	0.6219	0.12281	-2.25808393	1.267987733	57.40076	1.5258	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	47	194	3	9786077	chr3:9786077	GC	G	47	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	9860595	9860595	G	A	exonic	TTLL3	.	nonsynonymous SNV	TTLL3:NM_001025930:exon6:c.G949A:p.E317K	3.84E-14	0.080133074	0.919866926	.	.	0.0989	-0.214928658	37.7388535	1000.48997	6.0936	0.131	0.912	T	0.013	0.203	B	0.007	0.203	B	0.726	0.063	U	1.000	0.189	N	0.55	0.145	N	3.6	0.386	T	-1.79	0.461	N	0.327	0.449	-1.045	0.159	T	0.042	0.181	T	.	.	.	1.365	0.228	12.61	0.811	0.131	0.086	0.143	N	c	-0.426	-0.549	0.748	0.233	0.707	0.730	0	1.87	0.244	1.865	0.389	0.998	0.613	0.024	0.198	0.065	0.173	6.221	0.198	.	.	.	0.5	65	97	3	9860595	chr3:9860595	G	A	65	PASS	DP=97;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	9912079	9912079	G	T	intronic	CIDEC	.	.	.	0.001416632	0.665901653	0.332681714	DISEASE: Note=In omental adipose tissue of obese patients matched for BMI, expression levels tend to correlate with insulin sensitivity. Expression is increased 2-3 fold in the group of patients with high insulin sensitivity, compared to the insulin- resistant group. This observation is consistent with the idea that triglyceride storage in adipocytes plays an important role in sequestering triglycerides and fatty acids away from the circulation and peripheral tissues, thus enhancing insulin sensitivity in liver and muscle. This effect is not significant in subcutaneous adipose tissue (PubMed:18509062). In subcutaneous adipose tissue of diabetic patients, tends to negatively correlate with body mass index and total fat mass, independently of insulin sensitivity (PubMed:18334488). {ECO:0000269|PubMed:18334488, ECO:0000269|PubMed:18509062}.; DISEASE: Lipodystrophy, familial partial, 5 (FPLD5) [MIM:615238]: A form of lipodystrophy characterized by loss of subcutaneous adipose tissue affecting limb, femorogluteal and subcutaneous abdominal fat, preservation of visceral, neck and axilliary fat, hepatomegaly, hepatic steatosis and insulin-resistant diabetes. {ECO:0000269|PubMed:20049731}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20849	.	0.262810045	70.43524416	157.22556	2.74041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	3	9912079	chr3:9912079	G	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	9987398	9987398	-	A	UTR3	PRRT3	NM_207351:c.*512_*513insT	.	.	0.658018522	0.341744429	0.000237049	.	0.10702	0.08913	.	.	3828.2537	12.1724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	358	3	9987398	chr3:9987398	G	GA	93	PASS	DP=358;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	10367959	10367959	A	G	UTR3	ATP2B2	NM_001683:c.*2539T>C;NM_001330611:c.*2898T>C;NM_001001331:c.*2539T>C	.	.	0.999921506	7.85E-05	8.79E-13	.	0.69922	0.18045	-1.943881244	1.893135173	96.26442	2.12107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	114	3	10367959	chr3:10367959	A	G	80	PASS	DP=114;AN=4	GT	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.	./.
3	10491147	10491147	T	G	exonic	ATP2B2	.	synonymous SNV	ATP2B2:NM_001001331:exon2:c.A81C:p.T27T,ATP2B2:NM_001330611:exon2:c.A81C:p.T27T,ATP2B2:NM_001683:exon2:c.A81C:p.T27T	0.999921506	7.85E-05	8.79E-13	.	0.69922	0.18045	-1.943881244	1.893135173	96.26442	2.12107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	58	3	10491147	chr3:10491147	T	G	46	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	12574140	12574140	-	T	intronic	TSEN2	.	.	.	0.000104861	0.987514431	0.012380708	.	0.09274	0.08793	-0.753139731	13.67067705	284.29352	3.60987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	15	3	12574140	chr3:12574140	C	CT	41	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	12861586	12861586	T	C	exonic	CAND2	.	synonymous SNV	CAND2:NM_012298:exon9:c.T2667C:p.G889G,CAND2:NM_001162499:exon11:c.T2946C:p.G982G	4.53E-09	0.806271649	0.193728346	.	0.25408	0.11518	1.526690916	95.49422033	6172.51432	16.42964	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	37	3	12861586	chr3:12861586	T	C	52	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	13651011	13651011	A	G	splicing	FBLN2	NM_001998:exon4:c.1419-2A>G;NM_001004019:exon4:c.1419-2A>G;NM_001165035:exon4:c.1419-2A>G	.	.	0.629825153	0.370172306	2.54E-06	.	0.76637	0.22472	-1.091439713	6.988676575	754.76604	5.44846	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.312	0.457	22.9	0.984	0.407	0.949	0.625	D	c	0.869	0.656	0.998	0.361	0.078	0.016	0	4.79	0.608	5.907	0.694	1.135	0.883	1.000	0.715	0.690	0.307	12.761	0.566	.	.	.	0.5	.	36	3	13651011	chr3:13651011	A	G	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	13651139	13651139	C	A	exonic	FBLN2	.	stopgain	FBLN2:NM_001004019:exon4:c.C1545A:p.Y515X,FBLN2:NM_001165035:exon4:c.C1545A:p.Y515X,FBLN2:NM_001998:exon4:c.C1545A:p.Y515X	0.629825153	0.370172306	2.54E-06	.	0.76637	0.22472	-1.091439713	6.988676575	754.76604	5.44846	.	.	.	.	.	.	.	.	.	0.171	0.174	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.377	0.967	36	0.996	0.730	0.833	0.421	D	c	0.264	0.018	0.142	0.173	0.706	0.609	0	1.54	0.222	0.063	0.142	-1.011	0.022	0.992	0.373	0.341	0.244	6.913	0.234	Anaphylatoxin/fibulin|Growth factor receptor cysteine-rich domain	.	.	0.5	.	43	3	13651139	chr3:13651139	C	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	14208625	14208625	G	C	intronic	XPC	.	.	.	1.32E-10	0.769528282	0.230471718	DISEASE: Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. {ECO:0000269|PubMed:10766188, ECO:0000269|PubMed:8298653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28185	0.48408	0.45192103	78.03727294	310.38459	3.74818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	31	3	14208625	chr3:14208625	G	C	107	PASS	DP=31;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	14520577	14520577	C	T	intronic	SLC6A6	.	.	.	0.98227565	0.017723862	4.88E-07	.	0.32797	.	-0.291981272	33.20358575	72.45796	1.77348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	45	3	14520577	chr3:14520577	C	T	51	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	16216734	16216734	G	A	exonic	GALNT15	.	nonsynonymous SNV	GALNT15:NM_001319051:exon1:c.G76A:p.V26I,GALNT15:NM_054110:exon1:c.G76A:p.V26I	5.52E-10	0.376453241	0.623546758	.	0.30314	0.09703	-0.661316159	16.02382637	2902.69931	10.21345	0.04	0.437	D	0.203	0.281	B	0.01	0.139	B	0.259	0.037	N	1	0.090	N	1.21	0.306	L	0.58	0.580	T	-0.07	0.080	N	0.072	0.114	-1.059	0.120	T	0.075	0.303	T	0.039	0.588	D	-0.131	0.082	1.511	0.836	0.143	0.084	0.141	N	c	-1.094	-1.197	1.000	0.489	0.741	0.978	0	-4.59	0.031	-0.064	0.115	0.080	0.190	0.002	0.151	0.038	0.155	1.076	0.015	.	.	.	0.5	.	59	3	16216734	chr3:16216734	G	A	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	16679458	16679458	G	A	intergenic	DAZL;PLCL2	dist=32452;dist=246994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	15	3	16679458	chr3:16679458	G	A	50	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	17747513	17747513	C	G	intronic	TBC1D5	.	.	.	6.52E-10	0.96022617	0.039773829	.	0.28341	0.1005	0.090079492	60.64519934	185.71366	2.95909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	45	3	17747513	chr3:17747513	C	G	81	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	23848923	23848923	-	T	intronic	UBE2E1	.	.	.	0.872957997	0.125383932	0.00165807	.	0.62873	0.11262	0.279402865	70.86577023	246.66235	3.38871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	26	3	23848923	chr3:23848923	C	CT	39	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	28364889	28364889	G	-	UTR3	AZI2	NM_022461:c.*644delC;NM_001271650:c.*644delC	.	.	0.185308909	0.812253432	0.002437659	.	0.47993	0.11092	-0.405853867	26.23260203	14.46843	0.52075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	74	3	28364888	chr3:28364888	TG	T	42	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	33645746	33645746	C	T	intronic	CLASP2	.	.	.	0.99994836	5.16E-05	1.08E-16	.	0.48367	0.14642	.	.	656.28546	5.13608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	3	33645746	chr3:33645746	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	33887102	33887102	A	G	intronic	PDCD6IP	.	.	.	0.751958922	0.248040335	7.43E-07	.	0.26577	0.12495	-0.306750577	32.23047889	8447.59531	19.81694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	12	3	33887102	chr3:33887102	A	G	62	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	38023756	38023780	GTGGGACTCATTGCCCCAAACCAGG	-	UTR3	CTDSPL	NM_005808:c.*1398_*1422delGTGGGACTCATTGCCCCAAACCAGG;NM_001008392:c.*1398_*1422delGTGGGACTCATTGCCCCAAACCAGG	.	.	0.088848186	0.870209145	0.040942669	.	0.23991	0.1515	-0.029247611	51.40363293	80.58588	1.8968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	66	3	38023755	chr3:38023755	TGTGGGACTCATTGCCCCAAACCAGG	T	58	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	38040542	38040542	G	A	splicing	VILL	NM_015873:exon9:c.1081+1G>A	.	.	3.01E-12	0.679546705	0.320453295	.	0.36993	0.1181	-1.502810938	3.573956122	1844.77155	7.92187	.	.	.	.	.	.	.	.	.	.	.	.	0.992	0.239	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.775	0.168	9.311	0.763	0.110	0.553	0.296	D	c	0.227	-0.096	1.000	0.747	0.163	0.030	0	1.98	0.252	2.983	0.488	-0.541	0.048	0.993	0.376	0.000	0.016	9.694	0.391	.	.	.	0.5	.	108	3	38040542	chr3:38040542	G	A	.	PASS	DP=108;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	38040547	38040547	C	T	intronic	VILL	.	.	.	3.01E-12	0.679546705	0.320453295	.	0.36993	0.1181	-1.502810938	3.573956122	1844.77155	7.92187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	3	38040547	chr3:38040547	C	T	.	PASS	DP=106;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	38137959	38137959	-	T	intronic	DLEC1	.	.	.	6.45E-18	0.99562723	0.00437277	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of lung cancer.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:10213508}. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription may be implicated in the development of esophageal cancer.; 	0.98238	0.10873	0.161491526	64.92686954	3130.50362	10.64467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	141	3	38137959	chr3:38137959	G	GT	92	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	40468859	40468859	C	G	exonic	ENTPD3	.	nonsynonymous SNV	ENTPD3:NM_001248:exon11:c.C1450G:p.P484A,ENTPD3:NM_001291960:exon11:c.C1450G:p.P484A	2.56E-19	0.000141873	0.999858127	.	0.16865	0.16922	-0.26629572	34.81953291	1007.34812	6.11352	0.281	0.154	T	0.932	0.500	P	0.396	0.426	B	0.026	0.260	N	1	0.090	N	0.895	0.225	L	2.95	0.097	T	-2.65	0.567	D	0.348	0.409	-1.008	0.276	T	0.014	0.055	T	0.006	0.166	T	0.539	0.146	7.724	0.962	0.285	0.334	0.246	N	c	-0.354	-0.368	0.980	0.301	0.487	0.133	0	4.29	0.502	2.197	0.421	0.935	0.490	0.011	0.184	0.281	0.234	7.728	0.278	.	.	.	0.5	97	93	3	40468859	chr3:40468859	C	G	97	PASS	DP=93;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	40550121	40550121	-	T	intronic	ZNF620	.	.	.	6.83E-06	0.715071728	0.284921445	.	0.10981	.	0.350995466	74.37485256	198.29097	3.04284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10	73	3	40550121	chr3:40550121	C	CT	10	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	41266101	41266101	C	A	exonic	CTNNB1	.	nonsynonymous SNV	CTNNB1:NM_001098209:exon3:c.C98A:p.S33Y,CTNNB1:NM_001098210:exon3:c.C98A:p.S33Y,CTNNB1:NM_001904:exon3:c.C98A:p.S33Y,CTNNB1:NM_001330729:exon4:c.C77A:p.S26Y	0.99981275	0.00018725	3.61E-11	DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:9065402}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.; DISEASE: Pilomatrixoma (PTR) [MIM:132600]: Common benign skin tumor. {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:11703283}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10391090}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.; DISEASE: Mesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle- shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. {ECO:0000269|PubMed:11464291}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mental retardation, autosomal dominant 19 (MRD19) [MIM:615075]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD19 features include severe intellectual disability with absent or very limited speech, microcephaly, and spasticity which severely impaired the ability to walk. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:25326669}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99997	0.9963	-0.582225231	18.44184949	10.25364	0.37429	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.66	0.781	M	0.74	0.505	T	-5.89	0.887	D	0.239	0.784	-0.375	0.728	T	0.341	0.707	T	0.067	0.702	D	5.588	0.760	26.5	0.994	0.641	0.970	0.719	D	c	0.915	0.893	1.0	0.983	0.707	0.730	0	5.76	0.907	7.905	0.864	0.935	0.490	1.000	0.715	1.000	0.888	19.960	0.972	.	.	.	0.5	.	41	3	41266101	chr3:41266101	C	A	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	42299737	42299737	G	A	intronic	CCK	.	.	.	0.023105402	0.768016901	0.208877697	.	0.075	0.19392	-0.031067188	51.03798066	31.7441	0.99985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	9	3	42299737	chr3:42299737	G	A	50	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	43408393	43408393	G	A	UTR3	ANO10	NM_001204834:c.*5C>T;NM_001346465:c.*5C>T;NM_001204831:c.*107C>T;NM_001204833:c.*5C>T;NM_001346468:c.*5C>T;NM_001346464:c.*5C>T;NM_001204832:c.*5C>T;NM_018075:c.*5C>T;NM_001346469:c.*5C>T;NM_001346463:c.*5C>T;NM_001346466:c.*5C>T;NM_001346467:c.*5C>T	.	.	1.92E-06	0.880526516	0.119471561	.	0.13961	0.09565	0.957177419	90.14508139	912.19278	5.8726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	163	3	43408393	chr3:43408393	G	A	93	PASS	DP=163;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	45761125	45761128	TAAT	-	intronic	SACM1L	.	.	.	0.721901743	0.278097217	1.04E-06	.	0.55456	0.1049	-0.424258538	25.56027365	29.43851	0.94154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	14	3	45761124	chr3:45761124	GTAAT	G	63	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	46482898	46482898	T	-	intronic	LTF	.	.	.	1.76E-13	0.332110461	0.667889539	.	.	0.31989	0.521707177	80.39631989	121.1482	2.39786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	14	3	46482897	chr3:46482897	CT	C	44	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	46620760	46620760	T	G	exonic	TDGF1	.	nonsynonymous SNV	TDGF1:NM_001174136:exon3:c.T79G:p.Y27D,TDGF1:NM_003212:exon3:c.T127G:p.Y43D	3.98E-06	0.212748142	0.787247875	.	.	0.56496	0.238945317	69.20853975	351.82952	3.97563	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.759	0.096	N	1.000	0.090	P	-1.845	0.003	N	0.24	0.597	T	3.84	0.001	N	0.024	0.021	-1.040	0.172	T	0.000	0.000	T	.	.	.	-0.616	0.049	0.114	0.634	0.070	0.001	0.005	N	c	-1.407	-1.300	1.000	0.500	0.628	0.401	0	3.31	0.369	0.679	0.248	0.123	0.211	0.003	0.159	0.002	0.062	7.482	0.264	.	.	.	0.5	52	16	3	46620760	chr3:46620760	T	G	52	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	47452022	47452022	G	A	exonic	PTPN23	.	nonsynonymous SNV	PTPN23:NM_001304482:exon19:c.G2356A:p.V786M,PTPN23:NM_015466:exon20:c.G2734A:p.V912M	0.647596781	0.352403215	3.63E-09	.	0.09755	0.12139	-1.3304325	4.676810569	1113.07486	6.37437	0.115	0.285	T	0.003	0.102	B	0.004	0.093	B	0.956	0.077	N	1	0.090	N	1.01	0.254	L	4.26	0.026	T	-0.02	0.073	N	0.202	0.248	-0.899	0.481	T	0.005	0.017	T	0.007	0.188	T	-0.678	0.046	0.081	0.850	0.151	0.173	0.196	N	c	-1.205	-1.192	0.997	0.356	0.732	0.924	0	0.612	0.167	2.162	0.418	0.079	0.188	0.316	0.252	0.765	0.326	1.504	0.023	.	.	.	0.5	.	94	3	47452022	chr3:47452022	G	A	.	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	47460085	47460085	C	T	intronic	SCAP	.	.	.	0.02255475	0.977439846	5.40E-06	.	0.05282	0.16079	-2.188305787	1.391837698	3410.40993	11.19013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	3	47460085	chr3:47460085	C	T	.	PASS	DP=79;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	48681766	48681769	AGAG	-	intronic	CELSR3	.	.	.	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	12	3	48681765	chr3:48681765	CAGAG	C	42	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	48684190	48684190	G	C	intronic	CELSR3	.	.	.	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	91	3	48684190	chr3:48684190	G	C	99	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	50141668	50141668	-	T	intronic	RBM5	.	.	.	0.99999947	5.30E-07	2.25E-17	.	0.49937	0.11696	-1.111360919	6.717386176	14.39881	0.51975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	19	3	50141668	chr3:50141668	C	CT	40	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	50407863	50407863	G	A	intronic	CACNA2D2	.	.	.	0.999693297	0.000306703	4.08E-14	.	0.48941	0.15443	-0.549263935	19.95163954	590.52071	4.92605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	3	50407863	chr3:50407863	G	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	50407875	50407875	G	A	intronic	CACNA2D2	.	.	.	0.999693297	0.000306703	4.08E-14	.	0.48941	0.15443	-0.549263935	19.95163954	590.52071	4.92605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	99	3	50407875	chr3:50407875	G	A	67	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	52290115	52290115	T	C	UTR3	WDR82	NM_025222:c.*1391A>G	.	.	0.923062144	0.076843893	9.40E-05	.	0.64619	0.12971	-0.031067188	51.03798066	1.24663	0.04374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	3	52290115	chr3:52290115	T	C	.	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	52858010	52858010	G	A	exonic;splicing	ITIH4;ITIH4-AS1	NR_046615:exon1:c.59+1G>A	synonymous SNV	ITIH4:NM_001166449:exon10:c.C1182T:p.N394N,ITIH4:NM_002218:exon10:c.C1182T:p.N394N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	3	52858010	chr3:52858010	G	A	.	PASS	DP=93;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	53226714	53226714	T	G	UTR3	PRKCD	NM_212539:c.*432T>G;NM_006254:c.*432T>G;NM_001316327:c.*432T>G	.	.	0.997593707	0.00240629	3.69E-09	DISEASE: Autoimmune lymphoproliferative syndrome 3 (ALPS3) [MIM:615559]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. CVID9 patients have B-cell deficiency and severe autoimmunity. {ECO:0000269|PubMed:23319571}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.50726	0.64101	-1.041578376	7.773059684	38.38258	1.13875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	64	3	53226714	chr3:53226714	T	G	72	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	53321295	53321295	C	T	UTR3	DCP1A	NM_001290205:c.*303G>A;NM_001290206:c.*303G>A;NM_001290204:c.*303G>A;NM_018403:c.*303G>A;NM_001290207:c.*303G>A	.	.	0.943913888	0.056077565	8.55E-06	.	0.44145	0.11103	.	.	160.55737	2.76552	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	3	53321295	chr3:53321295	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	53529170	53529170	T	-	UTR5	CACNA1D	NM_001128839:c.-24del-;NM_000720:c.-24del-;NM_001128840:c.-24del-	.	.	1	1.06E-11	1.34E-31	DISEASE: Sinoatrial node dysfunction and deafness (SANDD) [MIM:614896]: A disease characterized by congenital severe to profound deafness without vestibular dysfunction, associated with episodic syncope due to intermittent pronounced bradycardia. {ECO:0000269|PubMed:21131953}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary aldosteronism, seizures, and neurologic abnormalities (PASNA) [MIM:615474]: A disorder characterized by hypertension, hypokalemia, and high aldosterone levels with low plasma renin activity and an elevated aldosterone/renin ratio. Other features include generalized seizures, cerebral palsy, spasticity, intellectual disability, and developmental delay. {ECO:0000269|PubMed:23913001}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53996	0.14577	-3.512328228	0.324368955	728.73949	5.35831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	127	3	53529169	chr3:53529169	GT	G	70	PASS	DP=127;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	53919752	53919752	C	A	intronic	SELENOK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	3	53919752	chr3:53919752	C	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	56763525	56763525	A	G	exonic	ARHGEF3	.	synonymous SNV	ARHGEF3:NM_001128616:exon10:c.T1372C:p.L458L,ARHGEF3:NM_019555:exon10:c.T1354C:p.L452L,ARHGEF3:NM_001289698:exon11:c.T1372C:p.L458L,ARHGEF3:NM_001128615:exon13:c.T1450C:p.L484L	0.991271358	0.008728557	8.58E-08	.	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	11	3	56763525	chr3:56763525	A	G	43	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	56835761	56835761	G	A	exonic	ARHGEF3	.	synonymous SNV	ARHGEF3:NM_019555:exon1:c.C66T:p.P22P	0.991271358	0.008728557	8.58E-08	.	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	197	353	3	56835761	chr3:56835761	G	A	197	PASS	DP=353;AN=2	GT	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	57140083	57140083	C	A	intronic	IL17RD	.	.	.	2.64E-05	0.98202302	0.017950625	.	0.6749	0.12392	-0.172654315	40.63458363	2297.79347	8.87861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	65	3	57140083	chr3:57140083	C	A	51	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	57335799	57335799	G	A	exonic	DNAH12	.	unknown	UNKNOWN	0.000394166	0.95768566	0.041920174	.	0.40937	0.09978	0.841481379	88.35810333	7404.50475	18.48845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	3	57335799	chr3:57335799	G	A	.	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	57563121	57563121	A	-	intronic	ARF4;PDE12	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	14	3	57563120	chr3:57563120	GA	G	43	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	57611367	57611367	-	A	UTR3	DENND6A	NM_152678:c.*2573_*2574insT	.	.	0.852272523	0.147727301	1.76E-07	.	0.26434	.	-0.0274281	51.65723048	40.37373	1.18488	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	30	3	57611367	chr3:57611367	T	TA	75	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	57843748	57843748	-	T	intronic	SLMAP	.	.	.	0.999325965	0.000674035	6.78E-12	.	0.43101	0.11509	-1.155457828	6.168907761	40.3211	1.1843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	50	3	57843748	chr3:57843748	C	CT	110	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	58112428	58112428	C	T	exonic	FLNB	.	synonymous SNV	FLNB:NM_001164317:exon24:c.C4161T:p.Y1387Y,FLNB:NM_001164318:exon24:c.C4161T:p.Y1387Y,FLNB:NM_001164319:exon24:c.C4161T:p.Y1387Y,FLNB:NM_001457:exon24:c.C4161T:p.Y1387Y	0.00243124	0.99756876	3.24E-12	DISEASE: Note=Interaction with FLNA may compensate for dysfunctional FLNA homodimer in the periventricular nodular heterotopia (PVNH) disorder.; DISEASE: Atelosteogenesis 1 (AO1) [MIM:108720]: A lethal chondrodysplasia characterized by distal hypoplasia of the humeri and femurs, hypoplasia of the mid-thoracic spine, occasionally complete lack of ossification of single hand bones, and the finding in cartilage of multiple degenerated chondrocytes which are encapsulated in fibrous tissue. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atelosteogenesis 3 (AO3) [MIM:108721]: A short-limb lethal skeletal dysplasia with vertebral abnormalities, disharmonious skeletal maturation, poorly modeled long bones and joint dislocations. Recurrent respiratory insufficiency and/or infections usually result in early death. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Boomerang dysplasia (BOOMD) [MIM:112310]: A perinatal lethal osteochondrodysplasia characterized by absence or underossification of the limb bones and vertebrae. Patients manifest dwarfism with short, bowed, rigid limbs and characteristic facies. Boomerang dysplasia is distinguished from atelosteogenesis on the basis of a more severe defect in mineralization, with complete absence of ossification in some limb elements and vertebral segments. {ECO:0000269|PubMed:15994868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Larsen syndrome (LRS) [MIM:150250]: An osteochondrodysplasia characterized by large-joint dislocations and characteristic craniofacial abnormalities. The cardinal features of the condition are dislocations of the hip, knee and elbow joints, with equinovarus or equinovalgus foot deformities. Spatula-shaped fingers, most marked in the thumb, are also present. Craniofacial anomalies include hypertelorism, prominence of the forehead, a depressed nasal bridge, and a flattened midface. Cleft palate and short stature are often associated features. Spinal anomalies include scoliosis and cervical kyphosis. Hearing loss is a well-recognized complication. {ECO:0000269|PubMed:14991055, ECO:0000269|PubMed:16801345}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondylocarpotarsal synostosis syndrome (SCT) [MIM:272460]: Disorder characterized by short stature and vertebral, carpal and tarsal fusions. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.45177	0.2159	-1.444990676	3.939608398	1028.35714	6.16096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	3	58112428	chr3:58112428	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	58368401	58368401	C	G	exonic	PXK	.	nonsynonymous SNV	PXK:NM_001289096:exon2:c.C263G:p.P88R,PXK:NM_001289100:exon2:c.C263G:p.P88R,PXK:NM_001349490:exon2:c.C263G:p.P88R,PXK:NM_001349500:exon2:c.C263G:p.P88R,PXK:NM_001349522:exon2:c.C263G:p.P88R,PXK:NM_001349524:exon2:c.C263G:p.P88R,PXK:NM_001289095:exon3:c.C311G:p.P104R,PXK:NM_001349494:exon3:c.C314G:p.P105R,PXK:NM_001349495:exon3:c.C314G:p.P105R,PXK:NM_001349496:exon3:c.C311G:p.P104R,PXK:NM_001349497:exon3:c.C311G:p.P104R,PXK:NM_001349501:exon3:c.C314G:p.P105R,PXK:NM_001349502:exon3:c.C311G:p.P104R,PXK:NM_001349510:exon3:c.C314G:p.P105R,PXK:NM_001349511:exon3:c.C314G:p.P105R,PXK:NM_001349512:exon3:c.C314G:p.P105R,PXK:NM_001349514:exon3:c.C311G:p.P104R,PXK:NM_001349515:exon3:c.C311G:p.P104R,PXK:NM_001349516:exon3:c.C314G:p.P105R,PXK:NM_001349517:exon3:c.C311G:p.P104R,PXK:NM_001349518:exon3:c.C311G:p.P104R,PXK:NM_001289098:exon4:c.C362G:p.P121R,PXK:NM_001289099:exon4:c.C113G:p.P38R,PXK:NM_001349488:exon4:c.C362G:p.P121R,PXK:NM_001349492:exon4:c.C362G:p.P121R,PXK:NM_001349493:exon4:c.C362G:p.P121R,PXK:NM_001349498:exon4:c.C302G:p.P101R,PXK:NM_001349499:exon4:c.C362G:p.P121R,PXK:NM_001349503:exon4:c.C362G:p.P121R,PXK:NM_001349504:exon4:c.C362G:p.P121R,PXK:NM_001349506:exon4:c.C362G:p.P121R,PXK:NM_001349507:exon4:c.C362G:p.P121R,PXK:NM_001349508:exon4:c.C362G:p.P121R,PXK:NM_001349509:exon4:c.C362G:p.P121R,PXK:NM_001349519:exon4:c.C362G:p.P121R,PXK:NM_001349520:exon4:c.C362G:p.P121R,PXK:NM_001349527:exon4:c.C362G:p.P121R,PXK:NM_017771:exon4:c.C362G:p.P121R,PXK:NM_001349489:exon5:c.C113G:p.P38R,PXK:NM_001349513:exon5:c.C113G:p.P38R,PXK:NM_001349521:exon5:c.C113G:p.P38R,PXK:NM_001349528:exon5:c.C113G:p.P38R,PXK:NM_001349529:exon5:c.C113G:p.P38R,PXK:NM_001349530:exon5:c.C113G:p.P38R,PXK:NM_001349531:exon5:c.C113G:p.P38R	0.932144256	0.06785563	1.15E-07	.	0.13995	0.09839	0.266447942	70.5826846	2672.1939	9.71802	0.045	0.784	D	0.751	0.487	P	0.327	0.479	B	0.000	0.843	D	1	0.810	D	3.1	0.878	M	1.06	0.398	T	-6.39	0.913	D	0.839	0.827	-0.699	0.605	T	0.203	0.561	T	0.028	0.508	D	5.715	0.780	26.8	0.996	0.710	0.986	0.847	D	c	0.610	0.657	1.000	0.747	0.732	0.924	0	5.57	0.840	7.347	0.784	0.935	0.490	1.000	0.715	1.000	0.888	19.545	0.953	Phox homologous domain;Phox homologous domain|Protein kinase domain	.	.	0.5	71	17	3	58368401	chr3:58368401	C	G	71	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	59737880	59737880	C	A	UTR3	FHIT	NM_001320901:c.*72G>T;NM_001320900:c.*72G>T;NM_001320899:c.*72G>T	.	.	0.001391839	0.662104571	0.33650359	DISEASE: Note=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.; DISEASE: Note=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.; 	0.25475	.	-0.560178693	19.30879925	49.36677	1.3751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	3	59737880	chr3:59737880	C	A	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	62535675	62535675	C	A	exonic	CADPS	.	synonymous SNV	CADPS:NM_003716:exon11:c.G1869T:p.T623T,CADPS:NM_183393:exon11:c.G1869T:p.T623T,CADPS:NM_183394:exon11:c.G1869T:p.T623T	0.052816468	0.94718353	2.47E-09	.	0.46523	.	-1.346642726	4.62962963	108.92082	2.26567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	88	3	62535675	chr3:62535675	C	A	88	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	63820995	63820995	A	C	ncRNA_intronic	C3orf49	.	.	.	.	.	.	.	0.11088	.	.	.	1468.35326	7.14177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	43	3	63820995	chr3:63820995	A	C	74	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	63898180	63898180	G	T	intronic	ATXN7	.	.	.	0.928556028	0.071440779	3.19E-06	DISEASE: Spinocerebellar ataxia 7 (SCA7) [MIM:164500]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA7 belongs to the autosomal dominant cerebellar ataxias type II (ADCA II) which are characterized by cerebellar ataxia with retinal degeneration and pigmentary macular dystrophy. {ECO:0000269|PubMed:9288099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40116	0.43982	0.205769367	67.49823071	3924.42931	12.38246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	133	3	63898180	chr3:63898180	G	T	109	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	65438846	65438846	C	T	intronic	MAGI1	.	.	.	0.999615675	0.000384325	2.89E-15	.	0.27232	0.12487	-1.383523256	4.358339231	581.76428	4.88893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	37	3	65438846	chr3:65438846	C	T	40	PASS	DP=37;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	71007068	71007068	G	A	UTR3	FOXP1	NM_001244813:c.*1330C>T;NM_001244814:c.*1330C>T;NM_001244815:c.*1330C>T;NM_001244810:c.*1330C>T;NM_001244816:c.*1330C>T;NM_001244812:c.*1330C>T;NM_001244808:c.*1330C>T;NM_032682:c.*1330C>T;NM_001349344:c.*1330C>T;NM_001349342:c.*1330C>T;NM_001349343:c.*1330C>T;NM_001349338:c.*1330C>T;NM_001349339:c.*1330C>T;NM_001349340:c.*1330C>T;NM_001349341:c.*1330C>T;NM_001349337:c.*1330C>T	.	.	0.999750735	0.000249265	1.47E-11	DISEASE: Note=A chromosomal aberration involving FOXP1 is found in acute lymphoblastic leukemia. Translocation t(9;3)(p13;p14.1) with PAX5.; DISEASE: Mental retardation with language impairment and autistic features (MRLIAF) [MIM:613670]: A developmental disorder characterized by mild to moderate mental retardation, language impairment, and autistic features. Patients show global delay, delayed walking, severely delayed speech development, and behavioral abnormalities, including irritability, hyperactivity, aggression, and stereotypical rigid behaviors. {ECO:0000269|PubMed:20950788}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57291	0.32628	-0.378346116	28.01368247	60.34446	1.57849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	3	71007068	chr3:71007068	G	A	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	73432720	73432720	C	T	exonic	PDZRN3	.	synonymous SNV	PDZRN3:NM_001303139:exon8:c.G2091A:p.R697R,PDZRN3:NM_001303140:exon8:c.G1968A:p.R656R,PDZRN3:NM_001303141:exon8:c.G2163A:p.R721R,PDZRN3:NM_001303142:exon8:c.G2148A:p.R716R,PDZRN3:NM_015009:exon10:c.G2997A:p.R999R	0.908376144	0.091617814	6.04E-06	.	0.4722	0.13321	-0.990222991	8.634111819	1513.34426	7.23005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	113	3	73432720	chr3:73432720	C	T	95	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	74334562	74334562	T	G	exonic	CNTN3	.	synonymous SNV	CNTN3:NM_020872:exon19:c.A2598C:p.L866L	0.014141786	0.985856032	2.18E-06	.	0.27019	0.43019	0.316000233	72.80018872	1496.00916	7.19616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	151	3	74334562	chr3:74334562	T	G	107	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	75478216	75478216	C	A	ncRNA_intronic	FAM86DP	.	.	.	.	.	.	.	0.06283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	276	3	75478216	chr3:75478216	C	A	140	PASS	DP=276;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	75480040	75480041	CA	-	ncRNA_exonic	FAM86DP	.	.	.	.	.	.	.	0.06283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	77	3	75480039	chr3:75480039	TCA	T	62	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	75672730	75672730	T	C	intergenic	FAM86DP;MIR1324	dist=188464;dist=7184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	3	75672730	chr3:75672730	T	C	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	78647220	78647220	G	A	UTR3	ROBO1	NM_001145845:c.*843C>T;NM_002941:c.*843C>T;NM_133631:c.*843C>T	.	.	3.04E-08	0.99999991	5.98E-08	.	0.94674	0.12413	-1.960545765	1.845954234	484.42539	4.53042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	3	78647220	chr3:78647220	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	87322555	87322555	A	T	exonic	POU1F1	.	nonsynonymous SNV	POU1F1:NM_000306:exon2:c.T156A:p.H52Q,POU1F1:NM_001122757:exon2:c.T234A:p.H78Q	0.618818419	0.379529678	0.001651904	DISEASE: Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]: Combined pituitary hormone deficiency is defined as the impaired production of growth hormone and one or more of the other five anterior pituitary hormones. CPHD1 is characterized by pleiotropic deficiencies of growth hormone, prolactin and thyroid- stimulating hormone, while the production of adrenocorticotropic hormone, luteinizing hormone, and follicle-stimulating hormone are preserved. In infancy severe growth deficiency from birth as well as distinctive facial features with prominent forehead, marked midfacial hypoplasia with depressed nasal bridge, deep-set eyes, and a short nose with anteverted nostrils and hypoplastic pituitary gland by MRI examination can be seen. Some cases present with severe mental retardation along with short stature. {ECO:0000269|PubMed:11297581, ECO:0000269|PubMed:1472057, ECO:0000269|PubMed:1509262, ECO:0000269|PubMed:1509263, ECO:0000269|PubMed:15928241, ECO:0000269|PubMed:16968807, ECO:0000269|PubMed:7852536, ECO:0000269|PubMed:8768831, ECO:0000269|PubMed:9485179, ECO:0000269|PubMed:9626142}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19992	0.28828	0.038710339	56.92380278	38.64856	1.14539	0.001	0.912	D	0.999	0.764	D	0.997	0.850	D	0.004	0.342	N	1.000	0.479	D	1.975	0.537	M	-0.19	0.659	T	-2.55	0.881	D	0.818	0.813	-0.480	0.694	T	0.340	0.706	T	0.034	0.553	D	3.849	0.519	23.4	0.989	0.485	0.742	0.360	D	c	0.087	0.012	0.000	0.046	0.428	0.059	0	-0.356	0.119	0.937	0.283	0.125	0.212	1.000	0.715	0.999	0.750	10.670	0.448	POU-specific domain	.	.	0.5	70	32	3	87322555	chr3:87322555	A	T	70	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
3	88101443	88101443	C	A	UTR3	CGGBP1	NM_003663:c.*3180G>T;NM_001195308:c.*3180G>T;NM_001008390:c.*3180G>T	.	.	0.777631518	0.215081104	0.007287378	.	0.22371	0.11109	0.013025609	54.62962963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	39	3	88101443	chr3:88101443	C	A	65	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	93722533	93722533	G	C	exonic	ARL13B	.	nonsynonymous SNV	ARL13B:NM_001174150:exon3:c.G161C:p.G54A,ARL13B:NM_182896:exon3:c.G161C:p.G54A,ARL13B:NM_001321328:exon4:c.G116C:p.G39A	1.39E-06	0.833651588	0.16634702	DISEASE: Joubert syndrome 8 (JBTS8) [MIM:612291]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:18674751}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06719	0.09956	-0.047654689	50.22410946	555.80587	4.78946	0.005	0.632	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	3.16	0.888	M	-1.49	0.812	T	-5.3	0.844	D	0.594	0.947	0.712	0.933	D	0.776	0.924	D	0.059	0.677	D	5.227	0.706	25.6	0.999	0.933	0.993	0.938	D	c	1.085	1.033	1.000	0.747	0.638	0.428	0	5.93	0.959	8.089	0.893	0.998	0.613	1.000	0.715	0.998	0.697	20.349	0.988	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	101	789	3	93722533	chr3:93722533	G	C	101	PASS	DP=789;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	97439081	97439081	A	C	intronic	EPHA6	.	.	.	0.954513147	0.045486811	4.19E-08	.	0.34698	.	-0.771553417	13.15168672	252.47147	3.41934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	107	3	97439081	chr3:97439081	A	C	95	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	100468103	100468103	-	TGAGTGATTTTCCTTCTCAGATAAAAGGTATAGTTGATT	downstream	ABI3BP;TFG	dist=76	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	48	3	100468103	chr3:100468103	G	GTGAGTGATTTTCCTTCTCAGATAAAAGGTATAGTTGATT	110	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	101006886	101006886	C	A	intronic	IMPG2	.	.	.	1.47E-08	0.997551473	0.002448512	DISEASE: Retinitis pigmentosa 56 (RP56) [MIM:613581]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:20673862}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular dystrophy, vitelliform, 5 (VMD5) [MIM:616152]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD5 features include late- onset moderate visual impairment and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:20673862, ECO:0000269|PubMed:25085631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11371	0.11319	-0.837696902	11.45317292	209.43193	3.12459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	148	3	101006886	chr3:101006886	C	A	.	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	101485483	101485484	AT	-	UTR3	CEP97	NM_024548:c.*1088_*1089delAT;NM_001303401:c.*1088_*1089delAT	.	.	1.33E-06	0.988939885	0.011058789	.	0.39973	0.09879	-0.595174814	18.21184242	175.1978	2.87864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	21	3	101485482	chr3:101485482	GAT	G	69	PASS	DP=21;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	101576029	101576029	-	ACTTTTAGAAAGCTTTAATAACC	splicing	NFKBIZ	NM_001005474:exon11:c.1635+2->ACTTTTAGAAAGCTTTAATAACC;NM_031419:exon10:c.1935+2->ACTTTTAGAAAGCTTTAATAACC	.	.	0.999616951	0.000383048	1.02E-09	.	0.49089	0.09707	-0.622676946	17.30950696	64.66853	1.65031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	31	3	101576029	chr3:101576029	T	TACTTTTAGAAAGCTTTAATAACC	76	PASS	DP=31;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	105470244	105470244	C	G	intronic	CBLB	.	.	.	0.913125167	0.086874824	8.83E-09	.	0.48496	0.38173	-0.839512508	11.40009436	332.72726	3.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	24	3	105470244	chr3:105470244	C	G	56	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	111873836	111873836	A	T	intronic	SLC9C1	.	.	.	7.82E-11	0.992493746	0.007506253	.	0.03558	0.05202	1.631430616	96.06628922	6774.45187	17.48499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	3	111873836	chr3:111873836	A	T	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	111873837	111873837	A	T	intronic	SLC9C1	.	.	.	7.82E-11	0.992493746	0.007506253	.	0.03558	0.05202	1.631430616	96.06628922	6774.45187	17.48499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	3	111873837	chr3:111873837	A	T	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	113236435	113236435	T	C	intergenic	SPICE1;SIDT1	dist=2401;dist=14783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	106	3	113236435	chr3:113236435	T	C	71	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	116088777	116088777	A	G	ncRNA_exonic	LSAMP-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	88	3	116088777	chr3:116088777	A	G	101	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	116163752	116163752	C	T	exonic	LSAMP	.	nonsynonymous SNV	LSAMP:NM_001318915:exon1:c.G127A:p.V43M,LSAMP:NM_002338:exon1:c.G127A:p.V43M	0.946283747	0.053678415	3.78E-05	.	0.72117	0.19389	0.03689118	56.64071715	22.84835	0.76216	0.001	0.912	D	0.984	0.899	D	0.738	0.774	P	0.004	0.344	N	0.832	0.355	D	3.89	0.961	H	-0.63	0.720	T	-1.81	0.473	N	0.461	0.525	0.552	0.913	D	0.597	0.856	D	0.105	0.780	D	6.619	0.909	32	0.999	0.966	0.862	0.451	D	c	0.768	0.692	1.000	0.747	0.652	0.477	0	4.47	0.536	5.574	0.669	0.932	0.445	1.000	0.715	1.000	0.888	16.369	0.831	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	111	3	116163752	chr3:116163752	C	T	.	PASS	DP=111;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	118865127	118865129	GAA	-	exonic	C3orf30	.	nonframeshift deletion	C3orf30:NM_152539:exon1:c.91_93del:p.E32del	1.65E-06	0.415511995	0.584486357	.	0.04106	.	3.199316096	99.33946686	2760.18176	9.91164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	14	3	118865126	chr3:118865126	GGAA	G	44	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	119395799	119395799	A	C	intronic	COX17	.	.	.	0.515141893	0.41831768	0.066540427	.	0.28472	0.1942	0.101211609	60.95777306	712.96801	5.30525	0.004	0.654	D	.	.	.	.	.	.	.	.	.	1	0.186	P	.	.	.	.	.	.	-0.19	0.100	N	0.07	0.058	-0.958	0.395	T	0.000	0.000	T	.	.	.	0.191	0.112	4.585	0.783	0.118	0.042	0.095	N	c	-0.529	-0.702	1.000	0.747	0.442	0.072	0	2.15	0.265	-0.315	0.081	1.088	0.866	0.000	0.063	0.003	0.074	5.117	0.141	.	ENSG00000138495.2|ENSG00000242052.1|ENSG00000183833.12|ENSG00000138495.2|ENSG00000138495.2|ENSG00000242052.1|ENSG00000242052.1|ENSG00000242052.1|ENSG00000183833.12|ENSG00000242052.1|ENSG00000183833.12|ENSG00000183833.12|ENSG00000183833.12|ENSG00000138495.2|ENSG00000183833.12|ENSG00000242052.1	Adipose_Subcutaneous|Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Colon_Sigmoid|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Thyroid	0.5	85	98	3	119395799	chr3:119395799	A	C	85	PASS	DP=98;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	119469924	119469924	C	G	exonic	MAATS1	.	nonsynonymous SNV	MAATS1:NM_001320318:exon15:c.C1906G:p.Q636E,MAATS1:NM_001320317:exon16:c.C2098G:p.Q700E,MAATS1:NM_001320316:exon17:c.C2224G:p.Q742E,MAATS1:NM_033364:exon17:c.C2284G:p.Q762E	9.78E-10	0.904945227	0.095054772	.	0.06869	0.09515	0.872633161	88.87119604	840.25979	5.67623	0.316	0.137	T	0.0	0.026	B	0.002	0.063	B	0.540	0.115	N	1	0.090	N	.	.	.	1.71	0.267	T	-0.37	0.132	N	0.029	0.115	-0.964	0.384	T	0.024	0.104	T	0.004	0.111	T	-1.774	0.011	0.002	0.649	0.074	0.073	0.132	N	c	-1.165	-1.145	0.304	0.192	0.638	0.428	0	0.059	0.136	0.546	0.228	0.841	0.343	0.000	0.063	0.002	0.062	6.517	0.213	.	.	.	0.5	59	33	3	119469924	chr3:119469924	C	G	59	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	119533787	119533787	C	-	intronic	NR1I2	.	.	.	0.000129417	0.846347083	0.1535235	.	0.4518	0.65028	-0.552898813	19.86317528	99.56266	2.15923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	70	3	119533786	chr3:119533786	TC	T	102	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	122078589	122078589	G	C	UTR3	CCDC58	NM_001017928:c.*127C>G;NM_001308326:c.*127C>G	.	.	0.080276122	0.872108394	0.047615484	.	0.59208	0.11262	-0.09720619	46.20193442	9.0286	0.33094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	98	3	122078589	chr3:122078589	G	C	59	PASS	DP=98;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	122078800	122078800	G	A	intronic	CCDC58	.	.	.	0.080276122	0.872108394	0.047615484	.	0.59208	0.11262	-0.09720619	46.20193442	9.0286	0.33094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	3	122078800	chr3:122078800	G	A	.	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	122255139	122255139	C	A	exonic	PARP9	.	nonsynonymous SNV	PARP9:NM_001146102:exon10:c.G2061T:p.K687N,PARP9:NM_001146103:exon10:c.G1956T:p.K652N,PARP9:NM_001146104:exon10:c.G1956T:p.K652N,PARP9:NM_001146105:exon10:c.G1956T:p.K652N,PARP9:NM_001146106:exon10:c.G1956T:p.K652N,PARP9:NM_031458:exon10:c.G2061T:p.K687N	5.14E-06	0.963727364	0.036267496	DISEASE: Note=Overexpressed at significantly higher levels in fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared to cured low-risk tumors. Overexpression in B-cell lymphoma transfectants may promote malignant B-cell migration. May therefore be involved in promoting B-cell migration and dissemination of high-risk DLB-CL tumors (PubMed:11110709). {ECO:0000269|PubMed:11110709}.; 	0.06342	0.08152	-0.394936437	27.02878037	529.88765	4.69811	0.004	0.682	D	1.0	0.899	D	0.992	0.971	D	0.002	0.370	N	0.965	0.408	D	3.75	0.951	H	2.05	0.315	T	-4.5	0.781	D	0.538	0.597	-0.690	0.610	T	0.202	0.560	T	0.014	0.346	T	6.051	0.833	28.0	0.998	0.900	0.875	0.467	D	c	0.597	0.494	0.999	0.392	0.707	0.730	0	5.37	0.769	1.494	0.350	0.935	0.490	0.995	0.385	0.999	0.750	9.963	0.407	Poly(ADP-ribose) polymerase, catalytic domain	.	.	0.5	.	38	3	122255139	chr3:122255139	C	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	122811188	122811188	-	T	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	262	3	122811187	chr3:122811187	GT	GTT,G,GTTTTT	110	PASS	DP=262;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	122811188	122811188	T	-	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	262	3	122811187	chr3:122811187	GT	GTT,G,GTTTTT	110	PASS	DP=262;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	122811188	122811188	-	TTTT	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	262	3	122811187	chr3:122811187	GT	GTT,G,GTTTTT	110	PASS	DP=262;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	124066047	124066047	G	T	exonic	KALRN	.	nonsynonymous SNV	KALRN:NM_001024660:exon10:c.G1699T:p.G567W,KALRN:NM_001322988:exon10:c.G1699T:p.G567W,KALRN:NM_001322989:exon10:c.G1699T:p.G567W,KALRN:NM_001322990:exon10:c.G1699T:p.G567W,KALRN:NM_001322991:exon10:c.G1699T:p.G567W,KALRN:NM_001322992:exon10:c.G1699T:p.G567W,KALRN:NM_003947:exon10:c.G1699T:p.G567W	0.999996915	3.08E-06	5.55E-19	DISEASE: Coronary heart disease 5 (CHDS5) [MIM:608901]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:17357071}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.66718	.	-3.651326374	0.271290399	881.44733	5.78506	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.675	0.786	M	0.79	0.491	T	-6.48	0.944	D	0.957	0.991	-0.026	0.817	T	0.499	0.810	T	0.337	0.919	D	5.508	0.748	26.3	0.997	0.784	0.984	0.824	D	c	0.639	0.686	1.000	0.747	0.633	0.409	0	5.31	0.750	10.003	0.997	1.045	0.669	1.000	0.715	1.000	0.888	19.173	0.935	.	.	.	0.5	.	38	3	124066047	chr3:124066047	G	T	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	125643940	125643940	C	G	ncRNA_exonic	FAM86JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	1456	3	125643940	chr3:125643940	C	G	173	PASS	DP=1456;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	125648158	125648158	G	T	ncRNA_exonic	FAM86JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	145	3	125648158	chr3:125648158	G	T	.	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	126229438	126229438	C	A	intronic	UROC1	.	.	.	3.36E-10	0.734541324	0.265458675	DISEASE: Urocanase deficiency (UROCD) [MIM:276880]: An inborn error of histidine metabolism resulting in urocanic aciduria and neurological manifestations including mental retardation, ataxia, episodic aggressive behavior or exaggerated affection-seeking. {ECO:0000269|PubMed:19304569}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10659	0.13811	0.319642692	72.82967681	647.41865	5.10863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	3	126229438	chr3:126229438	C	A	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	127964353	127964353	G	A	intronic	EEFSEC	.	.	.	0.013115288	0.954167067	0.032717646	.	0.26555	0.26974	-0.376526807	28.10804435	263.47872	3.48275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	3	127964353	chr3:127964353	G	A	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	129308224	129308224	G	A	exonic	PLXND1	.	synonymous SNV	PLXND1:NM_015103:exon2:c.C1458T:p.F486F	0.999989725	1.03E-05	5.15E-17	.	0.15642	0.1259	-1.306585655	4.883227176	2739.76702	9.86834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	156	3	129308224	chr3:129308224	G	A	.	PASS	DP=156;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	131081092	131081092	G	A	ncRNA_exonic	NUDT16P1	.	.	.	.	.	.	.	0.10767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	400	3	131081092	chr3:131081092	G	A	117	PASS	DP=400;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	131101931	131101931	C	G	intronic	NUDT16	.	.	.	0.001460676	0.436410802	0.562128522	.	0.22475	.	.	.	161.74115	2.77897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	46	3	131101931	chr3:131101931	C	G	82	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
3	132221198	132221199	AC	-	exonic	DNAJC13	.	frameshift deletion	DNAJC13:NM_015268:exon40:c.4602_4603del:p.Q1535Dfs*17,DNAJC13:NM_001329126:exon41:c.4617_4618del:p.Q1540Dfs*17	1	3.18E-10	4.43E-30	DISEASE: Parkinson disease 21 (PARK21) [MIM:616361]: An autosomal dominant form of adult-onset Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:24218364}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.41777	0.13911	0.17442557	65.77022883	851.5822	5.70174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.14	36	3	132221197	chr3:132221197	TAC	T	19.14	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	132363753	132363753	A	-	ncRNA_intronic	NPHP3-ACAD11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	157	3	132363752	chr3:132363752	TA	T	86	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	133475722	133475722	C	T	exonic	TF	.	synonymous SNV	TF:NM_001063:exon7:c.C739T:p.L247L	0.002372266	0.996916882	0.000710852	DISEASE: Atransferrinemia (ATRAF) [MIM:209300]: A rare autosomal recessive disorder characterized by abnormal synthesis of transferrin leading to iron overload and microcytic hypochromic anemia. {ECO:0000269|PubMed:11110675, ECO:0000269|PubMed:15466165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.62381	0.9477	-0.905656269	10.12031139	319.18799	3.79368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	25	3	133475722	chr3:133475722	C	T	58	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	133614314	133614314	G	T	UTR5	RAB6B	NM_016577:c.-4C>A	.	.	0.893311149	0.106470904	0.000217948	.	0.70633	0.14229	0.014844891	54.94810097	3.08689	0.1111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	102	3	133614314	chr3:133614314	G	T	.	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	137890399	137890399	T	-	intronic	DBR1	.	.	.	8.71E-05	0.930719935	0.069193013	.	0.26524	0.11154	-0.466531444	23.51380042	128.83429	2.47412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.43	23	3	137890398	chr3:137890398	GT	G	14.43	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	138351814	138351814	G	A	exonic	FAIM	.	nonsynonymous SNV	FAIM:NM_001033032:exon5:c.G433A:p.G145R,FAIM:NM_018147:exon5:c.G433A:p.G145R,FAIM:NM_001033030:exon6:c.G535A:p.G179R,FAIM:NM_001033031:exon6:c.G499A:p.G167R	0.068117194	0.871676576	0.06020623	.	0.1045	0.11959	0.170987912	65.5579146	4094.91295	12.69722	0.045	0.408	D	0.21	0.500	B	0.141	0.388	B	0.000	0.843	D	1	0.810	D	2.63	0.772	M	1.52	0.307	T	-5.19	0.836	D	0.633	0.795	-1.001	0.297	T	0.087	0.338	T	0.019	0.415	T	2.877	0.406	21.7	0.984	0.405	0.983	0.813	D	c	0.183	0.175	1.000	0.747	0.706	0.609	0	5.26	0.734	7.560	0.811	1.048	0.713	1.000	0.715	0.553	0.280	16.415	0.835	.	.	.	0.5	52	87	3	138351814	chr3:138351814	G	A	52	PASS	DP=87;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	138362810	138362810	T	-	intergenic	FAIM;PIK3CB	dist=10597;dist=8730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	137	3	138362809	chr3:138362809	CT	C	81	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	139077605	139077605	G	A	exonic	COPB2	.	nonsynonymous SNV	COPB2:NM_004766:exon20:c.C2534T:p.S845L	0.999998457	1.54E-06	1.50E-15	.	0.51577	0.19561	-0.934977358	9.465675867	73.10436	1.78585	0.175	0.232	T	0.0	0.026	B	0.002	0.063	B	0.001	0.405	N	0.951	0.377	D	1.355	0.339	L	-0.02	0.629	T	-1.34	0.334	N	0.362	0.423	-0.884	0.495	T	0.168	0.508	T	0.018	0.400	T	3.544	0.483	23.1	0.985	0.412	0.941	0.598	D	c	-0.162	-0.001	1.000	0.747	0.719	0.830	0	4.53	0.548	2.611	0.458	1.048	0.713	1.000	0.715	0.991	0.552	9.916	0.404	.	.	.	0.5	.	25	3	139077605	chr3:139077605	G	A	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	139257546	139257546	C	-	ncRNA_intronic	LOC100507291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	68	3	139257545	chr3:139257545	GC	G	72	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	141905409	141905409	C	T	intronic	GK5	.	.	.	0.519887601	0.480081245	3.12E-05	.	0.11834	0.10568	-0.582225231	18.44184949	25.18144	0.82292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	3	141905409	chr3:141905409	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	142184059	142184059	C	T	exonic	ATR	.	synonymous SNV	ATR:NM_001184:exon41:c.G6921A:p.Q2307Q	0.701297833	0.298702167	5.04E-17	DISEASE: Seckel syndrome 1 (SCKL1) [MIM:210600]: A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:12640452}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cutaneous telangiectasia and cancer syndrome, familial (FCTCS) [MIM:614564]: A disease characterized by cutaneous telangiectases in infancy with patchy alopecia over areas of affected skin, thinning of the lateral eyebrows, and mild dental and nail anomalies. Affected individuals are at increased risk of developing oropharyngeal cancer, and other malignancies have been reported as well. {ECO:0000269|PubMed:22341969}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.81267	0.14325	-1.639226005	2.789573013	836.25678	5.6623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	3	142184059	chr3:142184059	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	142546542	142546543	GC	-	intronic	PCOLCE2	.	.	.	6.88E-07	0.700523665	0.299475647	.	0.14001	0.08463	0.066214104	58.95848077	517.122	4.64926	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	50	3	142546541	chr3:142546541	GGC	G	117	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	145841052	145841052	C	G	intronic	PLOD2	.	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	88	3	145841052	chr3:145841052	C	G	109	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
3	145879271	145879271	G	T	UTR5	PLOD2	NM_000935:c.-495C>A;NM_182943:c.-495C>A	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	277	3	145879271	chr3:145879271	G	T	125	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	148711906	148711906	-	T	intronic	GYG1	.	.	.	6.91E-07	0.4631179	0.536881409	DISEASE: Glycogen storage disease 15 (GSD15) [MIM:613507]: A metabolic disorder resulting in muscle weakness, associated with the glycogen depletion in skeletal muscle, and cardiac arrhythmia, associated with the accumulation of abnormal storage material in the heart. The skeletal muscle shows a marked predominance of slow-twitch, oxidative muscle fibers and mitochondrial proliferation. {ECO:0000269|PubMed:20357282}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]: A glycogen storage disease characterized by polyglucosan accumulation in muscle, and skeletal myopathy without cardiac involvement. Most patients manifest slowly progressive, hip girdle, shoulder girdle, and/or hand and leg muscle weakness. Polyglucosan contains abnormally long and poorly branched glucosyl chains and is variably resistant to digestion by alpha-amylase. {ECO:0000269|PubMed:25272951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17298	0.16384	-0.069700724	48.54328851	98.90905	2.15121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	196	3	148711906	chr3:148711906	G	GT	81	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	149233577	149233577	T	-	intergenic	TM4SF4;WWTR1	dist=12396;dist=1439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	70	3	149233576	chr3:149233576	AT	A	39	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	157213185	157213185	T	C	UTR5	VEPH1	NM_024621:c.-47A>G;NM_001167911:c.-47A>G;NM_001167912:c.-47A>G;NM_001167916:c.-47A>G;NM_001167915:c.-47A>G;NM_001167917:c.-47A>G	.	.	9.33E-12	0.260769387	0.739230613	.	0.16283	0.09703	1.071061453	91.69025714	3650.39187	11.74053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	3	157213185	chr3:157213185	T	C	.	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	157822822	157822822	C	-	intronic	SHOX2	.	.	.	0.085211228	0.905107645	0.009681127	.	0.83131	0.12971	-0.405853867	26.23260203	17.09768	0.60161	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	318	3	157822821	chr3:157822821	GC	G	156	PASS	DP=318;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	160970544	160970544	T	-	intronic	NMD3	.	.	.	4.42E-05	0.991223131	0.008732642	.	0.07893	0.10797	-0.512444034	21.55579146	81.92408	1.91851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	271	3	160970543	chr3:160970543	AT	A	81	PASS	DP=271;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	164786506	164786506	G	T	intronic	SI	.	.	.	7.97E-26	0.86464771	0.13535229	DISEASE: Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900]: Autosomal recessive intestinal disorder that is clinically characterized by fermentative diarrhea, abdominal pain, and cramps upon ingestion of sugar. The symptoms are the consequence of absent or drastically reduced enzymatic activities of sucrase and isomaltase. The prevalence of CSID is 0.02 % in individuals of European descent and appears to be much higher in Greenland, Alaskan, and Canadian native people. CSID arises due to post-translational perturbations in the intracellular transport, polarized sorting, aberrant processing, and defective function of SI. {ECO:0000269|PubMed:10903344, ECO:0000269|PubMed:11340066, ECO:0000269|PubMed:14724820, ECO:0000269|PubMed:16329100, ECO:0000269|PubMed:8609217}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07211	0.17154	0.666787636	84.61901392	2753.13216	9.89427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	204	3	164786506	chr3:164786506	G	T	116	PASS	DP=204;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	169381231	169381231	C	T	UTR5	MECOM	NM_001205194:c.-531966G>A;NM_004991:c.-71G>A	.	.	0.999085313	0.000914686	3.49E-10	DISEASE: Note=A chromosomal aberration involving EVI1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with RUNX1/AML1. {ECO:0000269|PubMed:8313895}.; 	0.47994	0.30246	-0.993849454	8.56334041	1129.59722	6.41503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	147	3	169381231	chr3:169381231	C	T	.	PASS	DP=147;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	170727779	170727781	ATT	-	exonic	SLC2A2	.	nonframeshift deletion	SLC2A2:NM_001278658:exon3:c.105_107del:p.I36del,SLC2A2:NM_000340:exon4:c.462_464del:p.I155del	7.53E-05	0.98036244	0.019562243	DISEASE: Fanconi-Bickel syndrome (FBS) [MIM:227810]: Rare, well- defined clinical entity, inherited in an autosomal recessive mode and characterized by hepatorenal glycogen accumulation, proximal renal tubular dysfunction, and impaired utilization of glucose and galactose. {ECO:0000269|PubMed:10987651, ECO:0000269|PubMed:11044475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54341	0.73053	-0.224023033	37.4321774	1965.19505	8.16817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.23	73	3	170727778	chr3:170727778	AATT	A	13.23	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	174000599	174000599	T	-	UTR3	NLGN1	NM_014932:c.*1506delT	.	.	0.755797512	0.24411687	8.56E-05	.	0.34175	0.13453	-1.397999468	4.193205945	58.37576	1.54762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	285	3	174000598	chr3:174000598	AT	A,ATT	71	PASS	DP=285;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	174000599	174000599	-	T	UTR3	NLGN1	NM_014932:c.*1506_*1507insT	.	.	0.755797512	0.24411687	8.56E-05	.	0.34175	0.13453	-1.397999468	4.193205945	58.37576	1.54762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	285	3	174000598	chr3:174000598	AT	A,ATT	71	PASS	DP=285;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	179119110	179119110	-	A	intronic	GNB4	.	.	.	0.629775083	0.369918722	0.000306195	.	0.45415	0.12971	-0.029247611	51.40363293	17.25958	0.60544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	592	3	179119110	chr3:179119110	G	GA	93	PASS	DP=592;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	179525570	179525570	C	T	exonic	PEX5L	.	nonsynonymous SNV	PEX5L:NM_001349404:exon10:c.G992A:p.R331H,PEX5L:NM_001349401:exon11:c.G992A:p.R331H,PEX5L:NM_001256753:exon12:c.G1391A:p.R464H,PEX5L:NM_001349397:exon12:c.G1340A:p.R447H,PEX5L:NM_001349398:exon12:c.G1301A:p.R434H,PEX5L:NM_001349399:exon12:c.G992A:p.R331H,PEX5L:NM_001349410:exon12:c.G992A:p.R331H,PEX5L:NM_001256751:exon13:c.G1496A:p.R499H,PEX5L:NM_001256752:exon13:c.G1463A:p.R488H,PEX5L:NM_001256755:exon13:c.G1244A:p.R415H,PEX5L:NM_001256756:exon13:c.G992A:p.R331H,PEX5L:NM_001349392:exon13:c.G1535A:p.R512H,PEX5L:NM_001349396:exon13:c.G1367A:p.R456H,PEX5L:NM_001349406:exon13:c.G992A:p.R331H,PEX5L:NM_001349409:exon13:c.G992A:p.R331H,PEX5L:NM_001256750:exon14:c.G1562A:p.R521H,PEX5L:NM_001256754:exon14:c.G1439A:p.R480H,PEX5L:NM_001349388:exon14:c.G1640A:p.R547H,PEX5L:NM_001349390:exon14:c.G1628A:p.R543H,PEX5L:NM_001349391:exon14:c.G1538A:p.R513H,PEX5L:NM_001349393:exon14:c.G1535A:p.R512H,PEX5L:NM_001349394:exon14:c.G1445A:p.R482H,PEX5L:NM_001349395:exon14:c.G1439A:p.R480H,PEX5L:NM_001349408:exon14:c.G992A:p.R331H,PEX5L:NM_016559:exon14:c.G1568A:p.R523H,PEX5L:NM_001349386:exon15:c.G1733A:p.R578H,PEX5L:NM_001349387:exon15:c.G1640A:p.R547H,PEX5L:NM_001349389:exon15:c.G1634A:p.R545H	0.664004906	0.335985902	9.19E-06	.	0.15812	0.14485	-0.977252525	8.799245105	84.62819	1.95911	0.035	0.784	D	0.998	0.899	D	0.883	0.916	P	0.000	0.843	D	1	0.810	D	2.575	0.755	M	-1.4	0.805	T	-3.78	0.716	D	0.49	0.756	0.420	0.894	D	0.676	0.888	D	0.112	0.791	D	7.964	0.956	35	1.000	1.000	0.973	0.737	D	c	0.911	0.902	1.000	0.747	0.615	0.372	0	6.07	0.987	7.834	0.848	0.892	0.403	1.000	0.715	0.999	0.750	13.8	0.625	Tetratricopeptide repeat-containing domain|Tetratricopeptide-like helical domain	.	.	0.5	79	1066	3	179525570	chr3:179525570	C	T	79	PASS	DP=1066;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	180326488	180326488	G	C	splicing	TTC14	NM_001288582:exon11:c.1291-1G>C;NM_133462:exon11:c.1291-1G>C	.	.	4.42E-06	0.955823688	0.044171893	.	0.10216	0.1043	-0.020150552	52.25288983	125.31545	2.43621	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.409	0.590	24.1	0.995	0.675	0.998	0.995	D	c	1.224	1.087	1.000	0.747	0.295	0.044	0	5.64	0.864	8.519	0.903	1.048	0.713	1.000	0.715	1.000	0.888	19.701	0.960	.	.	.	0.5	60	33	3	180326488	chr3:180326488	G	C	60	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
3	180334046	180334046	T	-	intronic	CCDC39;TTC14	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	498	3	180334045	chr3:180334045	AT	A	83	PASS	DP=498;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	180559378	180559378	T	C	ncRNA_intronic	LOC101928882	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	56	3	180559378	chr3:180559378	T	C	95	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	180665635	180665635	-	T	intronic	FXR1	.	.	.	0.999992198	7.80E-06	7.76E-14	.	0.83345	0.19444	-0.648365105	16.35999056	32.43007	1.01245	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	457	3	180665635	chr3:180665635	A	AT	83	PASS	DP=457;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	182897192	182897192	C	G	exonic	MCF2L2	.	synonymous SNV	MCF2L2:NM_015078:exon30:c.G3321C:p.P1107P	1.61E-12	0.999318945	0.000681055	.	0.57276	0.09212	0.854236942	88.51144138	3783.20077	12.04253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	66	3	182897192	chr3:182897192	C	G	92	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	183210014	183210014	C	A	exonic	KLHL6	.	nonsynonymous SNV	KLHL6:NM_130446:exon7:c.G1567T:p.G523W	3.43E-06	0.797610641	0.202385932	.	0.22527	0.11012	-0.907472583	10.07313046	190.44155	2.99478	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.04	0.971	H	-3.47	0.945	D	-6.35	0.910	D	0.98	0.982	1.074	0.987	D	0.935	0.979	D	0.441	0.942	D	6.806	0.925	32	0.995	0.671	0.997	0.986	D	c	0.873	0.780	1.000	0.747	0.707	0.730	0	5.53	0.825	7.376	0.788	0.892	0.403	1.000	0.715	0.234	0.225	19.448	0.948	Kelch-type beta propeller	.	.	0.5	.	69	3	183210014	chr3:183210014	C	A	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	183681309	183681309	T	C	exonic	ABCC5	.	nonsynonymous SNV	ABCC5:NM_001320032:exon15:c.A683G:p.Y228C,ABCC5:NM_005688:exon15:c.A2099G:p.Y700C	0.896205135	0.103794865	2.35E-11	.	0.38723	0.35905	-1.967739992	1.816466148	80.81009	1.89955	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.185	0.615	M	-1.93	0.849	D	-8.67	0.976	D	0.96	0.964	0.612	0.921	D	0.739	0.911	D	0.496	0.951	D	5.844	0.800	27.3	0.999	0.940	0.983	0.816	D	c	0.803	0.788	1.000	0.747	0.732	0.924	0	5.7	0.886	7.658	0.826	1.061	0.807	1.000	0.715	0.972	0.466	15.968	0.797	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	135	112	3	183681309	chr3:183681309	T	C	135	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
3	183911026	183911026	A	T	intronic	ABCF3	.	.	.	0.004026166	0.995906699	6.71E-05	.	0.57953	0.15513	-0.771553417	13.15168672	319.46185	3.79528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	3	183911026	chr3:183911026	A	T	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	184062437	184062437	G	T	exonic	FAM131A	.	synonymous SNV	FAM131A:NM_001171093:exon6:c.G525T:p.L175L,FAM131A:NM_144635:exon6:c.G780T:p.L260L	0.031328424	0.925656059	0.043015517	.	0.38029	0.09699	-0.205617011	38.57631517	64.91238	1.65518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	140	3	184062437	chr3:184062437	G	T	.	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	184289032	184289032	T	G	intronic	EPHB3	.	.	.	0.956539592	0.043460371	3.73E-08	.	0.42115	0.22788	-2.677226852	0.731304553	89.15737	2.02905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	58	3	184289032	chr3:184289032	T	G	43	PASS	DP=58;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	184552423	184552423	-	T	intronic	VPS8	.	.	.	3.62E-06	0.999996197	1.85E-07	.	0.13365	0.11078	-0.365622677	28.30856334	3238.91039	10.83959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	32	3	184552422	chr3:184552422	CT	CTT,C	40	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	184552423	184552423	T	-	intronic	VPS8	.	.	.	3.62E-06	0.999996197	1.85E-07	.	0.13365	0.11078	-0.365622677	28.30856334	3238.91039	10.83959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	32	3	184552422	chr3:184552422	CT	CTT,C	40	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	185906191	185906191	C	T	intronic	DGKG	.	.	.	5.44E-06	0.99850148	0.001493082	.	0.45176	0.18992	-1.524862616	3.42061807	110.98235	2.29646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	3	185906191	chr3:185906191	C	T	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	186006618	186006618	G	C	exonic	DGKG	.	nonsynonymous SNV	DGKG:NM_001080744:exon6:c.C425G:p.T142S,DGKG:NM_001080745:exon6:c.C425G:p.T142S,DGKG:NM_001346:exon6:c.C425G:p.T142S	5.44E-06	0.99850148	0.001493082	.	0.45176	0.18992	-1.524862616	3.42061807	110.98235	2.29646	0.814	0.033	T	0.002	0.090	B	0.006	0.133	B	0.914	0.085	N	1	0.090	P	0.695	0.181	N	1.0	0.414	T	0.04	0.065	N	0.057	0.040	-0.922	0.453	T	0.000	0.000	T	.	.	.	-1.570	0.015	0.002	0.428	0.032	0.063	0.122	N	c	-1.255	-1.199	0.996	0.343	0.487	0.133	0	2.16	0.265	1.920	0.394	-0.752	0.034	0.802	0.295	0.000	0.016	5.379	0.154	Diacylglycerol kinase type I, N-terminal	.	.	0.5	54	15	3	186006618	chr3:186006618	G	C	54	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	186358318	186358318	G	T	exonic	FETUB	.	nonsynonymous SNV	FETUB:NM_001308077:exon1:c.G69T:p.Q23H,FETUB:NM_001308079:exon1:c.G69T:p.Q23H,FETUB:NM_014375:exon1:c.G69T:p.Q23H	6.88E-05	0.732564853	0.26736631	.	0.02716	.	0.621009802	83.41589998	583.45117	4.89852	0.226	0.245	T	0.641	0.385	P	0.275	0.383	B	0.000	0.003	N	1	0.090	N	0.805	0.203	L	0.93	0.441	T	-1.23	0.322	N	0.069	0.114	-1.064	0.109	T	0.071	0.289	T	0.010	0.262	T	-1.031	0.031	0.014	0.949	0.252	0.074	0.133	N	c	-1.190	-1.264	1.000	0.747	0.497	0.185	0	-0.705	0.106	-0.098	0.109	-0.443	0.057	0.000	0.063	0.000	0.016	2.956	0.055	Cystatin domain	.	.	0.5	.	48	3	186358318	chr3:186358318	G	T	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	186917751	186917751	C	G	exonic	RTP1	.	nonsynonymous SNV	RTP1:NM_153708:exon2:c.C685G:p.Q229E	0.563829726	0.423951854	0.01221842	.	0.79035	0.11684	0.064394823	58.84642604	2341.27335	8.96348	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.003	0.351	N	1	0.090	P	0.55	0.145	N	1.62	0.282	T	-0.48	0.154	N	0.056	0.039	-0.976	0.358	T	0.000	0.000	T	.	.	.	0.084	0.102	3.442	0.622	0.067	0.018	0.056	N	c	-0.780	-0.618	0.910	0.263	0.615	0.372	0	5.74	0.900	1.719	0.374	0.133	0.217	0.528	0.269	0.580	0.285	12.993	0.579	.	ENSG00000198491.3|ENSG00000175077.5	Artery_Aorta|Nerve_Tibial	0.5	142	253	3	186917751	chr3:186917751	C	G	142	PASS	DP=253;AN=4	GT	./.	0/1	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	187455476	187455476	C	T	intronic	BCL6	.	.	.	0.982525139	0.017474389	4.71E-07	DISEASE: Note=Chromosomal aberrations involving BCL6 are a cause of B-cell non-Hodgkin lymphomas (B-cell NHL), including diffuse large B-cell lymphoma and follicular lymphoma. Approximately 40% of diffuse large B-cell lymphomas and 5 to 10% of follicular lymphomas are associated with chromosomal translocations that deregulate expression of BCL6 by juxtaposing heterologous promoters to the BCL6 coding domain. Translocation t(3;14)(q27;q32). Translocation t(3;22)(q27;q11) with immunoglobulin gene regions. Translocation t(3;7)(q27;p12) with IKZF1 gene 5'non-coding region. Translocation t(3;6)(q27;p21) with Histone H4. Translocation t(3;16)(q27;p11) with IL21R. Translocation t(3;13)(q27;q14) with LCP1.; DISEASE: Note=A chromosomal aberration involving BCL6 may be a cause of a form of B-cell leukemia. Translocation t(3;11)(q27;q23) with POU2AF1/OBF1.; DISEASE: Note=A chromosomal aberration involving BCL6 may be a cause of lymphoma. Translocation t(3;4)(q27;p11) with ARHH/TTF.; 	0.3437	0.5169	-0.464712395	23.5727766	1225.27484	6.61711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	142	3	187455476	chr3:187455476	C	T	.	PASS	DP=142;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	188592084	188592084	C	A	intronic	LPP	.	.	.	0.582399908	0.417507007	9.31E-05	DISEASE: Note=A chromosomal aberration involving LPP is associated with pulmonary chondroid hamartomas. Translocation t(3;12)(q27- q28;q14-q15) with HMGA2 is detected in pulmonary chondroid hamartomas.; DISEASE: Note=A chromosomal aberration involving LPP is associated with parosteal lipomas. Translocation t(3;12)(q28;q14) with HMGA2 is also shown in one parosteal lipoma.; DISEASE: Note=A chromosomal aberration involving LPP is associated with acute monoblastic leukemia. Translocation t(3;11)(q28;q23) with KMT2A/MLL1 is associated with acute monoblastic leukemia.; 	0.24469	0.15914	1.050838371	91.36588818	2291.9413	8.8632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	3	188592084	chr3:188592084	C	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	189705447	189705447	C	A	exonic	P3H2	.	nonsynonymous SNV	P3H2:NM_001134418:exon5:c.G424T:p.V142L,P3H2:NM_018192:exon5:c.G967T:p.V323L	.	.	.	.	0.14234	0.13152	-0.554717505	19.79830149	.	.	0.254	0.178	T	0.0	0.026	B	0.0	0.013	B	0.025	0.262	N	0.821	0.348	D	1.5	0.380	L	1.76	0.260	T	-0.97	0.258	N	0.141	0.168	-1.032	0.198	T	0.032	0.137	T	0.006	0.159	T	2.954	0.415	22.1	0.985	0.421	0.626	0.316	D	c	-0.577	-0.445	0.806	0.242	0.732	0.924	0	3.2	0.357	0.486	0.219	0.935	0.490	0.001	0.137	1.000	0.888	5.443	0.157	Tetratricopeptide-like helical domain	.	.	0.5	119	182	3	189705447	chr3:189705447	C	A	119	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	193209178	193209178	T	C	exonic	ATP13A4	.	nonsynonymous SNV	ATP13A4:NM_032279:exon6:c.A543G:p.I181M	6.08E-10	0.999598041	0.000401958	DISEASE: Note=A chromosomal aberration involving ATP13A4 is found in 2 patients with specific language impairment (SLI) disorders. Paracentric inversion inv(3)(q25;q29). The inversion produces a disruption of the protein. {ECO:0000269|PubMed:15925480}.; 	0.08132	0.09862	-1.383523256	4.358339231	5510.00677	15.30149	0.153	0.282	T	0.998	0.764	D	0.981	0.769	D	0.000	0.629	D	0.109	0.359	P	2.085	0.579	M	-1.2	0.785	T	-1.6	0.387	N	0.226	0.389	-0.935	0.434	T	0.000	0.000	T	.	.	.	4.024	0.541	23.6	0.994	0.623	0.540	0.292	D	c	0.394	0.329	0.008	0.115	0.487	0.133	0	4.63	0.570	-0.414	0.071	1.011	0.635	0.712	0.285	1.000	0.888	9.318	0.369	Cation-transporting P-type ATPase, N-terminal	ENSG00000127249.10|ENSG00000127249.10	Lung|Testis	0.5	90	15	3	193209178	chr3:193209178	T	C	90	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0
3	195391050	195391050	A	G	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	445	3	195391050	chr3:195391050	A	G	122	PASS	DP=445;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	195400814	195400814	-	TT	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	305	3	195400814	chr3:195400814	C	CTT	103	PASS	DP=305;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	195400841	195400841	C	A	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	317	3	195400841	chr3:195400841	C	A	144	PASS	DP=317;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	195410627	195410627	A	G	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	382	3	195410627	chr3:195410627	A	G	130	PASS	DP=382;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	195453249	195453249	T	C	exonic	MUC20	.	nonsynonymous SNV	MUC20:NM_001282506:exon2:c.T1775C:p.M592T,MUC20:NM_001291833:exon4:c.T1262C:p.M421T,MUC20:NM_020790:exon4:c.T1319C:p.M440T,MUC20:NM_152673:exon4:c.T1262C:p.M421T	.	.	.	.	.	0.05395	.	.	2482.91489	9.29408	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.830	0.091	N	1	0.206	N	-1.65	0.004	N	3.45	0.086	T	2.15	0.004	N	0.419	0.476	-0.954	0.403	T	0.007	0.026	T	.	.	.	-2.240	0.005	0.001	0.392	0.027	0.000	0.001	N	c	-1.579	-1.475	0.000	0.064	0.516	0.203	0	2.7	0.309	0.520	0.224	-2.118	0.004	0.000	0.063	0.000	0.016	7.490	0.265	.	.	.	0.5	.	123	3	195453249	chr3:195453249	T	C	.	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	195505960	195505960	G	C	exonic	MUC4	.	nonsynonymous SNV	MUC4:NM_018406:exon2:c.C12491G:p.T4164S	.	.	.	.	0.37408	.	6.320387277	99.8643548	14250.21522	26.01128	0.291	0.149	T	0.613	0.378	P	0.213	0.357	B	.	.	.	1.000	0.588	D	.	.	.	1.38	0.358	T	-0.6	0.206	N	0.047	0.028	-1.047	0.153	T	0.046	0.198	T	.	.	.	-0.520	0.054	0.196	0.420	0.030	0.014	0.046	N	c	-1.001	-1.186	0.000	0.029	0.554	0.283	0	.	.	0.464	0.215	0.174	0.246	0.000	0.063	0.005	0.090	5.853	0.178	.	.	.	0.5	173	325	3	195505960	chr3:195505960	G	C	173	PASS	DP=325;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	195717077	195717077	-	GCGCCAG	ncRNA_exonic	SDHAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	150	3	195717077	chr3:195717077	A	AGCGCCAG	115	PASS	DP=150;AN=4	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	195965316	195965316	G	-	UTR3	PCYT1A	NM_001312673:c.*243delC;NM_005017:c.*243delC	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	50	3	195965315	chr3:195965315	TG	T,TGG	74	PASS	DP=50;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/2
3	195965316	195965316	-	G	UTR3	PCYT1A	NM_001312673:c.*242_*243insC;NM_005017:c.*242_*243insC	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	50	3	195965315	chr3:195965315	TG	T,TGG	74	PASS	DP=50;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/2
3	195977188	195977188	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	116	3	195977188	chr3:195977188	T	C	92	PASS	DP=116;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	195978138	195978138	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	97	3	195978138	chr3:195978138	T	C	96	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	195978246	195978246	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	80	3	195978246	chr3:195978246	T	C	81	PASS	DP=80;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	196529978	196529978	C	T	exonic	PAK2	.	synonymous SNV	PAK2:NM_002577:exon4:c.C379T:p.L127L	0.938688564	0.06130927	2.17E-06	.	0.8063	0.27444	-0.339715008	30.06605331	12.07124	0.43719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	27	3	196529978	chr3:196529978	C	T	65	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	197610474	197610474	G	T	intergenic	LRCH3;IQCG	dist=12018;dist=5472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	85	3	197610474	chr3:197610474	G	T	86	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	59454	59454	G	T	splicing	ZNF718	NM_001039127:exon2:c.133+2G>T;NM_001289931:exon2:c.37+2G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	4	59454	chr4:59454	G	T	.	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	337623	337623	A	T	exonic	ZNF141	.	nonsynonymous SNV	ZNF141:NM_001348278:exon2:c.A56T:p.K19I,ZNF141:NM_001348279:exon2:c.A56T:p.K19I,ZNF141:NM_001348280:exon2:c.A56T:p.K19I,ZNF141:NM_003441:exon2:c.A56T:p.K19I	0.161888983	0.82300848	0.015102537	.	0.39436	0.16446	0.795569043	87.49115357	156.94519	2.73623	0.001	0.784	D	0.971	0.689	D	0.9	0.644	P	.	.	.	1	0.090	N	1.76	0.459	L	4.56	0.020	T	-4.42	0.838	D	0.287	0.349	-0.968	0.375	T	0.015	0.058	T	0.001	0.019	T	2.620	0.376	20.3	0.991	0.520	0.002	0.010	N	c	-0.363	-0.566	0.002	0.089	0.732	0.924	0	-0.113	0.128	-2.009	0.015	-0.510	0.051	0.000	0.063	0.858	0.358	3.763	0.081	Krueppel-associated box	.	.	0.5	.	25	4	337623	chr4:337623	A	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	997905	997905	G	A	intronic	IDUA	.	.	.	2.64E-08	0.478326206	0.521673767	DISEASE: Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]: A severe form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1H usually present, within the first year of life, a combination of hepatosplenomegaly, skeletal deformities, corneal clouding and severe mental retardation. Obstructive airways disease, respiratory infection and cardiac complications usually result in death before 10 years of age. {ECO:0000269|PubMed:10466419, ECO:0000269|PubMed:10735634, ECO:0000269|PubMed:12559846, ECO:0000269|PubMed:1301941, ECO:0000269|PubMed:15300847, ECO:0000269|PubMed:21394825, ECO:0000269|PubMed:7550232, ECO:0000269|PubMed:7550242, ECO:0000269|PubMed:7951228, ECO:0000269|PubMed:8019563, ECO:0000269|PubMed:8328452, ECO:0000269|PubMed:8401515, ECO:0000269|Ref.20}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]: A form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. MPS1H/S represents an intermediate phenotype of the MPS1 clinical spectrum. It is characterized by relatively little neurological involvement, but most of the somatic symptoms described for severe MPS1 develop in the early to mid-teens, causing considerable loss of mobility. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]: A mild form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1S may have little or no neurological involvement, normal stature and life span, but present development of joints stiffness, mild hepatosplenomegaly, aortic valve disease and corneal clouding. {ECO:0000269|PubMed:12559846, ECO:0000269|PubMed:15300847, ECO:0000269|PubMed:19396826, ECO:0000269|PubMed:21394825, ECO:0000269|PubMed:25256405, ECO:0000269|PubMed:7550232, ECO:0000269|PubMed:7550242, ECO:0000269|PubMed:8213840}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08409	0.09876	.	.	2688.19258	9.75774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	98	4	997905	chr4:997905	G	A	58	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	1107119	1107119	C	T	intronic	RNF212	.	.	.	0.125225584	0.869720008	0.005054408	.	0.13995	.	.	.	166.87321	2.82299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	4	1107119	chr4:1107119	C	T	.	PASS	DP=122;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	1245879	1245879	-	A	ncRNA_exonic	CTBP1-AS2	.	.	.	.	.	.	.	0.12776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	140	4	1245879	chr4:1245879	G	GA	88	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	2460571	2460571	C	T	exonic	CFAP99	.	nonsynonymous SNV	CFAP99:NM_001193282:exon12:c.C1283T:p.A428V	.	.	.	.	.	.	.	.	.	.	0.561	0.063	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.05	0.078	N	0.034	0.014	-0.952	0.406	T	0.000	0.000	T	.	.	.	0.663	0.157	8.585	0.870	0.163	0.031	0.080	N	c	-0.964	-1.035	1.000	0.747	0.581	0.326	0	0.034	0.134	1.083	0.302	-0.858	0.029	0.764	0.290	0.005	0.090	0.910	0.012	.	ENSG00000206113.3|ENSG00000159733.9|ENSG00000159733.9	Colon_Transverse|Lung|Whole_Blood	0.5	118	77	4	2460571	chr4:2460571	C	T	118	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	3318413	3318413	A	G	exonic	RGS12	.	synonymous SNV	RGS12:NM_002926:exon2:c.A516G:p.S172S,RGS12:NM_198229:exon2:c.A516G:p.S172S	0.000560374	0.999430106	9.52E-06	.	0.22901	.	-0.463176509	23.57867422	1192.69117	6.54837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	13	4	3318413	chr4:3318413	A	G	51	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	3769789	3769789	-	GGGGAGCTTTCCCAGAGACCC	UTR3	ADRA2C	NM_000683:c.*67_*68insGGGGAGCTTTCCCAGAGACCC	.	.	0.645951821	0.347840902	0.006207277	.	0.03325	0.09956	.	.	2173.15437	8.58195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	186	200	4	3769789	chr4:3769789	G	GGGGGAGCTTTCCCAGAGACCC	186	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	3941999	3941999	A	G	intergenic	ADRA2C;FAM86EP	dist=171746;dist=1488	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	78	4	3941999	chr4:3941999	A	G	78	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	3942013	3942014	TG	-	intergenic	ADRA2C;FAM86EP	dist=171760;dist=1473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	67	4	3942012	chr4:3942012	CTG	C	70	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	3943067	3943067	C	G	downstream	FAM86EP	dist=420	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	65	4	3943067	chr4:3943067	C	G	90	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	3954878	3954878	T	C	ncRNA_exonic	FAM86EP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	62	4	3954878	chr4:3954878	T	C	88	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	4322770	4322770	T	C	exonic	ZBTB49	.	synonymous SNV	ZBTB49:NM_001330625:exon8:c.T2025C:p.G675G,ZBTB49:NM_145291:exon8:c.T2025C:p.G675G	0.009164155	0.98839363	0.002442215	.	0.13097	.	1.09310945	91.90846898	725.33362	5.34612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	16	4	4322770	chr4:4322770	T	C	43	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	4864485	4864485	G	T	exonic	MSX1	.	nonsynonymous SNV	MSX1:NM_002448:exon2:c.G527T:p.R176L	0.275361731	0.633641369	0.090996899	DISEASE: Tooth agenesis selective 1 (STHAG1) [MIM:106600]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). Tooth agenesis selective type 1 can be associated with orofacial cleft in some patients. {ECO:0000269|PubMed:12097313, ECO:0000269|PubMed:8696335}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MSX1 is deleted in some patients with Wolf- Hirschhorn syndrome (WHS). WHS results from sub-telomeric deletions in the short arm of chromosome 4. {ECO:0000305|PubMed:1969845}.; DISEASE: Ectodermal dysplasia 3, Witkop type (ECTD3) [MIM:189500]: A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD3 is characterized by abnormalities largely limited largely to teeth (some of which are missing) and nails (which are poorly formed early in life, especially toenails). This condition is distinguished from anhidrotic ectodermal dysplasia by autosomal dominant inheritance and little involvement of hair and sweat glands. The teeth are not as severely affected. {ECO:0000269|PubMed:11369996}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:12807959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83114	0.60631	.	.	590.93175	4.92812	0.001	0.784	D	0.999	0.764	D	0.995	0.818	D	0.000	0.843	D	1	0.810	D	3.825	0.957	H	-5.5	0.991	D	-6.31	0.908	D	0.973	0.974	1.010	0.974	D	0.986	0.996	D	0.494	0.951	D	6.872	0.930	33	0.998	0.907	0.988	0.863	D	c	1.006	0.883	1.0	0.983	0.765	0.991	0	4.84	0.620	9.823	0.983	1.048	0.713	1.000	0.715	0.985	0.512	18.326	0.902	Homeobox domain|Homeodomain-like	.	.	0.5	76	138	4	4864485	chr4:4864485	G	T	76	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	7064140	7064140	C	T	exonic	GRPEL1	.	synonymous SNV	GRPEL1:NM_025196:exon3:c.G279A:p.Q93Q	0.896268186	0.102748808	0.000983006	.	0.19622	0.11034	0.170987912	65.5579146	184.97165	2.95207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	56	4	7064140	chr4:7064140	C	T	51	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	8207201	8207201	G	T	intronic	SH3TC1	.	.	.	1.08E-27	1.60E-05	0.999983988	.	0.06743	.	1.017812819	90.87638594	4345.64439	13.13144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	4	8207201	chr4:8207201	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	8305930	8305930	G	C	exonic	HTRA3	.	nonsynonymous SNV	HTRA3:NM_053044:exon8:c.G1120C:p.A374P	1.72E-05	0.675145167	0.324837634	.	0.16158	0.11489	-0.822919685	11.76574664	170.60666	2.84944	0.272	0.159	T	0.172	0.271	B	0.063	0.256	B	0.091	0.203	N	0.858	0.284	N	0.75	0.191	N	2.43	0.153	T	-0.61	0.181	N	0.291	0.350	-1.044	0.162	T	0.027	0.117	T	0.006	0.163	T	2.478	0.359	19.32	0.976	0.341	0.128	0.173	N	c	-0.352	-0.257	1.000	0.747	0.507	0.198	0	1.61	0.226	2.509	0.449	0.998	0.613	1.000	0.715	0.997	0.653	7.319	0.255	PDZ domain	.	.	0.5	137	134	4	8305930	chr4:8305930	G	C	137	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	9557816	9557821	AGAAGG	-	ncRNA_exonic	MIR548I2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	35	4	9557815	chr4:9557815	TAGAAGG	T	65	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	9694448	9694448	C	G	intergenic	MIR548I2;DRD5	dist=136511;dist=88810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	175	4	9694448	chr4:9694448	C	G	147	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	9710546	9710546	G	A	intergenic	MIR548I2;DRD5	dist=152609;dist=72712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	4	9710546	chr4:9710546	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	9756888	9756888	C	T	intergenic	MIR548I2;DRD5	dist=198951;dist=26370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	90	4	9756888	chr4:9756888	C	T	.	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	13543752	13543752	G	T	exonic	NKX3-2	.	nonsynonymous SNV	NKX3-2:NM_001189:exon2:c.C867A:p.D289E	0.058492521	0.713863808	0.227643671	.	0.28515	0.14063	.	.	66.07302	1.67505	0.034	0.440	D	0.999	0.764	D	0.82	0.573	P	0.000	0.843	D	1.000	0.588	D	1.87	0.498	L	-2.77	0.909	D	-3.32	0.660	D	0.402	0.461	0.320	0.879	D	0.712	0.901	D	0.291	0.906	D	5.910	0.811	27.5	0.997	0.813	0.913	0.529	D	c	0.381	0.323	1.000	0.747	0.598	0.340	0	2.01	0.254	0.874	0.275	0.974	0.594	0.996	0.391	1.000	0.888	4.013	0.090	.	.	.	0.5	.	163	4	13543752	chr4:13543752	G	T	.	PASS	DP=163;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	15724487	15724487	T	G	intronic	BST1	.	.	.	2.81E-08	0.291985673	0.708014299	.	0.1269	0.19823	0.861712133	88.6883699	1705.28413	7.61637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	43	4	15724487	chr4:15724487	T	G	87	PASS	DP=43;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	15982007	15982101	AAAATGACCCCCACGTCTGTGGAAGCCCACATACTTACTCATCGTACACGTCCTCCGAATCCATTCGACGATAGTACTTAGCCAGTTTTACCGCA	-	exonic	PROM1	.	nonframeshift deletion	PROM1:NM_001145851:exon22:c.2406_2462del:p.A803_D821del,PROM1:NM_001145852:exon22:c.2406_2462del:p.A803_D821del,PROM1:NM_001145847:exon23:c.2406_2462del:p.A803_D821del,PROM1:NM_001145848:exon23:c.2406_2462del:p.A803_D821del,PROM1:NM_001145849:exon23:c.2433_2489del:p.A812_D830del,PROM1:NM_001145850:exon23:c.2433_2489del:p.A812_D830del,PROM1:NM_006017:exon23:c.2433_2489del:p.A812_D830del	7.17E-17	0.027832798	0.972167202	DISEASE: Retinitis pigmentosa 41 (RP41) [MIM:612095]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10587575, ECO:0000269|PubMed:17605048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 12 (CORD12) [MIM:612657]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stargardt disease 4 (STGD4) [MIM:603786]: A common hereditary macular degeneration. It is characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinal macular dystrophy 2 (MCDR2) [MIM:608051]: A bull's-eye macular dystrophy characterized by bilateral annular atrophy of retinal pigment epithelium at the macula. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31674	0.31496	-1.368693559	4.482189196	96.86296	2.12686	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.47	81	4	15982006	chr4:15982006	GAAAATGACCCCCACGTCTGTGGAAGCCCACATACTTACTCATCGTACACGTCCTCCGAATCCATTCGACGATAGTACTTAGCCAGTTTTACCGCA	G	16.47	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	15989410	15989410	C	T	intronic	PROM1	.	.	.	7.17E-17	0.027832798	0.972167202	DISEASE: Retinitis pigmentosa 41 (RP41) [MIM:612095]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10587575, ECO:0000269|PubMed:17605048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 12 (CORD12) [MIM:612657]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stargardt disease 4 (STGD4) [MIM:603786]: A common hereditary macular degeneration. It is characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinal macular dystrophy 2 (MCDR2) [MIM:608051]: A bull's-eye macular dystrophy characterized by bilateral annular atrophy of retinal pigment epithelium at the macula. {ECO:0000269|PubMed:18654668}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31674	0.31496	-1.368693559	4.482189196	96.86296	2.12686	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	42	4	15989410	chr4:15989410	C	T	43	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	17493754	17493754	G	C	intronic	QDPR	.	.	.	0.065816427	0.919602835	0.014580737	DISEASE: Hyperphenylalaninemia, BH4-deficient, C (HPABH4C) [MIM:261630]: Rare autosomal recessive disorder characterized by hyperphenylalaninemia and severe neurologic symptoms (malignant hyperphenylalaninemia) including axial hypotonia and truncal hypertonia, abnormal thermogenesis, and microcephaly. These signs are attributable to depletion of the neurotransmitters dopamine and serotonin, whose syntheses are controlled by tryptophan and tyrosine hydroxylases that use BH-4 as cofactor. Patients do not respond to phenylalanine-restricted diet. HPABH4C is lethal if untreated. {ECO:0000269|PubMed:10408783, ECO:0000269|PubMed:11153907, ECO:0000269|PubMed:2116088, ECO:0000269|PubMed:8326489, ECO:0000269|PubMed:9744478}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1631	0.40344	-0.383807564	27.41802312	13.56109	0.4928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	204	4	17493754	chr4:17493754	G	C	96	PASS	DP=204;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
4	17803853	17803853	G	A	UTR3	DCAF16	NM_017741:c.*1261C>T;NM_001345880:c.*1261C>T;NM_001345882:c.*1261C>T;NM_001345884:c.*1261C>T;NM_001345885:c.*1261C>T;NM_001345881:c.*1261C>T	.	.	0.00409866	0.653830628	0.342070712	.	0.21551	.	0.12689526	63.00424628	335.32468	3.8905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	98	4	17803853	chr4:17803853	G	A	70	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	21305358	21305358	C	A	intronic	KCNIP4	.	.	.	0.967714667	0.032233051	5.23E-05	.	0.37064	.	-0.339715008	30.06605331	5.58554	0.20809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	4	21305358	chr4:21305358	C	A	.	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	25315698	25315698	A	-	exonic	ZCCHC4	.	frameshift deletion	ZCCHC4:NM_001318148:exon2:c.158delA:p.E56Kfs*56,ZCCHC4:NM_024936:exon2:c.158delA:p.E56Kfs*56	3.22E-05	0.986356163	0.013611642	.	0.1632	0.09095	1.798708763	96.91554612	690.84581	5.24094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.89	36	4	25315697	chr4:25315697	CA	C	11.89	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	25315781	25315781	G	A	exonic	ZCCHC4	.	nonsynonymous SNV	ZCCHC4:NM_001318148:exon2:c.G241A:p.E81K,ZCCHC4:NM_024936:exon2:c.G241A:p.E81K	3.22E-05	0.986356163	0.013611642	.	0.1632	0.09095	1.798708763	96.91554612	690.84581	5.24094	0.051	0.393	T	0.999	0.764	D	0.982	0.739	D	0.000	0.843	D	1	0.810	D	2.47	0.719	M	1.84	0.247	T	-2.45	0.535	N	0.642	0.663	-0.978	0.355	T	0.155	0.486	T	0.014	0.337	T	7.141	0.943	34	0.999	0.988	0.939	0.592	D	c	0.855	0.862	1.000	0.747	0.660	0.490	0	5.77	0.910	9.313	0.953	0.953	0.551	1.000	0.715	1.000	0.888	18.772	0.918	Zinc finger, GRF-type	.	.	0.5	.	37	4	25315781	chr4:25315781	G	A	.	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	37947218	37947218	G	A	intronic	TBC1D1	.	.	.	3.94E-08	0.9998784	0.00012156	.	0.16285	0.20642	0.009173042	54.15782024	2012.94334	8.2609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	4	37947218	chr4:37947218	G	A	.	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	37974182	37974182	G	A	intronic	TBC1D1	.	.	.	3.94E-08	0.9998784	0.00012156	.	0.16285	0.20642	0.009173042	54.15782024	2012.94334	8.2609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	4	37974182	chr4:37974182	G	A	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	38937317	38937317	T	-	intronic	FAM114A1	.	.	.	2.38E-08	0.457538177	0.542461799	.	0.11964	.	0.358272123	74.66383581	2541.88338	9.41853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	37	4	38937316	chr4:38937316	CT	C	44	PASS	DP=37;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	0/1	./.	./.
4	41631761	41631772	GTTTCCCCCCCA	-	intronic	LIMCH1	.	.	.	0.999638379	0.000361621	3.01E-13	.	0.22998	0.08738	0.387604191	75.69591885	5384.20261	15.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	36	4	41631760	chr4:41631760	TGTTTCCCCCCCA	T	39	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	42618105	42618111	AAAAGCA	-	intronic	ATP8A1	.	.	.	0.999804446	0.000195554	5.58E-16	.	0.7991	0.1111	-0.641086234	16.6784619	389.36969	4.15685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	210	4	42618104	chr4:42618104	TAAAAGCA	T	69	PASS	DP=210;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	46314618	46314618	G	A	exonic	GABRA2	.	nonsynonymous SNV	GABRA2:NM_001114175:exon4:c.C371T:p.P124L,GABRA2:NM_001286827:exon4:c.C206T:p.P69L,GABRA2:NM_000807:exon5:c.C371T:p.P124L,GABRA2:NM_001330690:exon5:c.C371T:p.P124L	0.976963701	0.023031697	4.60E-06	.	0.31694	0.13475	-0.273576253	33.97027601	19.24152	0.66325	0.0	0.912	D	0.999	0.899	D	0.98	0.971	D	0.000	0.843	D	1	0.810	D	3.72	0.949	H	-5.0	0.985	D	-9.21	0.983	D	0.732	0.978	1.055	0.982	D	0.981	0.994	D	0.365	0.926	D	6.582	0.905	31	0.998	0.925	0.991	0.910	D	c	1.149	1.073	1.000	0.747	0.487	0.133	0	5.95	0.964	10.003	0.997	1.048	0.713	1.000	0.715	1.000	0.888	19.363	0.944	Neurotransmitter-gated ion-channel ligand-binding domain	.	.	0.5	137	71	4	46314618	chr4:46314618	G	A	137	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	46725760	46725760	-	T	intergenic	GABRA2;COX7B2	dist=333675;dist=11087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	59	4	46725760	chr4:46725760	G	GT	42	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	46994916	46994916	G	A	exonic	GABRA4	.	nonsynonymous SNV	GABRA4:NM_000809:exon2:c.C134T:p.T45I,GABRA4:NM_001204266:exon2:c.C77T:p.T26I,GABRA4:NM_001204267:exon2:c.C77T:p.T26I	0.981416569	0.018580722	2.71E-06	.	0.15547	0.13425	0.260991686	70.25831564	2958.52439	10.303	0.27	0.160	T	0.005	0.119	B	0.017	0.170	B	0.000	0.491	D	0.907	0.276	N	0	0.065	N	-1.46	0.810	T	-1.16	0.297	N	0.046	0.150	-0.847	0.522	T	0.243	0.612	T	0.032	0.543	D	2.022	0.304	16.35	0.996	0.748	0.942	0.603	D	c	-0.259	-0.031	1.000	0.517	0.583	0.331	0	4.61	0.566	7.139	0.767	0.998	0.613	1.000	0.715	0.999	0.750	11.618	0.502	.	.	.	0.5	85	127	4	46994916	chr4:46994916	G	A	85	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	47706240	47706240	A	-	intronic	CORIN	.	.	.	6.35E-20	0.011817234	0.988182766	DISEASE: Pre-eclampsia/eclampsia 5 (PEE5) [MIM:614595]: A hypertensive disorder of pregnancy characterized by new hypertension (blood pressure 140/90 or greater) presenting after 20 weeks' gestation with clinically relevant proteinuria. It impacts 2 individuals, the mother and her child, both of whom can be severely affected. Preeclampsia is one of the causes of maternal mortality and morbidity worldwide. {ECO:0000269|PubMed:22437503}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12664	.	-0.145152788	42.33899505	519.7225	4.65704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	51	4	47706239	chr4:47706239	GA	G	54	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	48485962	48485962	C	T	exonic	SLC10A4	.	synonymous SNV	SLC10A4:NM_152679:exon1:c.C384T:p.H128H	0.167299362	0.771814239	0.060886399	.	0.04161	.	.	.	57.29346	1.52517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	4	48485962	chr4:48485962	C	T	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	49491310	49491310	T	C	intergenic	CWH43;NONE	dist=427215;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	138	4	49491310	chr4:49491310	T	C	62	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	53732872	53732872	T	-	UTR3	RASL11B	NM_023940:c.*900delT	.	.	0.290784778	0.688380488	0.020834734	.	0.49003	0.10864	-0.095386216	46.48502005	63.84681	1.63863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	16	4	53732871	chr4:53732871	CT	C	43	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	55130041	55130041	C	T	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_001347827:exon4:c.C575T:p.T192I,PDGFRA:NM_001347829:exon4:c.C575T:p.T192I,PDGFRA:NM_001347830:exon4:c.C614T:p.T205I,PDGFRA:NM_006206:exon4:c.C575T:p.T192I,PDGFRA:NM_001347828:exon5:c.C650T:p.T217I	0.99987673	0.00012327	5.34E-13	DISEASE: Note=A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome. {ECO:0000269|PubMed:12808148}.; DISEASE: Gastrointestinal stromal tumor (GIST) [MIM:606764]: Common mesenchymal neoplasms arising in the gastrointestinal tract, most often in the stomach. They are histologically, immunohistochemically, and genetically different from typical leiomyomas, leiomyosarcomas, and schwannomas. Most GISTs are composed of a fairly uniform population of spindle-shaped cells. Some tumors are dominated by epithelioid cells or contain a mixture of spindle and epithelioid morphologies. Primary GISTs in the gastrointestinal tract commonly metastasize in the omentum and mesenteries, often as multiple nodules. However, primary tumors may also occur outside of the gastrointestinal tract, in other intra-abdominal locations, especially in the omentum and mesentery. {ECO:0000269|PubMed:12522257, ECO:0000269|PubMed:15928335}. Note=The gene represented in this entry may be involved in disease pathogenesis. Mutations causing PDGFRA constitutive activation have been found in gastrointestinal stromal tumors lacking KIT mutations (PubMed:12522257). {ECO:0000269|PubMed:12522257}.; 	0.96377	0.1167	-0.635637306	16.76102854	599.71226	4.95653	0.204	0.200	T	0.001	0.192	B	0.002	0.236	B	0.005	0.328	U	1.000	0.195	N	1.9	0.507	L	3.47	0.052	T	-1.62	0.518	N	0.311	0.372	-0.998	0.306	T	0.018	0.077	T	0.011	0.276	T	1.684	0.263	14.32	0.803	0.127	0.046	0.101	N	c	-0.568	-0.511	0.997	0.350	0.598	0.340	0	2.97	0.333	0.369	0.200	0.069	0.176	0.000	0.063	0.204	0.218	9.131	0.358	Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	50	35	4	55130041	chr4:55130041	C	T	50	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	62410161	62410161	A	G	intronic	ADGRL3	.	.	.	.	.	.	.	0.16776	0.14106	-0.369255208	28.25548478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	48	4	62410161	chr4:62410161	A	G	70	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	68719737	68719737	C	T	intronic	TMPRSS11D	.	.	.	0.06251897	0.934180679	0.003300351	.	0.13173	0.51855	-0.736552314	13.93606983	32.5418	1.01329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	13	4	68719737	chr4:68719737	C	T	.	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	71588258	71588258	C	G	UTR5	RUFY3	NM_014961:c.-33C>G;NM_001291994:c.-33C>G;NM_001037442:c.-33C>G	.	.	0.980976379	0.019023598	2.38E-08	.	0.86149	0.084	-0.844966979	11.1759849	66.52798	1.68028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	32	4	71588258	chr4:71588258	C	G	65	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	76787418	76787418	A	T	exonic	PPEF2	.	nonsynonymous SNV	PPEF2:NM_006239:exon15:c.T1844A:p.V615E	7.34E-10	0.869787638	0.130212361	.	0.37944	0.08962	1.164733225	92.65746638	2139.83122	8.51045	0.005	0.632	D	0.963	0.537	D	0.642	0.503	P	0.000	0.537	D	0.924	0.368	D	2.95	0.852	M	0.84	0.475	T	-4.43	0.775	D	0.788	0.779	-0.589	0.653	T	0.195	0.549	T	0.054	0.659	D	5.948	0.817	27.6	0.984	0.409	0.927	0.561	D	c	0.451	0.424	0.988	0.314	0.554	0.246	0	4.67	0.579	3.858	0.554	1.140	0.893	1.000	0.715	0.987	0.523	12.130	0.531	EF-hand domain pair	.	.	0.5	86	70	4	76787418	chr4:76787418	A	T	86	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	77969239	77969239	-	T	UTR3	CCNI	NM_001348133:c.*132_*133insA;NM_001348132:c.*132_*133insA;NM_001348134:c.*132_*133insA;NM_001348135:c.*132_*133insA;NM_001348136:c.*132_*133insA;NM_001348137:c.*132_*133insA;NM_001348138:c.*132_*133insA;NM_001348139:c.*132_*133insA;NM_001348140:c.*557_*558insA;NM_006835:c.*132_*133insA	.	.	0.789094043	0.209550825	0.001355133	.	0.26347	0.16383	0.104848986	61.49445624	48.69159	1.3608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	27	4	77969239	chr4:77969239	A	AT	56	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	79754716	79754716	-	T	intronic	BMP2K	.	.	.	0.001916525	0.99804383	3.96E-05	.	0.78082	.	0.273728691	70.74781788	1787.12697	7.80244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	23	4	79754716	chr4:79754716	A	AT	60	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	80957196	80957196	A	-	intronic	ANTXR2	.	.	.	0.405188748	0.594440676	0.000370576	DISEASE: Hyaline fibromatosis syndrome (HFS) [MIM:228600]: An autosomal recessive syndrome characterized by abnormal growth of hyalinized fibrous tissue usually affecting subcutaneous regions on the scalp, ears, neck, face, hands, and feet. The lesions appear as pearly papules or fleshy nodules. Additional features include gingival hypertrophy, progressive joint contractures resulting in severe limitation of mobility, osteopenia, and osteoporosis. Disease severity is variable. Some individuals manifest symptoms in infancy and have additional visceral or systemic involvement. Hyaline deposits in multiple organs, recurrent infections and intractable diarrhea often lead to early death. Surviving children may suffer from severely reduced mobility due to joint contractures. Other patients have later onset of a milder disorder affecting only the face and digits. {ECO:0000269|PubMed:12973667, ECO:0000269|PubMed:14508707, ECO:0000269|PubMed:15725249}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.29739	0.10893	0.573279816	82.08303845	200.14281	3.05718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	40	4	80957195	chr4:80957195	GA	G	67	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	82377924	82377924	-	A	exonic	RASGEF1B	.	frameshift insertion	RASGEF1B:NM_001300736:exon3:c.195dupT:p.A66Cfs*17,RASGEF1B:NM_001300735:exon4:c.318dupT:p.A107Cfs*17,RASGEF1B:NM_152545:exon4:c.318dupT:p.A107Cfs*17	0.488529662	0.511430599	3.97E-05	.	0.62004	0.10842	-0.514264485	21.41424864	73.40783	1.79055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	32.17	26	4	82377924	chr4:82377924	C	CA	32.17	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	84519902	84519902	C	T	intronic	GPAT3	.	.	.	.	.	.	.	0.13125	0.11511	-0.089927255	46.99221515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	4	84519902	chr4:84519902	C	T	.	PASS	DP=99;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	85166011	85166011	C	A	ncRNA_intronic	LOC101928978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	57	4	85166011	chr4:85166011	C	A	64	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	85715905	85715905	A	-	intronic	WDFY3	.	.	.	1	3.27E-17	4.23E-47	.	0.30087	0.1138	-2.817477736	0.62514744	213.17232	3.15112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	154	4	85715904	chr4:85715904	TA	T	62	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	86396732	86396732	G	A	intronic	ARHGAP24	.	.	.	0.004696081	0.995038485	0.000265435	.	0.39284	0.12435	-0.617221851	17.44515216	242.67907	3.36262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	4	86396732	chr4:86396732	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	88048163	88048163	-	T	intronic	AFF1	.	.	.	0.476646973	0.523352667	3.61E-07	DISEASE: Note=A chromosomal aberration involving AFF1 is associated with acute leukemias. Translocation t(4;11)(q21;q23) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.0974	0.1848	-1.183251814	5.909412597	190.31308	2.99434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	63	4	88048163	chr4:88048163	A	AT	116	PASS	DP=63;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	88813100	88813100	G	A	intergenic	MEPE;SPP1	dist=45132;dist=83702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	30	4	88813100	chr4:88813100	G	A	92	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	89345663	89345663	A	-	intronic	HERC6	.	.	.	3.19E-09	0.91230323	0.087696767	.	0.09058	0.08047	1.938319883	97.51120547	1555.21394	7.30701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	20	4	89345662	chr4:89345662	CA	C	48	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	90872905	90872905	A	-	intronic	MMRN1	.	.	.	9.35E-17	0.008835231	0.991164769	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	164	4	90872904	chr4:90872904	TA	T	62	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	95198159	95198159	A	C	intronic	SMARCAD1	.	.	.	0.999996803	3.20E-06	1.79E-15	.	0.31853	0.24651	0.266447942	70.5826846	3025.83606	10.4458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	187	4	95198159	chr4:95198159	A	C	129	PASS	DP=187;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	95494467	95494467	-	T	intronic	PDLIM5	.	.	.	0.012278281	0.986126064	0.001595655	.	0.21242	0.85159	1.335644081	94.24982307	220.34888	3.20885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	209	4	95494467	chr4:95494467	A	AT	82	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	100009836	100009836	C	A	intronic	ADH5	.	.	.	9.11E-07	0.313157521	0.686841567	.	0.26363	0.34407	0.193034296	66.82000472	62.29801	1.61087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	258	4	100009836	chr4:100009836	C	A	58	PASS	DP=258;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	100009921	100009921	G	A	UTR5	ADH5	NM_000671:c.-70C>T	.	.	9.11E-07	0.313157521	0.686841567	.	0.26363	0.34407	0.193034296	66.82000472	62.29801	1.61087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	109	4	100009921	chr4:100009921	G	A	58	PASS	DP=109;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	100263965	100263965	C	T	exonic	ADH1C	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	0.002	0.090	B	0.008	0.127	B	.	.	.	.	.	.	1.365	0.343	L	.	.	.	.	.	.	0.126	0.320	.	.	.	.	.	.	.	.	.	4.526	0.606	24.3	0.995	0.669	0.024	0.067	N	n	0.705	-0.044	0.000	0.012	0.061	0.009	0	1.77	0.237	0.447	0.213	-0.374	0.066	0.005	0.169	0.317	0.240	5.700	0.170	Alcohol dehydrogenase, C-terminal|NAD(P)-binding domain	ENSG00000248144.1|ENSG00000198099.4|ENSG00000248144.1|ENSG00000248144.1|ENSG00000248144.1|ENSG00000248144.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Brain_Putamen_basal_ganglia|Esophagus_Mucosa|Heart_Atrial_Appendage|Heart_Left_Ventricle	0.5	60	74	4	100263965	chr4:100263965	C	T	60	PASS	DP=74;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	100266112	100266112	C	T	exonic	ADH1C	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	113	4	100266112	chr4:100266112	C	T	65	PASS	DP=113;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	100268132	100268132	A	C	intronic	ADH1C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	61	4	100268132	chr4:100268132	A	C	66	PASS	DP=61;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	100784134	100784134	C	G	intronic	DAPP1	.	.	.	0.18349368	0.804567476	0.011938844	.	0.18283	0.11376	-0.075159878	47.78839349	10.06314	0.36728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	150	4	100784134	chr4:100784134	C	G	96	PASS	DP=150;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	101947097	101947097	G	A	exonic	PPP3CA	.	synonymous SNV	PPP3CA:NM_001130692:exon12:c.C1335T:p.N445N,PPP3CA:NM_001130691:exon13:c.C1461T:p.N487N,PPP3CA:NM_000944:exon14:c.C1491T:p.N497N	0.998148789	0.001851202	9.61E-09	.	0.91458	0.30319	-0.427900189	25.14744043	6.37885	0.23918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	4	101947097	chr4:101947097	G	A	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	102072740	102072740	C	T	intronic	PPP3CA	.	.	.	0.998148789	0.001851202	9.61E-09	.	0.91458	0.30319	-0.427900189	25.14744043	6.37885	0.23918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	57	4	102072740	chr4:102072740	C	T	65	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	103534741	103534741	A	-	intronic	NFKB1	.	.	.	0.994260375	0.005739624	1.26E-09	.	0.93844	0.94648	-0.483123186	22.78249587	84.42133	1.95667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	44	4	103534740	chr4:103534740	TA	T	39	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	105393431	105393431	G	A	UTR3	CXXC4	NM_025212:c.*48C>T	.	.	.	.	.	.	0.53604	0.11809	-0.009020804	52.8544468	98.64157	2.14793	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	4	105393431	chr4:105393431	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	107237814	107237814	C	T	UTR5	TBCK	NM_001163436:c.-7697G>A	.	.	3.22E-06	0.999352989	0.000643795	.	.	.	-0.042196577	50.49539986	1635.40912	7.4738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	238	4	107237814	chr4:107237814	C	T	142	PASS	DP=238;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	109010246	109010246	A	-	intronic	LEF1	.	.	.	0.970134677	0.029856575	8.75E-06	.	0.92691	0.83191	0.196671391	67.19155461	108.65686	2.26268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	198	4	109010245	chr4:109010245	CA	C	83	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	110737293	110737293	-	T	intronic	GAR1	.	.	.	0.81256498	0.187235181	0.000199839	.	0.15921	0.12543	0.347360312	73.97381458	48.13207	1.35139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	412	4	110737293	chr4:110737293	G	GT	77	PASS	DP=412;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	110971055	110971055	A	T	UTR3	ELOVL6	NM_024090:c.*1439T>A;NM_001130721:c.*1439T>A	.	.	0.971074457	0.028885714	3.98E-05	.	0.04544	0.03306	-0.207437529	38.2814343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	147	4	110971055	chr4:110971055	A	T	72	PASS	DP=147;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	111482530	111482530	G	T	intronic	ENPEP	.	.	.	3.58E-19	0.016944416	0.983055584	.	0.21927	0.47886	0.385781814	75.678226	422.73046	4.29372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	4	111482530	chr4:111482530	G	T	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	113178967	113178967	A	-	intronic	AP1AR	.	.	.	0.511166929	0.488021686	0.000811385	.	0.14777	0.14109	0.327131069	73.27199811	63.26348	1.62796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	47	4	113178966	chr4:113178966	TA	T	58	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	113568168	113568168	G	A	ncRNA_intronic	LOC109864269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	4	113568168	chr4:113568168	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	113578482	113578482	-	A	exonic	LARP7	.	nonframeshift insertion	LARP7:NM_015454:exon13:c.1749dupA:p.X583delinsX,LARP7:NM_016648:exon13:c.1749dupA:p.X583delinsX,LARP7:NM_001267039:exon15:c.1770dupA:p.X590delinsX	0.015080323	0.983738828	0.001180848	DISEASE: Alazami syndrome (ALAZS) [MIM:615071]: A syndromic form of primordial dwarfism, a condition characterized by severe growth restriction that has its onset in utero, and results in short stature and undersize. ALAZS patients manifest severe intellectual disability and distinct facial features including malar hypoplasia, deep-set eyes, broad nose, short philtrum, and macrostomia. Some patients have non-specific and inconsistent skeletal findings, for example, scoliosis and mild epiphyseal changes in the proximal phalanges, but no frank dysplasia. {ECO:0000269|PubMed:21937992, ECO:0000269|PubMed:22865833}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.4989	0.11332	0.242582624	69.45623968	898.22165	5.83839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	157	4	113578482	chr4:113578482	G	GA	69	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	113681900	113681900	C	T	intergenic	LARP7;ANK2	dist=103152;dist=57339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	4	113681900	chr4:113681900	C	T	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	120986916	120986916	G	A	exonic	MAD2L1	.	nonsynonymous SNV	MAD2L1:NM_002358:exon2:c.C131T:p.T44I	0.013167455	0.861483837	0.125348708	.	0.99211	0.15588	0.03689118	56.64071715	19.38659	0.66662	0.017	0.512	D	0.986	0.657	D	0.951	0.672	D	0.000	0.843	D	1	0.810	D	2.405	0.698	M	.	.	.	-3.54	0.686	D	0.789	0.784	-0.373	0.729	T	0.381	0.738	T	0.010	0.267	T	3.706	0.502	23.3	0.998	0.854	0.942	0.603	D	c	0.749	0.729	1.000	0.747	0.628	0.401	0	4.78	0.605	9.498	0.969	1.048	0.713	1.000	0.715	0.995	0.604	18.181	0.897	HORMA domain	.	.	0.5	.	31	4	120986916	chr4:120986916	G	A	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	126411032	126411032	C	A	intronic	FAT4	.	.	.	0.999999998	1.64E-09	5.84E-27	DISEASE: Van Maldergem syndrome 2 (VMLDS2) [MIM:615546]: An autosomal recessive disorder characterized by intellectual disability, typical craniofacial features, auditory malformations resulting in hearing loss, and skeletal and limb malformations. Some patients have renal hypoplasia. Brain MRI typically shows periventricular nodular heterotopia. {ECO:0000269|PubMed:24056717}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hennekam lymphangiectasia-lymphedema syndrome 2 (HKLLS2) [MIM:616006]: A form of Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymph-vessels dysplasia characterized by intestinal lymphangiectasia with severe lymphedema of the limbs, genitalia and face. In addition, affected individuals have unusual facies and severe mental retardation. HKLLS2 individuals have lymphangiectasia variably affecting the gut, pericardium, lungs, kidneys, and genitalia. Other features include camptodactyly and rare syndactyly. {ECO:0000269|PubMed:24913602}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2094	0.10056	-0.502828893	21.81528662	13346.97344	24.85144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	4	126411032	chr4:126411032	C	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	129869594	129869594	T	A	intronic	SCLT1	.	.	.	5.17E-12	0.788518493	0.211481507	.	0.34487	0.09874	-0.064242613	48.844067	315.8929	3.77458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	15	4	129869594	chr4:129869594	T	A	.	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	134071880	134071880	G	A	exonic	PCDH10	.	synonymous SNV	PCDH10:NM_020815:exon1:c.G585A:p.A195A,PCDH10:NM_032961:exon1:c.G585A:p.A195A	0.894430213	0.105568021	1.77E-06	.	0.58985	0.10504	-1.240018202	5.461193678	95.22371	2.1059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	4	134071880	chr4:134071880	G	A	.	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	140036425	140036425	-	G	intronic	ELF2	.	.	.	0.985385387	0.014613112	1.50E-06	.	0.19471	0.14089	0.52918614	80.81505072	355.52103	3.99118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	73	4	140036425	chr4:140036425	C	CG	42	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	140291505	140291505	G	A	exonic	NAA15	.	nonsynonymous SNV	NAA15:NM_057175:exon15:c.G1894A:p.D632N	0.99857684	0.00142316	2.07E-10	.	0.9902	0.19761	-0.890882376	10.30313753	36.48516	1.09367	0.146	0.250	T	0.011	0.147	B	0.053	0.243	B	0.035	0.247	N	1	0.810	D	2.38	0.688	M	0.98	0.421	T	-1.56	0.377	N	0.16	0.192	-1.025	0.221	T	0.129	0.439	T	0.014	0.343	T	5.568	0.757	26.4	0.999	0.940	0.993	0.941	D	c	0.232	0.418	1.000	0.747	0.732	0.924	0	5.77	0.910	9.406	0.966	1.048	0.713	1.000	0.715	0.999	0.750	19.599	0.955	.	.	.	0.5	.	26	4	140291505	chr4:140291505	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	141294814	141294814	G	C	exonic	SCOC	.	nonsynonymous SNV	SCOC:NM_001153484:exon1:c.G124C:p.V42L,SCOC:NM_001153552:exon1:c.G124C:p.V42L,SCOC:NM_001153663:exon1:c.G124C:p.V42L	0.280616506	0.631537689	0.087845805	.	0.3001	0.11229	0.701931997	85.34442085	698.26576	5.26029	0.036	0.433	D	0.001	0.067	B	0.001	0.040	B	0.167	0.031	N	1	0.197	P	1.04	0.263	L	.	.	.	-0.37	0.132	N	0.164	0.198	-1.089	0.057	T	0.000	0.001	T	.	.	.	1.962	0.297	15.98	0.586	0.059	0.236	0.219	N	c	-0.773	-0.755	1.000	0.747	0.442	0.072	0	3.31	0.369	1.416	0.341	1.048	0.713	0.007	0.175	0.003	0.074	6.448	0.209	.	ENSG00000153132.8|ENSG00000153132.8	Esophagus_Mucosa|Muscle_Skeletal	0.5	182	301	4	141294814	chr4:141294814	G	C	182	PASS	DP=301;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	141383166	141383166	T	A	intronic	MGAT4D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	4	141383166	chr4:141383166	T	A	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	143000716	143000716	G	T	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	4	143000716	chr4:143000716	G	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	143011461	143011461	T	-	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	74	4	143011460	chr4:143011460	AT	A	59	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	144465944	144465944	G	T	exonic	SMARCA5	.	nonsynonymous SNV	SMARCA5:NM_003601:exon17:c.G2227T:p.A743S	0.999999855	1.45E-07	9.54E-19	.	0.97888	0.36004	-0.979072682	8.752064166	9.86498	0.36124	1.0	0.010	T	0.06	0.217	B	0.101	0.292	B	0.000	0.843	D	1	0.810	D	0.75	0.191	N	-2.62	0.900	D	-0.64	0.187	N	0.685	0.692	-0.260	0.761	T	0.522	0.822	D	0.160	0.841	D	2.152	0.320	17.19	0.990	0.500	0.995	0.966	D	c	-0.020	0.238	1.000	0.747	0.707	0.730	0	5.8	0.921	9.896	0.986	1.048	0.713	1.000	0.715	0.997	0.653	20.058	0.977	ISWI, HAND domain	.	.	0.5	71	32	4	144465944	chr4:144465944	G	T	71	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
4	144468476	144468476	T	-	intronic	SMARCA5	.	.	.	0.999999855	1.45E-07	9.54E-19	.	0.97888	0.36004	-0.979072682	8.752064166	9.86498	0.36124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	167	4	144468475	chr4:144468475	AT	A	71	PASS	DP=167;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	146026683	146026683	A	G	intronic	ABCE1	.	.	.	0.999982597	1.74E-05	5.48E-13	.	0.54899	0.31462	-0.251530012	35.42108988	5.45332	0.20296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	46	4	146026683	chr4:146026683	A	G	60	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	146080578	146080578	T	-	UTR3	OTUD4	NM_017493:c.*73delA	.	.	0.999916478	8.35E-05	2.07E-13	.	0.46205	0.12897	-0.993849454	8.56334041	130.30354	2.48591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	23	4	146080577	chr4:146080577	AT	A	51	PASS	DP=23;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	151505075	151505075	C	A	exonic	MAB21L2	.	nonsynonymous SNV	MAB21L2:NM_006439:exon1:c.C894A:p.D298E	0.803779159	0.195111772	0.001109069	DISEASE: Microphthalmia, syndromic, 14 (MCOPS14) [MIM:615877]: A form of microphthalmia, a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS14 patients exhibit bilateral colobomatous microphthalmia or bilateral anophthalmia. Intellectual disability and rhizomelic skeletal dysplasia is present in some affected individuals. {ECO:0000269|PubMed:24906020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.67997	0.12971	-0.339715008	30.06605331	10.58824	0.3852	0.24	0.177	T	0.507	0.354	P	0.366	0.416	B	0.000	0.843	D	1	0.810	D	2.22	0.631	M	3.06	0.087	T	-0.5	0.158	N	0.613	0.635	-1.056	0.128	T	0.020	0.082	T	0.012	0.299	T	1.489	0.241	13.25	0.963	0.288	0.930	0.568	D	c	-0.315	-0.241	1.000	0.747	0.623	0.393	0	1.46	0.217	0.817	0.267	0.065	0.171	0.999	0.424	0.999	0.750	12.396	0.545	Mab-21 domain|Ricin B, lectin domain	.	.	0.5	111	166	4	151505075	chr4:151505075	C	A	111	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	151560820	151560820	A	T	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	4	151560820	chr4:151560820	A	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	151560835	151560835	A	-	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	75	4	151560834	chr4:151560834	TA	T	78	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
4	151560855	151560856	AC	-	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	104	4	151560854	chr4:151560854	GAC	G	88	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	151683004	151683004	A	-	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	39	4	151683003	chr4:151683003	TA	T	58	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	152025695	152025695	A	-	exonic	RPS3A	.	frameshift deletion	RPS3A:NM_001006:exon6:c.745delA:p.V250Lfs*24	0.744269731	0.253389263	0.002341006	.	0.99653	0.30163	0.013025609	54.62962963	4.49164	0.16244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	130	4	152025694	chr4:152025694	TA	T	58	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	153864407	153864407	T	C	exonic	FHDC1	.	synonymous SNV	FHDC1:NM_033393:exon1:c.T198C:p.L66L	0.024454127	0.975428958	0.000116915	.	0.39667	0.08948	0.969962249	90.20995518	6091.11428	16.31408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	177	245	4	153864407	chr4:153864407	T	C	177	PASS	DP=245;AN=2	GT	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
4	155471398	155471398	-	A	intronic	PLRG1	.	.	.	0.998224783	0.001775215	1.76E-09	.	0.55468	0.15289	-0.291981272	33.20358575	28.74018	0.91926	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	313	4	155471398	chr4:155471398	C	CA	54	PASS	DP=313;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	158281848	158281848	-	T	intronic	GRIA2	.	.	.	0.99550949	0.004490506	3.42E-09	.	0.3057	0.25829	-0.778825328	12.88039632	32.84712	1.01918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	111	4	158281848	chr4:158281848	G	GT	81	PASS	DP=111;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	159754866	159754866	T	-	intronic	FNIP2	.	.	.	0.997777002	0.002222998	6.15E-10	.	0.11511	0.08281	-0.10469683	45.64755839	731.02841	5.36823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	119	4	159754865	chr4:159754865	GT	G,GTT	53	PASS	DP=119;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
4	159754866	159754866	-	T	intronic	FNIP2	.	.	.	0.997777002	0.002222998	6.15E-10	.	0.11511	0.08281	-0.10469683	45.64755839	731.02841	5.36823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	119	4	159754865	chr4:159754865	GT	G,GTT	53	PASS	DP=119;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
4	169048922	169048922	C	T	intronic	ANXA10	.	.	.	1.28E-08	0.561130781	0.438869206	.	.	0.09365	0.817616644	87.95116773	140.03091	2.58142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	4	169048922	chr4:169048922	C	T	.	PASS	DP=62;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	169315628	169315628	T	-	exonic	DDX60L	.	frameshift deletion	DDX60L:NM_001012967:exon28:c.3798delA:p.I1269Lfs*2,DDX60L:NM_001291510:exon28:c.3801delA:p.I1270Lfs*2,DDX60L:NM_001345927:exon28:c.3801delA:p.I1270Lfs*2	8.17E-30	0.000634233	0.999365767	.	0.07164	0.0727	2.618410593	98.77919321	7052.9357	17.9578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	63	4	169315627	chr4:169315627	CT	C	88	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	169315633	169315633	C	A	exonic	DDX60L	.	nonsynonymous SNV	DDX60L:NM_001012967:exon28:c.G3793T:p.V1265L,DDX60L:NM_001291510:exon28:c.G3796T:p.V1266L,DDX60L:NM_001345927:exon28:c.G3796T:p.V1266L	8.17E-30	0.000634233	0.999365767	.	0.07164	0.0727	2.618410593	98.77919321	7052.9357	17.9578	0.016	0.518	D	0.011	0.276	B	0.002	0.272	B	0.573	0.055	U	1	0.090	N	-0.5	0.026	N	1.01	0.411	T	0.58	0.026	N	0.103	0.195	-0.987	0.335	T	0.042	0.182	T	0.010	0.272	T	2.202	0.326	17.52	0.903	0.190	0.017	0.053	N	c	-1.307	-1.384	0.996	0.344	0.732	0.924	0	-5.29	0.025	-0.051	0.117	-0.340	0.072	0.012	0.185	0.002	0.062	7.514	0.266	Helicase, C-terminal|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	79	62	4	169315633	chr4:169315633	C	A	79	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	173873171	173873171	G	T	intronic	GALNTL6	.	.	.	0.001655681	0.997152291	0.001192028	.	.	0.10877	-0.824740496	11.67728238	48.92451	1.36627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	321	4	173873171	chr4:173873171	G	T	112	PASS	DP=321;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	185687687	185687687	A	C	intronic	ACSL1	.	.	.	0.091837331	0.908159695	2.97E-06	.	0.24765	0.32858	-0.841329384	11.36470866	62.62006	1.61892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	72	4	185687687	chr4:185687687	A	C	67	PASS	DP=72;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	187518071	187518071	C	A	exonic	FAT1	.	nonsynonymous SNV	FAT1:NM_005245:exon25:c.G12623T:p.R4208L	1.78E-10	1	5.46E-11	.	0.43649	0.17117	-0.392997457	27.05826846	12587.77428	24.10511	0.01	0.564	D	0.61	0.377	P	0.082	0.276	B	0.006	0.322	N	0.995	0.233	N	1.995	0.543	M	-0.69	0.727	T	-1.57	0.379	N	0.235	0.288	-0.804	0.549	T	0.214	0.575	T	0.039	0.588	D	3.440	0.471	23.0	0.949	0.251	0.630	0.317	D	c	-0.508	-0.559	0.929	0.269	0.707	0.730	0	2.07	0.259	1.413	0.341	-0.328	0.075	0.232	0.244	0.003	0.074	8.717	0.334	.	.	.	0.5	.	40	4	187518071	chr4:187518071	C	A	.	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	190878577	190878577	A	G	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.A457G:p.N153D	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.004	0.654	D	0.481	0.349	P	0.6	0.489	P	0.000	0.843	D	1.000	0.588	D	2.56	0.750	M	1.75	0.505	T	-4.0	0.769	D	0.204	0.530	-0.731	0.589	T	0.247	0.616	T	.	.	.	4.427	0.593	24.2	0.993	0.572	0.982	0.800	D	c	0.095	0.054	1.000	0.427	0.707	0.730	0	2.99	0.335	7.501	0.803	0.136	0.221	1.000	0.715	0.992	0.562	8.215	0.305	Actin cross-linking	.	.	0.5	127	716	4	190878577	chr4:190878577	A	G	127	PASS	DP=716;AN=4	GT	./.	0/1	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	190878664	190878664	A	G	intronic	FRG1	.	.	.	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	270	4	190878664	chr4:190878664	A	G	110	PASS	DP=270;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	190894317	190894317	A	C	intergenic	FRG1;FRG2	dist=9958;dist=51206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	361	4	190894317	chr4:190894317	A	C	139	PASS	DP=361;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	233734	233734	C	G	exonic	SDHA	.	synonymous SNV	SDHA:NM_001294332:exon7:c.C894G:p.S298S,SDHA:NM_001330758:exon8:c.C1038G:p.S346S,SDHA:NM_004168:exon8:c.C1038G:p.S346S	9.39E-06	0.996636308	0.003354304	DISEASE: Mitochondrial complex II deficiency (MT-C2D) [MIM:252011]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. Note=The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:12794685}.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:10746566, ECO:0000269|PubMed:24781757, ECO:0000269|PubMed:7550341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20551992}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paragangliomas 5 (PGL5) [MIM:614165]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:20484225}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2964	.	-0.857930839	10.95187544	1260.39498	6.69421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	38	5	233734	chr5:233734	C	G	53	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	432898	432898	C	-	intronic	AHRR	.	.	.	6.76E-05	0.977269885	0.022662496	.	.	0.16352	1.004917985	90.78792168	1613.48158	7.43304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	21	5	432897	chr5:432897	TC	T	45	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	482225	482225	G	A	exonic	SLC9A3	.	synonymous SNV	SLC9A3:NM_001284351:exon8:c.C1377T:p.S459S,SLC9A3:NM_004174:exon8:c.C1404T:p.S468S	0.988153998	0.011845965	3.67E-08	.	0.13048	0.0991	-1.785892633	2.25878745	215.86732	3.17181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	5	482225	chr5:482225	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	666067	666067	C	T	intronic	TPPP	.	.	.	0.447860539	0.523687832	0.028451629	.	0.32775	0.16177	-0.315847836	31.68789809	36.35113	1.08938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	5	666067	chr5:666067	C	T	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	796015	796015	A	C	UTR3	ZDHHC11	NM_024786:c.*688T>G	.	.	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	.	.	.	.	.	.	.	.	.	.	.	.	0.994	0.422	D	.	.	.	.	.	.	.	.	.	.	.	-0.904	0.475	T	0.173	0.516	T	.	.	.	-0.255	0.072	0.839	0.492	0.041	0.066	0.125	N	c	-0.611	-0.824	0.000	0.052	0.258	0.037	0	1.07	0.193	-1.126	0.033	-0.703	0.037	0.000	0.063	0.002	0.062	3.397	0.068	.	.	.	0.5	122	65	5	796015	chr5:796015	A	C	122	PASS	DP=65;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	840661	840661	A	G	exonic	ZDHHC11	.	nonsynonymous SNV	ZDHHC11:NM_024786:exon5:c.T733C:p.F245L	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	1.0	0.108	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	N	0.09	0.084	N	1.96	0.386	T	1.6	0.332	N	0.468	0.519	-1.058	0.123	T	0.035	0.151	T	0.001	0.012	T	-3.140	0.001	0.001	0.082	0.001	0.002	0.011	N	c	-2.141	-2.214	0.998	0.363	0.696	0.567	0	-5.47	0.024	-0.923	0.041	-1.725	0.007	0.000	0.063	0.000	0.016	3.145	0.060	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	124	266	5	840661	chr5:840661	A	G	124	PASS	DP=266;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	840704	840704	G	A	exonic	ZDHHC11	.	synonymous SNV	ZDHHC11:NM_024786:exon5:c.C690T:p.T230T	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	895	5	840704	chr5:840704	G	A	109	PASS	DP=895;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	878461	878461	G	A	intronic	BRD9	.	.	.	0.249187874	0.749502264	0.001309862	.	0.12337	0.10817	-0.797234383	12.48525596	290.83161	3.64776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	123	5	878461	chr5:878461	G	A	135	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	1320805	1320805	G	C	exonic	CLPTM1L	.	nonsynonymous SNV	CLPTM1L:NM_030782:exon16:c.C1458G:p.I486M	0.311319339	0.688524082	0.000156579	.	0.22539	0.12562	-0.596992387	18.18825195	148.89252	2.66142	0.0	0.912	D	1.0	0.899	D	0.994	0.916	D	0.000	0.843	D	1	0.810	D	3.175	0.890	M	0.0	0.626	T	-2.61	0.571	D	0.922	0.914	0.133	0.848	D	0.507	0.814	D	0.178	0.854	D	6.197	0.855	28.7	0.998	0.847	0.938	0.590	D	c	0.822	0.754	1.000	0.747	0.707	0.730	0	5.05	0.674	4.408	0.593	0.933	0.449	1.000	0.715	1.000	0.888	17.527	0.876	.	.	.	0.5	90	203	5	1320805	chr5:1320805	G	C	90	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	1632941	1632941	T	G	ncRNA_intronic	LOC728613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	39	5	1632941	chr5:1632941	T	G	50	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	5447607	5447607	A	G	exonic	ICE1	.	synonymous SNV	ICE1:NM_015325:exon8:c.A492G:p.E164E	.	.	.	.	.	.	-0.174712176	40.57560745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	20	5	5447607	chr5:5447607	A	G	61	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	6651976	6651976	G	C	exonic	SRD5A1	.	synonymous SNV	SRD5A1:NM_001047:exon2:c.G315C:p.L105L,SRD5A1:NM_001324323:exon3:c.G96C:p.L32L	1.82E-06	0.252700789	0.747297393	.	0.05869	.	-0.073340031	48.11866006	31.3139	0.98785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	51	5	6651976	chr5:6651976	G	C	66	PASS	DP=51;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	7304281	7304281	T	A	ncRNA_intronic	LOC442132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	291	5	7304281	chr5:7304281	T	A	75	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	10390429	10390429	T	-	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	453	5	10390428	chr5:10390428	CT	C,CTT	75	PASS	DP=453;AN=6	GT	./.	0/1	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
5	10390429	10390429	-	T	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	453	5	10390428	chr5:10390428	CT	C,CTT	75	PASS	DP=453;AN=6	GT	./.	0/1	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
5	10397474	10397474	T	-	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	61	5	10397473	chr5:10397473	CT	C	92	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	14652316	14652316	C	T	downstream	SNORD141A;SNORD141B	dist=71	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	425	5	14652316	chr5:14652316	C	T	101	PASS	DP=425;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	17273722	17273722	A	C	intronic	BASP1	.	.	.	0.539222353	0.403650733	0.057126915	.	0.20195	0.13818	.	.	157.19188	2.73957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	287	5	17273722	chr5:17273722	A	C	165	PASS	DP=287;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	17498289	17498289	A	G	intergenic	LINC02218;LINC02223	dist=14234;dist=309094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	230	5	17498289	chr5:17498289	A	G	74	PASS	DP=230;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	24511520	24511520	G	T	exonic	CDH10	.	stopgain	CDH10:NM_001317224:exon5:c.C918A:p.Y306X,CDH10:NM_006727:exon6:c.C918A:p.Y306X	0.309152977	0.690814761	3.23E-05	.	0.42021	0.11113	-0.800872469	12.33191791	34.27199	1.04877	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.073	0.972	37	0.996	0.746	0.858	0.447	D	c	0.454	0.253	0.003	0.102	0.554	0.246	0	-0.294	0.121	1.501	0.351	0.067	0.174	1.000	0.715	0.999	0.750	10.529	0.440	Cadherin|Cadherin-like	.	.	0.5	.	54	5	24511520	chr5:24511520	G	T	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	31435976	31435976	A	-	intronic	DROSHA	.	.	.	0.996399648	0.003600352	2.77E-14	.	0.60911	0.25509	-0.461076406	23.66124086	2101.94263	8.44322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	11	5	31435975	chr5:31435975	CA	C	63	PASS	DP=11;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	32419849	32419849	T	C	intronic	ZFR	.	.	.	0.99999967	3.30E-07	7.06E-18	.	0.63808	0.14804	-0.754958418	13.57631517	2316.48591	8.91305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	50	5	32419849	chr5:32419849	T	C	52	PASS	DP=50;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	34811137	34811137	T	G	exonic	RAI14	.	synonymous SNV	RAI14:NM_001145523:exon7:c.T447G:p.L149L,RAI14:NM_001145520:exon8:c.T471G:p.L157L,RAI14:NM_001145522:exon8:c.T471G:p.L157L,RAI14:NM_015577:exon8:c.T471G:p.L157L,RAI14:NM_001145521:exon9:c.T471G:p.L157L,RAI14:NM_001145525:exon10:c.T480G:p.L160L	0.487656416	0.512341946	1.64E-06	.	0.2442	0.11401	-0.216746887	37.69757018	3767.60269	12.00361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	8	5	34811137	chr5:34811137	T	G	41	PASS	DP=8;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	34930047	34930047	C	T	intronic	DNAJC21	.	.	.	1.45E-05	0.991233393	0.008752095	.	0.13651	0.10368	-0.154246007	42.22694032	118.51193	2.36941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	301	5	34930047	chr5:34930047	C	T	.	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	35065313	35065313	G	T	exonic	PRLR	.	nonsynonymous SNV	PRLR:NM_001204314:exon7:c.C1444A:p.L482I,PRLR:NM_000949:exon10:c.C1747A:p.L583I	0.916128016	0.083848214	2.38E-05	DISEASE: Multiple fibroadenomas of the breast (MFAB) [MIM:615554]: A benign breast disease marked by lobuloalveolar growth with abnormally high proliferation of the epithelium, and characterized by the presence of more than 3 fibroadenomas in one breast. Fibroadenomas are adenomas containing fibrous tissue. {ECO:0000269|PubMed:18779591}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hyperprolactinemia (HPRL) [MIM:615555]: A disorder characterized by increased levels of prolactin in the blood not associated with gestation or the puerperium. HPRL may result in infertility, hypogonadism, and galactorrhea. {ECO:0000269|PubMed:24195502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07595	0.38344	0.020302773	55.60863411	347.86975	3.95295	0.131	0.266	T	0.745	0.443	P	0.231	0.429	B	0.354	0.043	N	1	0.090	N	2.19	0.618	M	-2.44	0.888	D	-0.52	0.162	N	0.086	0.092	-0.423	0.713	T	0.651	0.879	D	0.090	0.756	D	-0.605	0.050	0.121	0.935	0.227	0.108	0.160	N	c	-0.450	-0.585	0.103	0.164	0.554	0.283	0	1.92	0.248	0.448	0.213	0.953	0.551	0.000	0.063	0.498	0.270	9.175	0.361	.	.	.	0.5	116	180	5	35065313	chr5:35065313	G	T	116	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	36876996	36876996	G	T	UTR5	NIPBL	NM_015384:c.-76803G>T;NM_133433:c.-76803G>T	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	5	36876996	chr5:36876996	G	T	.	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	37036545	37036546	AT	-	exonic	NIPBL	.	frameshift deletion	NIPBL:NM_015384:exon33:c.5927_5928del:p.D1976Efs*3,NIPBL:NM_133433:exon33:c.5927_5928del:p.D1976Efs*2	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	118	5	37036544	chr5:37036544	GAT	G	60	PASS	DP=118;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	37051862	37051862	T	-	intronic	NIPBL	.	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	188	5	37051861	chr5:37051861	AT	A,ATT	87	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	37051862	37051862	-	T	intronic	NIPBL	.	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	188	5	37051861	chr5:37051861	AT	A,ATT	87	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	40798154	40798154	G	T	intronic	PRKAA1	.	.	.	0.035101034	0.96325073	0.001648236	.	0.90852	0.13068	-0.494039303	22.09247464	21.33891	0.72054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	277	5	40798154	chr5:40798154	G	T	62	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	40798325	40798325	G	A	upstream	PRKAA1	dist=28	.	.	0.035101034	0.96325073	0.001648236	.	0.90852	0.13068	-0.494039303	22.09247464	21.33891	0.72054	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	98	5	40798325	chr5:40798325	G	A	67	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	41904406	41904406	G	T	upstream	C5orf51	dist=40	.	.	0.0038889	0.957830834	0.038280267	.	.	.	0.104848986	61.49445624	180.03222	2.91542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	194	5	41904406	chr5:41904406	G	T	132	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	43122286	43122286	A	T	intronic	ZNF131	.	.	.	0.999460222	0.000539776	2.35E-09	.	0.28126	0.10787	0.128714042	63.19886766	86.63819	1.98849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	5	43122286	chr5:43122286	A	T	.	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	50055533	50055533	C	G	exonic	PARP8	.	nonsynonymous SNV	PARP8:NM_001178056:exon4:c.C241G:p.P81A,PARP8:NM_001331028:exon4:c.C178G:p.P60A,PARP8:NM_024615:exon4:c.C241G:p.P81A,PARP8:NM_001178055:exon5:c.C241G:p.P81A	0.119242934	0.880756988	7.77E-08	.	0.35408	.	-0.911109353	9.961075725	112.79172	2.31004	0.011	0.564	D	0.996	0.670	D	0.981	0.736	D	0.000	0.843	D	1.000	0.810	D	0.345	0.112	N	.	.	.	-1.05	0.916	N	0.595	0.723	-0.722	0.594	T	0.250	0.619	T	0.008	0.220	T	3.513	0.480	23.1	0.995	0.664	0.857	0.446	D	c	0.489	0.526	1.000	0.747	0.706	0.609	0	5.31	0.750	2.945	0.485	0.935	0.490	1.000	0.715	1.000	0.888	16.84	0.858	.	.	.	0.5	79	68	5	50055533	chr5:50055533	C	G	79	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	54468512	54468512	A	G	intronic	CDC20B	.	.	.	1.44E-11	0.098587056	0.901412944	.	0.13927	0.08133	0.933309256	89.82661005	1377.34214	6.95718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	5	54468512	chr5:54468512	A	G	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	54528179	54528179	C	T	intronic	CCNO	.	.	.	0.040710125	0.843060511	0.116229364	DISEASE: Ciliary dyskinesia, primary, 29 (CILD29) [MIM:615872]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. CILD29 patients do not exhibit situs inversus, a congenital abnormality in which visceral organs are opposite to their normal positions (situs solitus) due to lateral transposition. {ECO:0000269|PubMed:24747639}. Note=The disease is caused by mutations affecting the gene represented in this entry. Marked reduction of cilia in multiciliate cells due to defective mother centriole generation and placement. Remaining cilia correctly express axonemal motor proteins, are motile and do not show beating defects. Defects are probably caused by a strong reduction in the number of multiple motile cilia covering the cell surface in respiratory epithelial cells (PubMed:24747639). {ECO:0000269|PubMed:24747639}.; 	0.08032	0.19498	0.483275131	79.25218212	97.40203	2.13267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	113	5	54528179	chr5:54528179	C	T	92	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	55042105	55042105	G	T	intronic	DDX4	.	.	.	0.998516038	0.001483962	4.64E-11	.	0.68619	0.10786	-0.310388054	32.14791224	861.19729	5.72325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	5	55042105	chr5:55042105	G	T	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	56527030	56527030	G	A	exonic	GPBP1	.	nonsynonymous SNV	GPBP1:NM_001127236:exon4:c.G314A:p.R105H,GPBP1:NM_001127235:exon5:c.G314A:p.R105H,GPBP1:NM_001331037:exon5:c.G293A:p.R98H,GPBP1:NM_022913:exon5:c.G293A:p.R98H	0.975851112	0.024147841	1.05E-06	.	0.84318	0.11313	0.042348793	57.31304553	66.67652	1.68454	0.393	0.107	T	0.067	0.222	B	0.023	0.188	B	0.000	0.843	D	0.990	0.810	D	1.79	0.469	L	0.88	0.460	T	-1.64	0.422	N	0.322	0.388	-1.051	0.142	T	0.090	0.346	T	0.011	0.273	T	3.275	0.453	22.8	0.996	0.717	0.902	0.508	D	c	-0.134	0.035	1.000	0.473	0.722	0.854	0	4.9	0.635	2.869	0.479	0.108	0.203	1.000	0.715	0.999	0.750	9.911	0.404	.	.	.	0.5	.	28	5	56527030	chr5:56527030	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	61857068	61857068	C	G	exonic	IPO11	.	nonsynonymous SNV	IPO11:NM_001134779:exon27:c.C2686G:p.L896V,IPO11:NM_016338:exon27:c.C2566G:p.L856V	0.996456955	0.003543045	3.21E-12	.	0.69666	0.11055	-0.529034136	20.85987261	87.81015	2.0015	0.006	0.614	D	0.994	0.670	D	0.929	0.667	D	0.000	0.843	D	1.000	0.588	D	2.36	0.681	M	-0.92	0.751	T	-2.2	0.495	N	0.838	0.855	0.030	0.829	D	0.516	0.819	D	0.075	0.722	D	5.909	0.811	27.5	0.998	0.898	0.927	0.560	D	c	0.547	0.515	0.918	0.265	0.732	0.924	0	4.44	0.530	2.886	0.480	0.069	0.176	1.000	0.715	1.000	0.888	13.177	0.589	Armadillo-like helical|Armadillo-type fold;Armadillo-type fold	.	.	0.5	93	30	5	61857068	chr5:61857068	C	G	93	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	64756006	64756006	C	T	exonic	ADAMTS6	.	nonsynonymous SNV	ADAMTS6:NM_197941:exon4:c.G622A:p.G208R	0.998800473	0.001199527	1.13E-12	.	0.4309	0.11953	-0.574945567	18.90186365	218.20018	3.19214	0.021	0.491	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.455	0.715	M	0.14	0.609	T	-3.74	0.710	D	0.864	0.858	-0.396	0.722	T	0.368	0.728	T	0.067	0.701	D	6.838	0.927	33	0.999	0.997	0.988	0.872	D	c	0.759	0.797	1.000	0.747	0.707	0.730	0	6.06	0.983	7.435	0.794	0.935	0.490	1.000	0.715	1.000	0.888	20.640	0.995	.	.	.	0.5	.	23	5	64756006	chr5:64756006	C	T	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	65029420	65029420	G	T	intronic	NLN	.	.	.	3.60E-07	0.985541392	0.014458248	.	0.39163	0.14364	-0.354480518	29.42911064	1132.42209	6.4199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	112	5	65029420	chr5:65029420	G	T	93	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	68396765	68396765	G	-	intronic	SLC30A5	.	.	.	0.230512232	0.769423834	6.39E-05	.	0.61924	0.13187	-0.088107893	47.06298655	141.89318	2.60037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	16	5	68396764	chr5:68396764	TG	T	61	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	72204842	72204842	C	A	UTR3	TNPO1	NM_002270:c.*342C>A;NM_153188:c.*342C>A	.	.	0.999998701	1.30E-06	9.85E-16	.	0.97077	0.18297	-0.780646273	12.77423921	36.30496	1.0871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	5	72204842	chr5:72204842	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	78610548	78610548	G	A	exonic	JMY	.	nonsynonymous SNV	JMY:NM_152405:exon9:c.G2533A:p.E845K	0.999722637	0.000277363	1.90E-11	.	.	.	0.88921411	89.24274593	2992.00625	10.37986	0.01	0.564	D	0.465	0.346	P	0.124	0.310	B	0.001	0.432	D	0.763	0.340	D	1.255	0.319	L	1.59	0.288	T	-0.34	0.127	N	0.138	0.185	-1.058	0.123	T	0.048	0.204	T	0.007	0.194	T	2.966	0.417	22.1	0.997	0.838	0.940	0.597	D	c	-0.106	-0.003	0.129	0.171	0.563	0.310	0	4.91	0.638	1.969	0.399	0.953	0.551	0.107	0.227	0.992	0.562	8.579	0.326	.	.	.	0.5	.	47	5	78610548	chr5:78610548	G	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	79351686	79351686	G	A	exonic	THBS4	.	nonsynonymous SNV	THBS4:NM_001306214:exon3:c.G98A:p.R33Q,THBS4:NM_003248:exon3:c.G371A:p.R124Q,THBS4:NM_001306212:exon4:c.G98A:p.R33Q,THBS4:NM_001306213:exon4:c.G98A:p.R33Q	1.74E-08	0.998069808	0.001930175	.	0.18964	0.34036	-0.23697515	36.32342534	1138.51791	6.43453	0.641	0.050	T	0.026	0.181	B	0.005	0.104	B	0.001	0.403	N	0.573	0.311	N	0.895	0.225	L	4.44	0.022	T	-0.53	0.164	N	0.097	0.112	-0.979	0.353	T	0.006	0.021	T	0.006	0.145	T	4.129	0.554	23.8	0.984	0.408	0.557	0.297	D	c	-0.201	-0.013	1.000	0.747	0.742	0.980	0	5.84	0.934	3.131	0.500	0.998	0.613	1.000	0.715	0.862	0.360	9.776	0.396	Concanavalin A-like lectin/glucanase domain|Laminin G domain	.	.	0.5	91	294	5	79351686	chr5:79351686	G	A	91	PASS	DP=294;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	83402467	83402467	C	A	exonic	EDIL3	.	nonsynonymous SNV	EDIL3:NM_001278642:exon5:c.G621T:p.Q207H,EDIL3:NM_005711:exon6:c.G651T:p.Q217H	4.09E-05	0.990205567	0.009753556	.	0.47277	0.13726	-0.426079032	25.36565228	65.31372	1.66299	0.0	0.912	D	0.998	0.899	D	0.994	0.875	D	0.000	0.843	D	1	0.810	D	4.515	0.990	H	-5.16	0.988	D	-4.34	0.768	D	0.936	0.930	1.038	0.979	D	0.983	0.995	D	0.648	0.970	D	6.752	0.921	32	0.998	0.856	0.980	0.788	D	c	1.011	0.915	1.000	0.747	0.706	0.609	0	5.37	0.769	7.357	0.785	0.852	0.362	1.000	0.715	0.998	0.697	19.114	0.933	Coagulation factor 5/8 C-terminal domain|Galactose-binding domain-like	.	.	0.5	.	25	5	83402467	chr5:83402467	C	A	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	85582748	85582748	A	G	ncRNA_exonic	NBPF22P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	276	5	85582748	chr5:85582748	A	G	150	PASS	DP=276;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	86564459	86564459	G	T	exonic	RASA1	.	nonsynonymous SNV	RASA1:NM_002890:exon1:c.G191T:p.G64V	0.999998286	1.71E-06	7.92E-17	DISEASE: Note=Mutations in the SH2 domain of RASA seem to be oncogenic and cause basal cell carcinomas.; DISEASE: Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354]: A disorder characterized by atypical capillary malformations that are multiple, small, round to oval in shape and pinkish red in color. These capillary malformations are associated with either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome. {ECO:0000269|PubMed:14639529, ECO:0000269|PubMed:24038909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkes Weber syndrome (PKWS) [MIM:608355]: Disorder characterized by a cutaneous flush with underlying multiple micro- arteriovenous fistulas, in association with soft tissue and skeletal hypertrophy of the affected limb. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.71615	0.1353	-0.821100135	11.88369899	144.431	2.61738	0.01	0.564	D	0.889	0.469	P	0.238	0.368	B	0.239	0.036	N	0.995	0.426	D	0.695	0.181	N	-0.67	0.725	T	-0.43	0.144	N	0.453	0.511	-0.828	0.534	T	0.184	0.533	T	0.144	0.827	D	4.731	0.634	24.6	0.983	0.397	0.127	0.172	N	c	-0.132	-0.054	1.000	0.747	0.442	0.072	0	3.7	0.414	0.568	0.232	0.877	0.384	0.902	0.312	0.983	0.502	12.682	0.561	.	.	.	0.5	.	34	5	86564459	chr5:86564459	G	T	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	89999592	89999592	G	T	exonic	ADGRV1	.	stopgain	ADGRV1:NM_032119:exon35:c.G8266T:p.G2756X	.	.	.	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.07741	0.17025	8.124040712	99.95281906	.	.	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.580	0.999	51	0.990	0.505	0.994	0.960	D	c	1.211	1.057	1.000	0.747	0.554	0.246	0	5.15	0.702	9.222	0.943	1.048	0.713	1.000	0.715	0.877	0.367	18.825	0.920	Na-Ca exchanger/integrin-beta4	.	.	0.5	.	26	5	89999592	chr5:89999592	G	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	92923754	92923754	C	A	exonic	NR2F1	.	nonsynonymous SNV	NR2F1:NM_005654:exon2:c.C595A:p.P199T	.	.	.	DISEASE: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]: An autosomal dominant disorder characterized by optic atrophy associated with developmental delay and intellectual disability. Most patients also have evidence of cerebral visual impairment. {ECO:0000269|PubMed:24462372}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7496	0.11262	-0.339715008	30.06605331	3.34161	0.12228	0.03	0.453	D	0.997	0.689	D	0.975	0.717	D	0.000	0.843	D	1	0.810	D	1.57	0.397	L	0.72	0.510	T	-5.94	0.891	D	0.644	0.660	-0.669	0.619	T	0.274	0.646	T	0.045	0.621	D	2.325	0.341	18.33	0.997	0.823	0.996	0.981	D	c	0.524	0.446	1.000	0.747	0.707	0.730	0	4.5	0.542	7.879	0.856	0.932	0.445	1.000	0.715	0.971	0.463	17.383	0.872	Nuclear hormone receptor, ligand-binding domain	.	.	0.5	119	188	5	92923754	chr5:92923754	C	A	119	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	95733110	95733110	-	ATTTTTTTCAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTGTGTGAACAGACATGAAGTCCCAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	exonic	PCSK1	.	stopgain	PCSK1:NM_000439:exon12:c.1651_1652insGGGACTTCATGTCTGTTCACACATGGGGAGAGAACCCTATAGGTACTTGGACTTTGAGAATTGGGACTTCATGTCTGTTCACACAAGATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTGAAAAAAAT:p.T572Gfs*19,PCSK1:NM_001177875:exon12:c.1510_1511insGGGACTTCATGTCTGTTCACACATGGGGAGAGAACCCTATAGGTACTTGGACTTTGAGAATTGGGACTTCATGTCTGTTCACACAAGATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTGAAAAAAAT:p.T525Gfs*19	0.089639821	0.910344875	1.53E-05	DISEASE: Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955]: Characterized by obesity, hypogonadism, hypoadrenalism, reactive hypoglycemia as well as marked small- intestinal absorptive dysfunction It is due to impaired processing of prohormones. {ECO:0000269|PubMed:14617756, ECO:0000269|PubMed:17595246, ECO:0000269|PubMed:9207799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35142	0.33991	-0.420619508	25.72540694	2006.75712	8.2505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	23	5	95733048	chr5:95733048	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCCATTTTTTTCAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTGTGTGAACAGACATGAAGTCCCAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC,T	42	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	95733049	95733110	AATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	-	exonic	PCSK1	.	frameshift deletion	PCSK1:NM_000439:exon12:c.1652_1713del:p.W551Yfs*9,PCSK1:NM_001177875:exon12:c.1511_1572del:p.W504Yfs*9	0.089639821	0.910344875	1.53E-05	DISEASE: Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955]: Characterized by obesity, hypogonadism, hypoadrenalism, reactive hypoglycemia as well as marked small- intestinal absorptive dysfunction It is due to impaired processing of prohormones. {ECO:0000269|PubMed:14617756, ECO:0000269|PubMed:17595246, ECO:0000269|PubMed:9207799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35142	0.33991	-0.420619508	25.72540694	2006.75712	8.2505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	23	5	95733048	chr5:95733048	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCCATTTTTTTCAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTGTGTGAACAGACATGAAGTCCCAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC,T	42	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	96513395	96513399	AAAGC	-	intronic	RIOK2	.	.	.	0.001140112	0.988993674	0.009866214	.	0.64042	0.09168	1.065596954	91.61358811	3638.14552	11.71409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	21	5	96513394	chr5:96513394	TAAAGC	T	58	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	98217050	98217050	G	A	exonic	CHD1	.	nonsynonymous SNV	CHD1:NM_001270:exon20:c.C2897T:p.S966L	0.999999999	6.37E-10	3.50E-25	.	0.88289	0.17305	-0.813834387	12.05472989	1749.76488	7.72416	0.002	0.721	D	0.439	0.340	B	0.165	0.334	B	0.012	0.292	U	1	0.810	D	0.935	0.237	L	-3.74	0.955	D	-3.68	0.703	D	0.56	0.594	0.506	0.906	D	0.722	0.905	D	0.204	0.869	D	6.949	0.934	33	0.998	0.922	0.993	0.945	D	c	0.277	0.442	1.000	0.747	0.732	0.924	0	5.13	0.696	10.003	0.997	0.902	0.416	1.000	0.715	0.996	0.625	18.945	0.926	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	47	5	98217050	chr5:98217050	G	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	98860073	98860073	G	C	intergenic	LOC100289230;LINC02113	dist=593360;dist=9621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	186	5	98860073	chr5:98860073	G	C	93	PASS	DP=186;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	99403740	99403740	T	C	intergenic	LINC02113;LOC100133050	dist=490082;dist=311469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	331	5	99403740	chr5:99403740	T	C	131	PASS	DP=331;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	99728376	99728376	C	T	intergenic	LOC100133050;FAM174A	dist=4418;dist=142633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	280	5	99728376	chr5:99728376	C	T	127	PASS	DP=280;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	110284912	110284912	-	T	intergenic	SLC25A46;TSLP	dist=184038;dist=122478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	209	5	110284912	chr5:110284912	C	CT	76	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	111065696	111065696	-	AAAG	ncRNA_intronic	STARD4-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	17	5	111065696	chr5:111065696	C	CAAAG	50	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	111066697	111066697	T	C	exonic	NREP	.	nonsynonymous SNV	NREP:NM_001142483:exon3:c.A128G:p.E43G,NREP:NM_001142474:exon4:c.A230G:p.E77G,NREP:NM_001142475:exon4:c.A260G:p.E87G,NREP:NM_004772:exon4:c.A128G:p.E43G,NREP:NM_001142476:exon5:c.A128G:p.E43G,NREP:NM_001142477:exon5:c.A128G:p.E43G,NREP:NM_001142478:exon5:c.A128G:p.E43G,NREP:NM_001142479:exon5:c.A128G:p.E43G,NREP:NM_001142480:exon5:c.A128G:p.E43G,NREP:NM_001142481:exon5:c.A128G:p.E43G,NREP:NM_001142482:exon5:c.A128G:p.E43G	0.563643143	0.387749286	0.048607571	.	0.35283	.	0.72397987	85.91648974	72.00969	1.7668	0.145	0.348	T	0.012	0.151	B	0.016	0.166	B	0.093	0.203	N	1	0.192	P	.	.	.	0.6	0.537	T	-5.14	0.833	D	0.061	0.478	-1.064	0.109	T	0.000	0.000	T	.	.	.	-1.057	0.030	0.012	0.919	0.207	0.287	0.234	N	c	-0.900	-0.911	0.999	0.396	0.707	0.730	0	0.269	0.148	1.635	0.365	0.129	0.215	0.204	0.241	0.003	0.074	3.024	0.057	.	.	.	0.5	58	18	5	111066697	chr5:111066697	T	C	58	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	112175279	112175279	C	T	exonic	APC	.	nonsynonymous SNV	APC:NM_001127511:exon14:c.C3934T:p.P1312S,APC:NM_000038:exon16:c.C3988T:p.P1330S,APC:NM_001127510:exon17:c.C3988T:p.P1330S	0.999999928	7.23E-08	1.20E-23	DISEASE: Familial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. {ECO:0000269|PubMed:10470088, ECO:0000269|PubMed:1338691, ECO:0000269|PubMed:1338764, ECO:0000269|PubMed:1338904, ECO:0000269|PubMed:1651563, ECO:0000269|PubMed:7833149, ECO:0000269|PubMed:7833931, ECO:0000269|PubMed:8990002}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. {ECO:0000269|PubMed:10782927, ECO:0000269|PubMed:8940264}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:7661930}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.53216	0.57092	-2.523543479	0.902335456	395.17068	4.17713	0.532	0.070	T	0.0	0.026	B	0.0	0.013	B	0.836	0.091	N	1	0.090	N	0	0.065	N	-2.47	0.890	D	-2.3	0.511	N	0.05	0.080	-0.787	0.559	T	0.356	0.719	T	0.062	0.688	D	-1.816	0.011	0.002	0.814	0.132	0.566	0.299	D	c	-1.319	-1.272	0.011	0.121	0.707	0.730	0	-4.0	0.038	1.156	0.311	-1.032	0.021	0.517	0.269	0.006	0.095	9.433	0.376	.	.	.	0.5	.	34	5	112175279	chr5:112175279	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	115168370	115168370	A	G	intronic	ATG12	.	.	.	0.001658071	0.699322448	0.299019481	.	0.10345	0.10587	0.147123112	64.11299835	58.06341	1.54097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	5	115168370	chr5:115168370	A	G	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	115628156	115628157	TA	-	exonic	COMMD10	.	frameshift deletion	COMMD10:NM_001308080:exon7:c.537_538del:p.I180Tfs*56,COMMD10:NM_016144:exon7:c.579_580del:p.I194Tfs*56	7.84E-06	0.301803272	0.698188891	.	0.2446	0.1102	0.193034296	66.82000472	893.61877	5.82649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	18	5	115628155	chr5:115628155	CTA	C	44	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	116052145	116052145	C	T	intergenic	SEMA6A-AS2;LINC02214	dist=105249;dist=26853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	147	5	116052145	chr5:116052145	C	T	101	PASS	DP=147;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	118309599	118309599	G	A	intronic	DTWD2	.	.	.	2.16E-05	0.484452633	0.515525762	.	0.17158	0.1149	-0.448125345	24.19202642	92.81718	2.06998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	142	5	118309599	chr5:118309599	G	A	113	PASS	DP=142;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	122139264	122139264	A	G	exonic	SNX2	.	nonsynonymous SNV	SNX2:NM_001278199:exon6:c.A248G:p.H83R,SNX2:NM_003100:exon6:c.A599G:p.H200R	0.997941242	0.002058746	1.25E-08	.	0.339	0.13169	-0.692458599	14.96815287	25.76147	0.83932	1.0	0.085	T	0.001	0.067	B	0.01	0.139	B	0.000	0.629	D	1.000	0.588	D	1.005	0.253	L	1.29	0.358	T	-1.11	0.383	N	0.464	0.519	-1.076	0.082	T	0.050	0.213	T	0.012	0.306	T	0.454	0.138	7.070	0.927	0.217	0.983	0.817	D	c	-0.333	-0.115	0.988	0.315	0.732	0.924	0	4.38	0.519	7.334	0.783	1.028	0.649	1.000	0.715	0.999	0.750	11.303	0.484	Phox homologous domain;Sorting nexin, N-terminal	.	.	0.5	74	47	5	122139264	chr5:122139264	A	G	74	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	122522921	122522921	G	C	UTR3	PRDM6	NM_001136239:c.*26G>C	.	.	.	.	.	.	0.32166	0.09864	.	.	3796.30099	12.08898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	97	5	122522921	chr5:122522921	G	C	72	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	122714059	122714059	C	T	exonic	CEP120	.	nonsynonymous SNV	CEP120:NM_001166226:exon15:c.G2089A:p.E697K,CEP120:NM_153223:exon16:c.G2167A:p.E723K	4.34E-11	0.982961028	0.017038972	DISEASE: Short-rib thoracic dysplasia 13 with or without polydactyly (SRTD13) [MIM:616300]: A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. {ECO:0000269|PubMed:25361962}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20235	.	0.007353605	54.12243454	6832.03941	17.5857	0.005	0.632	D	1.0	0.899	D	0.994	0.807	D	0.000	0.843	D	1.000	0.548	D	2.58	0.756	M	0.25	0.595	T	-2.77	0.598	D	0.92	0.911	-0.280	0.756	T	0.429	0.772	T	0.065	0.696	D	6.733	0.919	32	0.999	0.986	0.992	0.931	D	c	0.819	0.798	1.000	0.747	0.732	0.924	0	5.8	0.921	6.636	0.740	0.932	0.445	1.000	0.715	0.892	0.376	20.056	0.976	.	.	.	0.5	.	33	5	122714059	chr5:122714059	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	127593605	127593605	C	A	UTR3	FBN2	NM_001999:c.*1542G>T	.	.	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	229	5	127593605	chr5:127593605	C	A	128	PASS	DP=229;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	127872118	127872118	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C314A:p.P105H	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.001	0.784	D	0.999	0.764	D	0.935	0.653	D	0.000	0.629	D	1.000	0.810	D	1.78	0.463	L	-1.96	0.869	D	-4.83	0.925	D	0.729	0.731	0.262	0.869	D	0.632	0.871	D	0.066	0.699	D	5.064	0.682	25.2	0.997	0.831	0.959	0.665	D	c	0.540	0.639	1.0	0.983	0.726	0.872	0	5.32	0.753	9.898	0.986	1.048	0.713	1.000	0.715	0.999	0.750	19.186	0.936	.	.	.	0.5	.	84	5	127872118	chr5:127872118	G	T	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	127872119	127872119	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C313A:p.P105T	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.066	0.365	T	0.208	0.282	B	0.068	0.262	B	0.000	0.629	D	1.000	0.588	D	1.32	0.331	L	-1.91	0.865	D	-4.1	0.860	D	0.708	0.716	-0.381	0.726	T	0.382	0.739	T	0.040	0.595	D	3.058	0.427	22.4	0.998	0.861	0.821	0.411	D	c	-0.104	0.122	1.000	0.747	0.726	0.872	0	5.32	0.753	2.895	0.481	1.048	0.713	1.000	0.715	0.998	0.697	13.803	0.625	.	.	.	0.5	.	84	5	127872119	chr5:127872119	G	T	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	130727893	130727893	G	A	UTR3	CDC42SE2	NM_020240:c.*300G>A;NM_001038702:c.*300G>A	.	.	0.753728627	0.236652022	0.009619351	.	0.27557	0.12378	-0.09720619	46.20193442	1.83486	0.05767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	5	130727893	chr5:130727893	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	131822133	131822133	T	C	intronic	IRF1	.	.	.	0.867788618	0.132133586	7.78E-05	DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:10395927, ECO:0000269|PubMed:9679752}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.72337	0.11079	-0.007201372	53.19061099	4.5089	0.16359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	21	5	131822133	chr5:131822133	T	C	59	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	131940703	131940703	C	T	intronic	RAD50	.	.	.	3.45E-15	0.992354993	0.007645007	DISEASE: Nijmegen breakage syndrome-like disorder (NBSLD) [MIM:613078]: A disorder similar to Nijmegen breakage syndrome and characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, short stature and bird-like face. Immunodeficiency is absent. {ECO:0000269|PubMed:19409520}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75384	0.58646	-0.501537595	21.83887709	175.25604	2.87907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	5	131940703	chr5:131940703	C	T	.	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	133307751	133307751	A	-	UTR3	VDAC1	NM_003374:c.*711delT	.	.	0.975595138	0.024378689	2.62E-05	.	.	.	-0.295622497	32.61972163	24.73819	0.81167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	14	5	133307750	chr5:133307750	GA	G	42	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	133640116	133640199	TTTGACTGTATTGTGACAGGCAATTCTGGAAAATGGAATTCTTTCCTGTCAGATCTGGAAAAATTCAGCTTCCTTTTGTTCTCA	-	exonic	CDKL3	.	nonframeshift deletion	CDKL3:NM_001349366:exon6:c.633_716del:p.N211_S238del,CDKL3:NM_001349364:exon7:c.633_716del:p.N211_S238del,CDKL3:NM_001349365:exon7:c.633_716del:p.N211_S238del,CDKL3:NM_001349363:exon8:c.951_1034del:p.N317_S344del,CDKL3:NM_001300853:exon10:c.951_1034del:p.N317_S344del,CDKL3:NM_001113575:exon11:c.1518_1601del:p.N506_S533del	4.33E-07	0.600309182	0.399690385	.	0.18586	0.10438	0.328949044	73.41354093	99.29071	2.15668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	17	5	133640115	chr5:133640115	TTTTGACTGTATTGTGACAGGCAATTCTGGAAAATGGAATTCTTTCCTGTCAGATCTGGAAAAATTCAGCTTCCTTTTGTTCTCA	T	40	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	133707247	133707247	-	T	UTR5	UBE2B	NM_003337:c.-40_-39insT	.	.	0.320977559	0.662551081	0.01647136	.	0.5202	0.16306	0.013025609	54.62962963	1.48948	0.0507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	114	5	133707247	chr5:133707247	C	CT	94	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	133948392	133948392	C	T	exonic	SAR1B	.	nonsynonymous SNV	SAR1B:NM_016103:exon4:c.G233A:p.G78E,SAR1B:NM_001033503:exon5:c.G233A:p.G78E	0.006300416	0.910141255	0.083558329	.	0.4566	0.14201	-0.229483771	36.86010852	11.40907	0.41222	0.001	0.912	D	0.998	0.715	D	0.979	0.728	D	0.000	0.629	D	1	0.810	D	4.555	0.992	H	-5.54	0.992	D	-7.04	0.946	D	0.986	0.991	0.998	0.972	D	0.988	0.997	D	0.688	0.974	D	7.223	0.946	34	0.998	0.887	0.993	0.935	D	c	1.138	1.048	1.000	0.747	0.732	0.924	0	5.95	0.964	7.893	0.858	0.920	0.431	1.000	0.715	0.997	0.653	20.393	0.990	P-loop containing nucleoside triphosphate hydrolase;P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	69	654	5	133948392	chr5:133948392	C	T	69	PASS	DP=654;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	133948430	133948430	G	A	exonic	SAR1B	.	synonymous SNV	SAR1B:NM_016103:exon4:c.C195T:p.T65T,SAR1B:NM_001033503:exon5:c.C195T:p.T65T	0.006300416	0.910141255	0.083558329	.	0.4566	0.14201	-0.229483771	36.86010852	11.40907	0.41222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	613	5	133948430	chr5:133948430	G	A	72	PASS	DP=613;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	134041132	134041132	G	A	intronic	SEC24A	.	.	.	1.31E-05	0.999969557	1.73E-05	.	0.19793	0.09969	-1.058182374	7.554847841	248.85929	3.3989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	56	5	134041132	chr5:134041132	G	A	63	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	134116962	134116962	T	A	intronic	DDX46	.	.	.	0.999997754	2.25E-06	3.09E-17	.	0.71667	0.11044	-1.111360919	6.717386176	12.79601	0.46528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	5	134116962	chr5:134116962	T	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	136476334	136476334	G	A	exonic	SPOCK1	.	synonymous SNV	SPOCK1:NM_004598:exon4:c.C282T:p.H94H	0.320886445	0.678398903	0.000714652	.	0.28758	0.20627	-0.490397599	22.50530786	83.60687	1.94449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	5	136476334	chr5:136476334	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	137451461	137451461	A	-	intronic	NME5	.	.	.	0.570640716	0.417771698	0.011587586	.	0.16576	.	0.3032669	72.009908	28.15255	0.90228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	18	5	137451460	chr5:137451460	GA	G	42	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	137909423	137909424	AT	-	intronic	HSPA9	.	.	.	0.981119322	0.018880654	2.34E-08	.	0.62414	0.7341	-0.846787714	11.05803255	21.59412	0.72579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	104	5	137909422	chr5:137909422	GAT	G	72	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	138718854	138718854	C	T	intronic	SLC23A1	.	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	5	138718854	chr5:138718854	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	138718897	138718897	C	T	intronic	SLC23A1	.	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	84	5	138718897	chr5:138718897	C	T	67	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	138718948	138718948	G	A	UTR5	SLC23A1	NM_152685:c.-6C>T;NM_005847:c.-6C>T	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	0.502	0.077	T	.	.	.	.	.	.	.	.	.	1.000	0.201	N	.	.	.	.	.	.	0.64	0.024	N	0.1	0.103	-1.017	0.247	T	0.034	0.145	T	.	.	.	1.738	0.270	14.63	0.970	0.315	0.426	0.267	N	c	-0.372	-0.415	1.000	0.747	0.660	0.495	0	1.08	0.194	1.060	0.299	0.154	0.240	0.737	0.288	0.995	0.604	1.435	0.022	.	.	.	0.5	.	64	5	138718948	chr5:138718948	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	138718965	138718965	G	A	UTR5	SLC23A1	NM_152685:c.-23C>T;NM_005847:c.-23C>T	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	0.006	0.614	D	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	-0.66	0.191	N	0.064	0.049	-0.745	0.582	T	0.229	0.594	T	.	.	.	1.582	0.252	13.75	0.995	0.692	0.790	0.388	D	c	0.029	0.038	1.000	0.747	0.421	0.056	0	4.15	0.478	2.812	0.474	0.154	0.240	0.823	0.298	0.923	0.397	8.439	0.318	.	.	.	0.5	.	69	5	138718965	chr5:138718965	G	A	.	PASS	DP=69;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	139227250	139227250	T	-	UTR3	NRG2	NM_001184935:c.*252delA;NM_004883:c.*252delA;NM_013981:c.*252delA;NM_013982:c.*252delA;NM_013983:c.*252delA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	123	5	139227249	chr5:139227249	CT	C,CTT	74	PASS	DP=123;AN=4	GT	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
5	139227250	139227250	-	T	UTR3	NRG2	NM_001184935:c.*251_*252insA;NM_004883:c.*251_*252insA;NM_013981:c.*251_*252insA;NM_013982:c.*251_*252insA;NM_013983:c.*251_*252insA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	123	5	139227249	chr5:139227249	CT	C,CTT	74	PASS	DP=123;AN=4	GT	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
5	140080299	140080299	G	T	intronic	ZMAT2	.	.	.	0.97143376	0.028527624	3.86E-05	.	0.64216	0.11262	-0.031067188	51.03798066	2.53643	0.09383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	5	140080299	chr5:140080299	G	T	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	140165915	140165915	C	T	exonic	PCDHA1	.	synonymous SNV	PCDHA1:NM_018900:exon1:c.C40T:p.L14L,PCDHA1:NM_031410:exon1:c.C40T:p.L14L,PCDHA1:NM_031411:exon1:c.C40T:p.L14L	0.000559475	0.973083018	0.026357507	.	0.08763	.	0.213053688	67.54541165	435.99793	4.35381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	190	5	140165915	chr5:140165915	C	T	137	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	140167202	140167202	G	A	exonic	PCDHA1	.	nonsynonymous SNV	PCDHA1:NM_018900:exon1:c.G1327A:p.V443M,PCDHA1:NM_031410:exon1:c.G1327A:p.V443M,PCDHA1:NM_031411:exon1:c.G1327A:p.V443M	0.000559475	0.973083018	0.026357507	.	0.08763	.	0.213053688	67.54541165	435.99793	4.35381	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.002	0.371	U	0.856	0.284	N	3.335	0.911	M	-0.68	0.726	T	-2.76	0.605	D	0.633	0.674	-0.087	0.804	T	0.577	0.848	D	0.045	0.621	D	5.444	0.738	26.1	0.998	0.923	0.884	0.481	D	c	0.610	0.462	0.977	0.297	0.581	0.326	0	3.89	0.439	3.871	0.555	0.953	0.551	1.000	0.715	0.893	0.376	8.718	0.334	Cadherin|Cadherin conserved site|Cadherin-like	.	.	0.5	.	138	5	140167202	chr5:140167202	G	A	.	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	140182065	140182065	G	A	exonic	PCDHA3	.	nonsynonymous SNV	PCDHA3:NM_018906:exon1:c.G1283A:p.R428Q,PCDHA3:NM_031497:exon1:c.G1283A:p.R428Q	1.46E-13	0.013151602	0.986848398	.	0.09532	.	-0.676105878	15.40457655	903.22009	5.85119	0.183	0.217	T	0.242	0.323	B	0.069	0.374	B	0.030	0.253	U	1	0.090	N	1.37	0.343	L	0.65	0.527	T	-3.34	0.663	D	0.238	0.293	-1.046	0.154	T	0.069	0.284	T	0.017	0.392	T	3.203	0.444	22.7	0.990	0.503	0.048	0.104	N	c	-0.660	-0.632	0.408	0.202	0.615	0.372	0	2.92	0.329	-0.016	0.124	0.994	0.605	0.000	0.063	0.319	0.240	6.199	0.197	Cadherin|Cadherin-like	.	.	0.5	.	152	5	140182065	chr5:140182065	G	A	.	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	140201593	140201593	T	A	exonic	PCDHA5	.	nonsynonymous SNV	PCDHA5:NM_018908:exon1:c.T233A:p.L78Q,PCDHA5:NM_031501:exon1:c.T233A:p.L78Q	0.003538248	0.986919756	0.009541996	.	0.09837	.	0.100999032	60.76315169	773.98299	5.50488	0.037	0.430	D	0.899	0.475	P	0.59	0.486	P	.	.	.	1	0.810	D	1.725	0.447	L	1.17	0.379	T	-4.49	0.780	D	0.207	0.479	-0.972	0.369	T	0.107	0.389	T	0.053	0.654	D	4.407	0.590	24.1	0.992	0.538	0.397	0.260	N	c	-0.293	-0.357	0.374	0.199	0.517	0.208	0	2.83	0.320	-0.729	0.050	0.908	0.420	0.000	0.063	1.000	0.888	3.128	0.060	Cadherin|Cadherin, N-terminal|Cadherin-like	.	.	0.5	.	216	5	140201593	chr5:140201593	T	A	.	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	140237387	140237387	T	G	exonic	PCDHA10	.	nonsynonymous SNV	PCDHA10:NM_018901:exon1:c.T1754G:p.V585G,PCDHA10:NM_031859:exon1:c.T1754G:p.V585G	4.18E-11	0.050751807	0.949248193	.	.	0.10821	1.611214866	95.93064402	3823.87742	12.16143	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	.	.	.	1.000	0.090	P	0.385	0.122	N	1.15	0.382	T	4.7	0.000	N	0.055	0.037	-0.971	0.371	T	0.000	0.000	T	.	.	.	-2.348	0.004	0.001	0.491	0.041	0.007	0.029	N	c	-1.390	-1.327	0.000	0.029	0.615	0.372	0	1.7	0.232	0.685	0.249	0.049	0.161	0.001	0.137	0.014	0.122	0.359	0.003	Cadherin|Cadherin-like	ENSG00000196963.2|ENSG00000204963.4|ENSG00000204967.6|ENSG00000196963.2|ENSG00000204967.6|ENSG00000196963.2|ENSG00000239389.3|ENSG00000204963.4|ENSG00000239389.3|ENSG00000204961.5|ENSG00000239389.3|ENSG00000204961.5|ENSG00000113119.8|ENSG00000239389.3|ENSG00000204961.5|ENSG00000250120.2|ENSG00000239389.3|ENSG00000204961.5|ENSG00000250120.2|ENSG00000239389.3|ENSG00000239389.3|ENSG00000213523.5|ENSG00000113141.11|ENSG00000120322.2|ENSG00000196963.2|ENSG00000196963.2|ENSG00000196963.2|ENSG00000204963.4|ENSG00000239389.3|ENSG00000239389.3|ENSG00000239389.3|ENSG00000176087.10	Adipose_Subcutaneous|Adipose_Subcutaneous|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Anterior_cingulate_cortex_BA24|Brain_Anterior_cingulate_cortex_BA24|Brain_Caudate_basal_ganglia|Brain_Cerebellar_Hemisphere|Brain_Cerebellar_Hemisphere|Brain_Cerebellum|Brain_Cerebellum|Brain_Cerebellum|Brain_Cortex|Brain_Cortex|Brain_Cortex|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Frontal_Cortex_BA9|Brain_Nucleus_accumbens_basal_ganglia|Cells_Transformed_fibroblasts|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Heart_Atrial_Appendage|Lung|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Thyroid|Whole_Blood	0.5	52	34	5	140237387	chr5:140237387	T	G	52	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	140516367	140516367	A	T	exonic	PCDHB5	.	nonsynonymous SNV	PCDHB5:NM_015669:exon1:c.A1351T:p.T451S	9.45E-07	0.318857036	0.681142019	.	0.07466	.	0.273728691	70.74781788	486.05983	4.53925	0.209	0.197	T	0.012	0.151	B	0.023	0.188	B	.	.	.	1.000	0.090	N	-0.035	0.050	N	4.16	0.028	T	-3.1	0.635	D	0.068	0.055	-0.888	0.491	T	0.003	0.011	T	.	.	.	-0.483	0.056	0.242	0.814	0.132	0.108	0.160	N	c	-1.077	-0.949	0.002	0.087	0.706	0.609	0	0.773	0.176	-0.393	0.073	0.149	0.237	0.000	0.063	0.953	0.430	5.715	0.171	Cadherin|Cadherin-like	.	.	0.5	60	119	5	140516367	chr5:140516367	A	T	60	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	140554539	140554539	C	T	exonic	PCDHB7	.	nonsynonymous SNV	PCDHB7:NM_018940:exon1:c.C2123T:p.A708V	1.30E-15	0.000818546	0.999181454	.	0.10741	.	1.63326524	96.08398207	4489.23646	13.44872	0.269	0.161	T	0.906	0.480	P	0.422	0.433	B	.	.	.	1	0.090	N	2.3	0.659	M	2.41	0.155	T	-3.32	0.660	D	0.159	0.191	-1.032	0.199	T	0.064	0.264	T	0.010	0.269	T	3.220	0.446	22.7	0.994	0.610	0.064	0.123	N	c	-0.107	-0.274	0.013	0.125	0.581	0.326	0	1.57	0.224	-0.928	0.041	-0.161	0.107	0.000	0.063	0.295	0.236	5.006	0.135	Cadherin, cytoplasmic C-terminal domain	.	.	0.5	87	1523	5	140554539	chr5:140554539	C	T	87	PASS	DP=1523;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	140559679	140559679	C	G	exonic	PCDHB8	.	synonymous SNV	PCDHB8:NM_019120:exon1:c.C2064G:p.T688T	4.80E-08	0.117922549	0.882077403	.	0.03421	.	2.739661384	98.96201934	8920.76586	20.40904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	77	5	140559679	chr5:140559679	C	G	61	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	140563616	140563616	G	A	exonic	PCDHB16	.	synonymous SNV	PCDHB16:NM_020957:exon1:c.G1482A:p.Q494Q	0.001770815	0.897216857	0.101012328	.	0.07988	0.19766	1.072886248	91.70794999	8831.34731	20.28873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	311	5	140563616	chr5:140563616	G	A	.	PASS	DP=311;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	140590171	140590171	G	T	exonic	PCDHB12	.	synonymous SNV	PCDHB12:NM_018932:exon1:c.G1692T:p.P564P	0.000155402	0.669826242	0.330018356	.	0.04439	.	2.476806522	98.62585515	2834.29925	10.05542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	627	5	140590171	chr5:140590171	G	T	98	PASS	DP=627;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	140590766	140590766	A	G	exonic	PCDHB12	.	nonsynonymous SNV	PCDHB12:NM_018932:exon1:c.A2287G:p.K763E	0.000155402	0.669826242	0.330018356	.	0.04439	.	2.476806522	98.62585515	2834.29925	10.05542	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	0.999	0.215	P	-3.455	0.000	N	2.72	0.120	T	3.46	0.001	N	0.028	0.021	-0.952	0.407	T	0.000	0.000	T	.	.	.	-0.381	0.063	0.429	0.487	0.040	0.026	0.071	N	c	-1.510	-1.264	0.487	0.208	0.534	0.214	0	3.13	0.349	5.514	0.665	-0.079	0.119	1.000	0.715	0.002	0.062	9.497	0.380	Cadherin, cytoplasmic C-terminal domain;Cadherin|Cadherin-like	ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000146001.4|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000196963.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000120322.2|ENSG00000253159.1|ENSG00000120322.2|ENSG00000113212.4|ENSG00000120327.4|ENSG00000120322.2	Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Coronary|Artery_Tibial|Brain_Cortex|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Esophagus_Gastroesophageal_Junction|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Lung|Nerve_Tibial|Pancreas|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis|Testis|Thyroid	0.5	55	22	5	140590766	chr5:140590766	A	G	55	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	140615413	140615413	C	G	ncRNA_exonic	PCDHB18P	.	.	.	.	.	.	.	0.0684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	56	5	140615413	chr5:140615413	C	G	71	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	141312733	141312733	G	A	intronic	KIAA0141	.	.	.	3.06E-10	0.281915895	0.718084105	.	0.04807	.	0.69078985	85.23826374	2730.37291	9.84899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	5	141312733	chr5:141312733	G	A	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	145508515	145508515	-	A	intronic	LARS	.	.	.	2.27E-05	0.999976973	3.23E-07	DISEASE: Infantile liver failure syndrome 1 (ILFS1) [MIM:615438]: A life-threatening disorder of hepatic function that manifests with acute liver failure in the first few months of life. Clinical features include anemia, renal tubulopathy, developmental delay, seizures, failure to thrive, and liver steatosis and fibrosis. {ECO:0000269|PubMed:22607940}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.76027	.	-0.437212558	24.67563105	3699.75044	11.85134	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	13	5	145508515	chr5:145508515	T	TA	50	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	147162132	147162132	-	T	UTR5	JAKMIP2	NM_014790:c.-110764_-110763insA;NM_001270934:c.-110764_-110763insA;NM_001282282:c.-112_-111insA;NM_001270941:c.-110764_-110763insA	.	.	0.999936528	6.35E-05	1.06E-13	.	0.66287	0.12537	-1.199555187	5.761972163	105.04961	2.21693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	120	5	147162132	chr5:147162132	G	GT	66	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	147474010	147474010	C	T	exonic	SPINK5	.	nonsynonymous SNV	SPINK5:NM_001127698:exon9:c.C760T:p.H254Y,SPINK5:NM_001127699:exon9:c.C760T:p.H254Y,SPINK5:NM_006846:exon9:c.C760T:p.H254Y	2.12E-17	0.920781311	0.079218689	DISEASE: Netherton syndrome (NETH) [MIM:256500]: An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration. {ECO:0000269|PubMed:10835624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2529	0.29285	2.831581484	99.08586931	18873.47781	29.29597	0.136	0.457	T	0.541	0.493	P	0.434	0.676	B	0.000	0.537	D	0.761	0.295	N	0.845	0.213	L	5.14	0.012	T	0.8	0.033	N	0.797	0.787	-0.977	0.357	T	0.008	0.028	T	0.015	0.353	T	5.885	0.807	27.4	0.991	0.520	0.696	0.340	D	c	0.041	0.153	0.999	0.390	0.615	0.372	0	5.04	0.672	2.764	0.470	0.852	0.362	1.000	0.715	1.000	0.888	14.256	0.655	Kazal domain	.	.	0.5	.	38	5	147474010	chr5:147474010	C	T	.	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	147504305	147504305	-	T	intronic	SPINK5	.	.	.	2.12E-17	0.920781311	0.079218689	DISEASE: Netherton syndrome (NETH) [MIM:256500]: An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration. {ECO:0000269|PubMed:10835624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2529	0.29285	2.831581484	99.08586931	18873.47781	29.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	81	5	147504305	chr5:147504305	C	CT	63	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	148386525	148386525	T	G	exonic	SH3TC2	.	synonymous SNV	SH3TC2:NM_024577:exon16:c.A3594C:p.P1198P	1.73E-12	0.792013075	0.207986925	DISEASE: Mononeuropathy of the median nerve mild (MNMN) [MIM:613353]: A disease characterized by median nerve mononeuropathy at the wrist. The clinical presentation ranges from a mild phenotype, consistent with carpal tunnel syndrome, to a severe median nerve mononeuropathy at the wrist associated with evidence of a more widespread axonal polyneuropathy. The latter phenotype is similar to that of patients with hereditary neuropathy with liability to pressure palsies. {ECO:0000269|PubMed:20220177}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13415	0.13877	0.018271026	55.22528898	877.38282	5.76827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	12	5	148386525	chr5:148386525	T	G	42	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	148579955	148579955	G	A	exonic	ABLIM3	.	nonsynonymous SNV	ABLIM3:NM_001301015:exon4:c.G412A:p.A138T,ABLIM3:NM_001301028:exon4:c.G412A:p.A138T,ABLIM3:NM_001345861:exon4:c.G412A:p.A138T,ABLIM3:NM_001301018:exon5:c.G412A:p.A138T,ABLIM3:NM_001301027:exon5:c.G436A:p.A146T,ABLIM3:NM_001345858:exon5:c.G412A:p.A138T,ABLIM3:NM_001345859:exon5:c.G412A:p.A138T,ABLIM3:NM_001345860:exon5:c.G412A:p.A138T,ABLIM3:NM_014945:exon5:c.G412A:p.A138T	0.016025349	0.983972836	1.82E-06	.	0.44749	0.10843	-1.150005948	6.286860109	169.47144	2.84089	0.42	0.098	T	0.0	0.026	B	0.0	0.063	B	0.002	0.382	N	0.997	0.228	N	-0.41	0.029	N	1.01	0.411	T	-0.03	0.095	N	0.019	0.080	-1.024	0.224	T	0.032	0.139	T	0.005	0.112	T	1.796	0.277	14.96	0.946	0.246	0.611	0.311	D	c	-0.602	-0.377	1.000	0.458	0.646	0.442	0	2.54	0.295	2.231	0.424	-0.513	0.050	1.000	0.715	0.995	0.604	4.614	0.117	Zinc finger, LIM-type	.	.	0.5	.	48	5	148579955	chr5:148579955	G	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	148683326	148683335	GAAATTAATA	-	intronic	AFAP1L1	.	.	.	4.07E-08	0.986445947	0.013554012	.	0.09622	0.10351	-0.124924535	44.10238264	344.87064	3.93917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.09	19	5	148683325	chr5:148683325	GGAAATTAATA	G	11.09	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	148999881	148999881	-	C	intronic	ARHGEF37	.	.	.	1.08E-13	0.021156722	0.978843278	.	.	.	1.183126933	92.82849729	8667.38708	20.12571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	14	5	148999881	chr5:148999881	G	GC	44	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	149473843	149473843	-	T	intronic	CSF1R	.	.	.	0.993497648	0.00650235	1.71E-09	DISEASE: Note=Aberrant expression of CSF1 or CSF1R can promote cancer cell proliferation, invasion and formation of metastases. Overexpression of CSF1 or CSF1R is observed in a significant percentage of breast, ovarian, prostate, and endometrial cancers.; DISEASE: Note=Aberrant expression of CSF1 or CSF1R may play a role in inflammatory diseases, such as rheumatoid arthritis, glomerulonephritis, atherosclerosis, and allograft rejection.; DISEASE: Leukoencephalopathy, diffuse hereditary, with spheroids (HDLS) [MIM:221820]: An autosomal dominant adult-onset rapidly progressive neurodegenerative disorder characterized by variable behavioral, cognitive, and motor changes. Patients often die of dementia within 6 years of onset. Brain imaging shows patchy abnormalities in the cerebral white matter, predominantly affecting the frontal and parietal lobes. {ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:24532199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42433	0.52469	0.609894095	82.95588582	987.59415	6.06031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	197	5	149473843	chr5:149473843	G	GT	71	PASS	DP=197;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	149599129	149599131	CCG	-	UTR3	CAMK2A	NM_171825:c.*3144_*3142delCGG;NM_015981:c.*3144_*3142delCGG	.	.	0.998004221	0.001995777	2.34E-09	.	0.6957	0.38769	-0.538132194	20.26421326	1.83486	0.0579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	96	5	149599128	chr5:149599128	CCCG	C	98	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	149599293	149599293	T	C	UTR3	CAMK2A	NM_171825:c.*2980A>G;NM_015981:c.*2980A>G	.	.	0.998004221	0.001995777	2.34E-09	.	0.6957	0.38769	-0.538132194	20.26421326	1.83486	0.0579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	5	149599293	chr5:149599293	T	C	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	149678006	149678006	G	T	exonic	ARSI	.	nonsynonymous SNV	ARSI:NM_001012301:exon2:c.C481A:p.R161S	1.05E-09	0.089882668	0.910117331	.	0.1223	0.15805	-1.03976177	7.802547771	156.19896	2.73165	0.162	0.248	T	0.26	0.298	B	0.233	0.367	B	0.000	0.843	D	1	0.810	D	0.73	0.189	N	-3.93	0.961	D	-2.07	0.563	N	0.903	0.909	0.380	0.888	D	0.743	0.912	D	0.099	0.772	D	3.232	0.448	22.8	0.992	0.537	0.953	0.641	D	c	-0.022	0.130	1.000	0.747	0.615	0.372	0	4.58	0.559	4.886	0.626	0.953	0.551	1.000	0.715	0.998	0.697	17.591	0.878	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain|Sulfatase, N-terminal	.	.	0.5	.	90	5	149678006	chr5:149678006	G	T	.	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	149755744	149755744	G	C	exonic	TCOF1	.	nonsynonymous SNV	TCOF1:NM_000356:exon12:c.G1762C:p.A588P,TCOF1:NM_001135245:exon12:c.G1762C:p.A588P,TCOF1:NM_001008657:exon13:c.G1993C:p.A665P,TCOF1:NM_001135243:exon13:c.G1993C:p.A665P,TCOF1:NM_001135244:exon13:c.G1993C:p.A665P,TCOF1:NM_001195141:exon13:c.G1993C:p.A665P	0.765232863	0.234767111	2.59E-08	DISEASE: Treacher Collins syndrome 1 (TCS1) [MIM:154500]: A form of Treacher Collins syndrome, a disorder of craniofacial development. Treacher Collins syndrome is characterized by a combination of bilateral downward slanting of the palpebral fissures, colobomas of the lower eyelids with a paucity of eyelashes medial to the defect, hypoplasia of the facial bones, cleft palate, malformation of the external ears, atresia of the external auditory canals, and bilateral conductive hearing loss. {ECO:0000269|PubMed:9042910}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11725	0.19531	0.466523353	78.69780609	3192.10978	10.76481	0.053	0.574	T	1.0	0.899	D	0.986	0.916	D	0.140	0.183	N	1.000	0.210	P	1.6	0.409	L	-0.52	0.707	T	-3.25	0.652	D	0.263	0.331	-0.797	0.553	T	0.033	0.140	T	.	.	.	2.841	0.402	21.6	0.993	0.601	0.462	0.275	N	c	-0.285	-0.468	0.999	0.380	0.707	0.730	0	1.85	0.243	0.260	0.181	0.017	0.142	0.595	0.275	0.003	0.074	3.913	0.086	Treacher Collins syndrome, treacle	.	.	0.5	43	10	5	149755744	chr5:149755744	G	C	43	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	149763305	149763305	A	G	exonic	TCOF1	.	nonsynonymous SNV	TCOF1:NM_001008657:exon18:c.A2864G:p.Q955R	0.765232863	0.234767111	2.59E-08	DISEASE: Treacher Collins syndrome 1 (TCS1) [MIM:154500]: A form of Treacher Collins syndrome, a disorder of craniofacial development. Treacher Collins syndrome is characterized by a combination of bilateral downward slanting of the palpebral fissures, colobomas of the lower eyelids with a paucity of eyelashes medial to the defect, hypoplasia of the facial bones, cleft palate, malformation of the external ears, atresia of the external auditory canals, and bilateral conductive hearing loss. {ECO:0000269|PubMed:9042910}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11725	0.19531	0.466523353	78.69780609	3192.10978	10.76481	0.023	0.481	D	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	.	.	.	-1.62	0.824	D	-0.03	0.075	N	0.189	0.231	-0.989	0.328	T	0.000	0.000	T	.	.	.	-0.207	0.075	1.063	0.465	0.037	0.010	0.038	N	c	-1.201	-1.438	0.869	0.254	0.563	0.310	0	-4.27	0.035	-0.935	0.040	-0.842	0.029	0.000	0.063	0.000	0.016	1.273	0.019	.	ENSG00000196743.4	Skin_Sun_Exposed_Lower_leg	0.5	65	40	5	149763305	chr5:149763305	A	G	65	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	150646278	150646278	T	-	intronic	GM2A	.	.	.	0.111186455	0.777402352	0.111411193	DISEASE: GM2-gangliosidosis AB (GM2GAB) [MIM:272750]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. It is characterized by GM2 gangliosides accumulation in the presence of both normal hexosaminidase A and B. {ECO:0000269|PubMed:1915858, ECO:0000269|PubMed:8244332, ECO:0000269|PubMed:8900233}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26723	0.19354	0.681699246	84.93158764	326.06898	3.83913	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	224	5	150646277	chr5:150646277	AT	A	53	PASS	DP=224;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	151180401	151180401	G	T	exonic	G3BP1	.	stopgain	G3BP1:NM_005754:exon11:c.G1165T:p.E389X,G3BP1:NM_198395:exon11:c.G1165T:p.E389X	0.988390764	0.011609063	1.73E-07	.	0.91724	0.16278	-0.361761279	28.6329323	35.68074	1.07372	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.690	0.997	47	0.997	0.833	0.994	0.953	D	c	1.242	1.102	1.000	0.747	0.719	0.830	0	5.54	0.828	9.219	0.943	1.048	0.713	1.000	0.715	1.000	0.888	19.502	0.951	Nucleotide-binding alpha-beta plait domain|RNA recognition motif domain	.	.	0.5	.	30	5	151180401	chr5:151180401	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	154169883	154169883	A	G	splicing	LARP1	NM_015315:exon2:c.206-2A>G	.	.	0.999952189	4.78E-05	5.32E-14	.	0.27569	0.0905	-1.350267166	4.600141543	57.4938	1.52959	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.357	0.583	24.1	0.995	0.685	0.998	0.994	D	c	1.065	0.893	1.000	0.747	0.257	0.036	0	5.39	0.775	7.727	0.837	1.199	0.960	1.000	0.715	0.907	0.385	15.442	0.748	.	.	.	0.5	65	58	5	154169883	chr5:154169883	A	G	65	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	156945760	156945760	G	A	intronic	ADAM19	.	.	.	4.20E-06	0.999906953	8.88E-05	.	0.71514	0.13137	0.918552705	89.5730125	5188.76456	14.82439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	124	5	156945760	chr5:156945760	G	A	58	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	158585721	158585721	G	T	exonic	RNF145	.	nonsynonymous SNV	RNF145:NM_001199380:exon11:c.C2039A:p.P680H,RNF145:NM_001199381:exon11:c.C2000A:p.P667H,RNF145:NM_001199382:exon11:c.C1991A:p.P664H,RNF145:NM_001199383:exon11:c.C1949A:p.P650H,RNF145:NM_144726:exon11:c.C2033A:p.P678H	0.663621979	0.336332443	4.56E-05	.	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	0.008	0.586	D	0.07	0.343	B	0.112	0.363	B	0.510	0.118	N	1	0.090	N	0.55	0.145	N	-1.36	0.801	T	-1.41	0.348	N	0.225	0.333	-0.779	0.564	T	0.270	0.641	T	0.078	0.731	D	1.234	0.214	11.92	0.941	0.236	0.152	0.186	N	c	-0.806	-0.840	1.000	0.747	0.707	0.730	0	-0.886	0.100	0.602	0.237	1.048	0.713	0.000	0.063	0.030	0.147	6.835	0.230	.	.	.	0.5	131	301	5	158585721	chr5:158585721	G	T	131	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	158585960	158585960	G	A	exonic	RNF145	.	synonymous SNV	RNF145:NM_001199380:exon11:c.C1800T:p.T600T,RNF145:NM_001199381:exon11:c.C1761T:p.T587T,RNF145:NM_001199382:exon11:c.C1752T:p.T584T,RNF145:NM_001199383:exon11:c.C1710T:p.T570T,RNF145:NM_144726:exon11:c.C1794T:p.T598T	0.663621979	0.336332443	4.56E-05	.	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	446	5	158585960	chr5:158585960	G	A	133	PASS	DP=446;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	159766443	159766443	T	C	intergenic	CCNJL;C1QTNF2	dist=26836;dist=8332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	90	5	159766443	chr5:159766443	T	C	62	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	167545508	167545508	C	T	intronic	TENM2	.	.	.	0.99995109	4.89E-05	9.42E-17	.	0.25516	.	.	.	688.9914	5.23649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	82	5	167545508	chr5:167545508	C	T	.	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	168044019	168044019	C	-	intergenic	PANK3;SLIT3	dist=37405;dist=44719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	211	5	168044018	chr5:168044018	GC	G	84	PASS	DP=211;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	168137995	168137995	C	A	exonic	SLIT3	.	nonsynonymous SNV	SLIT3:NM_001271946:exon25:c.G2624T:p.G875V,SLIT3:NM_003062:exon25:c.G2624T:p.G875V	0.991788384	0.008211616	4.20E-14	.	0.82846	0.13042	-2.196075097	1.374144845	779.81909	5.52544	0.015	0.546	D	0.981	0.577	D	0.938	0.656	D	0.000	0.843	D	1	0.810	D	2.075	0.572	M	-0.99	0.759	T	-5.58	0.867	D	0.854	0.888	0.185	0.857	D	0.561	0.841	D	0.097	0.767	D	6.759	0.922	32	0.998	0.882	0.975	0.747	D	c	0.699	0.649	0.999	0.399	0.554	0.283	0	4.8	0.610	4.939	0.630	0.935	0.490	1.000	0.715	0.986	0.517	18.416	0.905	Cysteine-rich flanking region, C-terminal|Leucine-rich repeat domain, L domain-like	.	.	0.5	.	113	5	168137995	chr5:168137995	C	A	.	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	168201337	168201337	G	C	exonic	SLIT3	.	nonsynonymous SNV	SLIT3:NM_001271946:exon13:c.C1198G:p.Q400E,SLIT3:NM_003062:exon13:c.C1198G:p.Q400E	0.991788384	0.008211616	4.20E-14	.	0.82846	0.13042	-2.196075097	1.374144845	779.81909	5.52544	0.01	0.564	D	0.238	0.362	B	0.102	0.380	B	0.000	0.843	D	1.000	0.588	D	0.67	0.164	N	1.87	0.241	T	-1.46	0.358	N	0.54	0.701	-1.094	0.049	T	0.066	0.272	T	0.011	0.283	T	2.479	0.359	19.33	0.987	0.441	0.982	0.804	D	c	0.275	0.425	1.000	0.439	0.554	0.246	0	5.5	0.813	7.813	0.845	1.048	0.713	1.000	0.715	0.913	0.390	19.431	0.947	Leucine-rich repeat domain, L domain-like	.	.	0.5	96	81	5	168201337	chr5:168201337	G	C	96	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	171710717	171710719	CCG	-	UTR5	UBTD2	NM_152277:c.-48_-50delCGG	.	.	0.748758502	0.241081607	0.010159892	.	0.39637	0.11262	0.125076652	62.7388535	49.28609	1.37266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	9	5	171710716	chr5:171710716	CCCG	C	43	PASS	DP=9;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	171763533	171763533	-	T	UTR3	SH3PXD2B	NM_001017995:c.*1839_*1840insA	.	.	0.018536793	0.981286619	0.000176588	DISEASE: Frank-Ter Haar syndrome (FTHS) [MIM:249420]: A syndrome characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones and flexion deformity of the fingers. {ECO:0000269|PubMed:20137777}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26216	0.10532	-0.279250919	33.56923803	389.35486	4.15627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	32	5	171763533	chr5:171763533	G	GT	50	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	172578610	172578610	-	T	exonic	BNIP1	.	frameshift insertion	BNIP1:NM_013979:exon3:c.220dupT:p.K77fs*0,BNIP1:NM_013980:exon3:c.220dupT:p.K77fs*0	0.001436928	0.871526967	0.127036106	.	0.26308	0.14515	-0.115612493	45.12856806	26.59592	0.86174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	21	5	172578610	chr5:172578610	A	AT	41	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	175792720	175792720	G	T	exonic	ARL10	.	nonsynonymous SNV	ARL10:NM_001317948:exon1:c.G154T:p.A52S,ARL10:NM_173664:exon1:c.G154T:p.A52S	4.90E-05	0.425964378	0.573986583	.	0.34084	.	-0.05129383	49.75819769	24.49093	0.80498	0.721	0.039	T	0.008	0.151	B	0.011	0.145	B	0.969	0.082	N	1	0.090	N	0.205	0.094	N	0.18	0.604	T	0.14	0.054	N	0.125	0.141	-1.017	0.246	T	0.096	0.361	T	0.739	0.979	D	-1.053	0.030	0.012	0.913	0.200	0.031	0.079	N	c	-1.241	-1.206	1.000	0.747	0.564	0.319	0	2.2	0.268	0.598	0.236	-0.044	0.124	0.000	0.063	0.526	0.275	8.926	0.346	.	.	.	0.5	76	87	5	175792720	chr5:175792720	G	T	76	PASS	DP=87;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	175824557	175824557	C	G	intronic	CLTB	.	.	.	0.11549246	0.85740865	0.02709889	.	0.42524	0.24613	-0.229483771	36.86010852	6.86616	0.25469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	426	5	175824557	chr5:175824557	C	G	96	PASS	DP=426;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	175957157	175957157	C	T	exonic	RNF44	.	synonymous SNV	RNF44:NM_014901:exon7:c.G852A:p.L284L	0.567929658	0.431553355	0.000516987	.	0.35919	.	-0.179930907	40.35739561	104.3157	2.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	5	175957157	chr5:175957157	C	T	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	175957163	175957163	G	A	exonic	RNF44	.	synonymous SNV	RNF44:NM_014901:exon7:c.C846T:p.Y282Y	0.567929658	0.431553355	0.000516987	.	0.35919	.	-0.179930907	40.35739561	104.3157	2.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	5	175957163	chr5:175957163	G	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	176636551	176636551	-	A	intronic	NSD1	.	.	.	0.999999999	8.21E-10	2.66E-26	DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. {ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NUP98.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in an adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into NSD1 generates a NUP98-NSD1 fusion product. {ECO:0000269|PubMed:15382262}.; 	0.66088	0.2415	-1.552781294	3.237791932	2326.46017	8.93558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	150	5	176636550	chr5:176636550	TA	TAA,T	58	PASS	DP=150;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/2	./.	./.	./.
5	176636551	176636551	A	-	intronic	NSD1	.	.	.	0.999999999	8.21E-10	2.66E-26	DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. {ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NUP98.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in an adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into NSD1 generates a NUP98-NSD1 fusion product. {ECO:0000269|PubMed:15382262}.; 	0.66088	0.2415	-1.552781294	3.237791932	2326.46017	8.93558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	150	5	176636550	chr5:176636550	TA	TAA,T	58	PASS	DP=150;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/2	./.	./.	./.
5	176759027	176759027	-	A	UTR3	LMAN2	NM_006816:c.*59_*60insT	.	.	0.0500443	0.927871421	0.022084279	.	0.12943	0.14229	-0.754958418	13.57631517	88.77601	2.02091	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	83	5	176759027	chr5:176759027	T	TA	72	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	176883771	176883771	T	A	UTR3	DBN1	NM_080881:c.*663A>T;NM_004395:c.*663A>T	.	.	0.962685619	0.037313758	6.23E-07	.	0.24114	0.19461	-0.086288664	47.11606511	845.8418	5.68937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	5	176883771	chr5:176883771	T	A	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	176930231	176930231	C	G	exonic	DOK3	.	nonsynonymous SNV	DOK3:NM_001144876:exon5:c.G502C:p.E168Q,DOK3:NM_001144875:exon6:c.G808C:p.E270Q	7.28E-05	0.743816689	0.256110523	.	0.16443	0.09799	-0.08265057	47.20452937	503.42172	4.60415	0.0	0.912	D	0.914	0.518	P	0.483	0.517	P	.	.	.	1	0.090	N	.	.	.	0.63	0.542	T	-0.4	0.138	N	0.022	0.005	-1.059	0.120	T	0.099	0.369	T	0.010	0.268	T	0.367	0.129	6.323	0.993	0.574	0.067	0.126	N	c	-0.725	-0.837	1.000	0.747	0.722	0.854	0	2.4	0.284	-0.378	0.074	0.461	0.278	0.000	0.063	0.005	0.090	8.393	0.315	IRS-type PTB domain|PH domain-like;PH domain-like|Pleckstrin homology domain	.	.	0.5	108	102	5	176930231	chr5:176930231	C	G	108	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	177099140	177099140	T	A	ncRNA_exonic	LOC202181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	178	5	177099140	chr5:177099140	T	A	137	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	177987759	177987759	A	-	intronic	COL23A1	.	.	.	9.57E-10	0.90264393	0.097356069	.	0.07258	0.08141	0.75875178	86.82472281	1444.11081	7.08807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	85	5	177987758	chr5:177987758	GA	G,GAA	70	PASS	DP=85;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/2
5	177987759	177987759	-	A	intronic	COL23A1	.	.	.	9.57E-10	0.90264393	0.097356069	.	0.07258	0.08141	0.75875178	86.82472281	1444.11081	7.08807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	85	5	177987758	chr5:177987758	GA	G,GAA	70	PASS	DP=85;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/2
5	178580562	178580562	G	A	exonic	ADAMTS2	.	nonsynonymous SNV	ADAMTS2:NM_014244:exon9:c.C1445T:p.P482L,ADAMTS2:NM_021599:exon9:c.C1445T:p.P482L	0.992213475	0.007786524	5.38E-10	DISEASE: Ehlers-Danlos syndrome 7C (EDS7C) [MIM:225410]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by extremely fragile tissues, hyperextensible skin and easy bruising. Facial skin contains numerous folds, as in the cutis laxa syndrome. {ECO:0000269|PubMed:10417273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.33346	0.31484	-1.800772772	2.217504128	5065.97781	14.58177	0.068	0.359	T	1.0	0.899	D	0.999	0.916	D	0.000	0.559	D	1	0.810	D	3.375	0.916	M	-0.34	0.685	T	-9.61	0.988	D	0.831	0.819	0.475	0.902	D	0.599	0.857	D	0.175	0.851	D	6.789	0.924	32	0.999	0.933	0.986	0.839	D	c	0.903	0.788	1.000	0.747	0.706	0.609	0	4.58	0.559	9.750	0.981	0.953	0.551	1.000	0.715	0.958	0.437	16.743	0.853	Metallopeptidase, catalytic domain	.	.	0.5	58	59	5	178580562	chr5:178580562	G	A	58	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
5	179041835	179041835	C	T	UTR3	HNRNPH1	NM_005520:c.*126G>A;NM_001257293:c.*126G>A	.	.	0.999148294	0.000851699	7.16E-09	.	0.83563	.	-0.273576253	33.97027601	18.26126	0.63463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	5	179041835	chr5:179041835	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	179150789	179150789	T	-	intronic	CANX	.	.	.	0.86247386	0.137522598	3.54E-06	.	0.78419	0.89499	-0.159704656	41.90846898	163.62404	2.79331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	40	5	179150788	chr5:179150788	GT	G,GTT	55	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	179150789	179150789	-	T	intronic	CANX	.	.	.	0.86247386	0.137522598	3.54E-06	.	0.78419	0.89499	-0.159704656	41.90846898	163.62404	2.79331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	40	5	179150788	chr5:179150788	GT	G,GTT	55	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	179762959	179762959	T	-	intronic	GFPT2	.	.	.	6.63E-07	0.993862342	0.006136996	.	0.72946	0.28603	-0.819281839	11.93677754	1696.47592	7.59462	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.37	29	5	179762958	chr5:179762958	AT	A	13.37	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	180055849	180055849	T	G	intronic	FLT4	.	.	.	0.999936679	6.33E-05	4.32E-15	DISEASE: Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:10856194, ECO:0000269|PubMed:16924388, ECO:0000269|PubMed:16965327, ECO:0000269|PubMed:17458866, ECO:0000269|PubMed:19289394, ECO:0000269|PubMed:26091405, ECO:0000269|PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.; 	0.19958	0.23555	0.707220641	85.53314461	835.41804	5.65903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	176	5	180055849	chr5:180055849	T	G	149	PASS	DP=176;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	2955802	2955802	T	C	exonic	SERPINB6	.	nonsynonymous SNV	SERPINB6:NM_001271822:exon3:c.A310G:p.M104V,SERPINB6:NM_001271823:exon3:c.A325G:p.M109V,SERPINB6:NM_001271824:exon3:c.A268G:p.M90V,SERPINB6:NM_001271825:exon3:c.A268G:p.M90V,SERPINB6:NM_001297699:exon3:c.A268G:p.M90V,SERPINB6:NM_001297700:exon3:c.A268G:p.M90V,SERPINB6:NM_004568:exon3:c.A268G:p.M90V,SERPINB6:NM_001195291:exon4:c.A280G:p.M94V	0.035668799	0.92837158	0.035959621	.	0.58499	.	-0.135838822	43.77211607	187.82392	2.97536	1.0	0.010	T	0.0	0.026	B	0.004	0.093	B	0.040	0.241	N	1	0.090	P	0.67	0.164	N	-1.79	0.838	D	0.35	0.038	N	0.063	0.320	-1.064	0.109	T	0.103	0.379	T	.	.	.	-0.718	0.044	0.066	0.393	0.027	0.237	0.220	N	c	-1.024	-0.932	0.999	0.380	0.707	0.730	0	3.8	0.427	2.232	0.424	1.061	0.807	0.033	0.204	0.018	0.130	9.206	0.363	Serpin domain	ENSG00000224846.1|ENSG00000124570.13|ENSG00000224846.1|ENSG00000124570.13|ENSG00000124588.15|ENSG00000224846.1|ENSG00000224846.1	Brain_Cerebellum|Nerve_Tibial|Pancreas|Skin_Sun_Exposed_Lower_leg|Thyroid|Thyroid|Whole_Blood	0.5	44	19	6	2955802	chr6:2955802	T	C	44	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	3157731	3157731	C	G	UTR5	TUBB2A	NM_001310315:c.-2552G>C;NM_001069:c.-34G>C	.	.	.	.	.	DISEASE: Cortical dysplasia, complex, with other brain malformations 5 (CDCBM5) [MIM:615763]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Clinical features include seizures, global developmental delay, and various brain malformations such as a diffuse simplified gyral pattern with reduced volume of white matter, globular basal ganglia, thin and dysmorphic corpus callosum, mild brainstem hypoplasia with a flat pons, mild cerebellar vermis hypoplasia, and mildly enlarged posterior fossa. {ECO:0000269|PubMed:24702957}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87839	0.33588	-0.119252484	44.53880632	2.40691	0.08385	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	276	6	3157731	chr6:3157731	C	G	124	PASS	DP=276;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	3224825	3224825	A	-	UTR3	TUBB2B	NM_178012:c.*160delT	.	.	.	.	.	DISEASE: Polymicrogyria, symmetric or asymmetric (PMGYSA) [MIM:610031]: A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization. {ECO:0000269|PubMed:19465910}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72371	0.27035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	21	6	3224824	chr6:3224824	GA	G	89	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	4079928	4079928	C	G	intronic	C6orf201	.	.	.	0.092248285	0.766851936	0.14089978	.	0.10331	.	1.414757139	94.83958481	1518.5566	7.24416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	156	6	4079928	chr6:4079928	C	G	96	PASS	DP=156;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	5000752	5000752	-	T	intronic	RPP40	.	.	.	0.002577208	0.932656444	0.064766348	.	0.09601	0.09999	0.52918614	80.81505072	902.88839	5.84863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	28	6	5000752	chr6:5000752	A	AT	50	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	7410735	7410735	-	T	intronic	RIOK1	.	.	.	8.14E-07	0.909984901	0.090014285	.	0.07427	0.09451	0.778977686	87.21396556	153.59995	2.71046	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	15	6	7410735	chr6:7410735	G	GT	51	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	10410424	10410424	G	A	exonic	TFAP2A	.	nonsynonymous SNV	TFAP2A:NM_001032280:exon2:c.C172T:p.P58S,TFAP2A:NM_001042425:exon2:c.C178T:p.P60S,TFAP2A:NM_003220:exon2:c.C190T:p.P64S	0.987223276	0.012771396	5.33E-06	DISEASE: Branchiooculofacial syndrome (BOFS) [MIM:113620]: A syndrome characterized by growth retardation, bilateral branchial sinus defects with hemangiomatous, scarred skin, cleft lip with or without cleft palate, pseudocleft of the upper lip, nasolacrimal duct obstruction, low set ears with posterior rotation, a malformed, asymmetrical nose with a broad bridge and flattened tip, conductive or sensorineural deafness, ocular and renal anomalies. {ECO:0000269|PubMed:18423521}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96726	0.95367	-0.427900189	25.14744043	13.97787	0.50725	0.01	0.574	D	0.911	0.899	P	0.433	0.916	B	0.000	0.843	D	1	0.810	D	1.73	0.448	L	-1.43	0.807	T	-3.81	0.795	D	0.582	0.618	0.042	0.831	D	0.497	0.810	T	0.281	0.903	D	4.324	0.579	24.0	0.999	0.972	0.996	0.982	D	c	0.601	0.576	1.000	0.747	0.447	0.083	0	3.8	0.427	9.982	0.992	0.902	0.416	1.000	0.715	1.000	0.888	12.724	0.564	.	.	.	0.5	67	284	6	10410424	chr6:10410424	G	A	67	PASS	DP=284;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	10419579	10419579	C	T	intronic	TFAP2A	.	.	.	0.987223276	0.012771396	5.33E-06	DISEASE: Branchiooculofacial syndrome (BOFS) [MIM:113620]: A syndrome characterized by growth retardation, bilateral branchial sinus defects with hemangiomatous, scarred skin, cleft lip with or without cleft palate, pseudocleft of the upper lip, nasolacrimal duct obstruction, low set ears with posterior rotation, a malformed, asymmetrical nose with a broad bridge and flattened tip, conductive or sensorineural deafness, ocular and renal anomalies. {ECO:0000269|PubMed:18423521}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96726	0.95367	-0.427900189	25.14744043	13.97787	0.50725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	33	6	10419579	chr6:10419579	C	T	58	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	10532046	10532046	G	T	intronic	GCNT2	.	.	.	0.019397722	0.900537076	0.080065202	DISEASE: Cataract 13, with adult i phenotype (CTRCT13) [MIM:116700]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT13 is associated with the rare adult i phenotype, in which adult red blood cells are rich in i antigen and contain low levels of I antigen. {ECO:0000269|PubMed:11739194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21275	0.15862	-1.300731691	4.948100967	83.70152	1.94658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	6	10532046	chr6:10532046	G	T	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	11213467	11213467	-	A	intronic	NEDD9	.	.	.	0.534981125	0.464991213	2.77E-05	.	0.38853	0.2374	-0.371072278	28.22009908	279.64751	3.58344	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	160	6	11213467	chr6:11213467	G	GA	62	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	15468723	15468729	GGGTGAG	-	intronic	JARID2	.	.	.	0.999862193	0.000137807	7.01E-13	.	0.98339	0.18221	-1.741783094	2.418023119	264.05908	3.48721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	44	6	15468722	chr6:15468722	AGGGTGAG	A	118	PASS	DP=44;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	17615492	17615492	-	T	UTR3	NUP153	NM_005124:c.*835_*836insA;NM_001278210:c.*835_*836insA;NM_001278209:c.*835_*836insA	.	.	0.999994457	5.54E-06	1.38E-15	.	0.98695	0.10551	0.839507251	88.23425336	6828.76712	17.57298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	297	6	17615492	chr6:17615492	A	AT	92	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	17779922	17779922	-	A	intronic	KIF13A	.	.	.	0.999958506	4.15E-05	5.23E-19	.	0.14914	0.13297	-0.093786226	46.49681529	493.50968	4.56777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.3	57	6	17779922	chr6:17779922	G	GA	13.3	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	25114003	25114003	T	C	ncRNA_exonic	CMAHP	.	.	.	.	.	.	.	0.1819	0.13388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	47	6	25114003	chr6:25114003	T	C	64	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	25426693	25426693	C	G	intronic	CARMIL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	60	6	25426693	chr6:25426693	C	G	61	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	26368343	26368343	T	G	intronic	BTN3A2	.	.	.	0.000124519	0.840379954	0.159495527	.	0.06491	0.07172	0.795569043	87.49115357	1740.69093	7.70186	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	10	6	26368343	chr6:26368343	T	G	53	PASS	DP=10;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	26406255	26406255	G	A	exonic	BTN3A1	.	synonymous SNV	BTN3A1:NM_001145008:exon3:c.G204A:p.V68V,BTN3A1:NM_001145009:exon3:c.G204A:p.V68V,BTN3A1:NM_007048:exon3:c.G204A:p.V68V,BTN3A1:NM_194441:exon3:c.G204A:p.V68V	8.65E-07	0.747593221	0.252405913	.	0.06787	0.07707	0.531004228	80.87992451	647.15095	5.10575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	159	6	26406255	chr6:26406255	G	A	.	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	26422353	26422353	C	T	ncRNA_exonic	BTN2A3P	.	.	.	.	.	.	.	0.08337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	6	26422353	chr6:26422353	C	T	.	PASS	DP=79;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	26451888	26451888	T	C	intronic	BTN3A3	.	.	.	7.19E-10	0.246806885	0.753193114	.	0.11114	0.09582	-0.28470423	33.48667138	154.38227	2.71544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	22	6	26451888	chr6:26451888	T	C	45	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	26860522	26860522	C	T	ncRNA_intronic	GUSBP2	.	.	.	.	.	.	.	0.09983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	77	6	26860522	chr6:26860522	C	T	58	PASS	DP=77;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	26864789	26864789	A	G	ncRNA_intronic	GUSBP2	.	.	.	.	.	.	.	0.09983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	334	6	26864789	chr6:26864789	A	G	100	PASS	DP=334;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	27115555	27115555	C	T	upstream;downstream	HIST1H2BK;HIST1H2AH;MIR3143	dist=918;dist=88	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	6	27115555	chr6:27115555	C	T	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	27420281	27420281	G	C	exonic	ZNF184	.	nonsynonymous SNV	ZNF184:NM_001318891:exon6:c.C1057G:p.Q353E,ZNF184:NM_001318892:exon6:c.C1057G:p.Q353E,ZNF184:NM_001318893:exon6:c.C829G:p.Q277E,ZNF184:NM_001347832:exon6:c.C829G:p.Q277E,ZNF184:NM_007149:exon6:c.C1057G:p.Q353E	0.133748636	0.865332288	0.000919077	.	0.21513	0.10412	-0.023789244	52.09365416	46.59463	1.31817	0.048	0.400	D	0.602	0.375	P	0.444	0.441	B	0.000	0.449	D	0.851	0.352	D	0.38	0.122	N	2.25	0.178	T	-2.17	0.490	N	0.477	0.526	-1.072	0.089	T	0.025	0.105	T	0.003	0.078	T	4.779	0.641	24.7	0.992	0.534	0.038	0.090	N	c	0.198	0.310	1.000	0.500	0.563	0.310	0	5.12	0.693	2.441	0.443	0.820	0.335	0.987	0.361	1.000	0.888	16.106	0.809	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	55	10	6	27420281	chr6:27420281	G	C	55	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	27834598	27834598	C	A	UTR3	HIST1H1B	NM_005322:c.*29G>T	.	.	0.509138756	0.421807909	0.069053335	.	0.27585	0.20571	0.575097644	82.1656051	458.1171	4.44431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	6	27834598	chr6:27834598	C	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	28352060	28352060	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15106;dist=4667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	106	6	28352060	chr6:28352060	C	G	97	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	28352670	28352670	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15716;dist=4057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	237	6	28352670	chr6:28352670	C	G	152	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	28352758	28352758	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15804;dist=3969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	181	6	28352758	chr6:28352758	C	G	138	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	32489753	32489753	C	G	exonic	HLA-DRB5	.	nonsynonymous SNV	HLA-DRB5:NM_002125:exon2:c.G299C:p.R100T	0.003227266	0.824923015	0.171849719	.	0.04311	0.1359	4.551415577	99.75230007	16958.17858	27.72811	0.044	0.410	D	0.006	0.309	B	0.01	0.581	B	0.000	0.002	N	1	0.090	N	1.105	0.287	L	8.05	0.003	T	-1.46	0.358	N	0.219	0.269	-0.935	0.435	T	0.000	0.002	T	.	.	.	-2.779	0.002	0.001	0.804	0.128	0.009	0.034	N	c	-2.193	-2.414	1.000	0.747	0.660	0.490	0	-9.43	0.005	-15.955	0.000	-7.606	0.000	0.000	0.063	0.000	0.016	2.902	0.053	MHC class II, alpha/beta chain, N-terminal|MHC class II, beta chain, N-terminal|MHC classes I/II-like antigen recognition protein	.	.	0.5	54	81	6	32489753	chr6:32489753	C	G	54	PASS	DP=81;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	33646313	33646313	C	T	exonic	ITPR3	.	nonsynonymous SNV	ITPR3:NM_002224:exon29:c.C3764T:p.T1255M	4.98E-12	0.999999998	1.88E-09	.	0.69563	.	-4.091558817	0.165133286	605.21718	4.97953	0.004	0.654	D	1.0	0.899	D	0.99	0.774	D	0.000	0.843	D	1.000	0.537	D	2.305	0.662	M	-2.5	0.892	D	-3.63	0.697	D	0.35	0.576	0.675	0.929	D	0.790	0.929	D	0.148	0.831	D	6.600	0.907	31	0.999	0.982	0.942	0.601	D	c	0.638	0.605	1.000	0.747	0.732	0.924	0	5.65	0.868	3.290	0.512	0.852	0.362	0.998	0.411	0.863	0.360	19.726	0.961	RIH (RyR and IP3R Homology) domain	.	.	0.5	.	73	6	33646313	chr6:33646313	C	T	.	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	34059787	34059787	C	T	exonic	GRM4	.	synonymous SNV	GRM4:NM_001256809:exon2:c.G402A:p.T134T,GRM4:NM_001256812:exon2:c.G102A:p.T34T,GRM4:NM_000841:exon3:c.G609A:p.T203T,GRM4:NM_001256811:exon3:c.G609A:p.T203T,GRM4:NM_001256813:exon3:c.G210A:p.T70T	0.979350085	0.020649771	1.44E-07	.	0.27001	0.19777	-2.478673049	0.96131163	76.44854	1.83436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	6	34059787	chr6:34059787	C	T	.	PASS	DP=112;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	34212805	34212805	C	T	UTR3	HMGA1	NM_001319081:c.*144C>T;NM_001319080:c.*144C>T;NM_001319082:c.*144C>T;NM_002131:c.*144C>T;NM_145899:c.*144C>T;NM_001319079:c.*144C>T;NM_001319078:c.*144C>T;NM_001319077:c.*144C>T;NM_145903:c.*144C>T;NM_145902:c.*144C>T;NM_145901:c.*144C>T;NM_145905:c.*144C>T	.	.	0.724299774	0.262579444	0.013120782	DISEASE: Note=A chromosomal aberration involving HMGA1 is found in pulmonary chondroid hamartoma. Translocation t(6;14)(p21;q23-24) with RAD51B. {ECO:0000269|PubMed:11978964}.; 	0.99432	0.53499	-0.053113545	49.38664779	74.66102	1.80667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	126	6	34212805	chr6:34212805	C	T	.	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	35262831	35262831	A	-	intronic	ZNF76	.	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	228	6	35262830	chr6:35262830	CA	C,CAA	62	PASS	DP=228;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/2	./.
6	35262831	35262831	-	A	intronic	ZNF76	.	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	228	6	35262830	chr6:35262830	CA	C,CAA	62	PASS	DP=228;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/2	./.
6	35263513	35263513	C	G	UTR3	ZNF76	NM_003427:c.*488C>G;NM_001292032:c.*488C>G	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	166	6	35263513	chr6:35263513	C	G	101	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	37427378	37427378	G	A	exonic	CMTR1	.	nonsynonymous SNV	CMTR1:NM_015050:exon10:c.G1013A:p.R338H	0.999294924	0.000705076	7.57E-12	.	0.3161	0.11198	-1.087493118	7.106628922	28.34808	0.90802	0.161	0.272	T	1.0	0.899	D	0.945	0.664	D	0.000	0.843	D	1	0.810	D	-0.115	0.046	N	0.97	0.425	T	-1.12	0.289	N	0.762	0.766	-1.009	0.271	T	0.103	0.379	T	0.012	0.313	T	6.359	0.878	29.4	0.999	0.999	0.988	0.868	D	c	0.597	0.689	1.0	0.983	0.722	0.854	0	6.17	0.997	6.324	0.727	1.048	0.713	1.000	0.715	1.000	0.888	19.868	0.968	Ribosomal RNA methyltransferase FtsJ domain|RrmJ-type ribose 2-O-methyltransferase domain|S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	124	76	6	37427378	chr6:37427378	G	A	124	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	40359453	40359453	G	A	UTR3	LRFN2	NM_020737:c.*229C>T	.	.	0.117460637	0.856182119	0.026357243	.	0.24906	0.11684	-1.240018202	5.461193678	778.81291	5.52227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	6	40359453	chr6:40359453	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	42176568	42176568	C	A	intronic	MRPS10	.	.	.	0.028212146	0.922237701	0.049550153	.	0.19668	0.10229	-0.0274281	51.65723048	31.89637	1.00349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	6	42176568	chr6:42176568	C	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	42625963	42625963	-	T	intronic	UBR2	.	.	.	0.99999988	1.20E-07	8.34E-24	.	0.72806	0.25871	-1.365077992	4.5175749	3342.51324	11.07201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	6	42625963	chr6:42625963	C	CT	41	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	44274142	44274144	AGA	-	intronic	AARS2	.	.	.	1.65E-07	0.999922899	7.69E-05	DISEASE: Combined oxidative phosphorylation deficiency 8 (COXPD8) [MIM:614096]: A mitochondrial disease characterized by a lethal infantile hypertrophic cardiomyopathy, generalized muscle dysfunction and some neurologic involvement. The liver is not affected. {ECO:0000269|PubMed:21549344}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukoencephalopathy, progressive, with ovarian failure (LKENP) [MIM:615889]: An autosomal recessive neurodegenerative disorder characterized by childhood- to adulthood-onset of signs of neurologic deterioration consisting of ataxia, spasticity, and cognitive decline with features of frontal lobe dysfunction. Brain MRI shows leukoencephalopathy with striking involvement of deep white matter, and cerebellar atrophy. All female patients develop premature ovarian failure. {ECO:0000269|PubMed:24808023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.143	0.11236	1.14268501	92.37438075	592.72341	4.93503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	21	6	44274141	chr6:44274141	GAGA	G	85	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	44418785	44418785	C	A	downstream	CDC5L	dist=624	.	.	0.999992549	7.45E-06	1.40E-14	DISEASE: Note=A chromosomal aberration involving CDC5L is found in multicystic renal dysplasia. Translocation t(6;19)(p21;q13.1) with USF2.; 	0.82165	0.15974	-0.799052816	12.45576787	81.93083	1.9192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	6	44418785	chr6:44418785	C	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	45390255	45390255	C	G	intronic	RUNX2	.	.	.	0.995958899	0.004040782	3.19E-07	DISEASE: Cleidocranial dysplasia (CLCD) [MIM:119600]: Autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies. {ECO:0000269|PubMed:10521292, ECO:0000269|PubMed:10545612, ECO:0000269|PubMed:10689183, ECO:0000269|PubMed:10980549, ECO:0000269|PubMed:11857736, ECO:0000269|PubMed:12081718, ECO:0000269|PubMed:12196916, ECO:0000269|PubMed:12424590, ECO:0000269|PubMed:16270353, ECO:0000269|PubMed:19744171, ECO:0000269|PubMed:20082269, ECO:0000269|PubMed:20648631, ECO:0000269|PubMed:9182765, ECO:0000269|PubMed:9207800}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly (MDMHB) [MIM:156510]: An autosomal dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth. {ECO:0000269|PubMed:23290074}. Note=The disease is caused by mutations affecting the gene represented in this entry. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A domain and the functionally essential DNA-binding Runt domain of RUNX2. The RUNX2 duplication found in individuals with MDMHB leads to a gain of function (PubMed:23290074). {ECO:0000269|PubMed:23290074}.; 	0.53349	0.8758	-0.446304853	24.33356924	87.92892	2.00467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	445	6	45390255	chr6:45390255	C	G	81	PASS	DP=445;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	45517650	45517650	C	T	UTR3	RUNX2	NM_001024630:c.*2608C>T;NM_001015051:c.*2608C>T;NM_001278478:c.*2608C>T	.	.	0.995958899	0.004040782	3.19E-07	DISEASE: Cleidocranial dysplasia (CLCD) [MIM:119600]: Autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies. {ECO:0000269|PubMed:10521292, ECO:0000269|PubMed:10545612, ECO:0000269|PubMed:10689183, ECO:0000269|PubMed:10980549, ECO:0000269|PubMed:11857736, ECO:0000269|PubMed:12081718, ECO:0000269|PubMed:12196916, ECO:0000269|PubMed:12424590, ECO:0000269|PubMed:16270353, ECO:0000269|PubMed:19744171, ECO:0000269|PubMed:20082269, ECO:0000269|PubMed:20648631, ECO:0000269|PubMed:9182765, ECO:0000269|PubMed:9207800}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly (MDMHB) [MIM:156510]: An autosomal dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth. {ECO:0000269|PubMed:23290074}. Note=The disease is caused by mutations affecting the gene represented in this entry. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A domain and the functionally essential DNA-binding Runt domain of RUNX2. The RUNX2 duplication found in individuals with MDMHB leads to a gain of function (PubMed:23290074). {ECO:0000269|PubMed:23290074}.; 	0.53349	0.8758	-0.446304853	24.33356924	87.92892	2.00467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	6	45517650	chr6:45517650	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	49412275	49412275	T	G	intronic	MUT	.	.	.	5.92E-18	0.006458009	0.993541991	DISEASE: Methylmalonic aciduria type mut (MMAM) [MIM:251000]: An often fatal disorder of organic acid metabolism. Common clinical features include lethargy, vomiting, failure to thrive, hypotonia, neurological deficit and early death. Two forms of the disease are distinguished by the presence (mut-) or absence (mut0) of residual enzyme activity. Mut0 patients have more severe neurological manifestations of the disease than do MUT- patients. MMAM is unresponsive to vitamin B12 therapy. {ECO:0000269|PubMed:10923046, ECO:0000269|PubMed:11350191, ECO:0000269|PubMed:1346616, ECO:0000269|PubMed:1351030, ECO:0000269|PubMed:15643616, ECO:0000269|PubMed:15781192, ECO:0000269|PubMed:16281286, ECO:0000269|PubMed:1670635, ECO:0000269|PubMed:1977311, ECO:0000269|PubMed:7909321, ECO:0000269|PubMed:7912889, ECO:0000269|PubMed:9285782, ECO:0000269|PubMed:9452100, ECO:0000269|PubMed:9554742}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11346	0.69122	0.20030965	67.3566879	2774.75191	9.94221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	11	6	49412275	chr6:49412275	T	G	42	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	50681703	50681703	-	T	UTR5	TFAP2D	NM_172238:c.-66_-65insT	.	.	0.981586998	0.018399928	1.31E-05	.	0.75149	0.14024	0.016664174	55.21939137	509.04894	4.62407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	361	6	50681703	chr6:50681703	A	AT	78	PASS	DP=361;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	51930801	51930801	C	T	exonic	PKHD1	.	nonsynonymous SNV	PKHD1:NM_138694:exon12:c.G853A:p.D285N,PKHD1:NM_170724:exon12:c.G853A:p.D285N	2.89E-23	1	2.32E-11	.	0.08201	0.25544	0.37824847	75.51309271	3737.47294	11.94762	0.087	0.357	T	0.787	0.438	P	0.447	0.484	P	0.001	0.424	D	0.746	0.297	N	1.555	0.395	L	-1.06	0.768	T	-3.02	0.660	D	0.061	0.045	-0.665	0.621	T	0.267	0.639	T	0.069	0.708	D	6.385	0.882	29.5	0.999	0.939	0.814	0.405	D	c	0.320	0.416	1.000	0.747	0.497	0.185	0	5.95	0.964	2.001	0.402	0.065	0.171	1.000	0.715	0.714	0.313	14.926	0.704	IPT domain|Immunoglobulin E-set|Immunoglobulin-like fold	.	.	0.5	.	21	6	51930801	chr6:51930801	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	52664027	52664027	C	A	exonic	GSTA1	.	synonymous SNV	GSTA1:NM_145740:exon2:c.G39T:p.R13R	0.059010542	0.867804347	0.073185111	.	0.05662	.	-0.181750739	40.15687662	74.35516	1.80096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	189	6	52664027	chr6:52664027	C	A	91	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	56626502	56626502	-	A	intronic	DST	.	.	.	1	9.56E-15	4.08E-50	DISEASE: Neuropathy, hereditary sensory and autonomic, 6 (HSAN6) [MIM:614653]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN6 is a severe autosomal recessive disorder characterized by neonatal hypotonia, respiratory and feeding difficulties, lack of psychomotor development, and autonomic abnormalities including labile cardiovascular function, lack of corneal reflexes leading to corneal scarring, areflexia, and absent axonal flare response after intradermal histamine injection. {ECO:0000269|PubMed:22522446}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, autosomal recessive 2 (EBSB2) [MIM:615425]: A form of epidermolysis bullosa, a dermatologic disorder characterized by localized blistering on the dorsal, lateral and plantar surfaces of the feet. EBSB2 is characterized by trauma-induced blistering mainly occurring on the feet and ankles. Ultrastructural analysis of skin biopsy shows abnormal hemidesmosomes with poorly formed inner plaques. {ECO:0000269|PubMed:20164846, ECO:0000269|PubMed:22113475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87634	0.40727	-0.532709792	20.70653456	9099.85464	20.71216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.84	31	6	56626502	chr6:56626502	T	TA	11.84	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	57393144	57393144	A	T	exonic	PRIM2	.	unknown	UNKNOWN	5.15E-08	0.39171957	0.608280379	.	0.89222	0.08308	.	.	55.84911	1.50063	.	.	.	0.134	0.257	B	0.091	0.284	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.391	0.451	.	.	.	.	.	.	.	.	.	2.510	0.363	19.53	0.889	0.178	0.926	0.558	D	n	1.419	0.069	1.000	0.747	0.258	0.037	0	4.7	0.586	5.569	0.669	1.093	0.878	1.000	0.715	0.948	0.423	10.683	0.448	.	.	.	0.5	86	31	6	57393144	chr6:57393144	A	T	86	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	71508548	71508548	C	G	intronic	SMAP1	.	.	.	0.983689233	0.016308801	1.97E-06	.	0.25151	.	-0.071520315	48.34866714	1636.02834	7.47505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	35	6	71508548	chr6:71508548	C	G	70	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
6	72951999	72951999	-	T	intronic	RIMS1	.	.	.	0.029211449	0.970788551	5.09E-11	DISEASE: Cone-rod dystrophy 7 (CORD7) [MIM:603649]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:12659814}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.52106	0.15134	-1.543300564	3.320358575	440.01281	4.37079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.55	26	6	72951999	chr6:72951999	C	CT	21.55	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	73951959	73951959	C	T	exonic	KHDC1	.	synonymous SNV	KHDC1:NM_030568:exon3:c.G114A:p.G38G,KHDC1:NM_001251874:exon4:c.G333A:p.G111G	6.80E-05	0.49146714	0.508464847	.	0.09427	.	0.038710339	56.92380278	694.65301	5.25432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	6	73951959	chr6:73951959	C	T	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	80194766	80194766	-	A	UTR3	LCA5	NM_181714:c.*1954_*1955insT;NM_001122769:c.*1954_*1955insT	.	.	0.004282174	0.994223193	0.001494632	DISEASE: Leber congenital amaurosis 5 (LCA5) [MIM:604537]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:17546029, ECO:0000269|PubMed:18000884, ECO:0000269|PubMed:18334959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1667	0.11088	-0.130380821	44.03161123	3626.18224	11.68454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	41	6	80194766	chr6:80194766	G	GA	60	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	80775100	80775100	A	T	intergenic	TTK;BCKDHB	dist=22856;dist=41227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	297	6	80775100	chr6:80775100	A	T	139	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	80837242	80837242	-	T	intronic	BCKDHB	.	.	.	2.91E-06	0.767207619	0.232789471	DISEASE: Maple syrup urine disease 1B (MSUD1B) [MIM:248600]: A metabolic disorder due to an enzyme defect in the catabolic pathway of the branched-chain amino acids leucine, isoleucine, and valine. Accumulation of these 3 amino acids and their corresponding keto acids leads to encephalopathy and progressive neurodegeneration. Clinical features include mental and physical retardation, feeding problems, and a maple syrup odor to the urine. The keto acids of the branched-chain amino acids are present in the urine. If untreated, maple syrup urine disease can lead to seizures, coma, and death. The disease is often classified by its pattern of signs and symptoms. The most common and severe form of the disease is the classic type, which becomes apparent soon after birth. Variant forms of the disorder become apparent later in infancy or childhood and are typically milder, but they still involve developmental delay and other medical problems if not treated. {ECO:0000269|PubMed:11509994, ECO:0000269|PubMed:22326532, ECO:0000269|PubMed:8161368}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21382	0.37665	-0.449946534	24.00330267	37.41729	1.11457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	96	6	80837242	chr6:80837242	A	AT	43	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	82910441	82910441	T	C	intronic	IBTK	.	.	.	0.901146102	0.098853897	5.05E-10	.	0.3651	0.08876	-0.659500046	16.07100731	1718.28989	7.64339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	6	82910441	chr6:82910441	T	C	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	86349956	86349956	C	T	exonic	SYNCRIP	.	nonsynonymous SNV	SYNCRIP:NM_001159673:exon3:c.G64A:p.D22N,SYNCRIP:NM_001159675:exon3:c.G358A:p.D120N,SYNCRIP:NM_001159676:exon3:c.G358A:p.D120N,SYNCRIP:NM_001159674:exon4:c.G358A:p.D120N,SYNCRIP:NM_001159677:exon4:c.G358A:p.D120N,SYNCRIP:NM_006372:exon4:c.G358A:p.D120N	0.999378591	0.000621405	3.32E-09	.	0.9771	0.24974	-0.560178693	19.30879925	10.81382	0.39248	0.35	0.247	T	0.11	0.532	B	0.05	0.542	B	0.000	0.843	D	1	0.810	D	2.585	0.758	M	1.55	0.301	T	-3.76	0.768	D	0.077	0.080	-1.144	0.012	T	0.068	0.277	T	0.018	0.400	T	3.602	0.490	23.2	0.994	0.644	0.981	0.798	D	c	0.227	0.374	1.0	0.983	0.660	0.490	0	5.42	0.786	6.155	0.714	0.015	0.141	1.000	0.715	1.000	0.888	18.812	0.920	.	.	.	0.5	56	50	6	86349956	chr6:86349956	C	T	56	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	86353381	86353381	C	T	upstream	SYNCRIP	dist=338	.	.	0.999378591	0.000621405	3.32E-09	.	0.9771	0.24974	-0.560178693	19.30879925	10.81382	0.39248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	6	86353381	chr6:86353381	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	89926966	89926966	T	C	exonic	GABRR1	.	nonsynonymous SNV	GABRR1:NM_001256703:exon1:c.A76G:p.M26V,GABRR1:NM_002042:exon1:c.A76G:p.M26V	2.12E-07	0.687205421	0.312794367	.	0.16436	0.12099	0.020302773	55.60863411	2268.00024	8.80716	1.0	0.037	T	0.0	0.026	B	0.0	0.013	B	0.074	0.213	N	1	0.588	P	0	0.065	N	1.89	0.237	T	0.21	0.102	N	0.008	0.003	-0.919	0.457	T	0.008	0.027	T	.	.	.	-1.057	0.030	0.012	0.929	0.219	0.125	0.171	N	c	-0.667	-0.448	0.512	0.210	0.497	0.185	0	2.91	0.328	0.192	0.168	-0.378	0.066	0.958	0.332	0.977	0.480	5.397	0.155	.	ENSG00000146276.7|ENSG00000146276.7|ENSG00000146276.7|ENSG00000146276.7|ENSG00000154548.8|ENSG00000146281.5|ENSG00000146276.7|ENSG00000146276.7|ENSG00000146276.7	Artery_Aorta|Artery_Coronary|Artery_Tibial|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg	0.5	42	13	6	89926966	chr6:89926966	T	C	42	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	91296568	91296570	GAG	-	exonic	MAP3K7	.	nonframeshift deletion	MAP3K7:NM_003188:exon1:c.33_35del:p.S14del,MAP3K7:NM_145331:exon1:c.33_35del:p.S14del,MAP3K7:NM_145332:exon1:c.33_35del:p.S14del,MAP3K7:NM_145333:exon1:c.33_35del:p.S14del	0.998336232	0.001663766	1.50E-09	.	0.79955	0.33817	-0.427900189	25.14744043	14.73281	0.53078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	29	6	91296567	chr6:91296567	CGAG	C	54	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	102247559	102247559	G	A	exonic	GRIK2	.	nonsynonymous SNV	GRIK2:NM_001166247:exon7:c.G988A:p.V330M,GRIK2:NM_021956:exon7:c.G988A:p.V330M,GRIK2:NM_175768:exon7:c.G988A:p.V330M	0.994567954	0.005432045	1.10E-09	DISEASE: Mental retardation, autosomal recessive 6 (MRT6) [MIM:611092]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic mental retardation. MRT6 patients display mild to severe mental retardation and psychomotor development delay in early childhood. Patients do not have neurologic problems, congenital malformations, or facial dysmorphism. Body height, weight, and head circumference are normal. {ECO:0000269|PubMed:17847003}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53627	.	-1.131590109	6.481481481	129.48869	2.48041	0.043	0.473	D	0.998	0.715	D	0.936	0.654	D	0.000	0.843	D	1.000	0.588	D	2.27	0.647	M	-1.63	0.825	D	-0.74	0.383	N	0.671	0.710	0.230	0.864	D	0.594	0.855	D	0.101	0.774	D	6.493	0.895	31	0.999	0.982	0.991	0.912	D	c	0.794	0.811	1.000	0.747	0.554	0.283	0	5.44	0.793	9.602	0.976	1.048	0.713	1.000	0.715	1.000	0.888	19.253	0.939	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	.	48	6	102247559	chr6:102247559	G	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	107566721	107566721	C	T	intronic	PDSS2	.	.	.	1.90E-05	0.695884938	0.304096105	DISEASE: Coenzyme Q10 deficiency, primary, 3 (COQ10D3) [MIM:614652]: A fatal encephalomyopathic form of coenzyme Q10 deficiency with nephrotic syndrome. Coenzyme Q10 deficiency is an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form. {ECO:0000269|PubMed:17186472}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07675	0.11464	-0.069700724	48.54328851	310.44253	3.74923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	223	6	107566721	chr6:107566721	C	T	60	PASS	DP=223;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	108214755	108214755	T	-	exonic	SEC63	.	frameshift deletion	SEC63:NM_007214:exon16:c.1605delA:p.K535Nfs*27	1.24E-05	0.999895028	9.25E-05	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	297	6	108214754	chr6:108214754	GT	G,GTT	72	PASS	DP=297;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
6	108214755	108214755	-	T	exonic	SEC63	.	frameshift insertion	SEC63:NM_007214:exon16:c.1604dupA:p.P536Tfs*23	1.24E-05	0.999895028	9.25E-05	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	297	6	108214754	chr6:108214754	GT	G,GTT	72	PASS	DP=297;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
6	109001232	109001232	C	T	UTR3	FOXO3	NM_201559:c.*237C>T;NM_001455:c.*237C>T	.	.	.	.	.	DISEASE: Note=A chromosomal aberration involving FOXO3 is found in secondary acute leukemias. Translocation t(6;11)(q21;q23) with KMT2A/MLL1.; 	.	0.59462	-0.492218069	22.35786742	267.4981	3.50708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	156	6	109001232	chr6:109001232	C	T	125	PASS	DP=156;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	109616762	109616762	A	G	ncRNA_exonic	CCDC162P	.	.	.	.	.	.	.	0.08175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	11	6	109616762	chr6:109616762	A	G	42	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	111696681	111696681	G	C	exonic	REV3L	.	synonymous SNV	REV3L:NM_002912:exon14:c.C2877G:p.L959L,REV3L:NM_001286432:exon15:c.C2643G:p.L881L,REV3L:NM_001286431:exon16:c.C2643G:p.L881L	1	6.81E-14	7.45E-35	.	0.85968	0.1947	-2.097226344	1.551073366	1709.50934	7.62408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	39	6	111696681	chr6:111696681	G	C	53	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	111701463	111701463	T	-	intronic	REV3L	.	.	.	1	6.81E-14	7.45E-35	.	0.85968	0.1947	-2.097226344	1.551073366	1709.50934	7.62408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	15	6	111701462	chr6:111701462	CT	C	44	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	118320463	118320463	T	G	intronic	SLC35F1	.	.	.	0.38850627	0.611072726	0.000421004	.	0.29195	0.10809	0.060756528	58.52795471	23.09728	0.77064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	176	6	118320463	chr6:118320463	T	G	91	PASS	DP=176;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	123696766	123696766	G	C	exonic	TRDN	.	nonsynonymous SNV	TRDN:NM_001251987:exon19:c.C1260G:p.D420E,TRDN:NM_006073:exon19:c.C1257G:p.D419E	1.82E-10	0.82694144	0.17305856	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) [MIM:615441]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, or sudden death after physical activity or emotional stress. Some patients have muscle weakness. {ECO:0000269|PubMed:22422768}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18235	0.15914	1.976952171	97.61146497	4408.1144	13.27537	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.327	0.142	N	1.000	0.090	P	-0.805	0.016	N	2.57	0.136	T	0.22	0.047	N	0.027	0.009	-0.910	0.469	T	0.004	0.012	T	0.018	0.402	T	0.655	0.156	8.529	0.298	0.016	0.425	0.267	N	c	-1.057	-0.785	0.000	0.052	0.487	0.133	0	4.14	0.477	0.616	0.239	-0.339	0.072	1.000	0.715	0.987	0.523	9.685	0.391	.	.	.	0.5	75	34	6	123696766	chr6:123696766	G	C	75	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
6	124721526	124721526	C	A	intronic	NKAIN2	.	.	.	0.007832385	0.928062091	0.064105523	.	0.35628	.	-0.163345027	41.24793583	15.60658	0.55645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	6	124721526	chr6:124721526	C	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	126075618	126075618	C	T	exonic	HEY2	.	nonsynonymous SNV	HEY2:NM_012259:exon4:c.C254T:p.A85V	0.444357733	0.549107414	0.006534853	.	0.37195	0.17951	-0.404032746	26.53338051	218.50627	3.19585	0.002	0.721	D	0.563	0.365	P	0.632	0.500	P	0.000	0.843	D	1	0.810	D	0.895	0.225	L	-4.62	0.979	D	-3.36	0.665	D	0.816	0.805	0.939	0.962	D	0.880	0.960	D	0.328	0.917	D	5.430	0.736	26.1	0.999	0.973	0.984	0.822	D	c	0.457	0.589	1.0	0.983	0.706	0.609	0	5.96	0.967	7.568	0.814	0.935	0.490	1.000	0.715	0.999	0.750	20.414	0.990	Myc-type, basic helix-loop-helix (bHLH) domain	.	.	0.5	.	29	6	126075618	chr6:126075618	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	126249914	126249914	T	G	exonic	NCOA7	.	nonsynonymous SNV	NCOA7:NM_001199622:exon6:c.T657G:p.D219E,NCOA7:NM_001199621:exon15:c.T2481G:p.D827E,NCOA7:NM_001122842:exon16:c.T2793G:p.D931E,NCOA7:NM_181782:exon16:c.T2826G:p.D942E,NCOA7:NM_001199619:exon17:c.T2826G:p.D942E,NCOA7:NM_001199620:exon18:c.T2826G:p.D942E	0.960907672	0.039092322	5.80E-09	.	0.10866	0.09333	-0.196519234	39.20736023	1154.66608	6.47379	1.0	0.010	T	0.0	0.026	B	0.0	0.040	B	0.000	0.843	N	1.000	0.090	P	-1.295	0.007	N	3.26	0.069	T	2.37	0.003	N	0.092	0.288	-0.967	0.378	T	0.010	0.035	T	.	.	.	0.059	0.099	3.180	0.712	0.092	0.283	0.233	N	c	-0.307	-0.145	1.000	0.462	0.707	0.730	0	4.1	0.470	1.701	0.372	0.136	0.221	1.000	0.715	0.998	0.697	6.278	0.201	TLDc domain	.	.	0.5	60	17	6	126249914	chr6:126249914	T	G	60	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	129635730	129635730	T	C	intronic	LAMA2	.	.	.	1.18E-24	0.999999998	2.28E-09	DISEASE: Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]: Characterized by difficulty walking, hypotonia, proximal weakness, hyporeflexia, and white matter hypodensity on MRI. {ECO:0000269|PubMed:11591858, ECO:0000269|PubMed:12552556}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30049	0.63589	0.497724973	79.64142486	3368.62227	11.11486	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	6	129635730	chr6:129635730	T	C	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	130387489	130387489	C	T	intronic	L3MBTL3	.	.	.	0.999498723	0.000501277	8.05E-11	.	0.63431	0.09837	-0.777005578	12.9747582	66.98885	1.69207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	6	130387489	chr6:130387489	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	130504536	130504536	G	A	intronic	SAMD3	.	.	.	1.10E-06	0.937046699	0.062952204	.	0.10152	0.10086	-0.354480518	29.42911064	120.51258	2.39131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	36	6	130504536	chr6:130504536	G	A	55	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	133119524	133119524	G	A	intronic	SLC18B1	.	.	.	3.95E-10	0.179498685	0.820501314	.	0.13733	.	-0.110153916	45.48832272	589.95485	4.92467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	164	6	133119524	chr6:133119524	G	A	144	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	133135715	133135715	C	A	UTR5	RPS12	NM_001016:c.-193C>A	.	.	0.827435142	0.168866928	0.00369793	.	0.26171	0.19444	0.035072054	56.2514744	9.87588	0.36197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	169	6	133135715	chr6:133135715	C	A	113	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	134212833	134212833	C	T	intronic	TCF21	.	.	.	0.805369944	0.189537108	0.005092948	.	0.50048	0.24689	0.25917371	70.05779665	477.84739	4.51344	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	353	6	134212833	chr6:134212833	C	T	.	PASS	DP=353;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	134212873	134212873	G	A	exonic	TCF21	.	nonsynonymous SNV	TCF21:NM_003206:exon2:c.G473A:p.G158E,TCF21:NM_198392:exon2:c.G473A:p.G158E	0.805369944	0.189537108	0.005092948	.	0.50048	0.24689	0.25917371	70.05779665	477.84739	4.51344	0.002	0.721	D	0.734	0.408	P	0.221	0.361	B	0.000	0.843	D	1	0.810	D	1.245	0.315	L	-4.05	0.965	D	-1.86	0.435	N	0.71	0.749	0.696	0.931	D	0.773	0.923	D	0.120	0.801	D	4.852	0.651	24.8	0.996	0.725	0.926	0.559	D	c	0.444	0.545	1.000	0.747	0.598	0.340	0	5.63	0.861	6.582	0.738	1.048	0.713	1.000	0.715	0.995	0.604	19.674	0.959	.	.	.	0.5	67	137	6	134212873	chr6:134212873	G	A	67	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	134212885	134212885	G	A	exonic	TCF21	.	nonsynonymous SNV	TCF21:NM_003206:exon2:c.G485A:p.S162N,TCF21:NM_198392:exon2:c.G485A:p.S162N	0.805369944	0.189537108	0.005092948	.	0.50048	0.24689	0.25917371	70.05779665	477.84739	4.51344	0.789	0.032	T	0.0	0.026	B	0.0	0.013	B	0.001	0.437	N	0.966	0.259	N	-0.405	0.030	N	-3.94	0.961	D	-0.09	0.084	N	0.017	0.004	-0.679	0.615	T	0.312	0.683	T	0.040	0.592	D	0.972	0.187	10.50	0.938	0.232	0.713	0.347	D	c	-0.635	-0.401	1.000	0.500	0.598	0.340	0	2.85	0.322	0.542	0.228	0.154	0.240	0.998	0.411	1.000	0.888	9.156	0.360	.	.	.	0.5	.	226	6	134212885	chr6:134212885	G	A	.	PASS	DP=226;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	134490613	134490613	-	A	UTR3	SGK1	NM_001143678:c.*792_*793insT;NM_005627:c.*792_*793insT;NM_001291995:c.*792_*793insT;NM_001143677:c.*792_*793insT;NM_001143676:c.*792_*793insT	.	.	0.986448163	0.013551585	2.52E-07	.	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.51	122	6	134490613	chr6:134490613	C	CA,CAA	15.51	PASS	DP=122;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.
6	134490613	134490613	-	AA	UTR3	SGK1	NM_001143678:c.*792_*793insTT;NM_005627:c.*792_*793insTT;NM_001291995:c.*792_*793insTT;NM_001143677:c.*792_*793insTT;NM_001143676:c.*792_*793insTT	.	.	0.986448163	0.013551585	2.52E-07	.	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.51	122	6	134490613	chr6:134490613	C	CA,CAA	15.51	PASS	DP=122;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.
6	134758928	134758932	TCCTT	-	ncRNA_exonic	LINC01010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	78	6	134758927	chr6:134758927	GTCCTT	G	136	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	136582417	136582417	G	A	exonic	BCLAF1	.	nonsynonymous SNV	BCLAF1:NM_001077440:exon11:c.C2590T:p.R864C,BCLAF1:NM_001077441:exon12:c.C2224T:p.R742C,BCLAF1:NM_001301038:exon12:c.C2737T:p.R913C,BCLAF1:NM_014739:exon12:c.C2743T:p.R915C	.	.	.	.	0.85841	0.18154	1.987926294	97.63505544	3652.78199	11.74717	0.032	0.469	D	1.0	0.899	D	0.988	0.850	D	0.000	0.629	D	1.000	0.588	D	0	0.065	N	4.26	0.161	T	-1.2	0.320	N	0.874	0.863	-0.997	0.309	T	0.084	0.329	T	.	.	.	4.562	0.611	24.4	0.992	0.542	0.972	0.729	D	c	0.262	0.417	1.000	0.747	0.707	0.730	0	5.71	0.890	5.465	0.662	1.048	0.713	1.000	0.715	1.000	0.888	18.034	0.892	.	.	.	0.5	96	137	6	136582417	chr6:136582417	G	A	96	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	138584685	138584685	T	G	exonic	ARFGEF3	.	nonsynonymous SNV	ARFGEF3:NM_020340:exon12:c.T2065G:p.S689A	.	.	.	.	.	0.12485	-2.2199121	1.338759141	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.002	N	1	0.090	P	-1.445	0.006	N	1.03	0.405	T	0.08	0.060	N	0.035	0.015	-0.999	0.301	T	0.017	0.071	T	.	.	.	-0.423	0.060	0.339	0.302	0.016	0.260	0.226	N	c	-0.775	-0.554	0.978	0.298	0.651	0.465	0	5.17	0.707	2.532	0.451	0.133	0.217	1.000	0.715	0.063	0.172	9.064	0.354	Sec7 domain	.	.	0.5	53	13	6	138584685	chr6:138584685	T	G	53	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	143746939	143746939	C	A	UTR3	ADAT2	NM_182503:c.*2661G>T;NM_001286259:c.*2661G>T	.	.	2.09E-08	0.073719475	0.926280504	.	0.33152	0.15545	0.193034296	66.82000472	44.95237	1.2876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	218	6	143746939	chr6:143746939	C	A	.	PASS	DP=218;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	144081696	144081696	A	-	exonic	PHACTR2	.	frameshift deletion	PHACTR2:NM_001100164:exon5:c.613delA:p.N207Ifs*79,PHACTR2:NM_014721:exon5:c.580delA:p.N196Ifs*79	0.007389423	0.992472999	0.000137578	.	0.7271	0.09166	-0.045835247	50.34206181	1505.57685	7.21249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	360	6	144081695	chr6:144081695	TA	T	69	PASS	DP=360;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
6	145093075	145093075	C	T	exonic	UTRN	.	nonsynonymous SNV	UTRN:NM_007124:exon58:c.C8528T:p.P2843L	2.97E-09	0.999999997	2.24E-20	.	0.17851	0.56056	-1.550042262	3.255484784	1957.13132	8.14203	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.513	D	1	0.810	D	2.81	0.821	M	-5.81	0.994	D	-7.02	0.986	D	0.791	0.866	1.067	0.985	D	0.984	0.995	D	0.697	0.975	D	7.456	0.951	34	0.999	0.943	0.997	0.985	D	c	0.923	0.880	1.000	0.747	0.706	0.609	0	5.66	0.872	7.305	0.780	0.935	0.490	1.000	0.715	1.000	0.888	19.746	0.962	EF-hand domain pair|WW domain	.	.	0.5	.	78	6	145093075	chr6:145093075	C	T	.	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	148835437	148835437	T	-	intronic	SASH1	.	.	.	0.003254445	0.996741817	3.74E-06	.	0.3689	0.11167	-0.562239385	19.06699693	3939.62918	12.40945	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	83	6	148835436	chr6:148835436	CT	C	92	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	149842224	149842224	C	A	exonic	PPIL4	.	synonymous SNV	PPIL4:NM_139126:exon10:c.G954T:p.S318S	1.68E-05	0.992867371	0.00711582	.	0.28458	0.1178	-0.159704656	41.90846898	84.52811	1.95737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	6	149842224	chr6:149842224	C	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	150211100	150211100	T	C	exonic	RAET1E	.	synonymous SNV	RAET1E:NM_001243325:exon2:c.A159G:p.E53E,RAET1E:NM_001243327:exon2:c.A267G:p.E89E,RAET1E:NM_139165:exon2:c.A267G:p.E89E,RAET1E:NM_001243328:exon3:c.A267G:p.E89E	1.86E-05	0.454025759	0.545955646	.	0.03332	0.12047	2.149758993	97.97711724	1343.90882	6.88288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	100	6	150211100	chr6:150211100	T	C	65	PASS	DP=100;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	151266564	151266564	T	C	intronic	MTHFD1L	.	.	.	0.082519529	0.917479751	7.19E-07	.	0.08466	0.26137	-0.350843407	29.54116537	277.38146	3.56775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	66	6	151266564	chr6:151266564	T	C	60	PASS	DP=66;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	152422082	152422082	C	T	UTR3	ESR1	NM_001122742:c.*1981C>T;NM_001291230:c.*1981C>T;NM_001122741:c.*1981C>T;NM_001291241:c.*1981C>T;NM_001122740:c.*1981C>T;NM_000125:c.*1981C>T	.	.	0.987167021	0.012831888	1.09E-06	DISEASE: Estrogen resistance (ESTRR) [MIM:615363]: A disorder characterized by partial or complete resistance to estrogens, in the presence of elevated estrogen serum levels. Clinical features include absence of the pubertal growth spurt, delayed bone maturation, unfused epiphyses, reduced bone mineral density, osteoporosis, continued growth into adulthood and very tall adult stature. Glucose intolerance, hyperinsulinemia and lipid abnormalities may also be present. {ECO:0000269|PubMed:23841731, ECO:0000269|PubMed:8961262}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99765	0.95064	0.242582624	69.45623968	148.46269	2.6565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	6	152422082	chr6:152422082	C	T	41	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	154520741	154520741	C	G	intronic	IPCEF1;OPRM1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	10	6	154520741	chr6:154520741	C	G	43	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	158049415	158049415	C	G	exonic	ZDHHC14	.	nonsynonymous SNV	ZDHHC14:NM_024630:exon4:c.C600G:p.N200K,ZDHHC14:NM_153746:exon4:c.C600G:p.N200K	0.982366558	0.01763106	2.38E-06	.	.	0.10652	0.350995466	74.37485256	67.03988	1.69272	0.001	0.912	D	1.0	0.899	D	0.995	0.971	D	0.000	0.843	D	1	0.810	D	3.71	0.948	H	1.72	0.266	T	-5.84	0.884	D	0.488	0.535	-0.374	0.729	T	0.221	0.584	T	0.072	0.714	D	6.510	0.897	31	0.998	0.908	0.972	0.734	D	c	0.872	0.798	1.000	0.747	0.706	0.609	0	5.56	0.836	5.746	0.681	0.935	0.490	1.000	0.715	1.000	0.888	19.535	0.952	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	44	44	6	158049415	chr6:158049415	C	G	44	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	158508009	158508009	C	-	exonic	SYNJ2	.	frameshift deletion	SYNJ2:NM_001178088:exon22:c.2620delC:p.P876Lfs*4,SYNJ2:NM_003898:exon23:c.3331delC:p.P1113Lfs*4	3.52E-05	0.999960576	4.19E-06	.	0.23517	.	-1.902173	1.952111347	376.38515	4.09028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	420	6	158508008	chr6:158508008	AC	A	91	PASS	DP=420;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	158923296	158923296	G	A	exonic	TULP4	.	synonymous SNV	TULP4:NM_020245:exon13:c.G2601A:p.K867K	0.999936803	6.32E-05	5.19E-13	.	0.23566	.	-2.528819961	0.896437839	581.49333	4.88756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	91	6	158923296	chr6:158923296	G	A	58	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	159191717	159191720	GTGG	-	intronic	EZR	.	.	.	0.98811019	0.011889627	1.83E-07	.	0.64339	0.72105	-1.197736472	5.785562633	62.54234	1.61602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	15	6	159191716	chr6:159191716	AGTGG	A	42	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	159459132	159459132	A	T	intronic	TAGAP	.	.	.	0.927102798	0.07289384	3.36E-06	.	0.651	0.13404	0.935129812	89.86199575	148.37259	2.65445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	6	159459132	chr6:159459132	A	T	.	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	159670100	159670100	A	G	exonic	FNDC1	.	nonsynonymous SNV	FNDC1:NM_032532:exon16:c.A4720G:p.T1574A	3.07E-07	0.999968249	3.14E-05	.	0.1324	0.09503	2.671889479	98.84996461	6512.79761	16.93629	0.042	0.416	D	0.15	0.264	B	0.066	0.260	B	0.264	0.153	N	0.227	0.342	P	0.17	0.090	N	3.04	0.088	T	0.15	0.053	N	0.022	0.214	-0.917	0.460	T	0.005	0.015	T	.	.	.	0.592	0.151	8.100	0.783	0.118	0.015	0.050	N	c	-1.004	-1.009	1.000	0.454	0.487	0.133	0	-3.14	0.049	-0.991	0.038	-1.017	0.021	0.000	0.063	0.012	0.117	4.383	0.107	.	.	.	0.5	147	71	6	159670100	chr6:159670100	A	G	147	PASS	DP=71;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	161121626	161121626	C	T	intergenic	LPA;PLG	dist=34219;dist=1599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	6	161121626	chr6:161121626	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	163991839	163991839	C	T	UTR3	QKI	NM_001301085:c.*97C>T;NM_206855:c.*7062C>T;NM_206854:c.*6097C>T;NM_206853:c.*4836C>T;NM_006775:c.*97C>T	.	.	0.963163356	0.036821914	1.47E-05	.	0.28593	0.19768	-0.229483771	36.86010852	6.7048	0.2474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	6	163991839	chr6:163991839	C	T	.	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
6	163991862	163991862	C	T	UTR3	QKI	NM_001301085:c.*120C>T;NM_206855:c.*7085C>T;NM_206854:c.*6120C>T;NM_206853:c.*4859C>T;NM_006775:c.*120C>T	.	.	0.963163356	0.036821914	1.47E-05	.	0.28593	0.19768	-0.229483771	36.86010852	6.7048	0.2474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	6	163991862	chr6:163991862	C	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	165713961	165713961	A	C	exonic	C6orf118	.	nonsynonymous SNV	C6orf118:NM_144980:exon3:c.T768G:p.I256M	1.46E-17	0.00041395	0.99958605	.	0.05882	.	0.935129812	89.86199575	1170.66372	6.50346	0.136	0.260	T	0.993	0.637	D	0.878	0.605	P	0.648	0.105	N	1	0.090	P	1.59	0.404	L	2.48	0.147	T	-1.07	0.279	N	0.082	0.075	-1.055	0.131	T	0.018	0.076	T	.	.	.	-2.709	0.002	0.001	0.781	0.117	0.004	0.021	N	c	-1.460	-1.770	0.999	0.392	0.487	0.133	0	-10.0	0.004	-1.978	0.016	-2.631	0.002	0.000	0.063	0.000	0.016	7.846	0.284	Translin-associated factor X-interacting protein 1, N-terminal	ENSG00000112539.10	Testis	0.5	43	12	6	165713961	chr6:165713961	A	C	43	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
6	167709636	167709636	G	A	exonic	UNC93A	.	nonsynonymous SNV	UNC93A:NM_001143947:exon3:c.G386A:p.R129H,UNC93A:NM_018974:exon3:c.G386A:p.R129H	1.38E-06	0.610062547	0.389936076	.	0.08771	0.10097	2.53746678	98.71431941	4005.17839	12.52307	0.123	0.275	T	0.01	0.144	B	0.022	0.184	B	0.044	0.019	N	1	0.090	N	-0.17	0.043	N	1.51	0.309	T	-1.41	0.348	N	0.083	0.227	-1.058	0.123	T	0.011	0.040	T	0.001	0.018	T	-1.025	0.031	0.014	0.910	0.197	0.056	0.114	N	c	-2.069	-2.096	0.804	0.242	0.487	0.133	0	-5.73	0.022	-0.262	0.086	-1.772	0.007	0.000	0.063	0.000	0.016	0.985	0.013	Major facilitator superfamily domain	.	.	0.5	89	133	6	167709636	chr6:167709636	G	A	89	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	168355107	168355107	-	T	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	28	6	168355107	chr6:168355107	C	CT	40	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	168439334	168439334	C	G	exonic	KIF25	.	nonsynonymous SNV	KIF25:NM_005355:exon5:c.C419G:p.A140G,KIF25:NM_030615:exon5:c.C419G:p.A140G	3.75E-09	0.098368373	0.901631624	.	0.04864	0.08777	1.936492053	97.50530786	587.48576	4.91639	0.586	0.059	T	0.002	0.090	B	0.004	0.139	B	0.715	0.063	N	1	0.090	N	-0.515	0.026	N	-0.68	0.726	T	0.13	0.055	N	0.063	0.097	-1.043	0.163	T	0.049	0.209	T	0.014	0.346	T	-0.926	0.035	0.023	0.088	0.001	0.012	0.043	N	c	-1.111	-1.079	0.119	0.168	0.646	0.450	0	0.843	0.180	1.421	0.342	-0.166	0.106	0.005	0.169	0.000	0.016	6.239	0.199	Kinesin motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	93	82	6	168439334	chr6:168439334	C	G	93	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	912131	912131	G	A	exonic	SUN1	.	nonsynonymous SNV	SUN1:NM_001171944:exon16:c.G1864A:p.E622K,SUN1:NM_025154:exon17:c.G1924A:p.E642K,SUN1:NM_001130965:exon18:c.G2173A:p.E725K	0.835840781	0.164158985	2.34E-07	.	0.12582	0.08767	0.834017099	88.13989148	1176.18927	6.51539	0.002	0.721	D	0.955	0.764	P	0.69	0.722	P	0.000	0.843	D	1	0.810	D	2.23	0.633	M	1.04	0.402	T	-3.42	0.687	D	0.315	0.689	-0.576	0.658	T	0.317	0.687	T	0.017	0.380	T	5.959	0.819	27.7	0.999	0.992	0.990	0.904	D	c	0.410	0.482	1.000	0.747	0.707	0.730	0	5.07	0.680	6.520	0.735	1.048	0.713	1.000	0.715	0.999	0.750	18.789	0.919	SUN domain	.	.	0.5	.	81	7	912131	chr7:912131	G	A	.	PASS	DP=81;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	975047	975047	G	A	exonic	ADAP1	.	synonymous SNV	ADAP1:NM_001284308:exon2:c.C210T:p.S70S,ADAP1:NM_006869:exon2:c.C177T:p.S59S	0.657926854	0.341835895	0.000237251	.	0.17754	0.12827	-0.933156985	9.54824251	48.02044	1.34684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	7	975047	chr7:975047	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	1474669	1474669	C	T	intronic	MICALL2	.	.	.	7.76E-17	0.004116347	0.995883653	.	0.27411	0.08337	1.39439264	94.65675867	907.55182	5.86145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	789	7	1474669	chr7:1474669	C	T	72	PASS	DP=789;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	1516129	1516129	-	CCTCTCCCGGATGGGCCACCC	intronic	INTS1	.	.	.	0.224121375	0.775878625	1.91E-10	.	0.15585	.	-5.050633482	0.070771408	422.05224	4.29253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	18	7	1516129	chr7:1516129	G	GCCTCTCCCGGATGGGCCACCC	44	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	1538608	1538608	C	T	intronic	INTS1	.	.	.	0.224121375	0.775878625	1.91E-10	.	0.15585	.	-5.050633482	0.070771408	422.05224	4.29253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	7	1538608	chr7:1538608	C	T	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	1540023	1540023	G	A	intronic	INTS1	.	.	.	0.224121375	0.775878625	1.91E-10	.	0.15585	.	-5.050633482	0.070771408	422.05224	4.29253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	630	7	1540023	chr7:1540023	G	A	75	PASS	DP=630;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	2296436	2296436	C	A	intronic	SNX8	.	.	.	0.165170969	0.831782233	0.003046798	.	0.16684	0.11365	0.376678994	75.50719509	357.15648	4.00401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	79	7	2296436	chr7:2296436	C	A	95	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	2686639	2686639	C	T	exonic	TTYH3	.	synonymous SNV	TTYH3:NM_025250:exon2:c.C276T:p.I92I	0.979598759	0.02039783	3.41E-06	.	0.20673	0.13236	-0.354480518	29.42911064	106.07775	2.23473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	7	2686639	chr7:2686639	C	T	.	PASS	DP=87;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	2702316	2702316	C	T	UTR3	TTYH3	NM_025250:c.*943C>T	.	.	0.979598759	0.02039783	3.41E-06	.	0.20673	0.13236	-0.354480518	29.42911064	106.07775	2.23473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	387	7	2702316	chr7:2702316	C	T	90	PASS	DP=387;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	3991295	3991295	T	G	intronic	SDK1	.	.	.	0.005015997	0.994984003	2.78E-11	.	0.23874	0.11227	-4.629838752	0.076669026	1933.799	8.09023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	7	3991295	chr7:3991295	T	G	.	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	4843227	4843227	C	A	exonic	RADIL	.	nonsynonymous SNV	RADIL:NM_018059:exon11:c.G2449T:p.G817C	1.31E-12	0.089137837	0.910862163	.	.	.	0.236922632	68.73083274	3259.52862	10.87748	0.016	0.518	D	0.989	0.637	D	0.584	0.559	P	0.736	0.064	N	1	0.090	N	0.69	0.170	N	3.33	0.062	T	-1.68	0.401	N	0.25	0.305	-1.030	0.203	T	0.019	0.080	T	0.045	0.621	D	4.241	0.568	23.9	0.988	0.468	0.022	0.064	N	c	-0.880	-1.102	0.005	0.108	0.646	0.450	0	-1.01	0.096	-1.559	0.022	-0.823	0.031	0.000	0.063	0.016	0.126	2.796	0.050	.	.	.	0.5	.	79	7	4843227	chr7:4843227	C	A	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	5413785	5413785	C	T	exonic	TNRC18	.	nonsynonymous SNV	TNRC18:NM_001080495:exon10:c.G3130A:p.G1044S	0.999973966	2.60E-05	1.21E-14	.	.	.	.	.	6309.78902	16.61915	0.392	0.108	T	0.028	0.184	B	0.011	0.145	B	.	.	.	1	0.090	N	-0.345	0.033	N	2.83	0.108	T	-0.47	0.152	N	0.079	0.071	-0.972	0.367	T	0.024	0.104	T	0.029	0.520	D	0.713	0.162	8.912	0.820	0.135	0.648	0.323	D	c	-0.699	-0.672	0.004	0.103	0.563	0.310	0	3.95	0.448	1.903	0.393	0.887	0.390	0.930	0.320	0.030	0.147	8.998	0.350	.	.	.	0.5	.	165	7	5413785	chr7:5413785	C	T	.	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	5460674	5460674	C	T	intronic	TNRC18	.	.	.	0.999973966	2.60E-05	1.21E-14	.	.	.	.	.	6309.78902	16.61915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	207	7	5460674	chr7:5460674	C	T	59	PASS	DP=207;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	5662432	5662432	C	T	UTR3	RNF216	NM_207116:c.*59G>A;NM_207111:c.*59G>A	.	.	0.409334345	0.590665052	6.03E-07	DISEASE: Gordon Holmes syndrome (GDHS) [MIM:212840]: A disease characterized by cerebellar symptoms and signs of sex steroid deficiency. Clinical features include cerebellar and brain stem atrophy, cerebellar ataxia, hypothalamic LHRH deficiency, hypogonadotrophic hypogonadism, lack of secondary sexual characteristics, and infertility. {ECO:0000269|PubMed:23656588}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12144	0.08992	-1.188670131	5.891719745	131.90997	2.5009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	113	7	5662432	chr7:5662432	C	T	86	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	5873281	5873281	T	C	ncRNA_intronic	ZNF815P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	7	5873281	chr7:5873281	T	C	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	5959485	5959485	G	A	exonic	CCZ1	.	nonsynonymous SNV	CCZ1:NM_015622:exon12:c.G994A:p.V332I	0.994694688	0.005304692	6.20E-07	.	0.2029	.	-0.159704656	41.90846898	84.72538	1.9605	0.44	0.092	T	0.001	0.067	B	0.004	0.093	B	0.045	0.236	N	1	0.090	P	.	.	.	.	.	.	-0.17	0.096	N	0.043	0.023	-1.016	0.249	T	0.000	0.000	T	.	.	.	-1.013	0.031	0.015	0.631	0.069	0.021	0.061	N	c	-1.612	-1.668	0.000	0.057	0.706	0.609	0	-5.07	0.027	0.961	0.287	-0.569	0.046	0.134	0.232	0.001	0.043	9.832	0.399	.	ENSG00000122674.8	Colon_Transverse	0.5	151	366	7	5959485	chr7:5959485	G	A	151	PASS	DP=366;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	6045627	6045627	C	T	exonic	PMS2	.	nonsynonymous SNV	PMS2:NM_000535:exon2:c.G59A:p.R20Q,PMS2:NM_001322006:exon2:c.G59A:p.R20Q,PMS2:NM_001322014:exon2:c.G59A:p.R20Q	1.14E-13	0.266962097	0.733037903	DISEASE: Hereditary non-polyposis colorectal cancer 4 (HNPCC4) [MIM:614337]: An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. {ECO:0000269|PubMed:15887124, ECO:0000269|PubMed:18178629, ECO:0000269|PubMed:23709753}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:15077197, ECO:0000269|PubMed:17557300, ECO:0000269|PubMed:7661930, ECO:0000269|PubMed:9419979}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7782	.	1.477080431	95.28780373	788.03656	5.54211	0.121	0.277	T	0.857	0.493	P	0.294	0.435	B	0.001	0.419	N	0.614	0.588	P	2.045	0.562	M	-1.77	0.862	D	-1.77	0.446	N	0.039	0.198	-0.606	0.646	T	0.051	0.218	T	.	.	.	2.877	0.406	21.7	0.997	0.780	0.589	0.305	D	c	-0.371	-0.359	0.741	0.232	0.732	0.924	0	0.771	0.176	0.288	0.186	-0.372	0.066	0.939	0.324	0.980	0.490	10.394	0.432	Histidine kinase-like ATPase, C-terminal domain	ENSG00000187953.6|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000187953.6|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10	Adipose_Subcutaneous|Adipose_Subcutaneous|Artery_Tibial|Breast_Mammary_Tissue|Esophagus_Mucosa|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Thyroid	0.5	85	138	7	6045627	chr7:6045627	C	T	85	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	6470058	6470058	-	T	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	127	7	6470058	chr7:6470058	C	CT	86	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	6647756	6647756	C	A	exonic	C7orf26	.	synonymous SNV	C7orf26:NM_024067:exon6:c.C1314A:p.I438I,C7orf26:NM_001303039:exon7:c.C1023A:p.I341I	0.82656656	0.172642585	0.000790855	.	0.15371	0.10416	-0.336073593	30.55555556	176.14971	2.8877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	7	6647756	chr7:6647756	C	A	.	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	6862017	6862017	-	A	intronic	CCZ1B	.	.	.	.	.	.	.	0.2431	.	0.881944684	89.02453409	2277.99326	8.83084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	542	7	6862017	chr7:6862017	G	GA	112	PASS	DP=542;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	6899511	6899511	C	A	intergenic	CCZ1B;MIR3683	dist=33585;dist=207084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	7	6899511	chr7:6899511	C	A	.	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	11091407	11091407	G	A	exonic	PHF14	.	synonymous SNV	PHF14:NM_014660:exon14:c.G2481A:p.T827T	0.20653924	0.793444436	1.63E-05	.	0.53698	0.10653	-0.532670911	20.78320359	132.45351	2.50445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	63	7	11091407	chr7:11091407	G	A	71	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	11630197	11630197	C	T	exonic	THSD7A	.	nonsynonymous SNV	THSD7A:NM_015204:exon4:c.G1343A:p.R448H	0.999280749	0.000719251	1.10E-16	.	0.27361	0.08944	-1.308377521	4.865534324	3259.76198	10.88292	0.235	0.180	T	0.391	0.328	B	0.049	0.237	B	0.000	0.843	D	1	0.810	D	2.185	0.615	M	0.25	0.595	T	-0.84	0.229	N	0.532	0.764	-0.859	0.514	T	0.182	0.530	T	0.025	0.481	T	6.182	0.853	28.6	0.999	0.999	0.980	0.786	D	c	0.128	0.242	1.000	0.747	0.563	0.310	0	5.8	0.921	6.109	0.710	0.935	0.490	0.999	0.424	0.467	0.265	20.055	0.976	.	.	.	0.5	143	628	7	11630197	chr7:11630197	C	T	143	PASS	DP=628;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	12668752	12668752	G	T	exonic	SCIN	.	nonsynonymous SNV	SCIN:NM_033128:exon7:c.G483T:p.R161S,SCIN:NM_001112706:exon9:c.G1224T:p.R408S	4.08E-16	0.001532187	0.998467813	.	0.49689	0.12425	1.223576934	93.23543289	4912.87103	14.2979	0.074	0.346	T	0.903	0.478	P	0.648	0.505	P	0.000	0.843	D	0.996	0.431	D	2.195	0.620	M	2.44	0.152	T	-2.37	0.522	N	0.35	0.707	-1.117	0.025	T	0.053	0.226	T	0.018	0.406	T	3.101	0.432	22.5	0.991	0.522	0.629	0.317	D	c	-0.099	-0.212	0.017	0.129	0.638	0.428	0	0.542	0.163	0.884	0.277	0.154	0.240	0.459	0.264	0.112	0.193	7.923	0.288	ADF-H/Gelsolin-like domain|Gelsolin-like domain	.	.	0.5	116	88	7	12668752	chr7:12668752	G	T	116	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	15347150	15347150	-	T	intronic	AGMO	.	.	.	3.26E-07	0.774065266	0.225934409	.	0.05711	0.12273	0.402364592	76.45081387	546.90919	4.75481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	68	7	15347150	chr7:15347150	G	GT	53	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	19748658	19748658	C	A	UTR5	TWISTNB	NM_001002926:c.-19G>T	.	.	0.309424388	0.672567774	0.018007838	.	0.14338	0.12628	-0.404032746	26.53338051	60.1892	1.57562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	7	19748658	chr7:19748658	C	A	.	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	21467955	21467955	C	T	intronic	SP4	.	.	.	0.951288043	0.04870596	6.00E-06	.	0.90308	0.23101	-0.844966979	11.1759849	141.72587	2.59835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	356	7	21467955	chr7:21467955	C	T	85	PASS	DP=356;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	21583121	21583121	C	T	exonic	DNAH11	.	synonymous SNV	DNAH11:NM_001277115:exon1:c.C258T:p.N86N	.	.	.	DISEASE: Kartagener syndrome (KTGS) [MIM:244400]: An autosomal recessive disorder characterized by the association of primary ciliary dyskinesia with situs inversus. Clinical features include recurrent respiratory infections, bronchiectasis, infertility, and lateral transposition of the viscera of the thorax and abdomen. The situs inversus is most often total, although it can be partial in some cases (isolated dextrocardia or isolated transposition of abdominal viscera). {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865, ECO:0000269|PubMed:25186273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia; reduced fertility is often observed in male patients due to abnormalities of sperm tails. Half of the patients exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12513	0.12171	.	.	20704.35568	30.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	7	21583121	chr7:21583121	C	T	.	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	23625204	23625204	C	T	ncRNA_exonic	CLK2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	227	7	23625204	chr7:23625204	C	T	123	PASS	DP=227;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	26576535	26576535	T	C	ncRNA_exonic	KIAA0087	.	.	.	.	.	.	.	.	.	.	.	17.91578	0.62616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	92	7	26576535	chr7:26576535	T	C	150	PASS	DP=92;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	26883762	26883762	A	-	intronic	SKAP2	.	.	.	0.909797278	0.090174061	2.87E-05	.	0.82035	0.26241	0.17280645	65.75843359	1007.31849	6.11261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.44	23	7	26883761	chr7:26883761	TA	T	18.44	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	28547355	28547355	G	T	exonic	CREB5	.	synonymous SNV	CREB5:NM_182899:exon3:c.G192T:p.R64R,CREB5:NM_004904:exon4:c.G270T:p.R90R,CREB5:NM_182898:exon4:c.G291T:p.R97R	0.989844565	0.010154821	6.14E-07	.	0.7763	.	-0.670411825	15.61689078	30.64753	0.97477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	152	7	28547355	chr7:28547355	G	T	97	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	29186256	29186256	A	G	exonic	CHN2	.	synonymous SNV	CHN2:NM_001293069:exon1:c.A57G:p.P19P	0.025502324	0.97183321	0.002664466	.	0.26539	.	-0.380166007	27.88393489	1077.81846	6.29228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	61	7	29186256	chr7:29186256	A	G	76	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	29771637	29771637	C	A	intergenic	DPY19L2P3;WIPF3	dist=43778;dist=74533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	7	29771637	chr7:29771637	C	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	29874354	29874354	C	T	exonic	WIPF3	.	nonsynonymous SNV	WIPF3:NM_001080529:exon2:c.C14T:p.P5L	0.000296999	0.799391174	0.200311827	.	0.16204	.	.	.	274.86842	3.55213	0.0	0.912	D	1.0	0.899	D	0.995	0.818	D	.	.	.	0.999	0.467	D	0.895	0.225	L	-0.98	0.759	T	-3.12	0.637	D	0.637	0.668	-0.087	0.804	T	0.457	0.789	T	0.070	0.709	D	5.556	0.755	26.4	0.944	0.241	0.635	0.318	D	c	0.498	0.465	0.912	0.264	0.615	0.372	0	4.63	0.570	3.112	0.498	0.935	0.490	0.659	0.280	0.952	0.428	13.153	0.587	.	.	.	0.5	64	346	7	29874354	chr7:29874354	C	T	64	PASS	DP=346;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	30795291	30795291	G	T	exonic	INMT	.	nonsynonymous SNV	INMT:NM_001199219:exon3:c.G613T:p.V205L,INMT:NM_006774:exon3:c.G616T:p.V206L	0.000120278	0.385695	0.614184722	.	0.10895	0.11082	1.976952171	97.61146497	4681.43934	13.79634	0.009	0.574	D	0.986	0.596	D	0.874	0.603	P	0.003	0.355	N	0.909	0.364	D	1.91	0.513	L	3.92	0.035	T	-2.07	0.473	N	0.284	0.420	-1.073	0.088	T	0.023	0.100	T	0.002	0.050	T	4.535	0.607	24.3	0.994	0.604	0.773	0.377	D	c	0.333	0.248	1.000	0.747	0.625	0.395	0	2.78	0.316	2.354	0.435	0.857	0.375	1.000	0.715	0.905	0.384	8.857	0.342	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	75	84	7	30795291	chr7:30795291	G	T	75	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	32529874	32529874	C	T	intronic	LSM5	.	.	.	0.018231933	0.725921529	0.255846538	.	0.68416	0.11388	-0.031067188	51.03798066	5.18241	0.19274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	7	32529874	chr7:32529874	C	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	32861170	32861171	AT	-	intergenic	LINC00997;DPY19L1P2	dist=58634;dist=4743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	28	7	32861169	chr7:32861169	CAT	C	72	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	33054388	33054388	T	C	exonic	NT5C3A	.	nonsynonymous SNV	NT5C3A:NM_001002010:exon9:c.A965G:p.D322G,NT5C3A:NM_001002009:exon10:c.A848G:p.D283G,NT5C3A:NM_016489:exon10:c.A848G:p.D283G,NT5C3A:NM_001166118:exon11:c.A812G:p.D271G	0.012372194	0.952227978	0.035399828	DISEASE: P5N deficiency (P5ND) [MIM:266120]: Autosomal recessive condition causing hemolytic anemia characterized by marked basophilic stippling and the accumulation of high concentrations of pyrimidine nucleotides within the erythrocyte. It is implicated in the anemia of lead poisoning and is possibly associated with learning difficulties. {ECO:0000269|PubMed:11369620, ECO:0000269|PubMed:12930399, ECO:0000269|PubMed:15238149, ECO:0000269|PubMed:15604219, ECO:0000269|PubMed:15968458, ECO:0000269|PubMed:16461318, ECO:0000269|PubMed:18499901, ECO:0000269|PubMed:25153905}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20158	0.29586	0.12689526	63.00424628	81.15003	1.90678	0.001	0.784	D	0.934	0.502	P	0.881	0.608	P	0.003	0.355	N	1	0.810	D	3.29	0.905	M	-2.5	0.892	D	-5.98	0.893	D	0.601	0.670	0.935	0.962	D	0.856	0.952	D	.	.	.	6.728	0.919	32	0.997	0.818	0.995	0.964	D	c	0.800	0.791	1.000	0.747	0.732	0.924	0	5.94	0.962	8.017	0.886	1.061	0.807	1.000	0.715	0.996	0.625	16.407	0.835	HAD-like domain	.	.	0.5	110	176	7	33054388	chr7:33054388	T	C	110	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	34867239	34867239	A	G	ncRNA_intronic	NPSR1-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	7	34867239	chr7:34867239	A	G	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	34874038	34874038	C	G	exonic	NPSR1	.	nonsynonymous SNV	NPSR1:NM_001300934:exon4:c.C525G:p.S175R,NPSR1:NM_001300933:exon6:c.C690G:p.S230R,NPSR1:NM_001300935:exon6:c.C723G:p.S241R,NPSR1:NM_207172:exon6:c.C723G:p.S241R,NPSR1:NM_207173:exon6:c.C723G:p.S241R	8.18E-07	0.736305525	0.263693657	.	0.23423	0.19297	1.335644081	94.24982307	5094.13552	14.62021	0.049	0.546	D	0.999	0.764	D	0.966	0.715	D	0.000	0.491	D	0.002	0.453	P	1.475	0.372	L	1.22	0.370	T	-2.73	0.580	D	0.381	0.441	-0.996	0.310	T	0.000	0.000	T	.	.	.	4.477	0.599	24.2	0.996	0.720	0.827	0.416	D	c	0.487	0.452	0.131	0.171	0.487	0.133	0	4.75	0.598	1.243	0.322	0.852	0.362	1.000	0.715	0.908	0.386	10.144	0.417	GPCR, rhodopsin-like, 7TM	.	.	0.5	57	17	7	34874038	chr7:34874038	C	G	57	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	34979817	34979817	G	A	exonic	DPY19L1	.	synonymous SNV	DPY19L1:NM_015283:exon19:c.C1593T:p.S531S	0.142871737	0.857094823	3.34E-05	.	0.22929	.	-0.404032746	26.53338051	2009.33576	8.25199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	7	34979817	chr7:34979817	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	38423310	38423311	GT	-	UTR3	AMPH	NM_139316:c.*1109_*1108delAC;NM_001635:c.*1109_*1108delAC	.	.	0.032266566	0.96771785	1.56E-05	.	0.23196	0.19053	0.225995239	68.51851852	678.4813	5.20472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	15	7	38423309	chr7:38423309	GGT	G	42	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	42007149	42007149	-	A	intronic	GLI3	.	.	.	0.999994739	5.26E-06	6.01E-15	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9964	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	37	7	42007149	chr7:42007149	G	GA	39	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	44054022	44054022	A	G	ncRNA_intronic	POLR2J4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	228	7	44054022	chr7:44054022	A	G	114	PASS	DP=228;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	44097842	44097842	C	G	exonic	DBNL	.	nonsynonymous SNV	DBNL:NM_001284313:exon5:c.C358G:p.R120G,DBNL:NM_001284315:exon5:c.C382G:p.R128G,DBNL:NM_001014436:exon7:c.C667G:p.R223G,DBNL:NM_001122956:exon7:c.C667G:p.R223G,DBNL:NM_014063:exon7:c.C667G:p.R223G	0.070981914	0.926323701	0.002694385	.	0.20108	0.72014	-0.023789244	52.09365416	77.70496	1.85644	0.015	0.574	D	0.799	0.577	P	0.401	0.585	B	0.001	0.393	N	0.999	0.506	D	3.4	0.918	M	1.8	0.338	T	-3.83	0.790	D	0.238	0.523	-1.076	0.082	T	0.092	0.352	T	0.079	0.733	D	6.393	0.883	29.6	0.996	0.729	0.519	0.288	D	c	-0.122	-0.110	1.000	0.747	0.722	0.854	0	4.05	0.462	-0.098	0.109	0.935	0.490	0.008	0.178	0.996	0.625	7.320	0.255	ADF-H/Gelsolin-like domain|Actin-depolymerising factor homology domain	.	.	0.5	90	76	7	44097842	chr7:44097842	C	G	90	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	44282825	44282825	G	T	intronic	CAMK2B	.	.	.	0.468620194	0.531370436	9.37E-06	.	0.30429	0.29938	-0.624497208	17.16206653	1301.92267	6.78858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	70	7	44282825	chr7:44282825	G	T	71	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	44664014	44664014	A	G	exonic	OGDH	.	synonymous SNV	OGDH:NM_001003941:exon2:c.A72G:p.S24S,OGDH:NM_001165036:exon2:c.A72G:p.S24S,OGDH:NM_002541:exon2:c.A72G:p.S24S	0.993695121	0.006304878	3.21E-10	.	0.54935	0.63558	-0.484940685	22.75300778	342.2782	3.9227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	94	7	44664014	chr7:44664014	A	G	79	PASS	DP=94;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	44802408	44802408	G	A	intronic	ZMIZ2	.	.	.	0.999620382	0.000379618	4.09E-11	.	0.21655	0.09565	-0.08446956	47.15145081	1705.86311	7.61894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	120	7	44802408	chr7:44802408	G	A	.	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	45956171	45956171	C	T	exonic	IGFBP3	.	synonymous SNV	IGFBP3:NM_000598:exon3:c.G726A:p.K242K,IGFBP3:NM_001013398:exon3:c.G744A:p.K248K	0.362251902	0.586835044	0.050913054	.	0.28872	0.82225	.	.	2102.84042	8.44477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	7	45956171	chr7:45956171	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	47342723	47342723	C	T	exonic	TNS3	.	synonymous SNV	TNS3:NM_022748:exon22:c.G3282A:p.G1094G	0.999389291	0.000610709	1.08E-12	.	0.29297	0.14134	0.132151962	63.36400094	726.40943	5.35297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	907	7	47342723	chr7:47342723	C	T	67	PASS	DP=907;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	47979921	47979921	A	-	intronic	PKD1L1	.	.	.	1.72E-23	0.999996492	3.51E-06	.	0.07124	.	2.171086137	98.04788865	3392.60955	11.14655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	7	47979920	chr7:47979920	GA	G,GAA	45	PASS	DP=38;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	47979921	47979921	-	A	intronic	PKD1L1	.	.	.	1.72E-23	0.999996492	3.51E-06	.	0.07124	.	2.171086137	98.04788865	3392.60955	11.14655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	7	47979920	chr7:47979920	GA	G,GAA	45	PASS	DP=38;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	48965281	48965281	G	T	ncRNA_exonic	CDC14C	.	.	.	.	.	.	.	.	0.09972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	300	7	48965281	chr7:48965281	G	T	120	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	55242466	55242480	GAATTAAGAGAAGCA	-	exonic	EGFR	.	nonframeshift deletion	EGFR:NM_001346941:exon13:c.1435_1449del:p.E479_A483del,EGFR:NM_001346897:exon18:c.2101_2115del:p.E701_A705del,EGFR:NM_001346899:exon18:c.2101_2115del:p.E701_A705del,EGFR:NM_001346898:exon19:c.2236_2250del:p.E746_A750del,EGFR:NM_001346900:exon19:c.2077_2091del:p.E693_A697del,EGFR:NM_005228:exon19:c.2236_2250del:p.E746_A750del	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	50	7	55242465	chr7:55242465	GGAATTAAGAGAAGCA	G	56	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	55259515	55259515	T	G	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_001346941:exon15:c.T1772G:p.L591R,EGFR:NM_001346897:exon20:c.T2438G:p.L813R,EGFR:NM_001346899:exon20:c.T2438G:p.L813R,EGFR:NM_001346898:exon21:c.T2573G:p.L858R,EGFR:NM_001346900:exon21:c.T2414G:p.L805R,EGFR:NM_005228:exon21:c.T2573G:p.L858R	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	0.0	0.912	D	0.999	0.899	D	0.956	0.916	D	0.000	0.504	D	1.000	0.810	D	3.65	0.943	H	-2.83	0.913	D	-5.23	0.839	D	0.989	0.993	0.987	0.970	D	0.881	0.960	D	0.698	0.975	D	6.930	0.933	33	0.998	0.896	0.981	0.798	D	c	0.927	0.868	1.000	0.747	0.741	0.978	0	5.71	0.890	7.960	0.873	1.061	0.807	1.000	0.715	1.000	0.888	14.811	0.695	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	81	46	7	55259515	chr7:55259515	T	G	81	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.
7	56129429	56129429	G	T	intronic	CCT6A	.	.	.	0.998661755	0.001338223	2.15E-08	.	0.24693	0.43796	-0.291981272	33.20358575	345.9113	3.94523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	91	7	56129429	chr7:56129429	G	T	.	PASS	DP=91;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	56141802	56141802	C	A	intronic	SUMF2	.	.	.	5.53E-05	0.883050597	0.11689414	.	0.07185	0.68732	0.420771676	77.15852795	226.86098	3.25511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	7	56141802	chr7:56141802	C	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	56146228	56146242	GGGGCCTTGTAGCTG	-	intronic	SUMF2	.	.	.	5.53E-05	0.883050597	0.11689414	.	0.07185	0.68732	0.420771676	77.15852795	226.86098	3.25511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.69	44	7	56146227	chr7:56146227	CGGGGCCTTGTAGCTG	C	12.69	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	56877090	56877090	G	A	ncRNA_exonic	LOC401357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	270	7	56877090	chr7:56877090	G	A	161	PASS	DP=270;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	56881152	56881152	A	G	upstream	LOC401357	dist=723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	1650	7	56881152	chr7:56881152	A	G	164	PASS	DP=1650;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	63020733	63020733	C	G	intergenic	LOC100287834;MIR4283-1	dist=161314;dist=60735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	7	63020733	chr7:63020733	C	G	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	63033363	63033363	G	T	intergenic	LOC100287834;MIR4283-1	dist=173944;dist=48105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	144	7	63033363	chr7:63033363	G	T	66	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	63225779	63225779	C	T	intergenic	MIR4283-1;ZNF722P	dist=144232;dist=233405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	132	7	63225779	chr7:63225779	C	T	112	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	63720706	63720706	C	A	exonic	ZNF679	.	stopgain	ZNF679:NM_153363:exon3:c.C147A:p.Y49X	1.43E-09	0.029818033	0.970181966	.	0.06744	.	1.903532842	97.3519698	2627.76478	9.6152	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6.635	0.910	32	0.981	0.377	0.009	0.034	N	c	-0.860	-1.269	0.000	0.029	0.487	0.133	0	-0.39	0.118	-1.105	0.034	-1.756	0.007	0.000	0.063	0.478	0.267	5.329	0.151	Krueppel-associated box	.	.	0.5	116	280	7	63720706	chr7:63720706	C	A	116	PASS	DP=280;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	64672804	64672804	A	G	ncRNA_exonic	INTS4P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	104	7	64672804	chr7:64672804	A	G	137	PASS	DP=104;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	65219668	65219668	G	T	ncRNA_intronic	CCT6P1;LOC441242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	29	7	65219668	chr7:65219668	G	T	59	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	65257835	65257835	C	G	intergenic	LOC441242;VKORC1L1	dist=22038;dist=80251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	207	295	7	65257835	chr7:65257835	C	G	207	PASS	DP=295;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	66463196	66463196	T	-	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	672	7	66463195	chr7:66463195	AT	A	127	PASS	DP=672;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	66703238	66703238	-	T	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	495	7	66703238	chr7:66703238	A	AT	99	PASS	DP=495;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	69064959	69064959	C	-	intronic	AUTS2	.	.	.	0.996187482	0.003812518	9.39E-11	.	0.83083	0.1075	-1.967739992	1.816466148	320.02805	3.80007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	18	7	69064958	chr7:69064958	AC	A	43	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	70229796	70229796	C	T	exonic	AUTS2	.	nonsynonymous SNV	AUTS2:NM_001127231:exon8:c.C1273T:p.H425Y,AUTS2:NM_015570:exon8:c.C1273T:p.H425Y	0.996187482	0.003812518	9.39E-11	.	0.83083	0.1075	-1.967739992	1.816466148	320.02805	3.80007	0.008	0.721	D	0.347	0.318	B	0.085	0.279	B	0.000	0.843	D	1.000	0.588	D	1.875	0.501	L	1.29	0.358	T	-2.63	0.597	D	0.321	0.385	-1.066	0.102	T	0.094	0.357	T	0.021	0.434	T	4.373	0.585	24.1	0.997	0.793	0.826	0.415	D	c	0.225	0.362	1.000	0.747	0.635	0.413	0	5.45	0.796	5.331	0.655	0.919	0.430	1.000	0.715	1.000	0.888	18.297	0.900	.	.	.	0.5	.	40	7	70229796	chr7:70229796	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	70229846	70229846	G	T	exonic	AUTS2	.	synonymous SNV	AUTS2:NM_001127231:exon8:c.G1323T:p.L441L,AUTS2:NM_015570:exon8:c.G1323T:p.L441L	0.996187482	0.003812518	9.39E-11	.	0.83083	0.1075	-1.967739992	1.816466148	320.02805	3.80007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	226	7	70229846	chr7:70229846	G	T	74	PASS	DP=226;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	70229870	70229870	G	A	exonic	AUTS2	.	synonymous SNV	AUTS2:NM_001127231:exon8:c.G1347A:p.Q449Q,AUTS2:NM_015570:exon8:c.G1347A:p.Q449Q	0.996187482	0.003812518	9.39E-11	.	0.83083	0.1075	-1.967739992	1.816466148	320.02805	3.80007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	7	70229870	chr7:70229870	G	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	72361246	72361246	A	T	UTR5	POM121	NM_001257190:c.-35705A>T;NM_172020:c.-35705A>T	.	.	.	.	.	.	0.2255	0.08649	-0.33061537	30.82094834	663.23352	5.16151	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	419	7	72361246	chr7:72361246	A	T	164	PASS	DP=419;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	72712011	72712011	T	A	intergenic	NCF1B;NSUN5	dist=62032;dist=4502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	114	7	72712011	chr7:72712011	T	A	96	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	72712404	72712404	G	A	intergenic	NCF1B;NSUN5	dist=62425;dist=4109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	311	7	72712404	chr7:72712404	G	A	118	PASS	DP=311;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	73254463	73254463	G	-	intronic	METTL27	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	19	7	73254462	chr7:73254462	TG	T	59	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	73513337	73513337	C	-	intronic	LIMK1	.	.	.	0.990896287	0.009103618	9.51E-08	DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.; 	0.30864	0.32739	-0.821100135	11.88369899	175.30019	2.8795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	240	7	73513336	chr7:73513336	TC	T	122	PASS	DP=240;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	73530070	73530070	G	T	intronic	LIMK1	.	.	.	0.990896287	0.009103618	9.51E-08	DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.; 	0.30864	0.32739	-0.821100135	11.88369899	175.30019	2.8795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	7	73530070	chr7:73530070	G	T	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	73814774	73814774	G	A	exonic	CLIP2	.	synonymous SNV	CLIP2:NM_032421:exon14:c.G2850A:p.R950R,CLIP2:NM_003388:exon15:c.G2955A:p.R985R	0.999881647	0.000118353	1.18E-11	DISEASE: Note=CLIP2 is located in the Williams-Beuren syndrome (WBS) critical region (PubMed:9799601). WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of CLIP2 may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. However, it has been demonstrated that haploinsufficiency of this gene alone is not sufficient to cause any of the cognitive or facial features of WBS (PubMed:22608712). {ECO:0000305|PubMed:22608712, ECO:0000305|PubMed:9799601}.; 	0.13125	.	-1.186862251	5.90351498	632.85889	5.0685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	301	7	73814774	chr7:73814774	G	A	132	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	74573036	74573036	C	G	ncRNA_intronic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	148	7	74573036	chr7:74573036	C	G	125	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	74573061	74573061	G	-	ncRNA_exonic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	164	7	74573060	chr7:74573060	CG	C	119	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	75684340	75684340	G	T	intronic	MDH2	.	.	.	0.177605136	0.809688717	0.012706147	.	0.32327	0.90548	-0.334253673	30.70299599	208.93323	3.11958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	7	75684340	chr7:75684340	G	T	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	76069902	76069902	G	C	exonic	ZP3	.	nonsynonymous SNV	ZP3:NM_001110354:exon7:c.G1034C:p.R345T,ZP3:NM_007155:exon8:c.G881C:p.R294T	0.001596815	0.88505152	0.113351664	.	0.2396	0.20208	0.775339069	87.13729653	870.97448	5.74737	0.263	0.164	T	0.002	0.197	B	0.004	0.176	B	0.499	0.120	U	1	0.090	N	1.175	0.300	L	2.41	0.252	T	-2.4	0.527	N	0.034	0.346	-0.987	0.332	T	0.030	0.131	T	.	.	.	-1.381	0.020	0.003	0.447	0.034	0.042	0.097	N	c	-1.589	-1.705	0.999	0.386	0.644	0.439	0	-8.56	0.008	-0.279	0.084	-0.405	0.062	0.000	0.063	0.000	0.016	12.211	0.535	Zona pellucida domain	.	.	0.5	93	52	7	76069902	chr7:76069902	G	C	93	PASS	DP=52;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	76135134	76135134	G	A	UTR3	DTX2	NM_020892:c.*216G>A;NM_001102594:c.*216G>A;NM_001102595:c.*216G>A;NM_001102596:c.*216G>A	.	.	0.106757916	0.886582047	0.006660037	.	0.25831	0.10988	-0.683363435	15.36329323	137.65609	2.55415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	376	7	76135134	chr7:76135134	G	A	96	PASS	DP=376;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	76610356	76610356	C	-	ncRNA_exonic	DTX2P1-UPK3BP1-PMS2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	1176	7	76610355	chr7:76610355	AC	A	119	PASS	DP=1176;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/1
7	76632802	76632802	T	C	ncRNA_intronic	DTX2P1-UPK3BP1-PMS2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	332	7	76632802	chr7:76632802	T	C	86	PASS	DP=332;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	76991911	76991911	T	-	exonic	GSAP	.	frameshift deletion	GSAP:NM_001350900:exon11:c.293delA:p.Y98Sfs*20,GSAP:NM_001350901:exon11:c.293delA:p.Y98Sfs*20,GSAP:NM_001350898:exon12:c.881delA:p.Y294Sfs*20,GSAP:NM_001350896:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_001350897:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_001350899:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_017439:exon13:c.938delA:p.Y313Sfs*20	3.60E-16	0.241435267	0.758564733	.	.	.	0.268267497	70.64166077	2346.20682	8.97223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	20	7	76991910	chr7:76991910	GT	G	59	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	77006579	77006579	G	T	intronic	GSAP	.	.	.	3.60E-16	0.241435267	0.758564733	.	.	.	0.268267497	70.64166077	2346.20682	8.97223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	282	7	77006579	chr7:77006579	G	T	94	PASS	DP=282;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	77006605	77006605	T	C	exonic	GSAP	.	nonsynonymous SNV	GSAP:NM_001350900:exon7:c.A34G:p.K12E,GSAP:NM_001350901:exon7:c.A34G:p.K12E,GSAP:NM_001350898:exon8:c.A622G:p.K208E,GSAP:NM_001350896:exon9:c.A679G:p.K227E,GSAP:NM_001350897:exon9:c.A679G:p.K227E,GSAP:NM_001350899:exon9:c.A679G:p.K227E,GSAP:NM_017439:exon9:c.A679G:p.K227E	3.60E-16	0.241435267	0.758564733	.	.	.	0.268267497	70.64166077	2346.20682	8.97223	0.048	0.400	D	0.023	0.176	B	0.021	0.181	B	0.066	0.218	U	0.752	0.296	N	1.81	0.478	L	1.92	0.231	T	-2.0	0.461	N	0.317	0.378	-1.087	0.060	T	0.061	0.254	T	0.006	0.156	T	1.735	0.270	14.61	0.996	0.747	0.820	0.410	D	c	-0.232	-0.145	0.078	0.158	0.651	0.465	0	2.72	0.310	1.798	0.382	0.894	0.410	0.980	0.350	0.995	0.604	7.485	0.264	.	.	.	0.5	74	140	7	77006605	chr7:77006605	T	C	74	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	77221481	77221481	-	T	intronic	PTPN12	.	.	.	0.999459859	0.000540141	9.66E-11	.	0.37635	0.16791	-0.488577883	22.64685067	1762.97619	7.75318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	135	7	77221481	chr7:77221481	A	AT	76	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	77265204	77265204	A	G	intronic	PTPN12	.	.	.	0.999459859	0.000540141	9.66E-11	.	0.37635	0.16791	-0.488577883	22.64685067	1762.97619	7.75318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	36	7	77265204	chr7:77265204	A	G	51	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	82764286	82764286	G	T	exonic	PCLO	.	synonymous SNV	PCLO:NM_014510:exon3:c.C2580A:p.T860T,PCLO:NM_033026:exon3:c.C2580A:p.T860T	1	1.11E-11	1.03E-35	DISEASE: Pontocerebellar hypoplasia 3 (PCH3) [MIM:608027]: A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum. Brain MRI shows an abnormally small cerebellum and brainstem, decreased cerebral white matter, and a thin corpus callosum. PCH3 features include seizures, short stature, optic atrophy, progressive microcephaly, severe developmental delay. {ECO:0000269|PubMed:25832664}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20691	0.08509	-0.175308288	40.56970984	9296.23295	20.89927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	78	7	82764286	chr7:82764286	G	T	58	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	86548597	86548597	T	C	exonic	KIAA1324L	.	nonsynonymous SNV	KIAA1324L:NM_001291991:exon10:c.A709G:p.S237G,KIAA1324L:NM_152748:exon10:c.A928G:p.S310G,KIAA1324L:NM_001142749:exon11:c.A1429G:p.S477G,KIAA1324L:NM_001291990:exon11:c.A1087G:p.S363G	0.000166955	0.998513153	0.001319892	.	0.42256	.	-0.396754488	26.97570182	453.25685	4.43012	0.002	0.784	D	0.985	0.615	D	0.81	0.572	P	0.000	0.843	D	1	0.810	D	2.765	0.810	M	0.96	0.429	T	-3.35	0.664	D	0.748	0.747	-0.778	0.564	T	0.205	0.564	T	0.010	0.257	T	5.387	0.730	26.0	0.998	0.885	0.966	0.695	D	c	0.636	0.657	0.998	0.357	0.706	0.609	0	6.08	0.990	3.958	0.562	1.057	0.759	1.000	0.715	1.000	0.888	15.824	0.784	Growth factor receptor cysteine-rich domain	.	.	0.5	60	55	7	86548597	chr7:86548597	T	C	60	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	86823977	86823977	-	T	intronic	DMTF1	.	.	.	0.956216303	0.043783659	3.80E-08	.	0.56131	0.12154	-0.111973265	45.35857514	283.65163	3.60477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	104	7	86823977	chr7:86823977	A	AT	42	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	87005287	87005287	-	T	intronic	CROT	.	.	.	6.75E-21	0.003162599	0.996837401	.	0.08801	0.20255	-0.374708069	28.15522529	169.89771	2.84516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	34	7	87005287	chr7:87005287	C	CT	84	PASS	DP=34;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	87323209	87323209	-	T	intronic	ABCB1;RUNDC3B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	19	7	87323209	chr7:87323209	A	AT	42	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	87760688	87760688	-	GAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	exonic	ADAM22	.	stopgain	ADAM22:NM_001324417:exon11:c.927_928insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y314_I869delinsQDYKTPFMETSLSFS,ADAM22:NM_001324418:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I964delinsQDYKTPFMETSLSFS,ADAM22:NM_001324419:exon11:c.927_928insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y314_I963delinsQDYKTPFMETSLSFS,ADAM22:NM_001324420:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I935delinsQDYKTPFMETSLSFS,ADAM22:NM_001324421:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_A890delinsQDYKTPFMETSLSFS,ADAM22:NM_004194:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_E859delinsQDYKTPFMETSLSFS,ADAM22:NM_016351:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I870delinsQDYKTPFMETSLSFS,ADAM22:NM_021721:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_E823delinsQDYKTPFMETSLSFS,ADAM22:NM_021722:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I899delinsQDYKTPFMETSLSFS,ADAM22:NM_021723:exon11:c.930_931insGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.Y315_I906delinsQDYKTPFMETSLSFS	0.999388899	0.000611101	2.19E-13	.	0.32606	0.10251	-0.551080959	19.93394669	868.56657	5.7407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	231	7	87760688	chr7:87760688	T	TGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG,TGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	56	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	87760688	87760688	-	GAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	exonic	ADAM22	.	stopgain	ADAM22:NM_001324417:exon11:c.927_928insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K313Nfs*12,ADAM22:NM_001324418:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_001324419:exon11:c.927_928insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K313Nfs*12,ADAM22:NM_001324420:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_001324421:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_004194:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_016351:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_021721:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_021722:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12,ADAM22:NM_021723:exon11:c.930_931insGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG:p.K314Nfs*12	0.999388899	0.000611101	2.19E-13	.	0.32606	0.10251	-0.551080959	19.93394669	868.56657	5.7407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	231	7	87760688	chr7:87760688	T	TGAGTTTATGAAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG,TGAGTTTATGAACAGGACTACAAAACTCCTTTCATGGAAACTTCTTTGAGTTTTAGTTAAAGG	56	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	88389357	88389357	G	A	exonic	ZNF804B	.	nonsynonymous SNV	ZNF804B:NM_181646:exon1:c.G67A:p.V23I	4.78E-14	0.047962738	0.952037262	.	0.09352	.	3.374093349	99.43972635	2368.37941	9.03579	0.007	0.599	D	0.639	0.385	P	0.159	0.330	B	0.049	0.232	N	0.506	0.318	D	0.805	0.203	L	3.22	0.070	T	-0.73	0.206	N	0.276	0.334	-1.071	0.092	T	0.017	0.071	T	0.005	0.121	T	4.557	0.610	24.4	0.998	0.928	0.883	0.478	D	c	0.259	0.385	1.000	0.517	0.455	0.088	0	5.08	0.682	5.290	0.652	0.998	0.613	1.000	0.715	1.000	0.888	12.998	0.579	.	.	.	0.5	.	96	7	88389357	chr7:88389357	G	A	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	91700154	91700154	-	A	intronic	AKAP9	.	.	.	2.29E-05	0.999977065	4.21E-21	DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14649	0.1106	0.223857359	68.44774711	6014.5693	16.20152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	159	7	91700153	chr7:91700153	CA	CAA,C	52	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	91700154	91700154	A	-	intronic	AKAP9	.	.	.	2.29E-05	0.999977065	4.21E-21	DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14649	0.1106	0.223857359	68.44774711	6014.5693	16.20152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	159	7	91700153	chr7:91700153	CA	CAA,C	52	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	91706301	91706301	C	T	exonic	AKAP9	.	stopgain	AKAP9:NM_005751:exon29:c.C6745T:p.Q2249X,AKAP9:NM_147185:exon29:c.C6721T:p.Q2241X	2.29E-05	0.999977065	4.21E-21	DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14649	0.1106	0.223857359	68.44774711	6014.5693	16.20152	.	.	.	.	.	.	.	.	.	0.005	0.334	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.728	0.993	43	0.997	0.828	0.967	0.703	D	c	1.114	0.980	1.000	0.517	0.732	0.924	0	5.59	0.846	4.468	0.597	0.852	0.362	1.000	0.715	0.982	0.498	19.956	0.972	.	.	.	0.5	58	82	7	91706301	chr7:91706301	C	T	58	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	92855652	92855652	G	A	intronic	HEPACAM2	.	.	.	8.71E-09	0.157127629	0.842872362	.	.	0.09316	0.639420866	83.8995046	181.19055	2.92629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	7	92855652	chr7:92855652	G	A	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	94285912	94285912	-	T	intronic	PEG10	.	.	.	0.894178858	0.10478651	0.001034632	.	0.70725	0.10969	-0.273576253	33.97027601	11.52995	0.4171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	63	7	94285912	chr7:94285912	G	GT	68	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	95025600	95025600	G	A	exonic	PON3	.	synonymous SNV	PON3:NM_000940:exon1:c.C63T:p.F21F	0.002536783	0.931423061	0.066040156	.	0.10846	0.11133	0.64123826	83.97617363	216.51685	3.17966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	238	7	95025600	chr7:95025600	G	A	82	PASS	DP=238;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	96637003	96637004	GG	-	exonic	DLX6	.	frameshift deletion	DLX6:NM_005222:exon2:c.490_491del:p.G164Efs*56	0.842830433	0.154279613	0.002889953	.	0.64931	0.18289	-0.163345027	41.24793583	1210.09882	6.58665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	34	7	96637002	chr7:96637002	AGG	A	62	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	97854222	97854222	C	-	intronic	TECPR1	.	.	.	2.43E-07	0.998926296	0.001073461	.	.	.	-2.24910054	1.29747582	1477.95454	7.16021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	27	7	97854221	chr7:97854221	AC	A	43	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	98602990	98602990	G	C	intronic	TRRAP	.	.	.	1	1.50E-21	1.65E-53	DISEASE: Note=TRRAP mutation Phe-722 has been frequently found in cutaneous malignant melanoma, suggesting that TRRAP may play a role in the pathogenesis of melanoma. {ECO:0000269|PubMed:21499247}.; 	0.90101	0.52705	-6.141724508	0.035385704	221.99559	3.22188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	114	7	98602990	chr7:98602990	G	C	75	PASS	DP=114;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	98639905	98639905	T	-	intronic	SMURF1	.	.	.	0.996803391	0.003196608	3.02E-10	.	0.34495	0.16861	-1.375949569	4.393724935	20.01889	0.68296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	14	7	98639904	chr7:98639904	AT	A	62	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	98857825	98857825	C	T	intergenic	KPNA7;MYH16	dist=52713;dist=13099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	224	7	98857825	chr7:98857825	C	T	79	PASS	DP=224;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	99752404	99752404	-	C	UTR3	C7orf43	NM_001303470:c.*229_*230insG;NM_018275:c.*229_*230insG	.	.	0.300413007	0.698742758	0.000844235	.	0.17356	0.1079	-0.53631094	20.53550366	39.8756	1.17381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	267	7	99752404	chr7:99752404	G	GC	75	PASS	DP=267;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	99905688	99905688	C	A	intronic	SPDYE3	.	.	.	0.825434138	0.173760887	0.000804975	.	.	.	.	.	7.34499	0.27357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	257	7	99905688	chr7:99905688	C	A	114	PASS	DP=257;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	99916287	99916287	C	T	intronic	SPDYE3	.	.	.	0.825434138	0.173760887	0.000804975	.	.	.	.	.	7.34499	0.27357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	7	99916287	chr7:99916287	C	T	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	99924207	99924208	CT	-	ncRNA_intronic	PMS2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	182	7	99924206	chr7:99924206	CCT	C	44	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	100202013	100202013	C	T	intronic	PCOLCE	.	.	.	0.500664878	0.498454987	0.000880135	.	0.75819	0.14881	-0.134019284	43.90776126	423.68346	4.2979	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	153	7	100202013	chr7:100202013	C	T	.	PASS	DP=153;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	100460331	100460331	G	A	exonic	SLC12A9	.	synonymous SNV	SLC12A9:NM_001267814:exon11:c.G1473A:p.P491P,SLC12A9:NM_001267812:exon13:c.G1740A:p.P580P,SLC12A9:NM_020246:exon13:c.G1740A:p.P580P	2.37E-06	0.976967908	0.02302972	.	0.23194	0.15806	-1.168429872	6.062750649	76.20765	1.82962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	192	7	100460331	chr7:100460331	G	A	90	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	100552044	100552044	T	G	exonic	MUC3A	.	synonymous SNV	MUC3A:NM_005960:exon4:c.T2625G:p.S875S	.	.	.	.	.	.	.	.	4720.00036	13.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	101	7	100552044	chr7:100552044	T	G	145	PASS	DP=101;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	100608268	100608268	-	CTTAACCCCTTGAT	intronic	MUC3A	.	.	.	.	.	.	.	.	.	.	.	4720.00036	13.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	133	7	100608268	chr7:100608268	C	CCTTAACCCCTTGAT	142	PASS	DP=133;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	100643308	100643308	C	T	exonic	MUC12	.	nonsynonymous SNV	MUC12:NM_001164462:exon2:c.C9464T:p.P3155L	.	.	.	.	0.09711	.	.	.	8273.45926	19.64989	0.003	0.682	D	.	.	.	.	.	.	.	.	.	1	0.090	N	1.04	0.263	L	2.47	0.149	T	-0.91	0.245	N	0.044	0.026	-0.967	0.378	T	0.019	0.079	T	0.009	0.229	T	1.208	0.211	11.79	0.496	0.042	0.007	0.031	N	c	-1.240	-1.397	0.000	0.029	0.638	0.428	0	-0.152	0.127	0.611	0.238	-0.415	0.060	0.001	0.137	0.000	0.016	5.189	0.144	.	.	.	0.5	.	603	7	100643308	chr7:100643308	C	T	.	PASS	DP=603;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	100683067	100683067	C	T	exonic	MUC17	.	synonymous SNV	MUC17:NM_001040105:exon3:c.C8370T:p.S2790S	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	72	7	100683067	chr7:100683067	C	T	88	PASS	DP=72;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	101575395	101575395	A	T	intronic	CUX1	.	.	.	0.999988878	1.11E-05	3.08E-16	.	0.78386	0.44868	-1.868734056	2.011087521	217.29988	3.18613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	7	101575395	chr7:101575395	A	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	102912324	102912324	A	-	ncRNA_intronic	DPY19L2P2	.	.	.	.	.	.	.	0.13982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	97	7	102912323	chr7:102912323	TA	T	53	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	103202348	103202348	C	A	exonic	RELN	.	nonsynonymous SNV	RELN:NM_005045:exon35:c.G5263T:p.D1755Y,RELN:NM_173054:exon35:c.G5263T:p.D1755Y	1	2.44E-15	3.10E-43	DISEASE: Lissencephaly 2 (LIS2) [MIM:257320]: A classic type lissencephaly associated with ataxia, mental retardation, seizures and abnormalities of the cerebellum, hippocampus and brainstem. {ECO:0000269|PubMed:10973257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]: A focal form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe. Seizures are usually accompanied by sensory symptoms, most often auditory in nature. {ECO:0000269|PubMed:26046367}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25073	.	-2.151227095	1.462609106	2605.03558	9.54865	0.006	0.632	D	0.997	0.899	D	0.956	0.850	D	0.000	0.843	D	1.000	0.588	D	2.125	0.592	M	1.59	0.288	T	-2.88	0.605	D	0.844	0.831	-0.849	0.521	T	0.186	0.537	T	0.039	0.587	D	5.137	0.693	25.4	0.995	0.650	0.976	0.754	D	c	0.662	0.639	1.000	0.747	0.624	0.395	0	5.78	0.914	5.628	0.672	0.935	0.490	1.000	0.715	0.500	0.271	20.012	0.974	Sialidases	.	.	0.5	.	43	7	103202348	chr7:103202348	C	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	107052928	107052929	AC	-	intronic	COG5	.	.	.	1.14E-11	0.904490338	0.095509662	DISEASE: Congenital disorder of glycosylation 2I (CDG2I) [MIM:613612]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments. {ECO:0000269|PubMed:19690088}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69254	0.10021	-0.016511957	52.31776362	860.42254	5.72159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	51	7	107052927	chr7:107052927	AAC	A	115	PASS	DP=51;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	107392911	107392911	C	G	intronic	CBLL1	.	.	.	0.997784848	0.002215079	7.36E-08	.	0.29297	0.11049	-0.516085732	21.20193442	14.90934	0.5368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	154	7	107392911	chr7:107392911	C	G	93	PASS	DP=154;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	116165017	116165017	T	-	UTR5	CAV1	NM_001753:c.-100del-	.	.	0.018707972	0.730737613	0.250554415	DISEASE: Congenital generalized lipodystrophy 3 (CGL3) [MIM:612526]: An autosomal recessive disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. {ECO:0000269|PubMed:18211975}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pulmonary hypertension, primary, 3 (PPH3) [MIM:615343]: A rare disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs. {ECO:0000269|PubMed:22474227}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome (LCCNS) [MIM:606721]: A form of familial partial lipodystrophy associated with congenital cataracts and neurodegeneration leading to cerebellar and spinal cord dysfunction. {ECO:0000269|PubMed:18237401}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48727	0.86293	-0.317668748	31.45789101	11.5877	0.41881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	801	7	116165016	chr7:116165016	CT	C	91	PASS	DP=801;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	122194609	122194609	A	G	exonic	CADPS2	.	synonymous SNV	CADPS2:NM_001009571:exon8:c.T1470C:p.H490H,CADPS2:NM_001167940:exon8:c.T1470C:p.H490H,CADPS2:NM_017954:exon8:c.T1470C:p.H490H	0.997778954	0.002221046	5.08E-12	.	0.45062	0.12261	-0.661316159	16.02382637	194.52292	3.0232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	222	7	122194609	chr7:122194609	A	G	149	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	123334697	123334697	T	-	intronic	WASL	.	.	.	0.961960487	0.038036282	3.23E-06	.	0.89386	0.35187	-0.692458599	14.96815287	24.64068	0.80952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	169	106	7	123334696	chr7:123334696	GT	G	169	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
7	124116470	124116470	A	G	intergenic	LOC101928211;GPR37	dist=124320;dist=269185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	174	7	124116470	chr7:124116470	A	G	80	PASS	DP=174;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	127326714	127326714	G	A	exonic	SND1	.	synonymous SNV	SND1:NM_014390:exon2:c.G126A:p.G42G	0.999917089	8.29E-05	4.11E-14	.	0.73895	0.12655	-1.063626766	7.484076433	188.34653	2.98065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	7	127326714	chr7:127326714	G	A	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	128033754	128033754	C	G	intronic	IMPDH1	.	.	.	0.005811859	0.993226508	0.000961634	DISEASE: Retinitis pigmentosa 10 (RP10) [MIM:180105]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:11875049, ECO:0000269|PubMed:11875050, ECO:0000269|PubMed:16384941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber congenital amaurosis 11 (LCA11) [MIM:613837]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:16384941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69586	0.09849	-0.244249595	36.17008728	74.88549	1.81072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	602	7	128033754	chr7:128033754	C	G	93	PASS	DP=602;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	128033797	128033797	G	A	intronic	IMPDH1	.	.	.	0.005811859	0.993226508	0.000961634	DISEASE: Retinitis pigmentosa 10 (RP10) [MIM:180105]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:11875049, ECO:0000269|PubMed:11875050, ECO:0000269|PubMed:16384941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber congenital amaurosis 11 (LCA11) [MIM:613837]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:16384941}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69586	0.09849	-0.244249595	36.17008728	74.88549	1.81072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	987	7	128033797	chr7:128033797	G	A	83	PASS	DP=987;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	128249582	128249582	T	-	intergenic	METTL2B;LINC01000	dist=106604;dist=31713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	19	7	128249581	chr7:128249581	GT	G	43	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	128553004	128553004	C	-	intergenic	KCP;IRF5	dist=2231;dist=24082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	121	7	128553003	chr7:128553003	TC	T	120	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	130037270	130037270	C	T	UTR3	CEP41	NM_001257158:c.*1462G>A;NM_001257159:c.*1462G>A;NM_018718:c.*1462G>A	.	.	0.000125629	0.956230668	0.043643703	DISEASE: Joubert syndrome 15 (JBTS15) [MIM:614464]: An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly. {ECO:0000269|PubMed:22246503}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variations in CEP41 may be associated with susceptibility to autism (PubMed:21438139). {ECO:0000269|PubMed:21438139}.; 	0.35352	0.12266	0.551232944	81.48148148	110.55518	2.28931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	7	130037270	chr7:130037270	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	130080672	130080672	G	A	intronic	CEP41	.	.	.	0.000125629	0.956230668	0.043643703	DISEASE: Joubert syndrome 15 (JBTS15) [MIM:614464]: An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly. {ECO:0000269|PubMed:22246503}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variations in CEP41 may be associated with susceptibility to autism (PubMed:21438139). {ECO:0000269|PubMed:21438139}.; 	0.35352	0.12266	0.551232944	81.48148148	110.55518	2.28931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	7	130080672	chr7:130080672	G	A	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	130288638	130288638	G	A	intronic	COPG2	.	.	.	0.056037357	0.925314655	0.018647988	.	0.54002	.	.	.	27.4635	0.88482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	7	130288638	chr7:130288638	G	A	.	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	130288699	130288699	C	-	intronic	COPG2	.	.	.	0.056037357	0.925314655	0.018647988	.	0.54002	.	.	.	27.4635	0.88482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	85	7	130288698	chr7:130288698	GC	G	75	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	131113757	131113757	T	-	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	21	7	131113756	chr7:131113756	CT	C	44	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	132174174	132174174	G	T	exonic	PLXNA4	.	synonymous SNV	PLXNA4:NM_001105543:exon3:c.C1248A:p.S416S,PLXNA4:NM_020911:exon3:c.C1248A:p.S416S,PLXNA4:NM_181775:exon4:c.C1248A:p.S416S	0.999999702	2.98E-07	4.57E-20	.	0.16772	0.11298	-0.194946553	39.21325784	462.81286	4.45854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	7	132174174	chr7:132174174	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	133201567	133201567	T	C	intronic	EXOC4	.	.	.	0.000726958	0.99924068	3.24E-05	.	0.45903	.	-1.280491183	5.16631281	159.10541	2.75629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	75	7	133201567	chr7:133201567	T	C	65	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	134221826	134221826	A	G	exonic	AKR1B10	.	synonymous SNV	AKR1B10:NM_020299:exon6:c.A576G:p.T192T	1.22E-05	0.600013778	0.399974041	.	0.15356	0.31956	0.374860183	75.43052607	369.36028	4.06189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	298	7	134221826	chr7:134221826	A	G	112	PASS	DP=298;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	137588705	137588705	T	-	exonic	CREB3L2	.	frameshift deletion	CREB3L2:NM_001318246:exon7:c.785delA:p.V263Wfs*14,CREB3L2:NM_194071:exon7:c.974delA:p.V326Wfs*14	0.609225184	0.390408619	0.000366197	DISEASE: Note=A chromosomal aberration involving CREB3L2 is found in low grade fibromyxoid sarcoma (LGFMS). Translocation t(7;16)(q33;p11) with FUS.; 	0.27206	0.13635	-0.688817379	15.20405756	81.88749	1.91782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	23	7	137588704	chr7:137588704	CT	C	44	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	137782541	137782541	C	A	intronic	AKR1D1	.	.	.	5.69E-08	0.23677999	0.763219953	.	0.1437	0.16811	-0.648365105	16.35999056	21.07566	0.71321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	35	7	137782541	chr7:137782541	C	A	52	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	138348905	138348905	G	C	intronic	SVOPL	.	.	.	0.001133272	0.953834922	0.045031805	.	0.11987	0.10578	-0.062423436	48.86765747	5022.7372	14.47469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	299	7	138348905	chr7:138348905	G	C	86	PASS	DP=299;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	138453958	138453958	C	T	exonic	ATP6V0A4	.	synonymous SNV	ATP6V0A4:NM_130840:exon3:c.G156A:p.V52V,ATP6V0A4:NM_130841:exon3:c.G156A:p.V52V,ATP6V0A4:NM_020632:exon4:c.G156A:p.V52V	1.94E-12	0.945100202	0.054899798	.	0.23229	0.22304	-0.169017544	40.67586695	1425.59356	7.05075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	110	7	138453958	chr7:138453958	C	T	.	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	139754451	139754451	T	C	intronic	PARP12	.	.	.	7.93E-06	0.979732601	0.020259469	.	0.14634	0.10401	-0.661316159	16.02382637	1281.17409	6.7401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	16	7	139754451	chr7:139754451	T	C	43	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	141671685	141671685	A	G	downstream	TAS2R38	dist=746	.	.	0.065390402	0.729870734	0.204738864	.	0.1324	0.10729	1.196071381	92.92285916	1623.12511	7.45029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	37	7	141671685	chr7:141671685	A	G	81	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	141987184	141987184	C	T	intergenic	TRY2P;MTRNR2L6	dist=15116;dist=386947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	42	7	141987184	chr7:141987184	C	T	81	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
7	142032275	142032275	C	A	intergenic	TRY2P;MTRNR2L6	dist=60207;dist=341856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	44	7	142032275	chr7:142032275	C	A	70	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	142231939	142231939	C	A	intergenic	TRY2P;MTRNR2L6	dist=259871;dist=142192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	115	7	142231939	chr7:142231939	C	A	106	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	142458878	142458878	G	C	intronic	PRSS1	.	.	.	0.001220295	0.848354593	0.150425112	DISEASE: Pancreatitis, hereditary (PCTT) [MIM:167800]: A disease characterized by pancreas inflammation, permanent destruction of the pancreatic parenchyma, maldigestion, and severe abdominal pain attacks. {ECO:0000269|PubMed:10204851, ECO:0000269|PubMed:10381903, ECO:0000269|PubMed:10930381, ECO:0000269|PubMed:11073545, ECO:0000269|PubMed:11788572, ECO:0000269|PubMed:11866271, ECO:0000269|PubMed:14695529, ECO:0000269|PubMed:15776435, ECO:0000269|PubMed:8841182, ECO:0000269|PubMed:9322498, ECO:0000269|PubMed:9633818}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.47806	0.78094	-0.117432389	44.89266336	35.65715	1.07286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	56	7	142458878	chr7:142458878	G	C	63	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	142983878	142983878	G	T	exonic	TMEM139	.	nonsynonymous SNV	TMEM139:NM_001282876:exon3:c.G607T:p.D203Y,TMEM139:NM_153345:exon3:c.G607T:p.D203Y,TMEM139:NM_001242773:exon4:c.G607T:p.D203Y,TMEM139:NM_001242775:exon4:c.G607T:p.D203Y,TMEM139:NM_001282877:exon4:c.G607T:p.D203Y,TMEM139:NM_001242774:exon5:c.G607T:p.D203Y	0.018754136	0.731195381	0.250050483	.	0.00814	0.04021	0.703746784	85.42108988	71.67324	1.7618	0.002	0.721	D	0.952	0.522	P	0.785	0.557	P	0.009	0.305	N	1	0.090	N	1.545	0.392	L	.	.	.	-5.56	0.863	D	0.472	0.522	-0.966	0.380	T	0.158	0.491	T	0.003	0.053	T	4.025	0.541	23.6	0.990	0.497	0.206	0.209	N	c	-0.127	-0.328	1.000	0.454	0.625	0.396	0	2.62	0.302	1.672	0.369	0.065	0.171	0.011	0.184	0.020	0.134	6.974	0.237	.	.	.	0.5	.	53	7	142983878	chr7:142983878	G	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	143453661	143453661	T	G	exonic	CTAGE6	.	nonsynonymous SNV	CTAGE6:NM_178561:exon1:c.A1091C:p.E364A	0.366836245	0.621526849	0.011636907	.	.	.	.	.	126.17664	2.44439	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	.	.	.	-3	0.000	N	3.5	0.050	T	.	.	.	0.041	0.021	.	.	.	.	.	.	.	.	.	-1.880	0.010	0.002	0.508	0.044	0.000	0.003	N	n	-0.640	-0.258	0.000	0.012	0.075	0.013	0	0.109	0.138	-0.293	0.083	-0.934	0.025	0.493	0.267	0.028	0.145	.	.	.	.	.	0.5	143	656	7	143453661	chr7:143453661	T	G	143	PASS	DP=656;AN=4	GT	./.	0/1	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	148106477	148106477	C	G	intronic	CNTNAP2	.	.	.	3.83E-05	0.99995799	3.72E-06	DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a patient with autism spectrum disorder. Paracentric inversion 46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes AUTS2 and CNTNAP2.; 	0.59066	0.10874	-2.24910054	1.29747582	193.23796	3.0143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	269	7	148106477	chr7:148106477	C	G	149	PASS	DP=269;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	148106490	148106490	G	A	exonic	CNTNAP2	.	synonymous SNV	CNTNAP2:NM_014141:exon23:c.G3723A:p.A1241A	3.83E-05	0.99995799	3.72E-06	DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a patient with autism spectrum disorder. Paracentric inversion 46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes AUTS2 and CNTNAP2.; 	0.59066	0.10874	-2.24910054	1.29747582	193.23796	3.0143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	266	7	148106490	chr7:148106490	G	A	145	PASS	DP=266;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	148516251	148516251	-	A	intronic	EZH2	.	.	.	0.999990079	9.92E-06	1.39E-13	DISEASE: Weaver syndrome (WVS) [MIM:277590]: A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand. {ECO:0000269|PubMed:22177091}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97537	0.31462	-0.53631094	20.53550366	732.50896	5.37129	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.97	230	7	148516251	chr7:148516251	T	TA	10.97	PASS	DP=230;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	149430875	149430875	G	C	exonic	KRBA1	.	unknown	UNKNOWN	1.47E-12	0.095501601	0.904498399	.	0.07786	.	.	.	814.97375	5.61027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	99	7	149430875	chr7:149430875	G	C	109	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	149497462	149497462	C	A	exonic	SSPO	.	nonsynonymous SNV	SSPO:NM_198455:exon49:c.C7220A:p.A2407E	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	0.0	0.026	B	0.002	0.063	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.115	0.126	.	.	.	.	.	.	.	.	.	1.592	0.253	13.81	0.879	0.170	0.023	0.066	N	n	0.827	2.765	0.857	0.251	0.070	0.012	0	-4.21	0.035	-1.105	0.034	-1.465	0.011	0.000	0.063	0.933	0.406	1.166	0.017	Low-density lipoprotein (LDL) receptor class A, conserved site	.	.	0.5	127	182	7	149497462	chr7:149497462	C	A	127	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	149518641	149518641	G	T	intronic	SSPO	.	.	.	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	7	149518641	chr7:149518641	G	T	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	149528234	149528234	G	A	exonic	SSPO	.	synonymous SNV	SSPO:NM_198455:exon108:c.G15150A:p.S5050S	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	7	149528234	chr7:149528234	G	A	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	150674901	150674901	C	T	intronic	KCNH2	.	.	.	0.996051302	0.003948686	1.23E-08	DISEASE: Long QT syndrome 2 (LQT2) [MIM:613688]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Deafness is often associated with long QT syndrome type 2. {ECO:0000269|PubMed:10086971, ECO:0000269|PubMed:10187793, ECO:0000269|PubMed:10220144, ECO:0000269|PubMed:10517660, ECO:0000269|PubMed:10735633, ECO:0000269|PubMed:10862094, ECO:0000269|PubMed:10973849, ECO:0000269|PubMed:11170080, ECO:0000269|PubMed:12062363, ECO:0000269|PubMed:12354768, ECO:0000269|PubMed:12442276, ECO:0000269|PubMed:12621127, ECO:0000269|PubMed:15051636, ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16414944, ECO:0000269|PubMed:16922724, ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:22314138, ECO:0000269|PubMed:7889573, ECO:0000269|PubMed:8635257, ECO:0000269|PubMed:8877771, ECO:0000269|PubMed:8914737, ECO:0000269|PubMed:9024139, ECO:0000269|PubMed:9452080, ECO:0000269|PubMed:9544837, ECO:0000269|PubMed:9600240, ECO:0000269|PubMed:9693036}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 1 (SQT1) [MIM:609620]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. {ECO:0000269|PubMed:14676148, ECO:0000269|PubMed:15828882}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.70537	0.29759	-1.460519861	3.809860816	1151.75419	6.46689	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	75	7	150674901	chr7:150674901	C	T	58	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	151479545	151479545	C	T	intronic	PRKAG2	.	.	.	0.977557429	0.022442395	1.77E-07	DISEASE: Wolff-Parkinson-White syndrome (WPWS) [MIM:194200]: A supernormal conduction disorder characterized by the presence of one or several accessory atrioventricular connections, which can lead to episodes of sporadic tachycardia. {ECO:0000269|PubMed:11407343, ECO:0000269|PubMed:11748095}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH6 patients present Wolff-Parkinson-White ventricular preexcitation, enlarged myocytes without myofiber disarray, and glycogen- containing cytosolic vacuoles within cardiomyocytes. {ECO:0000269|PubMed:11371514, ECO:0000269|PubMed:11827995}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]: Rare disease which leads to death within a few weeks to a few months after birth, through heart failure and respiratory compromise. {ECO:0000269|PubMed:15877279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75824	0.19412	-0.867014353	10.72776598	322.64102	3.81555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	7	151479545	chr7:151479545	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	151814378	151814378	T	C	exonic	GALNT11	.	nonsynonymous SNV	GALNT11:NM_001304514:exon8:c.T1127C:p.I376T,GALNT11:NM_022087:exon9:c.T1370C:p.I457T	0.004047419	0.995623523	0.000329058	DISEASE: Note=Defects in GALNT11 may be a cause of heterotaxy, a congenital heart disease resulting from abnormalities in left- right (LR) body patterning. {ECO:0000269|PubMed:21282601}.; 	0.13704	0.10054	-0.43902969	24.63434772	485.66524	4.53862	0.142	0.254	T	0.001	0.067	B	0.002	0.063	B	0.017	0.277	N	1	0.090	N	1.17	0.299	L	0.63	0.531	T	-0.95	0.253	N	0.13	0.149	-0.998	0.304	T	0.093	0.353	T	0.013	0.320	T	1.192	0.209	11.71	0.929	0.218	0.499	0.283	N	c	-0.636	-0.536	0.835	0.247	0.732	0.924	0	4.36	0.515	4.183	0.579	0.082	0.190	0.835	0.300	0.999	0.750	10.204	0.421	.	.	.	0.5	65	74	7	151814378	chr7:151814378	T	C	65	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	151878157	151878157	C	A	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon36:c.G6788T:p.G2263V	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.092	0.329	T	0.014	0.156	B	0.011	0.145	B	0.002	0.385	N	0.999	0.459	D	2.32	0.666	M	-1.81	0.840	D	-4.03	0.749	D	0.408	0.466	-0.401	0.720	T	0.405	0.755	T	0.072	0.715	D	1.809	0.278	15.04	0.985	0.420	0.913	0.531	D	c	-0.373	-0.280	0.542	0.212	0.707	0.730	0	2.91	0.328	1.520	0.353	0.870	0.379	1.000	0.715	0.958	0.437	10.289	0.426	.	.	.	0.5	.	51	7	151878157	chr7:151878157	C	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	151932916	151932916	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon16:c.G2755C:p.V919L	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.465	0.086	T	0.005	0.119	B	0.006	0.112	B	0.001	0.407	D	0.910	0.275	N	1.04	0.263	L	-1.76	0.836	D	-0.87	0.236	N	0.106	0.208	-0.782	0.562	T	0.290	0.662	T	.	.	.	1.682	0.263	14.31	0.935	0.226	0.885	0.481	D	c	-0.471	-0.289	0.000	0.060	0.737	0.974	0	3.05	0.341	0.914	0.280	0.892	0.403	0.989	0.365	1.000	0.888	9.075	0.355	.	.	.	0.5	144	446	7	151932916	chr7:151932916	C	G	144	PASS	DP=446;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	151935853	151935853	T	C	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.077	0.346	T	0.986	0.596	D	0.655	0.508	P	0.010	0.301	N	1.000	0.488	D	1.95	0.526	M	-2.06	0.860	D	-1.73	0.410	N	0.593	0.620	-0.013	0.820	T	0.585	0.851	D	.	.	.	4.196	0.562	23.9	0.998	0.907	0.978	0.770	D	c	0.478	0.540	1.000	0.747	0.651	0.465	0	5.53	0.825	7.411	0.791	1.061	0.807	1.000	0.715	1.000	0.888	15.955	0.796	.	.	.	0.5	146	240	7	151935853	chr7:151935853	T	C	146	PASS	DP=240;AN=4	GT	0/1	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	151936975	151936975	A	G	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	199	7	151936975	chr7:151936975	A	G	107	PASS	DP=199;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	151936982	151936982	C	A	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	51	7	151936982	chr7:151936982	C	A	59	PASS	DP=51;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	151945167	151945167	G	T	exonic	KMT2C	.	synonymous SNV	KMT2C:NM_170606:exon14:c.C2352A:p.S784S	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	58	7	151945167	chr7:151945167	G	T	50	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	151962290	151962290	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon8:c.G1017C:p.K339N	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.246	0.173	T	0.999	0.764	D	0.991	0.782	D	0.001	0.432	U	0.938	0.372	D	1.445	0.365	L	-5.16	0.988	D	-2.17	0.490	N	0.153	0.189	0.881	0.954	D	0.928	0.976	D	.	.	.	2.356	0.344	18.53	0.986	0.425	0.867	0.457	D	c	-0.067	-0.115	0.503	0.209	0.707	0.730	0	3.77	0.423	1.960	0.398	0.802	0.324	1.000	0.715	0.997	0.653	11.249	0.481	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Zinc finger, FYVE/PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	74	126	7	151962290	chr7:151962290	C	G	74	PASS	DP=126;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	151970705	151970705	A	C	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	104	7	151970705	chr7:151970705	A	C	86	PASS	DP=104;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	151970859	151970859	C	T	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon7:c.G943A:p.G315S	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.068	0.357	T	1.0	0.899	D	1.0	0.971	D	0.000	0.454	D	1.000	0.588	D	2.28	0.651	M	-0.67	0.725	T	-4.31	0.782	D	0.637	0.654	0.272	0.871	D	0.583	0.850	D	.	.	.	7.435	0.951	34	0.997	0.794	0.978	0.767	D	c	0.865	0.801	1.000	0.747	0.693	0.553	0	4.87	0.627	7.809	0.845	0.935	0.490	1.000	0.715	0.624	0.293	18.375	0.903	Zinc finger, PHD-type	.	.	0.5	100	224	7	151970859	chr7:151970859	C	T	100	PASS	DP=224;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	152055676	152055729	TTCCACAATCGTTTCTGTTTCTGTTGTCTCCAGCCCATCCATGCTGTCCTCATC	-	exonic	KMT2C	.	nonframeshift deletion	KMT2C:NM_170606:exon2:c.193_246del:p.D65_E82del	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.66	18	7	152055675	chr7:152055675	TTTCCACAATCGTTTCTGTTTCTGTTGTCTCCAGCCCATCCATGCTGTCCTCATC	T	12.66	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	155473484	155473484	G	T	exonic	RBM33	.	nonsynonymous SNV	RBM33:NM_053043:exon5:c.G449T:p.G150V	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	0.011	0.682	D	0.082	0.899	B	0.058	0.971	B	.	.	.	1	0.810	D	1.935	0.520	L	1.39	0.338	T	-6.03	0.898	D	0.4	0.581	-0.852	0.519	T	0.163	0.499	T	0.029	0.519	D	5.092	0.686	25.3	0.997	0.801	0.926	0.558	D	c	0.211	0.281	1.000	0.747	0.707	0.730	0	4.46	0.534	4.814	0.621	0.953	0.551	1.000	0.715	0.995	0.604	13.798	0.625	.	.	.	0.5	83	23	7	155473484	chr7:155473484	G	T	83	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	155532574	155532576	CAC	-	exonic	RBM33	.	nonframeshift deletion	RBM33:NM_053043:exon12:c.1903_1905del:p.H641del	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	291	7	155532573	chr7:155532573	GCAC	G	122	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	155567837	155567837	G	T	UTR3	RBM33	NM_053043:c.*102G>T	.	.	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	98	7	155567837	chr7:155567837	G	T	.	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	157931119	157931119	A	G	exonic	PTPRN2	.	synonymous SNV	PTPRN2:NM_001308267:exon6:c.T885C:p.A295A,PTPRN2:NM_130842:exon6:c.T948C:p.A316A,PTPRN2:NM_001308268:exon7:c.T1068C:p.A356A,PTPRN2:NM_002847:exon7:c.T999C:p.A333A,PTPRN2:NM_130843:exon7:c.T999C:p.A333A	0.016557153	0.983434299	8.55E-06	DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8878534}.; 	0.18753	0.09983	0.889106693	89.19556499	4454.24566	13.37565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	90	7	157931119	chr7:157931119	A	G	151	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	169305	169305	G	C	ncRNA_exonic	RPL23AP53	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	66	8	169305	chr8:169305	G	C	48	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	2044268	2044268	C	T	exonic	MYOM2	.	synonymous SNV	MYOM2:NM_003970:exon18:c.C2307T:p.I769I	1.49E-55	7.78E-11	1	.	0.22436	0.11601	-0.500487825	21.84477471	8300.21663	19.71178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	8	2044268	chr8:2044268	C	T	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	3000078	3000078	G	T	exonic	CSMD1	.	synonymous SNV	CSMD1:NM_033225:exon41:c.C6150A:p.P2050P	.	.	.	.	0.20953	0.12394	-7.110830664	0.023590469	1048.09747	6.2145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	80	8	3000078	chr8:3000078	G	T	69	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	6616271	6616271	G	T	UTR3	AGPAT5	NM_018361:c.*1362G>T	.	.	0.005794953	0.971837733	0.022367313	.	0.55788	0.12279	-0.512444034	21.55579146	130.88869	2.49182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	25	8	6616271	chr8:6616271	G	T	51	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
8	7217837	7217837	A	C	exonic	ZNF705G	.	nonsynonymous SNV	ZNF705G:NM_001164457:exon3:c.T157G:p.S53A	4.25E-09	0.029374202	0.970625794	.	.	.	.	.	148.15733	2.652	0.989	0.020	T	.	.	.	.	.	.	.	.	.	1	0.090	P	1.21	0.306	L	5.67	0.008	T	-0.81	0.223	N	0.063	0.052	-0.934	0.436	T	0.003	0.010	T	.	.	.	0.711	0.162	8.899	0.689	0.085	0.152	0.186	N	c	-0.796	-0.967	0.000	0.038	0.549	0.223	0	-0.55	0.112	0.991	0.291	0.493	0.279	0.948	0.327	0.012	0.117	2.993	0.056	Krueppel-associated box	.	.	0.5	118	65	8	7217837	chr8:7217837	A	C	118	PASS	DP=65;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	7218752	7218752	G	C	exonic	ZNF705G	.	nonsynonymous SNV	ZNF705G:NM_001164457:exon2:c.C19G:p.L7V	4.25E-09	0.029374202	0.970625794	.	.	.	.	.	148.15733	2.652	1.0	0.010	T	.	.	.	.	.	.	.	.	.	1	0.090	P	-0.835	0.015	N	5.86	0.007	T	1.95	0.004	N	0.023	0.008	-0.978	0.354	T	0.000	0.000	T	.	.	.	-1.536	0.016	0.002	0.347	0.021	0.000	0.003	N	c	-1.649	-1.680	0.833	0.247	0.598	0.340	0	1.24	0.203	-0.336	0.078	-0.597	0.044	0.002	0.151	0.132	0.200	2.834	0.051	Krueppel-associated box	.	.	0.5	92	43	8	7218752	chr8:7218752	G	C	92	PASS	DP=43;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	8092006	8092006	A	G	ncRNA_exonic	FAM86B3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	75	8	8092006	chr8:8092006	A	G	61	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	9623897	9623897	C	T	exonic	TNKS	.	synonymous SNV	TNKS:NM_003747:exon25:c.C3702T:p.C1234C	0.777115954	0.222884041	4.52E-09	.	0.74052	0.15224	-2.45481381	1.008492569	80.76873	1.89852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	8	9623897	chr8:9623897	C	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	10480513	10480513	C	A	exonic	RP1L1	.	stopgain	RP1L1:NM_178857:exon2:c.G199T:p.E67X	.	.	.	DISEASE: Occult macular dystrophy (OCMD) [MIM:613587]: An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina. {ECO:0000269|PubMed:20826268, ECO:0000269|PubMed:22605915}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09178	.	7.246646544	99.8997405	19576.13196	29.90294	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.943	0.979	38	0.998	0.866	0.987	0.861	D	c	1.005	0.829	1.000	0.517	0.554	0.283	0	4.78	0.605	3.787	0.549	0.934	0.450	0.998	0.411	0.995	0.604	16.962	0.861	Doublecortin domain	.	.	0.5	88	161	8	10480513	chr8:10480513	C	A	88	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	11142389	11142389	-	G	UTR5	MTMR9	NM_015458:c.-9_-8insG	.	.	0.210866149	0.789056594	7.73E-05	.	0.09655	0.1143	-0.819281839	11.93677754	192.38541	3.00675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	14	8	11142389	chr8:11142389	C	CG	63	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	11872395	11872395	A	G	intergenic	DEFB134;DEFB130B	dist=14134;dist=49503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	43	8	11872395	chr8:11872395	A	G	63	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	12040158	12040158	A	G	UTR3	FAM86B1	NM_001083537:c.*957T>C	.	.	0.744460341	0.244896121	0.010643538	.	.	.	.	.	492.38443	4.56268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	143	8	12040158	chr8:12040158	A	G	99	PASS	DP=143;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	12236231	12236231	A	C	ncRNA_intronic	FAM66A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	31	8	12236231	chr8:12236231	A	C	88	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	12459318	12459320	GGT	-	ncRNA_exonic	LOC729732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	31	8	12459317	chr8:12459317	AGGT	A	42	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	12522853	12522861	GTCCTCGCA	-	ncRNA_exonic	LOC729732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	160	290	8	12522852	chr8:12522852	CGTCCTCGCA	C	160	PASS	DP=290;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	17501955	17501955	-	AGAT	UTR3	MTUS1	NM_001166393:c.*1479_*1480insATCT;NM_020749:c.*1479_*1480insATCT;NM_001330470:c.*1479_*1480insATCT;NM_001001931:c.*1479_*1480insATCT;NM_001001924:c.*1479_*1480insATCT;NM_001001925:c.*1479_*1480insATCT	.	.	1.14E-05	0.999473952	0.00051461	DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. {ECO:0000269|PubMed:16650523}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.16371	0.10477	2.096551086	97.87096013	1447.42658	7.09602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	18	8	17501955	chr8:17501955	G	GAGAT	85	PASS	DP=18;AN=2	GT	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.
8	21955746	21955746	T	C	exonic	FAM160B2	.	synonymous SNV	FAM160B2:NM_022749:exon6:c.T693C:p.A231A	2.05E-05	0.974736924	0.025242552	.	0.14877	.	-0.591542347	18.24722812	2808.87174	10.00178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	8	21955746	chr8:21955746	T	C	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	25265493	25265493	C	A	intronic	DOCK5	.	.	.	0.001342686	0.998657314	3.76E-11	.	.	0.14957	-2.350524415	1.150035386	3159.36883	10.70955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	8	25265493	chr8:25265493	C	A	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	25287397	25287397	T	C	exonic	KCTD9	.	synonymous SNV	KCTD9:NM_017634:exon12:c.A1146G:p.L382L	0.073396831	0.926083873	0.000519296	.	0.10831	0.11262	-0.117432389	44.89266336	12.22101	0.44285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	25	8	25287397	chr8:25287397	T	C	81	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	26513709	26513709	A	T	UTR3	DPYSL2	NM_001197293:c.*487A>T;NM_001386:c.*487A>T;NM_001244604:c.*487A>T	.	.	0.995558289	0.00444163	8.13E-08	.	0.54792	0.54626	-0.756778259	13.44656759	125.03577	2.43271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	147	8	26513709	chr8:26513709	A	T	61	PASS	DP=147;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	28203175	28203175	C	A	UTR3	ZNF395	NM_018660:c.*3061G>T	.	.	0.819057406	0.180905829	3.68E-05	.	0.32677	.	-0.821100135	11.88369899	68.62215	1.71442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	8	28203175	chr8:28203175	C	A	.	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	33230301	33230302	CC	-	exonic	FUT10	.	stopgain	FUT10:NM_032664:exon5:c.1233_1234del:p.W411fs*0	3.08E-07	0.526483136	0.473516557	.	0.06224	0.09649	0.446457185	77.97829677	3746.81614	11.97903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	16	8	33230300	chr8:33230300	TCC	T	63	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	37968324	37968324	T	G	exonic	ASH2L	.	nonsynonymous SNV	ASH2L:NM_001282272:exon4:c.T141G:p.H47Q,ASH2L:NM_001105214:exon5:c.T276G:p.H92Q,ASH2L:NM_001261832:exon5:c.T276G:p.H92Q,ASH2L:NM_004674:exon5:c.T558G:p.H186Q	0.995792116	0.00420787	1.44E-08	.	0.14146	0.11705	-0.26993514	34.59542345	107.32611	2.24775	0.68	0.682	T	0.012	0.561	B	0.006	0.572	B	0.000	0.843	D	1	0.810	D	1.59	0.404	L	1.87	0.241	T	-0.4	0.247	N	0.736	0.790	-1.071	0.091	T	0.081	0.320	T	0.019	0.414	T	1.274	0.218	12.14	0.847	0.150	0.915	0.533	D	c	-0.183	-0.140	0.992	0.325	0.719	0.830	0	2.34	0.279	0.209	0.171	0.890	0.394	0.991	0.370	0.994	0.587	8.795	0.338	.	.	.	0.5	47	30	8	37968324	chr8:37968324	T	G	47	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	37978439	37978439	C	-	intronic	ASH2L	.	.	.	0.995792116	0.00420787	1.44E-08	.	0.14146	0.11705	-0.26993514	34.59542345	107.32611	2.24775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	21	8	37978438	chr8:37978438	TC	T	45	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	38876466	38876466	T	C	intronic	ADAM9	.	.	.	0.828249261	0.171750686	5.34E-08	.	0.23427	0.21827	-0.201976964	38.98325077	410.4595	4.24565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	37	8	38876466	chr8:38876466	T	C	80	PASS	DP=37;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	39128387	39128387	C	-	intronic	ADAM32	.	.	.	1.17E-08	0.929586072	0.070413916	.	0.05738	0.07564	0.380318343	75.63104506	768.55107	5.48756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	245	8	39128386	chr8:39128386	TC	T	71	PASS	DP=245;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	52321066	52321066	C	T	exonic	PXDNL	.	nonsynonymous SNV	PXDNL:NM_144651:exon17:c.G3118A:p.V1040M	1.94E-27	0.000599486	0.999400514	.	.	.	2.732433216	98.95022411	6585.72871	17.14983	0.004	0.654	D	0.998	0.715	D	0.95	0.671	D	0.000	0.469	D	0.541	0.320	D	2.84	0.828	M	-0.74	0.732	T	-2.12	0.481	N	0.208	0.398	0.565	0.914	D	0.615	0.864	D	0.006	0.165	T	4.884	0.656	24.9	0.997	0.809	0.111	0.162	N	c	0.087	-0.190	0.475	0.207	0.646	0.450	0	3.82	0.430	0.328	0.193	0.700	0.299	0.001	0.137	0.001	0.043	13.168	0.588	.	.	.	0.5	.	38	8	52321066	chr8:52321066	C	T	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	52732287	52732287	C	T	UTR3	PCMTD1	NM_052937:c.*624G>A;NM_001286783:c.*624G>A;NM_001286782:c.*624G>A	.	.	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	181	8	52732287	chr8:52732287	C	T	80	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	52733079	52733079	A	C	exonic	PCMTD1	.	nonsynonymous SNV	PCMTD1:NM_001286782:exon4:c.T678G:p.S226R,PCMTD1:NM_001286783:exon6:c.T378G:p.S126R,PCMTD1:NM_052937:exon6:c.T906G:p.S302R	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	0.069	0.496	T	0.999	0.764	D	0.994	0.807	D	0.000	0.629	N	1.000	0.588	D	1.955	0.530	M	0.98	0.421	T	-0.9	0.468	N	0.411	0.776	-0.920	0.455	T	0.174	0.518	T	.	.	.	1.490	0.241	13.26	0.998	0.850	0.846	0.434	D	c	0.047	0.054	0.982	0.303	0.707	0.730	0	0.773	0.176	1.452	0.345	0.237	0.263	1.000	0.715	0.999	0.750	6.433	0.209	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	65	30	8	52733079	chr8:52733079	A	C	65	PASS	DP=30;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	0/1	./.	./.	./.
8	53596199	53596199	C	T	exonic	RB1CC1	.	synonymous SNV	RB1CC1:NM_001083617:exon5:c.G279A:p.S93S,RB1CC1:NM_014781:exon5:c.G279A:p.S93S	0.999999799	2.01E-07	4.29E-19	.	0.82038	0.21518	-1.587406381	3.113941967	234.10831	3.30711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	252	8	53596199	chr8:53596199	C	T	63	PASS	DP=252;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	56025044	56025044	C	T	intronic	XKR4	.	.	.	0.97759169	0.022404012	4.30E-06	.	0.17775	0.1101	-0.824740496	11.67728238	24.17631	0.79377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	8	56025044	chr8:56025044	C	T	.	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	60032374	60032374	C	T	upstream	TOX	dist=607	.	.	0.892971025	0.106984331	4.46E-05	.	0.94527	0.20047	-0.622676946	17.30950696	265.75398	3.49664	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	82	8	60032374	chr8:60032374	C	T	.	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	61178677	61178677	T	-	intronic	CA8	.	.	.	0.783927467	0.215775275	0.000297259	DISEASE: Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CMARQ3) [MIM:613227]: A congenital cerebellar ataxia associated with dysarthia, quadrupedal gait and mental retardation. {ECO:0000269|PubMed:19461874}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43521	0.13588	-0.007201372	53.19061099	79.99996	1.89165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	14	8	61178676	chr8:61178676	CT	C	43	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	62555483	62555483	-	A	intronic	ASPH	.	.	.	1.02E-08	0.995846118	0.004153872	.	0.0978	0.18131	-1.236390924	5.520169851	189.544	2.98859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	220	8	62555482	chr8:62555482	GA	GAA,G	74	PASS	DP=220;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	62555483	62555483	A	-	intronic	ASPH	.	.	.	1.02E-08	0.995846118	0.004153872	.	0.0978	0.18131	-1.236390924	5.520169851	189.544	2.98859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	220	8	62555482	chr8:62555482	GA	GAA,G	74	PASS	DP=220;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	68255399	68255399	C	T	exonic	ARFGEF1	.	nonsynonymous SNV	ARFGEF1:NM_006421:exon1:c.G124A:p.E42K	0.999999909	9.06E-08	1.03E-22	.	0.89864	0.2827	-1.745389579	2.37084218	294.25109	3.66374	0.081	0.334	T	0.615	0.379	P	0.269	0.381	B	0.000	0.629	N	1.000	0.520	D	1.805	0.477	L	2.05	0.207	T	-2.64	0.664	D	0.355	0.444	-1.113	0.028	T	0.061	0.253	T	0.138	0.821	D	3.589	0.489	23.2	0.998	0.926	0.874	0.466	D	c	0.312	0.350	1.000	0.747	0.442	0.072	0	3.95	0.448	7.418	0.792	0.824	0.337	1.000	0.715	0.959	0.439	12.942	0.576	Mon2, dimerisation and cyclophilin-binding domain	.	.	0.5	81	316	8	68255399	chr8:68255399	C	T	81	PASS	DP=316;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	79673860	79673860	C	A	intronic	IL7	.	.	.	0.879873742	0.118691896	0.001434362	.	0.10724	0.49624	0.21326276	67.71644256	134.94454	2.52665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	8	79673860	chr8:79673860	C	A	.	PASS	DP=70;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	85833388	85833388	-	T	UTR3	RALYL	NM_001100393:c.*242_*243insT;NM_001100392:c.*242_*243insT;NM_001287243:c.*242_*243insT;NM_173848:c.*242_*243insT;NM_001100391:c.*242_*243insT;NM_001287244:c.*242_*243insT	.	.	0.029690036	0.924042635	0.046267328	.	0.21161	0.11262	-0.271755481	34.31823543	33.66101	1.03832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	22	8	85833388	chr8:85833388	G	GT	42	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	87755863	87755863	G	-	UTR5	CNGB3	NM_019098:c.-8delC	.	.	8.86E-11	0.884429906	0.115570094	DISEASE: Achromatopsia 3 (ACHM3) [MIM:262300]: An ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus. Achromatopsia type 3 patients manifest severe myopia. {ECO:0000269|PubMed:10888875, ECO:0000269|PubMed:10958649, ECO:0000269|PubMed:12357335, ECO:0000269|PubMed:14757870, ECO:0000269|PubMed:15657609, ECO:0000269|PubMed:15712225}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08889	.	1.673699792	96.331682	696.97117	5.25879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	17	8	87755862	chr8:87755862	TG	T	58	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	89051473	89051473	-	T	UTR3	MMP16	NM_005941:c.*2215_*2216insA	.	.	0.916974084	0.083021227	4.69E-06	.	0.21595	0.19444	-0.381986487	27.68931352	33.08522	1.02452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	134	8	89051473	chr8:89051473	G	GT	62	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	92365183	92365183	C	A	exonic	SLC26A7	.	synonymous SNV	SLC26A7:NM_001282357:exon11:c.C370A:p.R124R,SLC26A7:NM_052832:exon11:c.C1273A:p.R425R,SLC26A7:NM_134266:exon11:c.C1273A:p.R425R,SLC26A7:NM_001282356:exon12:c.C1273A:p.R425R	3.32E-08	0.923716211	0.076283756	.	0.50174	0.12722	0.112125503	62.09601321	242.55786	3.36166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	62	8	92365183	chr8:92365183	C	A	67	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	92971272	92971272	G	A	UTR3	RUNX1T1	NM_001198626:c.*1198C>T;NM_001198625:c.*1198C>T;NM_001198633:c.*1198C>T;NM_001198679:c.*1198C>T;NM_001198629:c.*1198C>T;NM_001198631:c.*1198C>T;NM_175635:c.*1198C>T;NM_175634:c.*1198C>T;NM_001198627:c.*1198C>T;NM_001198632:c.*1198C>T;NM_004349:c.*1198C>T;NM_001198630:c.*1198C>T;NM_001198634:c.*1198C>T;NM_175636:c.*1198C>T;NM_001198628:c.*1198C>T	.	.	0.999121688	0.000878304	7.71E-09	DISEASE: Note=A chromosomal aberration involving RUNX1T1 is a cause of acute myeloid leukemia (AML-M2). Translocation t(8;21)(q22;q22) with RUNX1/AML1. {ECO:0000269|PubMed:1423235, ECO:0000269|PubMed:7541640, ECO:0000269|PubMed:8334990, ECO:0000269|PubMed:8353289}.; 	0.85092	0.58871	-1.001120478	8.321538099	35.00756	1.06236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	8	92971272	chr8:92971272	G	A	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	95444348	95444348	-	A	UTR3	FSBP;RAD54B	NM_001256141:c.*10_*11insT;NM_001205262:c.*486_*487insT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	13	8	95444348	chr8:95444348	G	GA	52	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	95893369	95893369	T	G	UTR3	CCNE2	NM_057749:c.*491A>C	.	.	0.338179976	0.661197446	0.000622578	.	0.99576	0.16847	-0.005381972	53.50908233	124.43094	2.42611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	40	8	95893369	chr8:95893369	T	G	42	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	97274483	97274483	G	A	intronic	PTDSS1	.	.	.	0.857749192	0.142246932	3.88E-06	DISEASE: Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]: A syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. LMHD is characterized by the combination of sclerosing bone dysplasia, intellectual disability and distinct craniofacial, dental, cutaneous and distal limb anomalies. The progressive generalized hyperostosis associated with this syndrome affects the cranium, the vertebrae and the diaphyses of tubular bones, leading to severe growth restriction. {ECO:0000269|PubMed:24241535}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26928	0.12774	-0.359940251	28.93371078	145.442	2.62713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	8	97274483	chr8:97274483	G	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	97307359	97307359	G	T	exonic	PTDSS1	.	stopgain	PTDSS1:NM_001290225:exon3:c.G37T:p.E13X,PTDSS1:NM_014754:exon5:c.G475T:p.E159X	0.857749192	0.142246932	3.88E-06	DISEASE: Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]: A syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. LMHD is characterized by the combination of sclerosing bone dysplasia, intellectual disability and distinct craniofacial, dental, cutaneous and distal limb anomalies. The progressive generalized hyperostosis associated with this syndrome affects the cranium, the vertebrae and the diaphyses of tubular bones, leading to severe growth restriction. {ECO:0000269|PubMed:24241535}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26928	0.12774	-0.359940251	28.93371078	145.442	2.62713	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.049	0.988	41	0.998	0.846	0.986	0.848	D	c	1.097	0.934	1.000	0.747	0.706	0.609	0	4.68	0.582	8.049	0.891	0.953	0.551	1.000	0.715	1.000	0.888	16.130	0.811	.	.	.	0.5	.	37	8	97307359	chr8:97307359	G	T	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	100874068	100874068	G	T	exonic	VPS13B	.	synonymous SNV	VPS13B:NM_017890:exon58:c.G11184T:p.L3728L,VPS13B:NM_152564:exon58:c.G11109T:p.L3703L	9.81E-27	0.999999996	3.72E-09	.	0.28405	0.17647	-0.610811433	17.50412833	5683.91051	15.59736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	458	8	100874068	chr8:100874068	G	T	155	PASS	DP=458;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	101719034	101719114	CTAAAAAATAAGAACATTTTGTATTTTTATCTTGCTCTTTCAAATTGGTGATCAATTTTTAAAGGAAGGATTAAGACTCAC	-	splicing	PABPC1	.	.	.	0.999692443	0.000307557	1.21E-10	.	0.49883	0.4528	-0.383807564	27.41802312	3992.89486	12.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	31	8	101719033	chr8:101719033	GCTAAAAAATAAGAACATTTTGTATTTTTATCTTGCTCTTTCAAATTGGTGATCAATTTTTAAAGGAAGGATTAAGACTCAC	G	70	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	101960934	101960934	C	A	exonic	YWHAZ	.	nonsynonymous SNV	YWHAZ:NM_001135699:exon2:c.G184T:p.V62F,YWHAZ:NM_001135700:exon2:c.G184T:p.V62F,YWHAZ:NM_001135701:exon2:c.G184T:p.V62F,YWHAZ:NM_001135702:exon2:c.G184T:p.V62F,YWHAZ:NM_003406:exon2:c.G184T:p.V62F,YWHAZ:NM_145690:exon2:c.G184T:p.V62F	0.817170005	0.181916765	0.00091323	.	0.99976	0.58572	0.079165051	59.43029016	1.06384	0.02718	0.0	0.912	D	0.987	0.600	D	0.748	0.541	P	0.000	0.629	D	1.000	0.810	D	2.105	0.586	M	0.83	0.478	T	-2.39	0.623	N	0.82	0.821	-0.773	0.567	T	0.189	0.541	T	0.050	0.642	D	6.470	0.892	29.9	0.997	0.785	0.960	0.667	D	c	0.461	0.497	1.000	0.747	0.672	0.522	0	5.51	0.817	0.788	0.263	0.935	0.490	0.858	0.303	1.000	0.888	19.492	0.950	14-3-3 domain	.	.	0.5	128	189	8	101960934	chr8:101960934	C	A	128	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	103665675	103665675	-	A	intronic	KLF10	.	.	.	0.003421767	0.834210438	0.162367795	.	0.62417	0.17296	0.374860183	75.43052607	239.0998	3.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.46	48	8	103665675	chr8:103665675	T	TA	11.46	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	105501568	105501568	C	A	UTR3	LRP12	NM_013437:c.*1333G>T;NM_001135703:c.*1333G>T	.	.	0.969751549	0.030248081	3.70E-07	.	0.82964	0.19728	-0.596992387	18.18825195	240.40002	3.34916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	8	105501568	chr8:105501568	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	106331252	106331252	C	A	intronic	ZFPM2	.	.	.	0.999955694	4.43E-05	5.33E-12	DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269|PubMed:14517948, ECO:0000269|PubMed:20807224}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Diaphragmatic hernia 3 (DIH3) [MIM:610187]: Form of congenital diaphragmatic hernia (CDH). CDH refers to a group of congenital defects in the structural integrity of the diaphragm associated with often lethal pulmonary hypoplasia and pulmonary hypertension. {ECO:0000269|PubMed:16103912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 9 (SRXY9) [MIM:616067]: A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females or have ambiguous external genitalia. {ECO:0000269|PubMed:24549039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. {ECO:0000269|PubMed:20807224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.5623	0.26433	0.519883383	80.37272942	1899.90602	8.01507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	161	8	106331252	chr8:106331252	C	A	64	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	109455823	109455823	C	T	UTR5	EMC2	NM_014673:c.-65C>T;NM_001329495:c.-2665C>T;NM_001329494:c.-65C>T;NM_001329493:c.-65C>T	.	.	8.61E-05	0.929791463	0.070122436	.	0.3077	0.11065	-0.09720619	46.20193442	9.46573	0.34895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	129	8	109455823	chr8:109455823	C	T	69	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	113275776	113275776	A	T	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	24	8	113275776	chr8:113275776	A	T	75	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	113871300	113871300	G	A	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	8	113871300	chr8:113871300	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	114389215	114389215	C	T	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	8	114389215	chr8:114389215	C	T	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	120114575	120114575	-	T	intronic	COLEC10	.	.	.	0.098536735	0.866536224	0.034927041	.	0.26958	0.13784	-0.115612493	45.12856806	56.82362	1.5176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	319	8	120114575	chr8:120114575	G	GT	74	PASS	DP=319;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	124822508	124822508	T	-	intronic	FAM91A1	.	.	.	0.515693527	0.484306207	2.67E-07	.	0.30469	.	-0.622676946	17.30950696	54.36063	1.47405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	141	8	124822507	chr8:124822507	CT	C	114	PASS	DP=141;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	127153830	127153830	G	C	intergenic	LINC00861;LOC101927657	dist=190389;dist=183910	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	163	8	127153830	chr8:127153830	G	C	77	PASS	DP=163;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	128428462	128428462	C	-	exonic	POU5F1B	.	frameshift deletion	POU5F1B:NM_001159542:exon1:c.351delC:p.P119Lfs*3	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	1373	8	128428461	chr8:128428461	TC	T	97	PASS	DP=1373;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	128428591	128428591	G	A	exonic	POU5F1B	.	synonymous SNV	POU5F1B:NM_001159542:exon1:c.G480A:p.L160L	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	138	8	128428591	chr8:128428591	G	A	84	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	128428862	128428862	C	T	exonic	POU5F1B	.	stopgain	POU5F1B:NM_001159542:exon1:c.C751T:p.Q251X	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	0.000	0.537	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.918	0.960	35	0.986	0.430	0.241	0.221	N	c	0.201	-0.139	0.002	0.089	0.706	0.609	0	0.197	0.144	2.119	0.413	0.439	0.276	0.960	0.334	0.082	0.182	1.798	0.029	Homeobox domain|Homeodomain-like	.	.	0.5	109	204	8	128428862	chr8:128428862	C	T	109	PASS	DP=204;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	128429315	128429315	T	A	ncRNA_intronic	CASC8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	185	8	128429315	chr8:128429315	T	A	113	PASS	DP=185;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	128806836	128806836	G	T	ncRNA_exonic	PVT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	131	8	128806836	chr8:128806836	G	T	87	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	131072825	131072825	C	A	exonic	ASAP1	.	synonymous SNV	ASAP1:NM_018482:exon28:c.G3192T:p.T1064T,ASAP1:NM_001247996:exon29:c.G3171T:p.T1057T	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	390	8	131072825	chr8:131072825	C	A	.	PASS	DP=390;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	131140276	131140276	C	T	exonic	ASAP1	.	synonymous SNV	ASAP1:NM_018482:exon16:c.G1278A:p.E426E,ASAP1:NM_001247996:exon17:c.G1257A:p.E419E	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	8	131140276	chr8:131140276	C	T	.	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	131140355	131140355	G	A	intronic	ASAP1	.	.	.	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	8	131140355	chr8:131140355	G	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	131408987	131408987	C	T	intronic	ASAP1	.	.	.	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	8	131408987	chr8:131408987	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	139145002	139145002	G	T	exonic	FAM135B	.	nonsynonymous SNV	FAM135B:NM_015912:exon20:c.C4055A:p.P1352H	0.999998682	1.32E-06	2.06E-16	.	0.08052	0.09691	-1.425829947	4.051663128	148.31692	2.65323	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	2.85	0.831	M	2.3	0.170	T	-8.44	0.972	D	0.811	0.800	-0.912	0.466	T	0.145	0.469	T	0.051	0.647	D	6.407	0.884	29.6	0.997	0.789	0.993	0.943	D	c	0.971	0.946	1.000	0.747	0.487	0.133	0	5.74	0.900	9.754	0.981	1.048	0.713	1.000	0.715	0.996	0.625	18.906	0.924	.	.	.	0.5	.	46	8	139145002	chr8:139145002	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	139658939	139658940	AC	-	intronic	COL22A1	.	.	.	8.26E-32	0.34578943	0.65421057	.	0.08309	.	0.161491526	64.92686954	2203.69391	8.64163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.87	22	8	139658938	chr8:139658938	TAC	T	10.87	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	142222279	142222279	G	A	UTR3	SLC45A4	NM_001286648:c.*11C>T	.	.	0.00458961	0.988812046	0.006598344	.	0.25179	0.09355	-1.295313867	4.989384289	150.28485	2.67496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	8	142222279	chr8:142222279	G	A	.	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	142517131	142517131	G	-	intronic	MROH5	.	.	.	.	.	.	.	.	.	4.384391577	99.74050484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	100	8	142517130	chr8:142517130	TG	T	159	PASS	DP=100;AN=2	GT	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.
8	143425267	143425267	C	-	intronic	TSNARE1	.	.	.	3.60E-07	0.792734251	0.207265389	.	0.13119	0.10131	1.050838371	91.36588818	5557.39016	15.40816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	863	8	143425266	chr8:143425266	GC	G	99	PASS	DP=863;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	143607953	143607953	C	A	exonic	ADGRB1	.	nonsynonymous SNV	ADGRB1:NM_001702:exon23:c.C3363A:p.D1121E	.	.	.	.	0.12027	0.1959	.	.	.	.	0.005	0.632	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	U	0.997	0.437	D	1.975	0.537	M	1.24	0.367	T	-3.2	0.647	D	0.124	0.140	-0.935	0.434	T	0.128	0.437	T	0.117	0.797	D	5.552	0.755	26.4	0.995	0.679	0.167	0.193	N	c	-0.483	-0.681	0.338	0.195	0.696	0.567	0	-5.02	0.027	-0.272	0.085	-1.079	0.019	0.493	0.267	0.985	0.512	11.631	0.502	GPCR, family 2-like	.	.	0.5	.	66	8	143607953	chr8:143607953	C	A	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	144406691	144406691	G	C	exonic	TOP1MT	.	nonsynonymous SNV	TOP1MT:NM_001258447:exon6:c.C486G:p.I162M,TOP1MT:NM_052963:exon6:c.C780G:p.I260M,TOP1MT:NM_001258446:exon7:c.C486G:p.I162M	1.63E-19	0.001500191	0.998499809	.	0.18543	0.14812	-0.435396074	24.70511913	3501.83574	11.39955	0.052	0.395	T	0.95	0.519	P	0.864	0.597	P	0.125	0.189	U	0.739	0.338	D	2.215	0.627	M	0.91	0.449	T	-1.66	0.416	N	0.263	0.435	-0.797	0.553	T	0.150	0.478	T	0.005	0.141	T	2.172	0.322	17.33	0.991	0.510	0.737	0.358	D	c	-0.035	-0.191	0.993	0.331	0.707	0.730	0	1.66	0.230	0.250	0.179	0.797	0.323	0.998	0.411	0.184	0.214	0.936	0.012	DNA topoisomerase I, DNA binding, eukaryotic-type|DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type;DNA topoisomerase I, DNA binding, eukaryotic-type|DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type|DNA topoisomerase I, eukaryotic-type	.	.	0.5	90	74	8	144406691	chr8:144406691	G	C	90	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	144464706	144464706	C	G	exonic	RHPN1	.	nonsynonymous SNV	RHPN1:NM_052924:exon15:c.C1898G:p.P633R	1.30E-06	0.822567716	0.177430984	.	0.10052	0.10074	-0.529034136	20.85987261	149.9984	2.67044	0.003	0.682	D	0.998	0.715	D	0.962	0.690	D	0.004	0.348	N	0.827	0.348	D	1.83	0.482	L	0.45	0.565	T	-2.55	0.551	D	0.669	0.679	-0.489	0.691	T	0.246	0.615	T	0.053	0.653	D	4.491	0.601	24.3	0.997	0.825	0.164	0.192	N	c	0.097	-0.050	0.998	0.368	0.696	0.567	0	3.89	0.439	-0.180	0.097	0.852	0.362	0.000	0.063	0.438	0.260	9.219	0.363	.	.	.	0.5	112	551	8	144464706	chr8:144464706	C	G	112	PASS	DP=551;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144641688	144641688	C	G	exonic	GSDMD	.	nonsynonymous SNV	GSDMD:NM_024736:exon2:c.C183G:p.I61M,GSDMD:NM_001166237:exon5:c.C183G:p.I61M	4.81E-07	0.393297033	0.606702486	.	0.06547	0.09123	-0.086288664	47.11606511	230.01248	3.27773	0.019	0.512	D	1.0	0.899	D	0.996	0.832	D	0.001	0.400	N	0.896	0.278	N	2.34	0.674	M	1.7	0.269	T	-1.55	0.404	N	0.502	0.582	-0.954	0.403	T	0.148	0.473	T	0.026	0.491	D	5.188	0.700	25.5	0.997	0.785	0.508	0.285	D	c	0.454	0.341	1.000	0.747	0.696	0.567	0	3.98	0.452	2.629	0.459	0.843	0.344	0.034	0.205	0.998	0.697	9.211	0.363	.	.	.	0.5	60	54	8	144641688	chr8:144641688	C	G	60	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	144808652	144808652	G	A	exonic	FAM83H	.	synonymous SNV	FAM83H:NM_198488:exon5:c.C2979T:p.N993N	0.88482471	0.115121211	5.41E-05	.	0.27378	0.10604	.	.	1586.01963	7.36593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	8	144808652	chr8:144808652	G	A	.	PASS	DP=118;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144940706	144940706	C	T	exonic	EPPK1	.	nonsynonymous SNV	EPPK1:NM_031308:exon2:c.G6716A:p.R2239H	4.95E-21	0.001368596	0.998631404	.	.	.	.	.	5706.98129	15.64597	.	.	.	0.822	0.438	P	0.112	0.300	B	.	.	.	0.987	0.246	N	1.435	0.361	L	.	.	.	.	.	.	0.226	0.315	-0.897	0.483	T	0.164	0.501	T	.	.	.	5.942	0.816	27.6	0.997	0.809	0.275	0.231	N	c	-0.075	-0.050	1.000	0.747	0.716	0.820	0	3.7	0.414	-0.330	0.079	0.739	0.307	0.000	0.063	0.926	0.400	5.481	0.159	.	.	.	0.5	103	216	8	144940706	chr8:144940706	C	T	103	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	145106711	145106711	G	A	exonic	OPLAH	.	synonymous SNV	OPLAH:NM_017570:exon27:c.C3639T:p.A1213A	2.99E-11	0.887670231	0.112329769	DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. {ECO:0000269|PubMed:21651516}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11816	0.18621	.	.	2315.28938	8.91132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	8	145106711	chr8:145106711	G	A	.	PASS	DP=77;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	145110662	145110662	C	T	intronic	OPLAH	.	.	.	2.99E-11	0.887670231	0.112329769	DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. {ECO:0000269|PubMed:21651516}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11816	0.18621	.	.	2315.28938	8.91132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	488	8	145110662	chr8:145110662	C	T	96	PASS	DP=488;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145234350	145234350	C	T	intronic	MROH1	.	.	.	0.587142255	0.412416428	0.000441317	.	.	.	.	.	77.45123	1.85066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	55	8	145234350	chr8:145234350	C	T	64	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	145537789	145537789	G	A	exonic	HSF1	.	synonymous SNV	HSF1:NM_005526:exon13:c.G1386A:p.G462G	0.586374295	0.413181557	0.000444148	.	0.11458	0.16496	-0.865195027	10.79853739	350.11867	3.96676	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	8	145537789	chr8:145537789	G	A	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	145537799	145537799	G	T	exonic	HSF1	.	nonsynonymous SNV	HSF1:NM_005526:exon13:c.G1396T:p.V466L	0.586374295	0.413181557	0.000444148	.	0.11458	0.16496	-0.865195027	10.79853739	350.11867	3.96676	0.009	0.574	D	0.576	0.368	P	0.301	0.393	B	0.000	0.843	D	1.000	0.548	D	2.81	0.821	M	.	.	.	-1.68	0.401	N	0.325	0.560	-0.519	0.680	T	0.284	0.656	T	0.060	0.680	D	5.077	0.684	25.3	0.994	0.640	0.977	0.761	D	c	0.501	0.580	1.0	0.983	0.672	0.522	0	5.62	0.857	4.555	0.602	0.944	0.532	1.000	0.715	0.999	0.750	17.162	0.866	Vertebrate heat shock transcription factor, C-terminal domain	.	.	0.5	.	186	8	145537799	chr8:145537799	G	T	.	PASS	DP=186;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
8	145559866	145559866	G	A	UTR5	SCRT1	NM_031309:c.-35C>T	.	.	0.294251147	0.62556547	0.080183384	.	0.21303	.	.	.	10.3722	0.37768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	92	8	145559866	chr8:145559866	G	A	.	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	145652340	145652340	-	G	UTR5	VPS28	NM_016208:c.-13_-12insC;NM_183057:c.-13_-12insC	.	.	0.115974874	0.857110731	0.026914395	.	0.20134	0.1297	-0.404032746	26.53338051	18.89106	0.65215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	525	8	145652340	chr8:145652340	T	TG	82	PASS	DP=525;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	52577	52577	G	A	intergenic	FAM138C;PGM5P3-AS1	dist=16713;dist=20113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	260	9	52577	chr9:52577	G	A	110	PASS	DP=260;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	52584	52584	C	T	intergenic	FAM138C;PGM5P3-AS1	dist=16720;dist=20106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	259	9	52584	chr9:52584	C	T	123	PASS	DP=259;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	73247	73247	C	T	ncRNA_intronic	PGM5P3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	199	9	73247	chr9:73247	C	T	86	PASS	DP=199;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	117371	117371	C	G	exonic	FOXD4	.	nonsynonymous SNV	FOXD4:NM_207305:exon1:c.G749C:p.G250A	.	.	.	.	0.15599	.	0.885576705	89.14248644	2757.82566	9.90294	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-1.385	0.006	N	-3.38	0.942	D	0.03	0.066	N	0.045	0.025	-0.991	0.323	T	0.000	0.000	T	.	.	.	-2.220	0.005	0.001	0.636	0.071	0.002	0.009	N	c	-1.644	-1.642	0.010	0.120	0.598	0.340	0	0.496	0.160	0.134	0.156	-0.054	0.122	0.000	0.063	0.003	0.074	4.257	0.101	.	ENSG00000172785.14|ENSG00000170122.4|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14|ENSG00000172785.14	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Transverse|Esophagus_Mucosa|Heart_Atrial_Appendage|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid	0.5	170	294	9	117371	chr9:117371	C	G	170	PASS	DP=294;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	118535	118535	T	C	upstream	FOXD4	dist=118	.	.	.	.	.	.	0.15599	.	0.885576705	89.14248644	2757.82566	9.90294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	29	9	118535	chr9:118535	T	C	57	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	215700	215700	A	T	UTR5	C9orf66	NM_152569:c.-304T>A	.	.	0.000775174	0.53508837	0.464136456	.	.	.	.	.	4564.52887	13.55817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	150	9	215700	chr9:215700	A	T	118	PASS	DP=150;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	4125713	4125713	A	-	intronic	GLIS3	.	.	.	0.000100597	0.997176535	0.002722868	.	0.59622	.	-0.007415459	52.86034442	744.78269	5.41665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	51	9	4125712	chr9:4125712	GA	G	67	PASS	DP=51;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	8449660	8449660	T	C	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	25	9	8449660	chr9:8449660	T	C	63	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.
9	9425588	9425588	-	ACTT	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	48	9	9425588	chr9:9425588	C	CACTT	85	PASS	DP=48;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	14086859	14086859	G	A	UTR3	NFIB	NM_001190737:c.*1449C>T;NM_005596:c.*1449C>T;NM_001282787:c.*1337C>T;NM_001190738:c.*1449C>T	.	.	0.990809167	0.009190352	4.81E-07	.	0.94482	0.41901	-0.449946534	24.00330267	16.65407	0.58684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	9	14086859	chr9:14086859	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	15433520	15433520	-	T	intronic	SNAPC3	.	.	.	5.54E-05	0.883341296	0.116603314	.	0.17643	0.10767	-0.069700724	48.54328851	386.09549	4.13838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	72	9	15433520	chr9:15433520	A	AT	82	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	17332542	17332542	G	T	intronic	CNTLN	.	.	.	.	.	.	.	0.20604	0.17905	0.461041847	78.29087049	3754.49948	11.98604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	9	17332542	chr9:17332542	G	T	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	18706829	18706829	G	T	exonic	ADAMTSL1	.	synonymous SNV	ADAMTSL1:NM_001040272:exon14:c.G1659T:p.L553L	8.83E-05	0.999911689	4.59E-08	.	.	.	-0.860112269	10.89879689	3092.36494	10.5706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	66	9	18706829	chr9:18706829	G	T	110	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
9	19350926	19350926	-	T	intronic	DENND4C	.	.	.	0.406967594	0.593032405	1.03E-09	.	0.38649	.	-0.957327604	9.017456947	1816.18274	7.85903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	21	9	19350926	chr9:19350926	C	CT	52	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	21228040	21228040	C	G	exonic	IFNA17	.	nonsynonymous SNV	IFNA17:NM_021268:exon1:c.G133C:p.G45R	0.007025822	0.528540962	0.464433216	.	0.03731	0.5932	0.461228372	78.46190139	360.76195	4.02023	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.125	0.188	N	1	0.090	P	-2.335	0.001	N	4.11	0.029	T	5.54	0.000	N	0.031	0.012	-1.077	0.080	T	0.000	0.000	T	.	.	.	-2.750	0.002	0.001	0.417	0.030	0.010	0.038	N	c	-2.692	-2.643	0.001	0.081	0.487	0.133	0	-5.29	0.025	-0.247	0.088	-4.446	0.000	0.006	0.172	0.002	0.062	6.15	0.194	Four-helical cytokine, core|Four-helical cytokine-like, core	ENSG00000226393.1	Nerve_Tibial	0.5	73	21	9	21228040	chr9:21228040	C	G	73	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	21974695	21974695	G	T	exonic	CDKN2A	.	stopgain	CDKN2A:NM_000077:exon1:c.C132A:p.Y44X,CDKN2A:NM_001195132:exon1:c.C132A:p.Y44X,CDKN2A:NM_058197:exon1:c.C132A:p.Y44X	0.357648776	0.58984451	0.052506714	DISEASE: Note=The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.; DISEASE: Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:10651484, ECO:0000269|PubMed:10874641, ECO:0000269|PubMed:11506491, ECO:0000269|PubMed:12019208, ECO:0000269|PubMed:14646619, ECO:0000269|PubMed:19260062, ECO:0000269|PubMed:7987387, ECO:0000269|PubMed:8595405, ECO:0000269|PubMed:8653684, ECO:0000269|PubMed:8710906, ECO:0000269|PubMed:9328469, ECO:0000269|PubMed:9425228}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]: An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Melanoma-astrocytoma syndrome (MASTS) [MIM:155755]: Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma. {ECO:0000269|PubMed:11136714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03037	0.06846	0.725794416	85.98136353	20.60127	0.70067	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.848	0.956	35	0.984	0.403	0.199	0.206	N	c	-0.369	-0.750	1.000	0.747	0.658	0.486	0	-2.57	0.059	-1.027	0.037	0.108	0.203	0.000	0.063	0.004	0.083	3.596	0.075	Ankyrin repeat-containing domain	.	.	0.5	.	63	9	21974695	chr9:21974695	G	T	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	21994454	21994454	C	A	UTR5	CDKN2A	NM_058195:c.-124G>T	.	.	0.357648776	0.58984451	0.052506714	DISEASE: Note=The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.; DISEASE: Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:10651484, ECO:0000269|PubMed:10874641, ECO:0000269|PubMed:11506491, ECO:0000269|PubMed:12019208, ECO:0000269|PubMed:14646619, ECO:0000269|PubMed:19260062, ECO:0000269|PubMed:7987387, ECO:0000269|PubMed:8595405, ECO:0000269|PubMed:8653684, ECO:0000269|PubMed:8710906, ECO:0000269|PubMed:9328469, ECO:0000269|PubMed:9425228}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]: An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Melanoma-astrocytoma syndrome (MASTS) [MIM:155755]: Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma. {ECO:0000269|PubMed:11136714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03037	0.06846	0.725794416	85.98136353	20.60127	0.70067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	9	21994454	chr9:21994454	C	A	.	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	32986004	32986004	C	T	exonic	APTX	.	nonsynonymous SNV	APTX:NM_001195250:exon4:c.G388A:p.G130S,APTX:NM_001195254:exon4:c.G346A:p.G116S,APTX:NM_001195248:exon5:c.G550A:p.G184S,APTX:NM_001195249:exon5:c.G508A:p.G170S,APTX:NM_001195252:exon5:c.G334A:p.G112S,APTX:NM_175069:exon5:c.G550A:p.G184S,APTX:NM_001195251:exon6:c.G508A:p.G170S,APTX:NM_175073:exon6:c.G508A:p.G170S	7.73E-06	0.740449587	0.259542684	DISEASE: Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]: An autosomal recessive syndrome characterized by early-onset cerebellar ataxia, oculomotor apraxia, early areflexia and late peripheral neuropathy. {ECO:0000269|PubMed:11586299, ECO:0000269|PubMed:11586300, ECO:0000269|PubMed:12196655, ECO:0000269|PubMed:12629250, ECO:0000269|PubMed:14506070, ECO:0000269|PubMed:15699391, ECO:0000269|PubMed:15852392}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07205	0.29287	0.463046108	78.58575136	86.51936	1.98569	0.055	0.912	T	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	2.685	0.788	M	-1.92	0.916	D	-4.7	0.815	D	0.671	0.730	0.787	0.943	D	0.857	0.952	D	0.208	0.871	D	7.199	0.945	34	0.998	0.925	0.981	0.793	D	c	0.737	0.745	1.000	0.425	0.732	0.924	0	5.78	0.914	5.995	0.701	0.807	0.329	1.000	0.715	0.999	0.750	17.506	0.876	Forkhead-associated (FHA) domain;Forkhead-associated (FHA) domain|HIT-like domain;Forkhead-associated (FHA) domain|HIT-like domain|SMAD/FHA domain;Forkhead-associated (FHA) domain|SMAD/FHA domain	.	.	0.5	.	30	9	32986004	chr9:32986004	C	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	33034351	33034351	C	T	intronic	DNAJA1	.	.	.	0.260111369	0.738699815	0.001188817	.	0.49896	0.36254	-0.560178693	19.30879925	6.16298	0.23238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	9	33034351	chr9:33034351	C	T	.	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	33290467	33290467	G	T	UTR5	NFX1	NM_147134:c.-104G>T;NM_001318758:c.-104G>T;NM_002504:c.-104G>T	.	.	0.386441239	0.613558732	2.94E-08	.	0.44031	.	-1.591018721	3.084453881	335.711	3.89158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	261	9	33290467	chr9:33290467	G	T	138	PASS	DP=261;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	33290474	33290474	G	T	UTR5	NFX1	NM_147134:c.-97G>T;NM_001318758:c.-97G>T;NM_002504:c.-97G>T	.	.	0.386441239	0.613558732	2.94E-08	.	0.44031	.	-1.591018721	3.084453881	335.711	3.89158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	285	9	33290474	chr9:33290474	G	T	134	PASS	DP=285;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	33364821	33364821	-	A	intronic	NFX1	.	.	.	0.386441239	0.613558732	2.94E-08	.	0.44031	.	-1.591018721	3.084453881	335.711	3.89158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	18	9	33364821	chr9:33364821	G	GA	39	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	33401246	33401246	G	A	exonic	AQP7	.	synonymous SNV	AQP7:NM_001170:exon2:c.C15T:p.S5S,AQP7:NM_001318158:exon2:c.C15T:p.S5S	1.86E-09	0.034706833	0.965293165	.	0.0624	0.1324	0.108486928	61.90728946	500.92929	4.59263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	254	9	33401246	chr9:33401246	G	A	91	PASS	DP=254;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	33469406	33469406	C	T	intronic	NOL6	.	.	.	0.999078032	0.000921968	2.94E-12	.	0.21138	0.11067	-0.231522913	36.36470866	535.96118	4.71978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	79	9	33469406	chr9:33469406	C	T	109	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	33794798	33794799	GA	-	exonic	PRSS3	.	frameshift deletion	PRSS3:NM_001197097:exon2:c.9_10del:p.E5Dfs*27	4.80E-10	0.015739826	0.984260174	.	0.28887	0.8505	-0.139478553	43.29440906	1149.53078	6.46	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	16	9	33794797	chr9:33794797	TGA	T	60	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	34622389	34622389	A	C	exonic	ARID3C	.	nonsynonymous SNV	ARID3C:NM_001017363:exon5:c.T1003G:p.C335G	6.79E-07	0.269883999	0.730115322	.	0.32423	0.08104	0.52918614	80.81505072	546.80485	4.75348	0.416	0.099	T	0.0	0.026	B	0.0	0.013	B	0.079	0.210	N	1	0.090	P	-1.39	0.006	N	1.14	0.384	T	-0.16	0.095	N	0.024	0.007	-1.008	0.275	T	0.000	0.000	T	.	.	.	-0.996	0.032	0.016	0.709	0.092	0.001	0.006	N	c	-1.372	-1.249	0.980	0.300	0.549	0.223	0	0.293	0.149	-0.052	0.117	0.061	0.167	0.000	0.063	0.284	0.234	4.092	0.094	REKLES domain	ENSG00000230074.1|ENSG00000164967.5|ENSG00000230074.1|ENSG00000230074.1|ENSG00000164967.5|ENSG00000230074.1|ENSG00000230074.1|ENSG00000164967.5|ENSG00000205143.2|ENSG00000230074.1|ENSG00000230074.1|ENSG00000230074.1|ENSG00000122756.10|ENSG00000230074.1|ENSG00000164967.5|ENSG00000230074.1|ENSG00000164967.5|ENSG00000230074.1|ENSG00000230074.1|ENSG00000230074.1|ENSG00000230074.1|ENSG00000230074.1|ENSG00000147955.12|ENSG00000164967.5|ENSG00000230074.1|ENSG00000164967.5|ENSG00000230074.1|ENSG00000230074.1|ENSG00000230074.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Coronary|Artery_Tibial|Artery_Tibial|Brain_Cortex|Brain_Nucleus_accumbens_basal_ganglia|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Colon_Transverse|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Whole_Blood	0.5	70	24	9	34622389	chr9:34622389	A	C	70	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	35100569	35100569	A	G	intronic	STOML2	.	.	.	0.529200678	0.470656311	0.000143011	.	0.87655	0.14979	-0.471992905	23.03609342	30.66945	0.97588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	9	9	35100569	chr9:35100569	A	G	41	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	35713215	35713215	G	C	exonic	TLN1	.	synonymous SNV	TLN1:NM_006289:exon26:c.C3330G:p.A1110A	1	1.65E-12	2.92E-34	.	0.29532	0.38988	-3.420504246	0.365652276	1723.9194	7.6602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	9	35713215	chr9:35713215	G	C	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	35792272	35792272	T	A	upstream	NPR2	dist=134	.	.	0.991660782	0.008339218	2.60E-11	DISEASE: Acromesomelic dysplasia, Maroteaux type (AMDM) [MIM:602875]: An autosomal recessive acromesomelic chondrodysplasia. Acromesomelic chondrodysplasias are rare hereditary skeletal disorders characterized by short stature, very short limbs and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). AMDM is characterized by axial skeletal involvement with wedging of vertebral bodies. In AMDM all skeletal elements are present but show abnormal rates of linear growth. {ECO:0000269|PubMed:15146390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epiphyseal chondrodysplasia, Miura type (ECDM) [MIM:615923]: An overgrowth syndrome characterized by tall stature, long hands and feet with arachnodactyly, macrodactyly of the great toes, scoliosis, coxa valga and slipped capital femoral epiphysis. {ECO:0000269|PubMed:22870295, ECO:0000269|PubMed:23827346, ECO:0000269|PubMed:24057292, ECO:0000269|PubMed:24259409}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short stature with non-specific skeletal abnormalities (SNSK) [MIM:616255]: A condition characterized by short stature, defined as a height less than 2 SD below normal, and no endocrine abnormalities. {ECO:0000269|PubMed:24001744, ECO:0000269|PubMed:24471569}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1999	0.26645	-1.043396569	7.71408351	52.97375	1.44484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	173	9	35792272	chr9:35792272	T	A	.	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	35812099	35812104	ACCGCG	-	exonic	SPAG8	.	frameshift deletion	SPAG8:NM_001039592:exon1:c.41_44del:p.S14Yfs*2,SPAG8:NM_172312:exon1:c.41_44del:p.S14Yfs*2	2.75E-07	0.740885869	0.259113856	.	0.11804	0.1054	0.867166666	88.81811748	3548.41665	11.49875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	29	9	35812098	chr9:35812098	CACCGCG	C	42	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	37034032	37034032	G	T	UTR5	PAX5	NM_001280555:c.-4C>A;NM_001280554:c.-4C>A;NM_001280550:c.-4C>A;NM_001280548:c.-4C>A;NM_001280547:c.-4C>A;NM_001280553:c.-4C>A;NM_001280552:c.-4C>A;NM_001280551:c.-18953C>A;NM_016734:c.-4C>A;NM_001280549:c.-4C>A;NM_001280556:c.-18953C>A	.	.	0.984243989	0.015747099	8.91E-06	DISEASE: Note=A chromosomal aberration involving PAX5 is a cause of acute lymphoblastic leukemia. Translocation t(9;18)(p13;q11.2) with ZNF521. Translocation t(9;3)(p13;p14.1) with FOXP1. Translocation t(9;12)(p13;p13) with ETV6. {ECO:0000269|PubMed:17344859}.; DISEASE: Leukemia, acute lymphoblastic, 3 (ALL3) [MIM:613065]: A subtype of acute leukemia, a cancer of the white blood cells. Acute lymphoblastic anemia is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphonodes. {ECO:0000269|PubMed:24013638}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.43685	0.08086	-0.003562597	53.72729417	148.49912	2.65773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	9	37034032	chr9:37034032	G	T	.	PASS	DP=86;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	37708421	37708421	C	-	exonic	FRMPD1	.	frameshift deletion	FRMPD1:NM_014907:exon4:c.285delC:p.P96Lfs*7	3.53E-10	0.995711787	0.004288213	.	0.15661	0.09359	1.70862952	96.44373673	4200.93656	12.88726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	18	9	37708420	chr9:37708420	TC	T	96	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
9	38603140	38603140	-	T	intronic	ANKRD18A	.	.	.	0.000945591	0.578001567	0.421052842	.	0.01878	.	2.704844505	98.90894079	4407.02172	13.26594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	34	9	38603140	chr9:38603140	A	AT	83	PASS	DP=34;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	40332652	40332652	G	T	intergenic	FAM74A1;LOC105379450	dist=426433;dist=351167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	126	9	40332652	chr9:40332652	G	T	130	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	44093256	44093256	A	G	intergenic	CNTNAP3P2;XLOC_007697	dist=169199;dist=88255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	302	9	44093256	chr9:44093256	A	G	90	PASS	DP=302;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	44120283	44120284	TT	-	intergenic	CNTNAP3P2;XLOC_007697	dist=196226;dist=61227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	29	9	44120282	chr9:44120282	CTT	C	55	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	66457161	66457161	A	G	upstream	LINC01410	dist=128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	102	9	66457161	chr9:66457161	A	G	82	PASS	DP=102;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	66457299	66457299	G	T	ncRNA_exonic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	9	66457299	chr9:66457299	G	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	66457322	66457322	G	C	ncRNA_exonic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	9	66457322	chr9:66457322	G	C	.	PASS	DP=62;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	66457628	66457628	G	A	ncRNA_intronic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	258	9	66457628	chr9:66457628	G	A	136	PASS	DP=258;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	66513792	66513792	C	G	ncRNA_exonic	LOC403323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	283	9	66513792	chr9:66513792	C	G	135	PASS	DP=283;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	66553447	66553447	G	C	ncRNA_exonic	LOC403323;LOC728673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	329	9	66553447	chr9:66553447	G	C	129	PASS	DP=329;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	67293607	67293607	T	C	ncRNA_exonic	LOC102724580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	177	427	9	67293607	chr9:67293607	T	C	177	PASS	DP=427;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	68429152	68429152	T	C	ncRNA_exonic	FRG1JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	198	9	68429152	chr9:68429152	T	C	140	PASS	DP=198;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	68433481	68433481	-	CTC	ncRNA_exonic	FRG1JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	121	9	68433481	chr9:68433481	T	TCTC	107	PASS	DP=121;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	69067893	69067897	AAAAG	-	ncRNA_exonic	FRG1HP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	102	9	69067892	chr9:69067892	AAAAAG	A	86	PASS	DP=102;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	69082095	69082095	A	-	ncRNA_intronic	FRG1HP;PGM5P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	15	9	69082094	chr9:69082094	CA	C	54	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	69634644	69634644	A	T	intergenic	LOC105379252;LOC100133920	dist=152967;dist=16717	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	246	9	69634644	chr9:69634644	A	T	.	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	69830318	69830318	G	A	intergenic	LOC101928381;FOXD4L5	dist=72534;dist=345389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	300	9	69830318	chr9:69830318	G	A	109	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	69847082	69847082	C	T	intergenic	LOC101928381;FOXD4L5	dist=89298;dist=328625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	436	9	69847082	chr9:69847082	C	T	161	PASS	DP=436;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	70871836	70871836	C	G	splicing	CBWD3	NM_201453:exon5:c.431-1C>G	.	.	0.358916975	0.589020154	0.052062871	.	.	0.09807	.	.	7163.3464	18.21502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	67	9	70871836	chr9:70871836	C	G	128	PASS	DP=67;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	70993137	70993137	A	T	exonic	PGM5	.	nonsynonymous SNV	PGM5:NM_021965:exon2:c.A284T:p.Q95L	0.961611244	0.03838545	3.31E-06	.	0.47663	0.11828	-0.422438699	25.64284029	133.77721	2.51514	0.013	0.538	D	0.954	0.524	P	0.83	0.578	P	0.000	0.629	U	1	0.810	D	2.495	0.729	M	-0.04	0.633	T	-5.4	0.873	D	0.325	0.386	0.171	0.854	D	0.479	0.801	T	0.186	0.859	D	3.658	0.497	23.2	0.996	0.755	0.972	0.732	D	c	0.753	0.663	0.996	0.344	0.554	0.283	0	4.37	0.517	7.180	0.770	1.001	0.622	1.000	0.715	0.994	0.587	12.834	0.570	Alpha-D-phosphohexomutase, alpha/beta/alpha I/II/III|Alpha-D-phosphohexomutase, alpha/beta/alpha domain I	.	.	0.5	129	222	9	70993137	chr9:70993137	A	T	129	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	74331480	74331480	G	A	intronic	TMEM2	.	.	.	1.28E-09	0.999862594	0.000137405	.	0.07506	0.13257	-0.472233057	22.84147205	5982.23661	16.11897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	9	74331480	chr9:74331480	G	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	79318365	79318365	C	A	exonic	PRUNE2	.	stopgain	PRUNE2:NM_001308047:exon9:c.G8164T:p.E2722X,PRUNE2:NM_001308048:exon9:c.G8164T:p.E2722X,PRUNE2:NM_015225:exon9:c.G8164T:p.E2722X	3.68E-12	0.999991467	8.53E-06	.	0.07279	0.07799	2.779178029	99.02689314	10480.06134	22.38246	.	.	.	.	.	.	.	.	.	0.001	0.407	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.257	0.996	45	0.997	0.791	0.926	0.558	D	c	0.998	0.846	1.000	0.747	0.615	0.372	0	5.71	0.890	1.226	0.320	0.892	0.403	1.000	0.715	1.000	0.888	13.305	0.596	.	.	.	0.5	65	57	9	79318365	chr9:79318365	C	A	65	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	82242418	82242418	G	T	intronic	TLE4	.	.	.	0.99992164	7.84E-05	4.33E-12	.	0.94973	0.14686	-0.556537043	19.72753008	90.91723	2.05178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	9	82242418	chr9:82242418	G	T	.	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	82335174	82335174	G	A	exonic	TLE4	.	nonsynonymous SNV	TLE4:NM_001351564:exon13:c.G1522A:p.A508T,TLE4:NM_001282753:exon14:c.G1597A:p.A533T,TLE4:NM_001351562:exon14:c.G1576A:p.A526T,TLE4:NM_001351563:exon14:c.G1570A:p.A524T,TLE4:NM_001282749:exon15:c.G1729A:p.A577T,TLE4:NM_001351547:exon15:c.G1753A:p.A585T,TLE4:NM_001351550:exon15:c.G1744A:p.A582T,TLE4:NM_001351552:exon15:c.G1741A:p.A581T,TLE4:NM_001351556:exon15:c.G1735A:p.A579T,TLE4:NM_001351558:exon15:c.G1732A:p.A578T,TLE4:NM_001351560:exon15:c.G1726A:p.A576T,TLE4:NM_001351542:exon16:c.G1807A:p.A603T,TLE4:NM_001351543:exon16:c.G1801A:p.A601T,TLE4:NM_001351546:exon16:c.G1798A:p.A600T,TLE4:NM_007005:exon16:c.G1804A:p.A602T,TLE4:NM_001282748:exon17:c.G1900A:p.A634T,TLE4:NM_001282760:exon17:c.G1441A:p.A481T,TLE4:NM_001351541:exon17:c.G1843A:p.A615T	0.99992164	7.84E-05	4.33E-12	.	0.94973	0.14686	-0.556537043	19.72753008	90.91723	2.05178	0.004	0.721	D	0.99	0.899	D	0.8	0.679	P	0.000	0.843	D	1	0.810	D	2.08	0.576	M	0.23	0.597	T	-3.05	0.629	D	0.786	0.779	-0.388	0.724	T	0.369	0.729	T	0.035	0.561	D	6.891	0.931	33	0.999	0.992	0.992	0.922	D	c	0.815	0.821	1.000	0.747	0.707	0.730	0	5.71	0.890	10.003	0.997	0.998	0.613	1.000	0.715	0.966	0.452	19.856	0.967	WD40 repeat, conserved site|WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain;WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	.	.	0.5	.	47	9	82335174	chr9:82335174	G	A	.	PASS	DP=47;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	85607951	85607951	-	A	intronic	RASEF	.	.	.	3.27E-05	0.999404853	0.000562435	.	0.09812	.	0.42259095	77.22929936	665.99098	5.16516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	19	9	85607951	chr9:85607951	G	GA	40	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	86276863	86276863	-	A	intronic	UBQLN1	.	.	.	0.998753262	0.00124672	1.81E-08	.	0.49245	0.31063	-0.314027422	31.9297004	45.11361	1.28969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	127	9	86276863	chr9:86276863	G	GA	62	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	86593171	86593171	C	T	UTR5	HNRNPK	NM_001318187:c.-4G>A;NM_002140:c.-4G>A;NM_031263:c.-4G>A;NM_001318186:c.-4G>A;NM_001318188:c.-4G>A;NM_031262:c.-4G>A	.	.	0.999782389	0.000217611	2.57E-10	.	0.8864	0.67288	-0.207437529	38.2814343	5.95251	0.22372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	9	86593171	chr9:86593171	C	T	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	90746211	90746211	T	C	exonic	SPATA31C2	.	nonsynonymous SNV	SPATA31C2:NM_001166137:exon4:c.A1741G:p.S581G,SPATA31C2:NM_001350978:exon4:c.A1741G:p.S581G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	105	9	90746211	chr9:90746211	T	C	118	PASS	DP=105;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	91992903	91992903	G	A	UTR3	SEMA4D	NM_006378:c.*716C>T	.	.	0.995825192	0.004174794	1.41E-08	.	0.2355	0.224	0.123045693	62.23755603	3261.67374	10.88836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	33	9	91992903	chr9:91992903	G	A	58	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	94877628	94877628	C	A	exonic	SPTLC1	.	nonsynonymous SNV	SPTLC1:NM_001281303:exon1:c.G25T:p.V9F,SPTLC1:NM_006415:exon1:c.G25T:p.V9F,SPTLC1:NM_178324:exon1:c.G25T:p.V9F	2.78E-07	0.914098573	0.085901148	DISEASE: Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by prominent sensory abnormalities with a variable degree of motor and autonomic dysfunction. The neurological phenotype is often complicated by severe infections, osteomyelitis, and amputations. HSAN1A is an autosomal dominant axonal form with onset in the second or third decades. Initial symptoms are loss of pain, touch, heat, and cold sensation over the feet, followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic skin ulcers and distal amputations. {ECO:0000269|PubMed:11242114, ECO:0000269|PubMed:19651702, ECO:0000269|PubMed:21618344, ECO:0000269|PubMed:22302274, ECO:0000269|PubMed:24247255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=SPTLC1 mutations at Ser-331 are responsible for severe hereditary motor and sensory neuropathy (HMSN) forms, whose core features are severe, diffuse muscle wasting and hypotonia, motor and sensory disturbances, foot ulcers, amputations and/or burns, joint hypermobility, cataracts and considerable growth retardation. {ECO:0000269|PubMed:23454272}.; 	0.38002	0.22508	-0.247889024	35.98726115	180.38129	2.91802	0.204	0.506	T	0.686	0.511	P	0.235	0.465	B	0.000	0.843	D	1	0.810	D	2.67	0.784	M	-3.77	0.956	D	-1.22	0.309	N	0.822	0.810	0.727	0.935	D	0.825	0.941	D	0.465	0.946	D	4.047	0.544	23.7	0.986	0.431	0.917	0.538	D	c	0.237	0.328	1.0	0.983	0.025	0.001	3	4.81	0.613	4.084	0.571	0.674	0.295	1.000	0.715	0.996	0.625	16.789	0.854	.	.	.	0.5	.	277	9	94877628	chr9:94877628	C	A	.	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	95051604	95051605	TT	-	exonic	IARS	.	frameshift deletion	IARS:NM_002161:exon2:c.97_98del:p.K33Afs*4,IARS:NM_013417:exon2:c.97_98del:p.K33Afs*4	4.35E-09	0.999995165	4.83E-06	.	0.71817	0.19154	-1.074802575	7.336635999	1316.65812	6.82478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.77	44	9	95051603	chr9:95051603	CTT	C	14.77	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	95277135	95277135	C	-	exonic	ECM2	.	frameshift deletion	ECM2:NM_001197295:exon4:c.766delG:p.E256Rfs*15,ECM2:NM_001197296:exon4:c.766delG:p.E256Rfs*15,ECM2:NM_001393:exon4:c.832delG:p.E278Rfs*15	1.56E-06	0.85172241	0.148276027	.	0.08752	.	0.424410872	77.25878745	175.72328	2.88468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	126	9	95277134	chr9:95277134	TC	T	60	PASS	DP=126;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	96259884	96259884	A	-	intronic	FAM120A	.	.	.	0.99990705	9.29E-05	6.56E-12	.	0.24853	0.11006	-2.037519759	1.657230479	38.57086	1.14394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	179	9	96259883	chr9:96259883	TA	T	81	PASS	DP=179;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	99227651	99227651	T	C	exonic	HABP4	.	nonsynonymous SNV	HABP4:NM_014282:exon3:c.T545C:p.L182S	0.004932505	0.967203698	0.027863798	.	0.18355	0.11001	-0.560178693	19.30879925	16.2504	0.57669	0.098	0.308	T	0.974	0.559	D	0.462	0.447	P	0.524	0.117	N	1	0.090	N	1.7	0.440	L	1.42	0.332	T	-2.12	0.481	N	0.333	0.394	-1.024	0.223	T	0.057	0.238	T	0.014	0.333	T	0.843	0.174	9.729	0.986	0.428	0.118	0.167	N	c	-0.546	-0.639	0.733	0.231	0.732	0.924	0	-0.152	0.127	0.481	0.218	0.148	0.236	0.412	0.260	0.958	0.437	9.094	0.356	.	.	.	0.5	.	121	9	99227651	chr9:99227651	T	C	.	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	99962758	99962758	G	A	ncRNA_exonic	ANKRD18CP	.	.	.	.	.	.	.	0.02598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	9	99962758	chr9:99962758	G	A	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	100618882	100618900	GGTTCAGTCCAAATGGGGA	-	UTR3	FOXE1	NM_004473:c.*1564_*1582delGGTTCAGTCCAAATGGGGA	.	.	.	.	.	DISEASE: Bamforth-Lazarus syndrome (BLS) [MIM:241850]: A disease characterized by thyroid agenesis, cleft palate and choanal atresia. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:9697705}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.10592	.	.	82.34677	1.92681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	25	9	100618881	chr9:100618881	TGGTTCAGTCCAAATGGGGA	T	84	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	101051946	101051946	C	T	UTR3	GABBR2	NM_005458:c.*920G>A	.	.	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	9	101051946	chr9:101051946	C	T	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	101068579	101068579	C	T	exonic	GABBR2	.	nonsynonymous SNV	GABBR2:NM_005458:exon15:c.G2053A:p.A685T	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	0.012	0.546	D	0.999	0.764	D	0.996	0.832	D	0.000	0.843	D	1	0.810	D	1.01	0.254	L	-2.26	0.874	D	-3.06	0.630	D	0.739	0.736	0.767	0.940	D	0.799	0.932	D	0.171	0.849	D	4.022	0.540	23.6	0.999	0.995	0.994	0.954	D	c	0.706	0.605	1.000	0.747	0.706	0.609	0	5.15	0.702	7.676	0.832	0.935	0.490	1.000	0.715	0.969	0.458	16.142	0.813	GPCR family 3, C-terminal	.	.	0.5	110	114	9	101068579	chr9:101068579	C	T	110	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	101797339	101797339	A	G	exonic	COL15A1	.	nonsynonymous SNV	COL15A1:NM_001855:exon18:c.A2123G:p.K708R	3.68E-06	0.999996136	1.80E-07	.	0.21122	.	1.844643849	97.10426987	3519.49319	11.44267	0.052	0.390	T	0.01	0.144	B	0.016	0.166	B	0.102	0.198	N	1.000	0.186	N	0.685	0.165	N	-3.24	0.935	D	-0.62	0.183	N	0.114	0.124	-0.527	0.677	T	0.466	0.794	T	0.030	0.524	D	0.739	0.164	9.081	0.847	0.149	0.289	0.235	N	c	-0.745	-0.573	1.000	0.517	0.487	0.133	0	4.53	0.548	1.061	0.299	1.199	0.960	0.158	0.235	0.949	0.424	9.853	0.400	.	.	.	0.5	42	78	9	101797339	chr9:101797339	A	G	42	PASS	DP=78;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	102588038	102588038	G	T	UTR5	NR4A3	NM_006981:c.-2287G>T;NM_173200:c.-1015G>T;NM_173199:c.-2287G>T	.	.	.	.	.	DISEASE: Ewing sarcoma (ES) [MIM:612219]: A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving NR4A3 is found in patients with Erwing sarcoma. Translocation t(9;22)(q22- 31;q11-12) with EWSR1.; DISEASE: Note=A chromosomal aberration involving NR4A3 is a cause of a form of extraskeletal myxoid chondrosarcomas (EMC). Translocation t(9;17)(q22;q11) with TAF2N.; 	0.71461	0.18411	-0.339715008	30.06605331	1958.05838	8.14638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	103	9	102588038	chr9:102588038	G	T	102	PASS	DP=103;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	103275550	103275550	G	A	intronic	MSANTD3-TMEFF1;TMEFF1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	91	9	103275550	chr9:103275550	G	A	54	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	104170167	104170168	CA	-	intronic	ZNF189	.	.	.	0.004617885	0.964927865	0.03045425	.	0.74958	0.11322	0.154398214	64.73814579	98.59808	2.14648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	20.21	18	9	104170166	chr9:104170166	TCA	T	20.21	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	104309195	104309195	A	G	exonic	RNF20	.	nonsynonymous SNV	RNF20:NM_019592:exon7:c.A841G:p.I281V	0.000923365	0.999076445	1.90E-07	.	0.15368	0.12971	-0.598810865	18.13517339	121.63796	2.40133	0.539	0.068	T	0.803	0.432	P	0.785	0.557	P	0.000	0.843	D	1	0.810	D	1.12	0.289	L	-1.14	0.779	T	-0.3	0.119	N	0.33	0.391	-0.261	0.761	T	0.441	0.779	T	0.029	0.521	D	1.742	0.270	14.65	0.968	0.306	0.986	0.847	D	c	0.439	0.510	1.000	0.747	0.707	0.730	0	5.53	0.825	5.900	0.694	1.088	0.866	1.000	0.715	1.000	0.888	15.630	0.765	.	.	.	0.5	88	54	9	104309195	chr9:104309195	A	G	88	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
9	108072082	108072082	C	G	exonic	SLC44A1	.	nonsynonymous SNV	SLC44A1:NM_001286730:exon3:c.C204G:p.I68M,SLC44A1:NM_001330731:exon3:c.C204G:p.I68M,SLC44A1:NM_080546:exon3:c.C204G:p.I68M	0.999253571	0.000746428	1.05E-09	.	0.2337	0.13691	-0.534490515	20.70063694	1596.58474	7.39509	0.16	0.241	T	0.202	0.461	B	0.193	0.446	B	0.000	0.843	D	0.978	0.394	D	2.2	0.622	M	-1.27	0.793	T	-1.49	0.364	N	0.456	0.508	-0.600	0.648	T	0.313	0.683	T	0.054	0.659	D	3.617	0.492	23.2	0.973	0.326	0.737	0.358	D	c	-0.116	-0.024	1.000	0.747	0.781	0.997	0	2.89	0.326	0.799	0.265	0.065	0.171	1.000	0.715	1.000	0.888	6.856	0.231	.	.	.	0.5	52	31	9	108072082	chr9:108072082	C	G	52	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	115480313	115480313	C	G	UTR5	INIP	NM_021218:c.-1548G>C;NM_001329588:c.-23865G>C;NM_001329590:c.-23865G>C;NM_001329589:c.-23865G>C;NM_001329585:c.-20579G>C;NM_001329587:c.-1548G>C;NM_001329586:c.-1548G>C	.	.	0.017451553	0.717632071	0.264916376	.	0.26262	.	0.057118534	57.99716914	1.19806	0.03523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	428	9	115480313	chr9:115480313	C	G	147	PASS	DP=428;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	116155669	116155669	-	CCCCAA	intronic	ALAD	.	.	.	0.06295026	0.933785175	0.003264564	DISEASE: Acute hepatic porphyria (AHEPP) [MIM:612740]: A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AHP is characterized by attacks of gastrointestinal disturbances, abdominal colic, paralyses and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. {ECO:0000269|PubMed:10706561, ECO:0000269|PubMed:1309003, ECO:0000269|PubMed:1569184, ECO:0000269|PubMed:2063868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11936	0.55928	-0.558357437	19.54470394	471.54569	4.49402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	92	9	116155669	chr9:116155669	T	TCCCCAA	146	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	116359453	116359453	-	G	UTR3	RGS3	NM_144488:c.*220_*221insG;NM_001282923:c.*220_*221insG;NM_130795:c.*220_*221insG;NM_001276261:c.*220_*221insG;NM_001276260:c.*220_*221insG;NM_134427:c.*220_*221insG;NM_001322215:c.*220_*221insG;NM_001351526:c.*220_*221insG;NM_001282922:c.*220_*221insG;NM_144489:c.*220_*221insG;NM_001276262:c.*220_*221insG	.	.	9.68E-05	0.999879192	2.40E-05	.	0.27528	.	-0.356550349	29.16961548	669.24526	5.17392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	206	9	116359453	chr9:116359453	A	AG	123	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	117053128	117053128	C	A	exonic	COL27A1	.	synonymous SNV	COL27A1:NM_032888:exon48:c.C4407A:p.G1469G	0.999999361	6.39E-07	9.95E-23	DISEASE: Steel syndrome (STLS) [MIM:615155]: A syndrome characterized by dislocated hips and radial heads, fusion of carpal bones, short stature, scoliosis, and cervical spine anomalies. Facial features include prominent forehead, long oval- shaped face, hypertelorism and broad nasal bridge. {ECO:0000269|PubMed:24986830}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.70075	.	0.170613481	65.33970276	8956.48219	20.50775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	9	117053128	chr9:117053128	C	A	.	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	117143366	117143366	G	A	exonic	AKNA	.	nonsynonymous SNV	AKNA:NM_001317950:exon2:c.C248T:p.S83F,AKNA:NM_030767:exon2:c.C248T:p.S83F	0.02852574	0.971473491	7.69E-07	.	0.0634	0.0824	0.378330486	75.51899033	4847.69941	14.15107	0.255	0.168	T	0.001	0.067	B	0.003	0.080	B	0.850	0.090	N	1	0.090	N	1.525	0.387	L	2.65	0.332	T	-1.76	0.424	N	0.116	0.144	-1.009	0.273	T	0.047	0.200	T	0.004	0.086	T	0.779	0.168	9.333	0.770	0.113	0.041	0.094	N	c	-1.348	-1.382	1.000	0.411	0.672	0.522	0	1.13	0.197	0.793	0.264	-0.387	0.064	0.001	0.137	0.001	0.043	6.567	0.216	.	.	.	0.5	.	45	9	117143366	chr9:117143366	G	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	118228115	118228115	-	G	intergenic	DEC1;LOC101928775	dist=63192;dist=273834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	81	9	118228115	chr9:118228115	A	AG	159	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	119199765	119199765	G	A	intronic	ASTN2	.	.	.	0.989172284	0.010827716	2.44E-10	.	0.28632	0.11008	-2.271160931	1.256192498	1146.31095	6.45411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	145	9	119199765	chr9:119199765	G	A	80	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	125866154	125866154	C	T	UTR3	RABGAP1	NM_012197:c.*662C>T	.	.	0.9999998	2.00E-07	1.04E-17	.	0.29209	0.11542	-1.50825116	3.503184713	121.41418	2.40018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	25	9	125866154	chr9:125866154	C	T	50	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	126783433	126783433	G	C	exonic	LHX2	.	synonymous SNV	LHX2:NM_004789:exon4:c.G783C:p.P261P	0.946789689	0.053028912	0.000181399	.	0.99245	0.23835	-0.117432389	44.89266336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	17	9	126783433	chr9:126783433	G	C	53	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	127032349	127032349	C	-	intronic	NEK6	.	.	.	0.644137661	0.35559309	0.000269249	.	0.12306	0.11384	-0.359940251	28.93371078	287.30993	3.63133	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	85	9	127032348	chr9:127032348	GC	G,GCC	91	PASS	DP=85;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/2
9	127032349	127032349	-	C	intronic	NEK6	.	.	.	0.644137661	0.35559309	0.000269249	.	0.12306	0.11384	-0.359940251	28.93371078	287.30993	3.63133	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	85	9	127032348	chr9:127032348	GC	G,GCC	91	PASS	DP=85;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/2
9	129453229	129453229	A	G	exonic	LMX1B	.	synonymous SNV	LMX1B:NM_001174146:exon3:c.A441G:p.E147E,LMX1B:NM_001174147:exon3:c.A441G:p.E147E,LMX1B:NM_002316:exon3:c.A441G:p.E147E	0.82273227	0.177096322	0.000171408	.	0.35834	0.35026	-0.846787714	11.05803255	23.27331	0.77647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	235	9	129453229	chr9:129453229	A	G	102	PASS	DP=235;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	130206266	130206266	C	T	intronic	ZNF79	.	.	.	0.017129421	0.960225592	0.022644988	.	0.34316	0.20051	0.134171522	63.57041755	46.29924	1.31066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	98	9	130206266	chr9:130206266	C	T	64	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	130279245	130279245	C	A	exonic	FAM129B	.	nonsynonymous SNV	FAM129B:NM_001035534:exon8:c.G825T:p.E275D,FAM129B:NM_022833:exon8:c.G864T:p.E288D	0.096703214	0.903283319	1.35E-05	.	0.24632	0.10776	-1.346642726	4.62962963	224.45345	3.23964	0.223	0.188	T	0.122	0.252	B	0.056	0.247	B	0.000	0.504	D	0.933	0.370	D	0.61	0.157	N	1.87	0.241	T	-0.87	0.236	N	0.08	0.072	-1.069	0.096	T	0.042	0.182	T	0.010	0.257	T	1.657	0.260	14.17	0.986	0.433	0.078	0.136	N	c	-0.549	-0.502	1.000	0.517	0.672	0.522	0	3.9	0.441	-0.708	0.051	0.016	0.142	0.063	0.217	0.021	0.135	7.542	0.268	.	.	.	0.5	109	154	9	130279245	chr9:130279245	C	A	109	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	130536293	130536293	G	A	exonic	SH2D3C	.	nonsynonymous SNV	SH2D3C:NM_170600:exon2:c.C491T:p.P164L	0.000941187	0.996381628	0.002677185	.	0.33676	0.12268	-0.639268965	16.70794999	510.40629	4.62665	0.122	0.276	T	0.0	0.026	B	0.001	0.040	B	0.242	0.036	N	1	0.090	N	0	0.065	N	2.69	0.123	T	-0.16	0.095	N	0.156	0.186	-0.975	0.361	T	0.018	0.074	T	0.005	0.141	T	-0.032	0.091	2.287	0.763	0.110	0.010	0.037	N	c	-1.148	-1.168	1.000	0.747	0.707	0.730	0	-1.75	0.076	-2.349	0.012	-0.340	0.072	0.000	0.063	0.002	0.062	3.201	0.062	.	.	.	0.5	.	39	9	130536293	chr9:130536293	G	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	130571176	130571177	AG	-	intronic	FPGS	.	.	.	0.000112878	0.988716023	0.011171099	.	0.08683	0.26961	-0.534490515	20.70063694	105.84338	2.2299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.73	68	9	130571175	chr9:130571175	TAG	T	11.73	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	130652978	130652978	G	A	exonic	ST6GALNAC6	.	synonymous SNV	ST6GALNAC6:NM_001287000:exon4:c.C540T:p.A180A,ST6GALNAC6:NM_001287001:exon4:c.C540T:p.A180A,ST6GALNAC6:NM_001287002:exon4:c.C540T:p.A180A,ST6GALNAC6:NM_001286999:exon5:c.C642T:p.A214A,ST6GALNAC6:NM_013443:exon5:c.C642T:p.A214A	0.00205356	0.912791919	0.085154521	.	0.14025	0.09314	-1.023168368	7.944090587	40.49297	1.1878	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	304	9	130652978	chr9:130652978	G	A	116	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	130905129	130905204	TGGCCCAGGACAAGAGGAATCTGGGGTGTGGGGAGAAGGGGTCTATGGGGTCAAGGAGACTATGCTGGCTGCAAAA	-	intergenic	PTGES2-AS1;LCN2	dist=12216;dist=6505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.54	38	9	130905128	chr9:130905128	GTGGCCCAGGACAAGAGGAATCTGGGGTGTGGGGAGAAGGGGTCTATGGGGTCAAGGAGACTATGCTGGCTGCAAAA	G	12.54	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	131284958	131284958	G	A	exonic	GLE1	.	synonymous SNV	GLE1:NM_001003722:exon4:c.G444A:p.R148R,GLE1:NM_001499:exon4:c.G444A:p.R148R	1.54E-05	0.998327206	0.001657412	DISEASE: Lethal congenital contracture syndrome 1 (LCCS1) [MIM:253310]: A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS1 patients manifest early fetal hydrops and akinesia, micrognathia, pulmonary hypoplasia, pterygia, and multiple joint contractures. It leads to prenatal death. {ECO:0000269|PubMed:18204449}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal arthrogryposis with anterior horn cell disease (LAAHD) [MIM:611890]: A disorder characterized by fetal akinesia, arthrogryposis and motor neuron loss. The fetus often survives delivery, but dies early as a result of respiratory failure. Neuropathological findings resemble those of lethal congenital contracture syndrome type 1, but are less severe. {ECO:0000269|PubMed:18204449}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.33736	0.10182	-0.088107893	47.06298655	1002.42975	6.09812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	9	131284958	chr9:131284958	G	A	.	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	132935014	132935014	C	T	intronic	NCS1	.	.	.	0.947220876	0.052601383	0.000177741	.	0.18713	0.18619	-0.141298762	42.87567823	2.47706	0.0911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	9	132935014	chr9:132935014	C	T	.	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	132935066	132935066	C	-	intronic	NCS1	.	.	.	0.947220876	0.052601383	0.000177741	.	0.18713	0.18619	-0.141298762	42.87567823	2.47706	0.0911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	78	9	132935065	chr9:132935065	GC	G	52	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	133251913	133251913	C	T	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	9	133251913	chr9:133251913	C	T	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	133270429	133270429	C	T	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	9	133270429	chr9:133270429	C	T	.	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	133271583	133271583	C	G	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	0.08	0.230	B	0.025	0.193	B	.	.	.	.	.	.	-0.235	0.039	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.122	0.105	3.842	0.446	0.034	0.034	0.084	N	n	0.705	1.261	0.021	0.133	0.253	0.035	0	1.58	0.224	-0.550	0.061	-0.035	0.126	0.000	0.063	0.001	0.043	6.762	0.226	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	89	411	9	133271583	chr9:133271583	C	G	89	PASS	DP=411;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	133271590	133271590	G	A	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	206	9	133271590	chr9:133271590	G	A	.	PASS	DP=206;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	133285950	133285950	A	G	intronic	HMCN2	.	.	.	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	39	9	133285950	chr9:133285950	A	G	66	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	133948049	133948049	A	G	exonic	LAMC3	.	nonsynonymous SNV	LAMC3:NM_006059:exon19:c.A3244G:p.S1082G	9.82E-11	0.9988887	0.001111299	DISEASE: Cortical malformations occipital (OCCM) [MIM:614115]: A disease in which affected individuals develop seizures, sometimes associated with transient visual changes. Brain MRI shows both pachygyria and polymicrogyria restricted to the lateral occipital lobes. {ECO:0000269|PubMed:21572413}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15545	.	0.637377588	83.64000944	7208.01279	18.27431	0.515	0.074	T	0.0	0.026	B	0.001	0.040	B	0.512	0.118	N	1	0.090	P	-1.59	0.004	N	1.64	0.278	T	-0.08	0.082	N	0.011	0.001	-1.027	0.215	T	0.000	0.000	T	.	.	.	-0.178	0.078	1.221	0.639	0.071	0.004	0.020	N	c	-1.203	-1.153	1.000	0.747	0.706	0.609	0	2.24	0.271	0.511	0.223	-0.221	0.097	0.035	0.205	0.004	0.083	7.909	0.288	.	ENSG00000126878.8	Artery_Aorta	0.5	61	18	9	133948049	chr9:133948049	A	G	61	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	135612574	135612574	T	C	intronic	AK8	.	.	.	1.51E-07	0.384769812	0.615230037	.	0.13923	0.15909	0.068033485	59.0351498	497.62894	4.58369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	9	135612574	chr9:135612574	T	C	.	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	135779074	135779074	G	C	exonic	TSC1	.	nonsynonymous SNV	TSC1:NM_001162427:exon16:c.C2019G:p.I673M,TSC1:NM_000368:exon17:c.C2172G:p.I724M,TSC1:NM_001162426:exon17:c.C2169G:p.I723M	0.999978334	2.17E-05	3.82E-14	DISEASE: Tuberous sclerosis 1 (TSC1) [MIM:191100]: An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes. {ECO:0000269|PubMed:10227394, ECO:0000269|PubMed:10533069, ECO:0000269|PubMed:10570911, ECO:0000269|PubMed:10874311, ECO:0000269|PubMed:18830229, ECO:0000269|PubMed:22161988, ECO:0000269|PubMed:9328481}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Focal cortical dysplasia of Taylor balloon cell type (FCDBC) [MIM:607341]: Subtype of cortical dysplasias linked to chronic intractable epilepsy. Cortical dysplasias display a broad spectrum of structural changes, which appear to result from changes in proliferation, migration, differentiation, and apoptosis of neuronal precursors and neurons during cortical development. {ECO:0000269|PubMed:12112044}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.77672	0.4222	-1.03794674	7.832035858	754.82235	5.44924	0.07	0.377	T	1.0	0.899	D	0.981	0.736	D	0.000	0.843	D	0.998	0.810	D	2.015	0.552	M	-1.7	0.831	D	-0.28	0.121	N	0.413	0.471	0.011	0.825	D	0.565	0.842	D	0.101	0.775	D	4.308	0.577	24.0	0.997	0.810	0.994	0.960	D	c	0.542	0.559	1.000	0.747	0.731	0.878	0	5.32	0.753	5.002	0.635	1.048	0.713	1.000	0.715	0.960	0.441	13.394	0.601	.	.	.	0.5	82	100	9	135779074	chr9:135779074	G	C	82	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	135779219	135779219	G	T	intronic	TSC1	.	.	.	0.999978334	2.17E-05	3.82E-14	DISEASE: Tuberous sclerosis 1 (TSC1) [MIM:191100]: An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes. {ECO:0000269|PubMed:10227394, ECO:0000269|PubMed:10533069, ECO:0000269|PubMed:10570911, ECO:0000269|PubMed:10874311, ECO:0000269|PubMed:18830229, ECO:0000269|PubMed:22161988, ECO:0000269|PubMed:9328481}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Focal cortical dysplasia of Taylor balloon cell type (FCDBC) [MIM:607341]: Subtype of cortical dysplasias linked to chronic intractable epilepsy. Cortical dysplasias display a broad spectrum of structural changes, which appear to result from changes in proliferation, migration, differentiation, and apoptosis of neuronal precursors and neurons during cortical development. {ECO:0000269|PubMed:12112044}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.77672	0.4222	-1.03794674	7.832035858	754.82235	5.44924	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	9	135779219	chr9:135779219	G	T	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	135981408	135981408	C	A	intronic	RALGDS	.	.	.	0.296706348	0.703257909	3.57E-05	.	0.48158	0.16125	-1.344833561	4.641424864	2512.28764	9.3358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	9	135981408	chr9:135981408	C	A	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	136277480	136277480	A	G	exonic	REXO4	.	synonymous SNV	REXO4:NM_001279350:exon4:c.T438C:p.T146T,REXO4:NM_001279351:exon4:c.T570C:p.T190T,REXO4:NM_020385:exon4:c.T849C:p.T283T	9.99E-06	0.789928485	0.210061521	.	0.07311	0.09983	0.376678994	75.50719509	339.03688	3.90521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	17	9	136277480	chr9:136277480	A	G	62	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	136301993	136301993	C	A	exonic	ADAMTS13	.	synonymous SNV	ADAMTS13:NM_139025:exon12:c.C1353A:p.A451A,ADAMTS13:NM_139026:exon12:c.C1260A:p.A420A,ADAMTS13:NM_139027:exon12:c.C1353A:p.A451A	7.88E-11	0.998477308	0.001522692	DISEASE: Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150]: A hematologic disease characterized by hemolytic anemia with fragmentation of erythrocytes, thrombocytopenia, diffuse and non-focal neurologic findings, decreased renal function and fever. recessive. {ECO:0000269|PubMed:11586351, ECO:0000269|PubMed:12181489, ECO:0000269|PubMed:12393505, ECO:0000269|PubMed:12614216, ECO:0000269|PubMed:12753286, ECO:0000269|PubMed:14512317, ECO:0000269|PubMed:14563640, ECO:0000269|PubMed:15009458, ECO:0000269|PubMed:15126318, ECO:0000269|PubMed:15327386, ECO:0000269|PubMed:16449289, ECO:0000269|PubMed:16453338, ECO:0000269|PubMed:16796708, ECO:0000269|PubMed:16807643, ECO:0000269|PubMed:17003922, ECO:0000269|PubMed:18443791, ECO:0000269|PubMed:19055667, ECO:0000269|PubMed:19116307, ECO:0000269|PubMed:22075512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0682	0.12877	0.622690987	83.42179759	2255.36428	8.77522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	9	136301993	chr9:136301993	C	A	.	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	136412300	136412300	G	T	exonic	ADAMTSL2	.	nonsynonymous SNV	ADAMTSL2:NM_001145320:exon9:c.G904T:p.A302S,ADAMTSL2:NM_014694:exon9:c.G904T:p.A302S	0.071058667	0.916004048	0.012937285	DISEASE: Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]: An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone- shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. {ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:21415077}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26032	0.11516	.	.	74.41925	1.80297	0.0	0.912	D	1.0	0.899	D	0.984	0.745	D	0.002	0.372	N	1	0.810	D	1.455	0.369	L	0.56	0.546	T	-2.4	0.527	N	0.606	0.764	-0.625	0.638	T	0.310	0.681	T	0.024	0.468	T	4.603	0.617	24.4	0.998	0.850	0.989	0.883	D	c	0.695	0.670	1.000	0.747	0.646	0.450	0	5.16	0.704	9.847	0.984	1.048	0.713	1.000	0.715	0.997	0.653	18.645	0.913	ADAM-TS Spacer 1	.	.	0.5	87	196	9	136412300	chr9:136412300	G	T	87	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	137314506	137314523	GGACACTCCCCACTCCCG	-	intronic	RXRA	.	.	.	0.943607123	0.056350112	4.28E-05	.	0.72501	0.7625	-0.690637458	15.12149092	54.60468	1.47935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	125	9	137314505	chr9:137314505	CGGACACTCCCCACTCCCG	C	50	PASS	DP=125;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	137600270	137600270	T	-	intronic	COL5A1	.	.	.	1	2.48E-13	8.59E-33	DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10602121, ECO:0000269|PubMed:11992482, ECO:0000269|PubMed:15580559, ECO:0000269|PubMed:18972565, ECO:0000269|PubMed:9042913}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69297	.	-3.009169053	0.524887945	863.84203	5.72906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	20	9	137600269	chr9:137600269	GT	G	54	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	137702206	137702206	G	A	intronic	COL5A1	.	.	.	1	2.48E-13	8.59E-33	DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10602121, ECO:0000269|PubMed:11992482, ECO:0000269|PubMed:15580559, ECO:0000269|PubMed:18972565, ECO:0000269|PubMed:9042913}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69297	.	-3.009169053	0.524887945	863.84203	5.72906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	65	9	137702206	chr9:137702206	G	A	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	138377853	138377853	A	G	exonic	PPP1R26	.	synonymous SNV	PPP1R26:NM_014811:exon4:c.A1497G:p.V499V	0.985547303	0.014452401	2.96E-07	.	0.1034	0.10038	0.48857149	79.4821892	2978.84256	10.35088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	12	9	138377853	chr9:138377853	A	G	42	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	138648987	138648987	C	T	intronic	KCNT1	.	.	.	0.005348738	0.994649439	1.82E-06	DISEASE: Epileptic encephalopathy, early infantile, 14 (EIEE14) [MIM:614959]: A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another. {ECO:0000269|PubMed:23086397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]: An autosomal dominant focal epilepsy syndrome characterized by childhood onset of clusters of motor seizures during sleep. Some patients may develop behavioral or psychiatric manifestations and/or intellectual disability. The phenotype is more severe than observed in other genetic forms of nocturnal frontal lobe epilepsy. {ECO:0000269|PubMed:23086396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10242	0.10521	-2.070835943	1.615947157	121.99362	2.40558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	9	138648987	chr9:138648987	C	T	.	PASS	DP=100;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	138676404	138676404	C	A	exonic	KCNT1	.	synonymous SNV	KCNT1:NM_001272003:exon25:c.C2832A:p.I944I,KCNT1:NM_020822:exon26:c.C2967A:p.I989I	0.005348738	0.994649439	1.82E-06	DISEASE: Epileptic encephalopathy, early infantile, 14 (EIEE14) [MIM:614959]: A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another. {ECO:0000269|PubMed:23086397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]: An autosomal dominant focal epilepsy syndrome characterized by childhood onset of clusters of motor seizures during sleep. Some patients may develop behavioral or psychiatric manifestations and/or intellectual disability. The phenotype is more severe than observed in other genetic forms of nocturnal frontal lobe epilepsy. {ECO:0000269|PubMed:23086396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10242	0.10521	-2.070835943	1.615947157	121.99362	2.40558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	98	9	138676404	chr9:138676404	C	A	.	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
9	139402402	139402402	C	A	intronic	NOTCH1	.	.	.	0.999999994	5.68E-09	7.22E-23	DISEASE: Aortic valve disease 1 (AOVD1) [MIM:109730]: A common defect in the aortic valve in which two rather than three leaflets are present. It is often associated with aortic valve calcification, stenosis and insufficiency. In extreme cases, the blood flow may be so restricted that the left ventricle fails to grow, resulting in hypoplastic left heart syndrome. {ECO:0000269|PubMed:16025100}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Adams-Oliver syndrome 5 (AOS5) [MIM:616028]: A form of Adams-Oliver syndrome, a disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins. {ECO:0000269|PubMed:25132448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94531	0.91608	-3.510304589	0.330266572	576.67829	4.86776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	197	9	139402402	chr9:139402402	C	A	.	PASS	DP=197;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	139650595	139650595	T	G	intronic	LCN8	.	.	.	0.042675812	0.847352111	0.109972077	.	0.03683	.	0.373041938	75.29488087	1010.88949	6.12169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	116	9	139650595	chr9:139650595	T	G	74	PASS	DP=116;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	139734633	139734635	AGA	-	exonic	RABL6	.	nonframeshift deletion	RABL6:NM_001173988:exon14:c.1961_1963del:p.K661del,RABL6:NM_024718:exon14:c.1958_1960del:p.K660del	0.970513088	0.029485197	1.72E-06	.	0.10622	0.11255	-0.282886048	33.53385232	162.54419	2.78361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	47	35	9	139734632	chr9:139734632	GAGA	G	47	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	139839920	139839920	G	-	intronic	C8G	.	.	.	1.63E-09	0.032163822	0.967836176	.	0.04668	.	0.196671391	67.19155461	801.2629	5.57646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	583	9	139839919	chr9:139839919	TG	T	87	PASS	DP=583;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	139840877	139840877	G	C	intronic	C8G	.	.	.	1.63E-09	0.032163822	0.967836176	.	0.04668	.	0.196671391	67.19155461	801.2629	5.57646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	9	139840877	chr9:139840877	G	C	.	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	139905432	139905432	G	A	exonic	ABCA2	.	nonsynonymous SNV	ABCA2:NM_001606:exon39:c.C6049T:p.R2017W,ABCA2:NM_212533:exon39:c.C6139T:p.R2047W	0.999999516	4.84E-07	6.11E-21	.	0.34587	0.29822	-4.237700156	0.123849965	470.40443	4.48778	0.002	0.721	D	0.476	0.418	P	0.014	0.188	B	0.367	0.136	U	0.998	0.222	N	0	0.065	N	-1.27	0.793	T	-0.43	0.144	N	0.197	0.495	-0.894	0.486	T	0.159	0.493	T	0.633	0.969	D	6.690	0.916	32	0.991	0.509	0.895	0.497	D	c	-0.164	-0.066	0.772	0.237	0.696	0.567	0	3.42	0.381	4.976	0.633	0.870	0.379	1.000	0.715	0.994	0.587	8.885	0.344	.	.	.	0.5	.	143	9	139905432	chr9:139905432	G	A	.	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	140147003	140147003	G	-	ncRNA_intronic	STPG3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	66	9	140147002	chr9:140147002	CG	C	65	PASS	DP=66;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	140177108	140177108	G	A	downstream	TOR4A	dist=15	.	.	0.215534136	0.647904223	0.136561641	.	0.09004	0.12134	.	.	186.39911	2.9648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	9	140177108	chr9:140177108	G	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	140343969	140343969	C	G	intronic	NSMF	.	.	.	0.046546174	0.95238468	0.001069146	DISEASE: Hypogonadotropic hypogonadism 9 with or without anosmia (HH9) [MIM:614838]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:15362570, ECO:0000269|PubMed:21700882, ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. The genetics of hypogonadotropic hypogonadism involves various modes of transmission. Oligogenic inheritance has been reported in some patients carrying mutations in NSMF as well as in other HH-associated genes including FGFR1 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	0.15334	0.23802	-0.538132194	20.26421326	17.60779	0.61694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	163	9	140343969	chr9:140343969	C	G	84	PASS	DP=163;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	140686493	140686493	-	T	intronic	EHMT1	.	.	.	0.999999904	9.60E-08	3.49E-19	DISEASE: Kleefstra syndrome (KLESTS) [MIM:610253]: A syndrome characterized by severe mental retardation, hypotonia, brachy(micro)cephaly, and facial dysmorphisms. Additionally, congenital heart defects, urogenital defects, epilepsy and behavioral problems are frequently observed. {ECO:0000269|PubMed:16826528, ECO:0000269|PubMed:19264732}. Note=The disease is caused by mutations affecting the gene represented in this entry (PubMed:16826528). The syndrome can be either caused by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene or by a submicroscopic 9q34.3 deletion. Although it is not known if and to what extent other genes in the 9q34.3 region contribute to the syndrome observed in deletion cases, EHMT1 seems to be the major determinant of the core disease phenotype (PubMed:19264732). {ECO:0000269|PubMed:16826528, ECO:0000269|PubMed:19264732}.; 	0.19698	0.1459	-1.582005788	3.13163482	397.32742	4.1876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	171	9	140686492	chr9:140686492	CT	CTT,C	89	PASS	DP=171;AN=6	GT	0/1	./.	./.	./.	./.	./.	./.	0/2	./.	./.	0/2
9	140686493	140686493	T	-	intronic	EHMT1	.	.	.	0.999999904	9.60E-08	3.49E-19	DISEASE: Kleefstra syndrome (KLESTS) [MIM:610253]: A syndrome characterized by severe mental retardation, hypotonia, brachy(micro)cephaly, and facial dysmorphisms. Additionally, congenital heart defects, urogenital defects, epilepsy and behavioral problems are frequently observed. {ECO:0000269|PubMed:16826528, ECO:0000269|PubMed:19264732}. Note=The disease is caused by mutations affecting the gene represented in this entry (PubMed:16826528). The syndrome can be either caused by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene or by a submicroscopic 9q34.3 deletion. Although it is not known if and to what extent other genes in the 9q34.3 region contribute to the syndrome observed in deletion cases, EHMT1 seems to be the major determinant of the core disease phenotype (PubMed:19264732). {ECO:0000269|PubMed:16826528, ECO:0000269|PubMed:19264732}.; 	0.19698	0.1459	-1.582005788	3.13163482	397.32742	4.1876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	171	9	140686492	chr9:140686492	CT	CTT,C	89	PASS	DP=171;AN=6	GT	0/1	./.	./.	./.	./.	./.	./.	0/2	./.	./.	0/2
10	95108	95108	C	T	intronic	TUBB8	.	.	.	0.266953543	0.707835377	0.025211079	.	.	.	0.150760231	64.51403633	82.28258	1.92577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	188	10	95108	chr10:95108	C	T	92	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	858611	858611	A	-	UTR3	LARP4B	NM_015155:c.*255delT;NM_001351277:c.*255delT	.	.	0.999885804	0.000114196	1.08E-11	.	0.58444	0.10818	-1.063626766	7.484076433	58.52951	1.54984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	42	10	858610	chr10:858610	GA	G	57	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	1779236	1779236	G	A	intronic	ADARB2	.	.	.	0.738168861	0.261726193	0.000104945	.	0.18882	0.14637	-0.505170032	21.79759377	584.19726	4.90127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	219	10	1779236	chr10:1779236	G	A	111	PASS	DP=219;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	5922203	5922203	G	T	intronic	ANKRD16	.	.	.	2.58E-06	0.505168379	0.494829043	.	0.09505	.	0.707379532	85.62750649	1385.5909	6.96821	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	10	5922203	chr10:5922203	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	6506209	6506209	-	A	intronic	PRKCQ	.	.	.	0.967595406	0.032404576	1.80E-08	.	0.6701	0.45889	-0.378346116	28.01368247	672.23761	5.1805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	42	10	6506209	chr10:6506209	G	GA	39	PASS	DP=42;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	11367781	11367781	T	-	ncRNA_intronic	CELF2-AS1	.	.	.	.	.	.	.	0.03536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	39	10	11367780	chr10:11367780	CT	C	117	PASS	DP=39;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	11911550	11911550	C	-	exonic	PROSER2	.	frameshift deletion	PROSER2:NM_153256:exon4:c.453delC:p.P153Rfs*199	0.005463151	0.713979705	0.280557144	.	0.09537	.	.	.	802.73118	5.58207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	44	10	11911549	chr10:11911549	AC	A	43	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	16563920	16563920	C	T	UTR5	C1QL3	NM_001010908:c.-856G>A	.	.	0.718803252	0.267338417	0.013858331	.	0.58092	0.12378	.	.	0.76147	0.01334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	10	16563920	chr10:16563920	C	T	.	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	16957998	16957998	A	T	exonic	CUBN	.	nonsynonymous SNV	CUBN:NM_001081:exon46:c.T7032A:p.S2344R	3.03E-28	0.999999978	2.24E-08	DISEASE: Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100]: Due to selective malabsorption of vitamin B12. Defects in vitamin B12 absorption lead to impaired function of thymidine synthase. As a consequence DNA synthesis is interrupted. Rapidly dividing cells involved in erythropoiesis are particularly affected. {ECO:0000269|PubMed:10080186, ECO:0000269|PubMed:10887099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16009	0.3163	1.257700362	93.49492805	6532.49526	17.0026	0.059	0.375	T	0.569	0.366	P	0.21	0.356	B	0.073	0.214	N	0.998	0.446	D	2.345	0.676	M	2.13	0.196	T	-2.33	0.516	N	0.127	0.144	-1.108	0.032	T	0.043	0.187	T	0.014	0.336	T	2.972	0.417	22.1	0.966	0.298	0.293	0.236	N	c	-0.419	-0.465	0.024	0.136	0.516	0.203	0	1.92	0.248	-0.304	0.082	-0.114	0.115	0.002	0.151	0.024	0.140	8.923	0.346	CUB domain	.	.	0.5	.	56	10	16957998	chr10:16957998	A	T	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	17256638	17256638	C	A	ncRNA_exonic	VIM-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	10	17256638	chr10:17256638	C	A	.	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	17271400	17271400	G	C	ncRNA_exonic	VIM-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	144	10	17271400	chr10:17271400	G	C	85	PASS	DP=144;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	18430127	18430127	C	A	exonic	CACNB2	.	nonsynonymous SNV	CACNB2:NM_001167945:exon1:c.C19A:p.L7M,CACNB2:NM_201571:exon1:c.C19A:p.L7M,CACNB2:NM_201572:exon1:c.C19A:p.L7M	0.001820338	0.997139378	0.001040285	DISEASE: Brugada syndrome 4 (BRGDA4) [MIM:611876]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18213	0.15589	-0.705410796	14.77942911	766.55161	5.48442	0.141	0.330	T	0.742	0.442	P	0.047	0.293	B	.	.	.	1.000	0.516	D	.	.	.	-1.74	0.836	D	0.49	0.031	N	0.096	0.100	-0.844	0.524	T	0.163	0.500	T	0.098	0.770	D	2.148	0.319	17.17	0.967	0.301	0.340	0.247	N	c	-0.354	-0.239	1.000	0.405	0.598	0.340	0	2.63	0.303	1.396	0.339	0.739	0.307	1.000	0.715	1.000	0.888	6.157	0.194	.	.	.	0.5	.	30	10	18430127	chr10:18430127	C	A	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	20105997	20105999	GGC	-	UTR5	PLXDC2	NM_001282736:c.-12_-10del-;NM_032812:c.-12_-10del-	.	.	0.613047817	0.386937644	1.45E-05	.	0.46149	0.10853	0.531004228	80.87992451	87.18855	1.99411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	31	10	20105996	chr10:20105996	TGGC	T	42	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	20432280	20432280	G	T	exonic	PLXDC2	.	nonsynonymous SNV	PLXDC2:NM_001282736:exon4:c.G451T:p.A151S,PLXDC2:NM_032812:exon5:c.G598T:p.A200S	0.613047817	0.386937644	1.45E-05	.	0.46149	0.10853	0.531004228	80.87992451	87.18855	1.99411	0.0	0.912	D	0.957	0.528	D	0.769	0.549	P	0.000	0.843	D	1	0.810	D	3.195	0.893	M	-1.41	0.806	T	-2.97	0.623	D	0.868	0.858	0.352	0.884	D	0.649	0.878	D	0.172	0.849	D	6.217	0.858	28.8	0.998	0.860	0.992	0.927	D	c	0.852	0.866	1.000	0.747	0.706	0.609	0	5.82	0.927	9.958	0.990	1.047	0.674	1.000	0.715	1.000	0.888	20.109	0.979	.	.	.	0.5	.	40	10	20432280	chr10:20432280	G	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	21177143	21177143	-	A	intronic	NEBL	.	.	.	5.77E-24	0.009320316	0.990679684	.	0.56868	0.10631	0.567625503	81.74687426	2561.02103	9.45167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.55	39	10	21177143	chr10:21177143	G	GA	10.55	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	21803522	21803522	A	G	UTR3	SKIDA1	NM_207371:c.*503T>C	.	.	.	.	.	.	0.891	.	.	.	438.2434	4.36472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	161	10	21803522	chr10:21803522	A	G	119	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	26534837	26534837	-	T	intronic	GAD2	.	.	.	0.898626708	0.101371704	1.59E-06	.	0.46051	0.86241	-0.111973265	45.35857514	169.77404	2.8426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	43	10	26534837	chr10:26534837	A	AT	42	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	27538942	27538942	T	C	ncRNA_exonic	LRRC37A6P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	26	10	27538942	chr10:27538942	T	C	53	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	30901795	30901795	G	A	exonic	LYZL2	.	synonymous SNV	LYZL2:NM_183058:exon4:c.C471T:p.I157I	3.26E-06	0.191157736	0.808839004	.	0.10712	0.11669	0.084621747	60.31493277	217.1399	3.1852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	10	30901795	chr10:30901795	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	30978164	30978164	A	G	intergenic	LYZL2;SVILP1	dist=59517;dist=3039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	150	10	30978164	chr10:30978164	A	G	109	PASS	DP=150;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	30986286	30986286	G	C	ncRNA_intronic	SVILP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	257	10	30986286	chr10:30986286	G	C	103	PASS	DP=257;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	35360310	35360310	G	A	intronic	CUL2	.	.	.	0.99999841	1.59E-06	1.61E-15	.	0.72401	0.19444	-0.580403979	18.58928993	30.29769	0.96644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	143	10	35360310	chr10:35360310	G	A	78	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	35930412	35930412	-	G	upstream	FZD8;MIR4683	dist=50	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	19	10	35930412	chr10:35930412	C	CG	74	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	37442560	37442560	G	A	exonic	ANKRD30A	.	nonsynonymous SNV	ANKRD30A:NM_052997:exon13:c.G1600A:p.E534K	1.26E-23	0.003987679	0.996012321	.	0.05405	.	2.702925512	98.90304317	3097.8543	10.58328	0.0	0.912	D	0.963	0.537	D	0.424	0.434	B	.	.	.	1	0.090	N	0.695	0.181	N	3.4	0.057	T	-0.76	0.295	N	0.111	0.120	-0.965	0.381	T	0.014	0.058	T	0.001	0.014	T	2.209	0.327	17.57	0.989	0.471	0.017	0.054	N	c	-0.569	-0.769	0.060	0.152	0.487	0.133	0	1.47	0.217	1.040	0.297	0.636	0.291	0.041	0.208	0.006	0.095	6.435	0.209	.	.	.	0.5	.	53	10	37442560	chr10:37442560	G	A	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	38404064	38404064	C	A	intronic	ZNF37A	.	.	.	0.001924415	0.906226625	0.09184896	.	0.12669	0.0957	0.088260113	60.56853031	287.83652	3.63338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	101	10	38404064	chr10:38404064	C	A	.	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	38682004	38682004	C	A	ncRNA_intronic	SEPT7P9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	10	38682004	chr10:38682004	C	A	.	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	39011258	39011258	C	A	intergenic	ACTR3BP5;NONE	dist=19887;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	267	10	39011258	chr10:39011258	C	A	104	PASS	DP=267;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	42680959	42680959	C	A	intergenic	NONE;LOC441666	dist=NONE;dist=146355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	1246	10	42680959	chr10:42680959	C	A	122	PASS	DP=1246;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	42833142	42833142	A	T	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	143	164	10	42833142	chr10:42833142	A	T	143	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	42833154	42833154	T	C	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	176	10	42833154	chr10:42833154	T	C	153	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	42922698	42922698	C	T	ncRNA_intronic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	10	42922698	chr10:42922698	C	T	.	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	42924593	42924593	G	-	ncRNA_exonic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.85	115	10	42924592	chr10:42924592	AG	A	21.85	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	43318544	43318544	T	G	intronic	BMS1	.	.	.	0.995287036	0.004712964	6.45E-12	DISEASE: Aplasia cutis congenita, non-syndromic (ACC) [MIM:107600]: A disorder characterized by congenital absence of a portion of skin in a localized or widespread area of the body. The lesions are most commonly localized on the scalp, however aplasia cutis congenita can affect any part of the body. {ECO:0000269|PubMed:23785305}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	0.099178678	60.75725407	2238.17745	8.72857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	352	10	43318544	chr10:43318544	T	G	136	PASS	DP=352;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	0/1	./.	./.	./.
10	43694491	43694491	G	-	intronic	RASGEF1A	.	.	.	0.910096302	0.089875281	2.84E-05	.	0.28193	0.10809	0.084621747	60.31493277	52.5675	1.43524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	684	10	43694490	chr10:43694490	CG	C	78	PASS	DP=684;AN=6	GT	./.	./.	./.	0/1	./.	./.	./.	./.	0/1	0/1	./.
10	45488707	45488707	C	G	intronic	RASSF4	.	.	.	2.05E-11	0.01752444	0.98247556	.	0.0992	0.09317	0.733063566	86.27034678	1210.23369	6.58766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	236	10	45488707	chr10:45488707	C	G	124	PASS	DP=236;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	45644255	45644255	C	A	ncRNA_intronic	RSU1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	10	45644255	chr10:45644255	C	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	46195598	46195598	G	A	intergenic	ZFAND4;WASHC2C	dist=27337;dist=27050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	1109	10	46195598	chr10:46195598	G	A	101	PASS	DP=1109;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	46217869	46217869	C	G	intergenic	ZFAND4;WASHC2C	dist=49608;dist=4779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	107	10	46217869	chr10:46217869	C	G	122	PASS	DP=107;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	47207792	47207792	C	G	intronic	AGAP9	.	.	.	.	.	.	.	0.08138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	1307	10	47207792	chr10:47207792	C	G	108	PASS	DP=1307;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	48221451	48221451	A	-	intronic	AGAP9	.	.	.	.	.	.	.	0.08138	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	97	10	48221450	chr10:48221450	TA	T	68	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	49199763	49199763	T	C	intergenic	GLUD1P7;FAM25C	dist=219424;dist=3592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	399	10	49199763	chr10:49199763	T	C	92	PASS	DP=399;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	49199766	49199766	C	G	intergenic	GLUD1P7;FAM25C	dist=219427;dist=3589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	403	10	49199766	chr10:49199766	C	G	90	PASS	DP=403;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	49791107	49791107	C	G	exonic	ARHGAP22	.	nonsynonymous SNV	ARHGAP22:NM_001256024:exon2:c.G125C:p.G42A,ARHGAP22:NM_001256025:exon2:c.G143C:p.G48A,ARHGAP22:NM_001347735:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347737:exon2:c.G125C:p.G42A,ARHGAP22:NM_021226:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347736:exon3:c.G143C:p.G48A,ARHGAP22:NM_001347738:exon3:c.G143C:p.G48A	0.000724652	0.980744858	0.01853049	.	0.12203	0.13515	-0.396754488	26.97570182	185.07105	2.95338	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.588	D	3.81	0.956	H	-1.36	0.801	T	-4.73	0.800	D	0.464	0.732	0.820	0.947	D	0.781	0.926	D	0.206	0.871	D	5.863	0.803	27.3	0.998	0.928	0.993	0.936	D	c	0.987	0.894	1.000	0.747	0.707	0.730	0	5.28	0.740	7.531	0.807	0.935	0.490	1.000	0.715	0.916	0.392	17.462	0.875	PH domain-like|Pleckstrin homology domain	.	.	0.5	75	77	10	49791107	chr10:49791107	C	G	75	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	50031213	50031213	T	-	intronic	WDFY4	.	.	.	.	.	.	.	.	0.09927	4.264461124	99.72281198	5281.75473	15.01039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	24	10	50031212	chr10:50031212	CT	C	54	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	50339798	50339798	C	A	exonic	FAM170B	.	stopgain	FAM170B:NM_001164484:exon2:c.G712T:p.E238X	.	.	.	.	0.14419	.	1.436808095	95.04600142	2513.30848	9.33771	.	.	.	.	.	.	.	.	.	0.002	0.383	N	1.000	0.520	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.868	0.964	36	0.994	0.614	0.403	0.262	N	c	0.451	0.247	1.000	0.517	0.497	0.185	0	2.64	0.304	2.607	0.457	0.935	0.490	0.942	0.325	0.990	0.544	7.549	0.268	.	.	.	0.5	75	102	10	50339798	chr10:50339798	C	A	75	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	51093219	51093219	G	A	intronic	PARG	.	.	.	.	.	.	.	0.16017	0.13522	.	.	87.98386	2.00608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	10	51093219	chr10:51093219	G	A	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	51295198	51295198	A	C	ncRNA_intronic	PARGP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	57	10	51295198	chr10:51295198	A	C	70	PASS	DP=57;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1	./.
10	52445761	52445761	A	T	intergenic	SGMS1-AS1;ASAH2B	dist=54365;dist=53687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	232	10	52445761	chr10:52445761	A	T	131	PASS	DP=232;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	59997532	59997532	T	C	exonic	IPMK	.	synonymous SNV	IPMK:NM_152230:exon2:c.A234G:p.Q78Q	0.426106182	0.572340293	0.001553525	.	0.50963	0.09415	0.062575634	58.74026893	1147.67485	6.45706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	21	10	59997532	chr10:59997532	T	C	65	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	61549576	61549576	C	A	UTR3	CCDC6	NM_005436:c.*3099G>T	.	.	0.967799856	0.03219801	2.13E-06	DISEASE: Note=A chromosomal aberration involving CCDC6 is found in papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21) generates the RET/CCDC6 (PTC1) oncogene. {ECO:0000269|PubMed:2406025}.; 	0.4367	0.16675	-0.137658575	43.57159707	4670.49647	13.75925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	10	61549576	chr10:61549576	C	A	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	61897078	61897078	T	-	intronic	ANK3	.	.	.	1	7.92E-14	8.89E-37	DISEASE: Note=Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility. {ECO:0000269|PubMed:22865819}.; DISEASE: Mental retardation, autosomal recessive 37 (MRT37) [MIM:615493]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT37 patients manifest delayed global development with speech delay, hypotonia, spasticity, and a sleep disorder. Severe behavioral abnormalities include aggression, hyperactivity, and grinding of the teeth. Note=The disease is caused by mutations affecting the gene represented in this entry. A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation, has been shown to be the cause of moderate intellectual disability, an ADHD-like phenotype and behavioral problems in a consanguineous family (PubMed:23390136). {ECO:0000269|PubMed:23390136}.; 	0.85781	0.22949	-3.496995436	0.33616419	2889.35508	10.18323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	20.1	65	10	61897077	chr10:61897077	AT	A	20.1	PASS	DP=65;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	71168729	71168729	G	-	exonic	TACR2	.	frameshift deletion	TACR2:NM_001057:exon3:c.690delC:p.G231Dfs*14	9.88E-07	0.182986486	0.817012526	.	0.13034	0.15131	2.087222794	97.84736966	2401.1648	9.09848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	93	10	71168728	chr10:71168728	CG	C	69	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	71267365	71267366	GC	-	UTR3	TSPAN15	NM_001351263:c.*631_*632delGC;NM_012339:c.*631_*632delGC	.	.	0.001855808	0.902378587	0.095765605	.	0.29157	0.11343	0.350995466	74.37485256	209.06557	3.1214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	32.61	22	10	71267364	chr10:71267364	TGC	T	32.61	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	71267367	71267367	C	T	UTR3	TSPAN15	NM_001351263:c.*633C>T;NM_012339:c.*633C>T	.	.	0.001855808	0.902378587	0.095765605	.	0.29157	0.11343	0.350995466	74.37485256	209.06557	3.1214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	10	71267367	chr10:71267367	C	T	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	71664597	71664597	C	T	intronic	COL13A1	.	.	.	0.003928968	0.996068184	2.85E-06	.	0.28276	0.14899	-0.440847477	24.59896202	250.76638	3.41203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	10	71664597	chr10:71664597	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	72521914	72521914	A	-	UTR3	ADAMTS14	NM_139155:c.*1305delA;NM_080722:c.*1305delA	.	.	2.33E-06	0.999989194	8.47E-06	.	0.21639	0.12333	-0.5513802	19.86907289	5123.0958	14.71781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	10	10	72521913	chr10:72521913	GA	G	60	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
10	72620135	72620135	T	-	intronic	SGPL1	.	.	.	0.122514048	0.877267858	0.000218094	.	0.16544	0.43246	-0.290161348	33.33923095	406.33204	4.22621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	43	10	72620134	chr10:72620134	CT	C,CTT	53	PASS	DP=43;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/2
10	72620135	72620135	-	T	intronic	SGPL1	.	.	.	0.122514048	0.877267858	0.000218094	.	0.16544	0.43246	-0.290161348	33.33923095	406.33204	4.22621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	43	10	72620134	chr10:72620134	CT	C,CTT	53	PASS	DP=43;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/2
10	73571690	73571690	G	C	UTR5	CDH23	NM_001171936:c.-359G>C;NM_001171935:c.-359G>C	.	.	0.050692959	0.949268623	3.84E-05	DISEASE: Usher syndrome 1D (USH1D) [MIM:601067]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:11138009, ECO:0000269|PubMed:12075507, ECO:0000269|PubMed:15660226, ECO:0000269|PubMed:16679490, ECO:0000269|PubMed:18429043}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Usher syndrome 1D/F (USH1DF) [MIM:601067]: USH1DF patients are heterozygous for mutations in CDH23 and PCDH15, indicating a digenic inheritance pattern. {ECO:0000269|PubMed:15537665}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 12 (DFNB12) [MIM:601386]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:11090341, ECO:0000269|PubMed:12075507, ECO:0000269|PubMed:12522556, ECO:0000269|PubMed:15829536, ECO:0000269|PubMed:16679490, ECO:0000269|PubMed:17850630, ECO:0000269|PubMed:22899989, ECO:0000269|PubMed:24767429}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.32126	0.20307	-1.837761842	2.05826846	23222.44281	31.45196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	129	10	73571690	chr10:73571690	G	C	74	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	75415529	75415529	C	G	intronic	SYNPO2L	.	.	.	0.026739766	0.96128115	0.011979084	.	0.20396	0.09102	-0.486758915	22.69992923	4908.06476	14.28002	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	189	10	75415529	chr10:75415529	C	G	72	PASS	DP=189;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	75490355	75490358	AAGA	-	ncRNA_exonic	GLUD1P3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	62	10	75490354	chr10:75490354	GAAGA	G	54	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	75560464	75560464	C	-	exonic	ZSWIM8	.	frameshift deletion	ZSWIM8:NM_001242487:exon24:c.5078delC:p.Y1696Tfs*16,ZSWIM8:NM_001242488:exon24:c.5054delC:p.Y1688Tfs*119,ZSWIM8:NM_015037:exon24:c.5093delC:p.Y1701Tfs*16	0.999999921	7.91E-08	2.18E-19	.	0.68729	0.10641	-1.945684699	1.887237556	65.2417	1.66201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	80	10	75560463	chr10:75560463	TC	T	44	PASS	DP=80;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	75675042	75675115	CTGTTGTGAAGCTGATTTCCCACCGGGAGTGTCAGCAGCCCCACTACTACGGCTCTGAAGTCACCACCAAAATG	-	exonic	PLAU	.	frameshift deletion	PLAU:NM_001145031:exon9:c.953_1026del:p.V320Cfs*2,PLAU:NM_001319191:exon9:c.746_819del:p.V251Cfs*2,PLAU:NM_002658:exon10:c.1004_1077del:p.V337Cfs*2	0.00055027	0.972496454	0.026953276	DISEASE: Quebec platelet disorder (QPD) [MIM:601709]: An autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins. {ECO:0000269|PubMed:20007542}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08249	0.90261	0.308721233	72.59966973	135.07501	2.52903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	99	10	75675041	chr10:75675041	ACTGTTGTGAAGCTGATTTCCCACCGGGAGTGTCAGCAGCCCCACTACTACGGCTCTGAAGTCACCACCAAAATG	A	70	PASS	DP=99;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	75835805	75835805	C	T	intronic	VCL	.	.	.	0.994870402	0.005129598	3.92E-11	DISEASE: Cardiomyopathy, dilated 1W (CMD1W) [MIM:611407]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11815424, ECO:0000269|PubMed:16236538}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 15 (CMH15) [MIM:613255]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:16712796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84455	.	-1.793112871	2.229299363	332.65362	3.87638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	10	75835805	chr10:75835805	C	T	.	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	76994316	76994316	G	A	intronic	COMTD1	.	.	.	5.22E-06	0.245360812	0.754633963	.	0.23565	0.17097	.	.	97.13052	2.13085	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	184	10	76994316	chr10:76994316	G	A	93	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	77157785	77157785	T	-	UTR3	ZNF503	NM_032772:c.*722delA	.	.	0.887882313	0.110917243	0.001200444	.	0.92206	0.11115	.	.	889.95494	5.81207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	53	10	77157784	chr10:77157784	CT	C	43	PASS	DP=53;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	0/1	./.	./.	./.
10	78729786	78729786	T	-	exonic	KCNMA1	.	frameshift deletion	KCNMA1:NM_001161353:exon19:c.2132delA:p.K711Sfs*16,KCNMA1:NM_001271518:exon19:c.1982delA:p.K661Sfs*16,KCNMA1:NM_001322832:exon19:c.2132delA:p.K711Sfs*16,KCNMA1:NM_002247:exon19:c.2132delA:p.K711Sfs*16,KCNMA1:NM_001014797:exon20:c.2144delA:p.K715Sfs*16,KCNMA1:NM_001161352:exon20:c.2306delA:p.K769Sfs*16,KCNMA1:NM_001271519:exon20:c.2141delA:p.K714Sfs*16,KCNMA1:NM_001322829:exon20:c.2141delA:p.K714Sfs*16,KCNMA1:NM_001322835:exon20:c.2144delA:p.K715Sfs*16,KCNMA1:NM_001322836:exon20:c.2141delA:p.K714Sfs*16,KCNMA1:NM_001322837:exon20:c.2144delA:p.K715Sfs*16,KCNMA1:NM_001322830:exon21:c.2153delA:p.K718Sfs*16,KCNMA1:NM_001322838:exon21:c.1679delA:p.K560Sfs*16	0.999216603	0.000783397	1.98E-12	DISEASE: Generalized epilepsy and paroxysmal dyskinesia (GEPD) [MIM:609446]: Epilepsy is one of the most common and debilitating neurological disorders. Paroxysmal dyskinesias are neurological disorders characterized by sudden, unpredictable, disabling attacks of involuntary movement often requiring life-long treatment. The coexistence of epilepsy and paroxysmal dyskinesia in the same individual or family is an increasingly recognized phenomenon. Patients manifest absence seizures, generalized tonic- clonic seizures, paroxysmal nonkinesigenic dyskinesia, involuntary dystonic or choreiform movements. Onset is usually in childhood and patients may have seizures only, dyskinesia only, or both. {ECO:0000269|PubMed:15937479}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.76173	0.14035	-1.682848699	2.653927813	154.36657	2.71502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	17	10	78729785	chr10:78729785	CT	C	44	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	79551014	79551014	C	T	UTR3	DLG5	NM_004747:c.*1184G>A	.	.	0.999998542	1.46E-06	2.19E-18	.	0.27889	0.16537	-2.369063868	1.126444916	774.17189	5.50725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	10	79551014	chr10:79551014	C	T	.	PASS	DP=62;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	81272659	81272659	A	G	exonic	EIF5AL1	.	nonsynonymous SNV	EIF5AL1:NM_001099692:exon1:c.A254G:p.K85R	.	.	.	.	.	0.29774	.	.	18.72537	0.64596	0.091	0.318	T	1.0	0.899	D	0.997	0.850	D	.	.	.	0.950	0.377	D	1.96	0.533	M	0.91	0.449	T	-1.61	0.387	N	0.067	0.054	-0.816	0.542	T	0.190	0.542	T	0.007	0.193	T	2.177	0.323	17.36	0.994	0.641	0.423	0.266	N	c	0.228	0.064	0.091	0.161	0.706	0.609	0	1.02	0.190	3.229	0.507	-1.553	0.009	1.000	0.715	0.289	0.235	5.989	0.186	Nucleic acid-binding, OB-fold|Ribosomal protein L2 domain 2|Translation elongation factor, IF5A C-terminal|Translation protein SH3-like domain	.	.	0.5	57	18	10	81272659	chr10:81272659	A	G	57	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	81465992	81465992	T	A	exonic	NUTM2B	.	nonsynonymous SNV	NUTM2B:NM_001278495:exon2:c.T577A:p.C193S	0.841786847	0.155272462	0.002940691	.	.	.	.	.	421.0619	4.28418	0.471	0.084	T	.	.	.	.	.	.	.	.	.	1	0.090	N	0.345	0.112	N	2.01	0.213	T	0.45	0.043	N	0.093	0.092	-0.965	0.382	T	0.017	0.070	T	0.001	0.018	T	-1.849	0.010	0.002	0.285	0.015	0.003	0.016	N	c	-1.202	-1.417	0.000	0.012	0.554	0.246	0	-1.44	0.083	-1.628	0.021	-2.511	0.003	0.000	0.063	0.000	0.016	5.635	0.167	Nuclear Testis  protein, N-terminal	.	.	0.5	122	540	10	81465992	chr10:81465992	T	A	122	PASS	DP=540;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	84625104	84625104	G	C	intronic	NRG3	.	.	.	0.21033799	0.789584348	7.77E-05	.	0.1568	0.1028	-0.464712395	23.5727766	868.61501	5.74237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	55	10	84625104	chr10:84625104	G	C	90	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	87966306	87966306	G	A	exonic	GRID1	.	nonsynonymous SNV	GRID1:NM_017551:exon3:c.C335T:p.P112L	0.950796126	0.049203622	2.52E-07	.	0.40271	0.11711	-2.100076584	1.545175749	701.32829	5.26849	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	1.04	0.263	L	-2.92	0.918	D	-8.09	0.967	D	0.968	0.968	0.862	0.952	D	0.864	0.955	D	0.548	0.958	D	6.467	0.892	29.9	0.999	0.984	0.994	0.960	D	c	0.959	0.963	1.000	0.747	0.554	0.283	0	6.06	0.983	9.988	0.992	1.048	0.713	1.000	0.715	0.999	0.750	19.609	0.956	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	.	15	10	87966306	chr10:87966306	G	A	.	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	88834260	88834260	T	A	intronic	GLUD1	.	.	.	0.013935465	0.979595034	0.006469501	DISEASE: Familial hyperinsulinemic hypoglycemia 6 (HHF6) [MIM:606762]: Familial hyperinsulinemic hypoglycemia [MIM:256450], also referred to as congenital hyperinsulinism, nesidioblastosis, or persistent hyperinsulinemic hypoglycemia of infancy (PPHI), is the most common cause of persistent hypoglycemia in infancy and is due to defective negative feedback regulation of insulin secretion by low glucose levels. In HHF6 elevated oxidation rate of glutamate to alpha-ketoglutarate stimulates insulin secretion in the pancreatic beta cells, while they impair detoxification of ammonium in the liver. {ECO:0000269|PubMed:10636977, ECO:0000269|PubMed:11214910, ECO:0000269|PubMed:11297618, ECO:0000269|PubMed:9571255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.45386	0.70938	-0.029247611	51.40363293	74.75678	1.80903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	103	10	88834260	chr10:88834260	T	A	61	PASS	DP=103;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	88966676	88966676	-	T	intergenic	FAM35A;NUTM2A	dist=15436;dist=18529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	63	10	88966676	chr10:88966676	A	AT	55	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	89127071	89127071	A	T	intronic	NUTM2D	.	.	.	0.227557524	0.646694336	0.12574814	.	0.01294	.	.	.	4268.05044	12.98771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	322	10	89127071	chr10:89127071	A	T	118	PASS	DP=322;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	92656136	92656136	G	T	exonic	RPP30	.	synonymous SNV	RPP30:NM_001104546:exon10:c.G684T:p.A228A,RPP30:NM_006413:exon10:c.G684T:p.A228A	2.35E-05	0.912665745	0.08731072	.	0.25392	0.24934	0.106667882	61.73036093	95.28898	2.10698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	10	92656136	chr10:92656136	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	95099844	95099844	-	A	intronic	MYOF	.	.	.	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	212	10	95099844	chr10:95099844	G	GA	76	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	95107509	95107509	G	A	exonic	MYOF	.	nonsynonymous SNV	MYOF:NM_133337:exon36:c.C4075T:p.P1359S,MYOF:NM_013451:exon37:c.C4114T:p.P1372S	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	0.056	0.381	T	0.831	0.441	P	0.559	0.477	P	0.000	0.629	D	1.000	0.588	D	1.785	0.466	L	-0.24	0.668	T	-6.87	0.932	D	0.204	0.287	-0.393	0.723	T	0.327	0.696	T	0.023	0.460	T	3.151	0.438	22.6	0.999	0.959	0.976	0.759	D	c	0.437	0.418	1.000	0.747	0.722	0.854	0	5.68	0.880	7.847	0.851	1.048	0.713	1.000	0.715	0.978	0.483	10.822	0.456	C2 domain	.	.	0.5	84	316	10	95107509	chr10:95107509	G	A	84	PASS	DP=316;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	95107517	95107517	T	A	exonic	MYOF	.	nonsynonymous SNV	MYOF:NM_133337:exon36:c.A4067T:p.Y1356F,MYOF:NM_013451:exon37:c.A4106T:p.Y1369F	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	0.001	0.784	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	N	1.000	0.588	D	2.61	0.766	M	-2.17	0.866	D	-3.68	0.703	D	0.428	0.486	0.667	0.928	D	0.782	0.926	D	0.060	0.679	D	4.475	0.599	24.2	0.983	0.393	0.985	0.835	D	c	0.412	0.329	1.000	0.747	0.722	0.854	0	4.53	0.548	8.017	0.886	1.061	0.807	1.000	0.715	0.996	0.625	12.109	0.529	C2 domain	.	.	0.5	76	304	10	95107517	chr10:95107517	T	A	76	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	98510642	98510642	G	A	intergenic	PIK3AP1;MIR607	dist=30363;dist=77784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	107	10	98510642	chr10:98510642	G	A	65	PASS	DP=107;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	99219405	99219405	G	-	intronic	MMS19	.	.	.	0.831821999	0.16817795	5.05E-08	.	0.21908	.	-0.014692675	52.35314933	3051.13847	10.50027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	12	10	99219404	chr10:99219404	TG	T	40	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	99410790	99410790	T	C	exonic	PI4K2A	.	synonymous SNV	PI4K2A:NM_018425:exon2:c.T528C:p.P176P	0.980219633	0.019777207	3.16E-06	.	0.53922	.	0.549415813	81.38122199	145.91651	2.63201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	24	10	99410790	chr10:99410790	T	C	55	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	100242389	100242389	G	A	intronic	HPSE2	.	.	.	1.85E-06	0.875616336	0.124381812	DISEASE: Urofacial syndrome 1 (UFS1) [MIM:236730]: A rare autosomal recessive disorder characterized by facial grimacing when attempting to smile and failure of the urinary bladder to void completely despite a lack of anatomical bladder outflow obstruction or overt neurological damage. Affected individuals often have reflux of infected urine from the bladder to the upper renal tract, with a risk of kidney damage and renal failure. {ECO:0000269|PubMed:20560209, ECO:0000269|PubMed:20560210}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.29661	0.18462	0.088260113	60.56853031	215.03157	3.16398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	63	10	100242389	chr10:100242389	G	A	59	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	101455640	101455640	A	G	UTR3	COX15	NM_001320974:c.*593T>C	.	.	2.16E-09	0.245340645	0.754659352	DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:15235026, ECO:0000269|PubMed:15863660}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40736	0.14741	-0.246069119	36.06982779	123.8909	2.42262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	14	10	101455640	chr10:101455640	A	G	71	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	101959818	101959818	T	C	intronic	CHUK	.	.	.	0.998703705	0.001296295	1.65E-10	DISEASE: Cocoon syndrome (COCOS) [MIM:613630]: A lethal syndrome characterized by multiple fetal malformations including defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. {ECO:0000269|PubMed:20961246}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84106	0.63405	-0.201976964	38.98325077	135.45191	2.53221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	65	10	101959818	chr10:101959818	T	C	122	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
10	102770082	102770082	T	G	exonic	PDZD7	.	nonsynonymous SNV	PDZD7:NM_001195263:exon15:c.A2564C:p.N855T	0.722769808	0.27710588	0.000124312	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:20440071}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. PDZD7 mutations have been found in combination with mutations in USH2A and GPR98 in patients affected by Usher syndrome, suggesting a role as contributor to digenic Usher syndrome or a modifier of retinal disease expression. {ECO:0000269|PubMed:20440071}.; 	0.24004	0.11039	-0.356299879	29.31115829	127.88087	2.46471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.013	0.002	-1.030	0.206	T	0.000	0.000	T	.	.	.	1.131	0.203	11.38	0.677	0.082	0.008	0.032	N	c	-0.915	-0.946	0.999	0.379	0.035	0.002	2	1.35	0.210	0.131	0.156	-0.370	0.067	0.000	0.063	0.001	0.043	5.225	0.146	.	.	.	0.5	52	24	10	102770082	chr10:102770082	T	G	52	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	105049273	105049273	T	A	UTR3	INA	NM_032727:c.*847T>A	.	.	0.292917015	0.686595637	0.020487348	.	0.30146	0.26304	-0.095386216	46.48502005	174.52967	2.8739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	10	105049273	chr10:105049273	T	A	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	105881988	105881988	A	T	intronic	SFR1	.	.	.	0.000222755	0.506780782	0.492996463	.	0.0903	0.09372	-0.117432389	44.89266336	1205.57949	6.57654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	399	10	105881988	chr10:105881988	A	T	129	PASS	DP=399;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	113935379	113935379	T	C	exonic	GPAM	.	nonsynonymous SNV	GPAM:NM_001244949:exon6:c.A392G:p.E131G,GPAM:NM_020918:exon6:c.A392G:p.E131G	0.000580579	0.999410374	9.05E-06	.	0.22152	0.37514	-0.242430445	36.22906346	242.46149	3.3607	0.006	0.614	D	0.457	0.344	P	0.081	0.275	B	0.000	0.559	D	0.000	0.548	P	1.745	0.454	L	-0.52	0.707	T	-3.3	0.681	D	0.089	0.132	-0.903	0.477	T	0.000	0.000	T	.	.	.	4.433	0.593	24.2	0.998	0.901	0.984	0.825	D	c	0.178	0.277	1.000	0.500	0.563	0.310	0	5.11	0.691	7.113	0.766	1.061	0.807	1.000	0.715	0.996	0.625	13.501	0.607	.	.	.	0.5	58	15	10	113935379	chr10:113935379	T	C	58	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	114153810	114153810	C	-	intronic	ACSL5	.	.	.	0.016763711	0.983194812	4.15E-05	.	0.14592	0.15681	0.268267497	70.64166077	551.73015	4.77877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	11	10	114153809	chr10:114153809	GC	G	54	PASS	DP=11;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	114154662	114154662	-	T	intronic	ACSL5	.	.	.	0.016763711	0.983194812	4.15E-05	.	0.14592	0.15681	0.268267497	70.64166077	551.73015	4.77877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	66	10	114154662	chr10:114154662	G	GT	93	PASS	DP=66;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	116196144	116196144	A	-	intronic	ABLIM1	.	.	.	0.951991965	0.048008025	9.69E-09	.	0.24692	0.11524	-0.24061166	36.28214201	426.69086	4.31466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	20	10	116196143	chr10:116196143	GA	G	64	PASS	DP=20;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	116608351	116608351	T	-	intronic	FAM160B1	.	.	.	0.999984985	1.50E-05	3.82E-13	.	0.15009	.	-0.754958418	13.57631517	80.29201	1.89406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	11	10	116608350	chr10:116608350	CT	C	53	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	118615126	118615126	T	C	intronic	ENO4	.	.	.	.	.	.	.	.	.	.	.	139.77329	2.5778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	10	118615126	chr10:118615126	T	C	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	118927199	118927276	GGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	-	ncRNA_exonic	MIR3663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	964	10	118927198	chr10:118927198	TGGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	T	111	PASS	DP=964;AN=4	GT	./.	./.	./.	0/1	./.	0/1	./.	./.	./.	./.	./.
10	119764587	119764587	C	A	UTR3	RAB11FIP2	NM_014904:c.*3922G>T;NM_001330167:c.*3922G>T	.	.	0.910707841	0.089154579	0.000137579	.	0.32279	0.13177	0.086440867	60.47416844	470.93745	4.49152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	89	10	119764587	chr10:119764587	C	A	113	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
10	122348917	122348917	G	T	exonic	PLPP4	.	nonsynonymous SNV	PLPP4:NM_001318169:exon3:c.G268T:p.V90F,PLPP4:NM_001318167:exon5:c.G530T:p.S177I,PLPP4:NM_001030059:exon7:c.G719T:p.S240I	.	.	.	.	0.18611	0.10773	-0.249709319	35.74545883	.	.	0.17	0.250	T	0.763	0.417	P	0.293	0.390	B	0.000	0.445	D	1.000	0.588	D	0.695	0.181	N	0.87	0.464	T	-1.89	0.441	N	0.659	0.678	-0.882	0.496	T	0.121	0.421	T	0.020	0.429	T	2.990	0.420	22.2	0.984	0.404	0.987	0.852	D	c	0.391	0.492	0.981	0.302	0.707	0.730	0	4.45	0.532	7.580	0.817	1.044	0.665	1.000	0.715	0.965	0.450	14.435	0.667	.	.	.	0.5	71	46	10	122348917	chr10:122348917	G	T	71	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	123233234	123233235	AC	-	intergenic	WDR11;FGFR2	dist=564196;dist=4609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	71	10	123233233	chr10:123233233	AAC	A	50	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	124340406	124340406	G	C	exonic	DMBT1	.	nonsynonymous SNV	DMBT1:NM_001320644:exon11:c.G1028C:p.S343T,DMBT1:NM_004406:exon11:c.G1028C:p.S343T,DMBT1:NM_007329:exon11:c.G1028C:p.S343T,DMBT1:NM_017579:exon11:c.G1028C:p.S343T	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	0.674	0.079	T	0.007	0.365	B	0.005	0.288	B	.	.	.	1	0.090	N	0.345	0.112	N	1.89	0.250	T	0.2	0.172	N	0.058	0.213	-1.033	0.196	T	0.000	0.000	T	.	.	.	-3.190	0.001	0.001	0.121	0.002	0.000	0.004	N	c	-1.974	-2.081	0.937	0.272	0.487	0.133	0	-2.67	0.057	-4.937	0.002	-0.216	0.099	0.000	0.063	0.000	0.016	5.712	0.171	.	.	.	0.5	113	324	10	124340406	chr10:124340406	G	C	113	PASS	DP=324;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	124358490	124358490	G	T	exonic	DMBT1	.	stopgain	DMBT1:NM_004406:exon16:c.G1660T:p.G554X,DMBT1:NM_017579:exon25:c.G3127T:p.G1043X,DMBT1:NM_001320644:exon26:c.G3157T:p.G1053X,DMBT1:NM_007329:exon26:c.G3157T:p.G1053X	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	.	.	.	.	.	.	.	.	.	0.089	0.204	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.828	0.970	36	0.989	0.474	0.988	0.867	D	c	0.699	0.395	1.000	0.446	0.487	0.133	0	3.51	0.391	9.241	0.945	0.708	0.301	1.000	0.715	0.004	0.083	15.460	0.750	SRCR domain|SRCR-like domain	.	.	0.5	.	154	10	124358490	chr10:124358490	G	T	.	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	124377617	124377617	G	T	exonic	DMBT1	.	nonsynonymous SNV	DMBT1:NM_004406:exon25:c.G2705T:p.W902L,DMBT1:NM_017579:exon37:c.G4559T:p.W1520L,DMBT1:NM_001320644:exon38:c.G4589T:p.W1530L,DMBT1:NM_007329:exon38:c.G4589T:p.W1530L	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	0.004	0.654	D	0.95	0.899	P	0.378	0.971	B	0.107	0.026	N	0.668	0.346	D	4.23	0.980	H	0.61	0.535	T	-11.76	0.995	D	0.392	0.514	-0.603	0.647	T	0.515	0.818	D	0.052	0.652	D	6.347	0.876	29.3	0.989	0.471	0.963	0.681	D	c	0.706	0.559	0.990	0.318	0.487	0.133	0	3.2	0.357	6.260	0.723	0.957	0.564	1.000	0.715	0.984	0.507	10.728	0.451	SRCR domain|SRCR-like domain	.	.	0.5	.	209	10	124377617	chr10:124377617	G	T	.	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	124640270	124640270	G	T	ncRNA_exonic	LOC399815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	10	124640270	chr10:124640270	G	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	124740238	124740238	C	T	intronic	PSTK	.	.	.	0.004110024	0.960308594	0.035581382	.	0.25378	0.0959	0.527368849	80.73248408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	10	124740238	chr10:124740238	C	T	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	126138397	126138397	A	G	exonic	NKX1-2	.	nonsynonymous SNV	NKX1-2:NM_001146340:exon1:c.T116C:p.V39A	.	.	.	.	.	.	.	.	1240.59153	6.64779	0.097	0.309	T	0.006	0.126	B	0.003	0.080	B	.	.	.	1	0.090	N	0.55	0.145	N	-2.48	0.891	D	0.01	0.069	N	0.062	0.061	-0.620	0.640	T	0.488	0.805	T	0.123	0.804	D	1.805	0.278	15.01	0.962	0.286	0.068	0.127	N	c	-0.807	-0.796	1.000	0.747	0.767	0.994	0	0.062	0.136	-0.310	0.081	0.164	0.245	0.000	0.063	0.190	0.215	5.108	0.140	.	.	.	0.5	139	241	10	126138397	chr10:126138397	A	G	139	PASS	DP=241;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	126650990	126650990	T	-	intronic	ZRANB1	.	.	.	0.99983985	0.00016015	1.22E-10	.	0.15947	0.12378	-0.247889024	35.98726115	305.44181	3.72142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	116	10	126650989	chr10:126650989	CT	C	77	PASS	DP=116;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	127789605	127789605	-	T	intronic	ADAM12	.	.	.	0.341608447	0.658390535	1.02E-06	.	0.65368	0.23183	0.009173042	54.15782024	245.04565	3.37758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	184	10	127789605	chr10:127789605	C	CT	64	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	129903016	129903016	T	C	exonic	MKI67	.	nonsynonymous SNV	MKI67:NM_001145966:exon12:c.A6008G:p.N2003S,MKI67:NM_002417:exon13:c.A7088G:p.N2363S	4.17E-16	0.998663439	0.001336561	.	0.62381	.	7.633856952	99.91153574	13447.4791	25.13173	0.961	0.025	T	0.0	0.026	B	0.0	0.013	B	0.000	0.005	N	1	0.090	P	-1.905	0.002	N	4.72	0.017	T	0.46	0.031	N	0.004	0.000	-0.936	0.433	T	0.000	0.000	T	.	.	.	-2.735	0.002	0.001	0.198	0.007	0.043	0.097	N	c	-2.051	-2.056	1.000	0.428	0.707	0.730	0	-5.36	0.025	-0.267	0.086	-2.064	0.005	0.000	0.063	0.000	0.016	9.392	0.374	.	.	.	0.5	62	52	10	129903016	chr10:129903016	T	C	62	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	129903465	129903465	A	G	exonic	MKI67	.	synonymous SNV	MKI67:NM_001145966:exon12:c.T5559C:p.H1853H,MKI67:NM_002417:exon13:c.T6639C:p.H2213H	4.17E-16	0.998663439	0.001336561	.	0.62381	.	7.633856952	99.91153574	13447.4791	25.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	116	10	129903465	chr10:129903465	A	G	90	PASS	DP=116;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	134062542	134062542	C	T	intronic	STK32C	.	.	.	0.309709769	0.689507911	0.000782319	.	0.08231	0.1102	-0.356299879	29.31115829	1893.96573	8.00243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	10	134062542	chr10:134062542	C	T	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	134062572	134062572	C	T	intronic	STK32C	.	.	.	0.309709769	0.689507911	0.000782319	.	0.08231	0.1102	-0.356299879	29.31115829	1893.96573	8.00243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	10	134062572	chr10:134062572	C	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
10	135000148	135000148	T	C	exonic	KNDC1	.	synonymous SNV	KNDC1:NM_152643:exon6:c.T1296C:p.A432A	4.44E-05	0.999952561	3.01E-06	.	0.11621	0.09546	1.089385192	91.85539042	1045.18642	6.20522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	253	10	135000148	chr10:135000148	T	C	88	PASS	DP=253;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	135142432	135142432	C	A	exonic	CALY	.	nonsynonymous SNV	CALY:NM_015722:exon2:c.G62T:p.G21V	0.706613402	0.277792655	0.015593942	.	0.1537	0.13077	.	.	177.87988	2.8985	0.0	0.912	D	1.0	0.899	D	0.985	0.749	D	0.000	0.629	D	1.000	0.810	D	2.915	0.845	M	.	.	.	-5.47	0.904	D	0.651	0.771	-0.458	0.702	T	0.326	0.695	T	0.192	0.863	D	5.028	0.677	25.2	0.995	0.678	0.227	0.216	N	c	0.132	-0.057	0.997	0.354	0.598	0.340	0	2.62	0.302	0.230	0.175	0.047	0.160	0.010	0.182	0.020	0.134	6.860	0.231	.	.	.	0.5	86	169	10	135142432	chr10:135142432	C	A	86	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	135372870	135372870	C	G	intronic	SYCE1	.	.	.	0.000763635	0.981995413	0.017240952	.	.	0.08486	1.374284246	94.51521585	1749.70499	7.72284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	93	10	135372870	chr10:135372870	C	G	144	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	372737	372737	C	T	exonic	B4GALNT4	.	nonsynonymous SNV	B4GALNT4:NM_178537:exon3:c.C331T:p.P111S	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	0.54	0.068	T	0.147	0.262	B	0.024	0.190	B	0.898	0.073	N	1	0.090	N	2.25	0.640	M	3.54	0.048	T	-2.63	0.564	D	0.412	0.470	-0.926	0.448	T	0.016	0.064	T	0.026	0.494	D	3.718	0.504	23.3	0.997	0.820	0.056	0.114	N	c	-0.661	-0.659	0.999	0.370	0.696	0.567	0	3.17	0.354	2.491	0.447	0.715	0.302	0.670	0.281	0.881	0.369	5.761	0.173	.	.	.	0.5	.	65	11	372737	chr11:372737	C	T	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	373419	373419	-	CCGCCA	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	280	11	373419	chr11:373419	C	CCCGCCA	67	PASS	DP=280;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	373427	373427	C	T	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	295	11	373427	chr11:373427	C	T	101	PASS	DP=295;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	376149	376149	C	T	exonic	B4GALNT4	.	nonsynonymous SNV	B4GALNT4:NM_178537:exon12:c.C1171T:p.R391C	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	0.001	0.784	D	1.0	0.899	D	0.994	0.807	D	0.000	0.445	D	1.000	0.548	D	2.77	0.812	M	-0.63	0.720	T	-5.49	0.857	D	0.788	0.779	-0.177	0.783	T	0.422	0.767	T	0.687	0.974	D	7.024	0.938	33	0.999	0.950	0.789	0.387	D	c	0.370	0.279	0.057	0.151	0.696	0.567	0	3.01	0.337	0.665	0.246	0.742	0.308	0.999	0.424	0.994	0.587	10.272	0.425	.	.	.	0.5	.	490	11	376149	chr11:376149	C	T	.	PASS	DP=490;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	376239	376239	G	A	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	11	376239	chr11:376239	G	A	.	PASS	DP=152;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	771034	771034	A	G	exonic	GATD1	.	synonymous SNV	GATD1:NM_001318822:exon5:c.T357C:p.T119T,GATD1:NM_001318818:exon6:c.T465C:p.T155T,GATD1:NM_001318820:exon6:c.T507C:p.T169T,GATD1:NM_001318823:exon6:c.T465C:p.T155T,GATD1:NM_001318824:exon6:c.T507C:p.T169T,GATD1:NM_001318821:exon7:c.T615C:p.T205T,GATD1:NM_182612:exon7:c.T615C:p.T205T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	38	11	771034	chr11:771034	A	G	53	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	792809	792809	T	-	intronic	SLC25A22	.	.	.	0.568405565	0.42907803	0.002516405	.	0.4027	0.12155	0.128714042	63.19886766	219.59154	3.20559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	99	11	792808	chr11:792808	CT	C	84	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	792856	792856	C	-	intronic	SLC25A22	.	.	.	0.568405565	0.42907803	0.002516405	.	0.4027	0.12155	0.128714042	63.19886766	219.59154	3.20559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	184	11	792855	chr11:792855	TC	T	84	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	792865	792865	C	G	intronic	SLC25A22	.	.	.	0.568405565	0.42907803	0.002516405	.	0.4027	0.12155	0.128714042	63.19886766	219.59154	3.20559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	286	11	792865	chr11:792865	C	G	97	PASS	DP=286;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	822463	822463	-	C	exonic	PNPLA2	.	frameshift insertion	PNPLA2:NM_020376:exon5:c.554dupC:p.F187Lfs*5	0.001141193	0.838081873	0.160776935	DISEASE: Note=Genetic variations in PNPLA2 may be associated with risk of diabetes mellitus type 2. {ECO:0000269|PubMed:16644682}.; DISEASE: Neutral lipid storage disease with myopathy (NLSDM) [MIM:610717]: Neutral lipid storage disorder (NLSD) with myopathy but without ichthyosis. NLSDs are characterized by the presence of triglyceride-containing cytoplasmic droplets in leukocytes and in other tissues, including bone marrow, skin, and muscle. Individuals with NLSDM did not show obesity, in spite of a defect in triglyceride degradation in fibroblasts and in marked triglyceride storage in liver, muscles, and other visceral cells. {ECO:0000269|PubMed:17187067}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40021	0.21702	0.042348793	57.31304553	136.13585	2.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49.15	86	11	822463	chr11:822463	T	TC	49.15	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	1093551	1093551	G	C	exonic	MUC2	.	synonymous SNV	MUC2:NM_002457:exon31:c.G5370C:p.V1790V	4.55E-05	0.999954537	2.00E-10	.	0.12651	.	.	.	13226.52773	24.78411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	796	11	1093551	chr11:1093551	G	C	77	PASS	DP=796;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	1221758	1221758	G	A	exonic	MUC5AC	.	unknown	UNKNOWN	.	.	.	.	0.15646	.	.	.	993.41134	6.07467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.23	0.897	M	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.865	0.177	9.861	0.799	0.125	0.913	0.531	D	n	1.251	1.181	1.000	0.747	0.078	0.016	0	4.48	0.538	3.067	0.495	0.951	0.538	1.000	0.715	0.049	0.163	14.439	0.667	Cystine knot, C-terminal	.	.	0.5	114	87	11	1221758	chr11:1221758	G	A	114	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	1255933	1255933	G	A	intronic	MUC5B	.	.	.	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	11	1255933	chr11:1255933	G	A	.	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	1264683	1264683	G	-	exonic	MUC5B	.	frameshift deletion	MUC5B:NM_002458:exon31:c.6573delG:p.N2192Tfs*41	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	78	11	1264682	chr11:1264682	CG	C	64	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	1264890	1264890	A	G	exonic	MUC5B	.	synonymous SNV	MUC5B:NM_002458:exon31:c.A6780G:p.R2260R	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	107	11	1264890	chr11:1264890	A	G	69	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	1269651	1269651	C	G	exonic	MUC5B	.	synonymous SNV	MUC5B:NM_002458:exon31:c.C11541G:p.T3847T	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	499	11	1269651	chr11:1269651	C	G	147	PASS	DP=499;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	1276551	1276554	GCAC	-	intronic	MUC5B	.	.	.	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	40	11	1276550	chr11:1276550	TGCAC	T	43	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	1309956	1309956	C	T	exonic	TOLLIP	.	synonymous SNV	TOLLIP:NM_001318512:exon3:c.G267A:p.P89P,TOLLIP:NM_001318516:exon3:c.G234A:p.P78P,TOLLIP:NM_001318514:exon4:c.G210A:p.P70P,TOLLIP:NM_019009:exon4:c.G417A:p.P139P	0.522906268	0.473487996	0.003605736	.	0.16248	0.14352	-0.468351206	23.42533616	235.45459	3.31615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	217	11	1309956	chr11:1309956	C	T	103	PASS	DP=217;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	1457382	1457382	G	-	intronic	BRSK2	.	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	110	11	1457381	chr11:1457381	AG	A	66	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	1457389	1457389	G	A	intronic	BRSK2	.	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	144	11	1457389	chr11:1457389	G	A	64	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	1462163	1462163	G	-	intronic	BRSK2	.	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	49	11	1462162	chr11:1462162	AG	A	80	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	1478186	1478186	-	C	exonic	BRSK2	.	frameshift insertion	BRSK2:NM_001256629:exon19:c.1942dupC:p.P651Tfs*11,BRSK2:NM_001282218:exon19:c.1762dupC:p.P591Tfs*11	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	46	11	1478186	chr11:1478186	A	AC	44	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	1481963	1481963	C	-	UTR3	BRSK2	NM_001256627:c.*10delC;NM_001256630:c.*10delC	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	18	11	1481962	chr11:1481962	GC	G	56	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	2018440	2018440	G	A	ncRNA_exonic	H19	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	155	11	2018440	chr11:2018440	G	A	99	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	2329934	2329934	C	A	intronic	TSPAN32	.	.	.	0.000537261	0.88875402	0.110708719	.	0.07365	.	0.376678994	75.50719509	156.95947	2.73665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	109	11	2329934	chr11:2329934	C	A	.	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	2329988	2329988	C	T	exonic	TSPAN32	.	nonsynonymous SNV	TSPAN32:NM_139022:exon4:c.C302T:p.A101V	0.000537261	0.88875402	0.110708719	.	0.07365	.	0.376678994	75.50719509	156.95947	2.73665	0.917	0.040	T	0.425	0.336	B	0.106	0.296	B	0.120	0.027	N	1	0.242	N	-0.975	0.012	N	-1.1	0.773	T	0.45	0.032	N	0.115	0.492	-0.877	0.500	T	0.142	0.463	T	0.052	0.651	D	-0.186	0.077	1.175	0.214	0.008	0.014	0.047	N	c	-1.742	-1.817	0.791	0.240	0.403	0.052	0	-5.48	0.024	-2.393	0.011	-0.641	0.041	0.000	0.063	0.016	0.126	5.543	0.162	.	.	.	0.5	81	767	11	2329988	chr11:2329988	C	T	81	PASS	DP=767;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	2336474	2336474	A	G	intronic	TSPAN32	.	.	.	0.000537261	0.88875402	0.110708719	.	0.07365	.	0.376678994	75.50719509	156.95947	2.73665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	234	11	2336474	chr11:2336474	A	G	73	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	2356603	2356603	T	C	ncRNA_intronic	CD81-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	110	11	2356603	chr11:2356603	T	C	137	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	2356769	2356769	T	C	ncRNA_intronic	CD81-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	32	11	2356769	chr11:2356769	T	C	87	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	2975961	2975961	C	T	intronic	NAP1L4	.	.	.	0.99573103	0.004268896	7.38E-08	.	0.45495	0.10887	-0.159704656	41.90846898	741.74824	5.40816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	11	2975961	chr11:2975961	C	T	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	3047792	3047792	T	C	intronic	CARS	.	.	.	2.96E-06	0.999273135	0.000723902	DISEASE: Note=A chromosomal aberration involving CARS is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with ALK.; 	0.17352	0.23298	-0.394936437	27.02878037	1461.59792	7.13029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	120	11	3047792	chr11:3047792	T	C	119	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	3578576	3578576	G	T	ncRNA_intronic	LOC101927708	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	93	11	3578576	chr11:3578576	G	T	123	PASS	DP=93;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	3844147	3844147	C	T	exonic	PGAP2	.	nonsynonymous SNV	PGAP2:NM_001256235:exon4:c.C143T:p.A48V,PGAP2:NM_001346402:exon4:c.C209T:p.A70V	0.15222416	0.830890196	0.016885643	.	.	.	-0.291981272	33.20358575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.090	N	.	.	.	.	.	.	.	.	.	0.106	0.112	.	.	.	.	.	.	.	.	.	0.180	0.111	4.463	0.709	0.092	0.013	0.044	N	n	-0.128	-0.183	0.548	0.213	0.162	0.029	0	-2.29	0.064	-0.354	0.077	0.630	0.290	0.000	0.063	0.032	0.149	7.014	0.239	.	.	.	0.5	.	49	11	3844147	chr11:3844147	C	T	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	3845201	3845201	C	T	exonic	PGAP2	.	nonsynonymous SNV	PGAP2:NM_001256239:exon3:c.C254T:p.S85L,PGAP2:NM_001256240:exon3:c.C254T:p.S85L,PGAP2:NM_001145438:exon4:c.C425T:p.S142L,PGAP2:NM_001256237:exon4:c.C425T:p.S142L,PGAP2:NM_001256238:exon4:c.C254T:p.S85L,PGAP2:NM_001283038:exon4:c.C425T:p.S142L,PGAP2:NM_001346397:exon4:c.C407T:p.S136L,PGAP2:NM_001346398:exon4:c.C254T:p.S85L,PGAP2:NM_001346400:exon4:c.C254T:p.S85L,PGAP2:NM_001346404:exon4:c.C254T:p.S85L,PGAP2:NM_001346405:exon4:c.C254T:p.S85L,PGAP2:NM_014489:exon4:c.C437T:p.S146L,PGAP2:NM_001256235:exon5:c.C308T:p.S103L,PGAP2:NM_001256236:exon5:c.C608T:p.S203L,PGAP2:NM_001346402:exon5:c.C374T:p.S125L,PGAP2:NM_001346403:exon5:c.C437T:p.S146L	0.15222416	0.830890196	0.016885643	.	.	.	-0.291981272	33.20358575	.	.	0.18	0.721	T	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	1.76	0.459	L	1.04	0.402	T	-3.6	0.726	D	0.949	0.945	-0.886	0.493	T	0.219	0.582	T	0.018	0.406	T	5.634	0.768	26.6	0.999	0.976	0.933	0.577	D	c	0.719	0.737	1.000	0.747	0.719	0.830	0	5.86	0.939	7.090	0.764	0.935	0.490	1.000	0.715	0.930	0.404	15.677	0.770	.	.	.	0.5	.	102	11	3845201	chr11:3845201	C	T	.	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	4351584	4351584	C	A	intergenic	LOC100506082;OR52B4	dist=127701;dist=36909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	42	11	4351584	chr11:4351584	C	A	81	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	4827273	4827273	A	-	intergenic	OR52R1;OR51F2	dist=1663;dist=15343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	17	11	4827272	chr11:4827272	GA	G	54	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	5510245	5510245	G	C	exonic	OR52D1	.	nonsynonymous SNV	OR52D1:NM_001005163:exon1:c.G309C:p.Q103H	0.003674386	0.630310019	0.366015595	.	0.2152	.	0.553050905	81.54635527	3127.66018	10.64209	0.006	0.614	D	1.0	0.899	D	0.998	0.875	D	0.000	0.629	D	1	0.810	D	4.25	0.981	H	7.2	0.005	T	-4.87	0.812	D	0.79	0.780	-1.093	0.050	T	0.010	0.039	T	0.005	0.126	T	3.717	0.504	23.3	0.997	0.789	0.968	0.711	D	c	0.631	0.414	1.000	0.747	0.487	0.133	0	2.62	0.302	1.456	0.346	1.048	0.713	0.994	0.380	0.624	0.293	10.999	0.466	GPCR, rhodopsin-like, 7TM	.	.	0.5	65	58	11	5510245	chr11:5510245	G	C	65	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	6461846	6461846	A	-	intronic	HPX	.	.	.	0.004121447	0.988189736	0.007688816	.	0.27843	0.54325	0.112125503	62.09601321	344.00549	3.93368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	45	11	6461845	chr11:6461845	TA	T	67	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	6499215	6499215	A	G	intronic	ARFIP2	.	.	.	0.94293271	0.057023224	4.41E-05	.	0.14975	0.14609	-0.427900189	25.14744043	14.33009	0.51775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	88	11	6499215	chr11:6499215	A	G	77	PASS	DP=88;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	6561270	6561270	A	G	exonic	DNHD1	.	synonymous SNV	DNHD1:NM_144666:exon18:c.A3585G:p.Q1195Q	1.33E-18	0.411356392	0.588643608	.	0.08316	.	6.676327134	99.88204765	15349.22988	26.78541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	24	11	6561270	chr11:6561270	A	G	44	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	6644619	6644619	G	C	exonic	DCHS1	.	stopgain	DCHS1:NM_003737:exon21:c.C8288G:p.S2763X	0.999995438	4.56E-06	5.90E-20	DISEASE: Mitral valve prolapse 2 (MVP2) [MIM:607829]: A form of mitral valve prolapse, a valvular hearth disease characterized by abnormally elongated and thickened mitral valve leaflets, that typically show myxomatous degeneration with increased leaflet compliance. It is associated with mitral regurgitation. Myxomatous mitral valves have an abnormal layered architecture characterized by loose collagen in fibrosa, expanded spongiosa strongly positive for proteoglycans, and disrupted elastin in atrialis. In classic mitral valve prolapse, leaflets are at least 5 mm thick, whereas in the non-classic form, they are less than 5 mm thick. Severe classic mitral valve prolapse is strongly associated with arrhythmias, endocarditis, heart failure, and need for valve surgery. {ECO:0000269|PubMed:26258302}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.32953	0.13101	-1.375261521	4.399622552	2403.94476	9.1039	.	.	.	.	.	.	.	.	.	0.005	0.331	N	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.753	0.993	43	0.995	0.657	0.908	0.520	D	c	0.853	0.723	1.000	0.500	0.707	0.730	0	5.15	0.702	2.421	0.441	1.048	0.713	1.000	0.715	1.000	0.888	14.137	0.647	Cadherin|Cadherin-like	.	.	0.5	101	113	11	6644619	chr11:6644619	G	C	101	PASS	DP=113;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	7673080	7673080	G	C	intronic	PPFIBP2	.	.	.	1.42E-18	0.07197208	0.92802792	.	0.12626	0.10279	-0.279250919	33.56923803	1831.97955	7.88761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	196	11	7673080	chr11:7673080	G	C	56	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	8934008	8934008	G	C	exonic	AKIP1	.	nonsynonymous SNV	AKIP1:NM_001206647:exon3:c.G231C:p.E77D,AKIP1:NM_020642:exon3:c.G231C:p.E77D	1.86E-05	0.265853082	0.734128348	.	0.03648	0.0643	1.060147109	91.46614768	910.85343	5.87002	0.241	0.200	T	0.044	0.203	B	0.041	0.226	B	0.076	0.212	N	1.000	0.286	N	1.64	0.420	L	1.2	0.386	T	-0.88	0.287	N	0.115	0.163	-1.048	0.149	T	0.058	0.244	T	0.005	0.137	T	0.925	0.182	10.23	0.949	0.252	0.015	0.050	N	c	-0.914	-0.944	1.000	0.517	0.660	0.490	0	-3.52	0.044	-0.596	0.058	-0.010	0.132	0.034	0.205	0.974	0.471	1.336	0.020	.	.	.	0.5	70	63	11	8934008	chr11:8934008	G	C	70	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	9004402	9004402	C	T	UTR3	NRIP3	NM_020645:c.*690G>A	.	.	2.35E-05	0.501587461	0.498389076	.	0.10654	.	0.148941568	64.31941496	105.28116	2.22063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	45	11	9004402	chr11:9004402	C	T	64	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	9459831	9459831	C	T	exonic	IPO7	.	synonymous SNV	IPO7:NM_006391:exon22:c.C2694T:p.T898T	0.999998375	1.63E-06	3.44E-16	.	0.84877	0.28646	-0.712684326	14.49634348	29.04313	0.92887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	137	11	9459831	chr11:9459831	C	T	93	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	11292700	11292700	G	C	exonic	GALNT18	.	synonymous SNV	GALNT18:NM_198516:exon11:c.C1815G:p.L605L	0.047685176	0.951285056	0.001029769	.	0.20546	0.09952	-0.775187015	13.05142722	69.4345	1.72927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	35	11	11292700	chr11:11292700	G	C	55	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	12225946	12225946	T	G	exonic	MICAL2	.	synonymous SNV	MICAL2:NM_001282666:exon2:c.T414G:p.R138R,MICAL2:NM_001282667:exon2:c.T414G:p.R138R,MICAL2:NM_001282664:exon3:c.T414G:p.R138R,MICAL2:NM_001282665:exon3:c.T414G:p.R138R,MICAL2:NM_001346292:exon3:c.T414G:p.R138R,MICAL2:NM_001346294:exon3:c.T414G:p.R138R,MICAL2:NM_001346298:exon3:c.T414G:p.R138R,MICAL2:NM_001282663:exon4:c.T414G:p.R138R,MICAL2:NM_001282668:exon4:c.T414G:p.R138R,MICAL2:NM_001346293:exon4:c.T414G:p.R138R,MICAL2:NM_001346295:exon4:c.T414G:p.R138R,MICAL2:NM_001346296:exon4:c.T414G:p.R138R,MICAL2:NM_001346297:exon4:c.T414G:p.R138R,MICAL2:NM_001346299:exon4:c.T414G:p.R138R,MICAL2:NM_014632:exon4:c.T414G:p.R138R	0.132223746	0.867775935	3.19E-07	.	0.35711	0.10318	0.549230812	81.22788393	597.9475	4.94889	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	17	11	12225946	chr11:12225946	T	G	43	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	12525925	12525925	C	T	exonic	PARVA	.	synonymous SNV	PARVA:NM_018222:exon6:c.C726T:p.R242R	0.34376402	0.655640245	0.000595734	.	0.24069	0.17061	-0.405853867	26.23260203	31.71128	0.99845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	65	11	12525925	chr11:12525925	C	T	118	PASS	DP=65;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	14535143	14535143	C	-	exonic	PSMA1	.	frameshift deletion	PSMA1:NM_002786:exon7:c.517delG:p.E173Rfs*11,PSMA1:NM_148976:exon8:c.535delG:p.E179Rfs*11	0.947988405	0.051976702	3.49E-05	.	0.94257	0.50622	-0.229483771	36.86010852	24.18661	0.7943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	82	11	14535142	chr11:14535142	TC	T	63	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	14535216	14535217	AC	-	exonic	PSMA1	.	frameshift deletion	PSMA1:NM_002786:exon7:c.443_444del:p.C148Sfs*3,PSMA1:NM_148976:exon8:c.461_462del:p.C154Sfs*3	0.947988405	0.051976702	3.49E-05	.	0.94257	0.50622	-0.229483771	36.86010852	24.18661	0.7943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	283	11	14535215	chr11:14535215	GAC	G	67	PASS	DP=283;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	15134112	15134112	G	T	splicing	INSC	NM_001031853:exon1:c.96+1G>T	.	.	1.34E-09	0.338205484	0.661794515	.	0.24334	0.13495	0.892856963	89.28992687	1315.35282	6.81837	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.322	0.579	24.0	0.988	0.454	0.898	0.502	D	c	0.899	0.678	0.343	0.196	0.054	0.004	0	3.54	0.395	3.841	0.553	1.048	0.713	0.994	0.380	0.730	0.316	10.919	0.462	.	.	.	0.5	124	255	11	15134112	chr11:15134112	G	T	124	PASS	DP=255;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	17519742	17519742	C	G	exonic	USH1C	.	nonsynonymous SNV	USH1C:NM_001297764:exon18:c.G1500C:p.E500D,USH1C:NM_005709:exon19:c.G1557C:p.E519D,USH1C:NM_153676:exon24:c.G2457C:p.E819D	2.72E-12	0.964484478	0.035515522	DISEASE: Usher syndrome 1C (USH1C) [MIM:276904]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10973247}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 18A (DFNB18A) [MIM:602092]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12107438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07835	0.169	-0.40608828	25.86694975	3991.78955	12.49143	0.089	0.486	T	0.006	0.205	B	0.016	0.254	B	0.000	0.629	D	0.998	0.281	P	0.345	0.112	N	1.69	0.270	T	-1.43	0.356	N	0.128	0.202	-0.959	0.394	T	0.000	0.000	T	.	.	.	4.604	0.617	24.4	0.996	0.763	0.694	0.339	D	c	-0.392	-0.193	1.000	0.747	0.696	0.573	0	3.37	0.375	0.448	0.213	0.935	0.490	0.999	0.424	0.992	0.562	11.099	0.472	PDZ domain	.	.	0.5	86	15	11	17519742	chr11:17519742	C	G	86	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
11	17593709	17593709	T	C	exonic	OTOG	.	nonsynonymous SNV	OTOG:NM_001277269:exon17:c.T2074C:p.S692P,OTOG:NM_001292063:exon18:c.T2038C:p.S680P	.	.	.	DISEASE: Deafness, autosomal recessive, 18B (DFNB18B) [MIM:614945]: A form of non-syndromic deafness characterized by a moderate hearing impairment, which can be associated with vestibular dysfunction, and a flat to shallow "U" or slightly downsloping shaped audiograms. {ECO:0000269|PubMed:23122587}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08265	.	.	.	14123.45118	25.75321	0.457	0.088	T	.	.	.	.	.	.	0.728	0.063	N	1	0.090	P	0.94	0.237	L	2.36	0.161	T	-0.48	0.154	N	0.072	0.075	-0.984	0.341	T	0.000	0.000	T	.	.	.	0.042	0.098	3.006	0.956	0.267	0.111	0.162	N	c	-0.955	-1.068	0.868	0.253	0.487	0.133	0	-4.21	0.035	0.125	0.155	-0.328	0.075	0.000	0.063	0.671	0.303	8.573	0.326	von Willebrand factor, type D domain	.	.	0.5	46	13	11	17593709	chr11:17593709	T	C	46	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	18048061	18048061	G	A	exonic	TPH1	.	nonsynonymous SNV	TPH1:NM_004179:exon6:c.C779T:p.S260L	2.67E-05	0.924859058	0.075114211	.	0.42896	0.39606	-0.378346116	28.01368247	150.71244	2.68113	0.0	0.912	D	0.343	0.317	B	0.257	0.376	B	0.000	0.843	D	1	0.810	D	4.125	0.975	H	-6.22	0.996	D	-5.3	0.844	D	0.775	0.788	1.103	0.998	D	0.977	0.993	D	0.522	0.955	D	6.608	0.908	32	0.998	0.915	0.989	0.883	D	c	0.541	0.621	1.000	0.747	0.516	0.203	0	5.4	0.779	9.956	0.990	0.998	0.613	1.000	0.715	1.000	0.888	19.540	0.952	Aromatic amino acid hydroxylase, C-terminal	.	.	0.5	.	29	11	18048061	chr11:18048061	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	18291388	18291388	C	T	exonic	SAA1	.	nonsynonymous SNV	SAA1:NM_000331:exon4:c.C355T:p.P119S,SAA1:NM_199161:exon4:c.C355T:p.P119S,SAA1:NM_001178006:exon5:c.C355T:p.P119S	0.181814611	0.765265056	0.052920333	DISEASE: Note=Reactive, secondary amyloidosis is characterized by the extracellular accumulation in various tissues of the SAA1 protein. These deposits are highly insoluble and resistant to proteolysis; they disrupt tissue structure and compromise function. {ECO:0000269|PubMed:1463770}.; DISEASE: Note=Elevated serum SAA1 protein levels may be associated with lung cancer. {ECO:0000269|PubMed:1463770}.; 	0.07473	0.51812	0.103030231	61.2762444	286.88113	3.62775	0.05	0.395	D	0.999	0.764	D	0.996	0.832	D	0.000	0.477	D	0.997	0.437	D	2.925	0.847	M	2.78	0.113	T	-5.76	0.878	D	0.536	0.591	-0.884	0.495	T	0.107	0.390	T	0.004	0.093	T	5.605	0.763	26.5	0.998	0.926	0.843	0.431	D	c	0.630	0.481	1.000	0.517	0.581	0.326	0	3.55	0.396	3.416	0.522	0.932	0.445	1.000	0.715	0.989	0.536	12.917	0.574	.	.	.	0.5	.	57	11	18291388	chr11:18291388	C	T	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	18427177	18427177	G	C	intronic	LDHA	.	.	.	0.05865759	0.923941779	0.01740063	DISEASE: Glycogen storage disease 11 (GSD11) [MIM:612933]: A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43011	0.85387	-0.404032746	26.53338051	41.17522	1.20476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	49	11	18427177	chr11:18427177	G	C	60	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	18600278	18600278	G	A	exonic	UEVLD	.	synonymous SNV	UEVLD:NM_001040697:exon2:c.C120T:p.D40D,UEVLD:NM_001261382:exon2:c.C120T:p.D40D,UEVLD:NM_001261383:exon2:c.C120T:p.D40D,UEVLD:NM_001261385:exon2:c.C6T:p.D2D,UEVLD:NM_001261386:exon2:c.C120T:p.D40D,UEVLD:NM_001297771:exon2:c.C120T:p.D40D,UEVLD:NM_018314:exon2:c.C120T:p.D40D	1.09E-07	0.542920198	0.457079693	.	0.13244	0.14875	-0.402212257	26.7338995	286.11158	3.6211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	67	11	18600278	chr11:18600278	G	A	101	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
11	19735241	19735241	G	A	ncRNA_exonic	LOC100126784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	182	11	19735241	chr11:19735241	G	A	.	PASS	DP=182;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	19853946	19853946	A	T	intronic	NAV2	.	.	.	0.997517125	0.002482875	4.58E-16	.	0.41631	0.11088	-1.555318186	3.22009908	8281.16376	19.67042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	228	11	19853946	chr11:19853946	A	T	142	PASS	DP=228;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	35747672	35747672	A	G	exonic	TRIM44	.	synonymous SNV	TRIM44:NM_017583:exon3:c.A948G:p.Q316Q	0.163653747	0.82154148	0.014804773	.	0.5824	0.14627	-0.293801652	32.93819297	23.99448	0.78977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	59	11	35747672	chr11:35747672	A	G	73	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	45275989	45275989	A	T	intronic	SYT13	.	.	.	0.220165779	0.771535728	0.008298494	.	0.15386	0.125	-0.534490515	20.70063694	43.04749	1.24539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	54	11	45275989	chr11:45275989	A	T	65	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	45793154	45793154	A	C	ncRNA_exonic	DKFZp779M0652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	15	11	45793154	chr11:45793154	A	C	45	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	45931715	45931715	C	T	exonic	PEX16	.	synonymous SNV	PEX16:NM_057174:exon11:c.G966A:p.A322A	0.001746608	0.972862497	0.025390896	DISEASE: Peroxisome biogenesis disorder complementation group 9 (PBD-CG9) [MIM:614876]: A peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS). {ECO:0000269|PubMed:9837814}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 8A (PBD8A) [MIM:614876]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269|PubMed:9837814}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 8B (PBD8B) [MIM:614877]: A relatively mild peroxisome biogenesis disorder. Affected individuals manifest lower limb spasticity and ataxia resulting in wheelchair dependence. Other features include optic atrophy, cataracts, dysarthria, dysphagia, constipation, and a peripheral demyelinating motor and sensory neuropathy. Cognition is relatively preserved. Biochemical abnormalities are mild and include increased very-long-chain fatty acids (VLCFA), increased bile acid intermediates, and increased branched chain fatty acids. Phytanic acid alpha-oxidation, pristanic acid beta-oxidation, and red cell plasmalogen are normal. {ECO:0000269|PubMed:20647552}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07692	0.19429	0.262810045	70.43524416	256.14052	3.44234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	231	11	45931715	chr11:45931715	C	T	112	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	46001356	46001358	GTG	-	exonic	PHF21A	.	nonframeshift deletion	PHF21A:NM_001101802:exon6:c.313_315del:p.H105del,PHF21A:NM_016621:exon6:c.313_315del:p.H105del	0.999675486	0.000324514	1.38E-10	.	0.45911	0.13081	-0.622676946	17.30950696	1807.75543	7.84684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	36	11	46001355	chr11:46001355	CGTG	C	40	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	46539077	46539077	A	T	intronic	AMBRA1	.	.	.	0.999971641	2.84E-05	7.36E-14	.	0.36907	0.10363	-0.971800989	8.946685539	137.80881	2.55655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	132	11	46539077	chr11:46539077	A	T	70	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	46568662	46568662	C	T	splicing	AMBRA1	NM_001300731:exon4:c.378+1G>A;NM_017749:exon4:c.378+1G>A;NM_001267783:exon4:c.378+1G>A;NM_001267782:exon4:c.378+1G>A	.	.	0.999971641	2.84E-05	7.36E-14	.	0.36907	0.10363	-0.971800989	8.946685539	137.80881	2.55655	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.896	0.809	27.5	0.994	0.619	0.986	0.841	D	c	1.147	1.006	1.000	0.747	0.156	0.027	0	5.68	0.880	5.632	0.673	0.007	0.138	1.000	0.715	0.993	0.574	19.789	0.964	.	.	.	0.5	42	85	11	46568662	chr11:46568662	C	T	42	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	47193367	47193367	T	G	intronic	ARFGAP2	.	.	.	0.562990971	0.436986931	2.21E-05	.	0.45415	0.12888	0.531004228	80.87992451	3477.91758	11.35381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	27	11	47193367	chr11:47193367	T	G	54	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	47204533	47204533	C	-	intronic	PACSIN3	.	.	.	0.016793048	0.978273746	0.004933206	.	0.49122	0.20173	-0.532670911	20.78320359	1052.93556	6.23032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	333	11	47204532	chr11:47204532	TC	T	66	PASS	DP=333;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	49071098	49071098	C	A	intergenic	TRIM49B;TRIM64C	dist=11569;dist=4168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	11	49071098	chr11:49071098	C	A	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	49729300	49729300	C	-	ncRNA_intronic	LOC440040	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	47	11	49729299	chr11:49729299	AC	A	98	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	49896515	49896515	C	T	intergenic	LOC440040;OR4C13	dist=64546;dist=77428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	162	11	49896515	chr11:49896515	C	T	107	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	55029751	55029751	G	TTCTATGTCCTTTAT	exonic	TRIM48	.	stopgain	TRIM48:NM_024114:exon1:c.8delinsTTCTATGTCCTTTAT:p.R3Lfs*5	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	275	11	55029751	chr11:55029751	G	TTCTATGTCCTTTAT,GTCCTTTAT	72	PASS	DP=275;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	55029751	55029751	-	TCCTTTAT	exonic	TRIM48	.	stopgain	TRIM48:NM_024114:exon1:c.8_9insTCCTTTAT:p.R4Pfs*2	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	275	11	55029751	chr11:55029751	G	TTCTATGTCCTTTAT,GTCCTTTAT	72	PASS	DP=275;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	55032505	55032505	C	A	exonic	TRIM48	.	nonsynonymous SNV	TRIM48:NM_024114:exon2:c.C174A:p.N58K	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	0.277	0.156	T	0.17	0.270	B	0.297	0.392	B	.	.	.	0.993	0.237	N	0.1	0.085	N	3.18	0.075	T	-1.66	0.397	N	0.163	0.196	-0.884	0.494	T	0.013	0.052	T	0.002	0.026	T	1.003	0.190	10.68	0.593	0.060	0.564	0.299	D	c	-0.813	-0.864	0.000	0.035	0.487	0.133	0	0.596	0.166	4.273	0.585	0.142	0.226	0.366	0.257	0.655	0.299	7.138	0.246	Zinc finger, RING/FYVE/PHD-type	.	.	0.5	135	122	11	55032505	chr11:55032505	C	A	135	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	55579182	55579182	A	G	exonic	OR5L1	.	synonymous SNV	OR5L1:NM_001004738:exon1:c.A240G:p.K80K	5.94E-07	0.039026869	0.960972537	.	0.06073	0.09152	0.795569043	87.49115357	1193.77829	6.55439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	184	11	55579182	chr11:55579182	A	G	109	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	55587914	55587914	A	G	exonic	OR5D18	.	nonsynonymous SNV	OR5D18:NM_001001952:exon1:c.A809G:p.H270R	0.000954998	0.35843516	0.640609843	.	0.11145	.	0.485092724	79.37603208	428.76611	4.32426	0.69	0.043	T	0.004	0.112	B	0.021	0.181	B	0.022	0.268	N	1	0.090	P	-0.33	0.035	N	8.83	0.000	T	-1.14	0.293	N	0.068	0.068	-1.012	0.261	T	0.000	0.000	T	.	.	.	-1.272	0.023	0.005	0.289	0.015	0.118	0.167	N	c	-0.935	-0.850	0.000	0.012	0.487	0.133	0	2.44	0.287	0.706	0.252	0.018	0.143	0.000	0.063	0.496	0.270	5.983	0.185	GPCR, rhodopsin-like, 7TM	ENSG00000150244.8	Skin_Sun_Exposed_Lower_leg	0.5	54	15	11	55587914	chr11:55587914	A	G	54	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	57070189	57070189	G	A	exonic	TNKS1BP1	.	nonsynonymous SNV	TNKS1BP1:NM_033396:exon7:c.C4427T:p.S1476L	0.02971088	0.970285547	3.57E-06	.	0.31646	0.09844	1.91638269	97.43453645	1715.46291	7.63566	0.606	0.055	T	0.054	0.212	B	0.013	0.154	B	0.449	0.125	N	1	0.090	N	1.545	0.392	L	1.25	0.365	T	-2.85	0.600	D	0.165	0.199	-1.036	0.185	T	0.054	0.228	T	0.018	0.399	T	0.512	0.143	7.519	0.379	0.025	0.046	0.101	N	c	-1.327	-1.331	0.986	0.309	0.707	0.730	0	1.4	0.213	0.211	0.171	0.134	0.217	0.000	0.063	0.002	0.062	9.581	0.385	.	.	.	0.5	.	27	11	57070189	chr11:57070189	G	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	60666409	60666409	-	A	intronic	PRPF19	.	.	.	0.998566696	0.001433279	2.54E-08	.	0.60527	0.17956	-0.560178693	19.30879925	12.11009	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	220	11	60666409	chr11:60666409	G	GA	69	PASS	DP=220;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	61050464	61050464	C	T	intronic	VWCE	.	.	.	5.90E-13	0.798483808	0.201516192	.	0.19722	0.10094	-0.902027742	10.1556971	191.21648	2.99921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	11	61050464	chr11:61050464	C	T	.	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	61507049	61507049	C	T	exonic	DAGLA	.	nonsynonymous SNV	DAGLA:NM_006133:exon17:c.C1769T:p.T590I	0.953148342	0.046851612	4.51E-08	.	0.39271	0.11988	-0.573127851	18.96083982	278.59856	3.57787	0.062	0.369	T	0.838	0.444	P	0.446	0.442	B	0.000	0.843	D	1.000	0.530	D	1.245	0.315	L	1.78	0.257	T	-2.31	0.513	N	0.21	0.258	-1.064	0.108	T	0.072	0.294	T	0.017	0.380	T	3.874	0.522	23.5	0.994	0.608	0.923	0.550	D	c	0.254	0.257	1.000	0.517	0.651	0.465	0	4.23	0.492	6.038	0.704	0.852	0.362	1.000	0.715	0.822	0.344	17.000	0.862	.	.	.	0.5	78	110	11	61507049	chr11:61507049	C	T	78	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	61537709	61537709	C	T	intronic	MYRF	.	.	.	0.999847803	0.000152197	4.41E-12	.	0.22352	0.1057	-1.082044518	7.242274121	229.21291	3.27206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	164	11	61537709	chr11:61537709	C	T	124	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	61539013	61539013	C	-	exonic	MYRF	.	frameshift deletion	MYRF:NM_001127392:exon6:c.782delC:p.S264Afs*7,MYRF:NM_013279:exon6:c.755delC:p.S255Afs*7	0.999847803	0.000152197	4.41E-12	.	0.22352	0.1057	-1.082044518	7.242274121	229.21291	3.27206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	563	11	61539012	chr11:61539012	TC	T	75	PASS	DP=563;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	0/1	./.	./.
11	62295897	62295897	G	A	exonic	AHNAK	.	synonymous SNV	AHNAK:NM_001346445:exon5:c.C5992T:p.L1998L,AHNAK:NM_001346446:exon5:c.C5992T:p.L1998L,AHNAK:NM_001620:exon5:c.C5992T:p.L1998L	0.344567387	0.655432572	4.07E-08	.	0.19089	.	-2.834287974	0.613352206	5147.67106	14.73759	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	356	11	62295897	chr11:62295897	G	A	78	PASS	DP=356;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	62378331	62378331	T	A	intronic	EML3	.	.	.	0.394340909	0.605658415	6.76E-07	.	0.25723	0.09936	-0.843147538	11.2762444	758.07118	5.45547	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	114	11	62378331	chr11:62378331	T	A	144	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	62381083	62381083	-	G	exonic	ROM1	.	frameshift insertion	ROM1:NM_000327:exon1:c.331dupG:p.L114Afs*17	0.00326883	0.826982383	0.169748787	.	0.4113	0.2303	-0.224023033	37.4321774	133.6058	2.51197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	24	11	62381083	chr11:62381083	T	TG	60	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	62414680	62414680	G	A	exonic	INTS5	.	stopgain	INTS5:NM_030628:exon2:c.C2872T:p.Q958X	0.999284368	0.000715627	4.68E-09	.	0.31626	0.12936	-0.971800989	8.946685539	92.50703	2.06784	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.967	0.988	40	0.997	0.788	0.985	0.831	D	c	1.248	1.127	1.0	0.983	0.742	0.980	0	5.96	0.967	9.436	0.967	1.048	0.713	1.000	0.715	0.999	0.750	17.898	0.888	Integrator complex subunit 5, C-terminal	.	.	0.5	.	32	11	62414680	chr11:62414680	G	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	63256434	63256434	A	T	exonic	HRASLS5	.	nonsynonymous SNV	HRASLS5:NM_001146728:exon3:c.T284A:p.V95D,HRASLS5:NM_001146729:exon3:c.T254A:p.V85D,HRASLS5:NM_054108:exon3:c.T284A:p.V95D	0.00012337	0.619627423	0.380249207	.	0.04664	0.06022	1.484536216	95.31729181	289.40446	3.63903	0.0	0.912	D	0.828	0.441	P	0.372	0.418	B	0.000	0.004	N	1	0.090	N	0.805	0.203	L	1.41	0.334	T	-1.38	0.399	N	0.189	0.466	-1.038	0.179	T	0.055	0.233	T	0.002	0.043	T	1.656	0.260	14.16	0.858	0.156	0.056	0.114	N	c	-0.827	-0.986	1.000	0.416	0.706	0.609	0	-1.01	0.096	0.074	0.144	0.196	0.251	0.000	0.063	0.006	0.095	4.370	0.106	.	.	.	0.5	77	68	11	63256434	chr11:63256434	A	T	77	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	63706617	63706617	C	T	intronic	NAA40	.	.	.	0.005446684	0.970204184	0.024349133	.	0.15839	0.10522	-0.47017169	23.25430526	88.58642	2.01879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	140	11	63706617	chr11:63706617	C	T	64	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	63706627	63706627	C	T	intronic	NAA40	.	.	.	0.005446684	0.970204184	0.024349133	.	0.15839	0.10522	-0.47017169	23.25430526	88.58642	2.01879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	121	11	63706627	chr11:63706627	C	T	64	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	63970809	63970809	C	T	intronic	STIP1	.	.	.	0.999887764	0.000112236	1.04E-11	.	0.65119	0.18755	-0.558357437	19.54470394	25.94299	0.8431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	25	11	63970809	chr11:63970809	C	T	66	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	64374091	64374091	G	T	UTR3	NRXN2	NM_138734:c.*577C>A;NM_138732:c.*577C>A;NM_015080:c.*577C>A	.	.	0.999895574	0.000104426	7.22E-14	.	0.24191	0.10189	-2.164449385	1.427223402	1296.88776	6.77694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	110	11	64374091	chr11:64374091	G	T	.	PASS	DP=110;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	64602486	64602486	C	T	intronic	CDC42BPG	.	.	.	1.41E-17	0.874375116	0.125624884	.	0.12008	0.10369	-1.464556369	3.75678226	2467.86866	9.25649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	155	11	64602486	chr11:64602486	C	T	64	PASS	DP=155;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	64693059	64693059	-	G	UTR5	PPP2R5B	NM_006244:c.-148_-147insG	.	.	0.932458812	0.06752751	1.37E-05	.	0.16145	0.10681	-0.538132194	20.26421326	15.72909	0.56074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	101	11	64693059	chr11:64693059	T	TG	58	PASS	DP=101;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
11	64715290	64715290	C	T	exonic	MAJIN	.	synonymous SNV	MAJIN:NM_001037225:exon7:c.G351A:p.G117G,MAJIN:NM_001318808:exon7:c.G33A:p.G11G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	88	11	64715290	chr11:64715290	C	T	50	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	64880312	64880312	G	C	exonic	TM7SF2	.	nonsynonymous SNV	TM7SF2:NM_001277233:exon3:c.G279C:p.K93N,TM7SF2:NM_003273:exon3:c.G279C:p.K93N	0.000447934	0.964092177	0.035459889	.	0.09798	.	-0.380166007	27.88393489	2447.70004	9.20626	0.091	0.318	T	0.002	0.090	B	0.013	0.154	B	0.001	0.412	D	1	0.810	D	0.055	0.082	N	-4.54	0.990	D	1.13	0.020	N	0.098	0.153	0.613	0.921	D	0.852	0.951	D	0.128	0.811	D	3.585	0.488	23.2	0.989	0.474	0.924	0.553	D	c	-0.197	0.014	1.000	0.747	0.652	0.477	0	4.77	0.603	3.746	0.546	0.974	0.594	1.000	0.715	0.998	0.697	13.165	0.588	.	.	.	0.5	147	191	11	64880312	chr11:64880312	G	C	147	PASS	DP=191;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	65266480	65266480	T	C	ncRNA_exonic	MALAT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	175	11	65266480	chr11:65266480	T	C	90	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	65315391	65315391	C	G	exonic	LTBP3	.	nonsynonymous SNV	LTBP3:NM_001130144:exon12:c.G1846C:p.D616H,LTBP3:NM_001164266:exon12:c.G1495C:p.D499H,LTBP3:NM_021070:exon12:c.G1846C:p.D616H	0.996034359	0.003965641	1.03E-10	DISEASE: Dental anomalies and short stature (DASS) [MIM:601216]: A disorder characterized by hypoplastic amelogenesis imperfecta, significant short stature, brachyolmia-like anomalies including platyspondyly with short pedicles, narrow intervertebral and interpedicular distances, rectangular-shaped vertebrae with posterior scalloping and herniation of the nuclei, and broad femoral necks. Dental anomalies include widely spaced, small, yellow teeth, oligodontia, and severely reduced to absent enamel. {ECO:0000269|PubMed:19344874}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30397	0.12827	-0.93133804	9.613116301	914.10791	5.87861	0.001	0.784	D	0.998	0.899	D	0.947	0.971	D	0.000	0.447	D	1	0.810	D	3.245	0.900	M	-5.39	0.991	D	-6.17	0.902	D	0.48	0.582	-0.092	0.803	T	0.429	0.772	T	0.666	0.972	D	5.222	0.705	25.6	0.993	0.588	0.960	0.667	D	c	0.621	0.520	1.000	0.747	0.707	0.730	0	4.7	0.586	4.344	0.589	0.808	0.332	0.999	0.424	0.965	0.450	15.11	0.719	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|Growth factor receptor cysteine-rich domain	.	.	0.5	100	1263	11	65315391	chr11:65315391	C	G	100	PASS	DP=1263;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	65359372	65359372	G	A	intronic	EHBP1L1	.	.	.	8.08E-07	0.999807515	0.000191677	.	0.16998	0.08888	0.077132183	59.19438547	4618.64715	13.65497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	11	65359372	chr11:65359372	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	66049881	66049881	G	A	intronic	CNIH2	.	.	.	0.894540207	0.104434209	0.001025584	.	0.16073	0.11262	-0.119252484	44.53880632	2.28818	0.07752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	139	11	66049881	chr11:66049881	G	A	.	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	66249674	66249674	G	T	exonic	DPP3	.	nonsynonymous SNV	DPP3:NM_001256670:exon2:c.G3T:p.M1I,DPP3:NM_005700:exon2:c.G3T:p.M1I,DPP3:NM_130443:exon2:c.G3T:p.M1I	4.36E-09	0.939852021	0.060147975	.	.	0.29988	0.874458024	88.88888889	4443.48457	13.35156	0.034	0.538	D	0.225	0.342	B	0.047	0.264	B	0.000	0.843	D	1	0.810	D	.	.	.	1.98	0.433	T	-1.86	0.452	N	0.944	0.939	-1.010	0.269	T	0.093	0.355	T	0.050	0.642	D	4.266	0.571	23.9	0.996	0.722	0.995	0.970	D	c	0.323	0.476	1.000	0.747	0.742	0.980	0	5.71	0.890	7.961	0.874	0.948	0.535	1.000	0.715	1.000	0.888	15.355	0.740	.	.	.	0.5	.	65	11	66249674	chr11:66249674	G	T	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	66278427	66278427	-	T	intronic	BBS1	.	.	.	1.78E-07	0.962498134	0.037501688	DISEASE: Bardet-Biedl syndrome 1 (BBS1) [MIM:209900]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:12118255, ECO:0000269|PubMed:12524598, ECO:0000269|PubMed:12567324, ECO:0000269|PubMed:12677556, ECO:0000269|PubMed:12920096, ECO:0000269|PubMed:15770229, ECO:0000269|PubMed:21052717, ECO:0000269|PubMed:21344540}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	-0.264476624	34.8844067	2.96492	0.10746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	220	11	66278427	chr11:66278427	G	GT	78	PASS	DP=220;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	66512290	66512290	-	GGC	exonic	C11orf80	.	nonframeshift insertion	C11orf80:NM_024650:exon1:c.77_78insGGC:p.A34_G35insA	0.008462596	0.978338462	0.013198942	.	0.03682	.	0.106667882	61.73036093	116.69248	2.34991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	59	11	66512290	chr11:66512290	G	GGGC,GGGCGGC	98	PASS	DP=59;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/2
11	66512290	66512290	-	GGCGGC	exonic	C11orf80	.	nonframeshift insertion	C11orf80:NM_024650:exon1:c.77_78insGGCGGC:p.A34_G35insAA	0.008462596	0.978338462	0.013198942	.	0.03682	.	0.106667882	61.73036093	116.69248	2.34991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	59	11	66512290	chr11:66512290	G	GGGC,GGGCGGC	98	PASS	DP=59;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/2
11	66631419	66631419	C	G	exonic	PC	.	synonymous SNV	PC:NM_022172:exon10:c.G1194C:p.R398R,PC:NM_000920:exon11:c.G1194C:p.R398R,PC:NM_001040716:exon12:c.G1194C:p.R398R	0.71643567	0.283564107	2.23E-07	DISEASE: Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]: Leads to lactic acidosis, mental retardation and death. It occurs in three forms: mild or type A, severe neonatal or type B, and a very mild lacticacidemia. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19381	0.81784	-1.74358502	2.394432649	138.12153	2.55935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	60	11	66631419	chr11:66631419	C	G	69	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	67763129	67763129	G	A	exonic	UNC93B1	.	unknown	UNKNOWN	0.513837376	0.482295391	0.003867233	DISEASE: Herpes simplex encephalitis 1 (HSE1) [MIM:610551]: A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. HSE is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome. {ECO:0000269|PubMed:16973841}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in UNC93B1 resulting in autosomal recessive UNC93B1 deficieny predispose otherwise healthy individuals to isolated herpes simplex encephalitis due to impaired IFNs production. UNC93B1 deficieny, however, does not compromise immunity to most pathogens, unlike most known primary immunodeficiencies.; 	.	0.17596	.	.	149.92935	2.66921	0.305	0.142	T	0.506	0.354	P	0.051	0.240	B	0.000	0.559	N	0.820	0.348	D	2.075	0.572	M	-1.37	0.802	T	-2.22	0.498	N	0.371	0.432	-1.009	0.273	T	0.022	0.091	T	0.031	0.532	D	1.957	0.296	15.94	0.990	0.496	0.962	0.676	D	c	-0.222	-0.153	1.000	0.747	0.713	0.817	0	3.56	0.397	5.222	0.649	1.038	0.658	1.000	0.715	0.011	0.114	10.105	0.415	.	.	.	0.5	.	113	11	67763129	chr11:67763129	G	A	.	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	68133035	68133035	T	C	intronic	LRP5	.	.	.	0.99835557	0.00164443	2.44E-12	DISEASE: Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:15024691, ECO:0000269|PubMed:15346351, ECO:0000269|PubMed:15981244, ECO:0000269|PubMed:16929062, ECO:0000269|PubMed:19324841, ECO:0000269|PubMed:20340138, ECO:0000269|PubMed:24715757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:14727154, ECO:0000269|PubMed:15824851, ECO:0000269|PubMed:16234968}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]: A disease characterized by congenital or infancy-onset blindness and severe juvenile-onset osteoporosis and spontaneous fractures. Additional clinical manifestations may include microphthalmos, abnormalities of the iris, lens or vitreous, cataracts, short stature, microcephaly, ligamental laxity, mental retardation and hypotonia. {ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:16679074, ECO:0000269|PubMed:17437160, ECO:0000269|PubMed:18602879}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: High bone mass trait (HBM) [MIM:601884]: Rare phenotype characterized by exceptionally dense bones. HBM individuals show otherwise a completely normal skeletal structure and no other unusual clinical findings. {ECO:0000269|PubMed:11741193, ECO:0000269|PubMed:12015390, ECO:0000269|PubMed:15824861, ECO:0000269|PubMed:17295608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]: An autosomal dominant sclerosing bone dysplasia clinically characterized by elongation of the mandible, increased gonial angle, flattened forehead, and the presence of a slowly enlarging osseous prominence of the hard palate (torus palatinus). Serum calcium, phosphorus and alkaline phosphatase levels are normal. Radiologically, it is characterized by early thickening of the endosteum of long bones, the skull and of the mandible. With advancing age, the trabeculae of the metaphysis become thickened. WENHY becomes clinically and radiologically evident by adolescence, does not cause deformity except in the skull and mandible, and is not associated with bone pain or fracture. Affected patients have normal height, proportion, intelligence and longevity. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. OPTA1 is an autosomal dominant form characterized by generalized osteosclerosis most pronounced in the cranial vault. Patients are often asymptomatic, but some suffer from pain and hearing loss. It appears to be the only type of osteopetrosis not associated with an increased fracture rate. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Van Buchem disease 2 (VBCH2) [MIM:607636]: VBCH2 is an autosomal dominant sclerosing bone dysplasia characterized by cranial osteosclerosis, thickened calvaria and cortices of long bones, enlarged mandible and normal serum alkaline phosphatase levels. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07666	0.10394	-3.724445291	0.241802312	2445.60749	9.20072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	184	135	11	68133035	chr11:68133035	T	C	184	PASS	DP=135;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	68522887	68522887	T	-	UTR3	CPT1A	NM_001876:c.*2225delA	.	.	0.939139733	0.060860249	1.76E-08	DISEASE: Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]: Rare autosomal recessive metabolic disorder of long- chain fatty acid oxidation characterized by severe episodes of hypoketotic hypoglycemia usually occurring after fasting or illness. Onset is in infancy or early childhood. {ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:11441142, ECO:0000269|PubMed:12189492, ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:15110323, ECO:0000269|PubMed:15669684, ECO:0000269|PubMed:9691089}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11869	0.57549	-0.483123186	22.78249587	317.78824	3.78518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	25	11	68522886	chr11:68522886	CT	C	56	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	69933920	69933920	C	T	exonic	ANO1	.	synonymous SNV	ANO1:NM_018043:exon2:c.C171T:p.D57D	0.99308464	0.006915359	4.02E-10	.	0.29465	0.12257	-1.521247944	3.44420854	826.58674	5.63458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	11	69933920	chr11:69933920	C	T	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	70348840	70348840	-	C	intronic	SHANK2	.	.	.	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	37	11	70348840	chr11:70348840	G	GC	45	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	71507205	71507205	C	T	exonic	FAM86C1	.	nonsynonymous SNV	FAM86C1:NM_152563:exon3:c.C302T:p.P101L,FAM86C1:NM_001099653:exon4:c.C383T:p.P128L,FAM86C1:NM_018172:exon4:c.C404T:p.P135L	1.48E-08	0.031767811	0.968232174	.	0.09393	.	0.505321956	80.00707714	5743.67103	15.72823	1.0	0.044	T	0.0	0.067	B	0.0	0.013	B	.	.	.	1.000	0.090	N	.	.	.	2.38	0.158	T	-0.88	0.238	N	0.278	0.336	-1.010	0.268	T	0.000	0.000	T	.	.	.	-0.567	0.052	0.150	0.859	0.157	0.003	0.015	N	c	-1.780	-1.907	0.006	0.111	0.706	0.609	0	-2.98	0.051	-2.252	0.013	-0.390	0.064	0.000	0.063	0.016	0.126	1.306	0.019	.	.	.	0.5	123	436	11	71507205	chr11:71507205	C	T	123	PASS	DP=436;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	71507232	71507232	C	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	160	446	11	71507232	chr11:71507232	C	G	160	PASS	DP=446;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	71507261	71507261	A	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	191	404	11	71507261	chr11:71507261	A	G	191	PASS	DP=404;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	71507263	71507263	A	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	631	11	71507263	chr11:71507263	A	G	148	PASS	DP=631;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	71822165	71822165	-	TGCTGGGGTCTCTGTCTA	intronic	ANAPC15	.	.	.	0.564413605	0.423423147	0.012163248	.	0.39459	0.11262	0.079165051	59.43029016	5.13875	0.19088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	83	11	71822165	chr11:71822165	G	GTGCTGGGGTCTCTGTCTA	155	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
11	72412608	72412608	C	T	ncRNA_intronic	ARAP1-AS2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	246	11	72412608	chr11:72412608	C	T	87	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	72549649	72549649	-	A	UTR3	FCHSD2	NM_014824:c.*186_*187insT	.	.	0.994752587	0.005247408	5.00E-09	.	0.39961	0.11323	-0.88906181	10.36801132	103.87407	2.20142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	177	11	72549649	chr11:72549649	C	CA	75	PASS	DP=177;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	73499066	73499066	-	GGGGAGATGGCGGACGGTGCAGAGA	intronic	MRPL48	.	.	.	0.138891985	0.841256691	0.019851324	.	0.11788	0.09364	0.014844891	54.94810097	193.07651	3.01163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	133	11	73499066	chr11:73499066	C	CGGGGAGATGGCGGACGGTGCAGAGA	57	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	74336608	74336608	-	A	exonic	POLD3	.	frameshift insertion	POLD3:NM_006591:exon8:c.890dupA:p.R300Kfs*8	0.991394247	0.00860567	8.29E-08	.	0.60979	0.21476	0.575097644	82.1656051	193.7509	3.02008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	40	11	74336608	chr11:74336608	G	GA	39	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	74875100	74875100	C	A	exonic	SLCO2B1	.	nonsynonymous SNV	SLCO2B1:NM_001145211:exon3:c.C174A:p.F58L,SLCO2B1:NM_007256:exon3:c.C240A:p.F80L	0.003353563	0.996214752	0.000431685	.	0.12048	0.17779	-0.483123186	22.78249587	2109.9785	8.45565	0.001	0.784	D	0.945	0.513	P	0.667	0.512	P	0.000	0.460	D	0.989	0.810	D	4.135	0.976	H	-0.09	0.641	T	-5.13	0.832	D	0.543	0.580	-0.231	0.769	T	0.356	0.719	T	0.158	0.839	D	5.636	0.768	26.6	0.993	0.579	0.179	0.198	N	c	-0.187	-0.389	1.000	0.500	0.549	0.223	0	-3.11	0.049	-2.095	0.014	-1.093	0.019	0.000	0.063	0.935	0.408	10.527	0.440	Major facilitator superfamily domain	.	.	0.5	112	193	11	74875100	chr11:74875100	C	A	112	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	75277375	75277375	A	G	UTR5	SERPINH1	NM_001207014:c.-20A>G;NM_001235:c.-20A>G	.	.	0.16655085	0.819116317	0.014332833	DISEASE: Osteogenesis imperfecta 10 (OI10) [MIM:613848]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI10 is an autosomal recessive form characterized by multiple bone deformities and fractures, generalized osteopenia, dentinogenesis imperfecta, and blue sclerae. {ECO:0000269|PubMed:20188343}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83973	0.39597	-0.602450568	17.91106393	54.13484	1.46719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	175	11	75277375	chr11:75277375	A	G	100	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	77639466	77639466	A	G	exonic	INTS4	.	synonymous SNV	INTS4:NM_033547:exon11:c.T1293C:p.S431S	0.653071264	0.346928651	8.43E-08	.	0.16947	0.15282	-0.576764155	18.7839113	270.96358	3.52905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	66	11	77639466	chr11:77639466	A	G	127	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	82996972	82996972	C	G	exonic	CCDC90B	.	nonsynonymous SNV	CCDC90B:NM_021825:exon1:c.G44C:p.R15T	0.009063821	0.937639502	0.053296678	.	0.14281	0.09698	0.549415813	81.38122199	88.38564	2.01561	0.585	0.062	T	0.0	0.026	B	0.0	0.013	B	0.540	0.053	N	1	0.194	N	0.345	0.112	N	1.57	0.304	T	0.43	0.044	N	0.125	0.433	-1.016	0.249	T	0.046	0.198	T	0.004	0.108	T	-0.211	0.075	1.040	0.507	0.044	0.066	0.124	N	c	-0.980	-1.011	1.000	0.747	0.442	0.072	0	0.705	0.172	-0.555	0.060	-0.328	0.075	0.000	0.063	0.000	0.016	1.445	0.022	.	.	.	0.5	136	211	11	82996972	chr11:82996972	C	G	136	PASS	DP=211;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
11	85346790	85346790	G	T	exonic	TMEM126B	.	nonsynonymous SNV	TMEM126B:NM_001256547:exon3:c.G339T:p.L113F,TMEM126B:NM_001350393:exon3:c.G252T:p.L84F,TMEM126B:NM_018480:exon4:c.G477T:p.L159F,TMEM126B:NM_001193537:exon5:c.G417T:p.L139F,TMEM126B:NM_001193538:exon5:c.G387T:p.L129F,TMEM126B:NM_001256546:exon5:c.G387T:p.L129F	0.000531076	0.456608892	0.542860032	.	0.06517	0.073	0.393270925	76.04977589	58.25686	1.54509	0.004	0.654	D	0.999	0.764	D	0.977	0.722	D	0.000	0.629	D	0.998	0.444	D	2.7	0.793	M	0.58	0.542	T	-3.76	0.712	D	0.8	0.789	-0.629	0.637	T	0.307	0.678	T	0.041	0.596	D	4.043	0.543	23.7	0.998	0.920	0.754	0.366	D	c	-0.103	-0.187	0.812	0.243	0.732	0.924	0	1.31	0.207	1.035	0.296	1.048	0.713	1.000	0.715	0.867	0.362	8.126	0.300	.	.	.	0.5	.	33	11	85346790	chr11:85346790	G	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	86111856	86111856	-	T	intronic	CCDC81	.	.	.	2.79E-09	0.897689748	0.102310249	.	0.06368	.	1.155610133	92.59259259	889.04414	5.80784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	16	11	86111856	chr11:86111856	C	CT	41	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	90017138	90017138	A	T	ncRNA_intronic	DISC1FP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	11	90017138	chr11:90017138	A	T	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	96074739	96074739	C	G	exonic	MAML2	.	synonymous SNV	MAML2:NM_032427:exon1:c.G321C:p.P107P	0.998525114	0.001474885	1.12E-09	DISEASE: Note=A chromosomal aberration involving MAML2 is found in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. Translocation t(11;19)(q21;p13) with CRTC1. The fusion protein consists of the N-terminus of CRTC1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of CRTC1 has been detected in a small number of mucoepidermoid carcinomas. {ECO:0000269|PubMed:15729701}.; 	0.28735	0.13371	0.207589927	67.52182118	1240.98759	6.64881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	15	11	96074739	chr11:96074739	C	G	62	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	100211936	100211936	A	G	exonic	CNTN5	.	nonsynonymous SNV	CNTN5:NM_175566:exon20:c.A2807G:p.K936R,CNTN5:NM_001243270:exon22:c.A3029G:p.K1010R,CNTN5:NM_014361:exon23:c.A3029G:p.K1010R	0.001354061	0.998643262	2.68E-06	.	0.29361	0.20972	-0.080831688	47.22222222	849.40801	5.69596	0.038	0.427	D	0.986	0.609	D	0.689	0.600	P	0.000	0.843	D	1.000	0.548	D	2.16	0.606	M	0.73	0.507	T	-1.83	0.429	N	0.602	0.670	-0.617	0.641	T	0.255	0.626	T	0.026	0.488	D	4.222	0.566	23.9	0.999	0.941	0.920	0.544	D	c	0.629	0.611	0.998	0.360	0.487	0.133	0	5.46	0.799	6.232	0.721	1.199	0.960	1.000	0.715	0.985	0.512	14.709	0.687	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	79	79	11	100211936	chr11:100211936	A	G	79	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	100864088	100864088	T	A	UTR3	TMEM133	NM_032021:c.*659T>A	.	.	0.025317131	0.558322413	0.416360457	.	0.06337	.	0.080983847	59.76055674	196.60872	3.03256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	11	100864088	chr11:100864088	T	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	104869744	104869744	C	-	exonic	CASP5	.	frameshift deletion	CASP5:NM_001136110:exon5:c.538delG:p.E180Nfs*74,CASP5:NM_001136109:exon6:c.790delG:p.E264Nfs*74,CASP5:NM_001136112:exon7:c.1003delG:p.E335Nfs*74,CASP5:NM_004347:exon7:c.964delG:p.E322Nfs*74	8.11E-09	0.273167235	0.726832757	.	0.1193	0.11456	1.199707453	92.98183534	431.34997	4.33449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	14	11	104869743	chr11:104869743	TC	T	65	PASS	DP=14;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	106408032	106408037	CAAATG	-	intergenic	LOC101928535;GUCY1A2	dist=272400;dist=136701	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	30	11	106408031	chr11:106408031	TCAAATG	T	85	PASS	DP=30;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	111800579	111800579	T	G	exonic	DIXDC1	.	nonsynonymous SNV	DIXDC1:NM_001278542:exon2:c.T2G:p.M1R	4.27E-06	0.997885057	0.002110675	.	0.28623	0.1069	.	.	168.08416	2.83065	0.0	0.912	D	.	.	.	.	.	.	.	.	.	1.000	0.202	N	.	.	.	-1.09	0.772	T	0.31	0.040	N	0.403	0.462	0.109	0.843	D	0.527	0.824	D	0.146	0.829	D	5.466	0.742	26.2	0.981	0.380	0.900	0.506	D	c	0.335	0.403	0.998	0.360	0.554	0.283	0	5.2	0.716	3.860	0.555	1.011	0.635	1.000	0.715	1.000	0.888	11.380	0.488	.	.	.	0.5	.	28	11	111800579	chr11:111800579	T	G	.	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	111899202	111899202	C	G	intronic	DLAT	.	.	.	6.68E-06	0.974397294	0.02559603	DISEASE: Note=Primary biliary cirrhosis is a chronic, progressive cholestatic liver disease characterized by the presence of antimitochondrial autoantibodies in patients' serum. It manifests with inflammatory obliteration of intra-hepatic bile duct, leading to liver cell damage and cirrhosis. Patients with primary biliary cirrhosis show autoantibodies against the E2 component of pyruvate dehydrogenase complex.; DISEASE: Pyruvate dehydrogenase E2 deficiency (PDHE2 deficiency) [MIM:245348]: Pyruvate dehydrogenase (PDH) deficiency is a major cause of primary lactic acidosis and neurological dysfunction in infancy and early childhood. In this form of PDH deficiency episodic dystonia is the major neurological manifestation, with other more common features of pyruvate dehydrogenase deficiency, such as hypotonia and ataxia, being less prominent. {ECO:0000269|PubMed:16049940}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.80314	0.42344	0.356452144	74.62845011	6667.69783	17.30223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	38	11	111899202	chr11:111899202	C	G	59	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	113668841	113668841	G	A	UTR3	USP28	NM_001301029:c.*1121C>T;NM_001346263:c.*1121C>T;NM_001346265:c.*1121C>T;NM_001346259:c.*1121C>T;NM_001346252:c.*1121C>T;NM_001346269:c.*1121C>T;NM_001346267:c.*1121C>T;NM_001346262:c.*1121C>T;NM_001346258:c.*1121C>T;NM_001346264:c.*1121C>T;NM_001346255:c.*1121C>T;NM_001346270:c.*1121C>T;NM_001346253:c.*1121C>T;NM_001346257:c.*1121C>T;NM_001346271:c.*1121C>T;NM_020886:c.*1121C>T;NM_001346272:c.*1121C>T;NM_001346261:c.*1121C>T;NM_001346268:c.*1121C>T;NM_001346254:c.*1121C>T;NM_001346260:c.*1121C>T	.	.	0.031657505	0.968342468	2.69E-08	.	0.60849	0.11751	-0.791786324	12.59731069	79.98741	1.89131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	312	11	113668841	chr11:113668841	G	A	137	PASS	DP=312;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	116640793	116640793	A	C	intronic	BUD13	.	.	.	0.002295428	0.994047189	0.003657382	.	0.20921	0.07302	0.778977686	87.21396556	1508.32155	7.21483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	47	11	116640793	chr11:116640793	A	C	64	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	117045616	117045616	T	C	UTR3	PAFAH1B2	NM_001184748:c.*2T>C	.	.	0.962029472	0.037892339	7.82E-05	.	0.65851	0.15588	-0.075159878	47.78839349	4.02051	0.14794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	75	11	117045616	chr11:117045616	T	C	71	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	117161295	117161295	G	T	exonic	BACE1	.	synonymous SNV	BACE1:NM_001207048:exon7:c.C873A:p.G291G,BACE1:NM_001207049:exon7:c.C798A:p.G266G,BACE1:NM_012104:exon8:c.C1173A:p.G391G,BACE1:NM_138971:exon8:c.C1041A:p.G347G,BACE1:NM_138972:exon8:c.C1098A:p.G366G,BACE1:NM_138973:exon8:c.C966A:p.G322G	0.944278809	0.055712783	8.41E-06	.	0.32571	0.32145	-0.758599262	13.32861524	36.43549	1.09195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	20	11	117161295	chr11:117161295	G	T	50	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	118240262	118240263	AC	-	intronic	UBE4A	.	.	.	0.937619432	0.062380564	3.79E-09	.	0.20567	0.099	-1.085675268	7.147912243	92.47287	2.06712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.52	20	11	118240261	chr11:118240261	TAC	T	19.52	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	118769058	118769058	G	A	UTR3	BCL9L	NM_182557:c.*66C>T	.	.	0.998124599	0.001875399	2.01E-09	.	0.49572	0.2	-1.473536006	3.727294173	883.69076	5.78927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	145	11	118769058	chr11:118769058	G	A	.	PASS	DP=145;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
11	118914990	118914990	C	T	UTR3	HYOU1	NM_006389:c.*1315G>A;NM_001130991:c.*1315G>A	.	.	0.99977936	0.00022064	4.46E-13	.	0.5567	0.18042	-1.835411529	2.081858929	85.0696	1.96574	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	11	118914990	chr11:118914990	C	T	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	119032963	119032963	G	A	UTR3	ABCG4	NM_022169:c.*1147G>A;NM_001348192:c.*1147G>A;NM_001348191:c.*1147G>A;NM_001142505:c.*1147G>A	.	.	0.000455417	0.992033195	0.007511388	.	0.18664	0.15734	-0.067881249	48.69072895	196.06202	3.02988	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	110	11	119032963	chr11:119032963	G	A	89	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	119509432	119509432	C	G	intronic	NECTIN1	.	.	.	.	.	.	DISEASE: Ectodermal dysplasia, Margarita Island type (EDMI) [MIM:225060]: An autosomal recessive form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. It is a syndrome characterized by the association of cleft lip/palate, ectodermal dysplasia (sparse short and dry scalp hair, sparse eyebrows and eyelashes), and partial syndactyly of the fingers and/or toes. Two thirds of the patients do not manifest oral cleft but present with abnormal teeth and nails. {ECO:0000269|PubMed:10932188}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 7 (OFC7) [MIM:225060]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:10932188}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16543	0.24625	-0.238793231	36.3116301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	70	11	119509432	chr11:119509432	C	G	82	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	120008373	120008373	C	T	exonic	TRIM29	.	nonsynonymous SNV	TRIM29:NM_012101:exon1:c.G367A:p.E123K	9.17E-05	0.934953701	0.064954626	.	0.50874	0.11722	-0.064242613	48.844067	476.53225	4.50967	0.005	0.632	D	0.826	0.439	P	0.137	0.317	B	0.042	0.239	N	0.727	0.337	D	1.78	0.463	L	0.97	0.425	T	-0.55	0.168	N	0.114	0.138	-1.082	0.070	T	0.063	0.263	T	0.050	0.640	D	3.334	0.459	22.9	0.994	0.644	0.891	0.491	D	c	0.022	0.088	1.000	0.747	0.497	0.185	0	5.06	0.677	1.534	0.354	0.892	0.403	0.670	0.281	0.921	0.396	14.095	0.644	.	.	.	0.5	51	360	11	120008373	chr11:120008373	C	T	51	PASS	DP=360;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	120348214	120348214	G	A	exonic	ARHGEF12	.	nonsynonymous SNV	ARHGEF12:NM_001198665:exon35:c.G3454A:p.V1152I,ARHGEF12:NM_001301084:exon36:c.G3202A:p.V1068I,ARHGEF12:NM_015313:exon36:c.G3511A:p.V1171I	0.999998926	1.07E-06	8.61E-21	.	0.4712	.	-0.323344668	30.9447983	743.24174	5.41202	0.057	0.388	T	0.006	0.191	B	0.006	0.188	B	0.079	0.210	N	0.999	0.223	N	1.95	0.526	M	-0.19	0.659	T	-0.22	0.105	N	0.057	0.067	-0.979	0.352	T	0.118	0.415	T	0.012	0.295	T	2.294	0.337	18.13	0.992	0.557	0.827	0.416	D	c	-0.153	0.062	0.927	0.268	0.732	0.924	0	4.24	0.493	3.969	0.563	0.905	0.419	0.994	0.380	0.989	0.536	12.907	0.574	.	.	.	0.5	.	21	11	120348214	chr11:120348214	G	A	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	120979889	120979889	C	A	intronic	TECTA	.	.	.	1.06E-12	0.999989746	1.03E-05	DISEASE: Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:10196713, ECO:0000269|PubMed:10987647, ECO:0000269|PubMed:12162770, ECO:0000269|PubMed:15319541, ECO:0000269|PubMed:16718611, ECO:0000269|PubMed:17661817, ECO:0000269|PubMed:20947814, ECO:0000269|PubMed:21520338, ECO:0000269|PubMed:9590290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 21 (DFNB21) [MIM:603629]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12746400, ECO:0000269|PubMed:9949200}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.64735	0.20702	-2.430013277	1.032083038	4846.67098	14.13953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	11	120979889	chr11:120979889	C	A	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	123598941	123598941	T	C	exonic	ZNF202	.	synonymous SNV	ZNF202:NM_001301819:exon4:c.A60G:p.V20V,ZNF202:NM_001301780:exon5:c.A732G:p.V244V,ZNF202:NM_001301779:exon6:c.A732G:p.V244V,ZNF202:NM_003455:exon7:c.A732G:p.V244V	0.138743298	0.86039682	0.000859882	.	0.14654	0.1493	-0.200157416	39.11299835	48.89763	1.36475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	78	11	123598941	chr11:123598941	T	C	66	PASS	DP=78;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	123893791	123893791	A	C	exonic	OR10G9	.	synonymous SNV	OR10G9:NM_001001953:exon1:c.A72C:p.P24P	0.007138452	0.531885237	0.460976311	.	0.05817	0.09497	3.688480395	99.5576787	1919.79326	8.06598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	453	11	123893791	chr11:123893791	A	C	149	PASS	DP=453;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	123909691	123909691	T	G	exonic	OR10G7	.	synonymous SNV	OR10G7:NM_001004463:exon1:c.A18C:p.L6L	0.007122109	0.531402926	0.461474965	.	0.06744	0.08917	1.774838537	96.82118424	459.74042	4.44864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	147	11	123909691	chr11:123909691	T	G	135	PASS	DP=147;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	124015941	124015941	C	T	intronic	VWA5A	.	.	.	1.89E-15	0.026741774	0.973258226	.	0.04851	.	0.648517637	84.14720453	1165.38867	6.49454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	143	11	124015941	chr11:124015941	C	T	121	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	124086220	124086220	A	G	intergenic	VWA5A;OR8G2P	dist=68602;dist=9124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	111	11	124086220	chr11:124086220	A	G	88	PASS	DP=111;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	124096173	124096173	T	C	exonic	OR8G2P	.	nonsynonymous SNV	OR8G2P:NM_001291438:exon1:c.T776C:p.L259S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	176	11	124096173	chr11:124096173	T	C	84	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	124609887	124609887	G	C	UTR5	NRGN	NM_001126181:c.-94G>C;NM_006176:c.-94G>C	.	.	0.536942023	0.405084011	0.057973966	.	0.39546	0.19444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	30	11	124609887	chr11:124609887	G	C	78	PASS	DP=30;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.
11	124619690	124619690	C	T	exonic	VSIG2	.	nonsynonymous SNV	VSIG2:NM_001329920:exon4:c.G500A:p.S167N,VSIG2:NM_014312:exon4:c.G500A:p.S167N	0.000163566	0.680813504	0.31902293	.	0.10318	0.0917	-0.025608647	51.91672564	322.84124	3.81715	0.309	0.140	T	0.008	0.135	B	0.026	0.195	B	0.491	0.120	N	1	0.090	N	0.855	0.214	L	-0.23	0.667	T	-1.11	0.287	N	0.081	0.074	-0.956	0.400	T	0.189	0.541	T	0.012	0.299	T	0.576	0.149	7.987	0.896	0.184	0.268	0.229	N	c	-0.751	-0.708	1.000	0.473	0.490	0.173	0	1.08	0.194	0.375	0.201	0.059	0.165	0.997	0.399	0.510	0.273	4.931	0.132	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	34	11	124619690	chr11:124619690	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	124767067	124767067	T	C	exonic	ROBO4	.	nonsynonymous SNV	ROBO4:NM_019055:exon2:c.A161G:p.Q54R	1.67E-09	0.950296357	0.049703642	.	0.09052	0.12945	0.657639543	84.20028309	3167.49955	10.73314	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.292	0.147	N	1	0.228	P	-0.485	0.027	N	-0.25	0.670	T	1.4	0.008	N	0.022	0.007	-0.933	0.438	T	0.000	0.000	T	.	.	.	-0.531	0.054	0.184	0.788	0.120	0.011	0.041	N	c	-1.108	-1.025	1.000	0.747	0.628	0.401	0	0.134	0.140	-0.495	0.065	0.016	0.142	0.000	0.063	0.883	0.370	10.126	0.416	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	ENSG00000254568.1|ENSG00000154133.10|ENSG00000154134.10|ENSG00000154134.10|ENSG00000154134.10|ENSG00000203306.3|ENSG00000154134.10|ENSG00000154134.10	Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid	0.5	67	133	11	124767067	chr11:124767067	T	C	67	PASS	DP=133;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	124946649	124946649	G	A	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	11	124946649	chr11:124946649	G	A	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	124951304	124951304	-	T	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	366	11	124951303	chr11:124951303	AT	ATT,A	72	PASS	DP=366;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
11	124951304	124951304	T	-	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	366	11	124951303	chr11:124951303	AT	ATT,A	72	PASS	DP=366;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
11	125505377	125505377	-	A	exonic	CHEK1	.	frameshift insertion	CHEK1:NM_001330427:exon6:c.716dupA:p.T242Nfs*18,CHEK1:NM_001330428:exon6:c.386dupA:p.T132Nfs*18,CHEK1:NM_001114121:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001114122:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001244846:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001274:exon7:c.668dupA:p.T226Nfs*18	0.00024911	0.982312119	0.017438771	.	0.99413	0.5268	-0.315847836	31.68789809	581.70191	4.88824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	247	11	125505377	chr11:125505377	G	GA	75	PASS	DP=247;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	128615242	128615284	CTCCCAGAAAATGGACCTCCCCAGGCCCCACCTCCCTCCATCA	-	intronic	FLI1	.	.	.	0.819814084	0.180006653	0.000179263	DISEASE: Ewing sarcoma (ES) [MIM:612219]: A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. {ECO:0000269|PubMed:1522903, ECO:0000269|PubMed:1765382}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving FLI1 is found in patients with Erwing sarcoma. Translocation t(11;22)(q24;q12) with EWSR1. {ECO:0000269|PubMed:1522903, ECO:0000269|PubMed:1765382}.; 	0.6145	.	-0.890882376	10.30313753	37.50769	1.11686	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.87	22	11	128615241	chr11:128615241	TCTCCCAGAAAATGGACCTCCCCAGGCCCCACCTCCCTCCATCA	T	13.87	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	130059634	130059634	C	T	exonic	ST14	.	synonymous SNV	ST14:NM_021978:exon5:c.C441T:p.S147S	0.852676553	0.147322586	8.62E-07	DISEASE: Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:17273967, ECO:0000269|PubMed:18843291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43903	0.33644	-0.347208386	29.59424393	1268.8342	6.71293	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	42	11	130059634	chr11:130059634	C	T	72	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	132306153	132306153	T	C	intronic	OPCML	.	.	.	0.578155981	0.419519453	0.002324566	DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:12819783}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.58428	0.18409	-0.359940251	28.93371078	18.89153	0.65266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	10	11	132306153	chr11:132306153	T	C	55	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	133788992	133788992	T	C	intronic	IGSF9B	.	.	.	0.999873394	0.000126606	5.70E-13	.	0.1331	.	.	.	323.26411	3.81929	0.0	0.912	D	0.027	0.182	B	0.031	0.206	B	.	.	.	0.999	0.219	P	.	.	.	0.33	0.583	T	-0.46	0.150	N	0.217	0.399	-0.967	0.379	T	0.000	0.000	T	.	.	.	1.330	0.224	12.42	0.891	0.179	0.947	0.619	D	c	-0.450	-0.219	0.999	0.383	0.495	0.175	0	4.63	0.570	3.385	0.520	1.061	0.807	1.000	0.715	1.000	0.888	8.856	0.342	.	.	.	0.5	78	89	11	133788992	chr11:133788992	T	C	78	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	208258	208258	G	T	intronic	IQSEC3	.	.	.	0.925104239	0.074895032	7.29E-07	.	0.52569	.	-0.839512508	11.40009436	1171.33568	6.50545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	64	12	208258	chr12:208258	G	T	89	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	2602441	2602441	C	A	exonic	CACNA1C	.	synonymous SNV	CACNA1C:NM_000719:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129827:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129829:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129830:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129831:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129832:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129833:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129834:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129835:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129836:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129837:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129838:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129839:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129840:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129841:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129842:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129843:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129844:exon7:c.C993A:p.P331P,CACNA1C:NM_001129846:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167623:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167624:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167625:exon7:c.C1002A:p.P334P,CACNA1C:NM_199460:exon7:c.C1002A:p.P334P	0.999998433	1.57E-06	4.37E-21	DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism. {ECO:0000269|PubMed:15454078, ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:25260352}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66288	0.13071	-2.087541484	1.574663836	257.23512	3.4497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	160	12	2602441	chr12:2602441	C	A	94	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	2764329	2764410	CCCTGAATGATACCACAGAGATCAACCGGAACAACAACTTTCAGACCTTCCCCCAGGCCGTGCTGCTCCTCTTCAGGTGGGT	-	exonic	CACNA1C	.	frameshift deletion	CACNA1C:NM_001129837:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_001129838:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_001129839:exon33:c.4118_4193del:p.A1373Gfs*55,CACNA1C:NM_001129846:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_001167625:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_000719:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129829:exon34:c.4223_4298del:p.A1408Gfs*55,CACNA1C:NM_001129830:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129833:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129834:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129835:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129836:exon34:c.4208_4283del:p.A1403Gfs*55,CACNA1C:NM_001129840:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129841:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129842:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129843:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129844:exon34:c.4148_4223del:p.A1383Gfs*55,CACNA1C:NM_001167623:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001167624:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129831:exon35:c.4241_4316del:p.A1414Gfs*55,CACNA1C:NM_001129832:exon35:c.4217_4292del:p.A1406Gfs*55,CACNA1C:NM_001129827:exon36:c.4301_4376del:p.A1434Gfs*55,CACNA1C:NM_199460:exon36:c.4301_4376del:p.A1434Gfs*55	0.999998433	1.57E-06	4.37E-21	DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism. {ECO:0000269|PubMed:15454078, ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:25260352}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66288	0.13071	-2.087541484	1.574663836	257.23512	3.4497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	53	12	2764328	chr12:2764328	GCCCTGAATGATACCACAGAGATCAACCGGAACAACAACTTTCAGACCTTCCCCCAGGCCGTGCTGCTCCTCTTCAGGTGGGT	G	71	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	2929867	2929867	T	C	intronic	ITFG2	.	.	.	1.39E-06	0.833434348	0.166564262	.	0.12392	0.08912	-0.824740496	11.67728238	49.68317	1.3815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	87	12	2929867	chr12:2929867	T	C	72	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	2996987	2996987	C	T	intronic	RHNO1	.	.	.	0.000558185	0.704918917	0.294522899	.	0.10242	.	.	.	34.24976	1.04792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	12	2996987	chr12:2996987	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	4410589	4410589	C	T	UTR3	CCND2	NM_001759:c.*1414C>T	.	.	0.949000818	0.050836062	0.000163119	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]: A syndrome characterized by megalencephaly, ventriculomegaly that may lead to hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:24705253}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93215	0.74954	-0.185391282	39.67916962	14.77663	0.53228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	101	12	4410589	chr12:4410589	C	T	70	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	4410611	4410611	C	T	UTR3	CCND2	NM_001759:c.*1436C>T	.	.	0.949000818	0.050836062	0.000163119	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]: A syndrome characterized by megalencephaly, ventriculomegaly that may lead to hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:24705253}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93215	0.74954	-0.185391282	39.67916962	14.77663	0.53228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	12	4410611	chr12:4410611	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	4411082	4411082	-	T	UTR3	CCND2	NM_001759:c.*1907_*1908insT	.	.	0.949000818	0.050836062	0.000163119	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3) [MIM:615938]: A syndrome characterized by megalencephaly, ventriculomegaly that may lead to hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:24705253}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93215	0.74954	-0.185391282	39.67916962	14.77663	0.53228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	44	12	4411082	chr12:4411082	G	GT	42	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	5155256	5155256	A	T	UTR3	KCNA5	NM_002234:c.*101A>T	.	.	0.000687392	0.747420322	0.251892286	DISEASE: Atrial fibrillation, familial, 7 (ATFB7) [MIM:612240]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:16772329}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24009	0.20636	0.799205007	87.58551545	249.24831	3.40181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	12	5155256	chr12:5155256	A	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	5603607	5603607	G	A	exonic	NTF3	.	nonsynonymous SNV	NTF3:NM_002527:exon1:c.G227A:p.G76E,NTF3:NM_001102654:exon2:c.G266A:p.G89E	0.854440385	0.145066088	0.000493527	.	0.35201	0.52992	-0.073340031	48.11866006	726.21579	5.34917	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.018	0.276	N	1	0.090	P	-1.885	0.002	N	1.1	0.390	T	0.61	0.025	N	0.017	0.012	-1.022	0.230	T	0.000	0.000	T	.	.	.	-0.365	0.064	0.470	0.473	0.038	0.049	0.106	N	c	-1.009	-0.768	1.000	0.454	0.554	0.283	0	4.84	0.620	1.883	0.391	0.202	0.252	0.946	0.326	0.227	0.223	9.911	0.404	.	.	.	0.5	158	507	12	5603607	chr12:5603607	G	A	158	PASS	DP=507;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	6551754	6551755	CC	-	ncRNA_intronic	CD27-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	49	12	6551753	chr12:6551753	GCC	G	72	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	7805236	7805236	C	G	exonic	APOBEC1	.	nonsynonymous SNV	APOBEC1:NM_005889:exon2:c.G105C:p.M35I,APOBEC1:NM_001644:exon3:c.G240C:p.M80I,APOBEC1:NM_001304566:exon4:c.G240C:p.M80I	0.000144862	0.654645151	0.345209988	.	0.12544	0.14891	1.126294249	92.16206653	82.9695	1.93477	0.569	0.062	T	0.0	0.026	B	0.0	0.013	B	0.804	0.068	N	1	0.090	P	-1.95	0.002	N	-0.03	0.631	T	-0.35	0.129	N	0.051	0.032	-0.972	0.369	T	0.000	0.000	T	.	.	.	-0.248	0.072	0.868	0.572	0.056	0.001	0.007	N	c	-1.290	-1.189	0.000	0.012	0.487	0.133	0	2.61	0.301	-0.182	0.096	-0.371	0.067	0.000	0.063	0.025	0.141	4.417	0.108	APOBEC-like, N-terminal|APOBEC/CMP deaminase, zinc-binding|Cytidine and deoxycytidylate deaminases, zinc-binding|Cytidine deaminase-like	.	.	0.5	43	5	12	7805236	chr12:7805236	C	G	43	PASS	DP=5;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
12	7864192	7864192	C	T	exonic	DPPA3	.	nonsynonymous SNV	DPPA3:NM_199286:exon1:c.C26T:p.T9I	0.165194336	0.772640391	0.062165272	.	0.02429	0.07229	0.591694063	82.45458835	39.72884	1.1709	0.021	0.491	D	0.999	0.764	D	0.964	0.693	D	.	.	.	1	0.090	N	1.995	0.543	M	0.81	0.485	T	-3.58	0.691	D	0.194	0.238	-1.003	0.291	T	0.154	0.484	T	0.003	0.070	T	3.077	0.430	22.5	0.977	0.349	0.032	0.082	N	c	-0.473	-0.689	0.000	0.035	0.487	0.133	0	1.91	0.247	0.624	0.240	-0.042	0.124	0.003	0.159	0.002	0.062	7.119	0.245	.	.	.	0.5	67	106	12	7864192	chr12:7864192	C	T	67	PASS	DP=106;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	7864223	7864223	C	T	exonic	DPPA3	.	synonymous SNV	DPPA3:NM_199286:exon1:c.C57T:p.T19T	0.165194336	0.772640391	0.062165272	.	0.02429	0.07229	0.591694063	82.45458835	39.72884	1.1709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	12	7864223	chr12:7864223	C	T	.	PASS	DP=47;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	8074168	8074168	A	G	exonic	SLC2A3	.	synonymous SNV	SLC2A3:NM_006931:exon10:c.T1332C:p.A444A	0.519822946	0.47941858	0.000758474	.	0.35764	0.14971	0.619191319	83.36282142	55.14143	1.4881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	50	12	8074168	chr12:8074168	A	G	61	PASS	DP=50;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	8082367	8082367	T	C	exonic	SLC2A3	.	synonymous SNV	SLC2A3:NM_006931:exon6:c.A774G:p.L258L	0.519822946	0.47941858	0.000758474	.	0.35764	0.14971	0.619191319	83.36282142	55.14143	1.4881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	174	12	8082367	chr12:8082367	T	C	90	PASS	DP=174;AN=4	GT	0/1	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	8287231	8287231	T	C	ncRNA_exonic	POU5F1P3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	950	12	8287231	chr12:8287231	T	C	84	PASS	DP=950;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	9452017	9452017	C	A	ncRNA_exonic	LOC642846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	491	12	9452017	chr12:9452017	C	A	165	PASS	DP=491;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	9590651	9590651	-	CTGAGTAAC	ncRNA_exonic	DDX12P	.	.	.	.	.	.	.	.	0.11668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	57	12	9590651	chr12:9590651	A	ACTGAGTAAC	40	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	10783729	10783729	A	G	exonic	STYK1	.	synonymous SNV	STYK1:NM_018423:exon5:c.T366C:p.S122S	1.54E-05	0.860451491	0.139533145	.	0.30034	0.11766	0.176444282	66.07100731	48.89567	1.36414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	15	12	10783729	chr12:10783729	A	G	43	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	11461745	11461745	G	C	exonic	PRB4	.	nonsynonymous SNV	PRB4:NM_001261399:exon3:c.C172G:p.Q58E,PRB4:NM_002723:exon3:c.C172G:p.Q58E	8.85E-08	0.165369218	0.834630694	.	.	.	1.352234299	94.36777542	885.28057	5.79602	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	.	.	.	3.57	0.047	T	-0.53	0.170	N	0.055	0.097	-0.910	0.469	T	0.007	0.026	T	.	.	.	-3.199	0.001	0.001	0.119	0.002	0.002	0.013	N	c	-2.314	-2.369	0.000	0.042	0.554	0.246	0	-1.49	0.082	-2.301	0.012	-4.823	0.000	0.000	0.063	0.000	0.016	8.663	0.331	.	.	.	0.5	91	81	12	11461745	chr12:11461745	G	C	91	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	11506830	11506830	T	C	exonic	PRB1	.	synonymous SNV	PRB1:NM_199353:exon3:c.A207G:p.Q69Q,PRB1:NM_199354:exon3:c.A207G:p.Q69Q	2.09E-05	0.477852486	0.522126593	.	.	.	0.305084559	72.22811984	318.00442	3.78677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	155	12	11506830	chr12:11506830	T	C	80	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	11546686	11546686	C	T	exonic	PRB2	.	nonsynonymous SNV	PRB2:NM_006248:exon3:c.G326A:p.R109Q	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	0.092	0.237	B	0.002	0.063	B	.	.	.	1	0.090	P	-1.265	0.007	N	3.71	0.041	T	-0.04	0.076	N	0.093	0.092	-0.976	0.359	T	0.003	0.010	T	.	.	.	-0.596	0.050	0.128	0.427	0.031	0.000	0.003	N	c	-2.034	-2.056	0.000	0.042	0.554	0.246	0	-2.46	0.061	-2.259	0.013	-0.819	0.031	0.000	0.063	0.001	0.043	2.776	0.050	.	.	.	0.5	95	145	12	11546686	chr12:11546686	C	T	95	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	11546856	11546858	AGA	-	exonic	PRB2	.	nonframeshift deletion	PRB2:NM_006248:exon3:c.154_156del:p.S52del	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	157	12	11546855	chr12:11546855	GAGA	G	70	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	11546875	11546875	T	C	exonic	PRB2	.	nonsynonymous SNV	PRB2:NM_006248:exon3:c.A137G:p.K46R	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	0.938	0.506	P	0.188	0.346	B	.	.	.	1	0.090	N	1.1	0.281	L	3.61	0.045	T	-0.44	0.146	N	0.064	0.049	-0.945	0.418	T	0.005	0.018	T	0.000	0.002	T	-1.470	0.018	0.003	0.544	0.050	0.006	0.026	N	c	-1.017	-1.168	0.000	0.012	0.554	0.246	0	0.037	0.134	0.495	0.220	-0.566	0.046	0.001	0.137	0.000	0.016	5.784	0.175	.	.	.	0.5	42	127	12	11546875	chr12:11546875	T	C	42	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	12356138	12356138	G	A	exonic	LRP6	.	nonsynonymous SNV	LRP6:NM_002336:exon3:c.C646T:p.R216W	0.99997833	2.17E-05	5.31E-19	DISEASE: Coronary artery disease, autosomal dominant, 2 (ADCAD2) [MIM:610947]: A common heart disease characterized by reduced or absent blood flow in one or more of the arteries that encircle and supply the heart. Its most important complication is acute myocardial infarction. {ECO:0000269|PubMed:17332414}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47246	0.47221	-1.699477247	2.565463553	589.91488	4.92398	0.0	0.912	D	1.0	0.899	D	0.997	0.971	D	0.000	0.559	D	1	0.810	D	3.89	0.961	H	-4.48	0.976	D	-6.48	0.958	D	0.354	0.951	1.085	0.991	D	0.964	0.988	D	0.423	0.939	D	6.650	0.912	32	0.999	0.979	0.921	0.546	D	c	0.657	0.530	0.893	0.259	0.732	0.924	0	3.63	0.406	2.155	0.417	1.048	0.713	1.000	0.715	0.999	0.750	14.560	0.676	Six-bladed beta-propeller, TolB-like	.	.	0.5	41	35	12	12356138	chr12:12356138	G	A	41	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	14650683	14650683	G	T	exonic	ATF7IP	.	nonsynonymous SNV	ATF7IP:NM_001286514:exon15:c.G3486T:p.K1162N,ATF7IP:NM_018179:exon15:c.G3489T:p.K1163N,ATF7IP:NM_181352:exon15:c.G3513T:p.K1171N	0.999741038	0.000258962	3.26E-12	.	0.67749	0.10619	0.473967469	78.86293937	7630.06967	18.76351	0.001	0.784	D	0.996	0.670	D	0.985	0.749	D	0.003	0.358	N	1.000	0.537	D	1.73	0.448	L	1.54	0.301	T	-3.3	0.658	D	0.451	0.504	-1.006	0.283	T	0.117	0.414	T	0.028	0.505	D	3.711	0.503	23.3	0.998	0.896	0.989	0.886	D	c	0.305	0.313	0.894	0.259	0.707	0.730	0	4.04	0.461	3.383	0.520	-0.197	0.102	1.000	0.715	0.998	0.697	9.328	0.370	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	102	206	12	14650683	chr12:14650683	G	T	102	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	14930344	14930344	G	C	UTR3	H2AFJ	NM_177925:c.*2550G>C	.	.	0.765927442	0.225697347	0.008375211	.	0.87835	0.13522	0.147123112	64.11299835	3.65353	0.13509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	49	12	14930344	chr12:14930344	G	C	82	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	14941935	14941935	C	-	exonic	WBP11	.	frameshift deletion	WBP11:NM_016312:exon11:c.1442delG:p.G481Vfs*25	0.999928146	7.19E-05	1.73E-11	.	0.58677	0.11579	-0.137658575	43.57159707	100.52915	2.1724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	28	12	14941934	chr12:14941934	AC	A	60	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	14952533	14952533	T	C	intronic	WBP11	.	.	.	0.999928146	7.19E-05	1.73E-11	.	0.58677	0.11579	-0.137658575	43.57159707	100.52915	2.1724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	60	12	14952533	chr12:14952533	T	C	58	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	15702158	15702158	T	A	exonic	PTPRO	.	nonsynonymous SNV	PTPRO:NM_030668:exon2:c.T2A:p.M1K,PTPRO:NM_030669:exon2:c.T2A:p.M1K,PTPRO:NM_030670:exon2:c.T2A:p.M1K,PTPRO:NM_030671:exon2:c.T2A:p.M1K,PTPRO:NM_002848:exon14:c.T2435A:p.M812K,PTPRO:NM_030667:exon14:c.T2435A:p.M812K	0.30462609	0.695373854	5.61E-08	DISEASE: Nephrotic syndrome 6 (NPHS6) [MIM:614196]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. {ECO:0000269|PubMed:21722858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57353	.	-1.965936983	1.828261382	172.96294	2.86316	0.008	0.912	D	0.118	0.392	B	0.01	0.331	B	0.000	0.629	D	0.759	0.367	D	1.5	0.380	L	3.86	0.041	T	-1.22	0.543	N	0.809	0.798	-0.940	0.427	T	0.009	0.031	T	0.009	0.240	T	4.555	0.610	24.4	0.963	0.287	0.982	0.801	D	c	-0.019	0.148	0.999	0.372	0.706	0.609	0	4.63	0.570	3.957	0.562	1.061	0.807	1.000	0.715	1.000	0.888	14.514	0.673	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	75	39	12	15702158	chr12:15702158	T	A	75	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
12	21639499	21639499	G	T	exonic	RECQL	.	nonsynonymous SNV	RECQL:NM_002907:exon5:c.C415A:p.P139T,RECQL:NM_032941:exon6:c.C415A:p.P139T	7.14E-13	0.063180525	0.936819475	.	0.96604	0.29029	-0.973616687	8.8995046	602.74519	4.96976	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.72	0.995	H	0.53	0.551	T	-7.74	0.965	D	0.962	0.961	0.629	0.923	D	0.600	0.858	D	0.061	0.682	D	5.884	0.807	27.4	0.998	0.860	0.991	0.913	D	c	1.183	1.068	1.000	0.747	0.732	0.924	0	5.63	0.861	9.044	0.932	1.029	0.652	1.000	0.715	0.993	0.574	19.710	0.961	DEAD/DEAH box helicase domain|Helicase superfamily 1/2, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	46	12	21639499	chr12:21639499	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	21661377	21661377	T	C	exonic	GOLT1B	.	nonsynonymous SNV	GOLT1B:NM_016072:exon3:c.T178C:p.F60L	0.79838372	0.196019029	0.005597252	.	0.20274	0.11262	0.501689326	79.7888653	47.70445	1.342	0.08	0.501	T	0.127	0.254	B	0.241	0.369	B	0.000	0.843	D	1	0.810	D	1.585	0.400	L	0.9	0.453	T	-5.3	0.844	D	0.814	0.802	-0.890	0.489	T	0.155	0.487	T	0.012	0.312	T	6.079	0.837	28.2	0.999	0.984	0.987	0.862	D	c	0.316	0.464	1.000	0.747	0.719	0.830	0	5.9	0.949	7.972	0.875	1.042	0.661	1.000	0.715	0.998	0.697	16.332	0.828	.	.	.	0.5	107	44	12	21661377	chr12:21661377	T	C	107	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	21958999	21958999	A	-	intronic	ABCC9	.	.	.	0.000700543	0.999299455	2.34E-09	DISEASE: Cardiomyopathy, dilated 1O (CMD1O) [MIM:608569]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15034580}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 12 (ATFB12) [MIM:614050]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:17245405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]: A rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. The hypertrichosis leads to thick scalp hair, which extends onto the forehead, and a general increase in body hair. In addition, macrocephaly and coarse facial features, including a broad nasal bridge, epicanthal folds, a wide mouth, and full lips, can be suggestive of a storage disorder. About half of affected individuals are macrosomic and edematous at birth, whereas in childhood they usually have a muscular appearance with little subcutaneous fat. Thickened calvarium, narrow thorax, wide ribs, flattened or ovoid vertebral bodies, coxa valga, osteopenia, enlarged medullary canals, and metaphyseal widening of long bones have been reported. Cardiac manifestations such as patent ductus arteriosus, ventricular hypertrophy, pulmonary hypertension, and pericardial effusions are present in approximately 80% of cases. Motor development is usually delayed due to hypotonia. Most patients have a mild speech delay, and a small percentage have learning difficulties or intellectual disability. {ECO:0000269|PubMed:22608503, ECO:0000269|PubMed:22610116}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11236	0.15685	-1.967739992	1.816466148	117.11773	2.35297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	16	12	21958998	chr12:21958998	CA	C	50	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	25361202	25361202	G	A	UTR3	KRAS	NM_033360:c.*1648C>T;NM_004985:c.*1527C>T	.	.	0.001061193	0.603148256	0.395790551	DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269|PubMed:8955068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:17332249}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:16773572, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:17468812, ECO:0000269|PubMed:19396835}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:7773929}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. {ECO:0000269|PubMed:16247081}.; DISEASE: Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. {ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:21797849}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRAS mutations are involved in cancer development. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:1553789, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:3627975, ECO:0000269|PubMed:6092920, ECO:0000269|PubMed:6695174, ECO:0000269|PubMed:7773929}.; 	0.99997	0.53296	-0.141298762	42.87567823	3.46519	0.12617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	12	25361202	chr12:25361202	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	25361440	25361440	A	-	UTR3	KRAS	NM_033360:c.*1410delT;NM_004985:c.*1289delT	.	.	0.001061193	0.603148256	0.395790551	DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269|PubMed:8955068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:17332249}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:16773572, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:17468812, ECO:0000269|PubMed:19396835}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:7773929}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. {ECO:0000269|PubMed:16247081}.; DISEASE: Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. {ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:21797849}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRAS mutations are involved in cancer development. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:1553789, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:3627975, ECO:0000269|PubMed:6092920, ECO:0000269|PubMed:6695174, ECO:0000269|PubMed:7773929}.; 	0.99997	0.53296	-0.141298762	42.87567823	3.46519	0.12617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	545	12	25361439	chr12:25361439	TA	T	74	PASS	DP=545;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
12	26834804	26834804	-	ACTC	intronic	ITPR2	.	.	.	5.74E-11	1	2.30E-12	DISEASE: Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190]: An autosomal recessive disorder characterized by generalized, isolated anhidrosis, severe heat intolerance, and morphologically normal eccrine sweat glands. Body growth, teeth, hair, nails, and skin are normal. {ECO:0000269|PubMed:25329695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90112	0.20622	-1.641009998	2.777777778	698.25496	5.25954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	82	12	26834804	chr12:26834804	T	TACTC	90	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	27109508	27109508	C	A	exonic	FGFR1OP2	.	synonymous SNV	FGFR1OP2:NM_001171887:exon3:c.C168A:p.V56V,FGFR1OP2:NM_001171888:exon3:c.C168A:p.V56V,FGFR1OP2:NM_015633:exon3:c.C168A:p.V56V	0.429728003	0.568760515	0.001511482	.	0.16605	0.12716	-0.361761279	28.6329323	26.47953	0.85687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	12	27109508	chr12:27109508	C	A	.	PASS	DP=52;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	27461257	27461257	-	T	intronic	STK38L	.	.	.	0.965893632	0.034103905	2.46E-06	.	0.72805	0.12607	-0.361761279	28.6329323	9.52509	0.35064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	307	12	27461257	chr12:27461257	G	GT	84	PASS	DP=307;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	27648786	27648786	A	G	exonic	SMCO2	.	synonymous SNV	SMCO2:NM_001145010:exon8:c.A831G:p.A277A	.	.	.	.	.	.	0.881944684	89.02453409	398.02888	4.19168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	26	12	27648786	chr12:27648786	A	G	97	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	29486506	29486507	AG	-	intronic	FAR2	.	.	.	0.922173888	0.077806487	1.96E-05	.	0.11607	0.13485	-0.844966979	11.1759849	59.26666	1.56096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.87	39	12	29486505	chr12:29486505	CAG	C,CTAG	16.87	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	29486505	29486505	-	T	intronic	FAR2	.	.	.	0.922173888	0.077806487	1.96E-05	.	0.11607	0.13485	-0.844966979	11.1759849	59.26666	1.56096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.87	39	12	29486505	chr12:29486505	CAG	C,CTAG	16.87	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	29521181	29521181	C	A	exonic	ERGIC2	.	nonsynonymous SNV	ERGIC2:NM_016570:exon4:c.G255T:p.K85N	0.320357206	0.678925092	0.000717702	.	0.84052	0.08503	-0.339715008	30.06605331	9.56131	0.35232	0.098	0.318	T	0.563	0.365	P	0.487	0.454	P	0.000	0.559	D	0.915	0.365	D	2.38	0.688	M	.	.	.	-2.07	0.537	N	0.192	0.282	-0.273	0.758	T	0.327	0.696	T	0.010	0.257	T	5.379	0.729	25.9	0.998	0.917	0.953	0.640	D	c	0.319	0.368	0.059	0.152	0.732	0.924	0	5.37	0.769	0.998	0.291	0.875	0.382	1.000	0.715	1.000	0.888	16.644	0.850	.	.	.	0.5	.	57	12	29521181	chr12:29521181	C	A	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	29812859	29812859	A	T	intronic	TMTC1	.	.	.	3.06E-07	0.996221773	0.003777921	.	0.33022	0.13818	-0.418800956	25.79028073	1433.09079	7.06654	0.998	0.019	T	0.998	0.715	D	0.991	0.782	D	.	.	.	0.992	0.810	D	.	.	.	0.91	0.449	T	-0.81	0.223	N	0.309	0.465	-0.613	0.643	T	0.242	0.611	T	0.132	0.815	D	3.177	0.441	22.7	0.992	0.536	0.957	0.657	D	c	0.642	0.647	1.000	0.480	0.706	0.609	0	5.4	0.779	7.390	0.789	1.088	0.866	1.000	0.715	0.998	0.697	11.814	0.513	Domain of unknown function DUF1736	.	.	0.5	.	25	12	29812859	chr12:29812859	A	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	31289663	31289663	A	-	intergenic	DDX11;FAM60A	dist=31938;dist=143857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	22	12	31289662	chr12:31289662	TA	T	58	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	31595764	31595764	C	A	exonic	DENND5B	.	nonsynonymous SNV	DENND5B:NM_144973:exon7:c.G1957T:p.G653W,DENND5B:NM_001308339:exon9:c.G2062T:p.G688W	0.999945504	5.45E-05	3.62E-13	.	.	.	-0.440847477	24.59896202	5379.04327	15.1245	0.001	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.695	0.791	M	3.38	0.098	T	-4.2	0.778	D	0.897	0.897	-1.050	0.143	T	0.092	0.352	T	0.024	0.470	T	7.733	0.955	35	0.996	0.754	0.981	0.796	D	c	0.796	0.752	1.000	0.747	0.706	0.609	0	4.77	0.603	7.705	0.835	0.892	0.403	1.000	0.715	1.000	0.888	18.000	0.891	.	.	.	0.5	.	34	12	31595764	chr12:31595764	C	A	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	40001487	40001487	C	T	exonic	ABCD2	.	nonsynonymous SNV	ABCD2:NM_005164:exon3:c.G1150A:p.E384K	2.97E-06	0.927390257	0.072606773	.	0.08475	0.19889	-0.091746757	46.91554612	167.46052	2.82724	0.009	0.574	D	0.079	0.230	B	0.12	0.306	B	0.000	0.523	D	1.000	0.588	D	2.065	0.569	M	-4.36	0.973	D	-2.96	0.617	D	0.652	0.666	0.689	0.930	D	0.860	0.953	D	0.340	0.920	D	5.539	0.753	26.3	0.998	0.916	0.984	0.818	D	c	0.170	0.328	1.000	0.747	0.651	0.465	0	5.24	0.728	7.505	0.804	0.935	0.490	1.000	0.715	0.995	0.604	18.842	0.921	.	.	.	0.5	.	34	12	40001487	chr12:40001487	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	40011027	40011027	T	-	intronic	ABCD2	.	.	.	2.97E-06	0.927390257	0.072606773	.	0.08475	0.19889	-0.091746757	46.91554612	167.46052	2.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	16	12	40011025	chr12:40011025	CTT	CT,C	76	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
12	40011026	40011027	TT	-	intronic	ABCD2	.	.	.	2.97E-06	0.927390257	0.072606773	.	0.08475	0.19889	-0.091746757	46.91554612	167.46052	2.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	16	12	40011025	chr12:40011025	CTT	CT,C	76	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
12	40924177	40924177	G	A	intronic	MUC19	.	.	.	.	.	.	.	0.11557	.	.	.	41933.48624	39.90294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	12	40924177	chr12:40924177	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	40928541	40928541	G	A	exonic	MUC19	.	unknown	UNKNOWN	.	.	.	.	0.11557	.	.	.	41933.48624	39.90294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	12	40928541	chr12:40928541	G	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	43945629	43945629	T	-	intronic	ADAMTS20	.	.	.	4.85E-26	0.78318392	0.21681608	.	0.14489	0.09297	-0.753453827	13.58221279	1152.89729	6.46984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	70	12	43945628	chr12:43945628	CT	C	71	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	48174043	48174043	C	T	exonic	SLC48A1	.	synonymous SNV	SLC48A1:NM_017842:exon3:c.C420T:p.I140I	0.437511991	0.457729968	0.104758041	.	.	.	.	.	3.1238	0.11179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	219	12	48174043	chr12:48174043	C	T	52	PASS	DP=219;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	48184255	48184256	AG	-	intronic	HDAC7	.	.	.	0.998019873	0.001980126	4.64E-10	.	0.1103	.	-0.038558137	50.51899033	940.4494	5.94619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	51	12	48184254	chr12:48184254	AAG	A	53	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	48191101	48191101	C	T	intronic	HDAC7	.	.	.	0.998019873	0.001980126	4.64E-10	.	0.1103	.	-0.038558137	50.51899033	940.4494	5.94619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	212	12	48191101	chr12:48191101	C	T	76	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	48298283	48298283	C	G	intronic	VDR	.	.	.	0.392125212	0.605864041	0.002010747	DISEASE: Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]: A disorder of vitamin D metabolism resulting in severe rickets, hypocalcemia and secondary hyperparathyroidism. Most patients have total alopecia in addition to rickets. {ECO:0000269|PubMed:1652893, ECO:0000269|PubMed:2177843, ECO:0000269|PubMed:2849209, ECO:0000269|PubMed:7828346, ECO:0000269|PubMed:8106618, ECO:0000269|PubMed:8381803, ECO:0000269|PubMed:8392085, ECO:0000269|PubMed:8675579, ECO:0000269|PubMed:8961271, ECO:0000269|PubMed:9005998}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28629	0.77234	-0.622676946	17.30950696	55.75589	1.49969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	36	12	48298283	chr12:48298283	C	G	69	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	49398697	49398697	G	A	ncRNA_intronic	DDN-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	12	49398697	chr12:49398697	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	49691392	49691392	C	G	ncRNA_exonic	LOC101927267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	44	12	49691392	chr12:49691392	C	G	73	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	50026779	50026779	-	C	intronic	PRPF40B	.	.	.	0.988653394	0.011346606	2.74E-10	.	0.46946	0.08281	-1.460519861	3.809860816	70.83292	1.75248	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	285	12	50026779	chr12:50026779	G	GC	85	PASS	DP=285;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	50149603	50149603	C	G	intronic	TMBIM6	.	.	.	0.016169744	0.959289242	0.024541014	.	0.09972	0.13992	-0.251530012	35.42108988	61.1273	1.59193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	57	12	50149603	chr12:50149603	C	G	53	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	51796890	51796941	TTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	-	intronic	SLC4A8	.	.	.	0.999867374	0.000132626	6.38E-13	.	0.07064	0.11699	-0.799052816	12.45576787	53.47821	1.45321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	53	12	51796889	chr12:51796889	ATTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	A	133	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
12	52389579	52389579	C	G	UTR3	ACVR1B	NM_020328:c.*1685C>G;NM_004302:c.*1685C>G;NM_020327:c.*1685C>G	.	.	0.998904331	0.001095656	1.32E-08	DISEASE: Note=ACVRIB is abundantly expressed in systemic sclerosis patient fibroblasts and production of collagen is also induced by activin-A/INHBA. This suggests that the activin/ACRV1B signaling mechanism is involved in systemic sclerosis. {ECO:0000269|PubMed:21377836}.; 	0.88541	0.29686	-0.405853867	26.23260203	17.03945	0.59931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	12	52389579	chr12:52389579	C	G	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	52409427	52409500	CCCAGCGGGCCCCCAGGGGCATCAGGTGCTGGTCCTCCTCCCTCCTGGCCTCGACCCCTAAGGGCTTCGCCCCT	-	UTR3	GRASP	NM_181711:c.*444_*517delCCCAGCGGGCCCCCAGGGGCATCAGGTGCTGGTCCTCCTCCCTCCTGGCCTCGACCCCTAAGGGCTTCGCCCCT;NM_001271856:c.*444_*517delCCCAGCGGGCCCCCAGGGGCATCAGGTGCTGGTCCTCCTCCCTCCTGGCCTCGACCCCTAAGGGCTTCGCCCCT	.	.	0.930936502	0.068992108	7.14E-05	.	0.64717	0.15222	.	.	95.16207	2.10482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	25	12	52409426	chr12:52409426	ACCCAGCGGGCCCCCAGGGGCATCAGGTGCTGGTCCTCCTCCCTCCTGGCCTCGACCCCTAAGGGCTTCGCCCCT	A	41	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	52841672	52841672	C	T	exonic	KRT6B	.	synonymous SNV	KRT6B:NM_005555:exon7:c.G1314A:p.K438K	0.004792655	0.966239227	0.028968117	.	0.12487	.	-0.304932527	32.24817174	532.75963	4.70795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	131	12	52841672	chr12:52841672	C	T	.	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	52886478	52886478	T	C	exonic	KRT6A	.	synonymous SNV	KRT6A:NM_005554:exon1:c.A495G:p.E165E	0.948763036	0.051203361	3.36E-05	.	0.31132	0.27311	0.714657953	85.81623024	2798.4726	9.98404	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	255	12	52886478	chr12:52886478	T	C	123	PASS	DP=255;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	52912805	52912805	C	T	exonic	KRT5	.	nonsynonymous SNV	KRT5:NM_000424:exon2:c.G695A:p.S232N	0.469327658	0.529553221	0.001119121	DISEASE: Epidermolysis bullosa simplex, Dowling-Meara type (DM- EBS) [MIM:131760]: A severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement. {ECO:0000269|PubMed:10730767, ECO:0000269|PubMed:12655565, ECO:0000269|PubMed:1372711, ECO:0000269|PubMed:16786515, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:8757772, ECO:0000269|PubMed:9036937, ECO:0000269|PubMed:9406827, ECO:0000269|PubMed:9989794, ECO:0000269|Ref.16}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, with migratory circinate erythema (EBSMCE) [MIM:609352]: A form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, Weber-Cockayne type (WC- EBS) [MIM:131800]: A form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin. {ECO:0000269|PubMed:10782015, ECO:0000269|PubMed:12655565, ECO:0000269|PubMed:12707098, ECO:0000269|PubMed:14723728, ECO:0000269|PubMed:15140024, ECO:0000269|PubMed:15347343, ECO:0000269|PubMed:16786515, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:7506097, ECO:0000269|PubMed:7520042, ECO:0000269|PubMed:7688477, ECO:0000269|PubMed:8595431, ECO:0000269|PubMed:8807337, ECO:0000269|PubMed:9804357}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, Koebner type (K-EBS) [MIM:131900]: A form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, although it is less severe. {ECO:0000269|PubMed:11407988, ECO:0000269|PubMed:11973334, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:7534039, ECO:0000269|PubMed:7686424, ECO:0000269|PubMed:9740251, ECO:0000269|PubMed:9989794}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, with mottled pigmentation (MP-EBS) [MIM:131960]: A form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules. {ECO:0000269|PubMed:10494094, ECO:0000269|PubMed:16882168, ECO:0000269|PubMed:21623745, ECO:0000269|PubMed:8799157}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dowling-Degos disease 1 (DDD1) [MIM:179850]: An autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails. {ECO:0000269|PubMed:16465624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78233	0.59494	0.117584698	62.19037509	1967.54739	8.174	0.196	0.207	T	0.097	0.240	B	0.058	0.250	B	0.912	0.074	N	1	0.090	N	0.93	0.236	L	-2.38	0.883	D	-0.92	0.262	N	0.468	0.519	-0.570	0.660	T	0.494	0.808	T	0.058	0.671	D	-0.300	0.068	0.663	0.892	0.180	0.094	0.150	N	c	-0.855	-0.868	1.000	0.489	0.487	0.133	0	2.35	0.280	-0.042	0.119	0.852	0.362	0.000	0.063	0.059	0.170	8.049	0.296	.	.	.	0.5	.	208	12	52912805	chr12:52912805	C	T	.	PASS	DP=208;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	53045772	53045772	C	G	exonic	KRT2	.	nonsynonymous SNV	KRT2:NM_000423:exon1:c.G155C:p.G52A	0.067349919	0.929718637	0.002931445	DISEASE: Ichthyosis bullosa of Siemens (IBS) [MIM:146800]: A rare autosomal dominant skin disorder displaying a type of epidermolytic hyperkeratosis characterized by generalized erythema and extensive blistering from birth. Large, dark gray hyperkeratoses are observed in later weeks. The skin of IBS patients is unusually fragile and has a tendency to shed the outer layers of the epidermis, producing localized denuded areas (molting effect). IBS usually improves with age so that in most middle-aged patients the hyperkeratosis and keratotic lichenification is limited to the flexural folds of the major joints. {ECO:0000269|PubMed:10084318, ECO:0000269|PubMed:10233323, ECO:0000269|PubMed:10564334, ECO:0000269|PubMed:10620137, ECO:0000269|PubMed:10688369, ECO:0000269|PubMed:11167982, ECO:0000269|PubMed:11531804, ECO:0000269|PubMed:15949009, ECO:0000269|PubMed:7521371, ECO:0000269|PubMed:7524919, ECO:0000269|PubMed:8077693, ECO:0000269|PubMed:9036938, ECO:0000269|PubMed:9204966, ECO:0000269|PubMed:9804344, ECO:0000269|PubMed:9833038}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15783	0.10965	0.292133603	71.59707478	2551.90953	9.43604	0.129	0.268	T	0.956	0.527	P	0.409	0.430	B	.	.	.	0.625	0.327	D	1.405	0.356	L	-3.82	0.958	D	-1.19	0.303	N	0.306	0.366	0.587	0.917	D	0.777	0.924	D	0.061	0.684	D	1.351	0.226	12.53	0.969	0.308	0.781	0.382	D	c	-0.129	-0.229	0.084	0.159	0.497	0.185	0	3.9	0.441	-0.057	0.116	0.035	0.151	0.000	0.063	0.004	0.083	7.921	0.288	Keratin type II head	.	.	0.5	74	172	12	53045772	chr12:53045772	C	G	74	PASS	DP=172;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	53073971	53073973	ACC	-	exonic	KRT1	.	nonframeshift deletion	KRT1:NM_006121:exon1:c.160_162del:p.G54del	0.973618209	0.026380488	1.30E-06	DISEASE: Epidermolytic hyperkeratosis (EHK) [MIM:113800]: An autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth, erythroderma and blister formation diminish and hyperkeratoses develop. {ECO:0000269|PubMed:10232403, ECO:0000269|PubMed:10688370, ECO:0000269|PubMed:10844506, ECO:0000269|PubMed:11531804, ECO:0000269|PubMed:12406348, ECO:0000269|PubMed:1380725, ECO:0000269|PubMed:1381288, ECO:0000269|PubMed:21271994, ECO:0000269|PubMed:7507151, ECO:0000269|PubMed:7507152, ECO:0000269|PubMed:7512983, ECO:0000269|PubMed:9856846}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis hystrix, Curth-Macklin type (IHCM) [MIM:146590]: A genodermatosis with severe verrucous hyperkeratosis. Affected individuals manifest congenital verrucous black scale on the scalp, neck, and limbs with truncal erythema, palmoplantar keratoderma and keratoses on the lips, ears, nipples and buttocks. {ECO:0000269|PubMed:11286616}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Keratoderma, palmoplantar, non-epidermolytic (NEPPK) [MIM:600962]: A dermatological disorder characterized by well- demarcated hyperkeratosis is present over the palms and soles. A red band is frequently present at the periphery of the keratosis. It is usually non-transgredient, with a sharp demarcation of the lesions at the wrists. {ECO:0000269|PubMed:11286630, ECO:0000269|PubMed:7528239}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis annular epidermolytic (AEI) [MIM:607602]: A skin disorder resembling bullous congenital ichthyosiform erythroderma. Affected individuals present with bullous ichthyosis in early childhood and hyperkeratotic lichenified plaques in the flexural areas and extensor surfaces at later ages. The feature that distinguishes AEI from BCIE is dramatic episodes of flares of annular polycyclic plaques with scale, which coalesce to involve most of the body surface and can persist for several weeks or even months. {ECO:0000269|PubMed:10053007, ECO:0000269|PubMed:10597140}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Keratoderma, palmoplantar, striate 3 (SPPK3) [MIM:607654]: A dermatological disorder characterized by thickening of the stratum corneum and epidermal layers on palms and soles. There is no involvement of non-palmoplantar skin, and both hair and nails are normal. {ECO:0000269|PubMed:11982762}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.79851	0.61014	0.709197509	85.68058504	4311.14232	13.06797	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	44	12	53073970	chr12:53073970	TACC	T	51	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	53084970	53084970	G	T	exonic	KRT77	.	synonymous SNV	KRT77:NM_175078:exon9:c.C1716A:p.S572S	1.05E-06	0.785358392	0.214640555	.	0.11671	.	2.289361599	98.30738382	4908.5509	14.28597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	267	12	53084970	chr12:53084970	G	T	139	PASS	DP=267;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	54676165	54676165	-	T	ncRNA_intronic	HNRNPA1P10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	89	12	54676165	chr12:54676165	G	GT	64	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	56492265	56492266	CT	-	intronic	ERBB3	.	.	.	4.36E-06	0.9999955	1.41E-07	DISEASE: Lethal congenital contracture syndrome 2 (LCCS2) [MIM:607598]: A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS2 patients manifest craniofacial/ocular findings, lack of hydrops, multiple pterygia, and fractures, as well as a normal duration of pregnancy and a unique feature of a markedly distended urinary bladder (neurogenic bladder defect). The phenotype suggests a spinal cord neuropathic etiology. {ECO:0000269|PubMed:17701904}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.98417	0.53106	-0.655870776	16.12408587	704.71886	5.27522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	57	12	56492264	chr12:56492264	CCT	C	65	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	56622965	56622965	G	A	exonic	NABP2	.	nonsynonymous SNV	NABP2:NM_024068:exon7:c.G604A:p.G202S	0.956804648	0.043087592	0.00010776	.	0.29478	.	-0.141298762	42.87567823	1.67296	0.05407	0.01	0.564	D	1.0	0.899	D	0.987	0.759	D	0.000	0.629	D	1.000	0.480	D	0.975	0.246	L	-0.5	0.705	T	-2.38	0.524	N	0.57	0.618	-0.164	0.786	T	0.479	0.801	T	0.102	0.776	D	7.402	0.950	34	0.996	0.748	0.980	0.788	D	c	0.719	0.717	1.000	0.747	0.732	0.924	0	5.39	0.775	5.924	0.696	1.048	0.713	1.000	0.715	1.000	0.888	16.442	0.837	.	.	.	0.5	.	87	12	56622965	chr12:56622965	G	A	.	PASS	DP=87;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	56826840	56826840	G	A	exonic	TIMELESS	.	synonymous SNV	TIMELESS:NM_001330295:exon6:c.C501T:p.L167L,TIMELESS:NM_003920:exon6:c.C501T:p.L167L	1.04E-25	0.155176324	0.844823676	.	0.32396	0.2043	0.372852703	75.12974758	9968.9554	21.74053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	12	56826840	chr12:56826840	G	A	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	57522680	57522680	G	-	UTR5	LRP1	NM_002332:c.-68del-	.	.	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	417	12	57522679	chr12:57522679	TG	T	84	PASS	DP=417;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	57593101	57593101	G	A	exonic	LRP1	.	synonymous SNV	LRP1:NM_002332:exon61:c.G9783A:p.T3261T	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	44	12	57593101	chr12:57593101	G	A	65	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	57604120	57604120	G	A	exonic	LRP1	.	nonsynonymous SNV	LRP1:NM_002332:exon82:c.G12611A:p.C4204Y	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	0.0	0.912	D	0.998	0.715	D	0.991	0.782	D	0.000	0.843	D	1.000	0.588	D	4.215	0.979	H	1.6	0.286	T	-7.07	0.939	D	0.941	0.936	-0.201	0.777	T	0.288	0.660	T	0.036	0.571	D	6.395	0.883	29.6	0.991	0.528	0.923	0.551	D	c	0.905	0.797	1.000	0.747	0.672	0.522	0	4.44	0.530	7.637	0.823	1.048	0.713	1.000	0.715	1.000	0.888	16.366	0.831	EGF-like domain	.	.	0.5	62	47	12	57604120	chr12:57604120	G	A	62	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	57638386	57638386	T	A	exonic	STAC3	.	nonsynonymous SNV	STAC3:NM_001286257:exon6:c.A182T:p.Q61L,STAC3:NM_001286256:exon8:c.A623T:p.Q208L,STAC3:NM_145064:exon9:c.A740T:p.Q247L	0.004878302	0.989072823	0.006048875	DISEASE: Native American myopathy (NAM) [MIM:255995]: A disease characterized by congenital weakness and arthrogryposis, cleft palate, ptosis, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia provoked by anesthesia. {ECO:0000269|PubMed:23736855}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16182	0.10482	-0.137658575	43.57159707	50.70761	1.40292	0.26	0.165	T	0.01	0.144	B	0.004	0.093	B	0.104	0.197	N	0.750	0.306	N	1.15	0.294	L	1.62	0.282	T	-0.09	0.090	N	0.42	0.477	-1.018	0.244	T	0.021	0.087	T	0.008	0.226	T	2.404	0.350	18.85	0.973	0.329	0.810	0.402	D	c	-0.565	-0.295	1.000	0.500	0.706	0.609	0	3.87	0.437	0.181	0.166	0.964	0.580	0.991	0.370	1.000	0.888	6.628	0.219	SH3 domain	.	.	0.5	74	62	12	57638386	chr12:57638386	T	A	74	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	58090154	58090154	C	T	exonic	OS9	.	nonsynonymous SNV	OS9:NM_001261423:exon4:c.C400T:p.R134W,OS9:NM_001017956:exon5:c.C577T:p.R193W,OS9:NM_001017957:exon5:c.C577T:p.R193W,OS9:NM_001017958:exon5:c.C577T:p.R193W,OS9:NM_001261420:exon5:c.C577T:p.R193W,OS9:NM_006812:exon5:c.C577T:p.R193W	1.13E-07	0.933380259	0.066619628	.	.	.	-0.821100135	11.88369899	192.39758	3.00719	0.016	0.784	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.99	0.860	M	3.79	0.039	T	-4.9	0.902	D	0.81	0.900	-1.224	0.000	T	0.040	0.174	T	0.113	0.792	D	7.646	0.954	35	0.999	0.990	0.939	0.593	D	c	0.614	0.600	0.970	0.291	0.707	0.730	0	5.53	0.825	1.754	0.378	0.892	0.403	1.000	0.715	0.999	0.750	11.833	0.514	Glucosidase II beta subunit-like;Mannose-6-phosphate receptor binding domain	.	.	0.5	83	471	12	58090154	chr12:58090154	C	T	83	PASS	DP=471;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	58157466	58157466	G	T	exonic	CYP27B1	.	synonymous SNV	CYP27B1:NM_000785:exon8:c.C1341A:p.P447P	3.60E-06	0.806445692	0.193550707	.	0.09767	0.39937	-0.404032746	26.53338051	111.70148	2.30098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	12	58157466	chr12:58157466	G	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	62148744	62148744	G	T	exonic	FAM19A2	.	nonsynonymous SNV	FAM19A2:NM_178539:exon3:c.C168A:p.N56K	0.54745717	0.438689922	0.013852908	.	0.48543	0.09934	0.21326276	67.71644256	15.92723	0.56478	0.017	0.555	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.984	0.810	D	2.52	0.738	M	.	.	.	-5.93	0.895	D	0.352	0.415	-0.189	0.780	T	0.421	0.767	T	0.070	0.709	D	5.694	0.777	26.8	0.998	0.909	0.962	0.676	D	c	0.739	0.709	0.000	0.071	0.554	0.246	0	5.42	0.786	4.717	0.614	1.048	0.713	1.000	0.715	1.000	0.888	10.800	0.455	.	.	.	0.5	59	38	12	62148744	chr12:62148744	G	T	59	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	62799750	62799750	-	T	UTR3	USP15	NM_006313:c.*1595_*1596insT;NM_001252078:c.*1595_*1596insT;NM_001351166:c.*1595_*1596insT;NM_001351165:c.*1595_*1596insT;NM_001351164:c.*1595_*1596insT;NM_001351163:c.*1595_*1596insT;NM_001351159:c.*1595_*1596insT;NM_001351160:c.*1595_*1596insT	.	.	0.990365016	0.009634984	1.83E-10	.	0.80464	0.14896	-0.979072682	8.752064166	37.09012	1.10797	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	123	12	62799750	chr12:62799750	G	GT	64	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	64812755	64812755	T	-	exonic	XPOT	.	frameshift deletion	XPOT:NM_007235:exon6:c.370delT:p.F126Lfs*5	0.997933923	0.002066077	2.11E-11	.	0.58008	0.3831	-0.688817379	15.20405756	39.60468	1.16741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	32	12	64812754	chr12:64812754	GT	G	41	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	66152389	66152389	G	T	ncRNA_exonic	RPSAP52	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	253	12	66152389	chr12:66152389	G	T	110	PASS	DP=253;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	68946720	68946720	C	T	intergenic	LINC02384;RAP1B	dist=101456;dist=57899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	81	12	68946720	chr12:68946720	C	T	121	PASS	DP=81;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	70049190	70049190	C	T	exonic	BEST3	.	nonsynonymous SNV	BEST3:NM_152439:exon6:c.G865A:p.E289K,BEST3:NM_001282613:exon8:c.G1186A:p.E396K,BEST3:NM_032735:exon10:c.G1504A:p.E502K	3.69E-17	0.001380606	0.998619394	.	0.14764	0.10434	0.134171522	63.57041755	1059.3782	6.24526	0.001	0.784	D	0.999	0.764	D	0.994	0.807	D	0.075	0.212	N	0.647	0.810	D	1.935	0.520	L	-5.28	0.990	D	-1.1	0.326	N	0.471	0.686	1.082	0.989	D	0.967	0.990	D	0.354	0.924	D	4.793	0.643	24.7	0.999	0.935	0.937	0.586	D	c	0.206	0.110	1.000	0.747	0.487	0.133	0	4.6	0.564	4.645	0.609	-0.004	0.134	0.997	0.399	0.002	0.062	14.301	0.658	.	.	.	0.5	108	110	12	70049190	chr12:70049190	C	T	108	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	70747575	70747575	-	A	intronic	CNOT2	.	.	.	0.999868597	0.000131403	7.53E-11	.	0.28744	0.14229	-0.117432389	44.89266336	17.74579	0.62027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41.18	44	12	70747575	chr12:70747575	G	GA	41.18	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	72094581	72094581	T	C	intronic	TMEM19	.	.	.	0.001380694	0.866114693	0.132504613	.	0.0797	0.1104	0.350995466	74.37485256	257.67543	3.45315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	87	12	72094581	chr12:72094581	T	C	100	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	72665887	72665887	T	A	ncRNA_exonic	TRHDE-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	317	12	72665887	chr12:72665887	T	A	127	PASS	DP=317;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	76752551	76752552	TG	-	exonic	OSBPL8	.	frameshift deletion	OSBPL8:NM_001319655:exon19:c.2293_2294del:p.Q765Efs*12,OSBPL8:NM_001003712:exon21:c.2242_2243del:p.Q748Efs*12,OSBPL8:NM_001319653:exon22:c.2359_2360del:p.Q787Efs*12,OSBPL8:NM_020841:exon22:c.2368_2369del:p.Q790Efs*12,OSBPL8:NM_001319652:exon24:c.2242_2243del:p.Q748Efs*12	0.988348146	0.011651854	2.92E-10	.	0.77324	0.11113	-0.512444034	21.55579146	62.14451	1.60766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	16	12	76752550	chr12:76752550	CTG	C	62	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	78362403	78362403	G	T	exonic	NAV3	.	stopgain	NAV3:NM_001024383:exon5:c.G592T:p.E198X,NAV3:NM_014903:exon5:c.G592T:p.E198X	0.999999399	6.01E-07	4.23E-22	DISEASE: Note=A chromosomal aberration disrupting NAV3 has been found in patients with Sezary syndrome (PubMed:16166283). Translocation t(12;18)(q21;q21.2) (PubMed:16166283). {ECO:0000269|PubMed:16166283}.; 	0.8009	0.11717	-2.045202892	1.645435244	577.63321	4.87321	.	.	.	.	.	.	.	.	.	0.002	0.383	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.938	0.987	40	0.998	0.894	0.995	0.965	D	c	1.164	1.017	1.000	0.747	0.563	0.310	0	5.53	0.825	7.051	0.762	0.943	0.531	1.000	0.715	0.987	0.523	19.453	0.948	Calponin homology domain	.	.	0.5	114	69	12	78362403	chr12:78362403	G	T	114	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	86229896	86229896	G	C	intronic	RASSF9	.	.	.	7.70E-05	0.755070432	0.244852527	.	0.22794	0.10688	0.376678994	75.50719509	331.1863	3.8715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	57	12	86229896	chr12:86229896	G	C	78	PASS	DP=57;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	86229898	86229898	G	C	intronic	RASSF9	.	.	.	7.70E-05	0.755070432	0.244852527	.	0.22794	0.10688	0.376678994	75.50719509	331.1863	3.8715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	56	12	86229898	chr12:86229898	G	C	72	PASS	DP=56;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	91340253	91340253	T	-	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	100	12	91340252	chr12:91340252	CT	C,CTT	48	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	91340253	91340253	-	T	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	100	12	91340252	chr12:91340252	CT	C,CTT	48	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	93873164	93873164	C	T	exonic	MRPL42	.	synonymous SNV	MRPL42:NM_014050:exon4:c.C135T:p.C45C,MRPL42:NM_172177:exon4:c.C135T:p.C45C	0.027881567	0.797373303	0.17474513	.	0.03676	0.06595	-0.251530012	35.42108988	54.00078	1.46532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	12	93873164	chr12:93873164	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	94575260	94575260	G	A	exonic	PLXNC1	.	synonymous SNV	PLXNC1:NM_005761:exon3:c.G1242A:p.E414E	0.99971484	0.00028516	3.41E-14	.	0.69608	0.10916	-0.325161626	30.92120783	2196.06093	8.62704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	12	94575260	chr12:94575260	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	94975543	94975543	G	T	exonic	TMCC3	.	nonsynonymous SNV	TMCC3:NM_001301036:exon2:c.C757A:p.Q253K,TMCC3:NM_020698:exon2:c.C850A:p.Q284K	0.000392184	0.845537036	0.15407078	.	0.0962	0.10967	0.178263593	66.12998349	211.70761	3.13738	0.175	0.235	T	0.285	0.304	B	0.131	0.313	B	0.004	0.340	N	0.983	0.422	D	1.355	0.339	L	1.03	0.405	T	-1.45	0.356	N	0.368	0.429	-1.061	0.114	T	0.101	0.375	T	0.009	0.227	T	2.161	0.321	17.25	0.982	0.386	0.988	0.865	D	c	0.215	0.400	0.936	0.272	0.707	0.730	0	5.93	0.959	7.384	0.789	0.974	0.594	1.000	0.715	0.989	0.536	20.344	0.988	.	.	.	0.5	143	92	12	94975543	chr12:94975543	G	T	143	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	95479478	95479478	G	C	intronic	FGD6	.	.	.	0.995227689	0.004772311	3.29E-11	.	0.18424	0.0913	-1.076610636	7.324840764	1000.15705	6.09179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	28	12	95479478	chr12:95479478	G	C	73	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
12	98989188	98989188	-	T	intronic	SLC25A3	.	.	.	0.071557649	0.915646572	0.012795779	DISEASE: Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]: Fatal disorder of oxidative phosphorylation. Patients have lactic acidosis, hypertrophic cardiomyopathy and muscular hypotonia and die within the first year of life. {ECO:0000269|PubMed:17273968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30153	0.22672	-0.626318434	17.03231894	20.64253	0.70171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	149	12	98989187	chr12:98989187	AT	ATT,A	64	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	98989188	98989188	T	-	intronic	SLC25A3	.	.	.	0.071557649	0.915646572	0.012795779	DISEASE: Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]: Fatal disorder of oxidative phosphorylation. Patients have lactic acidosis, hypertrophic cardiomyopathy and muscular hypotonia and die within the first year of life. {ECO:0000269|PubMed:17273968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30153	0.22672	-0.626318434	17.03231894	20.64253	0.70171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	149	12	98989187	chr12:98989187	AT	ATT,A	64	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	99640033	99640033	G	A	intronic	ANKS1B	.	.	.	0.992771668	0.007228332	9.07E-11	.	0.21201	0.20962	-1.216154	5.667610285	347.70248	3.95239	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	12	99640033	chr12:99640033	G	A	.	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	100480151	100480151	G	-	intronic	UHRF1BP1L	.	.	.	0.989377601	0.010622399	2.33E-10	.	0.73214	.	1.49913011	95.38216561	1032.40429	6.1729	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	23	12	100480150	chr12:100480150	AG	A	52	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	102140523	102140523	A	-	UTR3	GNPTAB	NM_024312:c.*419delT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	115	12	102140522	chr12:102140522	GA	G	84	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	102301162	102301162	-	T	intronic	DRAM1	.	.	.	0.080700077	0.872050796	0.047249127	.	.	.	-0.229483771	36.86010852	8.7844	0.32424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	148	12	102301162	chr12:102301162	G	GT	70	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	104461712	104461712	T	-	intronic	HCFC2	.	.	.	0.994468276	0.005531718	5.69E-09	.	0.54137	0.20015	0.084621747	60.31493277	202.17732	3.06842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	46	12	104461711	chr12:104461711	CT	C	43	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	104517076	104517076	G	A	exonic	NFYB	.	synonymous SNV	NFYB:NM_006166:exon5:c.C357T:p.L119L	0.003273758	0.827223732	0.169502511	.	0.82614	0.23984	0.101211609	60.95777306	6.01187	0.22629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	12	104517076	chr12:104517076	G	A	.	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	108012065	108012065	A	C	exonic	BTBD11	.	nonsynonymous SNV	BTBD11:NM_001017523:exon8:c.A973C:p.S325R,BTBD11:NM_001018072:exon10:c.A2362C:p.S788R	0.993432981	0.00656701	8.66E-09	.	0.42445	0.12301	-0.462894052	23.62585515	7389.82344	18.4572	0.047	0.403	D	0.838	0.715	P	0.367	0.649	B	0.000	0.843	D	1.000	0.810	D	1.355	0.339	L	1.28	0.396	T	-1.65	0.395	N	0.562	0.647	-0.867	0.508	T	0.172	0.515	T	0.019	0.417	T	3.696	0.501	23.3	0.998	0.917	0.959	0.666	D	c	0.473	0.512	1.000	0.489	0.638	0.428	0	5.07	0.680	5.381	0.657	1.199	0.960	1.000	0.715	1.000	0.888	15.123	0.720	.	.	.	0.5	.	62	12	108012065	chr12:108012065	A	C	.	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	108913293	108913293	A	-	UTR3	FICD	NM_007076:c.*41delA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	218	12	108913292	chr12:108913292	GA	G,GAA	77	PASS	DP=218;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/2	./.
12	108913293	108913293	-	A	UTR3	FICD	NM_007076:c.*41_*42insA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	218	12	108913292	chr12:108913292	GA	G,GAA	77	PASS	DP=218;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/2	./.
12	108913381	108913382	TA	-	downstream	FICD	dist=1	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.06	89	12	108913380	chr12:108913380	TTA	T	10.06	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	109510087	109510087	T	-	intronic	USP30	.	.	.	0.309014179	0.69082627	0.000159551	.	0.17615	0.11045	-0.135838822	43.77211607	446.0984	4.39699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	36	12	109510086	chr12:109510086	GT	G	62	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	109696754	109696754	G	T	intronic	ACACB	.	.	.	5.12E-22	0.999983957	1.60E-05	.	0.16354	0.41174	-1.974635129	1.775182826	3979.35991	12.47962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	12	109696754	chr12:109696754	G	T	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	109921356	109921356	C	A	UTR5	UBE3B	NM_130466:c.-1C>A;NM_001270449:c.-1C>A;NM_001270450:c.-1C>A;NM_001270451:c.-1C>A;NM_183415:c.-1C>A	.	.	0.009387706	0.990612131	1.63E-07	.	0.19362	0.09343	-2.232421897	1.315168672	170.30974	2.84773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	12	109921356	chr12:109921356	C	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	110290214	110290214	C	T	UTR3	GLTP	NM_016433:c.*146G>A	.	.	0.227088706	0.737737795	0.035173498	.	.	0.15588	-0.139478553	43.29440906	22.60764	0.75634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	33	12	110290214	chr12:110290214	C	T	50	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	110895322	110895322	G	A	exonic	GPN3	.	nonsynonymous SNV	GPN3:NM_001164372:exon4:c.C560T:p.S187L,GPN3:NM_001164373:exon4:c.C473T:p.S158L,GPN3:NM_016301:exon4:c.C443T:p.S148L	0.000100472	0.804648765	0.195250764	.	0.5105	0.10747	-0.381986487	27.68931352	60.55868	1.58137	0.349	0.185	T	0.074	0.226	B	0.098	0.289	B	0.000	0.843	D	1	0.810	D	2.465	0.718	M	1.94	0.227	T	-2.47	0.540	N	0.338	0.816	-1.073	0.088	T	0.062	0.260	T	0.019	0.413	T	5.074	0.684	25.3	0.956	0.267	0.992	0.920	D	c	0.085	0.264	1.0	0.983	0.745	0.986	0	5.68	0.880	7.267	0.777	0.994	0.605	1.000	0.715	0.999	0.750	19.778	0.964	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	70	12	110895322	chr12:110895322	G	A	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	110933783	110933864	GAGATATTTGAGAAGGGAAAGGGAAATACATCACCTCATCGAAGTCTCCTCTCACAATATGAACATCACCAGCCAGAGTCTT	-	exonic	VPS29	.	nonframeshift deletion	VPS29:NM_001282151:exon2:c.148_195del:p.T51_K66del,VPS29:NM_016226:exon2:c.148_195del:p.K50_E65del,VPS29:NM_057180:exon3:c.160_207del:p.K54_E69del,VPS29:NM_001282150:exon4:c.244_291del:p.K82_E97del	0.934744448	0.064952736	0.000302816	.	0.45412	0.10309	0.079165051	59.43029016	5.00308	0.18601	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.22	28	12	110933782	chr12:110933782	GGAGATATTTGAGAAGGGAAAGGGAAATACATCACCTCATCGAAGTCTCCTCTCACAATATGAACATCACCAGCCAGAGTCTT	G	13.22	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	111375005	111375005	T	C	ncRNA_exonic	LINC01405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	12	111375005	chr12:111375005	T	C	.	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	111885600	111885600	C	G	exonic	SH2B3	.	synonymous SNV	SH2B3:NM_001291424:exon6:c.C771G:p.S257S,SH2B3:NM_005475:exon7:c.C1377G:p.S459S	0.00592219	0.972368399	0.021709411	DISEASE: Celiac disease 13 (CELIAC13) [MIM:612011]: A multifactorial, chronic disorder of the small intestine caused by intolerance to gluten. It is characterized by immune-mediated enteropathy associated with failed intestinal absorption, and malnutrition. In predisposed individuals, the ingestion of gluten- containing food such as wheat and rye induces a flat jejunal mucosa with infiltration of lymphocytes. {ECO:0000269|PubMed:18311140}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, insulin-dependent (IDDM) [MIM:222100]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:17554260}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.78211	0.35815	.	.	1095.64678	6.33313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	186	12	111885600	chr12:111885600	C	G	121	PASS	DP=186;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	112516042	112516042	C	T	exonic	NAA25	.	nonsynonymous SNV	NAA25:NM_024953:exon7:c.G614A:p.R205H	0.999989964	1.00E-05	1.19E-15	.	0.37094	0.10762	-0.111973265	45.35857514	2728.20466	9.84256	0.135	0.262	T	1.0	0.899	D	0.925	0.643	D	0.000	0.843	D	1	0.810	D	2.08	0.576	M	1.12	0.387	T	-0.88	0.238	N	0.774	0.766	-0.846	0.523	T	0.197	0.552	T	0.022	0.454	T	4.431	0.593	24.2	0.999	0.986	0.991	0.907	D	c	0.686	0.714	1.000	0.747	0.707	0.730	0	5.52	0.821	7.330	0.783	0.892	0.403	1.000	0.715	0.998	0.697	19.431	0.947	Tetratricopeptide-like helical domain	.	.	0.5	.	109	12	112516042	chr12:112516042	C	T	.	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	116397416	116397416	C	T	UTR3	MED13L	NM_015335:c.*1655G>A	.	.	0.999999999	1.32E-09	2.08E-24	DISEASE: Note=A chromosomal aberration involving MED13L is found in a patient with transposition of the great arteries, dextro- looped and mental retardation. Translocation t(12;17)(q24.1;q21). {ECO:0000269|PubMed:14638541}.; 	0.80264	0.11567	-2.736273894	0.690021231	206.98599	3.10912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	51	12	116397416	chr12:116397416	C	T	81	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	118405932	118405932	G	A	exonic	KSR2	.	synonymous SNV	KSR2:NM_173598:exon1:c.C42T:p.T14T	0.999946625	5.34E-05	1.70E-12	.	0.40754	0.12029	.	.	183.49029	2.93982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	12	118405932	chr12:118405932	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	120806124	120806124	C	-	intronic	MSI1	.	.	.	0.997146451	0.002853413	1.36E-07	.	0.66447	0.10166	-0.161524709	41.6430762	9.92984	0.36366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	134	12	120806123	chr12:120806123	TC	T	93	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	121764972	121764972	G	A	exonic	ANAPC5	.	nonsynonymous SNV	ANAPC5:NM_001137559:exon11:c.C1031T:p.A344V,ANAPC5:NM_001330489:exon11:c.C1328T:p.A443V,ANAPC5:NM_016237:exon11:c.C1367T:p.A456V	4.18E-05	0.99800999	0.00194821	.	0.36079	.	-0.554717505	19.79830149	76.22212	1.8303	0.934	0.062	T	0.001	0.067	B	0.0	0.040	B	0.009	0.305	N	1	0.090	N	-0.69	0.019	N	.	.	.	-0.93	0.281	N	0.049	0.210	-1.036	0.184	T	0.037	0.158	T	0.002	0.028	T	0.866	0.177	9.865	0.337	0.020	0.728	0.353	D	c	-0.672	-0.474	0.998	0.359	0.707	0.730	0	4.04	0.461	4.701	0.613	0.143	0.228	0.990	0.367	0.602	0.289	4.584	0.116	Anaphase-promoting complex subunit 5|Tetratricopeptide-like helical domain;Tetratricopeptide-like helical domain	.	.	0.5	117	236	12	121764972	chr12:121764972	G	A	117	PASS	DP=236;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	122017564	122017564	T	C	intronic	KDM2B	.	.	.	0.999785914	0.000214086	8.39E-14	.	0.3817	0.10945	-2.166248113	1.421325784	100.32428	2.17057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	222	12	122017564	chr12:122017564	T	C	65	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	122018029	122018029	G	A	UTR5	KDM2B	NM_001005366:c.-72C>T	.	.	0.999785914	0.000214086	8.39E-14	.	0.3817	0.10945	-2.166248113	1.421325784	100.32428	2.17057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	70	12	122018029	chr12:122018029	G	A	58	PASS	DP=70;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	122614210	122614210	T	-	intronic	MLXIP	.	.	.	0.975747589	0.024251353	1.06E-06	.	0.16616	0.11073	.	.	1241.38763	6.65087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	57	12	122614209	chr12:122614209	CT	C	77	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	122672313	122672313	C	T	exonic	LRRC43	.	synonymous SNV	LRRC43:NM_001098519:exon4:c.C588T:p.G196G,LRRC43:NM_152759:exon4:c.C33T:p.G11G	6.70E-14	0.015985486	0.984014514	.	0.05087	.	0.404185162	76.48619958	2151.99418	8.53257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	221	12	122672313	chr12:122672313	C	T	83	PASS	DP=221;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	122803726	122803726	C	G	intronic	CLIP1	.	.	.	0.968496014	0.031503986	1.39E-10	.	0.46737	0.3229	-1.098660656	6.95329087	8478.17859	19.85973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	18	12	122803726	chr12:122803726	C	G	61	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	123345086	123345086	-	G	intronic	HIP1R	.	.	.	1.44E-06	0.999915155	8.34E-05	.	0.26127	0.10468	-1.054560763	7.60202878	723.1398	5.33777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	166	12	123345086	chr12:123345086	T	TG	69	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	123687774	123687774	C	T	intronic	MPHOSPH9	.	.	.	0.000759987	0.999233869	6.14E-06	.	0.16591	0.08911	-0.214928658	37.7388535	739.49466	5.39891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	49	12	123687774	chr12:123687774	C	T	103	PASS	DP=49;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	123907659	123907659	T	C	exonic	RILPL2	.	synonymous SNV	RILPL2:NM_145058:exon3:c.A537G:p.K179K	0.060872187	0.868916205	0.070211608	.	0.07683	0.07466	-0.185391282	39.67916962	29.91633	0.9548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	58	12	123907659	chr12:123907659	T	C	54	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	124498691	124498691	G	-	UTR3	ZNF664	NM_152437:c.*1214delG;NM_001204298:c.*1214delG	.	.	0.001626794	0.457661202	0.540712004	.	0.24976	0.12378	0.347360312	73.97381458	461.1138	4.45297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.93	72	12	124498690	chr12:124498690	AG	A	17.93	PASS	DP=72;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	125396196	125396196	G	C	UTR3	UBC	NM_021009:c.*64C>G	.	.	0.704156667	0.292254881	0.003588452	.	.	.	-0.80269335	12.23755603	8.43713	0.30824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	12	125396196	chr12:125396196	G	C	.	PASS	DP=52;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	125603260	125603260	C	-	exonic	AACS	.	frameshift deletion	AACS:NM_001319839:exon10:c.1070delC:p.L359Wfs*14,AACS:NM_001319840:exon10:c.1070delC:p.L359Wfs*14,AACS:NM_023928:exon10:c.1070delC:p.L359Wfs*14	4.25E-12	0.171790101	0.828209899	.	0.18243	0.23898	-1.170241634	6.039160179	163.63033	2.79374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	76	12	125603259	chr12:125603259	TC	T	48	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	128899673	128899673	A	G	exonic	TMEM132C	.	nonsynonymous SNV	TMEM132C:NM_001136103:exon2:c.A482G:p.H161R	0.66707188	0.310682848	0.022245272	.	0.17363	.	.	.	3428.14645	11.24007	0.369	0.116	T	0.0	0.026	B	0.001	0.040	B	.	.	.	1	0.090	P	0.99	0.251	L	2.86	0.105	T	-1.34	0.334	N	0.015	0.002	-0.919	0.457	T	0.000	0.000	T	.	.	.	-2.555	0.003	0.001	0.396	0.027	0.076	0.134	N	c	-1.797	-1.890	0.121	0.169	0.554	0.246	0	-9.14	0.006	0.353	0.197	-0.145	0.109	0.000	0.063	0.002	0.062	8.807	0.339	Transmembrane protein TMEM132, N-terminal	.	.	0.5	59	38	12	128899673	chr12:128899673	A	G	59	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	130923006	130923006	G	A	exonic	RIMBP2	.	synonymous SNV	RIMBP2:NM_015347:exon10:c.C1509T:p.T503T,RIMBP2:NM_001351227:exon11:c.C1560T:p.T520T,RIMBP2:NM_001351226:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351228:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351229:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351230:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351231:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351232:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351233:exon13:c.C1233T:p.T411T	0.292582176	0.707410338	7.49E-06	.	0.1263	0.10358	-2.070835943	1.615947157	308.7902	3.74029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	12	130923006	chr12:130923006	G	A	.	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	132635999	132635999	G	T	intronic	NOC4L	.	.	.	.	.	.	.	0.5431	0.11298	-1.280491183	5.16631281	149.35551	2.66469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	12	132635999	chr12:132635999	G	T	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	19393160	19393160	G	A	ncRNA_intronic	ANKRD20A9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	58	13	19393160	chr13:19393160	G	A	65	PASS	DP=58;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
13	19393304	19393304	C	G	ncRNA_exonic	ANKRD20A9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	81	13	19393304	chr13:19393304	C	G	71	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	19393386	19393386	C	T	ncRNA_exonic	ANKRD20A9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	116	13	19393386	chr13:19393386	C	T	104	PASS	DP=116;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	19775753	19775753	G	A	intergenic	LOC101928697;ANKRD26P3	dist=14148;dist=61187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	82	13	19775753	chr13:19775753	G	A	88	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	20006737	20006737	C	T	intronic	TPTE2	.	.	.	3.69E-08	0.98450594	0.015494023	.	0.07785	0.18826	-0.178111357	40.44585987	120.84753	2.39632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	86	13	20006737	chr13:20006737	C	T	60	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	20413021	20413021	T	C	exonic	ZMYM5	.	nonsynonymous SNV	ZMYM5:NM_001039650:exon5:c.A691G:p.T231A,ZMYM5:NM_001142684:exon5:c.A691G:p.T231A	0.200378135	0.7895718	0.010050066	.	0.06748	0.07051	0.485092724	79.37603208	1157.52256	6.47872	0.041	0.477	D	0.048	0.207	B	0.013	0.158	B	0.004	0.342	N	0.999	0.588	P	0	0.065	N	1.01	0.411	T	0.31	0.058	N	0.061	0.109	-1.076	0.081	T	0.000	0.001	T	.	.	.	0.786	0.169	9.378	0.947	0.247	0.822	0.412	D	c	-0.835	-0.761	0.992	0.326	0.732	0.924	0	-0.334	0.120	0.570	0.232	-0.595	0.044	0.996	0.391	0.001	0.043	4.843	0.128	.	ENSG00000196199.9|ENSG00000196199.9|ENSG00000121390.13|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000215572.2|ENSG00000196199.9	Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Muscle_Skeletal|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Stomach|Testis|Thyroid	0.5	94	158	13	20413021	chr13:20413021	T	C	94	PASS	DP=158;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	22275888	22275888	A	G	UTR3	FGF9	NM_002010:c.*314A>G	.	.	0.91071591	0.088614167	0.000669923	DISEASE: Multiple synostoses syndrome 3 (SYNS3) [MIM:612961]: A bone disease characterized by multiple progressive joint fusions that commonly involve proximal interphalangeal, tarsal-carpal, humeroradial and cervical spine joints. Additional features can include progressive conductive deafness and facial dysmorphism. {ECO:0000269|PubMed:19589401}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90259	0.31502	0.169169615	65.33380514	24.43081	0.80364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	26	13	22275888	chr13:22275888	A	G	42	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	24853006	24853006	T	C	intronic	SPATA13	.	.	.	0.528844213	0.471126751	2.90E-05	.	0.28685	0.1118	2.008142452	97.67044114	1024.01032	6.15271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	61	13	24853006	chr13:24853006	T	C	42	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
13	25161438	25161438	T	A	ncRNA_exonic	TPTE2P6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	229	13	25161438	chr13:25161438	T	A	141	PASS	DP=229;AN=4	GT	0/1	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
13	25517090	25517090	C	-	ncRNA_exonic	TPTE2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	25	13	25517089	chr13:25517089	TC	T	54	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	26343298	26343298	C	T	exonic	ATP8A2	.	synonymous SNV	ATP8A2:NM_001313741:exon26:c.C2379T:p.H793H,ATP8A2:NM_016529:exon26:c.C2499T:p.H833H	0.4180779	0.581922099	9.45E-10	DISEASE: Note=A chromosomal aberration disrupting ATP8A2 has been found in a patient with severe mental retardation and major hypotonia. Translocation t(10;13)(p12.1;q12.13) (PubMed:20683487). {ECO:0000269|PubMed:20683487}.; 	0.33216	0.22285	-1.104093597	6.894314697	112.54149	2.30702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	13	26343298	chr13:26343298	C	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	26620924	26620924	G	A	exonic	SHISA2	.	synonymous SNV	SHISA2:NM_001007538:exon2:c.C615T:p.N205N	0.404087524	0.557503271	0.038409205	.	0.3978	0.10893	.	.	1189.34167	6.54035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	20	13	26620924	chr13:26620924	G	A	62	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	28519633	28519633	C	G	intergenic	PDX1;LINC00543	dist=19182;dist=8030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	15	13	28519633	chr13:28519633	C	G	.	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	29001292	29001292	C	A	intronic	FLT1	.	.	.	0.997806027	0.002193973	9.98E-13	DISEASE: Note=Can contribute to cancer cell survival, proliferation, migration, and invasion, and tumor angiogenesis and metastasis. May contribute to cancer pathogenesis by promoting inflammatory responses and recruitment of tumor-infiltrating macrophages.; DISEASE: Note=Abnormally high expression of soluble isoforms (isoform 2, isoform 3 or isoform 4) may be a cause of preeclampsia.; 	0.24106	0.64822	-1.521247944	3.44420854	121.53409	2.40056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	139	13	29001292	chr13:29001292	C	A	76	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	31821180	31821180	C	T	exonic	B3GLCT	.	synonymous SNV	B3GLCT:NM_194318:exon5:c.C291T:p.L97L	.	.	.	.	0.22185	0.13753	0.066214104	58.95848077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	13	31821180	chr13:31821180	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	32360691	32360691	-	AA	intronic	RXFP2	.	.	.	2.94E-08	0.978811653	0.021188317	.	0.16562	0.12616	-0.176292081	40.56381222	1150.99694	6.46394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	19	13	32360691	chr13:32360691	T	TAA	42	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	32907536	32907536	T	-	intronic	BRCA2	.	.	.	2.21E-15	0.999975298	2.47E-05	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97144	0.70346	3.731883424	99.58716678	775.59808	5.51436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	20	13	32907535	chr13:32907535	CT	C	75	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	36049080	36049080	T	G	UTR3	MAB21L1	NM_005584:c.*116A>C	.	.	0.367416502	0.620997062	0.011586436	.	0.79952	0.11262	-0.449946534	24.00330267	17.33297	0.60901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	9	13	36049080	chr13:36049080	T	G	41	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	38320457	38320457	G	T	exonic	TRPC4	.	nonsynonymous SNV	TRPC4:NM_001135955:exon3:c.C514A:p.H172N,TRPC4:NM_001135956:exon3:c.C514A:p.H172N,TRPC4:NM_001135957:exon3:c.C514A:p.H172N,TRPC4:NM_003306:exon3:c.C514A:p.H172N,TRPC4:NM_016179:exon3:c.C514A:p.H172N	0.967651076	0.032348906	1.79E-08	.	0.47812	.	-1.175687564	5.974286388	36.07747	1.08368	0.001	0.912	D	0.998	0.899	D	0.998	0.916	D	0.000	0.843	D	1	0.810	D	3.33	0.910	M	-0.74	0.803	T	-6.18	0.920	D	0.48	0.540	0.577	0.916	D	0.735	0.910	D	0.197	0.866	D	4.824	0.648	24.8	0.991	0.533	0.997	0.991	D	c	0.872	0.806	1.0	0.983	0.706	0.609	0	5.82	0.927	10.003	0.997	0.998	0.613	1.000	0.715	0.996	0.625	20.095	0.978	Ankyrin repeat-containing domain	.	.	0.5	69	236	13	38320457	chr13:38320457	G	T	69	PASS	DP=236;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	39603418	39603418	G	A	exonic	PROSER1	.	nonsynonymous SNV	PROSER1:NM_025138:exon4:c.C275T:p.S92L	0.736135592	0.263842666	2.17E-05	.	0.10421	0.09566	-0.170835809	40.65227648	338.0786	3.90357	0.466	0.122	T	0.103	0.764	B	0.03	0.774	B	.	.	.	0.998	0.442	D	-0.145	0.044	N	1.52	0.307	T	-2.34	0.587	N	0.252	0.308	-1.037	0.183	T	0.072	0.294	T	0.009	0.236	T	2.260	0.333	17.91	0.278	0.014	0.880	0.475	D	c	0.244	0.394	1.000	0.747	0.732	0.924	0	5.46	0.799	7.033	0.761	0.998	0.613	1.000	0.715	0.996	0.625	10.267	0.424	Domain of unknown function DUF4476	.	.	0.5	.	74	13	39603418	chr13:39603418	G	A	.	PASS	DP=74;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
13	41133191	41133191	T	C	intronic	FOXO1	.	.	.	0.966380394	0.033561804	5.78E-05	DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. Note=The gene represented in this entry may be involved in disease pathogenesis. Chromosomal aberrations involving FOXO1 are found in rhabdomyosarcoma. Translocation (2;13)(q35;q14) with PAX3 and translocation t(1;13)(p36;q14) with PAX7. The resulting protein is a transcriptional activator.; 	0.97621	0.82936	-0.468351206	23.42533616	329.3803	3.85852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	53	13	41133191	chr13:41133191	T	C	62	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	44964489	44964489	G	A	intronic	SERP2	.	.	.	0.229121363	0.646467406	0.12441123	.	0.26504	.	0.101211609	60.95777306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	13	44964489	chr13:44964489	G	A	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
13	45710920	45710920	T	C	exonic	GTF2F2	.	nonsynonymous SNV	GTF2F2:NM_004128:exon2:c.T119C:p.V40A	0.025230232	0.96173341	0.013036358	.	0.15957	0.11833	-0.163345027	41.24793583	12.47447	0.45368	0.066	0.361	T	0.997	0.689	D	0.989	0.769	D	0.000	0.843	D	1	0.810	D	2.455	0.715	M	.	.	.	-2.92	0.611	D	0.475	0.524	-0.208	0.775	T	0.415	0.762	T	0.027	0.503	D	4.361	0.584	24.1	0.999	0.940	0.917	0.539	D	c	0.690	0.656	1.000	0.747	0.732	0.924	0	5.44	0.793	6.056	0.705	1.011	0.635	1.000	0.715	1.000	0.888	13.445	0.604	Transcription Factor IIF, Rap30/Rap74, interaction	.	.	0.5	44	49	13	45710920	chr13:45710920	T	C	44	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
13	46946629	46946629	G	T	UTR5	RUBCNL	NM_001286762:c.-19C>A;NM_001349772:c.-19C>A;NM_025113:c.-19C>A;NM_001286761:c.-19C>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	13	46946629	chr13:46946629	G	T	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	49776080	49776080	A	G	exonic	FNDC3A	.	synonymous SNV	FNDC3A:NM_014923:exon22:c.A2964G:p.K988K,FNDC3A:NM_001079673:exon24:c.A3132G:p.K1044K,FNDC3A:NM_001278438:exon24:c.A3132G:p.K1044K	0.999884368	0.000115632	1.87E-14	.	0.44936	0.49287	-1.54691447	3.284972871	365.09768	4.0427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	55	13	49776080	chr13:49776080	A	G	88	PASS	DP=55;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	49796204	49796204	C	T	exonic	MLNR	.	synonymous SNV	MLNR:NM_001507:exon2:c.C930T:p.C310C	0.046587675	0.854459372	0.098952953	.	0.19209	0.11347	.	.	83.27787	1.93998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	174	13	49796204	chr13:49796204	C	T	44	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	50366649	50366649	G	T	UTR5	KPNA3	NM_002267:c.-7C>A	.	.	0.809823934	0.190167527	8.54E-06	.	0.70799	0.22385	-0.117432389	44.89266336	63.49368	1.63216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	358	13	50366649	chr13:50366649	G	T	76	PASS	DP=358;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	50570574	50570574	T	-	ncRNA_exonic	MIR3613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	139	13	50570573	chr13:50570573	CT	C	90	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	52333956	52333968	TTAACCCAAATCA	-	UTR3	WDFY2	NM_052950:c.*51_*63delTTAACCCAAATCA	.	.	0.003595002	0.987074972	0.009330027	.	0.16955	0.11257	-0.047654689	50.22410946	302.50677	3.70419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	34	13	52333955	chr13:52333955	TTTAACCCAAATCA	T	95	PASS	DP=34;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
13	53013249	53013249	C	T	exonic	VPS36	.	nonsynonymous SNV	VPS36:NM_001282168:exon3:c.G193A:p.A65T,VPS36:NM_001282169:exon3:c.G46A:p.A16T,VPS36:NM_016075:exon3:c.G220A:p.A74T	0.100608361	0.899084406	0.000307233	.	0.09703	0.1199	-0.295622497	32.61972163	29.0318	0.92832	0.382	0.111	T	0.07	0.224	B	0.034	0.212	B	0.000	0.629	D	1	0.810	D	1.405	0.356	L	.	.	.	-1.26	0.318	N	0.589	0.617	-0.907	0.472	T	0.175	0.519	T	0.004	0.107	T	3.780	0.511	23.4	0.989	0.484	0.990	0.898	D	c	0.033	0.236	1.000	0.747	0.706	0.609	0	5.38	0.772	6.964	0.757	0.935	0.490	1.000	0.715	0.998	0.697	18.492	0.908	PH domain-like|Vacuolar protein sorting protein 36, GLUE domain	.	.	0.5	42	72	13	53013249	chr13:53013249	C	T	42	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	76140768	76140768	C	T	intronic	UCHL3	.	.	.	1.95E-05	0.702089901	0.297890577	.	0.61491	0.11954	-0.163345027	41.24793583	18.24807	0.63412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	13	76140768	chr13:76140768	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
13	82264343	82264343	A	G	intergenic	LINC00564;NONE	dist=463225;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	24	13	82264343	chr13:82264343	A	G	42	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	97484970	97484970	C	T	exonic	HS6ST3	.	nonsynonymous SNV	HS6ST3:NM_153456:exon2:c.C934T:p.R312C	0.747377573	0.250362514	0.002259914	.	0.59827	0.11479	-0.113792788	45.25831564	369.2782	4.06133	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	2.95	0.852	M	0.98	0.421	T	-7.37	0.947	D	0.973	0.974	-0.217	0.773	T	0.354	0.717	T	0.052	0.650	D	7.687	0.954	35	0.999	0.996	0.986	0.839	D	c	0.971	0.921	1.000	0.747	0.554	0.246	0	5.65	0.868	7.902	0.860	0.935	0.490	1.000	0.715	1.000	0.888	19.715	0.961	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	58	186	13	97484970	chr13:97484970	C	T	58	PASS	DP=186;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	98119932	98119932	T	-	UTR3	RAP2A	NM_021033:c.*3236delT	.	.	0.717339657	0.268600965	0.014059378	.	0.15	0.18963	0.013025609	54.62962963	2.30275	0.0782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	14	13	98119931	chr13:98119931	CT	C	53	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
13	99098882	99098882	A	C	intronic	FARP1	.	.	.	0.045263074	0.954736546	3.80E-07	.	0.20246	0.11058	0.102819578	60.96956829	825.14469	5.63133	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	15	13	99098882	chr13:99098882	A	C	65	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	100635045	100635045	T	-	exonic	ZIC2	.	frameshift deletion	ZIC2:NM_007129:exon1:c.727delT:p.F244Sfs*12	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	304	13	100635044	chr13:100635044	CT	C	71	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	100637893	100637893	G	T	exonic	ZIC2	.	nonsynonymous SNV	ZIC2:NM_007129:exon3:c.G1556T:p.G519V	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	0.006	0.614	D	0.11	0.246	B	0.012	0.149	B	0.006	0.320	N	1.000	0.480	D	0.805	0.203	L	-1.22	0.788	T	-0.66	0.191	N	0.354	0.415	-0.658	0.624	T	0.265	0.636	T	0.850	0.988	D	3.223	0.447	22.7	0.981	0.380	0.790	0.388	D	c	-0.233	-0.118	1.000	0.517	0.543	0.218	0	2.81	0.318	4.421	0.594	0.779	0.314	1.000	0.715	0.991	0.552	10.976	0.465	.	.	.	0.5	113	150	13	100637893	chr13:100637893	G	T	113	PASS	DP=150;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	102047543	102047543	G	T	exonic	NALCN	.	synonymous SNV	NALCN:NM_001350748:exon3:c.C282A:p.G94G,NALCN:NM_001350749:exon3:c.C282A:p.G94G,NALCN:NM_001350750:exon3:c.C282A:p.G94G,NALCN:NM_001350751:exon3:c.C282A:p.G94G,NALCN:NM_052867:exon3:c.C282A:p.G94G	0.000169004	0.999830996	3.03E-11	DISEASE: Hypotonia, infantile, with psychomotor retardation and characteristic facies (IHPRF) [MIM:615419]: A neurodegenerative disease characterized by variable degrees of hypotonia, speech impairment, intellectual disability, pyramidal signs, subtle facial dysmorphism, and chronic constipation. Some patients manifest neuroaxonal dystrophy, optic atrophy, unmyelinated axons and spheroid bodies in tissue biopsies. {ECO:0000269|PubMed:23749988, ECO:0000269|PubMed:24075186}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]: A disease characterized by congenital contractures of the limbs and face, resulting in characteristic facial features, abnormal tone, most commonly manifested as hypotonia, and variable degrees of developmental delay. {ECO:0000269|PubMed:25683120}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43129	0.10307	-1.611264137	2.984194385	137.54866	2.55255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	58	13	102047543	chr13:102047543	G	T	80	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	102106265	102106265	C	A	exonic	ITGBL1	.	synonymous SNV	ITGBL1:NM_001271755:exon2:c.C130A:p.R44R,ITGBL1:NM_004791:exon2:c.C130A:p.R44R	0.170877824	0.828540578	0.000581598	.	0.17697	0.12974	0.64123826	83.97617363	1434.7471	7.07106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	13	102106265	chr13:102106265	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	103449265	103449265	T	C	exonic	KDELC1	.	nonsynonymous SNV	KDELC1:NM_024089:exon2:c.A277G:p.K93E	6.42E-06	0.892032262	0.10796132	.	0.13538	0.0976	-0.091746757	46.91554612	4102.6627	12.70963	0.094	0.313	T	0.172	0.271	B	0.155	0.328	B	0.000	0.497	D	1.000	0.493	D	2.62	0.769	M	-1.82	0.841	D	-1.58	0.381	N	0.539	0.577	-0.026	0.817	T	0.576	0.847	D	0.057	0.668	D	2.440	0.354	19.08	0.997	0.835	0.952	0.634	D	c	0.159	0.290	1.000	0.747	0.706	0.609	0	5.69	0.883	3.377	0.519	0.961	0.567	1.000	0.715	1.000	0.888	16.248	0.822	Immunoglobulin E-set|Immunoglobulin-like fold	.	.	0.5	74	56	13	103449265	chr13:103449265	T	C	74	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	107822287	107822287	A	T	UTR3	FAM155A	NM_001080396:c.*558T>A	.	.	0.800415326	0.199346781	0.000237893	.	0.22573	.	-0.005381972	53.50908233	761.08845	5.47031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	13	107822287	chr13:107822287	A	T	.	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
13	111164469	111164469	C	T	exonic	COL4A2	.	synonymous SNV	COL4A2:NM_001846:exon48:c.C5070T:p.A1690A	2.11E-06	0.999997874	1.64E-08	DISEASE: Porencephaly 2 (POREN2) [MIM:614483]: A neurologic disorder characterized by a fluid-filled cysts or cavities within the cerebral hemispheres. Affected individuals typically have hemiplegia, seizures, and intellectual disability. Porencephaly type 2, or schizencephalic porencephaly, is usually symmetric and represents a primary defect in the development of the cerebral ventricles. {ECO:0000269|PubMed:22209246}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intracerebral hemorrhage (ICH) [MIM:614519]: A pathological condition characterized by bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. Intracerebral bleeding is a common cause of stroke. {ECO:0000269|PubMed:22209247}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.26795	.	-0.643198486	16.53102147	2430.98324	9.15844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	256	13	111164469	chr13:111164469	C	T	88	PASS	DP=256;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	111371701	111371701	A	T	exonic	ING1	.	stopgain	ING1:NM_001267728:exon2:c.A211T:p.K71X,ING1:NM_005537:exon2:c.A691T:p.K231X,ING1:NM_198217:exon2:c.A130T:p.K44X,ING1:NM_198218:exon2:c.A55T:p.K19X,ING1:NM_198219:exon2:c.A262T:p.K88X	0.011435702	0.979963341	0.008600957	DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:10866301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78935	0.17351	-0.512444034	21.55579146	154.20317	2.71419	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.978	0.988	40	0.995	0.707	0.991	0.918	D	c	0.884	0.760	1.000	0.747	0.632	0.406	0	5.14	0.699	8.731	0.912	1.053	0.755	1.000	0.715	1.000	0.888	14.967	0.707	Inhibitor of growth protein, N-terminal histone-binding	.	.	0.5	76	190	13	111371701	chr13:111371701	A	T	76	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	111944635	111944635	A	G	exonic	ARHGEF7	.	nonsynonymous SNV	ARHGEF7:NM_001320854:exon14:c.A1600G:p.T534A,ARHGEF7:NM_001330598:exon17:c.A1834G:p.T612A,ARHGEF7:NM_001113512:exon18:c.A2218G:p.T740A,ARHGEF7:NM_001330597:exon19:c.A1834G:p.T612A,ARHGEF7:NM_145735:exon19:c.A2305G:p.T769A,ARHGEF7:NM_001113511:exon20:c.A2368G:p.T790A	0.953985931	0.046013857	2.13E-07	.	0.22379	0.62409	-1.03976177	7.802547771	94.43621	2.0915	1.0	0.026	T	0.0	0.026	B	0.0	0.040	B	0.003	0.357	N	0.937	0.810	D	1.1	0.281	L	0.76	0.608	T	-0.27	0.114	N	0.043	0.023	-1.095	0.048	T	0.077	0.309	T	0.006	0.155	T	0.702	0.161	8.841	0.829	0.140	0.680	0.334	D	c	-0.664	-0.444	0.986	0.310	0.372	0.050	0	3.24	0.361	1.431	0.343	-0.252	0.090	1.000	0.715	0.994	0.587	7.416	0.261	.	.	.	0.5	41	53	13	111944635	chr13:111944635	A	G	41	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	111973303	111973303	G	A	intronic	TEX29	.	.	.	0.001451668	0.671141973	0.32740636	.	0.02058	.	-0.139478553	43.29440906	19.3167	0.66507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	13	111973303	chr13:111973303	G	A	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
13	112763092	112763092	C	T	downstream	LINC00403	dist=763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	13	112763092	chr13:112763092	C	T	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
13	113140521	113140521	G	A	intronic	TUBGCP3	.	.	.	0.952526134	0.047473866	3.86E-10	.	0.55085	0.13487	-1.50825116	3.503184713	46.90553	1.32419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	13	113140521	chr13:113140521	G	A	.	PASS	DP=66;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	113473599	113473600	AT	-	intronic	ATP11A	.	.	.	0.967333743	0.032666257	3.07E-11	.	0.22056	0.10642	-1.605857744	3.007784855	269.18999	3.51905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	107	13	113473598	chr13:113473598	CAT	C	145	PASS	DP=107;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
13	113534907	113534907	T	C	intronic	ATP11A	.	.	.	0.967333743	0.032666257	3.07E-11	.	0.22056	0.10642	-1.605857744	3.007784855	269.18999	3.51905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	417	13	113534907	chr13:113534907	T	C	97	PASS	DP=417;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	113882334	113882334	G	A	exonic	CUL4A	.	nonsynonymous SNV	CUL4A:NM_001008895:exon4:c.G413A:p.C138Y,CUL4A:NM_001278513:exon4:c.G113A:p.C38Y,CUL4A:NM_001278514:exon4:c.G113A:p.C38Y,CUL4A:NM_003589:exon4:c.G113A:p.C38Y	0.999412877	0.000587123	5.85E-10	.	0.61067	0.26405	-0.422438699	25.64284029	1807.63636	7.84549	0.049	0.398	D	0.052	0.210	B	0.067	0.261	B	0.000	0.843	D	1	0.810	D	2.08	0.576	M	-0.75	0.733	T	-5.39	0.850	D	0.956	0.956	-0.545	0.670	T	0.342	0.708	T	0.036	0.568	D	2.221	0.328	17.64	0.815	0.133	0.995	0.968	D	c	0.027	0.179	1.0	0.983	0.707	0.730	0	5.51	0.817	9.684	0.979	1.045	0.669	1.000	0.715	0.960	0.441	19.454	0.949	Cullin repeat-like-containing domain|Cullin, N-terminal	.	.	0.5	.	21	13	113882334	chr13:113882334	G	A	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	19378020	19378020	C	A	exonic	OR11H12	.	nonsynonymous SNV	OR11H12:NM_001013354:exon1:c.C427A:p.R143S	0.79839868	0.196005182	0.005596138	.	.	.	.	.	4405.8371	13.26123	0.075	0.344	T	0.162	0.268	B	0.039	0.223	B	0.819	0.092	N	.	.	.	1.19	0.302	L	5.03	0.013	T	-3.74	0.710	D	0.161	0.193	-0.951	0.408	T	0.004	0.014	T	.	.	.	0.707	0.161	8.876	0.755	0.107	0.005	0.022	N	c	-1.241	-1.393	0.000	0.012	0.487	0.133	0	-1.17	0.091	-5.359	0.002	0.200	0.252	0.000	0.063	0.008	0.104	6.168	0.195	GPCR, rhodopsin-like, 7TM	.	.	0.5	124	341	14	19378020	chr14:19378020	C	A	124	PASS	DP=341;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	19806550	19806550	A	T	intergenic	DUXAP10;LINC01296	dist=113634;dist=73659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	343	14	19806550	chr14:19806550	A	T	139	PASS	DP=343;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	19806717	19806717	A	C	intergenic	DUXAP10;LINC01296	dist=113801;dist=73492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	53	14	19806717	chr14:19806717	A	C	69	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	19807147	19807147	A	C	intergenic	DUXAP10;LINC01296	dist=114231;dist=73062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	218	14	19807147	chr14:19807147	A	C	149	PASS	DP=218;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	19807304	19807304	T	A	intergenic	DUXAP10;LINC01296	dist=114388;dist=72905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	14	19807304	chr14:19807304	T	A	.	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	19889580	19889580	-	GGTGGAGCGTGACCGCCTCGCCGC	ncRNA_exonic	BMS1P22	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	119	14	19889580	chr14:19889580	G	GGGTGGAGCGTGACCGCCTCGCCGC	132	PASS	DP=119;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	19889720	19889720	G	C	ncRNA_intronic	BMS1P22;DUXAP10;LINC01296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.337	0.066	0.545	0.456	0.036	0.003	0.017	N	n	-0.404	-0.229	0.000	0.012	0.075	0.013	0	.	.	0.939	0.284	0.209	0.254	0.004	0.165	0.004	0.083	.	.	.	.	.	0.5	109	486	14	19889720	chr14:19889720	G	C	109	PASS	DP=486;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	20086244	20086244	G	A	intergenic	POTEM;OR11H2	dist=65972;dist=94819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	174	14	20086244	chr14:20086244	G	A	151	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	20228354	20228354	A	G	intergenic	OR4Q3;OR4M1	dist=11826;dist=20128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	46	14	20228354	chr14:20228354	A	G	51	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	21542838	21542838	G	A	exonic	ARHGEF40	.	nonsynonymous SNV	ARHGEF40:NM_018071:exon3:c.G949A:p.E317K	7.19E-05	0.999928131	1.25E-08	.	.	.	-0.226073511	37.1255013	1688.98262	7.57807	0.169	0.230	T	0.004	0.165	B	0.004	0.127	B	0.042	0.239	N	1	0.090	N	0	0.065	N	4.45	0.022	T	-0.36	0.221	N	0.126	0.290	-0.898	0.482	T	0.005	0.016	T	0.009	0.234	T	-0.348	0.065	0.516	0.816	0.133	0.137	0.178	N	c	-0.826	-0.745	0.997	0.355	0.632	0.406	0	4.23	0.492	2.765	0.471	1.048	0.713	0.115	0.229	0.034	0.151	11.400	0.489	.	.	.	0.5	91	217	14	21542838	chr14:21542838	G	A	91	PASS	DP=217;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	21702046	21702046	-	A	intronic	HNRNPC	.	.	.	0.985848437	0.014144716	6.85E-06	.	0.16171	0.28104	-0.075159878	47.78839349	6.88559	0.25634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	11	14	21702046	chr14:21702046	C	CA	41	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	21762904	21762904	C	T	exonic	RPGRIP1	.	stopgain	RPGRIP1:NM_020366:exon2:c.C154T:p.R52X	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	.	.	.	.	.	.	.	.	.	0.591	0.110	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.421	0.975	37	0.998	0.892	0.875	0.467	D	c	0.739	0.580	0.417	0.203	0.487	0.133	0	4.52	0.546	4.035	0.568	0.832	0.339	0.998	0.411	0.036	0.153	12.617	0.558	.	.	.	0.5	58	191	14	21762904	chr14:21762904	C	T	58	PASS	DP=191;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	21762919	21762919	C	A	exonic	RPGRIP1	.	nonsynonymous SNV	RPGRIP1:NM_020366:exon2:c.C169A:p.H57N	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	1.0	0.010	T	0.172	0.271	B	0.015	0.162	B	0.003	0.363	N	1	0.090	N	1.08	0.273	L	-0.28	0.676	T	-0.3	0.142	N	0.178	0.466	-1.006	0.282	T	0.122	0.423	T	0.012	0.300	T	-0.568	0.052	0.150	0.677	0.082	0.043	0.097	N	c	-0.819	-0.763	0.002	0.087	0.487	0.133	0	2.64	0.304	0.073	0.144	0.832	0.339	0.024	0.198	0.419	0.257	9.075	0.355	.	.	.	0.5	.	49	14	21762919	chr14:21762919	C	A	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	21762920	21762920	A	T	exonic	RPGRIP1	.	nonsynonymous SNV	RPGRIP1:NM_020366:exon2:c.A170T:p.H57L	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	0.007	0.599	D	0.915	0.486	P	0.302	0.394	B	0.003	0.363	N	1	0.090	N	2.36	0.681	M	-1.21	0.787	T	-4.57	0.787	D	0.522	0.663	-0.748	0.581	T	0.243	0.611	T	0.035	0.562	D	1.437	0.235	12.98	0.939	0.233	0.047	0.103	N	c	-0.324	-0.447	0.001	0.075	0.487	0.133	0	0.783	0.176	2.220	0.423	0.064	0.169	0.036	0.206	0.414	0.256	0.820	0.010	.	.	.	0.5	.	49	14	21762920	chr14:21762920	A	T	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	21762978	21762978	G	A	intronic	RPGRIP1	.	.	.	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	38	14	21762978	chr14:21762978	G	A	42	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	21931820	21931820	C	G	exonic	RAB2B	.	nonsynonymous SNV	RAB2B:NM_001163380:exon5:c.G331C:p.E111Q,RAB2B:NM_032846:exon6:c.G469C:p.E157Q	0.000147822	0.659028489	0.340823689	.	0.37953	0.11262	0.014844891	54.94810097	24.84507	0.81541	0.001	0.784	D	0.979	0.585	D	0.846	0.587	P	0.000	0.629	D	1	0.810	D	0.965	0.241	L	-1.19	0.784	T	-2.57	0.555	D	0.546	0.583	0.051	0.833	D	0.532	0.827	D	0.046	0.626	D	6.274	0.866	29.0	0.998	0.847	0.985	0.837	D	c	0.731	0.780	1.000	0.747	0.732	0.924	0	6.01	0.974	7.681	0.833	0.932	0.445	1.000	0.715	1.000	0.888	19.286	0.940	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	56	48	14	21931820	chr14:21931820	C	G	56	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	22038042	22038042	C	A	exonic	OR10G3	.	synonymous SNV	OR10G3:NM_001005465:exon1:c.G834T:p.T278T	0.234560474	0.645560257	0.119879269	.	0.12713	0.09782	1.174022298	92.72823779	733.81635	5.37359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	106	14	22038042	chr14:22038042	C	A	99	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	22314985	22314985	T	C	intergenic	OR4E1;LINC02332	dist=175753;dist=710220	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	20	14	22314985	chr14:22314985	T	C	57	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	22315060	22315060	T	G	intergenic	OR4E1;LINC02332	dist=175828;dist=710145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	34	14	22315060	chr14:22315060	T	G	62	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
14	22974041	22974041	T	G	intergenic	OR4E1;LINC02332	dist=834809;dist=51164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	95	14	22974041	chr14:22974041	T	G	72	PASS	DP=95;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	23312863	23312863	C	G	intronic	MMP14	.	.	.	0.987123657	0.01287612	2.23E-07	DISEASE: Winchester syndrome (WNCHRS) [MIM:277950]: A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes. {ECO:0000269|PubMed:22922033}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54891	0.55746	0.04598748	57.47817882	1317.7477	6.82691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	25	14	23312863	chr14:23312863	C	G	54	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	23315908	23315908	G	-	UTR3	MMP14	NM_004995:c.*660delG	.	.	0.987123657	0.01287612	2.23E-07	DISEASE: Winchester syndrome (WNCHRS) [MIM:277950]: A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes. {ECO:0000269|PubMed:22922033}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54891	0.55746	0.04598748	57.47817882	1317.7477	6.82691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	165	98	14	23315907	chr14:23315907	AG	A	165	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	23445934	23445934	G	C	UTR5	AJUBA	NM_198086:c.-1633C>G	.	.	0.833400048	0.166570625	2.93E-05	.	0.11613	0.11895	.	.	120.81183	2.39516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	49	14	23445934	chr14:23445934	G	C	63	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	23745310	23745310	A	-	exonic	HOMEZ	.	frameshift deletion	HOMEZ:NM_020834:exon2:c.1127delT:p.L376Yfs*13	0.342229012	0.654816905	0.002954083	.	0.12857	0.09376	0.286674996	71.49681529	4926.41666	14.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	279	14	23745309	chr14:23745309	TA	T	62	PASS	DP=279;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	23777193	23777193	G	T	exonic	BCL2L2;BCL2L2-PABPN1	.	nonsynonymous SNV	BCL2L2:NM_001199839:exon3:c.G217T:p.G73C,BCL2L2-PABPN1:NM_001199864:exon3:c.G217T:p.G73C,BCL2L2:NM_004050:exon3:c.G217T:p.G73C	.	.	.	.	.	.	.	.	.	.	0.052	0.682	T	0.592	0.556	P	0.281	0.677	B	0.000	0.473	D	0.562	0.461	N	2.095	0.583	M	2.66	0.126	T	-3.18	0.656	D	0.308	0.454	-0.824	0.537	T	0.136	0.452	T	0.031	0.535	D	4.130	0.554	23.8	0.996	0.724	0.971	0.723	D	c	0.021	0.101	1.000	0.747	0.660	0.490	0	4.94	0.645	4.022	0.567	1.048	0.713	1.000	0.715	1.000	0.888	12.745	0.565	.	.	.	0.5	145	347	14	23777193	chr14:23777193	G	T	145	PASS	DP=347;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	23792215	23792215	G	A	exonic	BCL2L2-PABPN1;PABPN1	.	synonymous SNV	PABPN1:NM_004643:exon3:c.G474A:p.P158P,BCL2L2-PABPN1:NM_001199864:exon5:c.G555A:p.P185P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	97	14	23792215	chr14:23792215	G	A	67	PASS	DP=97;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	23795278	23795278	G	A	UTR3	BCL2L2-PABPN1;PABPN1	NM_001199864:c.*783G>A;NM_004643:c.*783G>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	14	23795278	chr14:23795278	G	A	.	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	23829836	23829836	G	T	exonic	EFS	.	nonsynonymous SNV	EFS:NM_005864:exon2:c.C225A:p.S75R	2.45E-06	0.494202308	0.505795246	.	0.41116	0.14682	1.734373503	96.61476763	5246.98871	14.94057	0.358	0.120	T	0.004	0.112	B	0.002	0.063	B	0.117	0.192	N	1	0.810	D	2.005	0.547	M	1.95	0.225	T	-1.16	0.297	N	0.14	0.163	-1.066	0.103	T	0.032	0.138	T	0.003	0.077	T	0.906	0.180	10.11	0.950	0.253	0.321	0.243	N	c	-0.687	-0.628	1.000	0.747	0.632	0.408	0	3.16	0.353	0.726	0.255	1.048	0.713	0.002	0.151	0.950	0.426	5.295	0.150	SH3 domain	.	.	0.5	108	98	14	23829836	chr14:23829836	G	T	108	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	23852497	23852497	T	C	exonic	MYH6	.	synonymous SNV	MYH6:NM_002471:exon37:c.A5598G:p.L1866L	1.28E-17	0.998347117	0.001652883	DISEASE: Atrial septal defect 3 (ASD3) [MIM:614089]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:15735645}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 14 (CMH14) [MIM:613251]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sick sinus syndrome 3 (SSS3) [MIM:614090]: The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors. {ECO:0000269|PubMed:21378987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. The lifetime risk of being diagnosed with sick sinus syndrome is higher for carriers of variant p.Arg721Trp than for non-carriers. {ECO:0000269|PubMed:21378987}.; 	0.84563	0.11625	-2.784931854	0.660533145	5098.77916	14.63955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	209	14	23852497	chr14:23852497	T	C	87	PASS	DP=209;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	23874506	23874506	C	A	exonic	MYH6	.	nonsynonymous SNV	MYH6:NM_002471:exon5:c.G428T:p.R143L	1.28E-17	0.998347117	0.001652883	DISEASE: Atrial septal defect 3 (ASD3) [MIM:614089]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:15735645}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 14 (CMH14) [MIM:613251]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sick sinus syndrome 3 (SSS3) [MIM:614090]: The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors. {ECO:0000269|PubMed:21378987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. The lifetime risk of being diagnosed with sick sinus syndrome is higher for carriers of variant p.Arg721Trp than for non-carriers. {ECO:0000269|PubMed:21378987}.; 	0.84563	0.11625	-2.784931854	0.660533145	5098.77916	14.63955	0.001	0.784	D	0.718	0.403	P	0.589	0.486	P	.	.	.	1.000	0.499	D	1.495	0.376	L	-2.32	0.878	D	-4.74	0.801	D	0.866	0.853	0.601	0.919	D	0.714	0.902	D	0.171	0.849	D	6.311	0.872	29.2	0.998	0.913	0.981	0.791	D	c	0.534	0.531	1.000	0.747	0.447	0.083	0	4.41	0.524	5.895	0.693	0.839	0.342	1.000	0.715	1.000	0.888	17.184	0.867	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	73	154	14	23874506	chr14:23874506	C	A	73	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	24470138	24470138	C	T	exonic	DHRS4L2	.	stopgain	DHRS4L2:NM_001193636:exon4:c.C172T:p.R58X,DHRS4L2:NM_198083:exon4:c.C475T:p.R159X,DHRS4L2:NM_001193635:exon5:c.C289T:p.R97X	0.357376762	0.630130113	0.012493125	.	0.03505	0.0907	2.465816951	98.61405992	3973.73722	12.46785	.	.	.	.	.	.	.	.	.	0.000	0.843	D	0.000	0.810	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.590	0.976	37	0.997	0.825	0.706	0.344	D	c	0.417	0.212	0.002	0.088	0.706	0.609	0	2.84	0.321	1.494	0.350	0.715	0.302	1.000	0.715	0.996	0.625	10.151	0.418	NAD(P)-binding domain	ENSG00000187630.10|ENSG00000187630.10|ENSG00000215256.3|ENSG00000157326.14|ENSG00000215256.3|ENSG00000197775.1|ENSG00000225766.4|ENSG00000187630.10|ENSG00000215256.3|ENSG00000157326.14|ENSG00000157326.14|ENSG00000215256.3|ENSG00000197775.1|ENSG00000225766.4|ENSG00000215256.3|ENSG00000197775.1	Adipose_Subcutaneous|Artery_Tibial|Artery_Tibial|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Testis|Thyroid|Thyroid	0.5	146	179	14	24470138	chr14:24470138	C	T	146	PASS	DP=179;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	24610079	24610079	C	T	intronic	EMC9	.	.	.	0.000353828	0.606584552	0.39306162	.	0.19996	0.09543	0.283038099	71.26680821	78.56922	1.87008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	196	14	24610079	chr14:24610079	C	T	59	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	31575373	31575373	-	A	intronic	HECTD1	.	.	.	1	2.36E-13	1.27E-35	.	0.71166	0.10385	-2.227040428	1.332861524	686.62409	5.23205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	198	14	31575373	chr14:31575373	T	TA	96	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	31926571	31926571	G	C	exonic	DTD2	.	nonsynonymous SNV	DTD2:NM_080664:exon1:c.C29G:p.A10G	0.001708149	0.467463368	0.530828483	.	0.25961	0.07098	-0.053113545	49.38664779	6.20561	0.23402	0.079	0.344	T	0.476	0.348	P	0.132	0.314	B	0.008	0.310	N	1.000	0.548	D	2.24	0.636	M	0.27	0.592	T	-2.5	0.543	D	0.416	0.607	-0.768	0.570	T	0.181	0.528	T	0.045	0.617	D	3.890	0.524	23.5	0.996	0.726	0.947	0.619	D	c	-0.046	-0.001	1.0	0.983	0.442	0.072	0	4.09	0.469	6.242	0.721	0.079	0.188	1.000	0.715	0.362	0.248	12.504	0.551	D-Tyr tRNAtyr deacylase-like domain	.	.	0.5	150	463	14	31926571	chr14:31926571	G	C	150	PASS	DP=463;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	32561340	32561340	G	A	exonic	ARHGAP5	.	nonsynonymous SNV	ARHGAP5:NM_001030055:exon2:c.G1465A:p.E489K,ARHGAP5:NM_001173:exon2:c.G1465A:p.E489K	0.987053698	0.012946293	9.23E-09	.	0.23723	0.16401	-0.545632343	20.02241095	177.4302	2.89547	0.043	0.413	D	0.734	0.422	P	0.562	0.519	P	0.000	0.843	D	1	0.810	D	0	0.065	N	1.47	0.320	T	-1.43	0.352	N	0.567	0.601	-1.060	0.117	T	0.106	0.388	T	.	.	.	4.656	0.624	24.5	0.998	0.901	0.993	0.948	D	c	0.617	0.730	1.0	0.983	0.707	0.730	0	6.02	0.975	10.003	0.997	1.048	0.713	1.000	0.715	1.000	0.888	20.547	0.993	FF domain	.	.	0.5	52	29	14	32561340	chr14:32561340	G	A	52	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	33408505	33408505	A	-	UTR5	NPAS3	NM_001164749:c.-18del-;NM_001165893:c.-18del-;NM_022123:c.-18del-;NM_173159:c.-18del-	.	.	0.98054867	0.019451206	1.24E-07	.	0.30103	0.1462	-1.350267166	4.600141543	902.6267	5.84777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	88	14	33408504	chr14:33408504	GA	G	69	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	33836421	33836421	A	T	exonic	NPAS3	.	nonsynonymous SNV	NPAS3:NM_001165893:exon3:c.A325T:p.S109C,NPAS3:NM_022123:exon3:c.A319T:p.S107C,NPAS3:NM_001164749:exon4:c.A415T:p.S139C,NPAS3:NM_173159:exon4:c.A376T:p.S126C	0.98054867	0.019451206	1.24E-07	.	0.30103	0.1462	-1.350267166	4.600141543	902.6267	5.84777	0.005	0.784	D	0.982	0.647	D	0.789	0.654	P	0.000	0.843	D	0.999	0.504	D	1.15	0.294	L	3.35	0.080	T	-2.44	0.548	N	0.703	0.771	-0.755	0.577	T	0.179	0.526	T	0.021	0.442	T	5.178	0.699	25.5	0.993	0.574	0.975	0.748	D	c	0.571	0.625	0.998	0.359	0.487	0.133	0	5.53	0.825	6.911	0.754	1.088	0.866	1.000	0.715	0.999	0.750	15.662	0.769	Myc-type, basic helix-loop-helix (bHLH) domain	.	.	0.5	.	31	14	33836421	chr14:33836421	A	T	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	35409214	35409214	T	C	ncRNA_exonic	IGBP1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	92	14	35409214	chr14:35409214	T	C	90	PASS	DP=92;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	36096377	36096377	G	A	exonic	RALGAPA1	.	nonsynonymous SNV	RALGAPA1:NM_001330075:exon33:c.C6635T:p.P2212L,RALGAPA1:NM_001346243:exon33:c.C5258T:p.P1753L,RALGAPA1:NM_001346246:exon33:c.C5258T:p.P1753L,RALGAPA1:NM_001346248:exon33:c.C6635T:p.P2212L,RALGAPA1:NM_014990:exon33:c.C5258T:p.P1753L,RALGAPA1:NM_194301:exon33:c.C5258T:p.P1753L,RALGAPA1:NM_001283043:exon34:c.C5297T:p.P1766L,RALGAPA1:NM_001283044:exon34:c.C5399T:p.P1800L,RALGAPA1:NM_001346245:exon34:c.C5399T:p.P1800L,RALGAPA1:NM_001346247:exon34:c.C5399T:p.P1800L,RALGAPA1:NM_001346249:exon34:c.C6776T:p.P2259L	0.999999978	2.19E-08	3.25E-24	.	0.75239	0.12918	-1.210720546	5.708893607	2267.65022	8.8021	0.001	0.784	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	N	1.000	0.810	D	2.07	0.570	M	-3.11	0.927	D	-7.27	0.967	D	0.231	0.418	-0.384	0.726	T	0.361	0.723	T	0.331	0.918	D	4.690	0.629	24.6	0.996	0.728	0.943	0.605	D	c	0.113	0.145	0.818	0.244	0.615	0.372	0	3.58	0.400	8.095	0.893	-0.234	0.093	1.000	0.715	0.988	0.529	12.161	0.532	Rap GTPase activating protein domain	.	.	0.5	.	40	14	36096377	chr14:36096377	G	A	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	36988512	36988512	C	A	exonic	NKX2-1	.	nonsynonymous SNV	NKX2-1:NM_003317:exon1:c.G51T:p.L17F,NKX2-1:NM_001079668:exon2:c.G141T:p.L47F	0.081926486	0.871861122	0.046212392	DISEASE: Chorea, hereditary benign (BHC) [MIM:118700]: A rare autosomal dominant movement disorder, defined by early onset in childhood, a stable or non-progressive course of chorea, and no mental deterioration. Chorea is characterized by involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. {ECO:0000269|PubMed:11971878, ECO:0000269|PubMed:15955952}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction (CAHTP) [MIM:610978]: An autosomal dominant disorder that manifests in infancy with neurological disturbances, hypothyroidism, and respiratory problems. It is characterized by movement abnormalities beginning with muscular hypotonia followed by the development of chorea, athetosis, dystonia, ataxia, and dysarthria. {ECO:0000269|PubMed:11854318, ECO:0000269|PubMed:11854319, ECO:0000269|PubMed:15289765, ECO:0000269|PubMed:24714694}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.81487	0.52282	1.273147413	93.66595895	44.04874	1.26407	0.0	0.912	D	0.999	0.764	D	0.998	0.875	D	0.000	0.523	D	1	0.810	D	2.155	0.604	M	-0.95	0.754	T	-3.04	0.640	D	0.954	0.952	0.226	0.864	D	0.563	0.841	D	0.321	0.915	D	5.424	0.736	26.0	0.989	0.485	0.978	0.773	D	c	0.682	0.636	1.000	0.747	0.437	0.062	0	4.16	0.480	4.559	0.603	0.855	0.374	1.000	0.715	1.000	0.888	15.002	0.710	.	.	.	0.5	123	248	14	36988512	chr14:36988512	C	A	123	PASS	DP=248;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	39591562	39591562	-	T	intronic	GEMIN2	.	.	.	0.006609197	0.97473644	0.018654363	.	0.1302	0.1438	0.016664174	55.21939137	6043.31497	16.22939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.34	29	14	39591562	chr14:39591562	C	CT	25.34	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	39746198	39746198	G	T	exonic	MIA2	.	stopgain	MIA2:NM_001247988:exon2:c.G37T:p.E13X,MIA2:NM_001247989:exon2:c.G124T:p.E42X,MIA2:NM_005930:exon2:c.G124T:p.E42X,MIA2:NM_203354:exon2:c.G88T:p.E30X,MIA2:NM_203355:exon2:c.G124T:p.E42X,MIA2:NM_203356:exon2:c.G37T:p.E13X,MIA2:NM_001329214:exon7:c.G1948T:p.E650X	0.00020882	0.908098694	0.091692485	.	0.18559	0.10293	1.133561642	92.28591649	1216.13549	6.59678	.	.	.	.	.	.	.	.	.	0.057	0.225	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.945	0.979	38	0.998	0.855	0.947	0.617	D	c	1.071	0.904	1.000	0.747	0.651	0.465	0	5.01	0.663	5.575	0.669	1.048	0.713	1.000	0.715	0.996	0.625	17.248	0.869	.	.	.	0.5	.	37	14	39746198	chr14:39746198	G	T	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	45431332	45431332	T	C	upstream	KLHL28;TOGARAM1	dist=61	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	203	14	45431332	chr14:45431332	T	C	.	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	45716019	45716019	T	-	exonic	MIS18BP1	.	frameshift deletion	MIS18BP1:NM_018353:exon2:c.471delA:p.K157Nfs*23	2.30E-05	0.999045195	0.000931804	.	0.25957	0.06969	1.743518989	96.6383581	1469.92348	7.14407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	31	14	45716018	chr14:45716018	AT	A	42	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	47120678	47120678	G	A	exonic	RPL10L	.	stopgain	RPL10L:NM_080746:exon1:c.C262T:p.R88X	0.02605492	0.787247686	0.186697394	.	0.97891	0.12334	0.17280645	65.75843359	88.18617	2.01137	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.141	0.973	37	0.998	0.916	0.835	0.423	D	c	0.658	0.470	0.000	0.048	0.487	0.133	0	2.27	0.274	6.074	0.707	0.953	0.551	1.000	0.715	1.000	0.888	11.021	0.467	Ribosomal protein L10e/L16	.	.	0.5	.	49	14	47120678	chr14:47120678	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	50300780	50300780	-	T	intronic	NEMF	.	.	.	0.981706446	0.018293554	1.48E-12	.	0.95132	.	-1.703090605	2.535975466	82.89587	1.93339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	96	14	50300780	chr14:50300780	A	AT	102	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	53064965	53064965	T	-	intronic	GPR137C	.	.	.	0.695444477	0.303743533	0.000811989	.	0.18845	.	-0.315847836	31.68789809	2850.01654	10.09383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	26	14	53064964	chr14:53064964	AT	A	40	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	53223298	53223298	C	T	exonic	STYX	.	nonsynonymous SNV	STYX:NM_145251:exon5:c.C272T:p.P91L,STYX:NM_001130701:exon6:c.C272T:p.P91L	0.972068618	0.027923972	7.41E-06	.	0.34326	0.10535	-0.163345027	41.24793583	41.45856	1.21063	0.029	0.457	D	0.883	0.466	P	0.751	0.542	P	0.000	0.843	N	1	0.810	D	2.265	0.646	M	-1.97	0.852	D	-4.26	0.761	D	0.83	0.825	0.113	0.844	D	0.671	0.886	D	0.062	0.687	D	5.296	0.716	25.7	0.998	0.897	0.989	0.889	D	c	0.579	0.611	1.000	0.747	0.706	0.609	0	5.47	0.803	6.924	0.755	0.848	0.348	1.000	0.715	1.000	0.888	19.704	0.960	Dual specificity phosphatase, catalytic domain|Dual specificity protein phosphatase domain|Protein-tyrosine phosphatase-like	.	.	0.5	.	49	14	53223298	chr14:53223298	C	T	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	59113339	59113339	G	C	exonic	DACT1	.	synonymous SNV	DACT1:NM_001079520:exon4:c.G1887C:p.V629V,DACT1:NM_016651:exon4:c.G1998C:p.V666V	0.816597553	0.183214244	0.000188203	DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22610794}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.15217	0.12544	0.202129237	67.42745931	2431.69074	9.16027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	14	59113339	chr14:59113339	G	C	.	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	59798084	59798084	G	C	exonic	DAAM1	.	nonsynonymous SNV	DAAM1:NM_014992:exon13:c.G1718C:p.G573A,DAAM1:NM_001270520:exon14:c.G1718C:p.G573A	0.999990849	9.15E-06	9.48E-16	.	0.80371	0.12758	-1.550537744	3.249587167	138.50311	2.56335	1.0	0.010	T	0.004	0.112	B	0.008	0.127	B	0.000	0.843	D	1.000	0.588	D	2.11	0.588	M	2.03	0.210	T	-1.43	0.352	N	0.349	0.410	-1.085	0.064	T	0.077	0.308	T	0.022	0.447	T	1.182	0.208	11.65	0.862	0.159	0.990	0.896	D	c	0.243	0.418	1.000	0.747	0.651	0.465	0	6.16	0.993	7.458	0.797	1.048	0.713	1.000	0.715	0.965	0.450	20.470	0.992	.	.	.	0.5	71	54	14	59798084	chr14:59798084	G	C	71	PASS	DP=54;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	64669478	64669478	T	-	intronic	SYNE2	.	.	.	1.85E-11	1	3.59E-33	DISEASE: Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21106	.	3.839142661	99.63434772	10907.00643	22.66019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	391	14	64669477	chr14:64669477	GT	G,GTT	82	PASS	DP=391;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2	./.
14	64669478	64669478	-	T	intronic	SYNE2	.	.	.	1.85E-11	1	3.59E-33	DISEASE: Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21106	.	3.839142661	99.63434772	10907.00643	22.66019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	391	14	64669477	chr14:64669477	GT	G,GTT	82	PASS	DP=391;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2	./.
14	66479768	66479768	A	C	intergenic	FUT8;CCDC196	dist=268929;dist=473321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	126	14	66479768	chr14:66479768	A	C	71	PASS	DP=126;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	67648273	67648273	G	A	UTR3	GPHN	NM_020806:c.*619G>A;NM_001024218:c.*619G>A	.	.	0.999981473	1.85E-05	1.29E-13	DISEASE: Molybdenum cofactor deficiency, complementation group C (MOCODC) [MIM:615501]: A form of molybdenum cofactor deficiency, an autosomal recessive metabolic disorder leading to the pleiotropic loss of molybdoenzyme activities. It is clinically characterized by onset in infancy of poor feeding, intractable seizures, severe psychomotor retardation, and death in early childhood in most patients. {ECO:0000269|PubMed:11095995, ECO:0000269|PubMed:22040219}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13794	0.40936	0.062575634	58.74026893	27.01369	0.87259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	14	67648273	chr14:67648273	G	A	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	68039013	68039013	G	-	intronic	PLEKHH1	.	.	.	0.000660285	0.999338194	1.52E-06	.	0.14941	0.0838	1.256589163	93.48903043	7095.83143	18.11317	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.19	79	14	68039012	chr14:68039012	CG	C	13.19	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	68221767	68221767	C	T	splicing	ZFYVE26	NM_015346:exon37:c.6986+1G>A	.	.	1.04E-11	0.999999984	1.60E-08	DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0833	0.10527	-0.274087418	33.5928285	2850.19714	10.09609	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.773	0.789	27.0	0.996	0.723	0.998	0.992	D	c	1.136	0.988	1.000	0.747	0.156	0.027	0	5.31	0.750	7.310	0.781	0.935	0.490	1.000	0.715	0.967	0.454	19.337	0.943	.	.	.	0.5	43	52	14	68221767	chr14:68221767	C	T	43	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	69254591	69254591	C	T	UTR3	ZFP36L1	NM_001244701:c.*1659G>A;NM_004926:c.*1659G>A;NM_001244698:c.*942G>A	.	.	0.506697565	0.474555905	0.01874653	.	0.93468	.	-0.053113545	49.38664779	17.82662	0.62283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	14	69254591	chr14:69254591	C	T	.	PASS	DP=70;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	70714144	70714144	A	G	ncRNA_exonic	ADAM21P1	.	.	.	.	.	.	.	.	0.09205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	14	70714144	chr14:70714144	A	G	.	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	71500710	71500710	C	T	exonic	PCNX1	.	nonsynonymous SNV	PCNX1:NM_001308160:exon16:c.C3398T:p.S1133F,PCNX1:NM_014982:exon18:c.C3731T:p.S1244F	.	.	.	.	0.12609	0.10474	-1.951619288	1.869544704	.	.	0.006	0.614	D	0.997	0.715	D	0.994	0.807	D	0.000	0.629	D	1	0.810	D	1.905	0.510	L	3.26	0.108	T	-2.64	0.566	D	0.23	0.723	-1.128	0.019	T	0.080	0.318	T	0.046	0.625	D	6.610	0.908	32	0.999	0.935	0.992	0.932	D	c	0.701	0.704	1.000	0.747	0.732	0.924	0	5.2	0.716	5.472	0.663	0.935	0.490	1.000	0.715	0.998	0.697	18.749	0.917	.	.	.	0.5	.	46	14	71500710	chr14:71500710	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	72204995	72204995	G	T	exonic	SIPA1L1	.	nonsynonymous SNV	SIPA1L1:NM_001284245:exon20:c.G5161T:p.D1721Y,SIPA1L1:NM_001284246:exon20:c.G5158T:p.D1720Y,SIPA1L1:NM_001284247:exon20:c.G5221T:p.D1741Y,SIPA1L1:NM_015556:exon21:c.G5224T:p.D1742Y	0.999999774	2.26E-07	1.15E-19	.	0.53561	0.11441	-2.73449852	0.701816466	229.73804	3.27537	1.0	0.059	T	0.904	0.479	P	0.439	0.490	B	0.000	0.513	D	0.998	0.444	D	-0.35	0.031	N	1.55	0.299	T	-0.63	0.249	N	0.645	0.711	-1.080	0.073	T	0.054	0.230	T	0.008	0.218	T	3.841	0.518	23.4	0.284	0.015	0.963	0.685	D	c	0.088	0.283	1.000	0.747	0.732	0.924	0	5.92	0.955	3.817	0.551	1.048	0.713	1.000	0.715	1.000	0.888	14.470	0.669	Signal-induced proliferation-associated 1-like protein, C-terminal	.	.	0.5	.	27	14	72204995	chr14:72204995	G	T	.	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	72941317	72941317	-	T	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	233	14	72941317	chr14:72941317	G	GT	70	PASS	DP=233;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	73442401	73442403	TTG	-	exonic	ZFYVE1	.	nonframeshift deletion	ZFYVE1:NM_001281735:exon6:c.417_419del:p.N140del,ZFYVE1:NM_178441:exon6:c.417_419del:p.N140del,ZFYVE1:NM_001281734:exon9:c.1620_1622del:p.N541del,ZFYVE1:NM_021260:exon9:c.1662_1664del:p.N555del	0.953726203	0.04627273	1.07E-06	.	0.28604	0.1203	-1.195919584	5.832743572	270.27144	3.52655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	63	14	73442400	chr14:73442400	ATTG	A	106	PASS	DP=63;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	73959622	73959622	C	T	exonic	RIOX1	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	0.803	0.432	P	0.471	0.450	P	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.406	0.232	12.82	0.904	0.191	0.882	0.477	D	n	1.877	0.469	1.000	0.747	0.288	0.042	1	5.95	0.964	3.791	0.549	0.935	0.490	1.000	0.715	0.998	0.697	18.574	0.911	.	.	.	0.5	.	29	14	73959622	chr14:73959622	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	74404756	74404756	T	C	exonic	FAM161B	.	nonsynonymous SNV	FAM161B:NM_152445:exon6:c.A1649G:p.K550R	9.86E-11	0.27905519	0.72094481	.	0.09509	0.08229	0.536463361	81.06864827	3600.98595	11.61635	0.241	0.176	T	0.767	0.418	P	0.279	0.385	B	0.016	0.281	N	0.144	0.353	P	0.995	0.252	L	1.88	0.239	T	-0.27	0.114	N	0.053	0.146	-0.906	0.474	T	0.000	0.000	T	.	.	.	1.201	0.210	11.75	0.993	0.593	0.806	0.399	D	c	0.059	0.127	0.940	0.274	0.563	0.310	0	4.31	0.505	0.772	0.261	0.964	0.580	0.998	0.411	1.000	0.888	9.615	0.387	.	ENSG00000140043.7|ENSG00000119723.11|ENSG00000140043.7|ENSG00000119723.11|ENSG00000140043.7|ENSG00000119723.11|ENSG00000119723.11|ENSG00000156050.4|ENSG00000119725.13|ENSG00000140043.7|ENSG00000119725.13|ENSG00000140043.7|ENSG00000119725.13|ENSG00000119723.11|ENSG00000140043.7|ENSG00000140043.7|ENSG00000119725.13|ENSG00000140043.7|ENSG00000119723.11|ENSG00000258586.1|ENSG00000119725.13|ENSG00000119723.11|ENSG00000119725.13|ENSG00000140043.7|ENSG00000140043.7|ENSG00000119723.11|ENSG00000258891.1|ENSG00000119723.11|ENSG00000140043.7|ENSG00000119725.13	Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Cerebellum|Breast_Mammary_Tissue|Cells_EBV-transformed_lymphocytes|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Heart_Left_Ventricle|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Small_Intestine_Terminal_Ileum|Stomach|Testis|Testis|Thyroid|Thyroid|Thyroid	0.5	56	25	14	74404756	chr14:74404756	T	C	56	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	74409329	74409329	G	A	exonic	FAM161B	.	nonsynonymous SNV	FAM161B:NM_152445:exon4:c.C1204T:p.R402W	9.86E-11	0.27905519	0.72094481	.	0.09509	0.08229	0.536463361	81.06864827	3600.98595	11.61635	0.007	0.599	D	0.999	0.764	D	0.877	0.604	P	0.872	0.088	N	1	0.090	N	2.72	0.798	M	1.86	0.243	T	-2.32	0.514	N	0.083	0.334	-0.982	0.346	T	0.106	0.387	T	0.019	0.413	T	1.981	0.299	16.09	0.992	0.560	0.174	0.196	N	c	-0.640	-0.899	1.000	0.500	0.651	0.465	0	-3.09	0.050	0.953	0.286	-1.318	0.013	0.026	0.200	0.000	0.016	5.619	0.166	.	.	.	0.5	83	162	14	74409329	chr14:74409329	G	A	83	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	74534275	74534275	-	A	intronic	ALDH6A1	.	.	.	1.62E-05	0.992502487	0.00748129	DISEASE: Methylmalonate semialdehyde dehydrogenase deficiency (MMSDHD) [MIM:614105]: A metabolic disorder characterized by elevated beta-alanine, 3-hydroxypropionic acid, and both isomers of 3-amino and 3-hydroxyisobutyric acids in urine organic acids. {ECO:0000269|PubMed:10947204}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20099	0.21694	-0.402212257	26.7338995	42.69019	1.23859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	245	14	74534274	chr14:74534274	TA	TAA,T	62	PASS	DP=245;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
14	74534275	74534275	A	-	intronic	ALDH6A1	.	.	.	1.62E-05	0.992502487	0.00748129	DISEASE: Methylmalonate semialdehyde dehydrogenase deficiency (MMSDHD) [MIM:614105]: A metabolic disorder characterized by elevated beta-alanine, 3-hydroxypropionic acid, and both isomers of 3-amino and 3-hydroxyisobutyric acids in urine organic acids. {ECO:0000269|PubMed:10947204}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20099	0.21694	-0.402212257	26.7338995	42.69019	1.23859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	245	14	74534274	chr14:74534274	TA	TAA,T	62	PASS	DP=245;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
14	74876120	74876120	G	T	exonic	SYNDIG1L	.	nonsynonymous SNV	SYNDIG1L:NM_001105579:exon2:c.C328A:p.Q110K	0.003664182	0.629708936	0.366626881	.	0.14052	.	0.571462851	81.99457419	795.52044	5.55885	1.0	0.010	T	0.008	0.135	B	0.011	0.145	B	0.684	0.061	N	1	0.090	N	2.135	0.597	M	-3.63	0.951	D	-0.64	0.187	N	0.169	0.204	-0.221	0.772	T	0.721	0.905	D	0.037	0.575	D	-1.358	0.020	0.004	0.562	0.054	0.437	0.269	N	c	-0.604	-0.574	0.999	0.371	0.615	0.372	0	3.69	0.413	2.897	0.481	0.994	0.605	0.344	0.255	0.004	0.083	13.224	0.592	.	.	.	0.5	.	46	14	74876120	chr14:74876120	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	75279493	75279493	C	T	intronic	YLPM1	.	.	.	0.999933059	6.69E-05	3.39E-19	.	.	0.10158	-2.445873847	1.020287804	805.81445	5.59253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	21	14	75279493	chr14:75279493	C	T	50	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	75388240	75388240	C	A	exonic	RPS6KL1	.	nonsynonymous SNV	RPS6KL1:NM_031464:exon2:c.G5T:p.S2I	0.000674281	0.9788712	0.020454519	.	0.10194	.	0.04598748	57.47817882	4892.98014	14.2268	0.0	0.912	D	0.998	0.715	D	0.991	0.807	D	0.011	0.298	N	0.993	0.238	N	2.39	0.691	M	0.01	0.625	T	-3.15	0.895	D	0.458	0.510	-0.860	0.513	T	0.248	0.617	T	0.061	0.683	D	5.601	0.763	26.5	0.995	0.703	0.788	0.386	D	c	0.270	0.224	1.000	0.458	0.660	0.495	0	3.26	0.363	2.273	0.428	0.852	0.362	1.000	0.715	0.781	0.330	6.163	0.195	.	.	.	0.5	81	121	14	75388240	chr14:75388240	C	A	81	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	76198733	76198734	GG	-	exonic	TTLL5	.	frameshift deletion	TTLL5:NM_015072:exon13:c.1095_1096del:p.E366Sfs*9	1.98E-09	0.999999387	6.11E-07	DISEASE: Cone-rod dystrophy 19 (CORD19) [MIM:615860]: A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:24791901}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.60603	.	-0.916836882	9.831328143	5848.36871	15.85461	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.05	24	14	76198732	chr14:76198732	TGG	T	10.05	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	77491136	77491136	C	-	UTR3	IRF2BPL	NM_024496:c.*609delG	.	.	0.968935346	0.031017133	4.75E-05	.	0.69645	0.11157	.	.	62.7394	1.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	88	14	77491135	chr14:77491135	TC	T	57	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	77491444	77491444	G	A	UTR3	IRF2BPL	NM_024496:c.*301C>T	.	.	0.968935346	0.031017133	4.75E-05	.	0.69645	0.11157	.	.	62.7394	1.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	14	77491444	chr14:77491444	G	A	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	77492786	77492786	G	A	exonic	IRF2BPL	.	synonymous SNV	IRF2BPL:NM_024496:exon1:c.C1350T:p.G450G	0.968935346	0.031017133	4.75E-05	.	0.69645	0.11157	.	.	62.7394	1.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	92	14	77492786	chr14:77492786	G	A	.	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	80320317	80320317	-	T	intronic	NRXN3	.	.	.	0.999855501	0.000144499	1.92E-11	.	0.61924	0.11925	-1.548724932	3.273177636	47.34272	1.33505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	311	14	80320317	chr14:80320317	A	AT	82	PASS	DP=311;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	80677829	80677829	T	C	ncRNA_exonic	DIO2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	66	14	80677829	chr14:80677829	T	C	60	PASS	DP=66;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	88945982	88945982	C	T	exonic	PTPN21	.	nonsynonymous SNV	PTPN21:NM_007039:exon13:c.G1793A:p.R598H	2.36E-07	0.999953846	4.59E-05	.	0.15764	0.14576	0.435344483	77.36494456	3246.49545	10.85309	0.003	0.682	D	1.0	0.899	D	0.996	0.832	D	0.000	0.843	D	1.000	0.513	D	2.74	0.803	M	-1.18	0.783	T	-2.89	0.606	D	0.626	0.646	0.357	0.884	D	0.639	0.874	D	0.402	0.934	D	7.427	0.951	34	1.000	1.000	0.991	0.913	D	c	0.772	0.719	1.000	0.747	0.718	0.821	0	5.26	0.734	6.106	0.710	0.852	0.362	1.000	0.715	0.921	0.396	18.871	0.922	.	.	.	0.5	.	67	14	88945982	chr14:88945982	C	T	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	88945998	88945998	C	T	exonic	PTPN21	.	nonsynonymous SNV	PTPN21:NM_007039:exon13:c.G1777A:p.D593N	2.36E-07	0.999953846	4.59E-05	.	0.15764	0.14576	0.435344483	77.36494456	3246.49545	10.85309	0.002	0.721	D	1.0	0.899	D	0.995	0.818	D	0.000	0.843	D	1.000	0.537	D	2.865	0.834	M	-1.6	0.822	D	-3.51	0.683	D	0.094	0.130	0.603	0.919	D	0.736	0.910	D	0.501	0.952	D	6.622	0.909	32	0.999	0.975	0.991	0.913	D	c	0.722	0.635	1.000	0.747	0.718	0.821	0	5.26	0.734	7.837	0.849	0.852	0.362	1.000	0.715	0.976	0.476	18.871	0.922	.	.	.	0.5	.	68	14	88945998	chr14:88945998	C	T	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	89629000	89629000	C	A	exonic	FOXN3	.	nonsynonymous SNV	FOXN3:NM_005197:exon6:c.G1165T:p.D389Y,FOXN3:NM_001085471:exon7:c.G1231T:p.D411Y	0.90779936	0.092051233	0.000149407	.	0.74209	0.17554	-0.356299879	29.31115829	47.54211	1.33837	0.002	0.721	D	0.997	0.689	D	0.863	0.596	P	0.000	0.491	D	0.999	0.462	D	2.395	0.694	M	-0.02	0.629	T	-3.17	0.650	D	0.739	0.736	-0.309	0.747	T	0.383	0.739	T	0.061	0.684	D	5.522	0.750	26.3	0.994	0.620	0.996	0.980	D	c	0.748	0.758	1.000	0.747	0.707	0.730	0	5.95	0.964	7.883	0.857	0.066	0.173	1.000	0.715	0.928	0.402	19.988	0.973	.	.	.	0.5	.	83	14	89629000	chr14:89629000	C	A	.	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	91467522	91467522	A	-	intronic	RPS6KA5	.	.	.	0.999801807	0.000198193	4.15E-11	.	0.66327	0.31031	-0.178111357	40.44585987	117.20806	2.35411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	73	14	91467521	chr14:91467521	GA	G	59	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	94088721	94088721	C	T	exonic	UNC79	.	synonymous SNV	UNC79:NM_020818:exon30:c.C4611T:p.L1537L,UNC79:NM_001346218:exon31:c.C5292T:p.L1764L	1	2.61E-11	1.21E-30	.	0.13734	0.1172	-1.113491624	6.634819533	491.26186	4.56078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	14	94088721	chr14:94088721	C	T	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	94245463	94245463	C	T	intronic	PRIMA1	.	.	.	0.367086766	0.583623514	0.049289721	.	0.17164	0.15948	-0.163345027	41.24793583	5.69887	0.21345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	14	94245463	chr14:94245463	C	T	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	94245589	94245589	G	A	exonic	PRIMA1	.	synonymous SNV	PRIMA1:NM_178013:exon3:c.C162T:p.C54C	0.367086766	0.583623514	0.049289721	.	0.17164	0.15948	-0.163345027	41.24793583	5.69887	0.21345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	14	94245589	chr14:94245589	G	A	.	PASS	DP=61;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	96788614	96788614	A	-	intronic	ATG2B	.	.	.	8.13E-05	0.999918726	1.75E-11	.	0.31648	.	0.486743222	79.3819297	1250.48072	6.67455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	171	14	96788613	chr14:96788613	CA	C,CAA	84	PASS	DP=171;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	96788614	96788614	-	A	intronic	ATG2B	.	.	.	8.13E-05	0.999918726	1.75E-11	.	0.31648	.	0.486743222	79.3819297	1250.48072	6.67455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	171	14	96788613	chr14:96788613	CA	C,CAA	84	PASS	DP=171;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	97022210	97022210	C	G	exonic	PAPOLA	.	nonsynonymous SNV	PAPOLA:NM_001293632:exon16:c.C941G:p.T314R,PAPOLA:NM_001293627:exon18:c.C1688G:p.T563R,PAPOLA:NM_001293628:exon18:c.C941G:p.T314R,PAPOLA:NM_032632:exon18:c.C1691G:p.T564R	0.99997169	2.83E-05	3.62E-13	.	0.90955	0.10702	-0.626318434	17.03231894	20.93686	0.70876	0.398	0.310	T	0.365	0.382	B	0.135	0.316	B	0.000	0.523	D	1.000	0.503	D	2.005	0.547	M	.	.	.	-0.2	0.197	N	0.329	0.674	-1.017	0.247	T	0.111	0.400	T	0.005	0.125	T	2.244	0.331	17.80	0.967	0.301	0.975	0.752	D	c	0.070	0.224	1.000	0.747	0.707	0.730	0	4.92	0.640	5.366	0.656	0.935	0.490	1.000	0.715	1.000	0.888	15.066	0.715	.	.	.	0.5	55	46	14	97022210	chr14:97022210	C	G	55	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	99976600	99976600	C	T	exonic	CCNK	.	synonymous SNV	CCNK:NM_001099402:exon11:c.C1224T:p.A408A	0.997144332	0.002855531	1.37E-07	.	0.88116	0.11977	-0.361761279	28.6329323	38.13805	1.13298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	14	99976600	chr14:99976600	C	T	.	PASS	DP=161;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	99976649	99976649	C	A	exonic	CCNK	.	nonsynonymous SNV	CCNK:NM_001099402:exon11:c.C1273A:p.P425T	0.997144332	0.002855531	1.37E-07	.	0.88116	0.11977	-0.361761279	28.6329323	38.13805	1.13298	0.0	0.912	D	0.19	0.277	B	0.055	0.246	B	0.000	0.629	D	1.000	0.810	D	0.975	0.246	L	2.01	0.213	T	-2.39	0.526	N	0.373	0.434	-1.066	0.103	T	0.032	0.139	T	0.025	0.484	D	2.436	0.354	19.06	0.971	0.316	0.960	0.670	D	c	-0.541	-0.466	1.000	0.489	0.651	0.465	0	3.07	0.343	5.323	0.654	0.708	0.301	1.000	0.715	0.554	0.280	11.447	0.492	.	.	.	0.5	.	267	14	99976649	chr14:99976649	C	A	.	PASS	DP=267;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	100595003	100595004	CC	-	exonic	EVL	.	frameshift deletion	EVL:NM_001330221:exon6:c.629_630del:p.Q211Gfs*83,EVL:NM_016337:exon6:c.635_636del:p.Q213Gfs*83	0.99261527	0.007384449	2.82E-07	.	0.74284	0.16663	-0.359940251	28.93371078	237.51255	3.32761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	151	14	100595002	chr14:100595002	GCC	G	62	PASS	DP=151;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	100947656	100947656	T	-	intronic	WDR25	.	.	.	0.04222611	0.951707462	0.006066428	.	0.17238	0.09554	0.270087468	70.69473933	325.26772	3.83376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	324	14	100947655	chr14:100947655	CT	C	62	PASS	DP=324;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	101012878	101012878	C	T	exonic	BEGAIN	.	nonsynonymous SNV	BEGAIN:NM_001159531:exon2:c.G136A:p.A46T,BEGAIN:NM_020836:exon3:c.G136A:p.A46T	0.890710075	0.109057883	0.000232042	.	0.15443	0.10913	-0.600630256	18.06440198	2832.62632	10.04643	0.084	0.329	T	1.0	0.899	D	0.998	0.875	D	0.000	0.843	U	1	0.810	D	1.67	0.430	L	0.89	0.456	T	-0.59	0.221	N	0.403	0.462	-0.946	0.417	T	0.169	0.510	T	0.427	0.939	D	6.399	0.883	29.6	0.997	0.787	0.751	0.365	D	c	0.340	0.344	1.0	0.983	0.685	0.552	0	4.59	0.561	2.610	0.457	0.869	0.378	0.970	0.340	0.997	0.653	14.965	0.707	.	.	.	0.5	.	91	14	101012878	chr14:101012878	C	T	.	PASS	DP=91;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	102302490	102302490	-	T	intronic	PPP2R5C	.	.	.	0.997672663	0.00232732	1.68E-08	.	0.16008	0.12741	0.018483465	55.44939844	1821.40468	7.87398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	75	14	102302490	chr14:102302490	G	GT	79	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	103193645	103193645	G	T	UTR3	RCOR1	NM_015156:c.*802G>T	.	.	0.994042795	0.005957038	1.67E-07	.	0.15896	0.16064	-0.251530012	35.42108988	30.15903	0.962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	14	103193645	chr14:103193645	G	T	.	PASS	DP=66;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	104515928	104515928	T	-	intronic	TDRD9	.	.	.	3.82E-07	0.999438651	0.000560967	.	0.12943	0.10013	-0.191064116	39.27813163	513.83114	4.63761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	36	14	104515927	chr14:104515927	CT	C	44	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	104563874	104563874	C	T	intronic	ASPG	.	.	.	1.18E-06	0.576666352	0.423332466	.	.	0.11691	0.560331224	81.70559094	4760.58672	13.97008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	225	14	104563874	chr14:104563874	C	T	82	PASS	DP=225;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	104573616	104573616	G	A	exonic	ASPG	.	nonsynonymous SNV	ASPG:NM_001080464:exon12:c.G1367A:p.R456K	1.18E-06	0.576666352	0.423332466	.	.	0.11691	0.560331224	81.70559094	4760.58672	13.97008	1.0	0.044	T	0.003	0.112	B	0.002	0.139	B	.	.	.	1	0.090	N	0.22	0.096	N	-0.11	0.645	T	-0.42	0.172	N	0.039	0.048	-1.015	0.253	T	0.097	0.365	T	0.047	0.630	D	-0.627	0.049	0.107	0.383	0.026	0.028	0.074	N	c	-1.176	-1.165	0.925	0.268	0.581	0.326	0	1.08	0.194	-0.215	0.092	1.029	0.652	0.000	0.063	0.025	0.141	5.347	0.152	Ankyrin repeat-containing domain	.	.	0.5	112	194	14	104573616	chr14:104573616	G	A	112	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	104573618	104573618	-	TT	exonic	ASPG	.	frameshift insertion	ASPG:NM_001080464:exon12:c.1369_1370insTT:p.G457Vfs*4	1.18E-06	0.576666352	0.423332466	.	.	0.11691	0.560331224	81.70559094	4760.58672	13.97008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	195	14	104573618	chr14:104573618	G	GTT	108	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	105196230	105196230	A	C	exonic	ADSSL1	.	nonsynonymous SNV	ADSSL1:NM_199165:exon1:c.A1C:p.M1L	0.000383323	0.990043419	0.009573258	.	0.25728	0.15503	-0.020150552	52.25288983	212.40167	3.1447	0.072	0.349	T	0.003	0.102	B	0.0	0.013	B	.	.	.	0.000	0.810	P	.	.	.	1.09	0.392	T	0.1	0.058	N	0.026	0.008	-0.939	0.429	T	0.000	0.000	T	.	.	.	-1.742	0.012	0.002	0.594	0.061	0.011	0.040	N	c	-1.464	-1.611	1.000	0.747	0.403	0.052	0	-0.317	0.120	-1.196	0.031	-1.937	0.005	0.040	0.208	0.001	0.043	.	.	.	ENSG00000184990.8|ENSG00000184990.8|ENSG00000185100.6|ENSG00000185100.6|ENSG00000184990.8|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000258430.1|ENSG00000179627.9|ENSG00000142208.11	Artery_Aorta|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Thyroid|Thyroid	0.5	159	140	14	105196230	chr14:105196230	A	C	159	PASS	DP=140;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	105269393	105269393	G	A	UTR3	ZBTB42	NM_001137601:c.*590G>A	.	.	.	.	.	.	.	.	0.768075923	86.8895966	146.30778	2.63567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	181	14	105269393	chr14:105269393	G	A	70	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	105269409	105269409	G	-	UTR3	ZBTB42	NM_001137601:c.*606delG	.	.	.	.	.	.	.	.	0.768075923	86.8895966	146.30778	2.63567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	297	14	105269408	chr14:105269408	TG	T	127	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	105409907	105409907	T	C	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.A11581G:p.M3861V,AHNAK2:NM_138420:exon7:c.A11881G:p.M3961V	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.821	0.029	T	0.001	0.067	B	0.002	0.063	B	.	.	.	1	0.090	P	-1.81	0.003	N	5.91	0.007	T	0.82	0.018	N	0.029	0.010	-1.031	0.201	T	0.000	0.000	T	.	.	.	-2.862	0.002	0.001	0.314	0.018	0.001	0.009	N	c	-2.060	-1.979	0.000	0.053	0.707	0.730	0	-1.33	0.086	-2.756	0.009	-2.887	0.002	0.000	0.063	0.000	0.016	5.609	0.166	.	ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000140104.9|ENSG00000185567.6|ENSG00000140104.9	Adipose_Subcutaneous|Adrenal_Gland|Artery_Tibial|Brain_Cerebellum|Brain_Cortex|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Esophagus_Muscularis|Skin_Sun_Exposed_Lower_leg	0.5	90	352	14	105409907	chr14:105409907	T	C	90	PASS	DP=352;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	105411260	105411260	A	G	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.T10228C:p.S3410P,AHNAK2:NM_138420:exon7:c.T10528C:p.S3510P	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-2.03	0.002	N	6.68	0.005	T	4.92	0.000	N	0.026	0.008	-0.939	0.428	T	0.000	0.000	T	.	.	.	-1.455	0.018	0.003	0.105	0.001	0.000	0.003	N	c	-1.915	-1.755	0.000	0.071	0.707	0.730	0	1.14	0.197	0.438	0.211	-1.940	0.005	0.006	0.172	0.000	0.016	3.781	0.081	.	.	.	0.5	76	157	14	105411260	chr14:105411260	A	G	76	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	105412138	105412138	A	G	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.T9350C:p.L3117P,AHNAK2:NM_138420:exon7:c.T9650C:p.L3217P	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.114	0.286	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.045	0.002	N	6.64	0.005	T	2.0	0.004	N	0.055	0.037	-1.036	0.187	T	0.001	0.002	T	.	.	.	0.084	0.102	3.433	0.304	0.017	0.001	0.005	N	c	-1.613	-1.536	0.000	0.061	0.476	0.093	0	2.59	0.300	-0.281	0.084	-0.582	0.045	0.000	0.063	0.000	0.016	5.350	0.152	.	.	.	0.5	65	60	14	105412138	chr14:105412138	A	G	65	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	105416936	105416936	T	C	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.A4552G:p.K1518E,AHNAK2:NM_138420:exon7:c.A4852G:p.K1618E	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.926	0.023	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.294	N	-1.4	0.006	N	5.64	0.008	T	0.63	0.024	N	0.061	0.045	-0.963	0.386	T	0.001	0.004	T	.	.	.	-0.927	0.035	0.023	0.172	0.005	0.001	0.005	N	c	-1.420	-1.302	0.006	0.110	0.672	0.522	0	4.15	0.478	0.001	0.128	-0.077	0.119	0.002	0.151	0.001	0.043	8.565	0.325	.	.	.	0.5	66	86	14	105416936	chr14:105416936	T	C	66	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	105905065	105905065	G	T	exonic	MTA1	.	stopgain	MTA1:NM_001203258:exon2:c.G85T:p.E29X,MTA1:NM_004689:exon2:c.G85T:p.E29X	0.999747857	0.000252143	7.46E-11	.	0.88976	0.22648	-1.061810361	7.519462137	2414.87209	9.12745	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.744	0.977	38	0.996	0.756	0.986	0.847	D	c	1.018	0.822	1.000	0.747	0.672	0.522	0	4.91	0.638	9.838	0.983	0.949	0.536	1.000	0.715	0.961	0.442	15.172	0.724	Bromo adjacent homology (BAH) domain	.	.	0.5	.	80	14	105905065	chr14:105905065	G	T	.	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	106091504	106091504	A	G	intergenic	MIR8071-2;MIR8071-2	dist=3987;dist=15001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	30	14	106091504	chr14:106091504	A	G	88	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	106137412	106137412	-	A	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.45	126	14	106137412	chr14:106137412	G	GA	14.45	PASS	DP=126;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	106206603	106206603	A	G	intergenic	ELK2AP;MIR4507	dist=67459;dist=117690	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	166	664	14	106206603	chr14:106206603	A	G	166	PASS	DP=664;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106206606	106206606	A	G	intergenic	ELK2AP;MIR4507	dist=67462;dist=117687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	163	658	14	106206606	chr14:106206606	A	G	163	PASS	DP=658;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106518848	106518848	T	C	intergenic	ADAM6;LINC00226	dist=80490;dist=225421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	102	14	106518848	chr14:106518848	T	C	99	PASS	DP=102;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106573251	106573251	G	A	intergenic	ADAM6;LINC00226	dist=134893;dist=171018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	132	14	106573251	chr14:106573251	G	A	130	PASS	DP=132;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106579211	106579211	A	T	intergenic	ADAM6;LINC00226	dist=140853;dist=165058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	14	106579211	chr14:106579211	A	T	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	106725332	106725332	C	T	intergenic	ADAM6;LINC00226	dist=286974;dist=18937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	201	14	106725332	chr14:106725332	C	T	128	PASS	DP=201;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	106780803	106780803	C	G	intergenic	LINC00226;LINC00221	dist=35837;dist=157642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	185	14	106780803	chr14:106780803	C	G	121	PASS	DP=185;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	106993734	106993734	C	G	intergenic	LINC00221;MIR7641-2	dist=42205;dist=98982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	30	14	106993734	chr14:106993734	C	G	69	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	107078567	107078567	T	C	intergenic	LINC00221;MIR7641-2	dist=127038;dist=14149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	33	14	107078567	chr14:107078567	T	C	84	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
14	107083633	107083633	T	C	intergenic	LINC00221;MIR7641-2	dist=132104;dist=9083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	65	14	107083633	chr14:107083633	T	C	64	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	107114193	107114193	A	G	intergenic	MIR7641-2;MIR5195	dist=21428;dist=144907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	118	14	107114193	chr14:107114193	A	G	59	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	20362835	20362835	G	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=125162	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	74	15	20362835	chr15:20362835	G	C	76	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	20434040	20434040	T	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=53957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	15	20434040	chr15:20434040	T	A	.	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	20444807	20444807	C	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=43190	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	305	15	20444807	chr15:20444807	C	A	101	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	20446047	20446047	T	G	intergenic	NONE;CHEK2P2	dist=NONE;dist=41950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	95	15	20446047	chr15:20446047	T	G	67	PASS	DP=95;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	20448169	20448169	A	G	intergenic	NONE;CHEK2P2	dist=NONE;dist=39828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	245	15	20448169	chr15:20448169	A	G	66	PASS	DP=245;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	20450231	20450231	C	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=37766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	551	15	20450231	chr15:20450231	C	A	126	PASS	DP=551;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	20457244	20457244	G	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=30753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	205	15	20457244	chr15:20457244	G	C	85	PASS	DP=205;AN=4	GT	0/1	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	20489389	20489389	G	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	146	15	20489389	chr15:20489389	G	C	78	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	20495286	20495286	A	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	277	15	20495286	chr15:20495286	A	C	159	PASS	DP=277;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.	./.
15	20495339	20495339	C	T	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	334	15	20495339	chr15:20495339	C	T	106	PASS	DP=334;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	22368600	22368600	G	C	exonic;splicing	OR4M2;LINC02203	NR_015416:exon9:c.1264+1G>C	nonsynonymous SNV	OR4M2:NM_001004719:exon1:c.G25C:p.V9L	.	.	.	.	.	.	.	.	.	.	0.006	0.614	D	0.258	0.297	B	0.126	0.311	B	0.001	0.424	D	0.780	0.293	N	2.505	0.732	M	5.64	0.008	T	-2.37	0.522	N	0.395	0.454	-1.133	0.017	T	0.006	0.021	T	0.004	0.091	T	2.568	0.370	19.90	0.990	0.492	0.632	0.318	D	c	-0.194	-0.226	0.999	0.383	0.487	0.133	0	2.5	0.292	0.492	0.220	0.681	0.295	0.094	0.225	0.584	0.286	10.808	0.455	.	.	.	0.5	73	76	15	22368600	chr15:22368600	G	C	73	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	22369145	22369145	C	T	exonic	OR4M2	.	synonymous SNV	OR4M2:NM_001004719:exon1:c.C570T:p.A190A	.	.	.	.	0.05315	0.08153	3.177250279	99.31587639	740.16744	5.40199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	15	22369145	chr15:22369145	C	T	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	22383141	22383141	C	T	exonic	OR4N4	.	synonymous SNV	OR4N4:NM_001005241:exon1:c.C669T:p.C223C	0.018050601	0.724040025	0.257909374	.	0.09536	0.07409	2.241610517	98.18353385	4448.2419	13.37082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	123	15	22383141	chr15:22383141	C	T	85	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	22413972	22413972	C	A	ncRNA_exonic	OR4N3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	15	22413972	chr15:22413972	C	A	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	22960868	22960868	G	C	exonic	CYFIP1	.	synonymous SNV	CYFIP1:NM_001033028:exon3:c.G768C:p.L256L,CYFIP1:NM_001324125:exon15:c.G1695C:p.L565L,CYFIP1:NM_001324124:exon17:c.G1971C:p.L657L,CYFIP1:NM_001324126:exon17:c.G1959C:p.L653L,CYFIP1:NM_001324119:exon18:c.G2163C:p.L721L,CYFIP1:NM_001324120:exon18:c.G2061C:p.L687L,CYFIP1:NM_001324123:exon18:c.G2061C:p.L687L,CYFIP1:NM_014608:exon18:c.G2061C:p.L687L,CYFIP1:NM_001287810:exon19:c.G2061C:p.L687L,CYFIP1:NM_001324122:exon19:c.G381C:p.L127L	0.994933032	0.005066968	1.56E-12	.	0.18853	0.14087	-1.295313867	4.989384289	2808.37817	9.99956	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	15	15	22960868	chr15:22960868	G	C	64	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	23200294	23200294	T	C	ncRNA_exonic	WHAMMP3	.	.	.	.	.	.	.	.	0.09497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	20	15	23200294	chr15:23200294	T	C	44	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	23441118	23441118	T	A	ncRNA_exonic	GOLGA8EP	.	.	.	.	.	.	.	0.09256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	15	23441118	chr15:23441118	T	A	.	PASS	DP=152;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	23892037	23892037	C	T	exonic	MAGEL2	.	nonsynonymous SNV	MAGEL2:NM_019066:exon1:c.G853A:p.G285R	0.922411269	0.077492727	9.60E-05	.	.	.	.	.	653.05336	5.12739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.166	0.200	.	.	.	.	.	.	.	.	.	3.130	0.436	22.6	0.894	0.182	0.021	0.062	N	n	1.027	1.211	1.000	0.404	0.162	0.030	1	2.18	0.267	0.361	0.199	0.790	0.321	0.005	0.169	0.963	0.446	8.335	0.312	.	.	.	0.5	.	67	15	23892037	chr15:23892037	C	T	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	24921380	24921380	G	A	exonic	NPAP1	.	nonsynonymous SNV	NPAP1:NM_018958:exon1:c.G366A:p.M122I	0.273009366	0.721810072	0.005180563	.	0.05519	0.05806	3.546886998	99.49280491	286.08933	3.62008	0.082	0.332	T	0.001	0.067	B	0.0	0.013	B	0.005	0.010	N	1	0.090	N	0	0.065	N	3.37	0.059	T	-0.84	0.229	N	0.057	0.040	-0.978	0.356	T	0.009	0.034	T	0.000	0.001	T	-1.330	0.021	0.004	0.729	0.098	0.001	0.009	N	c	-1.563	-1.664	0.069	0.155	0.487	0.133	0	-3.13	0.049	-0.735	0.050	0.535	0.282	0.000	0.063	0.009	0.108	0.246	0.002	.	.	.	0.5	.	91	15	24921380	chr15:24921380	G	A	.	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	25299375	25299375	-	A	ncRNA_exonic	SNORD116-2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	111	15	25299375	chr15:25299375	C	CA	50	PASS	DP=111;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	25432640	25432640	G	T	ncRNA_intronic	SNHG14	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	15	15	25432640	chr15:25432640	G	T	82	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.
15	25451471	25451471	A	G	ncRNA_exonic	SNORD115-20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	70	15	25451471	chr15:25451471	A	G	70	PASS	DP=70;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	25926186	25926186	G	A	exonic	ATP10A	.	synonymous SNV	ATP10A:NM_024490:exon18:c.C3528T:p.A1176A	0.611013499	0.388986496	5.02E-09	.	0.1176	0.15831	1.291519174	93.86058033	7442.03783	18.53574	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	45	15	25926186	chr15:25926186	G	A	65	PASS	DP=45;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	25926198	25926198	C	G	exonic	ATP10A	.	nonsynonymous SNV	ATP10A:NM_024490:exon18:c.G3516C:p.W1172C	0.611013499	0.388986496	5.02E-09	.	0.1176	0.15831	1.291519174	93.86058033	7442.03783	18.53574	0.0	0.912	D	1.0	0.899	D	0.984	0.745	D	0.000	0.843	D	0.000	0.588	P	2.985	0.859	M	-0.76	0.734	T	-10.64	0.991	D	0.503	0.548	-0.921	0.454	T	0.007	0.024	T	.	.	.	4.480	0.600	24.2	0.992	0.552	0.990	0.904	D	c	0.726	0.623	1.000	0.747	0.554	0.283	0	4.84	0.620	7.651	0.825	0.852	0.362	1.000	0.715	0.984	0.507	17.938	0.889	P-type ATPase, C-terminal	.	.	0.5	66	36	15	25926198	chr15:25926198	C	G	66	PASS	DP=36;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	25926204	25926204	C	G	exonic	ATP10A	.	synonymous SNV	ATP10A:NM_024490:exon18:c.G3510C:p.T1170T	0.611013499	0.388986496	5.02E-09	.	0.1176	0.15831	1.291519174	93.86058033	7442.03783	18.53574	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	35	15	25926204	chr15:25926204	C	G	65	PASS	DP=35;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	28419779	28419779	A	G	intronic	HERC2	.	.	.	1	3.99E-17	4.70E-51	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	128	15	28419779	chr15:28419779	A	G	93	PASS	DP=128;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	29444087	29444087	-	CCC	intronic	FAM189A1	.	.	.	.	.	.	.	.	.	1.460671256	95.18164661	1223.91052	6.61202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	92	15	29444087	chr15:29444087	T	TCCC	119	PASS	DP=92;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	30011233	30011233	G	A	exonic	TJP1	.	nonsynonymous SNV	TJP1:NM_175610:exon20:c.C2873T:p.T958I,TJP1:NM_001301026:exon21:c.C2885T:p.T962I,TJP1:NM_001330239:exon21:c.C3113T:p.T1038I,TJP1:NM_003257:exon21:c.C3113T:p.T1038I,TJP1:NM_001301025:exon22:c.C3314T:p.T1105I	0.999999982	1.77E-08	4.72E-23	.	0.25442	0.73774	-1.784094322	2.264685067	1761.96515	7.74921	0.083	0.361	T	0.0	0.026	B	0.001	0.063	B	0.000	0.523	D	0.997	0.227	N	-0.345	0.033	N	3.36	0.059	T	-1.4	0.404	N	0.025	0.012	-0.917	0.460	T	0.008	0.028	T	0.005	0.128	T	1.444	0.236	13.02	0.978	0.354	0.861	0.451	D	c	-0.447	-0.234	0.999	0.387	0.707	0.730	0	4.05	0.462	0.794	0.264	0.094	0.197	0.996	0.391	0.872	0.365	2.983	0.056	.	.	.	0.5	.	29	15	30011233	chr15:30011233	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	30771339	30771339	A	G	ncRNA_exonic	LOC100288203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	116	15	30771339	chr15:30771339	A	G	89	PASS	DP=116;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	30808681	30808681	G	A	intergenic	LOC100288203;DNM1P50	dist=26165;dist=52120	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	392	15	30808681	chr15:30808681	G	A	136	PASS	DP=392;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	30850264	30850264	G	C	intergenic	LOC100288203;DNM1P50	dist=67748;dist=10537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	136	15	30850264	chr15:30850264	G	C	124	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	31233063	31233063	A	C	UTR3	MTMR10	NM_017762:c.*610T>G	.	.	0.035049797	0.964614838	0.000335366	.	0.04354	.	0.378498378	75.58386412	720.47875	5.32943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	54	19	15	31233063	chr15:31233063	A	C	54	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	1/1	./.	./.	./.	./.
15	34812832	34812832	C	T	intergenic	NONE;GOLGA8B	dist=NONE;dist=4652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	297	15	34812832	chr15:34812832	C	T	113	PASS	DP=297;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	36887201	36887201	A	G	intronic	C15orf41	.	.	.	0.015552565	0.958545112	0.025902323	DISEASE: Anemia, congenital dyserythropoietic, 1B (CDAN1B) [MIM:615631]: An autosomal recessive blood disorder characterized by morphological abnormalities of erythroblasts, ineffective erythropoiesis, macrocytic anemia and secondary hemochromatosis. It is occasionally associated with bone abnormalities, especially of the hands and feet (acrodysostosis), nail hypoplasia, and scoliosis. Ultrastructural features include internuclear chromatin bridges connecting some nearly completely separated erythroblasts and an abnormal appearance (spongy or Swiss-cheese appearance) of the heterochromatin in a high proportion of the erythroblasts. {ECO:0000269|PubMed:23716552}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20546	0.10734	-0.005381972	53.50908233	4297.62941	13.04105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	36	15	36887201	chr15:36887201	A	G	40	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	40066796	40066796	G	A	intronic	FSIP1	.	.	.	4.51E-07	0.609400584	0.390598965	.	0.09176	0.07645	1.556142814	95.65935362	3550.99356	11.51445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	15	40066796	chr15:40066796	G	A	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	40384100	40384100	A	-	intronic	BMF	.	.	.	0.354021066	0.633166286	0.012812648	.	0.10921	0.1088	-0.229483771	36.86010852	9.98435	0.36607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	57	15	40384099	chr15:40384099	GA	G	103	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	41793740	41793740	A	C	exonic	ITPKA	.	nonsynonymous SNV	ITPKA:NM_002220:exon2:c.A569C:p.Q190P	0.821022369	0.17811602	0.000861612	.	0.21376	0.12708	.	.	45.24026	1.29149	0.001	0.784	D	0.998	0.715	D	0.992	0.790	D	0.000	0.843	D	1	0.810	D	2.415	0.700	M	2.16	0.192	T	-5.36	0.865	D	0.938	0.963	-0.878	0.500	T	0.139	0.458	T	0.078	0.729	D	5.972	0.821	27.7	0.992	0.559	0.990	0.899	D	c	0.755	0.710	1.000	0.747	0.455	0.088	0	4.71	0.589	9.315	0.954	1.088	0.866	1.000	0.715	0.994	0.587	14.341	0.660	.	.	.	0.5	75	103	15	41793740	chr15:41793740	A	C	75	PASS	DP=103;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	42037557	42037557	C	A	intronic	MGA	.	.	.	1	3.53E-10	3.41E-27	.	0.96192	.	-0.613924518	17.48053786	3694.31204	11.84454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	115	15	42037557	chr15:42037557	C	A	.	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	42144979	42144979	C	-	intronic	SPTBN5	.	.	.	1.09E-70	6.32E-11	1	.	0.16852	0.12091	.	.	13728.76893	25.43136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	375	15	42144978	chr15:42144978	GC	G	97	PASS	DP=375;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	42438404	42438404	C	G	exonic	PLA2G4F	.	synonymous SNV	PLA2G4F:NM_213600:exon14:c.G1455C:p.A485A	1.40E-09	0.985845067	0.014154932	.	0.06296	0.09823	1.32640619	94.10238264	1110.4377	6.37148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	94	15	42438404	chr15:42438404	C	G	118	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
15	42736369	42736369	G	A	intronic	ZNF106	.	.	.	0.219458519	0.780541481	4.04E-11	.	0.28817	0.10531	-0.448371699	24.00920028	657.40284	5.14043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	232	15	42736369	chr15:42736369	G	A	70	PASS	DP=232;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	43021459	43021459	C	T	exonic	CDAN1	.	nonsynonymous SNV	CDAN1:NM_138477:exon18:c.G2509A:p.A837T	0.928144193	0.071855806	1.10E-09	.	0.11601	0.18383	-0.828637633	11.54163718	8611.31398	20.08023	0.519	0.073	T	0.001	0.067	B	0.004	0.093	B	0.000	0.449	N	0.971	0.388	D	0	0.065	N	-1.05	0.767	T	-0.18	0.098	N	0.051	0.126	-0.927	0.446	T	0.210	0.570	T	0.041	0.597	D	2.696	0.385	20.8	0.829	0.139	0.714	0.347	D	c	-0.437	-0.302	0.999	0.398	0.646	0.442	0	0.808	0.178	0.466	0.216	0.921	0.432	0.993	0.376	0.987	0.523	2.458	0.042	Codanin-1, C-terminal domain	.	.	0.5	.	59	15	43021459	chr15:43021459	C	T	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	43622483	43622483	C	A	exonic	LCMT2	.	nonsynonymous SNV	LCMT2:NM_014793:exon1:c.G205T:p.A69S	7.27E-08	0.268667513	0.731332415	.	0.07788	0.11769	-0.042196577	50.49539986	231.36801	3.28766	0.504	0.076	T	0.506	0.354	P	0.281	0.386	B	0.052	0.229	N	1	0.810	D	1.445	0.365	L	1.9	0.235	T	0.34	0.038	N	0.264	0.321	-1.123	0.022	T	0.047	0.201	T	0.024	0.472	T	2.050	0.307	16.53	0.832	0.141	0.946	0.614	D	c	-0.343	-0.246	1.000	0.747	0.006	0.001	3	4.63	0.570	3.175	0.503	0.049	0.161	1.000	0.715	0.311	0.239	12.395	0.545	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	92	138	15	43622483	chr15:43622483	C	A	92	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	43638146	43638146	G	T	exonic	ADAL	.	nonsynonymous SNV	ADAL:NM_001012969:exon8:c.G520T:p.V174F,ADAL:NM_001159280:exon9:c.G520T:p.V174F,ADAL:NM_001324364:exon9:c.G520T:p.V174F,ADAL:NM_001324365:exon9:c.G520T:p.V174F,ADAL:NM_001324366:exon9:c.G520T:p.V174F,ADAL:NM_001324367:exon9:c.G520T:p.V174F,ADAL:NM_001324368:exon9:c.G520T:p.V174F	8.52E-09	0.044008879	0.955991112	.	0.06081	0.11351	0.260991686	70.25831564	135.20538	2.52983	0.001	0.784	D	0.993	0.657	D	0.971	0.742	D	0.000	0.843	D	1	0.810	D	3.35	0.913	M	-3.72	0.954	D	-4.13	0.759	D	0.976	0.980	1.058	0.983	D	0.936	0.979	D	0.446	0.943	D	6.431	0.887	29.8	0.996	0.738	0.986	0.846	D	c	0.943	0.904	1.000	0.747	0.732	0.924	0	5.87	0.942	7.503	0.803	1.048	0.713	1.000	0.715	0.987	0.523	18.072	0.893	Adenosine/AMP deaminase domain|Metal-dependent hydrolase	.	.	0.5	85	57	15	43638146	chr15:43638146	G	T	85	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
15	44818174	44818174	A	-	UTR3	CTDSPL2	NM_016396:c.*1802delA	.	.	0.995978214	0.004021723	6.38E-08	.	0.20513	0.11371	-0.0274281	51.65723048	83.72355	1.94762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	16	15	44818173	chr15:44818173	CA	C	41	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	44941137	44941137	C	T	exonic	SPG11	.	nonsynonymous SNV	SPG11:NM_001160227:exon7:c.G1529A:p.S510N,SPG11:NM_025137:exon7:c.G1529A:p.S510N	2.91E-22	0.995686251	0.004313749	.	0.48298	0.1128	-0.481610219	22.78839349	5573.81365	15.43136	0.167	0.332	T	1.0	0.899	D	0.999	0.916	D	0.000	0.843	N	0.999	0.467	D	2.74	0.803	M	-1.42	0.807	T	-1.1	0.314	N	0.052	0.094	0.170	0.854	D	0.608	0.861	D	0.038	0.580	D	5.898	0.809	27.5	0.993	0.596	0.900	0.506	D	c	0.545	0.535	1.000	0.424	0.707	0.730	0	4.93	0.643	3.608	0.536	0.935	0.490	1.000	0.715	1.000	0.888	14.360	0.662	.	.	.	0.5	59	37	15	44941137	chr15:44941137	C	T	59	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	45364707	45364707	G	-	intronic	SORD	.	.	.	0.004347946	0.962638319	0.033013735	.	0.48997	0.60308	0.863528995	88.74144845	2436.461	9.17126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	18	15	45364706	chr15:45364706	TG	T	42	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	45400207	45400207	G	A	intronic	DUOX2	.	.	.	1.90E-37	3.81E-06	0.999996187	DISEASE: Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]: A disorder due to a defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:12110737, ECO:0000269|PubMed:16134168, ECO:0000269|PubMed:16322276, ECO:0000269|PubMed:20187165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15059	0.21524	0.227640447	68.52441614	1216.76018	6.60084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	15	45400207	chr15:45400207	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	49117125	49117125	-	T	UTR3	SHC4	NM_203349:c.*1042_*1043insA	.	.	1.17E-05	0.988149866	0.011838437	.	0.29902	0.12806	-0.709045403	14.673272	251.32202	3.41544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	19	15	49117125	chr15:49117125	G	GT	98	PASS	DP=19;AN=2	GT	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	49584749	49584749	G	C	intronic	GALK2	.	.	.	8.74E-06	0.924426156	0.075565103	.	0.20809	0.14099	-0.179930907	40.35739561	96.73851	2.12614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	34	15	49584749	chr15:49584749	G	C	53	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	56435086	56435086	G	A	exonic	RFX7	.	synonymous SNV	RFX7:NM_022841:exon4:c.C291T:p.A97A	0.999680946	0.000319054	1.32E-10	.	0.76512	0.10256	.	.	372.49082	4.07209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	43	15	56435086	chr15:56435086	G	A	72	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	59912375	59912375	T	-	downstream	GCNT3	dist=165	.	.	4.04E-09	0.054399435	0.945600561	.	0.11221	0.09788	0.446457185	77.97829677	58.26865	1.54572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	180	15	59912374	chr15:59912374	AT	A	65	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	59981640	59981640	C	A	UTR5	BNIP2	NM_001320674:c.-1G>T;NM_004330:c.-1G>T	.	.	1.69E-05	0.671754446	0.328228624	.	0.59599	0.12477	-0.336073593	30.55555556	3900.56272	12.33278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	189	15	59981640	chr15:59981640	C	A	128	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	62534764	62534764	A	-	ncRNA_exonic	GOLGA2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	29.9	59	15	62534763	chr15:62534763	TA	T	29.9	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	62994910	62994990	TGGCACTGGAGGAAATGCGTTTTCTTTCCAATTAAGGTGTGTTGTTTGTTCACAGCCTCGACAGACAGTTTTGACTGCTGC	-	exonic	TLN2	.	frameshift deletion	TLN2:NM_015059:exon16:c.1906_1931del:p.P636Wfs*17	0.999853231	0.000146769	3.85E-21	.	0.30553	0.44698	-3.469503166	0.353857042	2221.48407	8.67915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.23	16	15	62994909	chr15:62994909	ATGGCACTGGAGGAAATGCGTTTTCTTTCCAATTAAGGTGTGTTGTTTGTTCACAGCCTCGACAGACAGTTTTGACTGCTGC	A	18.23	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	63447893	63447893	C	G	exonic	RPS27L	.	nonsynonymous SNV	RPS27L:NM_015920:exon3:c.G153C:p.Q51H	0.335851902	0.603407942	0.060740156	.	0.35212	0.08617	0.101211609	60.95777306	22.08009	0.7413	0.008	0.599	D	0.977	0.566	D	0.926	0.644	D	0.000	0.843	D	0.999	0.463	D	.	.	.	.	.	.	-4.7	0.806	D	0.937	0.931	-0.385	0.725	T	0.364	0.725	T	0.027	0.500	D	4.623	0.619	24.5	0.997	0.795	0.876	0.469	D	c	0.429	0.400	1.000	0.747	0.660	0.490	0	2.71	0.310	4.090	0.572	0.935	0.490	1.000	0.715	0.997	0.653	9.976	0.408	Ribosomal protein S27e, zinc-binding domain|Zinc-binding ribosomal protein	.	.	0.5	71	47	15	63447893	chr15:63447893	C	G	71	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	63481976	63481976	G	T	intronic	RAB8B	.	.	.	0.049515248	0.92805035	0.022434402	.	0.09665	0.13588	-0.053113545	49.38664779	6.15812	0.23191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	15	63481976	chr15:63481976	G	T	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	63578882	63578882	G	C	intronic	APH1B	.	.	.	0.000234972	0.755441753	0.244323275	.	0.35427	0.1717	0.527368849	80.73248408	641.866	5.09067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	69	15	63578882	chr15:63578882	G	C	73	PASS	DP=69;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	63638658	63638658	G	A	intronic	CA12	.	.	.	9.91E-09	0.168655225	0.831344765	.	0.21265	0.1284	-0.622676946	17.30950696	40.85482	1.19656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	15	63638658	chr15:63638658	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	64983838	64983838	T	-	intronic	OAZ2	.	.	.	0.866153028	0.131948234	0.001898738	.	0.70388	.	.	.	17.63191	0.61771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.25	34	15	64983837	chr15:64983837	AT	A	13.25	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	65208025	65208025	G	A	exonic	ANKDD1A	.	nonsynonymous SNV	ANKDD1A:NM_182703:exon2:c.G64A:p.A22T	1.16E-15	0.005458509	0.994541491	.	0.10053	0.09163	-0.24061166	36.28214201	2935.68232	10.27688	.	.	.	1.0	0.899	D	0.999	0.916	D	.	.	.	1.000	0.501	D	3.245	0.900	M	.	.	.	.	.	.	0.517	0.559	0.233	0.865	D	0.650	0.878	D	0.017	0.382	T	5.257	0.710	25.7	0.999	0.970	0.782	0.383	D	c	0.393	0.221	1.000	0.747	0.554	0.283	0	2.88	0.325	4.419	0.593	0.100	0.199	1.000	0.715	0.746	0.321	7.207	0.249	Ankyrin repeat-containing domain	.	.	0.5	.	29	15	65208025	chr15:65208025	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	65674776	65674776	C	T	UTR3	IGDCC4	NM_020962:c.*1571G>A	.	.	0.014885498	0.985104501	1.00E-05	.	.	0.12313	0.85606445	88.52323661	4828.87634	14.09369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	15	65674776	chr15:65674776	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	66207746	66207746	C	T	intronic	MEGF11	.	.	.	2.52E-24	0.000112093	0.999887907	.	0.35561	0.08845	-0.635637306	16.76102854	4063.5662	12.63975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	15	66207746	chr15:66207746	C	T	.	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	66786707	66786709	GAG	-	UTR3	SNAPC5	NM_001329615:c.*67_*65delCTC;NM_001329614:c.*67_*65delCTC;NM_001329613:c.*67_*65delCTC	.	.	1.40E-05	0.125603911	0.874382068	.	0.08216	0.11262	-0.09720619	46.20193442	24.24987	0.79777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	38	15	66786706	chr15:66786706	TGAG	T	105	PASS	DP=38;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	67892147	67892147	G	A	intronic	MAP2K5	.	.	.	0.475918461	0.524072679	8.86E-06	.	0.38366	0.21895	-0.692458599	14.96815287	37.4829	1.11572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	15	67892147	chr15:67892147	G	A	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	67999548	67999548	C	T	intronic	MAP2K5	.	.	.	0.475918461	0.524072679	8.86E-06	.	0.38366	0.21895	-0.692458599	14.96815287	37.4829	1.11572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	15	67999548	chr15:67999548	C	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	69018137	69018137	C	T	intronic	CORO2B	.	.	.	0.779053737	0.220882015	6.42E-05	.	0.50461	0.11034	-0.380166007	27.88393489	54.48241	1.47592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	15	15	69018137	chr15:69018137	C	T	50	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	69072347	69072347	-	G	UTR3	ANP32A	NM_006305:c.*72_*73insC	.	.	0.973870036	0.026098984	3.10E-05	.	0.54777	0.25991	-0.075159878	47.78839349	4.49266	0.16267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	179	15	69072346	chr15:69072346	AG	AGG,A	54	PASS	DP=179;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	69072347	69072347	G	-	UTR3	ANP32A	NM_006305:c.*73delC	.	.	0.973870036	0.026098984	3.10E-05	.	0.54777	0.25991	-0.075159878	47.78839349	4.49266	0.16267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	179	15	69072346	chr15:69072346	AG	AGG,A	54	PASS	DP=179;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	71256253	71256253	A	G	exonic	LRRC49	.	synonymous SNV	LRRC49:NM_001199017:exon9:c.A918G:p.L306L,LRRC49:NM_017691:exon9:c.A903G:p.L301L,LRRC49:NM_001199018:exon10:c.A771G:p.L257L,LRRC49:NM_001284357:exon10:c.A873G:p.L291L	0.446510312	0.553478597	1.11E-05	.	0.18522	0.11023	-0.666770504	15.86459071	4621.78815	13.66012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	44	15	71256253	chr15:71256253	A	G	83	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
15	74368297	74368297	C	G	exonic	GOLGA6A	.	nonsynonymous SNV	GOLGA6A:NM_001038640:exon8:c.G594C:p.Q198H	0.224411354	0.739591664	0.035996982	.	.	0.07726	.	.	525.23752	4.67589	0.099	0.306	T	0.966	0.542	D	0.891	0.614	P	.	.	.	1	0.090	N	2.4	0.697	M	1.85	0.245	T	-2.28	0.508	N	0.036	0.016	-1.040	0.172	T	0.079	0.313	T	.	.	.	1.002	0.190	10.67	0.970	0.314	0.001	0.007	N	c	-0.614	-0.905	0.000	0.052	0.554	0.246	0	-1.05	0.095	-1.640	0.021	-0.440	0.057	0.000	0.063	0.000	0.016	5.104	0.140	.	.	.	0.5	145	145	15	74368297	chr15:74368297	C	G	145	PASS	DP=145;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	74510992	74510992	G	A	intergenic	STRA6;CCDC33	dist=8946;dist=17638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	149	15	74510992	chr15:74510992	G	A	113	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	75981256	75981256	G	T	exonic	CSPG4	.	nonsynonymous SNV	CSPG4:NM_001897:exon3:c.C2150A:p.A717E	8.90E-05	0.999905547	5.48E-06	.	0.14288	0.14191	0.347031518	73.79098844	3644.03559	11.72399	0.417	0.099	T	0.808	0.433	P	0.274	0.383	B	0.433	0.127	N	1	0.090	N	2.6	0.763	M	1.79	0.255	T	-0.4	0.138	N	0.377	0.437	-1.081	0.072	T	0.051	0.217	T	0.010	0.255	T	-0.941	0.034	0.021	0.756	0.108	0.778	0.380	D	c	-0.083	-0.098	0.992	0.328	0.598	0.340	0	4.56	0.555	4.615	0.607	0.970	0.593	0.998	0.411	0.049	0.163	10.038	0.411	.	.	.	0.5	.	46	15	75981256	chr15:75981256	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	75981972	75981972	A	G	exonic	CSPG4	.	synonymous SNV	CSPG4:NM_001897:exon3:c.T1434C:p.H478H	8.90E-05	0.999905547	5.48E-06	.	0.14288	0.14191	0.347031518	73.79098844	3644.03559	11.72399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	15	75981972	chr15:75981972	A	G	.	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	75981976	75981976	C	T	exonic	CSPG4	.	nonsynonymous SNV	CSPG4:NM_001897:exon3:c.G1430A:p.R477H	8.90E-05	0.999905547	5.48E-06	.	0.14288	0.14191	0.347031518	73.79098844	3644.03559	11.72399	0.544	0.067	T	0.513	0.355	P	0.079	0.272	B	0.000	0.443	D	0.953	0.264	N	2.595	0.761	M	2.14	0.194	T	-1.73	0.410	N	0.372	0.433	-1.046	0.155	T	0.043	0.183	T	0.012	0.305	T	1.800	0.277	14.99	0.985	0.415	0.249	0.223	N	c	-0.353	-0.402	0.998	0.357	0.554	0.283	0	4.19	0.485	0.882	0.276	0.785	0.317	0.003	0.159	0.003	0.074	9.359	0.372	.	.	.	0.5	.	107	15	75981976	chr15:75981976	C	T	.	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	76074518	76074518	T	G	intergenic	MIR4313;UBE2Q2	dist=19862;dist=61109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	160	161	15	76074518	chr15:76074518	T	G	160	PASS	DP=161;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	76463300	76463300	G	T	intronic	TMEM266	.	.	.	.	.	.	.	0.25737	.	0.20030965	67.3566879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	15	76463300	chr15:76463300	G	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	77310786	77310786	T	-	intronic	PSTPIP1	.	.	.	0.00072615	0.980795876	0.018477974	DISEASE: PAPA syndrome (PAPAS) [MIM:604416]: Characterized by autosomal dominant inheritance of early-onset, primarily affecting skin and joint tissues. Recurring inflammatory episodes lead to accumulation of sterile, pyogenic, neutrophil-rich material within the affected joints, ultimately resulting in significant destruction. {ECO:0000269|PubMed:11971877, ECO:0000269|PubMed:22161697}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18907	0.17191	0.312359769	72.71172446	220.82961	3.2135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	239	15	77310785	chr15:77310785	CT	C,CTT	66	PASS	DP=239;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	77310786	77310786	-	T	intronic	PSTPIP1	.	.	.	0.00072615	0.980795876	0.018477974	DISEASE: PAPA syndrome (PAPAS) [MIM:604416]: Characterized by autosomal dominant inheritance of early-onset, primarily affecting skin and joint tissues. Recurring inflammatory episodes lead to accumulation of sterile, pyogenic, neutrophil-rich material within the affected joints, ultimately resulting in significant destruction. {ECO:0000269|PubMed:11971877, ECO:0000269|PubMed:22161697}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18907	0.17191	0.312359769	72.71172446	220.82961	3.2135	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	239	15	77310785	chr15:77310785	CT	C,CTT	66	PASS	DP=239;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	78207469	78207469	C	G	ncRNA_exonic	LOC645752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	18	15	78207469	chr15:78207469	C	G	61	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	78207569	78207569	G	A	ncRNA_exonic	LOC645752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	139	15	78207569	chr15:78207569	G	A	.	PASS	DP=139;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	78207729	78207729	G	C	ncRNA_intronic	LOC645752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	100	15	78207729	chr15:78207729	G	C	73	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	78214375	78214375	T	C	ncRNA_exonic	LOC645752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	59	15	78214375	chr15:78214375	T	C	76	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	78271392	78271394	TGG	-	intergenic	LOC645752;LOC91450	dist=52204;dist=14181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	38	15	78271391	chr15:78271391	CTGG	C	112	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	78310281	78310282	TG	-	exonic	TBC1D2B	.	stopgain	TBC1D2B:NM_015079:exon7:c.1488_1489del:p.Y496fs*0,TBC1D2B:NM_144572:exon7:c.1488_1489del:p.Y496fs*0	6.51E-05	0.99487708	0.00505782	.	0.17736	0.11001	0.068033485	59.0351498	1987.47287	8.21355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	22	15	78310280	chr15:78310280	TTG	T	39	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	78397503	78397503	-	T	UTR3	CIB2	NM_001301224:c.*149_*150insA;NM_001271889:c.*149_*150insA;NM_001271888:c.*149_*150insA;NM_006383:c.*149_*150insA	.	.	0.000468493	0.667683033	0.331848474	DISEASE: Usher syndrome 1J (USH1J) [MIM:614869]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:23023331}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40943	0.13588	-0.293801652	32.93819297	57.97419	1.53939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	174	15	78397503	chr15:78397503	G	GT	116	PASS	DP=174;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
15	78632830	78632830	C	G	exonic	CRABP1	.	synonymous SNV	CRABP1:NM_004378:exon1:c.C60G:p.L20L	0.125504894	0.780082092	0.094413014	.	0.5128	0.35026	-0.163345027	41.24793583	9.97302	0.36559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	49	15	78632830	chr15:78632830	C	G	55	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	80452172	80452172	G	C	exonic	FAH	.	synonymous SNV	FAH:NM_000137:exon3:c.G267C:p.L89L	2.81E-11	0.142874356	0.857125644	.	0.1414	0.24341	-0.909290275	10.03184713	149.7435	2.66839	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	20	15	80452172	chr15:80452172	G	C	52	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	81281900	81281900	G	A	intronic	MESD	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	198	15	81281900	chr15:81281900	G	A	87	PASS	DP=198;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	82935129	82935129	C	G	exonic	GOLGA6L10	.	nonsynonymous SNV	GOLGA6L10:NM_001322400:exon6:c.G451C:p.E151Q	0.36895894	0.48046894	0.15057212	.	.	.	.	.	738.28141	5.39276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	410	15	82935129	chr15:82935129	C	G	83	PASS	DP=410;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	83014106	83014106	T	C	exonic	GOLGA6L10	.	synonymous SNV	GOLGA6L10:NM_001164465:exon6:c.A477G:p.V159V	0.36895894	0.48046894	0.15057212	.	.	.	.	.	738.28141	5.39276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	197	15	83014106	chr15:83014106	T	C	72	PASS	DP=197;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	83216008	83216008	T	-	intronic	CPEB1	.	.	.	0.999591314	0.000408684	1.20E-09	.	0.40504	0.10369	-0.556537043	19.72753008	3672.85414	11.77381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	53	15	83216007	chr15:83216007	CT	C	42	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	84527569	84527569	C	T	exonic	ADAMTSL3	.	nonsynonymous SNV	ADAMTSL3:NM_001301110:exon8:c.C779T:p.T260I,ADAMTSL3:NM_207517:exon8:c.C779T:p.T260I	9.55E-09	0.999999675	3.15E-07	.	0.29754	0.10931	0.334233824	73.62585515	5035.60394	14.49965	0.107	0.295	T	0.589	0.764	P	0.413	0.832	B	0.884	0.072	N	0.989	0.409	D	1.23	0.308	L	-0.15	0.659	T	-1.63	0.418	N	0.55	0.690	-0.712	0.599	T	0.356	0.719	T	0.036	0.571	D	3.940	0.530	23.5	0.998	0.876	0.836	0.424	D	c	0.106	0.111	0.993	0.329	0.554	0.246	0	3.64	0.407	4.101	0.573	0.807	0.329	0.998	0.411	0.995	0.604	10.341	0.429	.	.	.	0.5	.	28	15	84527569	chr15:84527569	C	T	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	84945512	84945512	C	T	intergenic	GOLGA6L4;LOC103171574	dist=31392;dist=31705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	159	15	84945512	chr15:84945512	C	T	82	PASS	DP=159;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	84946642	84946642	C	G	intergenic	GOLGA6L4;LOC103171574	dist=32522;dist=30575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	111	15	84946642	chr15:84946642	C	G	105	PASS	DP=111;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	86286780	86286780	G	C	exonic	AKAP13	.	nonsynonymous SNV	AKAP13:NM_001270546:exon28:c.G3979C:p.E1327Q,AKAP13:NM_006738:exon36:c.G8128C:p.E2710Q,AKAP13:NM_007200:exon36:c.G8116C:p.E2706Q	0.84956602	0.15043398	4.29E-15	.	0.2224	0.22007	1.988827491	97.64095305	3944.37006	12.42106	0.008	0.586	D	0.993	0.670	D	0.782	0.615	P	.	.	.	0.629	0.328	D	2.075	0.572	M	0.84	0.475	T	-1.2	0.305	N	0.34	0.401	-0.464	0.700	T	0.251	0.621	T	0.022	0.455	T	3.840	0.518	23.4	0.998	0.850	0.982	0.802	D	c	0.609	0.577	1.000	0.747	0.707	0.730	0	5.73	0.897	6.416	0.730	1.048	0.713	1.000	0.715	0.039	0.156	17.069	0.864	.	.	.	0.5	65	51	15	86286780	chr15:86286780	G	C	65	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	89416087	89416087	A	T	intronic	ACAN	.	.	.	0.999993945	6.06E-06	1.71E-15	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3407	0.5702	1.284310712	93.77211607	15528.89086	26.89264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	55	15	89416087	chr15:89416087	A	T	88	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
15	89421327	89421327	A	G	exonic	HAPLN3	.	synonymous SNV	HAPLN3:NM_178232:exon5:c.T957C:p.G319G,HAPLN3:NM_001307952:exon6:c.T1143C:p.G381G	3.92E-06	0.370376544	0.629619539	.	0.1436	0.10628	-0.354480518	29.42911064	4444.58352	13.35637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	206	250	15	89421327	chr15:89421327	A	G	206	PASS	DP=250;AN=2	GT	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	89659704	89659704	C	T	exonic	ABHD2	.	nonsynonymous SNV	ABHD2:NM_152924:exon3:c.C146T:p.S49L,ABHD2:NM_007011:exon7:c.C146T:p.S49L	0.84946372	0.150426271	0.000110009	.	0.19174	0.12265	-0.025608647	51.91672564	42.87383	1.24066	0.063	0.614	T	0.377	0.325	B	0.079	0.272	B	0.000	0.629	D	1.000	0.588	D	1.525	0.387	L	2.36	0.161	T	-2.73	0.757	D	0.404	0.481	-1.130	0.018	T	0.042	0.181	T	0.010	0.255	T	4.455	0.596	24.2	0.998	0.927	0.991	0.913	D	c	0.320	0.490	1.0	0.983	0.707	0.730	0	5.91	0.952	7.905	0.864	0.935	0.490	1.000	0.715	0.995	0.604	20.299	0.986	.	.	.	0.5	65	63	15	89659704	chr15:89659704	C	T	65	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	90774448	90774451	AGAG	-	intronic	CIB1	.	.	.	0.016102965	0.883934356	0.099962679	.	0.1621	0.27055	-0.295622497	32.61972163	38.05583	1.13067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	40	15	90774447	chr15:90774447	TAGAG	T	40	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	90808018	90808018	T	C	upstream	NGRN	dist=877	.	.	0.022406215	0.910697225	0.06689656	.	0.03947	.	-0.047654689	50.22410946	226.47856	3.25183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	47	65	15	90808018	chr15:90808018	T	C	47	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	91575679	91575681	CCT	-	intergenic	LOC101926911;SV2B	dist=1310;dist=67137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	38	15	91575678	chr15:91575678	GCCT	G	44	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	93534774	93534774	C	G	intronic	CHD2	.	.	.	0.999999999	1.15E-09	1.23E-26	DISEASE: Epileptic encephalopathy, childhood-onset (EEOC) [MIM:615369]: A severe form of epilepsy characterized by onset of multiple seizure types in the first few years of life and associated with poor prognosis. Affected individuals have cognitive regression and intellectual disability. {ECO:0000269|PubMed:23708187}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56985	0.10377	-1.745389579	2.37084218	175.7961	2.88554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	48	15	93534774	chr15:93534774	C	G	65	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	99023968	99023968	T	G	exonic	FAM169B	.	synonymous SNV	FAM169B:NM_182562:exon4:c.A45C:p.L15L	0.001356899	0.656623918	0.342019183	.	.	.	0.749657564	86.56522765	50.63929	1.40077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	10	15	99023968	chr15:99023968	T	G	43	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
15	100331824	100331824	A	C	ncRNA_exonic	DNM1P46	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	321	15	100331824	chr15:100331824	A	C	102	PASS	DP=321;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	100821467	100821467	G	A	exonic	ADAMTS17	.	synonymous SNV	ADAMTS17:NM_139057:exon4:c.C756T:p.A252A	3.83E-11	0.995733613	0.004266387	DISEASE: Weill-Marchesani-like syndrome (WMLS) [MIM:613195]: A disorder characterized by many of the key features of Weill- Marchesani syndrome, including lenticular myopia, ectopia lentis, glaucoma, spherophakia and short stature. However, the characteristic brachydactyly or decreased joint flexibility of Weill-Marchesani syndrome are absent. {ECO:0000269|PubMed:19836009}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24727	0.12398	-2.267592656	1.262090116	3746.43136	11.97553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	432	15	100821467	chr15:100821467	G	A	112	PASS	DP=432;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	102287990	102287990	T	-	upstream	LOC100128108	dist=917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	198	15	102287989	chr15:102287989	AT	A	71	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	102315105	102315105	C	T	intergenic	LOC100128108;OR4F6	dist=28032;dist=30818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	38	15	102315105	chr15:102315105	C	T	61	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	102515257	102515257	C	T	ncRNA_exonic	WASH3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	1098	15	102515257	chr15:102515257	C	T	168	PASS	DP=1098;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	102516373	102516373	C	T	ncRNA_exonic	WASH3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	619	15	102516373	chr15:102516373	C	T	149	PASS	DP=619;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	74287	74287	C	G	ncRNA_exonic	WASIR2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	885	16	74287	chr16:74287	C	G	153	PASS	DP=885;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	242923	242923	C	G	intronic	LUC7L	.	.	.	0.164212797	0.835159363	0.00062784	.	0.53946	0.08557	0.040529541	57.15380986	47.06421	1.32691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	253	16	242923	chr16:242923	C	G	83	PASS	DP=253;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	336252	336252	G	C	intronic	PDIA2	.	.	.	2.53E-21	1.80E-05	0.999982002	.	0.14665	0.10678	2.702925512	98.90304317	3052.49003	10.50276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	97	16	336252	chr16:336252	G	C	95	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	456416	456416	T	G	intronic	DECR2	.	.	.	3.47E-09	0.04976336	0.950236636	.	0.30516	0.13063	-0.244249595	36.17008728	109.53122	2.27353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	91	16	456416	chr16:456416	T	G	86	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	737687	737687	G	C	exonic	WDR24	.	synonymous SNV	WDR24:NM_032259:exon2:c.C534G:p.T178T	0.004702416	0.98892357	0.006374014	.	0.17124	0.10703	-0.461076406	23.66124086	1952.56454	8.13191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	16	737687	chr16:737687	G	C	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	1245077	1245077	C	T	exonic	CACNA1H	.	synonymous SNV	CACNA1H:NM_001005407:exon3:c.C405T:p.I135I,CACNA1H:NM_021098:exon3:c.C405T:p.I135I	0.755916976	0.244083023	1.19E-09	DISEASE: Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. {ECO:0000269|PubMed:15048902}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, childhood absence 6 (ECA6) [MIM:611942]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:12891677}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.1215	0.15825	-2.059460781	1.627742392	3476.91536	11.35078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	95	16	1245077	chr16:1245077	C	T	65	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	1260333	1260333	G	A	intronic	CACNA1H	.	.	.	0.755916976	0.244083023	1.19E-09	DISEASE: Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. {ECO:0000269|PubMed:15048902}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, childhood absence 6 (ECA6) [MIM:611942]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:12891677}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.1215	0.15825	-2.059460781	1.627742392	3476.91536	11.35078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	16	1260333	chr16:1260333	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	1260386	1260386	C	A	exonic	CACNA1H	.	nonsynonymous SNV	CACNA1H:NM_001005407:exon19:c.C3862A:p.Q1288K,CACNA1H:NM_021098:exon19:c.C3862A:p.Q1288K	0.755916976	0.244083023	1.19E-09	DISEASE: Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. {ECO:0000269|PubMed:15048902}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, childhood absence 6 (ECA6) [MIM:611942]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:12891677}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.1215	0.15825	-2.059460781	1.627742392	3476.91536	11.35078	0.098	0.308	T	0.003	0.228	B	0.009	0.225	B	0.000	0.629	D	0.994	0.421	D	3.1	0.878	M	-4.11	0.967	D	-2.36	0.521	N	0.208	0.612	0.677	0.929	D	0.821	0.940	D	0.232	0.884	D	2.348	0.343	18.48	0.903	0.189	0.989	0.877	D	c	-0.104	-0.038	1.000	0.500	0.696	0.567	0	3.75	0.421	5.883	0.693	0.798	0.323	1.000	0.715	0.219	0.221	15.057	0.715	.	.	.	0.5	62	94	16	1260386	chr16:1260386	C	A	62	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	1382898	1382898	-	A	upstream	BAIAP3	dist=708	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	133	16	1382898	chr16:1382898	G	GA	41	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	1388492	1388492	G	T	intronic	BAIAP3	.	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	16	1388492	chr16:1388492	G	T	.	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	1395408	1395408	G	A	intronic	BAIAP3	.	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	16	1395408	chr16:1395408	G	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	1402200	1402200	G	T	intronic	GNPTG	.	.	.	6.00E-08	0.243287932	0.756712008	DISEASE: Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]: Autosomal recessive disease of lysosomal hydrolase trafficking. Unlike the related diseases, mucolipidosis II and IIIA, the enzyme affected in mucolipidosis IIIC (GlcNAc- phosphotransferase) retains full transferase activity on synthetic substrates but lacks activity on lysosomal hydrolases. Typical clinical findings include stiffness of the hands and shoulders, claw-hand deformity, scoliosis, short stature, coarse facies, and mild mental retardation. Radiographically, severe dysostosis multiplex of the hip is characteristic and frequently disabling. The clinical diagnosis can be confirmed by finding elevated serum lysosomal enzyme levels and/or decreased lysosomal enzyme levels in cultured fibroblasts. {ECO:0000269|PubMed:10712439, ECO:0000269|PubMed:15532026, ECO:0000269|PubMed:24316125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTG have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.11006	0.14352	-0.334253673	30.70299599	52.40877	1.43216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	53	16	1402200	chr16:1402200	G	T	113	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	1741779	1741783	GGGGT	-	intronic	JPT2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	35	16	1741778	chr16:1741778	GGGGGT	G	42	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	1821294	1821294	A	G	exonic	NME3	.	nonsynonymous SNV	NME3:NM_002513:exon2:c.T164C:p.L55P	2.37E-06	0.086504203	0.913493423	.	0.27797	0.18492	.	.	94.46567	2.09186	0.001	0.784	D	1.0	0.899	D	0.989	0.769	D	0.001	0.408	D	1	0.810	D	3.675	0.945	H	0.41	0.571	T	-5.19	0.836	D	0.821	0.809	0.013	0.825	D	0.419	0.765	T	0.900	0.993	D	6.246	0.862	28.9	0.998	0.882	0.937	0.586	D	c	0.736	0.596	1.000	0.747	0.767	0.994	0	3.52	0.393	6.967	0.757	1.004	0.623	1.000	0.715	0.999	0.750	11.893	0.517	.	.	.	0.5	.	65	16	1821294	chr16:1821294	A	G	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	2009697	2009697	C	T	exonic	NDUFB10	.	synonymous SNV	NDUFB10:NM_004548:exon1:c.C72T:p.I24I	0.046629914	0.854526808	0.098843278	.	0.06368	0.09902	-0.471992905	23.03609342	20.73017	0.70328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	175	253	16	2009697	chr16:2009697	C	T	175	PASS	DP=253;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	2030628	2030628	C	T	intronic	NOXO1	.	.	.	3.17E-11	0.011808231	0.988191769	.	0.0626	0.1393	0.240763792	69.36777542	563.1205	4.81832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	251	16	2030628	chr16:2030628	C	T	101	PASS	DP=251;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	2223956	2223956	G	A	exonic	TRAF7	.	synonymous SNV	TRAF7:NM_032271:exon13:c.G1170A:p.G390G	0.460647228	0.539342814	9.96E-06	.	0.16599	0.14085	-1.50825116	3.503184713	28.55417	0.91487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	16	2223956	chr16:2223956	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	2235420	2235420	A	C	intronic	CASKIN1	.	.	.	0.999956295	4.37E-05	1.04E-12	.	0.23556	0.11347	.	.	504.89212	4.61185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	16	2235420	chr16:2235420	A	C	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	2348569	2348569	C	A	intronic	ABCA3	.	.	.	7.48E-08	0.999990122	9.80E-06	DISEASE: Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]: A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. {ECO:0000269|PubMed:15044640}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13416	0.16987	-1.477690451	3.709601321	188.10316	2.97844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	16	2348569	chr16:2348569	C	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	3131940	3131940	-	GG	intergenic	IL32;ZSCAN10	dist=12120;dist=6951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	76	16	3131940	chr16:3131940	C	CGG	90	PASS	DP=76;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	4659106	4659106	G	A	UTR3	UBALD1	NM_145253:c.*528C>T;NM_001330467:c.*528C>T	.	.	0.700158646	0.283270811	0.016570543	.	0.21518	.	0.25917371	70.05779665	2776.98923	9.95318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	16	4659106	chr16:4659106	G	A	.	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	5037499	5037499	G	-	intronic	SEC14L5	.	.	.	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	170	16	5037498	chr16:5037498	TG	T,TGG	111	PASS	DP=170;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
16	5037499	5037499	-	G	intronic	SEC14L5	.	.	.	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	170	16	5037498	chr16:5037498	TG	T,TGG	111	PASS	DP=170;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
16	5040768	5040768	G	T	exonic	SEC14L5	.	nonsynonymous SNV	SEC14L5:NM_014692:exon5:c.G346T:p.V116F	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	0.001	0.784	D	1.0	0.899	D	0.997	0.850	D	0.000	0.537	D	1	0.810	D	2.79	0.817	M	2.21	0.184	T	-4.03	0.743	D	0.729	0.728	-0.781	0.563	T	0.148	0.475	T	0.058	0.674	D	6.411	0.885	29.7	0.996	0.712	0.984	0.824	D	c	0.865	0.784	1.000	0.747	0.615	0.372	0	4.37	0.517	9.492	0.969	1.048	0.713	1.000	0.715	0.953	0.430	17.101	0.865	PRELI/MSF1 domain	.	.	0.5	.	48	16	5040768	chr16:5040768	G	T	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	7560323	7560323	-	T	intronic	RBFOX1	.	.	.	0.935961018	0.064036563	2.42E-06	.	.	.	-0.466531444	23.51380042	64.21028	1.64414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	181	16	7560323	chr16:7560323	G	GT	65	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	10935149	10935149	T	C	intergenic	TVP23A;CIITA	dist=22498;dist=35906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	28	16	10935149	chr16:10935149	T	C	63	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	11022763	11022763	T	-	UTR3	DEXI	NM_014015:c.*803delA	.	.	0.453687572	0.450603985	0.095708443	.	.	.	0.079165051	59.43029016	3.59417	0.13074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.49	30	16	11022762	chr16:11022762	AT	A	21.49	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	11367195	11367195	G	C	exonic	PRM3	.	nonsynonymous SNV	PRM3:NM_021247:exon1:c.C258G:p.H86Q	.	.	.	.	0.18725	0.10186	.	.	12.87986	0.46948	0.659	0.047	T	.	.	.	.	.	.	0.371	0.135	N	1	0.090	P	.	.	.	1.04	0.402	T	1.71	0.006	N	0.01	0.001	-1.064	0.107	T	0.000	0.000	T	.	.	.	-2.539	0.003	0.001	0.417	0.030	0.005	0.024	N	c	-1.945	-2.168	1.000	0.747	0.497	0.185	0	-9.63	0.005	-3.218	0.006	-3.178	0.001	0.000	0.063	0.000	0.016	0.748	0.009	.	ENSG00000175643.7|ENSG00000175643.7|ENSG00000175643.7|ENSG00000175643.7|ENSG00000175643.7|ENSG00000175643.7|ENSG00000175643.7|ENSG00000175643.7	Adipose_Visceral_Omentum|Artery_Tibial|Brain_Putamen_basal_ganglia|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Thyroid	0.5	54	34	16	11367195	chr16:11367195	G	C	54	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	11544509	11544509	C	G	intergenic	RMI2;LOC101927131	dist=98889;dist=14607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.001	0.416	N	0.999	0.218	P	1.755	0.458	L	3.82	0.038	T	.	.	.	0.074	0.064	-1.058	0.123	T	0.001	0.004	T	.	.	.	3.068	0.429	22.4	0.961	0.281	0.104	0.157	N	c	-0.481	-0.567	0.781	0.238	0.661	0.498	0	1.72	0.234	0.947	0.285	-0.032	0.126	0.008	0.178	0.030	0.147	9.731	0.393	.	.	.	0.5	43	20	16	11544509	chr16:11544509	C	G	43	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	12371915	12371915	T	C	intronic	SNX29	.	.	.	1.78E-06	0.992709756	0.007288459	.	0.22646	.	-0.556537043	19.72753008	208.69672	3.11731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	90	16	12371915	chr16:12371915	T	C	71	PASS	DP=90;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	14013993	14013993	T	A	upstream	ERCC4	dist=21	.	.	3.33E-10	0.733032262	0.266967737	DISEASE: Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. XP-F patients show a mild phenotype. {ECO:0000269|PubMed:8797827, ECO:0000269|PubMed:9579555, ECO:0000269|PubMed:9580660}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: XFE progeroid syndrome (XFEPS) [MIM:610965]: A syndrome characterized by aged bird-like facies, lack of subcutaneous fat, dwarfism, cachexia and microcephaly. Additional features include sun-sensitivity from birth, learning disabilities, hearing loss, and visual impairment. {ECO:0000269|PubMed:17183314}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Xeroderma pigmentosum type F/Cockayne syndrome (XPF/CS) [MIM:278760]: A variant form of Cockayne syndrome, a disorder characterized by growth retardation, microcephaly, impairment of nervous system development, pigmentary retinopathy, peculiar facies, and progeria together with abnormal skin photosensitivity. Cockayne syndrome dermatological features are milder than those in xeroderma pigmentosum and skin cancers are not found in affected individuals. XPF/CS patients, however, present with severe skin phenotypes, including severe photosensitivity, abnormal skin pigmentation, and skin cancer predisposition. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group Q (FANCQ) [MIM:615272]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:23623386, ECO:0000269|PubMed:24027083}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.8426	0.47836	-0.367438677	28.29087049	549.8051	4.76877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	483	16	14013993	chr16:14013993	T	A	100	PASS	DP=483;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	14312764	14312764	C	T	exonic	MKL2	.	nonsynonymous SNV	MKL2:NM_001308142:exon8:c.C602T:p.A201V,MKL2:NM_014048:exon8:c.C602T:p.A201V	0.999938116	6.19E-05	2.44E-12	DISEASE: Note=A chromosomal aberration involving C11orf95 is found in 3 chondroid lipomas. Translocation t(11;16)(q13;p13) with C11orf95 produces a C11orf95-MKL2 fusion protein (PubMed:20607705). {ECO:0000269|PubMed:20607705}.; 	0.38756	0.08351	-1.548724932	3.273177636	106.48563	2.23956	0.011	0.555	D	0.951	0.899	P	0.242	0.690	B	0.000	0.559	D	1.000	0.548	D	2.075	0.572	M	-7.08	0.998	D	-3.46	0.677	D	0.334	0.507	0.996	0.971	D	0.991	0.998	D	0.715	0.977	D	5.691	0.776	26.8	0.999	0.961	0.980	0.790	D	c	0.387	0.418	1.000	0.747	0.651	0.465	0	5.52	0.821	3.951	0.561	0.935	0.490	0.998	0.411	0.375	0.250	18.471	0.907	.	.	.	0.5	69	338	16	14312764	chr16:14312764	C	T	69	PASS	DP=338;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	15022146	15022146	A	G	ncRNA_intronic	PKD1P3-NPIPA1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	1643	16	15022146	chr16:15022146	A	G	168	PASS	DP=1643;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	15223599	15223599	G	A	ncRNA_intronic	PKD1P6-NPIPP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	267	16	15223599	chr16:15223599	G	A	93	PASS	DP=267;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	15474951	15474951	C	T	intergenic	NPIPA5;MPV17L	dist=2800;dist=14660	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	189	16	15474951	chr16:15474951	C	T	97	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	15474958	15474960	AAA	-	intergenic	NPIPA5;MPV17L	dist=2807;dist=14651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.21	40	16	15474957	chr16:15474957	TAAA	T,TAAAA	14.21	PASS	DP=40;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.
16	15474960	15474960	-	A	intergenic	NPIPA5;MPV17L	dist=2809;dist=14651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.21	40	16	15474957	chr16:15474957	TAAA	T,TAAAA	14.21	PASS	DP=40;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.
16	16457549	16457549	C	T	ncRNA_intronic	PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	574	16	16457549	chr16:16457549	C	T	164	PASS	DP=574;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	18437726	18437726	C	A	ncRNA_exonic	LOC100288162;PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	242	16	18437726	chr16:18437726	C	A	.	PASS	DP=242;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	18540782	18540782	G	A	intronic	NOMO2	.	.	.	.	.	.	.	.	0.10593	.	.	370.47787	4.06416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	67	16	18540782	chr16:18540782	G	A	58	PASS	DP=67;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	18872151	18872151	-	A	intronic	SMG1	.	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	106	16	18872151	chr16:18872151	T	TA	66	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	18882785	18882785	C	A	exonic	SMG1	.	nonsynonymous SNV	SMG1:NM_015092:exon16:c.G2203T:p.A735S	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	0.044	0.410	D	0.093	0.238	B	0.013	0.154	B	0.000	0.629	U	0.994	0.420	D	1.32	0.331	L	-0.22	0.665	T	-0.99	0.262	N	0.296	0.560	-0.924	0.450	T	0.164	0.502	T	0.015	0.361	T	3.760	0.509	23.3	0.991	0.533	0.987	0.862	D	c	-0.054	0.166	0.976	0.296	0.707	0.730	0	5.21	0.719	5.719	0.679	0.927	0.437	1.000	0.715	1.000	0.888	19.116	0.933	.	.	.	0.5	.	71	16	18882785	chr16:18882785	C	A	.	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	19127777	19127777	-	A	UTR3	ITPRIPL2	NM_001034841:c.*386_*387insA	.	.	0.018503394	0.896702885	0.084793722	.	.	.	0.551232944	81.48148148	484.31785	4.52979	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	14	16	19127777	chr16:19127777	T	TA	40	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	19132593	19132593	-	A	UTR3	ITPRIPL2	NM_001034841:c.*5202_*5203insA	.	.	0.018503394	0.896702885	0.084793722	.	.	.	0.551232944	81.48148148	484.31785	4.52979	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	212	16	19132593	chr16:19132593	G	GA	81	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	19222944	19222944	G	T	intronic	SYT17	.	.	.	0.02363635	0.962035787	0.014327863	.	.	0.13066	-1.265702118	5.237084218	47.70433	1.3417	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	143	16	19222944	chr16:19222944	G	T	58	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	20448536	20448536	A	G	intronic	ACSM5	.	.	.	5.09E-08	0.838533958	0.161465991	.	0.05514	0.09249	3.184574415	99.32767162	7462.84206	18.58355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	96	16	20448536	chr16:20448536	A	G	75	PASS	DP=96;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	20824587	20824588	TA	-	exonic	REXO5	.	frameshift deletion	REXO5:NM_001144924:exon3:c.214_215del:p.Y72Cfs*54,REXO5:NM_001199053:exon3:c.214_215del:p.Y72Cfs*54,REXO5:NM_030941:exon3:c.214_215del:p.Y72Cfs*54	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	90	16	20824586	chr16:20824586	GTA	G	41	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	20911490	20911490	G	C	intronic	DCUN1D3;LYRM1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	113	16	20911490	chr16:20911490	G	C	65	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	21624014	21624014	T	A	exonic	METTL9	.	nonsynonymous SNV	METTL9:NM_001077180:exon2:c.T214A:p.F72I,METTL9:NM_001288659:exon2:c.T94A:p.F32I,METTL9:NM_001288660:exon2:c.T94A:p.F32I,METTL9:NM_016025:exon2:c.T214A:p.F72I	0.377292455	0.611945921	0.010761624	.	0.26755	0.1138	-0.141298762	42.87567823	2.36913	0.08046	0.006	0.632	D	0.989	0.764	D	0.985	0.749	D	0.000	0.843	D	1	0.810	D	2.79	0.817	M	.	.	.	-4.65	0.794	D	0.757	0.801	-0.007	0.821	T	0.460	0.790	T	0.059	0.675	D	6.339	0.875	29.3	0.992	0.544	0.965	0.693	D	c	0.877	0.857	1.000	0.747	0.737	0.974	0	6.02	0.975	7.674	0.830	1.061	0.807	1.000	0.715	1.000	0.888	14.497	0.671	.	.	.	0.5	.	73	16	21624014	chr16:21624014	T	A	.	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	21823156	21823156	A	G	ncRNA_exonic	RRN3P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	43	16	21823156	chr16:21823156	A	G	105	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	23646821	23646821	T	C	exonic	PALB2	.	nonsynonymous SNV	PALB2:NM_024675:exon4:c.A1046G:p.N349S	1.33E-10	0.770851369	0.229148631	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:17287723, ECO:0000269|PubMed:22241545}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Breast cancer susceptibility is strongly associated with PALB2 truncating mutations. Conversely, rare missense mutations do not strongly influence breast cancer risk (PubMed:22241545). {ECO:0000269|PubMed:22241545}.; DISEASE: Fanconi anemia complementation group N (FANCN) [MIM:610832]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:17200672}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 3 (PNCA3) [MIM:613348]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:19264984}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16352	0.27931	0.321464691	72.85326728	296.6407	3.67511	0.084	0.329	T	0.084	0.233	B	0.037	0.218	B	0.199	0.166	N	1	0.090	N	1.15	0.294	L	2.22	0.182	T	-1.98	0.457	N	0.123	0.138	-1.027	0.215	T	0.042	0.181	T	0.011	0.290	T	-0.146	0.080	1.411	0.904	0.191	0.093	0.149	N	c	-0.822	-0.834	0.124	0.169	0.563	0.310	0	2.31	0.277	1.108	0.305	0.039	0.154	0.204	0.241	0.982	0.498	7.409	0.260	.	.	.	0.5	42	39	16	23646821	chr16:23646821	T	C	42	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	23702685	23702685	G	T	exonic	ERN2	.	nonsynonymous SNV	ERN2:NM_001308220:exon19:c.C2282A:p.A761E,ERN2:NM_033266:exon20:c.C2438A:p.A813E	1.79E-15	0.517166148	0.482833852	.	0.37292	0.11979	-1.697674421	2.583156405	1512.87602	7.22771	0.991	0.030	T	0.002	0.349	B	0.012	0.360	B	0.001	0.403	N	0.540	0.314	N	1.595	0.408	L	1.58	0.291	T	-0.93	0.249	N	0.264	0.321	-1.057	0.126	T	0.046	0.199	T	0.010	0.263	T	1.702	0.266	14.42	0.941	0.237	0.893	0.494	D	c	-0.441	-0.289	1.000	0.747	0.676	0.548	0	4.83	0.617	1.374	0.337	1.048	0.713	0.601	0.275	0.985	0.512	13.880	0.630	KEN domain;KEN domain|PUG domain	.	.	0.5	81	217	16	23702685	chr16:23702685	G	T	81	PASS	DP=217;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	25255080	25255080	-	AAAACTCCTTGGTTTTGCACC	intronic	ZKSCAN2	.	.	.	0.002937675	0.996956495	0.00010583	.	0.11037	.	0.343511191	73.73790988	3138.88928	10.66791	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	48	16	25255080	chr16:25255080	T	TAAAACTCCTTGGTTTTGCACC	75	PASS	DP=48;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	28354353	28354353	T	G	exonic	NPIPB6	.	nonsynonymous SNV	NPIPB6:NM_001282524:exon7:c.A853C:p.T285P	0.636136512	0.335207165	0.028656323	.	.	.	.	.	364.15712	4.03989	1.0	0.010	T	0.001	0.067	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.05	0.002	N	1.83	0.248	T	4.72	0.000	N	0.045	0.025	-1.037	0.182	T	0.011	0.041	T	.	.	.	-3.438	0.000	0.001	0.069	0.000	0.000	0.002	N	c	-2.800	-2.809	0.142	0.173	0.638	0.428	0	.	.	-4.246	0.003	-4.857	0.000	0.001	0.137	0.000	0.016	.	.	.	.	.	0.5	87	39	16	28354353	chr16:28354353	T	G	87	PASS	DP=39;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	28618446	28618446	T	C	intronic	SULT1A1	.	.	.	2.24E-09	0.073319455	0.926680543	.	0.09968	0.40709	-0.156065314	42.16206653	63.72574	1.63669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	179	238	16	28618446	chr16:28618446	T	C	179	PASS	DP=238;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	28734579	28734581	GAG	-	exonic	EIF3C;EIF3CL	.	nonframeshift deletion	EIF3C:NM_001267574:exon8:c.871_873del:p.E294del,EIF3C:NM_001037808:exon9:c.871_873del:p.E294del,EIF3CL:NM_001099661:exon9:c.871_873del:p.E294del,EIF3C:NM_001199142:exon9:c.871_873del:p.E294del,EIF3C:NM_001286478:exon9:c.841_843del:p.E284del,EIF3CL:NM_001317856:exon9:c.871_873del:p.E294del,EIF3CL:NM_001317857:exon9:c.871_873del:p.E295del,EIF3C:NM_003752:exon9:c.871_873del:p.E294del	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	72	16	28734578	chr16:28734578	TGAG	T	56	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	28845869	28845869	C	T	exonic	ATXN2L	.	nonsynonymous SNV	ATXN2L:NM_001308230:exon18:c.C2306T:p.S769L,ATXN2L:NM_007245:exon18:c.C2288T:p.S763L,ATXN2L:NM_017492:exon18:c.C2288T:p.S763L,ATXN2L:NM_145714:exon18:c.C2288T:p.S763L,ATXN2L:NM_148414:exon18:c.C2288T:p.S763L,ATXN2L:NM_148415:exon18:c.C2288T:p.S763L,ATXN2L:NM_148416:exon18:c.C2288T:p.S763L	0.999950396	4.96E-05	5.82E-14	.	0.45112	0.12083	-1.725143594	2.447511205	101.85413	2.1834	0.002	0.784	D	0.936	0.504	P	0.795	0.561	P	0.000	0.629	D	1.000	0.497	D	1.905	0.510	L	0.65	0.531	T	-2.82	0.595	D	0.325	0.656	-0.903	0.477	T	0.198	0.554	T	0.082	0.739	D	6.868	0.929	33	0.999	0.983	0.977	0.765	D	c	0.442	0.512	1.000	0.747	0.672	0.522	0	5.72	0.893	4.389	0.592	0.935	0.490	0.987	0.361	0.998	0.697	18.643	0.913	.	.	.	0.5	.	148	16	28845869	chr16:28845869	C	T	.	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	28846506	28846506	A	G	exonic	ATXN2L	.	nonsynonymous SNV	ATXN2L:NM_001308230:exon19:c.A2579G:p.Y860C,ATXN2L:NM_007245:exon19:c.A2561G:p.Y854C,ATXN2L:NM_017492:exon19:c.A2561G:p.Y854C,ATXN2L:NM_145714:exon19:c.A2561G:p.Y854C,ATXN2L:NM_148414:exon19:c.A2561G:p.Y854C,ATXN2L:NM_148415:exon19:c.A2561G:p.Y854C,ATXN2L:NM_148416:exon19:c.A2561G:p.Y854C	0.999950396	4.96E-05	5.82E-14	.	0.45112	0.12083	-1.725143594	2.447511205	101.85413	2.1834	0.0	0.912	D	1.0	0.899	D	0.997	0.850	D	0.001	0.420	D	1.000	0.588	D	2.05	0.567	M	0.72	0.520	T	-3.04	0.761	D	0.558	0.838	-0.745	0.582	T	0.224	0.588	T	0.029	0.520	D	5.946	0.816	27.6	0.997	0.820	0.991	0.917	D	c	0.610	0.606	1.000	0.747	0.672	0.522	0	5.03	0.669	7.181	0.770	1.199	0.960	1.000	0.715	1.000	0.888	13.881	0.630	Ataxin 2, SM domain	.	.	0.5	92	114	16	28846506	chr16:28846506	A	G	92	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	28883182	28883182	C	T	exonic	SH2B1	.	nonsynonymous SNV	SH2B1:NM_001308294:exon5:c.C383T:p.S128L,SH2B1:NM_015503:exon5:c.C1391T:p.S464L,SH2B1:NM_001145795:exon6:c.C1391T:p.S464L,SH2B1:NM_001145796:exon6:c.C1391T:p.S464L,SH2B1:NM_001145797:exon6:c.C1391T:p.S464L,SH2B1:NM_001145812:exon6:c.C1391T:p.S464L,SH2B1:NM_001308293:exon8:c.C1391T:p.S464L	0.95682971	0.043165859	4.43E-06	.	0.50303	0.23508	-0.244249595	36.17008728	1577.15232	7.34901	0.012	0.546	D	0.99	0.764	D	0.53	0.611	P	0.027	0.259	N	0.998	0.446	D	0.695	0.181	N	0.8	0.491	T	-0.99	0.262	N	0.796	0.834	-0.858	0.515	T	0.157	0.490	T	0.023	0.464	T	6.125	0.844	28.3	0.999	0.974	0.986	0.846	D	c	0.420	0.484	1.000	0.747	0.707	0.730	0	5.14	0.699	2.597	0.456	0.892	0.403	0.989	0.365	0.998	0.697	17.383	0.872	.	.	.	0.5	60	207	16	28883182	chr16:28883182	C	T	60	PASS	DP=207;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	28906289	28906289	C	A	intronic	ATP2A1	.	.	.	7.04E-09	0.998563754	0.001436239	DISEASE: Brody myopathy (BRM) [MIM:601003]: A disorder of muscle function that is characterized by painless muscle cramping and exercise-induced impairment of muscle relaxation. {ECO:0000269|PubMed:10914677}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78274	.	-1.392555112	4.269874971	168.67085	2.83491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	16	28906289	chr16:28906289	C	A	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	29113497	29113497	-	T	ncRNA_intronic	RRN3P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	149	16	29113497	chr16:29113497	A	AT	84	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	29376056	29376056	T	A	ncRNA_exonic	SNX29P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	16	29376056	chr16:29376056	T	A	.	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	29431068	29431068	C	T	intergenic	NPIPB11;SMG1P6	dist=15945;dist=5664	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	685	16	29431068	chr16:29431068	C	T	86	PASS	DP=685;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	29498327	29498327	G	A	intergenic	LOC388242;SMG1P2	dist=19428;dist=58005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.370	0.064	0.457	0.361	0.023	0.001	0.006	N	n	-0.443	-0.240	0.000	0.012	0.078	0.016	0	-1.06	0.094	0.064	0.142	0.177	0.246	0.185	0.239	0.091	0.185	.	.	.	.	.	0.5	96	284	16	29498327	chr16:29498327	G	A	96	PASS	DP=284;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	29624821	29624821	C	T	ncRNA_exonic	SMG1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	251	16	29624821	chr16:29624821	C	T	124	PASS	DP=251;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	29825016	29825016	C	-	exonic	PRRT2	.	frameshift deletion	PRRT2:NM_001256442:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_001256443:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_145239:exon2:c.641delC:p.R217Efs*11	0.301735693	0.679146035	0.019118272	DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An autosomal dominant neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. {ECO:0000269|PubMed:22101681, ECO:0000269|PubMed:22120146, ECO:0000269|PubMed:22131361, ECO:0000269|PubMed:22209761}. Note=The disease is caused by mutations affecting the gene represented in this entry. Disease- causing mutations that produce truncation of the C-terminus of the protein alter subcellular location, from plasma membrane to cytosplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.; DISEASE: Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by clinical features of benign familial infantile seizures and episodic kinesigenic dyskinesia. Benign familial infantile seizures is a disorder characterized by afebrile seizures occurring during the first year of life, without neurologic sequelae. Paroxysmal choreoathetosis is a disorder of involuntary movements characterized by attacks that occur spontaneously or are induced by a variety of stimuli. {ECO:0000269|PubMed:22243967}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seizures, benign familial infantile 2 (BFIS2) [MIM:605751]: An autosomal dominant disorder in which afebrile seizures occur in clusters during the first year of life, without neurologic sequelae. {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22399141, ECO:0000269|PubMed:22623405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30697	0.08082	0.549415813	81.38122199	216.41438	3.17873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	44	16	29825015	chr16:29825015	GC	G	66	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	29889679	29889679	A	G	exonic	SEZ6L2	.	synonymous SNV	SEZ6L2:NM_001114100:exon8:c.T1299C:p.Y433Y,SEZ6L2:NM_001243333:exon9:c.T1509C:p.Y503Y,SEZ6L2:NM_001114099:exon10:c.T1431C:p.Y477Y,SEZ6L2:NM_001243332:exon10:c.T1641C:p.Y547Y,SEZ6L2:NM_012410:exon10:c.T1431C:p.Y477Y,SEZ6L2:NM_201575:exon10:c.T1641C:p.Y547Y	0.13015316	0.869807213	3.96E-05	.	0.53499	0.10324	-1.124330456	6.575843359	637.27687	5.07921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	294	16	29889679	chr16:29889679	A	G	150	PASS	DP=294;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	30016652	30016652	-	C	exonic	INO80E	.	frameshift insertion	INO80E:NM_001304562:exon6:c.508dupC:p.T173Hfs*15,INO80E:NM_173618:exon7:c.625dupC:p.T212Hfs*15	0.017414685	0.891403715	0.0911816	.	0.18786	0.11011	-0.073340031	48.11866006	41.31906	1.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	44	16	30016652	chr16:30016652	G	GC	61	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	30680303	30680303	G	A	intronic	FBRS	.	.	.	0.981524682	0.018462136	1.32E-05	.	0.32662	.	.	.	201.82278	3.06617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	16	30680303	chr16:30680303	G	A	.	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	30990543	30990543	C	T	exonic	SETD1A	.	nonsynonymous SNV	SETD1A:NM_014712:exon14:c.C3436T:p.R1146C	0.999996231	3.77E-06	5.40E-16	.	0.31946	.	-2.934884757	0.560273649	360.97151	4.02191	0.129	0.268	T	0.002	0.090	B	0.001	0.040	B	0.008	0.313	N	1	0.090	N	0.895	0.225	L	-3.42	0.944	D	-1.28	0.322	N	0.246	0.301	-0.071	0.808	T	0.721	0.904	D	0.722	0.978	D	0.938	0.184	10.30	0.618	0.066	0.083	0.140	N	c	-1.359	-1.356	0.843	0.249	0.696	0.567	0	3.05	0.341	0.045	0.138	-1.104	0.018	0.000	0.063	0.001	0.043	10.509	0.438	.	.	.	0.5	75	83	16	30990543	chr16:30990543	C	T	75	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	30992180	30992180	G	A	intronic	SETD1A	.	.	.	0.999996231	3.77E-06	5.40E-16	.	0.31946	.	-2.934884757	0.560273649	360.97151	4.02191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	16	30992180	chr16:30992180	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	31008054	31008054	C	T	exonic	STX1B	.	nonsynonymous SNV	STX1B:NM_052874:exon7:c.G487A:p.E163K	0.944474733	0.05548414	4.11E-05	DISEASE: Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172]: An autosomal dominant neurologic disorder characterized by febrile and/or afebrile seizures manifesting in early childhood. Seizure are variable and include generalized tonic-clonic, atonic, myoclonic, complex partial, and absence types. Most patients have remission of seizures later in childhood with no residual neurologic deficits. Rarely, patients may show mild developmental delay or mild intellectual disabilities. {ECO:0000269|PubMed:25362483}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22761	0.14229	-0.163345027	41.24793583	5.61252	0.20995	0.001	0.784	D	0.613	0.418	P	0.319	0.399	B	0.000	0.629	D	1	0.810	D	2.33	0.670	M	0.28	0.591	T	-3.86	0.726	D	0.923	0.918	-0.219	0.772	T	0.297	0.669	T	0.085	0.745	D	5.918	0.812	27.5	0.999	0.983	0.992	0.920	D	c	0.605	0.609	1.0	0.983	0.789	0.998	0	4.76	0.600	7.867	0.854	0.870	0.379	1.000	0.715	0.995	0.604	16.694	0.851	Syntaxin, N-terminal domain|t-SNARE	.	.	0.5	105	243	16	31008054	chr16:31008054	C	T	105	PASS	DP=243;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	31196420	31196420	C	T	exonic	FUS	.	synonymous SNV	FUS:NM_001170634:exon6:c.C681T:p.G227G,FUS:NM_001170937:exon6:c.C672T:p.G224G,FUS:NM_004960:exon6:c.C684T:p.G228G	0.999963786	3.62E-05	3.26E-12	DISEASE: Note=A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.; DISEASE: Note=A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG. {ECO:0000269|PubMed:8187069}.; DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving FUS is found in a patient with angiomatoid fibrous histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1 protein. {ECO:0000269|PubMed:11063792}.; DISEASE: Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302, ECO:0000269|PubMed:20124201}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. {ECO:0000269|PubMed:22863194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42621	0.49093	-1.001120478	8.321538099	78.86065	1.87589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	611	16	31196420	chr16:31196420	C	T	.	PASS	DP=611;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	31368547	31368547	C	A	intronic	ITGAX	.	.	.	6.11E-05	0.999936982	1.90E-06	.	0.09861	.	-0.915030414	9.837225761	3879.17486	12.28742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	63	16	31368547	chr16:31368547	C	A	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	31734070	31734070	C	T	exonic	ZNF720	.	synonymous SNV	ZNF720:NM_001130913:exon2:c.C127T:p.L43L	0.055960456	0.707057236	0.236982308	.	0.06899	.	0.58987904	82.3720217	19.56487	0.67154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	16	31734070	chr16:31734070	C	T	.	PASS	DP=47;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	32007186	32007186	G	T	intergenic	ZNF267;LOC102723753	dist=78557;dist=156247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	164	16	32007186	chr16:32007186	G	T	.	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32133768	32133768	G	C	intergenic	ZNF267;LOC102723753	dist=205139;dist=29665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	176	711	16	32133768	chr16:32133768	G	C	176	PASS	DP=711;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32198297	32198297	C	-	ncRNA_intronic	HERC2P4;LOC102723753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.53	39	16	32198296	chr16:32198296	AC	A	11.53	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	32264985	32264985	G	T	exonic	TP53TG3D	.	nonsynonymous SNV	TP53TG3D:NM_001243722:exon1:c.G311T:p.R104I	0.641056796	0.331383233	0.027559972	.	.	.	.	.	22.6399	0.75766	0.105	0.298	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	1.5	0.312	T	-4.65	0.794	D	0.193	0.236	.	.	.	.	.	.	0.013	0.329	T	-1.470	0.018	0.003	0.418	0.030	0.006	0.026	N	n	-0.706	-0.063	0.681	0.225	0.487	0.133	0	.	.	-0.998	0.038	-1.042	0.020	0.003	0.159	0.004	0.083	.	.	.	.	.	0.5	108	554	16	32264985	chr16:32264985	G	T	108	PASS	DP=554;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32329429	32329429	G	T	intergenic	LOC390705;TP53TG3E	dist=28127;dist=355416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	834	16	32329429	chr16:32329429	G	T	132	PASS	DP=834;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32859230	32859230	C	A	intergenic	TP53TG3;SLC6A10P	dist=171780;dist=29567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	656	16	32859230	chr16:32859230	C	A	114	PASS	DP=656;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32890992	32890992	G	T	ncRNA_exonic	SLC6A10P	.	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	144	16	32890992	chr16:32890992	G	T	89	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32896603	32896603	C	A	upstream	SLC6A10P	dist=140	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	326	16	32896603	chr16:32896603	C	A	.	PASS	DP=326;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	32916782	32916782	G	A	intergenic	SLC6A10P;TP53TG3B	dist=20319;dist=288801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	378	16	32916782	chr16:32916782	G	A	97	PASS	DP=378;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	33123817	33123817	C	A	intergenic	SLC6A10P;TP53TG3B	dist=227354;dist=81766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	271	16	33123817	chr16:33123817	C	A	139	PASS	DP=271;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	33366720	33366720	A	G	intergenic	LOC390705;ENPP7P13	dist=68018;dist=205124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	395	16	33366720	chr16:33366720	A	G	159	PASS	DP=395;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	33497515	33497515	C	A	intergenic	LOC390705;ENPP7P13	dist=198813;dist=74329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	16	33497515	chr16:33497515	C	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	33503779	33503779	C	A	intergenic	LOC390705;ENPP7P13	dist=205077;dist=68065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	660	16	33503779	chr16:33503779	C	A	111	PASS	DP=660;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	46661227	46661227	C	G	intergenic	SHCBP1;VPS35	dist=5913;dist=30664	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	25	16	46661227	chr16:46661227	C	G	55	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	54966439	54966439	G	T	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon2:c.G279T:p.M93I,IRX5:NM_005853:exon2:c.G279T:p.M93I	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.154	0.309	T	0.063	0.219	B	0.168	0.335	B	0.000	0.843	D	1	0.810	D	0.82	0.209	L	0.34	0.592	T	-2.07	0.558	N	0.51	0.570	-0.820	0.539	T	0.188	0.540	T	0.019	0.410	T	2.204	0.326	17.54	0.992	0.553	0.895	0.497	D	c	0.119	0.267	1.000	0.747	0.598	0.340	0	4.68	0.582	6.624	0.739	0.953	0.551	1.000	0.715	0.994	0.587	16.332	0.828	.	.	.	0.5	126	229	16	54966439	chr16:54966439	G	T	126	PASS	DP=229;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	54967692	54967692	G	C	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon3:c.G1356C:p.L452F,IRX5:NM_005853:exon3:c.G1359C:p.L453F	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.045	0.912	D	0.998	0.715	D	0.996	0.832	D	0.001	0.434	D	1	0.810	D	1.04	0.263	L	0.15	0.608	T	-1.07	0.475	N	0.369	0.431	-0.567	0.662	T	0.296	0.668	T	0.022	0.446	T	2.369	0.346	18.62	0.986	0.426	0.941	0.598	D	c	0.604	0.608	1.000	0.747	0.598	0.340	0	4.77	0.603	5.274	0.652	1.048	0.713	1.000	0.715	1.000	0.888	17.973	0.890	.	.	.	0.5	.	142	16	54967692	chr16:54967692	G	C	.	PASS	DP=142;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	55866900	55866900	T	C	intronic	CES1	.	.	.	6.77E-14	0.00837054	0.99162946	.	0.4719	0.33344	1.912614283	97.42863883	1302.69006	6.79071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	208	16	55866900	chr16:55866900	T	C	88	PASS	DP=208;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	56391118	56391119	TG	-	UTR3	GNAO1	NM_020988:c.*1132_*1133delTG	.	.	0.984288177	0.015702972	8.85E-06	DISEASE: Epileptic encephalopathy, early infantile, 17 (EIEE17) [MIM:615473]: A severe neurologic disorder characterized by onset of intractable seizures in the first weeks or months of life and usually associated with EEG abnormalities. Affected infants have very poor psychomotor development and may have brain abnormalities, such as cerebral atrophy or thin corpus callosum. Some patients may show involuntary movements. {ECO:0000269|PubMed:23993195}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24762	0.17859	-0.736552314	13.93606983	11.79169	0.42714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.17	37	16	56391117	chr16:56391117	CTG	C	11.17	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	56673143	56673143	A	G	intronic	MT1A	.	.	.	0.007776186	0.549963564	0.44226025	.	0.10097	.	0.567831482	81.78225997	3587.00557	11.59065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	7	16	56673143	chr16:56673143	A	G	41	PASS	DP=7;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	57015545	57015545	C	T	intronic	CETP	.	.	.	5.18E-12	0.191291722	0.808708278	DISEASE: Hyperalphalipoproteinemia 1 (HALP1) [MIM:143470]: A condition characterized by high levels of high density lipoprotein (HDL) and increased HDL cholesterol levels. {ECO:0000269|PubMed:12091484, ECO:0000269|PubMed:2215607, ECO:0000269|PubMed:8408659}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16082	0.36962	-0.064242613	48.844067	320.75729	3.80433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	77	16	57015545	chr16:57015545	C	T	87	PASS	DP=77;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	57054565	57054565	C	T	intronic	NLRC5	.	.	.	6.72E-05	0.999932818	2.78E-09	.	0.07927	0.08967	0.514279338	80.30195801	898.09245	5.83754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	63	16	57054565	chr16:57054565	C	T	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	57088993	57088993	G	T	exonic	NLRC5	.	nonsynonymous SNV	NLRC5:NM_032206:exon25:c.G3646T:p.G1216C,NLRC5:NM_001330552:exon26:c.G3646T:p.G1216C	6.72E-05	0.999932818	2.78E-09	.	0.07927	0.08967	0.514279338	80.30195801	898.09245	5.83754	0.005	0.632	D	0.999	0.899	D	0.906	0.739	P	.	.	.	1	0.090	N	2.48	0.723	M	-0.61	0.740	T	-3.25	0.722	D	0.417	0.522	-0.996	0.312	T	0.132	0.445	T	0.058	0.674	D	3.605	0.491	23.2	0.994	0.649	0.165	0.192	N	c	-0.326	-0.442	0.659	0.222	0.632	0.406	0	2.87	0.324	1.302	0.328	0.108	0.203	0.012	0.185	0.018	0.130	7.330	0.256	Leucine-rich repeat domain, L domain-like	.	.	0.5	95	105	16	57088993	chr16:57088993	G	T	95	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	57509698	57509699	CT	-	intronic	DOK4	.	.	.	0.19760291	0.792064709	0.010332382	.	0.55569	0.13588	-0.66859065	15.76433121	109.57389	2.27428	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	469	16	57509697	chr16:57509697	CCT	C	115	PASS	DP=469;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1	./.
16	58021306	58021306	C	G	exonic	TEPP	.	synonymous SNV	TEPP:NM_199046:exon8:c.C873G:p.V291V,TEPP:NM_199456:exon8:c.C792G:p.V264V	6.80E-05	0.729947501	0.269984542	.	.	.	-0.069700724	48.54328851	39.64027	1.16858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	23	16	58021306	chr16:58021306	C	G	55	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	58312358	58312358	T	-	intronic	CCDC113	.	.	.	3.95E-13	0.023524609	0.976475391	.	0.05168	0.08022	-0.336073593	30.55555556	127.02556	2.45806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.72	127	16	58312357	chr16:58312357	CT	C	18.72	PASS	DP=127;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	58550456	58550456	T	G	exonic	SETD6	.	nonsynonymous SNV	SETD6:NM_001160305:exon4:c.T551G:p.I184S,SETD6:NM_024860:exon5:c.T479G:p.I160S	1.02E-09	0.088411248	0.911588751	.	0.3769	.	0.132352165	63.48785091	65.5989	1.6682	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.810	D	2.045	0.562	M	-1.46	0.810	T	-3.11	0.636	D	0.905	0.902	0.275	0.872	D	0.624	0.868	D	0.255	0.893	D	5.503	0.747	26.2	0.994	0.634	0.981	0.791	D	c	0.575	0.540	1.000	0.747	0.722	0.854	0	5.37	0.769	5.949	0.698	1.011	0.635	1.000	0.715	0.921	0.396	14.217	0.652	SET domain	.	.	0.5	69	73	16	58550456	chr16:58550456	T	G	69	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	60392816	60392816	G	-	exonic	LOC729159	.	frameshift deletion	LOC729159:NM_001282301:exon1:c.791delC:p.P264Qfs*13	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	98	16	60392815	chr16:60392815	TG	T	86	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	66801325	66801325	C	G	exonic	TERB1	.	nonsynonymous SNV	TERB1:NM_001136505:exon16:c.G1773C:p.R591S	.	.	.	.	.	.	.	.	.	.	.	.	.	0.131	0.256	B	0.039	0.223	B	.	.	.	1	0.810	D	2.19	0.618	M	.	.	.	.	.	.	0.631	0.649	-1.052	0.140	T	0.127	0.433	T	0.013	0.319	T	2.334	0.342	18.39	0.802	0.126	0.134	0.176	N	c	-0.803	-0.834	0.005	0.109	0.487	0.133	0	-4.68	0.031	-1.002	0.038	-0.379	0.065	0.223	0.243	0.976	0.476	11.526	0.496	.	.	.	0.5	.	34	16	66801325	chr16:66801325	C	G	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	66947383	66947383	C	G	intronic	CDH16	.	.	.	6.80E-13	0.212349983	0.787650017	.	0.09081	0.12844	-0.946125119	9.377211607	998.46283	6.08909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	27	16	66947383	chr16:66947383	C	G	60	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	67116095	67116095	G	A	intronic	CBFB	.	.	.	0.905733874	0.09410794	0.000158186	DISEASE: Note=A chromosomal aberration involving CBFB is associated with acute myeloid leukemia of M4EO subtype. Pericentric inversion inv(16)(p13;q22). The inversion produces a fusion protein that consists of the 165 N-terminal residues of CBF-beta (PEPB2) with the tail region of MYH11. {ECO:0000269|PubMed:8351518}.; 	0.85519	0.21981	-0.009020804	52.8544468	11.84242	0.42885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	16	67116095	chr16:67116095	G	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	67212597	67212597	C	-	intronic	KIAA0895L	.	.	.	0.018433058	0.961138313	0.02042863	.	.	.	0.150760231	64.51403633	718.9968	5.32337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	44	16	67212596	chr16:67212596	TC	T	42	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	67212710	67212710	C	-	intronic	KIAA0895L	.	.	.	0.018433058	0.961138313	0.02042863	.	.	.	0.150760231	64.51403633	718.9968	5.32337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	162	16	67212709	chr16:67212709	GC	G	65	PASS	DP=162;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	67670520	67670520	A	G	intronic	CTCF	.	.	.	0.997924958	0.002075029	1.27E-08	DISEASE: Mental retardation, autosomal dominant 21 (MRD21) [MIM:615502]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD21 features include short stature, microcephaly, and developmental delay. {ECO:0000269|PubMed:23746550}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78428	0.25142	-0.293801652	32.93819297	9.66001	0.35497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	116	16	67670520	chr16:67670520	A	G	101	PASS	DP=116;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	67670535	67670536	CA	-	intronic	CTCF	.	.	.	0.997924958	0.002075029	1.27E-08	DISEASE: Mental retardation, autosomal dominant 21 (MRD21) [MIM:615502]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD21 features include short stature, microcephaly, and developmental delay. {ECO:0000269|PubMed:23746550}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78428	0.25142	-0.293801652	32.93819297	9.66001	0.35497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.55	32	16	67670534	chr16:67670534	TCA	T	13.55	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	67763279	67763281	GAG	-	exonic	RANBP10	.	nonframeshift deletion	RANBP10:NM_001320238:exon9:c.903_905del:p.S305del,RANBP10:NM_001320239:exon9:c.1086_1088del:p.S366del,RANBP10:NM_020850:exon10:c.1254_1256del:p.S422del,RANBP10:NM_001320240:exon13:c.567_569del:p.S193del	0.951824229	0.04817459	1.18E-06	.	0.5861	0.11289	-0.843147538	11.2762444	72.21908	1.77081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	38	16	67763278	chr16:67763278	CGAG	C	43	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	67840192	67840192	G	A	intronic	RANBP10	.	.	.	0.951824229	0.04817459	1.18E-06	.	0.5861	0.11289	-0.843147538	11.2762444	72.21908	1.77081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	16	67840192	chr16:67840192	G	A	.	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	68057932	68057932	G	A	intronic	DUS2	.	.	.	0.000272032	0.999072268	0.0006557	.	0.08346	0.11249	-0.400392389	26.85185185	261.28866	3.47039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	72	16	68057932	chr16:68057932	G	A	.	PASS	DP=72;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	69364876	69364876	C	A	exonic	COG8	.	nonsynonymous SNV	COG8:NM_032382:exon5:c.G1705T:p.A569S	1.87E-05	0.693345213	0.306636056	DISEASE: Congenital disorder of glycosylation 2H (CDG2H) [MIM:611182]: CDGs are a family of severe inherited diseases caused by a defect in protein N-glycosylation. They are characterized by under-glycosylated serum proteins. These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:17331980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28449	0.10981	-0.222203495	37.54423213	266.21683	3.50111	0.696	0.042	T	0.006	0.126	B	0.01	0.139	B	0.123	0.189	N	0.987	0.246	N	0	0.065	N	0.98	0.421	T	0.42	0.034	N	0.099	0.134	-1.048	0.149	T	0.049	0.208	T	0.013	0.316	T	1.681	0.263	14.30	0.705	0.090	0.930	0.568	D	c	-0.545	-0.337	1.000	0.747	0.442	0.072	0	5.45	0.796	2.942	0.485	0.917	0.428	0.851	0.302	0.072	0.177	17.125	0.865	.	.	.	0.5	.	56	16	69364876	chr16:69364876	C	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	69364877	69364877	C	A	exonic	COG8	.	nonsynonymous SNV	COG8:NM_032382:exon5:c.G1704T:p.Q568H	1.87E-05	0.693345213	0.306636056	DISEASE: Congenital disorder of glycosylation 2H (CDG2H) [MIM:611182]: CDGs are a family of severe inherited diseases caused by a defect in protein N-glycosylation. They are characterized by under-glycosylated serum proteins. These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:17331980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28449	0.10981	-0.222203495	37.54423213	266.21683	3.50111	0.055	0.384	T	0.162	0.268	B	0.054	0.244	B	0.284	0.149	N	0.926	0.272	N	1.1	0.281	L	0.9	0.453	T	-0.88	0.238	N	0.106	0.152	-1.066	0.104	T	0.070	0.286	T	0.020	0.425	T	1.900	0.289	15.59	0.925	0.213	0.832	0.420	D	c	-0.422	-0.333	1.000	0.747	0.442	0.072	0	3.48	0.388	1.339	0.333	0.917	0.428	0.835	0.300	0.068	0.175	9.680	0.390	.	.	.	0.5	.	56	16	69364877	chr16:69364877	C	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	69988359	69988359	A	G	exonic	CLEC18A	.	synonymous SNV	CLEC18A:NM_001136214:exon4:c.A339G:p.L113L,CLEC18A:NM_001271197:exon4:c.A339G:p.L113L,CLEC18A:NM_182619:exon4:c.A339G:p.L113L	0.144113695	0.778785582	0.077100722	.	.	.	.	.	3437.51904	11.25783	.	.	.	.	.	.	.	.	.	.	.	.	0.000	0.588	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.764	0.167	9.239	0.305	0.017	0.026	0.071	N	c	-0.605	-0.680	0.001	0.080	0.554	0.246	0	1.97	0.252	0.164	0.162	-0.026	0.128	0.993	0.376	0.084	0.183	4.761	0.124	.	ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000223496.1|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000223496.1|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000196696.8|ENSG00000157335.15|ENSG00000157322.12|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157335.15|ENSG00000157322.12|ENSG00000157322.12|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000196696.8|ENSG00000157322.12|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Coronary|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Brain_Caudate_basal_ganglia|Brain_Cerebellum|Brain_Cortex|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Heart_Left_Ventricle|Lung|Lung|Lung|Lung|Lung|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Ovary|Pancreas|Pancreas|Pancreas|Pancreas|Prostate|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Small_Intestine_Terminal_Ileum|Spleen|Spleen|Stomach|Stomach|Testis|Testis|Testis|Thyroid|Thyroid|Thyroid|Thyroid|Vagina|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood	0.5	146	234	16	69988359	chr16:69988359	A	G	146	PASS	DP=234;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	69996985	69996985	G	C	intronic	CLEC18A	.	.	.	0.144113695	0.778785582	0.077100722	.	.	.	.	.	3437.51904	11.25783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	339	16	69996985	chr16:69996985	G	C	119	PASS	DP=339;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	70013125	70013125	G	A	ncRNA_intronic	PDXDC2P-NPIPB14P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	271	16	70013125	chr16:70013125	G	A	.	PASS	DP=271;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	70515600	70515600	T	-	intronic	COG4	.	.	.	4.39E-06	0.997966814	0.002028798	DISEASE: Congenital disorder of glycosylation 2J (CDG2J) [MIM:613489]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:19494034}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26914	0.11324	-0.995664936	8.539749941	119.45307	2.37823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	199	16	70515599	chr16:70515599	GT	G	70	PASS	DP=199;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	70693872	70693872	-	T	intronic	IL34	.	.	.	0.114215553	0.85818846	0.027595987	.	0.23864	0.07227	0.841481379	88.35810333	232.37986	3.29666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	95	16	70693872	chr16:70693872	C	CT	139	PASS	DP=95;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	70714811	70714811	-	GG	intronic	MTSS1L	.	.	.	0.86986055	0.130124337	1.51E-05	.	.	0.1222	-1.548724932	3.273177636	236.86198	3.32283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	30	16	70714811	chr16:70714811	C	CGG	60	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	71895793	71895793	C	T	exonic	ZNF821	.	nonsynonymous SNV	ZNF821:NM_017530:exon5:c.G344A:p.R115Q,ZNF821:NM_001201553:exon6:c.G470A:p.R157Q,ZNF821:NM_001201554:exon6:c.G344A:p.R115Q,ZNF821:NM_001318239:exon6:c.G20A:p.R7Q,ZNF821:NM_001201552:exon7:c.G470A:p.R157Q,ZNF821:NM_001318238:exon7:c.G20A:p.R7Q	0.158430833	0.838272719	0.003296448	.	0.16787	0.10783	-0.183570861	39.95046001	15.0966	0.54233	0.003	0.682	D	0.998	0.715	D	0.992	0.790	D	0.000	0.843	D	1	0.810	D	1.04	0.263	L	2.4	0.544	T	-1.28	0.346	N	0.843	0.831	-1.123	0.022	T	0.093	0.353	T	0.065	0.695	D	7.782	0.955	35	1.000	1.000	0.983	0.817	D	c	0.759	0.807	1.000	0.747	0.707	0.730	0	6.08	0.990	7.568	0.814	0.892	0.403	1.000	0.715	1.000	0.888	20.672	0.997	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	.	26	16	71895793	chr16:71895793	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	72817165	72817165	C	T	UTR3	ZFHX3	NM_006885:c.*3898G>A;NM_001164766:c.*3898G>A	.	.	1	1.41E-10	8.85E-27	.	0.74579	0.15507	-4.263203714	0.117952347	6032.74571	16.21079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	16	72817165	chr16:72817165	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	72830474	72830474	G	A	exonic	ZFHX3	.	nonsynonymous SNV	ZFHX3:NM_001164766:exon8:c.C3365T:p.T1122I,ZFHX3:NM_006885:exon9:c.C6107T:p.T2036I	1	1.41E-10	8.85E-27	.	0.74579	0.15507	-4.263203714	0.117952347	6032.74571	16.21079	0.008	0.614	D	0.889	0.469	P	0.444	0.441	B	0.001	0.415	D	1.000	0.588	D	0.55	0.145	N	-0.82	0.741	T	-2.68	0.572	D	0.501	0.575	-0.362	0.732	T	0.320	0.689	T	0.059	0.677	D	2.478	0.359	19.33	0.988	0.461	0.982	0.799	D	c	0.180	0.230	1.000	0.473	0.651	0.465	0	4.69	0.584	6.931	0.755	0.056	0.163	1.000	0.715	0.989	0.536	16.740	0.852	.	.	.	0.5	.	74	16	72830474	chr16:72830474	G	A	.	PASS	DP=74;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	74943751	74943751	C	T	exonic	WDR59	.	nonsynonymous SNV	WDR59:NM_001324171:exon15:c.G1454A:p.R485H,WDR59:NM_030581:exon15:c.G1454A:p.R485H	3.44E-11	0.995036935	0.004963065	.	0.21989	0.10981	-1.256630467	5.343241331	409.53463	4.24211	0.003	0.682	D	0.979	0.571	D	0.451	0.443	P	0.000	0.843	D	1	0.810	D	2.475	0.721	M	0.98	0.421	T	-3.82	0.720	D	0.276	0.699	-0.738	0.586	T	0.170	0.511	T	0.029	0.515	D	7.682	0.954	35	0.999	0.999	0.994	0.956	D	c	0.720	0.753	1.000	0.747	0.732	0.924	0	5.66	0.872	7.749	0.839	0.935	0.490	1.000	0.715	1.000	0.888	20.115	0.979	RWD domain|Ubiquitin-conjugating enzyme/RWD-like	.	.	0.5	.	55	16	74943751	chr16:74943751	C	T	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	75267786	75267786	G	T	exonic	BCAR1	.	synonymous SNV	BCAR1:NM_001170721:exon5:c.C1428A:p.G476G,BCAR1:NM_001170715:exon6:c.C2112A:p.G704G,BCAR1:NM_001170716:exon6:c.C2112A:p.G704G,BCAR1:NM_001170717:exon6:c.C2112A:p.G704G,BCAR1:NM_001170718:exon6:c.C2058A:p.G686G,BCAR1:NM_001170719:exon6:c.C2052A:p.G684G,BCAR1:NM_014567:exon6:c.C2058A:p.G686G,BCAR1:NM_001170714:exon7:c.C2196A:p.G732G,BCAR1:NM_001170720:exon7:c.C1614A:p.G538G	0.992956578	0.007043171	2.51E-07	.	0.47335	.	1.53037684	95.51191319	778.41129	5.52069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	312	16	75267786	chr16:75267786	G	T	107	PASS	DP=312;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	75327731	75327731	-	A	UTR3	CFDP1	NM_006324:c.*118_*119insT	.	.	0.084939582	0.90532901	0.009731408	.	0.69235	0.12239	-0.115612493	45.12856806	45.52056	1.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	91	16	75327731	chr16:75327731	G	GA	62	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	78011559	78011559	C	T	exonic	VAT1L	.	synonymous SNV	VAT1L:NM_020927:exon9:c.C1227T:p.S409S	1.90E-05	0.696133091	0.30384793	.	.	0.13287	-0.290161348	33.33923095	120.82271	2.39555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	91	16	78011559	chr16:78011559	C	T	58	PASS	DP=91;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	81157187	81157187	C	A	intronic	PKD1L2	.	.	.	2.37E-09	0.020877049	0.979122949	.	0.09644	0.07722	6.86111443	99.88794527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	16	81157187	chr16:81157187	C	A	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	81744000	81744000	A	G	UTR3	CMIP	NM_198390:c.*596A>G;NM_030629:c.*596A>G	.	.	0.999886587	0.000113413	5.26E-11	.	.	.	-1.530301957	3.367539514	21.62477	0.72736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	187	16	81744000	chr16:81744000	A	G	81	PASS	DP=187;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	81744041	81744041	C	T	UTR3	CMIP	NM_198390:c.*637C>T;NM_030629:c.*637C>T	.	.	0.999886587	0.000113413	5.26E-11	.	.	.	-1.530301957	3.367539514	21.62477	0.72736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	181	16	81744041	chr16:81744041	C	T	.	PASS	DP=181;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	84035871	84035871	G	T	intronic	NECAB2	.	.	.	.	.	.	.	0.13866	0.11297	-0.126743121	44.0905874	2833.50108	10.05093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	126	16	84035871	chr16:84035871	G	T	.	PASS	DP=126;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	84218459	84218459	C	A	exonic	TAF1C	.	stopgain	TAF1C:NM_001243156:exon2:c.G136T:p.E46X,TAF1C:NM_005679:exon2:c.G136T:p.E46X	3.23E-11	0.472377146	0.527622854	.	0.24194	0.0925	0.593325282	82.46048596	1956.88534	8.14058	.	.	.	.	.	.	.	.	.	0.173	0.031	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.443	0.472	23.0	0.894	0.182	0.010	0.037	N	c	-0.490	-0.957	1.000	0.747	0.731	0.878	0	-7.45	0.012	-2.252	0.013	-2.251	0.004	0.000	0.063	0.003	0.074	2.072	0.034	.	.	.	0.5	108	231	16	84218459	chr16:84218459	C	A	108	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	84900431	84900431	T	-	intronic	CRISPLD2	.	.	.	7.38E-06	0.977631394	0.02236123	.	0.77714	0.10639	0.448277766	77.99598962	4030.53322	12.57901	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	16	16	84900430	chr16:84900430	CT	C	44	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	85146100	85146100	G	A	UTR5	FAM92B	NM_198491:c.-142C>T	.	.	3.59E-11	0.024359717	0.975640283	.	0.07343	0.09186	0.396906589	76.30927105	291.69998	3.65342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	245	16	85146100	chr16:85146100	G	A	61	PASS	DP=245;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	86565882	86565882	G	C	exonic	MTHFSD	.	nonsynonymous SNV	MTHFSD:NM_001159377:exon8:c.C887G:p.S296C,MTHFSD:NM_001159378:exon8:c.C887G:p.S296C,MTHFSD:NM_001159379:exon8:c.C884G:p.S295C,MTHFSD:NM_001159380:exon8:c.C827G:p.S276C,MTHFSD:NM_022764:exon8:c.C884G:p.S295C	3.76E-09	0.098530815	0.901469182	.	0.09755	0.09128	1.309952855	94.01981599	2917.56396	10.24622	0.06	0.375	T	0.002	0.090	B	0.002	0.063	B	0.037	0.018	U	1	0.090	P	1.7	0.440	L	2.42	0.192	T	-1.18	0.362	N	0.037	0.025	-0.934	0.436	T	0.000	0.000	T	.	.	.	0.535	0.145	7.696	0.798	0.125	0.326	0.244	N	c	-0.763	-0.750	0.027	0.138	0.646	0.450	0	2.07	0.259	2.850	0.477	0.936	0.528	0.207	0.242	0.045	0.161	8.401	0.316	Nucleotide-binding alpha-beta plait domain	.	.	0.5	61	14	16	86565882	chr16:86565882	G	C	61	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	86600947	86600947	G	T	exonic	FOXC2	.	nonsynonymous SNV	FOXC2:NM_005251:exon1:c.G6T:p.Q2H	.	.	.	DISEASE: Lymphedema-distichiasis (LYD) [MIM:153400]: A disorder characterized by primary limb lymphedema associated with distichiasis (double rows of eyelashes, with extra eyelashes growing from the Meibomian gland orifices). Swelling of the extremities, due to altered lymphatic flow, usually appears in late childhood or puberty. Most affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia. Drooping of the upper eyelid (ptosis) is a variable feature of the lymphedema-distichiasis syndrome, occurring in about 30% of patients. {ECO:0000269|PubMed:11078474, ECO:0000269|PubMed:11371511, ECO:0000269|PubMed:11499682}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.38597	0.23829	.	.	50.82093	1.40445	0.0	0.912	D	0.999	0.764	D	0.99	0.774	D	0.615	0.057	U	0.994	0.422	D	2.015	0.552	M	-4.1	0.967	D	-3.49	0.680	D	0.725	0.724	0.608	0.920	D	0.914	0.972	D	0.585	0.963	D	5.864	0.804	27.3	0.996	0.740	0.975	0.751	D	c	0.453	0.349	1.000	0.747	0.623	0.393	0	1.4	0.213	6.207	0.719	0.952	0.539	1.000	0.715	1.000	0.888	8.527	0.323	.	.	.	0.5	84	133	16	86600947	chr16:86600947	G	T	84	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	87723838	87723838	T	C	exonic	JPH3	.	synonymous SNV	JPH3:NM_020655:exon4:c.T1872C:p.H624H	0.986177997	0.013815541	6.46E-06	DISEASE: Huntington disease-like 2 (HDL2) [MIM:606438]: Huntington disease (HD) is a neurodegenerative disorder resulting primarily from the loss of medium spiny projection neurons in the striatum, especially in the caudate nucleus, and, to a lesser extent, atrophy of mesencephalic and cortical structures. The typical clinical picture of HD combines familial adult onset chorea and subcortical dementia that usually begin during the fourth decade of life. {ECO:0000269|PubMed:11914418, ECO:0000269|PubMed:14557581}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13441	0.26404	-1.230963997	5.543760321	231.25612	3.28718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	27	16	87723838	chr16:87723838	T	C	54	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	88017809	88017809	C	T	exonic	BANP	.	synonymous SNV	BANP:NM_001173539:exon4:c.C306T:p.V102V,BANP:NM_001173540:exon4:c.C324T:p.V108V,BANP:NM_001173541:exon4:c.C306T:p.V102V,BANP:NM_001173542:exon4:c.C306T:p.V102V,BANP:NM_001173543:exon4:c.C282T:p.V94V,BANP:NM_017869:exon4:c.C306T:p.V102V,BANP:NM_079837:exon4:c.C306T:p.V102V	0.958647668	0.041348352	3.98E-06	.	0.64532	0.13415	-0.822919685	11.76574664	798.42168	5.56845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	52	16	88017809	chr16:88017809	C	T	52	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	88105395	88105395	T	-	intronic	BANP	.	.	.	0.958647668	0.041348352	3.98E-06	.	0.64532	0.13415	-0.822919685	11.76574664	798.42168	5.56845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	104	16	88105394	chr16:88105394	CT	C	95	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	88499564	88499564	C	A	exonic	ZNF469	.	nonsynonymous SNV	ZNF469:NM_001127464:exon2:c.C5602A:p.P1868T	.	.	.	.	.	.	.	.	3862.54073	12.24999	0.0	0.912	D	0.767	0.418	P	0.344	0.408	B	.	.	.	1	0.090	N	1.7	0.440	L	2.21	0.184	T	-2.63	0.564	D	0.305	0.365	-1.052	0.139	T	0.025	0.107	T	0.411	0.936	D	3.911	0.527	23.5	0.952	0.257	0.044	0.098	N	c	-0.393	-0.436	0.443	0.205	0.646	0.450	0	3.49	0.389	0.033	0.135	0.807	0.329	0.000	0.063	0.045	0.161	2.867	0.052	.	.	.	0.5	107	203	16	88499564	chr16:88499564	C	A	107	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	88593209	88593211	CCT	-	intronic	ZFPM1	.	.	.	0.031491837	0.959089121	0.009419042	.	0.18944	.	.	.	1660.90603	7.52751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	9	16	88593208	chr16:88593208	CCCT	C	43	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	88945792	88945792	C	T	exonic	CBFA2T3	.	synonymous SNV	CBFA2T3:NM_175931:exon10:c.G1290A:p.A430A,CBFA2T3:NM_005187:exon11:c.G1548A:p.A516A	0.454440082	0.54530519	0.000254728	DISEASE: Note=A chromosomal aberration involving CBFA2T3 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein. {ECO:0000269|PubMed:10995019, ECO:0000269|PubMed:11224496, ECO:0000269|PubMed:9596646}.; 	0.5017	0.1813	-1.015898037	8.144609578	345.59186	3.94358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	419	16	88945792	chr16:88945792	C	T	116	PASS	DP=419;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	89592827	89592827	G	C	exonic	SPG7	.	nonsynonymous SNV	SPG7:NM_003119:exon5:c.G709C:p.A237P,SPG7:NM_199367:exon5:c.G709C:p.A237P	1.38E-18	0.005285187	0.994714813	DISEASE: Note=Defects in SPG7 may cause autosomal recessive osteogenesis imperfecta (OI). Osteogenesis imperfecta defines a group of connective tissue disorders characterized by bone fragility and low bone mass. Clinical features of SPG7-related osteogenesis imperfecta include recurrent fractures, mild bone deformities, delayed tooth eruption, normal hearing and white sclera.; 	0.13976	.	-1.052752328	7.619721632	2153.42654	8.54208	1.0	0.022	T	0.0	0.067	B	0.002	0.112	B	0.057	0.225	N	1.000	0.204	N	-0.995	0.012	N	-0.8	0.739	T	0.97	0.058	N	0.13	0.149	-0.999	0.302	T	0.130	0.441	T	0.020	0.430	T	0.999	0.190	10.66	0.608	0.064	0.750	0.364	D	c	-0.665	-0.455	0.547	0.213	0.707	0.730	0	4.36	0.515	2.129	0.414	0.091	0.195	0.842	0.301	0.431	0.259	7.307	0.255	Peptidase M41, FtsH extracellular	.	.	0.5	93	137	16	89592827	chr16:89592827	G	C	93	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	89652189	89652189	G	A	exonic	CPNE7	.	nonsynonymous SNV	CPNE7:NM_153636:exon7:c.G776A:p.G259E,CPNE7:NM_014427:exon9:c.G1001A:p.G334E	1.63E-13	0.026868774	0.973131226	.	0.10022	.	-1.343026423	4.647322482	1754.91457	7.73074	0.506	0.076	T	0.0	0.067	B	0.001	0.063	B	0.108	0.196	N	1.000	0.207	N	0.495	0.134	N	2.5	0.145	T	0.02	0.068	N	0.048	0.029	-0.940	0.427	T	0.014	0.057	T	0.004	0.088	T	-1.122	0.028	0.009	0.267	0.013	0.099	0.153	N	c	-1.187	-1.130	0.999	0.371	0.706	0.609	0	-2.01	0.070	1.953	0.397	-0.061	0.121	0.998	0.411	0.048	0.163	9.838	0.400	C2 domain	.	.	0.5	.	107	16	89652189	chr16:89652189	G	A	.	PASS	DP=107;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	89657510	89657510	C	T	intronic	CPNE7	.	.	.	1.63E-13	0.026868774	0.973131226	.	0.10022	.	-1.343026423	4.647322482	1754.91457	7.73074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	151	16	89657510	chr16:89657510	C	T	107	PASS	DP=151;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	89715671	89715671	T	C	intronic	CHMP1A	.	.	.	0.252036809	0.719472862	0.028490329	DISEASE: Pontocerebellar hypoplasia 8 (PCH8) [MIM:614961]: An autosomal recessive neurodevelopmental disorder characterized by severe psychomotor retardation, abnormal movements, hypotonia, spasticity, and variable visual defects. Brain MRI shows pontocerebellar hypoplasia, decreased cerebral white matter, and a thin corpus callosum. {ECO:0000269|PubMed:23023333}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08801	.	0.150760231	64.51403633	463.07131	4.4604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	181	16	89715671	chr16:89715671	T	C	84	PASS	DP=181;AN=4	GT	0/1	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	89715916	89715916	C	G	intronic	CHMP1A	.	.	.	0.252036809	0.719472862	0.028490329	DISEASE: Pontocerebellar hypoplasia 8 (PCH8) [MIM:614961]: An autosomal recessive neurodevelopmental disorder characterized by severe psychomotor retardation, abnormal movements, hypotonia, spasticity, and variable visual defects. Brain MRI shows pontocerebellar hypoplasia, decreased cerebral white matter, and a thin corpus callosum. {ECO:0000269|PubMed:23023333}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08801	.	0.150760231	64.51403633	463.07131	4.4604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	190	16	89715916	chr16:89715916	C	G	97	PASS	DP=190;AN=4	GT	0/1	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	89828321	89828321	T	C	intronic	FANCA	.	.	.	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	29	16	89828321	chr16:89828321	T	C	41	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	89858417	89858417	C	A	exonic	FANCA	.	synonymous SNV	FANCA:NM_000135:exon13:c.G1143T:p.T381T,FANCA:NM_001286167:exon13:c.G1143T:p.T381T	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	18	16	89858417	chr16:89858417	C	A	58	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	89986075	89986075	G	T	exonic	MC1R	.	nonsynonymous SNV	MC1R:NM_002386:exon1:c.G409T:p.A137S	3.25E-07	0.052370692	0.947628983	DISEASE: Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:17434924, ECO:0000269|PubMed:19338054}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	0.68939	0.34168906	73.72611465	1416.53832	7.03613	0.012	0.654	D	0.7	0.399	P	0.519	0.463	P	0.001	0.392	U	0.994	0.236	N	3.31	0.908	M	2.11	0.199	T	-2.03	0.466	N	0.058	0.332	-1.056	0.128	T	0.082	0.323	T	0.015	0.355	T	4.232	0.567	23.9	0.996	0.738	0.669	0.330	D	c	-0.007	-0.082	1.000	0.747	0.615	0.372	0	1.64	0.228	2.657	0.461	0.091	0.195	0.997	0.399	0.004	0.083	9.907	0.404	GPCR, rhodopsin-like, 7TM	.	.	0.5	117	107	16	89986075	chr16:89986075	G	T	117	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
16	90030423	90030423	T	G	intronic	DEF8	.	.	.	0.389991488	0.609924177	8.43E-05	.	0.16968	0.10329	-0.021969881	52.14673272	223.67964	3.23402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	224	16	90030423	chr16:90030423	T	G	85	PASS	DP=224;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	11343	11343	C	T	intronic	DOC2B	.	.	.	0.382719812	0.476953142	0.140327046	.	0.22422	0.11084	.	.	58.48664	1.54921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	17	11343	chr17:11343	C	T	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	982599	982599	T	A	exonic	ABR	.	nonsynonymous SNV	ABR:NM_001092:exon5:c.A560T:p.K187M,ABR:NM_001159746:exon6:c.A533T:p.K178M,ABR:NM_001322840:exon6:c.A533T:p.K178M,ABR:NM_001322841:exon6:c.A1448T:p.K483M,ABR:NM_021962:exon6:c.A671T:p.K224M	0.999949479	5.05E-05	1.49E-12	.	0.59342	.	-1.03976177	7.802547771	211.79342	3.13829	0.002	0.721	D	0.979	0.764	D	0.905	0.736	P	0.000	0.629	D	0.999	0.453	D	2.725	0.800	M	-0.13	0.648	T	-3.2	0.658	D	0.556	0.686	-0.257	0.762	T	0.405	0.755	T	0.115	0.795	D	6.051	0.833	28.0	0.996	0.750	0.982	0.806	D	c	0.593	0.532	1.000	0.747	0.767	0.994	0	4.12	0.473	5.317	0.654	0.964	0.580	1.000	0.715	1.000	0.888	9.380	0.373	Dbl homology (DH) domain	.	.	0.5	.	55	17	982599	chr17:982599	T	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	1174703	1174703	G	C	downstream	BHLHA9	dist=138	.	.	.	.	.	DISEASE: Split-hand/foot malformation with long bone deficiency 3 (SHFLD3) [MIM:612576]: A disease characterized by the association of split-hand/foot malformation with long bone deficiency involving the tibia and fibula. Split-hand/foot malformation is a limb malformation involving the central rays of the autopod. Phenotypic expression is extremely variable between and within families, and even between limbs of a single patient, ranging from syndactyly and oligodactyly to the most severe monodactyly with only a single phalanx. Limb features include median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. {ECO:0000269|PubMed:22147889}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry. A copy number variation (CNV) resulting in BHLHA9 duplications is a necessary but not sufficient susceptibility factor for Split-hand/foot malformation with long bone deficiency, a highly variable phenotype with reduced penetrance, particularly in females (PubMed:22147889). {ECO:0000269|PubMed:22147889}.; DISEASE: Syndactyly, mesoaxial synostotic, with phalangeal reduction (MSSD) [MIM:609432]: An autosomal recessive, non- syndromic digit anomaly characterized by mesoaxial osseous synostosis at a metacarpal level, reduction of one or more phalanges, hypoplasia of distal phalanges of preaxial and postaxial digits, clinodactyly of fifth fingers, and preaxial fusion of toes. {ECO:0000269|PubMed:25466284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	.	13.47449	0.48957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	340	17	1174703	chr17:1174703	G	C	142	PASS	DP=340;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	1359255	1359255	C	T	exonic	CRK	.	nonsynonymous SNV	CRK:NM_005206:exon1:c.G157A:p.E53K,CRK:NM_016823:exon1:c.G157A:p.E53K	0.864536311	0.135055982	0.000407707	.	0.73088	0.53296	-0.339715008	30.06605331	5.16406	0.19181	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	1.305	0.328	L	1.82	0.885	T	-3.75	0.711	D	0.463	0.753	-1.044	0.161	T	0.131	0.443	T	0.835	0.987	D	6.949	0.934	33	0.999	0.992	0.933	0.577	D	c	0.689	0.684	1.0	0.983	0.442	0.072	0	4.93	0.643	7.593	0.818	0.907	0.419	1.000	0.715	0.998	0.697	16.011	0.801	SH2 domain	.	.	0.5	.	52	17	1359255	chr17:1359255	C	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	1370542	1370542	C	A	exonic	MYO1C	.	synonymous SNV	MYO1C:NM_001080779:exon31:c.G3159T:p.L1053L,MYO1C:NM_001080950:exon31:c.G3102T:p.L1034L,MYO1C:NM_033375:exon31:c.G3054T:p.L1018L	3.89E-08	0.99997491	2.51E-05	.	0.24832	0.21196	-1.113491624	6.634819533	761.68047	5.47188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	410	17	1370542	chr17:1370542	C	A	150	PASS	DP=410;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	1953325	1953325	G	A	upstream;downstream	MIR132;MIR212	dist=23;dist=240	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	17	1953325	chr17:1953325	G	A	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	2995994	2995994	T	C	exonic	OR1D2	.	synonymous SNV	OR1D2:NM_002548:exon1:c.A297G:p.T99T	0.002382562	0.536721251	0.460896187	.	0.24373	0.0871	1.0178651	90.91766926	2083.61947	8.40767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	120	17	2995994	chr17:2995994	T	C	73	PASS	DP=120;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	3628362	3628362	T	C	exonic	HASPIN	.	nonsynonymous SNV	HASPIN:NM_031965:exon1:c.T1133C:p.V378A	.	.	.	.	.	.	.	.	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.470	0.049	N	1	0.090	P	-1.24	0.008	N	3.47	0.052	T	0.92	0.016	N	0.006	0.000	-0.977	0.356	T	0.000	0.000	T	.	.	.	-1.165	0.026	0.008	0.764	0.111	0.007	0.029	N	c	-1.314	-1.277	1.000	0.462	0.543	0.218	0	0.989	0.188	-0.138	0.103	-1.107	0.018	0.000	0.063	0.001	0.043	4.249	0.101	.	.	.	0.5	45	9	17	3628362	chr17:3628362	T	C	45	PASS	DP=9;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	3976075	3976075	C	G	intronic	ZZEF1	.	.	.	0.999923091	7.69E-05	6.61E-24	.	0.3881	0.10288	-3.376061946	0.389242746	5318.26057	15.07421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	50	17	3976075	chr17:3976075	C	G	61	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	4623871	4623871	G	T	exonic	ARRB2	.	nonsynonymous SNV	ARRB2:NM_001257331:exon13:c.G1063T:p.V355F,ARRB2:NM_001257330:exon14:c.G1108T:p.V370F	0.769282968	0.230644341	7.27E-05	.	0.58827	0.57942	-0.670411825	15.61689078	141.04803	2.59189	.	.	.	0.013	0.154	B	0.017	0.170	B	0.038	0.243	U	1	0.090	N	.	.	.	2.51	0.143	T	.	.	.	0.12	0.134	-1.081	0.070	T	0.040	0.173	T	0.001	0.007	T	-0.581	0.051	0.139	0.172	0.005	0.030	0.078	N	c	-1.501	-1.618	1.000	0.489	0.732	0.924	0	-3.08	0.050	-2.289	0.012	-2.092	0.004	0.000	0.063	0.000	0.016	1.004	0.014	Arrestin, C-terminal|Immunoglobulin E-set	.	.	0.5	.	46	17	4623871	chr17:4623871	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	4646580	4646580	C	-	intronic	ZMYND15	.	.	.	1.44E-05	0.998157386	0.001828251	DISEASE: Spermatogenic failure 14 (SPGF14) [MIM:615842]: A disorder resulting in the absence (azoospermia) or reduction (oligozoospermia) of sperm in the semen, leading to male infertility. {ECO:0000269|PubMed:24431330}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18983	.	-0.951568548	9.271054494	291.84505	3.65548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	31	17	4646579	chr17:4646579	TC	T	44	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	4750525	4750525	-	TTCA	intronic	MINK1	.	.	.	0.999984022	1.60E-05	7.45E-16	.	0.46968	0.13857	-1.456898556	3.862939372	2119.37505	8.47592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	39	17	4750525	chr17:4750525	G	GTTCA	87	PASS	DP=39;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	5118228	5118229	TC	-	exonic	SCIMP	.	frameshift deletion	SCIMP:NM_001271842:exon4:c.253_254del:p.E85Rfs*19,SCIMP:NM_001319190:exon4:c.253_254del:p.E85Rfs*64,SCIMP:NM_207103:exon4:c.274_275del:p.E92Rfs*19	0.012575344	0.855696202	0.131728455	.	0.1304	.	-0.163345027	41.24793583	10.11893	0.36946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.39	37	17	5118227	chr17:5118227	TTC	T	12.39	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	5323631	5323631	A	G	intronic	RPAIN	.	.	.	6.36E-06	0.271529765	0.728463876	.	0.19849	.	-0.005381972	53.50908233	771.71707	5.49858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	81	17	5323631	chr17:5323631	A	G	79	PASS	DP=81;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	5389505	5389505	C	-	UTR5	DERL2	NM_016041:c.-24delG;NM_001304779:c.-24delG;NM_001304777:c.-24delG	.	.	0.932959932	0.066973865	6.62E-05	.	0.60196	0.13588	-0.141298762	42.87567823	650.6157	5.11656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	29	17	5389504	chr17:5389504	AC	A	81	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	6665416	6665416	G	T	intronic	XAF1	.	.	.	2.07E-08	0.073341496	0.926658483	.	0.05763	0.08526	0.995816767	90.62278839	600.13477	4.95792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	96	17	6665416	chr17:6665416	G	T	114	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
17	6920052	6920052	G	A	ncRNA_intronic	MIR497HG;RNASEK-C17orf49	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	17	6920052	chr17:6920052	G	A	.	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	6978296	6978296	G	T	UTR3	CLEC10A	NM_006344:c.*77C>A;NM_182906:c.*77C>A;NM_001330070:c.*77C>A	.	.	4.25E-08	0.203022746	0.796977211	.	0.05732	0.1098	1.218120595	93.15876386	329.25844	3.85744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	17	6978296	chr17:6978296	G	T	.	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	7363094	7363094	A	-	UTR3	ZBTB4	NM_020899:c.*2165delT;NM_001128833:c.*2165delT	.	.	0.998490203	0.001509768	2.89E-08	.	0.3783	0.08224	-0.10469683	45.64755839	312.5211	3.76241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	320	17	7363093	chr17:7363093	GA	G,GAA	85	PASS	DP=320;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2	./.
17	7363094	7363094	-	A	UTR3	ZBTB4	NM_020899:c.*2164_*2165insT;NM_001128833:c.*2164_*2165insT	.	.	0.998490203	0.001509768	2.89E-08	.	0.3783	0.08224	-0.10469683	45.64755839	312.5211	3.76241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	320	17	7363093	chr17:7363093	GA	G,GAA	85	PASS	DP=320;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2	./.
17	7578263	7578263	G	A	exonic	TP53	.	stopgain	TP53:NM_001126115:exon2:c.C190T:p.R64X,TP53:NM_001126116:exon2:c.C190T:p.R64X,TP53:NM_001126117:exon2:c.C190T:p.R64X,TP53:NM_001276697:exon2:c.C109T:p.R37X,TP53:NM_001276698:exon2:c.C109T:p.R37X,TP53:NM_001276699:exon2:c.C109T:p.R37X,TP53:NM_001126118:exon5:c.C469T:p.R157X,TP53:NM_000546:exon6:c.C586T:p.R196X,TP53:NM_001126112:exon6:c.C586T:p.R196X,TP53:NM_001126113:exon6:c.C586T:p.R196X,TP53:NM_001126114:exon6:c.C586T:p.R196X,TP53:NM_001276695:exon6:c.C469T:p.R157X,TP53:NM_001276696:exon6:c.C469T:p.R157X,TP53:NM_001276760:exon6:c.C469T:p.R157X,TP53:NM_001276761:exon6:c.C469T:p.R157X	0.912222953	0.087750328	2.67E-05	DISEASE: Note=TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is frequently mutated or inactivated in about 60% of cancers. TP53 defects are found in Barrett metaplasia a condition in which the normally stratified squamous epithelium of the lower esophagus is replaced by a metaplastic columnar epithelium. The condition develops as a complication in approximately 10% of patients with chronic gastroesophageal reflux disease and predisposes to the development of esophageal adenocarcinoma.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981, ECO:0000269|PubMed:1565144, ECO:0000269|PubMed:1737852, ECO:0000269|PubMed:1933902, ECO:0000269|PubMed:1978757, ECO:0000269|PubMed:2259385, ECO:0000269|PubMed:7887414, ECO:0000269|PubMed:8825920, ECO:0000269|PubMed:9452042}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Papilloma of choroid plexus (CPP) [MIM:260500]: A benign tumor of neuroectodermal origin that generally occurs in childhood, but has also been reported in adults. Although generally found within the ventricular system, choroid plexus papillomas can arise ectopically in the brain parenchyma or disseminate throughout the neuraxis. Patients present with signs and symptoms of increased intracranial pressure including headache, hydrocephalus, papilledema, nausea, vomiting, cranial nerve deficits, gait impairment, and seizures. {ECO:0000269|PubMed:12085209}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Adrenocortical carcinoma (ADCC) [MIM:202300]: A malignant neoplasm of the adrenal cortex and a rare childhood tumor. It occurs with increased frequency in patients with Beckwith- Wiedemann syndrome and Li-Fraumeni syndrome. {ECO:0000269|PubMed:11481490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Basal cell carcinoma 7 (BCC7) [MIM:614740]: A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter. {ECO:0000269|PubMed:21946351}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.99999	0.9998	-0.247889024	35.98726115	15.3263	0.55115	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.697	0.964	36	0.995	0.682	0.959	0.662	D	c	0.403	0.225	0.406	0.202	0.722	0.854	0	4.44	0.530	2.230	0.424	0.953	0.551	1.000	0.715	0.999	0.750	12.305	0.540	p53, DNA-binding domain|p53-like transcription factor, DNA-binding|p53/RUNT-type transcription factor, DNA-binding domain	.	.	0.5	.	46	17	7578263	chr17:7578263	G	A	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	7804735	7804735	C	-	intronic	CHD3	.	.	.	0.999999996	4.48E-09	1.38E-26	.	0.81281	0.12928	-2.475079584	0.973106865	670.89222	5.17831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	72	17	7804734	chr17:7804734	TC	T	58	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	8049417	8049417	G	A	exonic	PER1	.	nonsynonymous SNV	PER1:NM_002616:exon17:c.C2077T:p.P693S	0.875748962	0.124251034	4.54E-09	.	0.81937	0.22945	-1.889004548	1.981599434	289.79879	3.64159	0.144	0.335	T	0.139	0.470	B	0.04	0.432	B	0.007	0.315	N	1.000	0.182	N	1.7	0.440	L	2.62	0.367	T	-1.71	0.406	N	0.088	0.217	-1.066	0.103	T	0.077	0.308	T	0.017	0.381	T	-0.276	0.070	0.752	0.994	0.613	0.935	0.581	D	c	-0.363	-0.342	1.000	0.480	0.732	0.924	0	4.47	0.536	3.083	0.496	0.142	0.226	0.263	0.248	0.006	0.095	11.954	0.521	.	.	.	0.5	.	79	17	8049417	chr17:8049417	G	A	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	8062649	8062649	C	A	UTR3	VAMP2	NM_001330125:c.*1524G>T;NM_014232:c.*1524G>T	.	.	0.837117601	0.159707638	0.003174761	.	0.42512	0.11262	-0.053113545	49.38664779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	17	8062649	chr17:8062649	C	A	.	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	8063659	8063659	A	T	UTR3	VAMP2	NM_001330125:c.*514T>A;NM_014232:c.*514T>A	.	.	0.837117601	0.159707638	0.003174761	.	0.42512	0.11262	-0.053113545	49.38664779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	17	8063659	chr17:8063659	A	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	8063677	8063677	G	C	UTR3	VAMP2	NM_001330125:c.*496C>G;NM_014232:c.*496C>G	.	.	0.837117601	0.159707638	0.003174761	.	0.42512	0.11262	-0.053113545	49.38664779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	46	17	8063677	chr17:8063677	G	C	65	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	8789796	8789796	C	T	exonic	PIK3R5	.	nonsynonymous SNV	PIK3R5:NM_001251852:exon12:c.G874A:p.E292K,PIK3R5:NM_001251853:exon12:c.G874A:p.E292K,PIK3R5:NM_001251855:exon12:c.G874A:p.E292K,PIK3R5:NM_001142633:exon13:c.G2032A:p.E678K,PIK3R5:NM_001251851:exon13:c.G874A:p.E292K,PIK3R5:NM_014308:exon13:c.G2032A:p.E678K	0.817693684	0.182304778	1.54E-06	DISEASE: Ataxia-oculomotor apraxia 3 (AOA3) [MIM:615217]: An autosomal recessive disease characterized by cerebellar ataxia, oculomotor apraxia, areflexia and peripheral neuropathy. {ECO:0000269|PubMed:22065524}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0917	0.10099	-0.461076406	23.66124086	168.04756	2.8298	0.611	0.054	T	0.998	0.715	D	0.951	0.672	D	0.000	0.629	D	1.000	0.524	D	2.72	0.798	M	-1.13	0.777	T	-0.44	0.146	N	0.408	0.503	-0.518	0.680	T	0.389	0.744	T	0.188	0.861	D	4.478	0.600	24.2	0.942	0.238	0.873	0.465	D	c	-0.045	-0.104	0.829	0.246	0.632	0.406	0	3.24	0.361	4.403	0.592	0.852	0.362	1.000	0.715	0.115	0.194	13.085	0.584	.	.	.	0.5	90	175	17	8789796	chr17:8789796	C	T	90	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	10204985	10204985	C	T	exonic	MYH13	.	synonymous SNV	MYH13:NM_003802:exon40:c.G5703A:p.R1901R	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	17	10204985	chr17:10204985	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	10219247	10219247	G	T	exonic	MYH13	.	nonsynonymous SNV	MYH13:NM_003802:exon28:c.C3834A:p.N1278K	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	0.057	0.379	T	0.06	0.217	B	0.314	0.398	B	.	.	.	0.982	0.250	N	2.39	0.691	M	-1.11	0.775	T	-1.37	0.340	N	0.092	0.143	-0.238	0.767	T	0.522	0.822	D	0.072	0.714	D	4.382	0.587	24.1	0.998	0.882	0.361	0.252	N	c	-0.290	-0.338	0.000	0.012	0.497	0.185	0	1.08	0.194	-0.472	0.066	0.939	0.529	0.000	0.063	1.000	0.888	8.421	0.317	Myosin tail	.	.	0.5	76	105	17	10219247	chr17:10219247	G	T	76	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	10417160	10417160	C	A	exonic	MYH1	.	nonsynonymous SNV	MYH1:NM_005963:exon8:c.G719T:p.R240M	1.29E-29	0.041852309	0.958147691	.	0.69127	0.30625	-1.080656478	7.248171739	785.49267	5.53734	0.0	0.912	D	0.999	0.764	D	0.986	0.754	D	0.000	0.481	U	1	0.810	D	2.995	0.861	M	-2.47	0.890	D	-4.87	0.812	D	0.951	0.947	0.981	0.969	D	0.885	0.962	D	0.205	0.870	D	6.732	0.919	32	0.965	0.296	0.959	0.663	D	c	1.028	0.958	1.0	0.983	0.534	0.214	0	5.58	0.843	7.875	0.855	0.935	0.490	1.000	0.715	1.000	0.888	19.947	0.972	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	64	137	17	10417160	chr17:10417160	C	A	64	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	11840616	11840616	G	A	intronic	DNAH9	.	.	.	1.37E-35	0.999999244	7.56E-07	.	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	50	17	11840616	chr17:11840616	G	A	58	PASS	DP=50;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	11865150	11865150	C	T	intronic	DNAH9	.	.	.	1.37E-35	0.999999244	7.56E-07	.	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	48	17	11865150	chr17:11865150	C	T	58	PASS	DP=48;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	12920458	12920458	C	T	intronic	ELAC2	.	.	.	4.06E-11	0.920902555	0.079097445	DISEASE: Combined oxidative phosphorylation deficiency 17 (COXPD17) [MIM:615440]: An autosomal recessive disorder of mitochondrial dysfunction characterized by onset of severe hypertrophic cardiomyopathy in the first year of life. Other features include hypotonia, poor growth, lactic acidosis, and failure to thrive. The disorder may be fatal in early childhood. {ECO:0000269|PubMed:23849775}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.04345	0.09787	-0.905656269	10.12031139	1342.48638	6.87747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	17	12920458	chr17:12920458	C	T	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	15215660	15215660	T	C	exonic	TEKT3	.	synonymous SNV	TEKT3:NM_031898:exon7:c.A1017G:p.Q339Q	3.20E-14	0.010360828	0.989639172	.	0.04933	0.09715	0.911261639	89.50813871	3686.69181	11.82421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	11	17	15215660	chr17:15215660	T	C	44	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	15496612	15496612	G	A	intronic	CDRT1	.	.	.	.	.	.	.	.	.	0.846940207	88.47605567	5108.29652	14.68503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	97	17	15496612	chr17:15496612	G	A	75	PASS	DP=97;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	15522759	15522759	A	T	exonic	CDRT1	.	nonsynonymous SNV	CDRT1:NM_001282540:exon1:c.T68A:p.I23N,CDRT1:NM_006382:exon1:c.T68A:p.I23N	.	.	.	.	.	.	0.846940207	88.47605567	5108.29652	14.68503	0.024	0.481	D	0.553	0.363	P	0.146	0.323	B	.	.	.	1.000	0.186	N	0.69	0.170	N	1.84	0.247	T	-2.82	0.620	D	0.216	0.265	-0.981	0.349	T	0.000	0.002	T	.	.	.	1.532	0.246	13.48	0.899	0.186	0.124	0.171	N	c	-0.830	-0.838	0.286	0.190	0.526	0.212	0	3.92	0.444	1.613	0.363	0.223	0.255	0.023	0.197	0.002	0.062	10.567	0.442	.	.	.	0.5	.	62	17	15522759	chr17:15522759	A	T	.	PASS	DP=62;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	15690863	15690863	T	A	ncRNA_exonic	MEIS3P1	.	.	.	.	.	.	.	0.18471	.	-0.134019284	43.90776126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	200	17	15690863	chr17:15690863	T	A	83	PASS	DP=200;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	15878110	15878112	CAA	-	exonic	ADORA2B	.	nonframeshift deletion	ADORA2B:NM_000676:exon2:c.453_455del:p.N153del	2.01E-05	0.276665266	0.723314659	.	0.08265	0.18465	0.639420866	83.8995046	449.84282	4.40801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	16	17	15878109	chr17:15878109	CCAA	C	45	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	16068463	16068463	C	T	exonic	NCOR1	.	nonsynonymous SNV	NCOR1:NM_001190438:exon2:c.G121A:p.G41R,NCOR1:NM_001190440:exon4:c.G448A:p.G150R,NCOR1:NM_006311:exon5:c.G448A:p.G150R	0.999999999	7.43E-10	7.08E-30	.	0.57767	0.62451	-2.137013188	1.49799481	297.95501	3.68236	0.012	0.546	D	0.569	0.689	P	0.071	0.588	B	0.022	0.266	N	0.840	0.350	D	1.04	0.263	L	0.93	0.441	T	-2.42	0.625	N	0.305	0.441	-0.944	0.421	T	0.156	0.488	T	.	.	.	4.658	0.624	24.5	0.979	0.362	0.893	0.494	D	c	0.255	0.320	0.004	0.104	0.707	0.730	0	5.04	0.672	2.271	0.428	0.847	0.346	1.000	0.715	1.000	0.888	13.205	0.590	N-CoR, GPS2-interacting domain	.	.	0.5	89	127	17	16068463	chr17:16068463	C	T	89	PASS	DP=127;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	17707151	17707151	G	A	exonic	RAI1	.	nonsynonymous SNV	RAI1:NM_030665:exon4:c.G5647A:p.A1883T	0.999136112	0.000863888	6.14E-11	DISEASE: Smith-Magenis syndrome (SMS) [MIM:182290]: Characterized by congenital mental retardation associated with development and growth delays. Affected persons have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. {ECO:0000269|PubMed:11404004, ECO:0000269|PubMed:12652298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13693	0.11743	-3.683732498	0.253597547	223.68182	3.23449	0.0	0.912	D	0.999	0.764	D	0.995	0.818	D	.	.	.	1.000	0.810	D	4.17	0.977	H	-0.97	0.757	T	-3.46	0.677	D	0.668	0.791	0.488	0.904	D	0.663	0.883	D	0.358	0.925	D	7.132	0.943	34	0.965	0.295	0.994	0.953	D	c	0.983	0.925	1.000	0.747	0.707	0.730	0	5.46	0.799	9.735	0.980	1.048	0.713	1.000	0.715	0.997	0.653	18.908	0.924	Zinc finger, PHD-type	.	.	0.5	83	146	17	17707151	chr17:17707151	G	A	83	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	18051883	18051883	G	A	splicing	MYO15A	NM_016239:exon31:c.6764+1G>A	.	.	.	.	.	.	0.38072	0.15993	-1.25610141	5.349138948	5977.14295	16.09179	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.605	0.763	26.5	0.995	0.687	0.992	0.925	D	c	1.108	0.930	1.000	0.747	0.078	0.016	0	4.3	0.504	9.480	0.969	0.953	0.551	1.000	0.715	1.000	0.888	16.520	0.841	.	.	.	0.5	.	78	17	18051883	chr17:18051883	G	A	.	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	18326023	18326023	T	C	ncRNA_exonic	KRT17P5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	29	17	18326023	chr17:18326023	T	C	64	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	18334142	18334142	T	G	ncRNA_intronic	KRT17P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	694	17	18334142	chr17:18334142	T	G	119	PASS	DP=694;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	18353610	18353621	GCGGCATCGGGG	-	intergenic	KRT16P1;LGALS9C	dist=7402;dist=26478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	259	17	18353609	chr17:18353609	TGCGGCATCGGGG	T	99	PASS	DP=259;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	18918505	18918505	G	A	exonic	SLC5A10	.	nonsynonymous SNV	SLC5A10:NM_001270648:exon10:c.G1153A:p.V385M,SLC5A10:NM_001270649:exon10:c.G1126A:p.V376M,SLC5A10:NM_001282417:exon10:c.G1033A:p.V345M,SLC5A10:NM_001042450:exon11:c.G1234A:p.V412M,SLC5A10:NM_152351:exon11:c.G1282A:p.V428M	3.66E-12	0.158427678	0.841572322	.	0.13415	0.12866	-0.817464788	11.97806086	259.29549	3.46053	0.001	0.784	D	1.0	0.899	D	0.991	0.782	D	0.021	0.269	N	1.000	0.588	D	2.92	0.846	M	-2.47	0.895	D	-2.71	0.577	D	0.859	0.846	0.902	0.957	D	0.846	0.949	D	0.279	0.902	D	4.973	0.669	25.1	0.998	0.885	0.973	0.735	D	c	0.583	0.452	1.000	0.747	0.581	0.326	0	4.31	0.505	6.737	0.744	0.951	0.538	1.000	0.715	0.886	0.372	14.027	0.640	.	.	.	0.5	58	86	17	18918505	chr17:18918505	G	A	58	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	19091405	19091405	C	G	intergenic	LOC79999;LOC79999	dist=25468;dist=27538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	310	17	19091405	chr17:19091405	C	G	.	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	19314785	19314786	CA	-	intronic	RNF112	.	.	.	0.00365674	0.987234978	0.009108282	.	0.32157	0.24246	.	.	57.58728	1.53211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	125	17	19314784	chr17:19314784	TCA	T	78	PASS	DP=125;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	19350020	19350049	CCGCGGCCTTGGCCCCGGCCCCGTCCACGG	-	intergenic	RNF112;SLC47A1	dist=29431;dist=87118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	158	222	17	19350019	chr17:19350019	TCCGCGGCCTTGGCCCCGGCCCCGTCCACGG	T	158	PASS	DP=222;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	20416895	20416895	A	C	intergenic	KRT16P3;CDRT15L2	dist=9084;dist=66142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	364	17	20416895	chr17:20416895	A	C	88	PASS	DP=364;AN=4	GT	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.
17	20418848	20418848	G	T	intergenic	KRT16P3;CDRT15L2	dist=11037;dist=64189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	196	17	20418848	chr17:20418848	G	T	104	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	20769722	20769722	A	T	intronic	CCDC144NL	.	.	.	8.14E-06	0.171830686	0.828161171	.	.	.	1.26585432	93.59518754	271.43253	3.53005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	17	20769722	chr17:20769722	A	T	.	PASS	DP=141;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	21205359	21205364	GGGGCT	-	intronic	MAP2K3	.	.	.	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	8	17	21205358	chr17:21205358	GGGGGCT	G	42	PASS	DP=8;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	21216758	21216758	-	CTTC	intronic	MAP2K3	.	.	.	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	154	140	17	21216758	chr17:21216758	G	GCTTC	154	PASS	DP=140;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	21216846	21216846	G	C	exonic	MAP2K3	.	synonymous SNV	MAP2K3:NM_002756:exon11:c.G870C:p.L290L,MAP2K3:NM_145109:exon11:c.G957C:p.L319L,MAP2K3:NM_001316332:exon12:c.G870C:p.L290L	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	185	293	17	21216846	chr17:21216846	G	C	185	PASS	DP=293;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	21535980	21535981	CA	-	intergenic	C17orf51;UBBP4	dist=81039;dist=193620	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	15	17	21535979	chr17:21535979	TCA	T	43	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	25783897	25783897	G	A	intergenic	TBC1D3P5;KSR1	dist=25248;dist=15139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	395	17	25783897	chr17:25783897	G	A	128	PASS	DP=395;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	25974223	25974223	G	-	intronic	LGALS9	.	.	.	0.00139054	0.964148727	0.034460733	.	0.13572	0.22025	0.797386419	87.53833451	2358.5758	9.00919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	151	17	25974222	chr17:25974222	AG	A	104	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	26522835	26522835	T	-	UTR3	NLK	NM_016231:c.*1173delT	.	.	0.998934347	0.001065641	1.24E-08	.	0.96706	0.16306	-0.494039303	22.09247464	16.84134	0.5932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	29	17	26522834	chr17:26522834	AT	A	61	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	26684787	26684787	G	A	exonic	TMEM199	.	nonsynonymous SNV	TMEM199:NM_152464:exon1:c.G94A:p.A32T	0.000653685	0.737375253	0.261971062	.	0.18423	0.10808	0.373041938	75.29488087	1107.44888	6.35994	0.204	0.200	T	0.963	0.537	D	0.444	0.441	B	0.010	0.301	N	0.991	0.241	N	2.14	0.601	M	1.39	0.338	T	-0.78	0.216	N	0.243	0.306	-1.058	0.123	T	0.058	0.242	T	0.014	0.346	T	1.149	0.205	11.48	0.787	0.120	0.910	0.525	D	c	-0.169	-0.157	1.0	0.983	0.442	0.072	0	4.84	0.620	3.615	0.537	0.953	0.551	0.994	0.380	0.078	0.180	14.974	0.708	.	.	.	0.5	.	199	17	26684787	chr17:26684787	G	A	.	PASS	DP=199;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	27044323	27044323	G	C	exonic	RAB34	.	nonsynonymous SNV	RAB34:NM_001256281:exon1:c.C404G:p.S135W	4.68E-06	0.849259752	0.150735569	.	0.49492	0.14267	-0.60427181	17.74593064	14.52455	0.522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	61	17	27044323	chr17:27044323	G	C	83	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	27074223	27074223	C	A	intronic	TRAF4	.	.	.	0.840038712	0.159831706	0.000129581	.	0.35071	0.20238	-0.404032746	26.53338051	39.67284	1.16916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	188	17	27074223	chr17:27074223	C	A	117	PASS	DP=188;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	27419327	27419327	C	A	intronic	MYO18A	.	.	.	0.999417504	0.000582496	3.26E-16	.	0.45342	0.14389	-1.618952458	2.895730125	551.10541	4.7741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	17	27419327	chr17:27419327	C	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	28011635	28011653	CTACCATTAGTTGAAACCA	-	exonic	SSH2	.	frameshift deletion	SSH2:NM_001282131:exon4:c.347_365del:p.V116Dfs*9,SSH2:NM_001282130:exon5:c.326_344del:p.V109Dfs*9,SSH2:NM_033389:exon5:c.326_344del:p.V109Dfs*9,SSH2:NM_001282129:exon6:c.407_425del:p.V136Dfs*9	0.999753485	0.000246515	5.85E-13	.	0.53245	0.09592	-0.099241008	45.68294409	1818.77446	7.86582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	83	17	28011634	chr17:28011634	TCTACCATTAGTTGAAACCA	T	41	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	28886747	28886747	G	T	intronic	TBC1D29	.	.	.	8.25E-05	0.321646341	0.678271175	.	0.07418	.	0.215080721	67.91696155	10.20934	0.37212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	198	17	28886747	chr17:28886747	G	T	.	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	29171852	29171852	G	A	splicing	ATAD5	NM_024857:exon6:c.2369-1G>A	.	.	0.999999945	5.46E-08	8.84E-20	.	0.36789	.	-0.053328617	48.95022411	8284.30154	19.69105	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.681	0.775	26.7	0.994	0.637	0.992	0.921	D	c	1.181	1.041	1.000	0.500	0.156	0.027	0	5.74	0.900	7.180	0.770	1.030	0.653	1.000	0.715	1.000	0.888	17.498	0.876	.	.	.	0.5	.	73	17	29171852	chr17:29171852	G	A	.	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	30320860	30320860	-	T	intronic	SUZ12	.	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	17	17	30320860	chr17:30320860	C	CT	54	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	30695056	30695056	C	T	intronic	ZNF207	.	.	.	0.054263846	0.944894719	0.000841434	.	0.55618	0.11352	-0.181750739	40.15687662	380.34086	4.1114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	262	17	30695056	chr17:30695056	C	T	62	PASS	DP=262;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	30714694	30714694	A	G	intergenic	ZNF207;PSMD11	dist=17226;dist=56787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	89	17	30714694	chr17:30714694	A	G	77	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	30817689	30817689	-	A	UTR3	CDK5R1	NM_003885:c.*2127_*2128insA	.	.	0.738441122	0.250212258	0.011346619	.	0.54497	0.18399	-0.141298762	42.87567823	4.68969	0.1682	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	125	17	30817689	chr17:30817689	T	TA	69	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	33769038	33769038	C	A	exonic	SLFN13	.	nonsynonymous SNV	SLFN13:NM_144682:exon5:c.G1466T:p.R489L	8.75E-15	0.004834494	0.995165506	.	0.05976	0.06727	2.763559657	98.99740505	1954.11134	8.1348	0.635	0.051	T	0.388	0.327	B	0.083	0.277	B	0.287	0.039	N	1	0.090	P	2.24	0.636	M	4.49	0.035	T	-2.15	0.486	N	0.188	0.241	-0.948	0.414	T	0.008	0.030	T	.	.	.	0.520	0.144	7.585	0.425	0.031	0.004	0.019	N	c	-1.448	-1.614	0.119	0.168	0.707	0.730	0	-6.09	0.020	-6.973	0.001	-2.795	0.002	0.000	0.063	0.000	0.016	5.552	0.163	.	.	.	0.5	166	349	17	33769038	chr17:33769038	C	A	166	PASS	DP=349;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	33769060	33769060	C	G	exonic	SLFN13	.	nonsynonymous SNV	SLFN13:NM_144682:exon5:c.G1444C:p.E482Q	8.75E-15	0.004834494	0.995165506	.	0.05976	0.06727	2.763559657	98.99740505	1954.11134	8.1348	0.662	0.078	T	0.017	0.373	B	0.028	0.371	B	0.094	0.025	N	1	0.090	N	0.835	0.211	L	4.46	0.036	T	-0.29	0.132	N	0.097	0.098	-0.951	0.409	T	0.011	0.041	T	0.002	0.045	T	-0.534	0.054	0.181	0.165	0.004	0.020	0.060	N	c	-0.993	-1.083	0.000	0.070	0.707	0.730	0	0.85	0.180	-0.990	0.038	-0.600	0.044	0.000	0.063	0.000	0.016	4.176	0.097	.	.	.	0.5	102	520	17	33769060	chr17:33769060	C	G	102	PASS	DP=520;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	33805119	33805119	A	T	exonic	SLFN12L	.	synonymous SNV	SLFN12L:NM_001195790:exon3:c.T1179A:p.I393I	2.35E-05	0.501639472	0.498337059	.	0.08168	.	2.771030479	99.00920028	1908.34734	8.04469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	17	33805119	chr17:33805119	A	T	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	33849692	33849692	A	T	intergenic	SLFN12L;SLFN14	dist=34934;dist=25452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	217	17	33849692	chr17:33849692	A	T	96	PASS	DP=217;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	33998753	33998753	-	T	intronic	AP2B1	.	.	.	0.999667233	0.000332767	2.97E-11	.	0.71824	0.31324	-0.957024976	9.088228356	7.40151	0.27523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	150	17	33998753	chr17:33998753	C	CT	78	PASS	DP=150;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	34070317	34070317	G	T	UTR3	RASL10B	NM_033315:c.*1993G>T	.	.	0.036792615	0.832766797	0.130440588	.	0.19256	0.11192	0.170987912	65.5579146	48.9651	1.36687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	190	17	34070317	chr17:34070317	G	T	99	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	35297622	35297622	G	A	exonic	LHX1	.	nonsynonymous SNV	LHX1:NM_005568:exon2:c.G206A:p.G69D	0.289265566	0.689648123	0.021086311	.	0.86552	0.33462	0.150760231	64.51403633	193.33354	3.01652	.	.	.	1.0	0.899	D	0.991	0.782	D	0.000	0.843	D	1	0.810	D	1.76	0.459	L	.	.	.	.	.	.	0.933	0.926	0.664	0.927	D	0.760	0.918	D	0.109	0.786	D	6.235	0.861	28.8	0.999	0.939	0.982	0.805	D	c	0.799	0.746	1.000	0.747	0.598	0.340	0	4.05	0.462	10.003	0.997	1.048	0.713	1.000	0.715	1.000	0.888	17.516	0.876	Zinc finger, LIM-type	.	.	0.5	.	49	17	35297622	chr17:35297622	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	35307623	35307623	G	A	exonic	AATF	.	synonymous SNV	AATF:NM_012138:exon2:c.G201A:p.T67T	1.62E-07	0.845766703	0.154233135	.	0.66679	0.29381	-0.286522835	33.47487615	319.73191	3.79794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	341	17	35307623	chr17:35307623	G	A	65	PASS	DP=341;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	35896123	35896123	T	C	exonic	SYNRG	.	synonymous SNV	SYNRG:NM_001163547:exon17:c.A3006G:p.V1002V,SYNRG:NM_001163544:exon18:c.A3390G:p.V1130V,SYNRG:NM_001163545:exon18:c.A3387G:p.V1129V,SYNRG:NM_001163546:exon18:c.A3255G:p.V1085V,SYNRG:NM_080550:exon18:c.A3390G:p.V1130V,SYNRG:NM_198882:exon18:c.A3390G:p.V1130V,SYNRG:NM_007247:exon19:c.A3624G:p.V1208V	0.972748212	0.027251786	2.37E-09	.	0.05386	0.09802	-0.699966832	14.82071243	2722.3113	9.83401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	16	17	35896123	chr17:35896123	T	C	43	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	36352489	36352489	A	C	ncRNA_exonic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	8	17	36352489	chr17:36352489	A	C	69	PASS	DP=8;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.
17	36357125	36357144	AAATATATTTGAGCACTTAA	-	ncRNA_intronic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	303	17	36357124	chr17:36357124	TAAATATATTTGAGCACTTAA	T	78	PASS	DP=303;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	36358089	36358089	G	A	ncRNA_intronic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	102	17	36358089	chr17:36358089	G	A	.	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	36875820	36875820	G	A	exonic	MLLT6	.	nonsynonymous SNV	MLLT6:NM_005937:exon13:c.G1993A:p.E665K	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	0.996	0.670	D	0.99	0.774	D	0.000	0.513	D	1	0.810	D	1.895	0.505	L	.	.	.	.	.	.	0.232	0.721	-1.157	0.008	T	0.071	0.288	T	0.008	0.223	T	4.628	0.620	24.5	0.999	0.955	0.979	0.776	D	c	0.677	0.661	1.000	0.747	0.726	0.872	0	4.73	0.593	7.708	0.835	1.029	0.652	1.000	0.715	1.000	0.888	16.627	0.848	.	.	.	0.5	.	119	17	36875820	chr17:36875820	G	A	.	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	36883483	36883483	-	T	UTR3	MLLT6	NM_005937:c.*1632_*1633insT	.	.	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	47	17	36883483	chr17:36883483	G	GT	81	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	37070646	37070646	G	A	exonic	LASP1	.	synonymous SNV	LASP1:NM_001271608:exon4:c.G258A:p.E86E,LASP1:NM_006148:exon5:c.G426A:p.E142E	0.866739435	0.132870174	0.000390391	.	0.33295	0.11829	-0.449946534	24.00330267	12.83432	0.46825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	50	17	37070646	chr17:37070646	G	A	42	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	37366900	37366900	G	-	UTR3	STAC2	NM_001351360:c.*1645delC;NM_198993:c.*1645delC	.	.	1.66E-05	0.871297263	0.128686133	.	0.2536	0.10406	-0.977252525	8.799245105	52.09893	1.4266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	31	17	37366899	chr17:37366899	TG	T	54	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	37873563	37873563	C	-	intronic	ERBB2	.	.	.	0.998894657	0.001105343	1.88E-13	DISEASE: Hereditary diffuse gastric cancer (HDGC) [MIM:137215]: A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Note=Chromosomal aberrations involving ERBB2 may be a cause gastric cancer. Deletions within 17q12 region producing fusion transcripts with CDK12, leading to CDK12-ERBB2 fusion leading to truncated CDK12 protein not in-frame with ERBB2.; 	0.99949	0.89401	-0.5879134	18.28261382	5901.30986	15.94968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	45	17	37873562	chr17:37873562	GC	G	56	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	38975328	38975328	G	A	exonic	KRT10	.	nonsynonymous SNV	KRT10:NM_000421:exon7:c.C1459T:p.H487Y	0.020062694	0.976136429	0.003800877	DISEASE: Epidermolytic hyperkeratosis (EHK) [MIM:113800]: An autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth, erythroderma and blister formation diminish and hyperkeratoses develop. {ECO:0000269|PubMed:10201536, ECO:0000269|PubMed:1380725, ECO:0000269|PubMed:1381287, ECO:0000269|PubMed:21271994, ECO:0000269|PubMed:7507150, ECO:0000269|PubMed:7507152, ECO:0000269|PubMed:7508181, ECO:0000269|PubMed:7512983, ECO:0000269|Ref.7}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis annular epidermolytic (AEI) [MIM:607602]: A skin disorder resembling bullous congenital ichthyosiform erythroderma. Affected individuals present with bullous ichthyosis in early childhood and hyperkeratotic lichenified plaques in the flexural areas and extensor surfaces at later ages. The feature that distinguishes AEI from BCIE is dramatic episodes of flares of annular polycyclic plaques with scale, which coalesce to involve most of the body surface and can persist for several weeks or even months. {ECO:0000269|PubMed:9036939, ECO:0000269|PubMed:9856845}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Erythroderma, ichthyosiform, congenital reticular (CRIE) [MIM:609165]: A rare skin condition characterized by slowly enlarging islands of normal skin surrounded by erythematous ichthyotic patches in a reticulated pattern. The condition starts in infancy as a lamellar ichthyosis, with small islands of normal skin resembling confetti appearing in late childhood and at puberty. Histopathologic findings include band-like parakeratosis, psoriasiform acanthosis, and vacuolization of keratinocytes with binucleated cells in the upper epidermis, sometimes associated with amyloid deposition in the dermis. Ultrastructural abnormalities include perinuclear shells formed from a network of fine filaments in the upper epidermis. {ECO:0000269|PubMed:20798280}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54103	0.54019	0.220536484	68.38287332	1152.47941	6.46886	0.27	0.160	T	0.0	0.026	B	0.0	0.013	B	0.913	0.074	N	1	0.090	P	-2.005	0.002	N	-2.39	0.884	D	-0.62	0.183	N	0.115	0.126	-0.955	0.402	T	0.000	0.000	T	.	.	.	1.579	0.251	13.74	0.944	0.241	0.012	0.043	N	c	-1.289	-1.313	1.000	0.747	0.623	0.393	0	-1.49	0.082	-0.352	0.077	-0.849	0.029	0.000	0.063	0.000	0.016	2.944	0.054	.	ENSG00000167920.4|ENSG00000186395.6|ENSG00000167920.4|ENSG00000167920.4|ENSG00000167920.4|ENSG00000167920.4|ENSG00000167920.4|ENSG00000167920.4|ENSG00000167920.4|ENSG00000167920.4	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Nerve_Tibial|Pancreas|Pituitary|Stomach|Thyroid	0.5	51	43	17	38975328	chr17:38975328	G	A	51	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	39203522	39203534	TGGTGTCTGAGGC	-	UTR5	KRTAP2-1	NM_001123387:c.-3_-15delGCCTCAGACACCA	.	.	.	.	.	.	0.24626	.	.	.	6079.05555	16.29512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	231	17	39203521	chr17:39203521	GTGGTGTCTGAGGC	G	122	PASS	DP=231;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	39216243	39216284	GCAGCAGCCTCCCCCGTAGCTCAGGGAGGACAAGGTGGAGCC	-	exonic	KRTAP2-3	.	nonframeshift deletion	KRTAP2-3:NM_001165252:exon1:c.19_60del:p.G7_C20del	0.0777172	0.541195919	0.381086882	.	0.24626	.	.	.	4812.04517	14.06529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	55	17	39216242	chr17:39216242	GGCAGCAGCCTCCCCCGTAGCTCAGGGAGGACAAGGTGGAGCC	G	59	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	39240661	39240661	C	G	exonic	KRTAP4-7	.	nonsynonymous SNV	KRTAP4-7:NM_033061:exon1:c.C203G:p.T68S	1.11E-05	0.110363647	0.889625229	.	.	.	0.323496558	72.93583392	3093.65412	10.57314	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.001	0.006	N	1	0.090	P	.	.	.	5.16	0.012	T	1.18	0.011	N	0.065	0.051	-1.010	0.271	T	0.000	0.000	T	.	.	.	-2.048	0.007	0.001	0.571	0.056	0.001	0.004	N	c	-1.535	-1.629	0.008	0.116	0.487	0.133	0	-3.84	0.040	-2.458	0.011	-0.537	0.048	0.000	0.063	0.008	0.104	3.948	0.088	.	ENSG00000204880.6|ENSG00000198090.3	Esophagus_Mucosa|Whole_Blood	0.5	109	424	17	39240661	chr17:39240661	C	G	109	PASS	DP=424;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	39257792	39257801	GAGGGGAGGG	-	intronic	KRTAP4-8	.	.	.	0.009770819	0.598577344	0.391651837	.	0.12236	.	.	.	6576.55433	17.09261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	40	17	39257791	chr17:39257791	TGAGGGGAGGG	T	107	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	39261933	39261933	C	T	exonic	KRTAP4-9	.	nonsynonymous SNV	KRTAP4-9:NM_001146041:exon1:c.C293T:p.A98V	0.001503782	0.44209467	0.556401547	.	0.16136	.	0.812172405	87.75654636	1745.942	7.71103	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.005	U	1	0.090	P	-2.06	0.002	N	1.49	0.315	T	0.72	0.021	N	0.126	0.143	-0.991	0.325	T	0.022	0.093	T	.	.	.	-0.559	0.052	0.158	0.635	0.070	0.002	0.013	N	c	-2.041	-2.030	0.009	0.118	0.447	0.083	0	-2.04	0.069	-4.879	0.002	-2.760	0.002	0.000	0.063	0.000	0.016	5.086	0.139	.	.	.	0.5	106	473	17	39261933	chr17:39261933	C	T	106	PASS	DP=473;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	39411615	39411615	A	G	intronic	KRTAP9-9	.	.	.	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	93	17	39411615	chr17:39411615	A	G	86	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	39412133	39412133	C	A	exonic	KRTAP9-9	.	nonsynonymous SNV	KRTAP9-9:NM_030975:exon1:c.C496A:p.P166T,KRTAP9-9:NM_001318227:exon2:c.C511A:p.P171T	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	0.037	0.430	D	0.975	0.561	D	0.763	0.547	P	.	.	.	0.999	0.220	N	.	.	.	4.67	0.018	T	-4.87	0.812	D	0.492	0.539	-0.980	0.350	T	0.013	0.050	T	0.004	0.112	T	4.329	0.580	24.0	0.993	0.575	0.117	0.166	N	c	-0.033	-0.185	0.004	0.103	0.447	0.083	0	1.48	0.218	0.044	0.138	0.718	0.303	0.000	0.063	0.957	0.436	4.831	0.127	.	.	.	0.5	121	355	17	39412133	chr17:39412133	C	A	121	PASS	DP=355;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	39594980	39594980	C	T	exonic	KRT38	.	nonsynonymous SNV	KRT38:NM_006771:exon4:c.G863A:p.R288H	2.17E-05	0.724250939	0.275727343	.	0.08393	0.1123	-0.33061537	30.82094834	172.03352	2.86058	0.061	0.371	T	0.083	0.232	B	0.016	0.166	B	0.094	0.202	N	0.995	0.233	N	1.82	0.479	L	-2.6	0.899	D	-4.0	0.740	D	0.167	0.202	-0.436	0.709	T	0.381	0.738	T	.	.	.	4.125	0.553	23.8	0.981	0.374	0.200	0.207	N	c	-0.665	-0.734	0.000	0.071	0.497	0.185	0	-0.39	0.118	-0.681	0.053	0.077	0.185	0.000	0.063	0.540	0.278	4.993	0.135	.	.	.	0.5	76	171	17	39594980	chr17:39594980	C	T	76	PASS	DP=171;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	39595539	39595539	A	G	exonic	KRT38	.	synonymous SNV	KRT38:NM_006771:exon3:c.T648C:p.D216D	2.17E-05	0.724250939	0.275727343	.	0.08393	0.1123	-0.33061537	30.82094834	172.03352	2.86058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	333	17	39595539	chr17:39595539	A	G	133	PASS	DP=333;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	39633317	39633317	A	G	exonic	KRT35	.	synonymous SNV	KRT35:NM_002280:exon7:c.T1359C:p.G453G	0.017032338	0.960141959	0.022825703	.	0.11567	0.11898	0.604424343	82.90280727	1949.21087	8.12325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	34	17	39633317	chr17:39633317	A	G	54	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	39634625	39634625	A	G	exonic	KRT35	.	synonymous SNV	KRT35:NM_002280:exon5:c.T987C:p.A329A	0.017032338	0.960141959	0.022825703	.	0.11567	0.11898	0.604424343	82.90280727	1949.21087	8.12325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	27	17	39634625	chr17:39634625	A	G	64	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	39776818	39776818	A	-	intronic	KRT17	.	.	.	7.07E-06	0.722413326	0.2775796	DISEASE: Pachyonychia congenita 2 (PC2) [MIM:167210]: An autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma and hyperhidrosis, follicular hyperkeratosis, multiple epidermal cysts, absent/sparse eyebrow and body hair, and by the presence of natal teeth. {ECO:0000269|PubMed:10571744, ECO:0000269|PubMed:11348474, ECO:0000269|PubMed:11874497, ECO:0000269|PubMed:11886499, ECO:0000269|PubMed:15102078, ECO:0000269|PubMed:15795125, ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:16625196, ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:18547302, ECO:0000269|PubMed:19470054, ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:23278621, ECO:0000269|PubMed:23855588, ECO:0000269|PubMed:7539673, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Steatocystoma multiplex (SM) [MIM:184500]: Disease characterized by round or oval cystic tumors widely distributed on the back, anterior trunk, arms, scrotum, and thighs. {ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.; 	.	0.22756	-0.244249595	36.17008728	729.66866	5.36212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.61	102	17	39776817	chr17:39776817	GA	G	12.61	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	39974642	39974642	A	G	exonic	FKBP10	.	nonsynonymous SNV	FKBP10:NM_021939:exon4:c.A590G:p.K197R	0.000807425	0.983229411	0.015963164	DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44644	0.10813	-0.751322189	13.71196037	103.41854	2.19663	1.0	0.010	T	0.0	0.026	B	0.003	0.080	B	0.041	0.240	N	1	0.090	P	-1.85	0.003	N	0.82	0.481	T	1.41	0.008	N	0.036	0.016	-0.983	0.343	T	0.001	0.003	T	.	.	.	-2.128	0.006	0.001	0.143	0.003	0.204	0.208	N	c	-1.729	-1.528	0.971	0.292	0.722	0.854	0	1.37	0.211	3.252	0.509	-0.229	0.095	0.999	0.424	0.808	0.339	11.540	0.497	FKBP-type peptidyl-prolyl cis-trans isomerase domain	ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000259623.1|ENSG00000141698.12	Adipose_Subcutaneous|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Thyroid|Whole_Blood	0.5	182	153	17	39974642	chr17:39974642	A	G	182	PASS	DP=153;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	39976722	39976722	G	-	intronic	FKBP10	.	.	.	0.000807425	0.983229411	0.015963164	DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44644	0.10813	-0.751322189	13.71196037	103.41854	2.19663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	277	17	39976721	chr17:39976721	CG	C	76	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	40283682	40283682	G	A	UTR5	RAB5C	NM_001252039:c.-47C>T	.	.	0.826569532	0.172639649	0.000790818	.	0.57797	0.12971	0.215080721	67.91696155	28.22907	0.90529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	17	40283682	chr17:40283682	G	A	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	40461067	40461067	A	G	exonic	STAT5A	.	nonsynonymous SNV	STAT5A:NM_001288719:exon16:c.A1975G:p.K659E,STAT5A:NM_001288720:exon16:c.A1972G:p.K658E,STAT5A:NM_001288718:exon17:c.A2065G:p.K689E,STAT5A:NM_003152:exon18:c.A2065G:p.K689E	0.999866029	0.000133971	1.60E-11	.	0.68233	0.58998	-0.644723694	16.52512385	205.21053	3.09506	0.291	0.215	T	0.063	0.219	B	0.023	0.262	B	0.587	0.111	N	1.000	0.588	D	2.645	0.776	M	-3.96	0.962	D	-1.24	0.314	N	0.668	0.678	0.455	0.899	D	0.831	0.944	D	0.084	0.744	D	1.099	0.200	11.21	0.949	0.252	0.991	0.912	D	c	-0.155	-0.073	1.000	0.747	0.672	0.522	0	4.91	0.638	9.161	0.938	1.140	0.893	1.000	0.715	0.212	0.220	14.570	0.677	SH2 domain	.	.	0.5	82	63	17	40461067	chr17:40461067	A	G	82	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	40660662	40660662	C	T	intronic	ATP6V0A1	.	.	.	0.997249735	0.002750265	4.23E-11	.	0.44599	0.50341	-0.688817379	15.20405756	53.36179	1.45103	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	192	17	40660662	chr17:40660662	C	T	74	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	41102792	41102792	A	-	intronic	AARSD1;PTGES3L-AARSD1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	175	17	41102791	chr17:41102791	CA	C	71	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	41362009	41362009	G	A	exonic	NBR1	.	synonymous SNV	NBR1:NM_005899:exon21:c.G2817A:p.L939L,NBR1:NM_031862:exon21:c.G2817A:p.L939L	0.000436707	0.999230855	0.000332438	.	.	.	0.867166666	88.81811748	3800.47731	12.10337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	17	41362009	chr17:41362009	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	41622671	41622671	G	A	exonic	ETV4	.	nonsynonymous SNV	ETV4:NM_001261437:exon2:c.C8T:p.P3L,ETV4:NM_001261438:exon2:c.C8T:p.P3L,ETV4:NM_001079675:exon3:c.C125T:p.P42L,ETV4:NM_001986:exon3:c.C125T:p.P42L	0.00270291	0.994402078	0.002895012	.	0.5648	0.45988	0.286674996	71.49681529	207.59681	3.11139	0.086	0.912	T	0.465	0.899	P	0.033	0.916	B	0.602	0.109	N	0.999	0.479	D	1.845	0.488	L	2.08	0.202	T	-1.31	0.328	N	0.374	0.442	-1.149	0.011	T	0.100	0.372	T	0.013	0.331	T	4.969	0.668	25.1	0.999	0.941	0.941	0.598	D	c	0.322	0.366	1.000	0.747	0.564	0.319	0	4.32	0.507	5.122	0.643	1.047	0.674	1.000	0.715	0.998	0.697	12.962	0.577	PEA3-type ETS-domain transcription factor, N-terminal	.	.	0.5	.	60	17	41622671	chr17:41622671	G	A	.	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	42255660	42255660	C	T	exonic	ASB16	.	nonsynonymous SNV	ASB16:NM_080863:exon5:c.C1264T:p.R422W	2.42E-10	0.073433168	0.926566831	.	0.22798	0.10536	1.580015895	95.77140835	5016.34156	14.46226	0.102	0.302	T	0.97	0.550	D	0.567	0.479	P	0.521	0.117	N	1	0.090	N	1.15	0.294	L	0.92	0.445	T	-1.54	0.373	N	0.247	0.302	-1.048	0.149	T	0.103	0.379	T	0.009	0.246	T	5.280	0.714	25.7	0.998	0.897	0.223	0.215	N	c	0.028	0.005	1.000	0.451	0.646	0.450	0	4.34	0.511	1.253	0.323	0.068	0.175	0.000	0.063	0.003	0.074	13.142	0.587	SOCS box domain	.	.	0.5	.	114	17	42255660	chr17:42255660	C	T	.	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	42267817	42267817	C	T	intronic	TMUB2	.	.	.	0.001301139	0.647548425	0.351150436	.	0.39207	.	-0.337894035	30.37272942	380.91104	4.11369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	17	42267817	chr17:42267817	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	42336517	42336517	C	T	intronic	SLC4A1	.	.	.	0.909484295	0.090515465	2.40E-07	DISEASE: Ovalocytosis, Southeast Asian (SAO) [MIM:166900]: A hereditary hematologic disorder characterized by ovalocytic erythrocytes that are rigid and exhibit reduced expression of many erythrocyte antigens. Clinical manifestations include mild hemolysis, intermittent jaundice and gallstones. However, the disorder is most often asymptomatic. {ECO:0000269|PubMed:1538405, ECO:0000269|PubMed:1722314}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 4 (SPH4) [MIM:612653]: Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. {ECO:0000269|PubMed:10580570, ECO:0000269|PubMed:10745622, ECO:0000269|PubMed:10942416, ECO:0000269|PubMed:11380459, ECO:0000269|PubMed:1378323, ECO:0000269|PubMed:15813913, ECO:0000269|PubMed:16227998, ECO:0000269|PubMed:7530501, ECO:0000269|PubMed:8547122, ECO:0000269|PubMed:8640229, ECO:0000269|PubMed:8943874, ECO:0000269|PubMed:9012689, ECO:0000269|PubMed:9207478, ECO:0000269|PubMed:9233560, ECO:0000269|PubMed:9973643}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal tubular acidosis, distal, autosomal dominant (AD- dRTA) [MIM:179800]: An autosomal dominant disease characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal tubular acidosis, distal, with hemolytic anemia (dRTA-HA) [MIM:611590]: A disease characterized by the association of hemolytic anemia with distal renal tubular acidosis, the reduced ability to acidify urine resulting in variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. {ECO:0000269|PubMed:10926824, ECO:0000269|PubMed:15211439, ECO:0000269|PubMed:9854053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Renal tubular acidosis, distal, with normal red cell morphology (dRTA-NRC) [MIM:611590]: A disease characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. {ECO:0000269|PubMed:15211439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10965	0.57746	-0.789972689	12.61500354	702.26691	5.26999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	401	17	42336517	chr17:42336517	C	T	58	PASS	DP=401;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	43626397	43626397	G	C	intergenic	LRRC37A4P;MAPK8IP1P2	dist=28508;dist=51072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	571	17	43626397	chr17:43626397	G	C	118	PASS	DP=571;AN=4	GT	./.	./.	./.	0/1	./.	0/1	./.	./.	./.	./.	./.
17	44117135	44117135	C	T	exonic	KANSL1	.	synonymous SNV	KANSL1:NM_001193466:exon8:c.G2136A:p.P712P,KANSL1:NM_015443:exon8:c.G2136A:p.P712P,KANSL1:NM_001193465:exon9:c.G2136A:p.P712P	0.999733506	0.000266494	3.49E-12	.	0.60193	0.13678	-0.321528174	30.95069592	5743.08683	15.71165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	131	17	44117135	chr17:44117135	C	T	88	PASS	DP=131;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	44953931	44953931	G	A	exonic	WNT9B	.	synonymous SNV	WNT9B:NM_003396:exon4:c.G921A:p.R307R	0.051616811	0.861298955	0.087084234	.	0.12092	0.18289	0.532823122	80.96249115	202.94359	3.07608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	101	17	44953931	chr17:44953931	G	A	88	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	45234303	45234303	G	C	exonic	CDC27	.	nonsynonymous SNV	CDC27:NM_001293091:exon6:c.C635G:p.A212G,CDC27:NM_001114091:exon7:c.C818G:p.A273G,CDC27:NM_001256:exon7:c.C818G:p.A273G,CDC27:NM_001293089:exon7:c.C818G:p.A273G	0.486673202	0.513325147	1.65E-06	.	0.94354	0.15358	-0.117432389	44.89266336	13.5224	0.49131	0.018	0.512	D	0.304	0.429	B	0.15	0.359	B	0.000	0.559	D	1.000	0.537	D	2.075	0.572	M	-0.37	0.690	T	-1.4	0.366	N	0.54	0.598	-0.773	0.567	T	0.187	0.538	T	.	.	.	2.860	0.404	21.7	0.968	0.306	0.989	0.890	D	c	0.310	0.470	1.0	0.983	0.716	0.820	0	5.64	0.864	9.384	0.966	0.998	0.613	1.000	0.715	0.997	0.653	17.208	0.867	.	.	.	0.5	86	61	17	45234303	chr17:45234303	G	C	86	PASS	DP=61;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	45364391	45364395	TTTGT	-	intronic	ITGB3	.	.	.	0.141699545	0.858266504	3.40E-05	DISEASE: Glanzmann thrombasthenia (GT) [MIM:273800]: A common inherited disease of platelet aggregation. It is characterized by mucocutaneous bleeding of mild-to-moderate severity. GT has been classified clinically into types I and II. In type I, platelets show absence of the glycoprotein IIb-IIIa complexes at their surface and lack fibrinogen and clot retraction capability. In type II, the platelets express the GPIIb-IIIa complex at reduced levels, have detectable amounts of fibrinogen, and have low or moderate clot retraction capability. {ECO:0000269|PubMed:10233432, ECO:0000269|PubMed:11588040, ECO:0000269|PubMed:11897046, ECO:0000269|PubMed:12083483, ECO:0000269|PubMed:12353082, ECO:0000269|PubMed:1371279, ECO:0000269|PubMed:1438206, ECO:0000269|PubMed:15583747, ECO:0000269|PubMed:15634267, ECO:0000269|PubMed:15748237, ECO:0000269|PubMed:1602006, ECO:0000269|PubMed:20020534, ECO:0000269|PubMed:2392682, ECO:0000269|PubMed:8781422, ECO:0000269|PubMed:9215749, ECO:0000269|PubMed:9376589, ECO:0000269|PubMed:9684783, ECO:0000269|PubMed:9790984}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bleeding disorder, platelet-type 16 (BDPLT16) [MIM:187800]: An autosomal dominant form of congenital macrothrombocytopenia associated with platelet anisocytosis. It is a disorder of platelet production. Affected individuals may have no or only mildly increased bleeding tendency. In vitro studies show mild platelet functional abnormalities. {ECO:0000269|PubMed:18065693}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54409	0.86055	-1.017713296	8.103326256	169.39233	2.84003	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	32	17	45364390	chr17:45364390	ATTTGT	A	78	PASS	DP=32;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	45664574	45664577	TTTT	-	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.87	162	17	45664573	chr17:45664573	CTTTT	C,CTTTTT,CTTT	11.87	PASS	DP=162;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.
17	45664577	45664577	-	T	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.87	162	17	45664573	chr17:45664573	CTTTT	C,CTTTTT,CTTT	11.87	PASS	DP=162;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.
17	45664577	45664577	T	-	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.87	162	17	45664573	chr17:45664573	CTTTT	C,CTTTTT,CTTT	11.87	PASS	DP=162;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.
17	45669359	45669359	T	G	exonic	NPEPPS	.	nonsynonymous SNV	NPEPPS:NM_006310:exon11:c.T1298G:p.F433C,NPEPPS:NM_001330257:exon12:c.T1286G:p.F429C	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.65	0.994	H	2.93	0.098	T	-7.52	0.960	D	0.708	0.991	-0.296	0.751	T	0.186	0.537	T	.	.	.	6.465	0.892	29.9	0.994	0.647	0.983	0.810	D	c	1.055	0.941	1.000	0.747	0.732	0.924	0	5.51	0.817	7.834	0.848	0.875	0.382	1.000	0.715	1.000	0.888	15.626	0.765	Peptidase M1, membrane alanine aminopeptidase, N-terminal	.	.	0.5	95	134	17	45669359	chr17:45669359	T	G	95	PASS	DP=134;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	45727515	45727515	C	G	UTR5	KPNB1	NM_002265:c.-96C>G	.	.	0.999994328	5.67E-06	7.22E-15	.	0.99948	0.5595	-0.624497208	17.16206653	28.74247	0.91953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	144	17	45727515	chr17:45727515	C	G	74	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	45727516	45727516	C	T	UTR5	KPNB1	NM_002265:c.-95C>T	.	.	0.999994328	5.67E-06	7.22E-15	.	0.99948	0.5595	-0.624497208	17.16206653	28.74247	0.91953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	17	45727516	chr17:45727516	C	T	.	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	45727525	45727525	C	T	UTR5	KPNB1	NM_002265:c.-86C>T	.	.	0.999994328	5.67E-06	7.22E-15	.	0.99948	0.5595	-0.624497208	17.16206653	28.74247	0.91953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	162	17	45727525	chr17:45727525	C	T	85	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	46622002	46622002	G	-	exonic	HOXB2	.	frameshift deletion	HOXB2:NM_002145:exon1:c.272delC:p.P91Rfs*7	0.001838308	0.720699042	0.277462649	.	0.38232	.	-0.091746757	46.91554612	148.37143	2.65404	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	1002	17	46622001	chr17:46622001	CG	C	113	PASS	DP=1002;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	47076450	47076450	T	-	intronic	IGF2BP1	.	.	.	0.998573997	0.001426002	1.03E-09	.	0.92265	0.48799	-0.381986487	27.68931352	33.32025	1.02987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	49	17	47076449	chr17:47076449	AT	A	39	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	47210429	47210429	A	G	exonic	B4GALNT2	.	synonymous SNV	B4GALNT2:NM_153446:exon1:c.A42G:p.E14E	9.64E-07	0.768740676	0.23125836	.	0.05778	0.28364	0.802845857	87.69167256	3125.19031	10.63438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	84	17	47210429	chr17:47210429	A	G	68	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	47241481	47241541	TACCAAGACTTTCCTCCGCCCCCACAAGCTCATGATCATGCTCCGGAGTATTCGAGAGTAT	-	exonic	B4GALNT2	.	frameshift deletion	B4GALNT2:NM_001159387:exon8:c.798_858del:p.K268Qfs*2,B4GALNT2:NM_001159388:exon8:c.720_780del:p.K242Qfs*2,B4GALNT2:NM_153446:exon8:c.978_1038del:p.K328Qfs*2	9.64E-07	0.768740676	0.23125836	.	0.05778	0.28364	0.802845857	87.69167256	3125.19031	10.63438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	8	17	47241480	chr17:47241480	CTACCAAGACTTTCCTCCGCCCCCACAAGCTCATGATCATGCTCCGGAGTATTCGAGAGTAT	C	39	PASS	DP=8;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	47486893	47486903	TGTTTTTTTTT	-	intronic	PHB	.	.	.	0.82163215	0.177514223	0.000853627	.	0.87417	0.68456	0.03689118	56.64071715	11.35938	0.40904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	73	17	47486892	chr17:47486892	GTGTTTTTTTTT	G	76	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	47755280	47755280	C	T	intronic	SPOP	.	.	.	0.992531223	0.007467347	1.43E-06	.	0.21933	0.18619	-0.185391282	39.67916962	25.23464	0.82534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	17	47755280	chr17:47755280	C	T	.	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	48195470	48195470	G	T	intronic	SAMD14	.	.	.	0.02026443	0.975990271	0.003745299	.	0.19905	0.10658	-0.53631094	20.53550366	50.42659	1.39709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	17	48195470	chr17:48195470	G	T	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	48277042	48277042	C	A	intronic	COL1A1	.	.	.	0.999999999	1.02E-09	2.21E-25	DISEASE: Caffey disease (CAFFD) [MIM:114000]: Characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age. {ECO:0000269|PubMed:15864348}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10739762, ECO:0000269|PubMed:17211858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome 7A (EDS7A) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:1634225, ECO:0000269|PubMed:16638323, ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1718984, ECO:0000269|PubMed:1737847, ECO:0000269|PubMed:17875077, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:24682174, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:3244312, ECO:0000269|PubMed:8223589}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1460047, ECO:0000269|PubMed:1511982, ECO:0000269|PubMed:1613761, ECO:0000269|PubMed:16566045, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:1939261, ECO:0000269|PubMed:1953667, ECO:0000269|PubMed:2035536, ECO:0000269|PubMed:2036375, ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2116413, ECO:0000269|PubMed:2211725, ECO:0000269|PubMed:2339700, ECO:0000269|PubMed:2470760, ECO:0000269|PubMed:25958000, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:2913053, ECO:0000269|PubMed:3016737, ECO:0000269|PubMed:3108247, ECO:0000269|PubMed:3403550, ECO:0000269|PubMed:3667599, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7679635, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7961597, ECO:0000269|PubMed:8100209, ECO:0000269|PubMed:8349697, ECO:0000269|PubMed:8349698, ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456808, ECO:0000269|PubMed:8786074, ECO:0000269|PubMed:9143923, ECO:0000269|Ref.47, ECO:0000269|Ref.50}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2511192, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8019571, ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456809, ECO:0000269|PubMed:8669434, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:9101304}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:17875077, ECO:0000269|PubMed:1988452, ECO:0000269|PubMed:2745420, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7982948, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8339541, ECO:0000269|PubMed:9600458}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:8841196, ECO:0000269|PubMed:9535665}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF.; 	0.99194	0.99087	-1.785892633	2.25878745	137.3096	2.54895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	19	17	48277042	chr17:48277042	C	A	74	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	48594609	48594612	CCTG	-	intronic	MYCBPAP	.	.	.	0.001733006	0.998221165	4.58E-05	.	0.09337	0.08885	2.011818712	97.67633876	2351.86361	8.98627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	13	17	48594608	chr17:48594608	TCCTG	T	40	PASS	DP=13;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	48653249	48653251	CAC	-	exonic	CACNA1G	.	nonframeshift deletion	CACNA1G:NM_001256324:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256325:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256326:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256327:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256328:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256329:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256330:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256331:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256332:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256333:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256334:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256359:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256360:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_001256361:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_018896:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198376:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198377:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198378:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198379:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198380:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198382:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198383:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198384:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198385:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198386:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198387:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198388:exon8:c.1486_1488del:p.H504del,CACNA1G:NM_198396:exon8:c.1486_1488del:p.H504del	0.999996517	3.48E-06	7.46E-19	.	0.50605	0.17372	-2.374358198	1.114649682	288.88842	3.63697	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	59	17	48653248	chr17:48653248	GCAC	G	62	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	48750766	48750766	C	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	65	17	48750766	chr17:48750766	C	T	82	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	48750768	48750768	G	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	66	17	48750768	chr17:48750768	G	T	81	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	55334367	55334367	C	-	intronic	MSI2	.	.	.	0.963858042	0.036127911	1.40E-05	DISEASE: Note=Chromosomal aberrations involving MSI2 may contribute to disease progression in chronic myeloid leukemia. Translocation t(7;17)(p15;q23) with HOXA9; translocation t(7;17)(q32-34;q23). {ECO:0000269|PubMed:12649177}.; 	0.22637	0.09832	0.12689526	63.00424628	34.77251	1.05981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	58	17	55334366	chr17:55334366	TC	T	67	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	56083848	56083848	A	-	exonic	SRSF1	.	frameshift deletion	SRSF1:NM_001078166:exon2:c.235delT:p.Y79Tfs*58,SRSF1:NM_006924:exon2:c.235delT:p.Y79Tfs*58	0.991994023	0.008004282	1.70E-06	.	0.85062	0.04472	-0.009020804	52.8544468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114.1	80	17	56083847	chr17:56083847	TA	T	114.1	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	56332206	56332206	C	A	exonic	LPO	.	synonymous SNV	LPO:NM_001160102:exon7:c.C891A:p.A297A,LPO:NM_006151:exon9:c.C1140A:p.A380A	2.91E-11	0.264081682	0.735918318	.	0.15837	0.32199	-1.240018202	5.461193678	1144.41107	6.45117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	17	56332206	chr17:56332206	C	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	58300951	58300951	-	A	intronic	USP32	.	.	.	0.999999997	2.88E-09	5.68E-25	.	0.99543	0.10507	-2.078019896	1.580561453	184.4083	2.94681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	14	17	58300951	chr17:58300951	T	TA	40	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	59857600	59857600	A	-	intronic	BRIP1	.	.	.	5.38E-13	0.932068251	0.067931749	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20765	0.27124	-0.637452658	16.73743808	155.97826	2.72998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	94	17	59857599	chr17:59857599	CA	C,CAA	67	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	59857600	59857600	-	A	intronic	BRIP1	.	.	.	5.38E-13	0.932068251	0.067931749	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20765	0.27124	-0.637452658	16.73743808	155.97826	2.72998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	94	17	59857599	chr17:59857599	CA	C,CAA	67	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	59974795	59974795	T	-	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	218	17	59974794	chr17:59974794	CT	C,CTT	64	PASS	DP=218;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2	./.
17	59974795	59974795	-	T	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	218	17	59974794	chr17:59974794	CT	C,CTT	64	PASS	DP=218;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2	./.
17	60217010	60217010	G	T	intergenic	MED13;TBC1D3P2	dist=74367;dist=125057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	122	17	60217010	chr17:60217010	G	T	74	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	60345044	60345044	A	T	ncRNA_intronic	TBC1D3P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	17	60345044	chr17:60345044	A	T	.	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	60757562	60757564	ACG	-	exonic	MRC2	.	nonframeshift deletion	MRC2:NM_006039:exon15:c.2330_2332del:p.D781del	0.985888158	0.014111842	3.87E-12	.	0.68336	0.13319	-1.163005113	6.086341118	972.4639	6.02816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	46	17	60757561	chr17:60757561	CACG	C	44	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	60814330	60814330	C	T	exonic	MARCH10	.	nonsynonymous SNV	MARCH10:NM_001100875:exon6:c.G899A:p.C300Y,MARCH10:NM_152598:exon6:c.G899A:p.C300Y,MARCH10:NM_001288779:exon7:c.G1013A:p.C338Y,MARCH10:NM_001288780:exon7:c.G896A:p.C299Y	.	.	.	.	.	.	.	.	.	.	0.041	0.419	D	0.143	0.287	B	0.057	0.308	B	0.009	0.306	N	1.000	0.192	N	0	0.065	N	1.49	0.315	T	-0.18	0.098	N	0.156	0.214	-0.989	0.329	T	0.031	0.135	T	0.001	0.012	T	0.290	0.122	5.598	0.592	0.060	0.007	0.030	N	c	-0.933	-0.821	0.242	0.186	0.447	0.083	0	4.16	0.480	1.732	0.375	0.182	0.247	0.957	0.332	0.001	0.043	7.162	0.247	.	.	.	0.5	.	26	17	60814330	chr17:60814330	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	60827660	60827660	A	G	intronic	MARCH10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.090	P	.	.	.	.	.	.	.	.	.	0.045	0.025	.	.	.	.	.	.	.	.	.	0.449	0.137	7.030	0.418	0.030	0.002	0.011	N	n	0.337	-0.089	0.040	0.144	0.487	0.133	0	4.37	0.517	1.484	0.349	-0.945	0.024	0.007	0.175	0.000	0.016	7.680	0.275	.	ENSG00000173838.7|ENSG00000265702.1|ENSG00000265702.1	Artery_Tibial|Cells_Transformed_fibroblasts|Testis	0.5	51	24	17	60827660	chr17:60827660	A	G	51	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	61615660	61615660	-	G	intronic	KCNH6	.	.	.	3.94E-17	0.010222186	0.989777814	.	0.29959	0.16889	-0.606336534	17.51002595	660.24764	5.15277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	14	17	61615660	chr17:61615660	T	TG	45	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	61772392	61772392	C	T	UTR3	MAP3K3	NM_001330431:c.*1255C>T;NM_203351:c.*1255C>T;NM_002401:c.*1255C>T	.	.	0.999526987	0.000473013	6.99E-11	.	0.79837	0.23984	-1.06726444	7.372021703	91.94105	2.06355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	17	61772392	chr17:61772392	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	61838289	61838289	T	C	exonic	CCDC47	.	synonymous SNV	CCDC47:NM_020198:exon6:c.A720G:p.P240P	0.002588177	0.994331313	0.00308051	.	0.46552	0.10992	-0.624497208	17.16206653	32.82785	1.01862	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	97	17	61838289	chr17:61838289	T	C	.	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	61939715	61939715	C	A	ncRNA_exonic	TCAM1P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	104	17	61939715	chr17:61939715	C	A	72	PASS	DP=104;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	61949621	61949621	G	T	exonic	CSH2	.	nonsynonymous SNV	CSH2:NM_022645:exon3:c.C234A:p.D78E,CSH2:NM_020991:exon5:c.C519A:p.D173E	0.458223921	0.515305	0.026471079	.	0.04737	0.07342	-0.139478553	43.29440906	29.18154	0.93272	0.044	0.784	D	0.887	0.715	P	0.86	0.818	P	0.002	0.009	N	1	0.810	D	2.675	0.786	M	-2.3	0.885	D	-2.76	0.634	D	0.516	0.569	-0.268	0.759	T	0.868	0.956	D	0.018	0.404	T	3.095	0.432	22.5	0.995	0.660	0.671	0.330	D	c	0.430	0.263	0.000	0.042	0.447	0.083	0	2.96	0.332	0.749	0.258	0.973	0.593	0.999	0.424	0.739	0.319	6.177	0.195	Four-helical cytokine, core|Four-helical cytokine-like, core	.	.	0.5	123	452	17	61949621	chr17:61949621	G	T	123	PASS	DP=452;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	62007074	62007074	G	A	intronic	CD79B	.	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	121	17	62007074	chr17:62007074	G	A	.	PASS	DP=121;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	62009640	62009640	G	T	UTR5	CD79B	NM_021602:c.-19C>A;NM_000626:c.-19C>A;NM_001329050:c.-19C>A;NM_001039933:c.-19C>A	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	185	17	62009640	chr17:62009640	G	T	130	PASS	DP=185;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	62290515	62290515	C	A	exonic	TEX2	.	nonsynonymous SNV	TEX2:NM_001288732:exon2:c.G1063T:p.G355W,TEX2:NM_001288733:exon2:c.G1063T:p.G355W,TEX2:NM_018469:exon2:c.G1063T:p.G355W	0.44097988	0.559019647	4.74E-07	.	0.17386	0.08006	-0.946125119	9.377211607	521.90393	4.66418	0.001	0.784	D	0.999	0.764	D	0.975	0.717	D	0.000	0.843	D	0.998	0.445	D	1.67	0.430	L	0.46	0.563	T	-2.27	0.506	N	0.593	0.620	-0.538	0.673	T	0.305	0.676	T	0.053	0.654	D	6.215	0.858	28.7	0.946	0.245	0.931	0.571	D	c	0.696	0.709	1.000	0.747	0.615	0.372	0	6.03	0.978	4.527	0.600	0.935	0.490	1.000	0.715	0.912	0.389	20.557	0.993	.	.	.	0.5	.	44	17	62290515	chr17:62290515	C	A	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	62852056	62852056	A	G	intronic	LRRC37A3	.	.	.	.	.	.	.	.	.	.	.	193.95095	3.02097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	195	17	62852056	chr17:62852056	A	G	.	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	65068106	65068106	C	T	UTR3	HELZ	NM_014877:c.*6262G>A;NM_001330447:c.*6262G>A	.	.	1	3.48E-11	7.19E-27	.	0.33626	0.09834	-1.210720546	5.708893607	2913.40807	10.24388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	17	65068106	chr17:65068106	C	T	.	PASS	DP=66;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	65073947	65073947	C	T	UTR3	HELZ	NM_014877:c.*421G>A;NM_001330447:c.*421G>A	.	.	1	3.48E-11	7.19E-27	.	0.33626	0.09834	-1.210720546	5.708893607	2913.40807	10.24388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	17	65073947	chr17:65073947	C	T	.	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	65720151	65720151	-	T	intronic	NOL11	.	.	.	0.027829353	0.972074352	9.63E-05	.	0.4979	0.07984	0.290313621	71.56758669	595.1741	4.93918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	173	17	65720150	chr17:65720150	CT	CTT,C	65	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	65720151	65720151	T	-	intronic	NOL11	.	.	.	0.027829353	0.972074352	9.63E-05	.	0.4979	0.07984	0.290313621	71.56758669	595.1741	4.93918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	173	17	65720150	chr17:65720150	CT	CTT,C	65	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	66124328	66124328	C	T	ncRNA_exonic	LINC00674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	108	17	66124328	chr17:66124328	C	T	81	PASS	DP=108;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	66525038	66525038	C	T	exonic	PRKAR1A	.	nonsynonymous SNV	PRKAR1A:NM_001276290:exon8:c.C797T:p.T266M,PRKAR1A:NM_001278433:exon9:c.C797T:p.T266M,PRKAR1A:NM_002734:exon9:c.C797T:p.T266M,PRKAR1A:NM_212471:exon9:c.C797T:p.T266M,PRKAR1A:NM_212472:exon9:c.C797T:p.T266M,PRKAR1A:NM_001276289:exon10:c.C797T:p.T266M	0.999223269	0.000776725	5.72E-09	DISEASE: Carney complex 1 (CNC1) [MIM:160980]: CNC is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas. {ECO:0000269|PubMed:15371594, ECO:0000269|PubMed:18241045, ECO:0000269|PubMed:22785148, ECO:0000269|PubMed:23323113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intracardiac myxoma (INTMYX) [MIM:255960]: Inheritance is autosomal recessive. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary pigmented nodular adrenocortical disease 1 (PPNAD1) [MIM:610489]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. PPNAD1 is most often diagnosed in patients with Carney complex, a multiple neoplasia syndrome. However it can also be observed in patients without other manifestations. {ECO:0000269|PubMed:12213893}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]: A form of skeletal dysplasia characterized by short stature, severe brachydactyly, facial dysostosis, and nasal hypoplasia. Affected individuals often have advanced bone age and obesity. Laboratory studies show resistance to multiple hormones, including parathyroid, thyrotropin, calcitonin, growth hormone-releasing hormone, and gonadotropin. However, not all patients show endocrine abnormalities. {ECO:0000269|PubMed:21651393, ECO:0000269|PubMed:22464250, ECO:0000269|PubMed:22464252, ECO:0000269|PubMed:22723333, ECO:0000269|PubMed:23043190, ECO:0000269|PubMed:23425300}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93386	0.7266	-0.339715008	30.06605331	5.79493	0.21858	0.011	0.555	D	0.999	0.764	D	0.854	0.591	P	0.000	0.843	D	1	0.810	D	3.18	0.890	M	-0.6	0.717	T	-4.4	0.773	D	0.699	0.703	0.320	0.879	D	0.598	0.857	D	0.153	0.835	D	5.630	0.767	26.6	0.998	0.854	0.982	0.806	D	c	0.908	0.869	1.000	0.747	0.732	0.924	0	5.89	0.947	6.180	0.717	0.015	0.141	1.000	0.715	0.706	0.311	20.244	0.984	Cyclic nucleotide-binding domain|Cyclic nucleotide-binding-like|RmlC-like jelly roll fold	.	.	0.5	58	53	17	66525038	chr17:66525038	C	T	58	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	68175166	68175167	AG	-	UTR3	KCNJ2	NM_000891:c.*2702_*2703delAG	.	.	0.820229028	0.178898897	0.000872075	DISEASE: Long QT syndrome 7 (LQT7) [MIM:170390]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features. {ECO:0000269|PubMed:11371347, ECO:0000269|PubMed:12148092, ECO:0000269|PubMed:12163457, ECO:0000269|PubMed:16571646, ECO:0000269|PubMed:17324964}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 3 (SQT3) [MIM:609622]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. SQT3 has a unique ECG phenotype characterized by asymmetrical T waves. {ECO:0000269|PubMed:15761194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:15922306}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42866	0.22085	-0.582225231	18.44184949	8.98775	0.32999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	32	17	68175165	chr17:68175165	TAG	T	52	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	68175917	68175917	-	A	UTR3	KCNJ2	NM_000891:c.*3453_*3454insA	.	.	0.820229028	0.178898897	0.000872075	DISEASE: Long QT syndrome 7 (LQT7) [MIM:170390]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features. {ECO:0000269|PubMed:11371347, ECO:0000269|PubMed:12148092, ECO:0000269|PubMed:12163457, ECO:0000269|PubMed:16571646, ECO:0000269|PubMed:17324964}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 3 (SQT3) [MIM:609622]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. SQT3 has a unique ECG phenotype characterized by asymmetrical T waves. {ECO:0000269|PubMed:15761194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:15922306}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42866	0.22085	-0.582225231	18.44184949	8.98775	0.32999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	288	17	68175917	chr17:68175917	G	GA	86	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	72368450	72368450	C	T	exonic	GPR142	.	nonsynonymous SNV	GPR142:NM_001331076:exon4:c.C836T:p.T279I,GPR142:NM_001331077:exon4:c.C836T:p.T279I,GPR142:NM_181790:exon4:c.C1100T:p.T367I	5.60E-05	0.689421967	0.310522078	.	.	.	-0.214928658	37.7388535	583.16278	4.89646	0.463	0.086	T	0.166	0.295	B	0.038	0.234	B	0.120	0.190	N	0.982	0.250	N	0.14	0.088	N	-0.36	0.688	T	0.17	0.051	N	0.156	0.186	-1.036	0.187	T	0.105	0.384	T	0.027	0.500	D	1.117	0.202	11.31	0.909	0.196	0.315	0.241	N	c	-0.610	-0.497	0.068	0.155	0.497	0.185	0	3.63	0.406	2.018	0.404	0.925	0.434	0.005	0.169	0.980	0.490	6.953	0.236	GPCR, rhodopsin-like, 7TM	.	.	0.5	112	101	17	72368450	chr17:72368450	C	T	112	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	72736980	72736980	C	T	exonic	RAB37	.	nonsynonymous SNV	RAB37:NM_001006638:exon2:c.C167T:p.S56F,RAB37:NM_001163989:exon2:c.C182T:p.S61F,RAB37:NM_001330471:exon2:c.C86T:p.S29F	8.23E-05	0.76782021	0.23209752	.	0.08186	0.11813	0.040529541	57.15380986	48.09219	1.35018	0.003	0.721	D	0.884	0.473	P	0.816	0.571	P	0.000	0.449	D	0.999	0.810	D	2.03	0.557	M	-1.14	0.779	T	-3.79	0.724	D	0.38	0.440	0.185	0.857	D	0.556	0.838	D	0.226	0.881	D	5.061	0.682	25.2	0.998	0.867	0.990	0.891	D	c	0.476	0.436	1.000	0.747	0.706	0.609	0	5.1	0.688	4.832	0.622	0.921	0.432	1.000	0.715	0.999	0.750	17.296	0.870	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	71	200	17	72736980	chr17:72736980	C	T	71	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	72949146	72949146	C	T	exonic	HID1	.	synonymous SNV	HID1:NM_030630:exon16:c.G2007A:p.P669P	0.46550532	0.534447268	4.74E-05	.	0.15824	0.09962	-1.172055164	6.027364945	387.7479	4.1476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	350	17	72949146	chr17:72949146	C	T	97	PASS	DP=350;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	73258083	73258085	GCG	-	intronic	GGA3;MRPS7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	64	17	73258082	chr17:73258082	AGCG	A	54	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	73262902	73262904	CAG	-	exonic	MIF4GD	.	nonframeshift deletion	MIF4GD:NM_001242501:exon5:c.586_588del:p.L196del,MIF4GD:NM_001242500:exon6:c.688_690del:p.L230del,MIF4GD:NM_001242498:exon7:c.709_711del:p.L237del,MIF4GD:NM_020679:exon7:c.688_690del:p.L230del	3.58E-05	0.592434276	0.407529922	.	0.03324	.	-0.183570861	39.95046001	1028.74548	6.16188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	70	17	73262901	chr17:73262901	CCAG	C	79	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	73565171	73565171	T	C	exonic	LLGL2	.	nonsynonymous SNV	LLGL2:NM_001031803:exon13:c.T1435C:p.F479L,LLGL2:NM_004524:exon13:c.T1435C:p.F479L	8.27E-07	0.999084868	0.000914305	.	.	.	1.04528704	91.31280962	9919.23727	21.67473	0.788	0.032	T	0.0	0.026	B	0.0	0.013	B	0.000	0.497	N	0.999	0.216	P	-1.95	0.002	N	2.97	0.095	T	1.31	0.009	N	0.101	0.104	-1.019	0.241	T	0.000	0.000	T	.	.	.	0.764	0.167	9.237	0.965	0.294	0.563	0.298	D	c	-0.787	-0.561	0.000	0.059	0.696	0.567	0	4.33	0.509	2.054	0.407	0.069	0.176	1.000	0.715	0.956	0.434	2.731	0.049	WD40-repeat-containing domain	ENSG00000073350.9|ENSG00000073350.9	Cells_EBV-transformed_lymphocytes|Whole_Blood	0.5	96	282	17	73565171	chr17:73565171	T	C	96	PASS	DP=282;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	73570259	73570259	A	T	intronic	LLGL2	.	.	.	8.27E-07	0.999084868	0.000914305	.	.	.	1.04528704	91.31280962	9919.23727	21.67473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	17	73570259	chr17:73570259	A	T	.	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	73620205	73620205	G	C	intronic	MYO15B	.	.	.	.	.	.	.	0.14983	0.11459	.	.	4109.50851	12.72624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	17	73620205	chr17:73620205	G	C	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	73774999	73774999	C	T	exonic	H3F3B	.	synonymous SNV	H3F3B:NM_005324:exon3:c.G174A:p.S58S	0.80972478	0.185480955	0.004794265	.	0.29831	.	-0.207437529	38.2814343	2211.25884	8.6579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	234	17	73774999	chr17:73774999	C	T	.	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	73908392	73908392	A	-	intronic	FBF1	.	.	.	1.14E-19	0.008665209	0.991334791	.	0.10085	0.103	-0.694532205	14.83840528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	351	17	73908391	chr17:73908391	GA	G	71	PASS	DP=351;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	73967898	73967899	AC	-	intronic	ACOX1	.	.	.	0.094435306	0.905495422	6.93E-05	.	0.16046	0.77183	0.134171522	63.57041755	194.54546	3.02364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	300	17	73967897	chr17:73967897	AAC	A	61	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	73967906	73967906	T	-	intronic	ACOX1	.	.	.	0.094435306	0.905495422	6.93E-05	.	0.16046	0.77183	0.134171522	63.57041755	194.54546	3.02364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	45	17	73967905	chr17:73967905	GT	G	42	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	74017594	74017594	A	G	exonic	EVPL	.	synonymous SNV	EVPL:NM_001320747:exon9:c.T966C:p.C322C,EVPL:NM_001988:exon9:c.T966C:p.C322C	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	151	17	74017594	chr17:74017594	A	G	.	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	74017790	74017790	C	A	exonic	EVPL	.	nonsynonymous SNV	EVPL:NM_001320747:exon8:c.G880T:p.V294L,EVPL:NM_001988:exon8:c.G880T:p.V294L	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	0.801	0.031	T	0.43	0.338	B	0.1	0.291	B	0.005	0.332	N	0.830	0.288	N	1.43	0.360	L	1.54	0.301	T	-0.74	0.208	N	0.227	0.278	-1.015	0.253	T	0.037	0.162	T	0.011	0.275	T	2.800	0.397	21.4	0.961	0.281	0.672	0.331	D	c	-0.544	-0.460	0.034	0.142	0.515	0.199	0	0.936	0.185	-0.394	0.073	0.889	0.393	0.087	0.223	0.996	0.625	3.251	0.064	.	.	.	0.5	.	65	17	74017790	chr17:74017790	C	A	.	PASS	DP=65;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	74017795	74017795	C	T	exonic	EVPL	.	nonsynonymous SNV	EVPL:NM_001320747:exon8:c.G875A:p.R292H,EVPL:NM_001988:exon8:c.G875A:p.R292H	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	0.007	0.599	D	0.993	0.899	D	0.64	0.850	P	0.000	0.559	D	0.999	0.455	D	2.35	0.677	M	1.44	0.327	T	-3.02	0.626	D	0.479	0.528	-0.739	0.585	T	0.184	0.533	T	0.112	0.791	D	6.262	0.865	29.0	0.999	0.997	0.585	0.304	D	c	0.437	0.374	0.994	0.335	0.515	0.199	0	4.33	0.509	2.194	0.421	0.889	0.393	0.554	0.271	0.981	0.494	14.345	0.661	.	.	.	0.5	.	60	17	74017795	chr17:74017795	C	T	.	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	74388160	74388160	C	-	exonic	UBE2O	.	frameshift deletion	UBE2O:NM_022066:exon16:c.2981delG:p.R994Qfs*35	0.999985318	1.47E-05	7.32E-14	.	0.53648	0.1104	-0.813834387	12.05472989	3680.76091	11.80398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	36	17	74388159	chr17:74388159	TC	T	69	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	74722899	74722899	C	T	upstream	JMJD6;METTL23	dist=13	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	87	17	74722899	chr17:74722899	C	T	59	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	74722910	74722910	C	T	upstream	JMJD6;METTL23	dist=2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	17	74722910	chr17:74722910	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	74723008	74723009	GC	-	UTR5	METTL23	NM_001206985:c.-6169_-6168del-;NM_001080510:c.-2785_-2784del-;NM_001206987:c.-6169_-6168del-;NM_001206986:c.-6169_-6168del-;NM_001206983:c.-2785_-2784del-	.	.	0.113237609	0.778025357	0.108737034	DISEASE: Mental retardation, autosomal recessive 44 (MRT44) [MIM:615942]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT44 manifestations include mild to severe cognitive impairment, delayed psychomotor development, seizures in some patients, and dysmorphic features. {ECO:0000269|PubMed:24501276, ECO:0000269|PubMed:24626631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.08223	0.349177632	74.18023119	73.16169	1.78753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	111	17	74723007	chr17:74723007	GGC	G	66	PASS	DP=111;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	75494803	75494803	C	T	UTR3	SEPT9	NM_001293695:c.*63C>T;NM_001113491:c.*63C>T;NM_001113492:c.*63C>T;NM_006640:c.*63C>T;NM_001113493:c.*63C>T;NM_001113494:c.*63C>T;NM_001293696:c.*63C>T;NM_001113496:c.*63C>T;NM_001293697:c.*63C>T;NM_001293698:c.*63C>T;NM_001113495:c.*63C>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	91	17	75494803	chr17:75494803	C	T	70	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	75495353	75495353	C	G	UTR3	SEPT9	NM_001293695:c.*613C>G;NM_001113491:c.*613C>G;NM_001113492:c.*613C>G;NM_006640:c.*613C>G;NM_001113493:c.*613C>G;NM_001113494:c.*613C>G;NM_001293696:c.*613C>G;NM_001113496:c.*613C>G;NM_001293697:c.*613C>G;NM_001293698:c.*613C>G;NM_001113495:c.*613C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	184	17	75495353	chr17:75495353	C	G	88	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	76446798	76446798	G	T	exonic	DNAH17	.	nonsynonymous SNV	DNAH17:NM_173628:exon67:c.C10865A:p.T3622N	.	.	.	.	0.10041	.	.	.	8793.71322	20.21811	.	.	.	0.009	0.139	B	0.02	0.179	B	0.002	0.385	N	0.895	0.360	D	1.065	0.271	L	-0.24	0.668	T	.	.	.	0.152	0.181	-0.930	0.441	T	0.155	0.486	T	0.006	0.164	T	1.568	0.250	13.68	0.934	0.225	0.921	0.546	D	c	-0.349	-0.193	0.171	0.177	0.615	0.372	0	2.33	0.279	1.201	0.317	0.953	0.551	0.877	0.307	1.000	0.888	9.725	0.393	.	.	.	0.5	.	30	17	76446798	chr17:76446798	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	77043574	77043574	T	C	intronic	C1QTNF1	.	.	.	7.24E-05	0.504506997	0.495420602	.	0.34557	0.12013	-0.358119787	29.16371786	33.51466	1.03494	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	45	17	77043574	chr17:77043574	T	C	63	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	77807049	77807049	G	T	UTR3	CBX4	NM_003655:c.*709C>A	.	.	0.381198482	0.608349045	0.010452473	.	0.87942	0.1035	0.106667882	61.73036093	1044.2776	6.20429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	72	17	77807049	chr17:77807049	G	T	.	PASS	DP=72;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	77809367	77809367	C	-	intronic	CBX4	.	.	.	0.381198482	0.608349045	0.010452473	.	0.87942	0.1035	0.106667882	61.73036093	1044.2776	6.20429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	623	17	77809366	chr17:77809366	AC	A	78	PASS	DP=623;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	78087109	78087109	A	G	exonic	GAA	.	synonymous SNV	GAA:NM_000152:exon15:c.A2133G:p.T711T,GAA:NM_001079804:exon15:c.A2133G:p.T711T,GAA:NM_001079803:exon16:c.A2133G:p.T711T	4.62E-11	0.781839838	0.218160162	DISEASE: Glycogen storage disease 2 (GSD2) [MIM:232300]: A metabolic disorder with a broad clinical spectrum. The severe infantile form, or Pompe disease, presents at birth with massive accumulation of glycogen in muscle, heart and liver. Cardiomyopathy and muscular hypotonia are the cardinal features of this form whose life expectancy is less than two years. The juvenile and adult forms present as limb-girdle muscular dystrophy beginning in the lower limbs. Final outcome depends on respiratory muscle failure. Patients with the adult form can be free of clinical symptoms for most of their life but finally develop a slowly progressive myopathy. {ECO:0000269|PubMed:10189220, ECO:0000269|PubMed:10206684, ECO:0000269|PubMed:10338092, ECO:0000269|PubMed:10737124, ECO:0000269|PubMed:11071489, ECO:0000269|PubMed:11738358, ECO:0000269|PubMed:12601120, ECO:0000269|PubMed:12923862, ECO:0000269|PubMed:14643388, ECO:0000269|PubMed:14695532, ECO:0000269|PubMed:14972326, ECO:0000269|PubMed:15145338, ECO:0000269|PubMed:15668445, ECO:0000269|PubMed:16433701, ECO:0000269|PubMed:1652892, ECO:0000269|PubMed:16782080, ECO:0000269|PubMed:1684505, ECO:0000269|PubMed:16917947, ECO:0000269|PubMed:17643989, ECO:0000269|PubMed:18425781, ECO:0000269|PubMed:18429042, ECO:0000269|PubMed:1898413, ECO:0000269|PubMed:19588081, ECO:0000269|PubMed:20080426, ECO:0000269|PubMed:20350966, ECO:0000269|PubMed:21109266, ECO:0000269|PubMed:22644586, ECO:0000269|PubMed:22676651, ECO:0000269|PubMed:25681614, ECO:0000269|PubMed:7695647, ECO:0000269|PubMed:7717400, ECO:0000269|PubMed:7866409, ECO:0000269|PubMed:7881422, ECO:0000269|PubMed:7981676, ECO:0000269|PubMed:8094613, ECO:0000269|PubMed:8401535, ECO:0000269|PubMed:8834250, ECO:0000269|PubMed:9521422, ECO:0000269|PubMed:9535769, ECO:0000269|PubMed:9660056, ECO:0000269|Ref.5}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11717	0.93517	-1.159397299	6.098136353	1841.49194	7.915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	329	17	78087109	chr17:78087109	A	G	96	PASS	DP=329;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	78440791	78440791	T	A	UTR3	NPTX1	NM_002522:c.*3822A>T	.	.	0.426444497	0.566089052	0.007466451	.	0.3732	0.18467	-0.291981272	33.20358575	668.26251	5.17027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	17	78440791	chr17:78440791	T	A	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	78444425	78444425	C	G	UTR3	NPTX1	NM_002522:c.*188G>C	.	.	0.426444497	0.566089052	0.007466451	.	0.3732	0.18467	-0.291981272	33.20358575	668.26251	5.17027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	91	17	78444425	chr17:78444425	C	G	60	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	78445556	78445556	G	T	exonic	NPTX1	.	synonymous SNV	NPTX1:NM_002522:exon4:c.C1053A:p.G351G	0.426444497	0.566089052	0.007466451	.	0.3732	0.18467	-0.291981272	33.20358575	668.26251	5.17027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	346	17	78445556	chr17:78445556	G	T	129	PASS	DP=346;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	78935197	78935197	C	T	exonic	RPTOR	.	synonymous SNV	RPTOR:NM_001163034:exon27:c.C3135T:p.R1045R,RPTOR:NM_020761:exon31:c.C3609T:p.R1203R	0.999999983	1.67E-08	4.96E-21	.	.	.	-2.583601763	0.831564048	64.74857	1.65128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	464	17	78935197	chr17:78935197	C	T	108	PASS	DP=464;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	79220110	79220110	C	-	exonic	SLC38A10	.	frameshift deletion	SLC38A10:NM_001037984:exon16:c.2606delG:p.G869Afs*38	4.09E-08	0.986554606	0.013445353	.	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49	54	17	79220109	chr17:79220109	GC	G	49	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	79246270	79246270	-	C	intronic	SLC38A10	.	.	.	4.09E-08	0.986554606	0.013445353	.	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	143	67	17	79246270	chr17:79246270	G	GC	143	PASS	DP=67;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	79683805	79683805	G	A	intronic	SLC25A10	.	.	.	0.002439368	0.928274848	0.069285784	.	0.18311	0.12721	-0.448125345	24.19202642	41.5856	1.21268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	182	17	79683805	chr17:79683805	G	A	98	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	79916149	79916172	TCCCTGCCCTGCCATCCGGCCCCG	-	intronic	NOTUM	.	.	.	0.0008604	0.984521789	0.014617811	.	0.24251	0.12435	-0.468351206	23.42533616	393.9962	4.17307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	60	17	79916148	chr17:79916148	CTCCCTGCCCTGCCATCCGGCCCCG	C	53	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
17	80377690	80377690	T	G	exonic	HEXDC	.	synonymous SNV	HEXDC:NM_001330542:exon2:c.T15G:p.T5T,HEXDC:NM_173620:exon2:c.T15G:p.T5T	1.59E-06	0.854020781	0.145977631	.	0.1403	.	0.560331224	81.70559094	113.59821	2.32178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	29	17	80377690	chr17:80377690	T	G	77	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	80396772	80396823	GGGGCGAGGCTCCTCCTCCCCCAGAGCAGCGGCGCATCCTTCAGGCGAGCCT	-	intronic	HEXDC	.	.	.	1.59E-06	0.854020781	0.145977631	.	0.1403	.	0.560331224	81.70559094	113.59821	2.32178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.07	24	17	80396771	chr17:80396771	CGGGGCGAGGCTCCTCCTCCCCCAGAGCAGCGGCGCATCCTTCAGGCGAGCCT	C	10.07	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	80887089	80887089	G	A	exonic	TBCD	.	nonsynonymous SNV	TBCD:NM_005993:exon31:c.G2794A:p.D932N	6.98E-05	0.999929838	3.18E-07	.	0.12203	0.11011	-1.453286053	3.892427459	630.24341	5.05995	0.095	0.312	T	0.007	0.158	B	0.037	0.218	B	0.030	0.254	N	1	0.090	N	2.395	0.694	M	-0.26	0.672	T	-1.57	0.379	N	0.071	0.077	-0.822	0.538	T	0.219	0.583	T	0.034	0.553	D	1.823	0.280	15.12	0.991	0.533	0.166	0.193	N	c	-0.469	-0.459	0.405	0.202	0.707	0.730	0	5.13	0.696	2.663	0.462	1.048	0.713	0.513	0.268	0.016	0.126	9.679	0.390	Armadillo-type fold|Tubulin-specific chaperone D, C-terminal;Tubulin-specific chaperone D, C-terminal	.	.	0.5	.	40	17	80887089	chr17:80887089	G	A	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	49208	49208	G	A	intergenic	LOC102723376;ROCK1P1	dist=33278;dist=59857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.25	0.791	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.269	0.120	5.391	0.711	0.092	0.191	0.203	N	n	-0.126	-0.174	0.000	0.012	0.554	0.283	0	0.109	0.138	-0.406	0.072	0.344	0.273	0.844	0.301	0.001	0.043	2.943	0.054	.	.	.	0.5	142	207	18	49208	chr18:49208	G	A	142	PASS	DP=207;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	658064	658064	G	C	exonic	TYMSOS	.	nonsynonymous SNV	TYMSOS:NM_001012716:exon1:c.C184G:p.R62G	.	.	.	.	0.06401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	47	18	658064	chr18:658064	G	C	63	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	722366	722366	-	G	UTR3	YES1	NM_005433:c.*2057_*2058insC	.	.	0.046391622	0.953390447	0.000217931	.	0.92686	0.51349	-0.203796826	38.81811748	69.86384	1.73424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	8	18	722366	chr18:722366	T	TG	40	PASS	DP=8;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	8376501	8376501	T	C	exonic	PTPRM	.	nonsynonymous SNV	PTPRM:NM_002845:exon24:c.T3329C:p.I1110T,PTPRM:NM_001105244:exon26:c.T3368C:p.I1123T	0.999958214	4.18E-05	1.30E-17	.	0.20617	0.12992	-2.02851154	1.704411418	316.58577	3.77934	0.306	0.142	T	0.707	0.715	P	0.599	0.875	P	0.000	0.843	D	1	0.810	D	1.31	0.329	L	1.5	0.312	T	-2.04	0.468	N	0.871	0.934	-1.026	0.218	T	0.106	0.388	T	0.024	0.471	T	3.426	0.470	23.0	0.998	0.890	0.978	0.774	D	c	0.475	0.569	1.000	0.747	0.638	0.428	0	5.88	0.945	8.017	0.886	1.011	0.635	1.000	0.715	1.000	0.888	16.290	0.825	PTP type protein phosphatase|Protein-tyrosine phosphatase-like|Tyrosine specific protein phosphatases domain	.	.	0.5	110	72	18	8376501	chr18:8376501	T	C	110	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
18	9814142	9814142	A	C	intronic	RAB31	.	.	.	0.054033484	0.863833858	0.082132658	.	0.06168	0.10905	-0.141298762	42.87567823	10.46141	0.38035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	18	9814142	chr18:9814142	A	C	.	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	11999004	11999004	G	A	intronic	IMPA2	.	.	.	0.237822649	0.755127914	0.007049436	.	0.53908	0.23623	0.327131069	73.27199811	212.72651	3.14791	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	18	11999004	chr18:11999004	G	A	.	PASS	DP=93;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
18	12254880	12254880	C	A	exonic	CIDEA	.	nonsynonymous SNV	CIDEA:NM_001318383:exon1:c.C65A:p.P22H	0.014628439	0.873805652	0.111565909	.	0.15442	0.18847	0.595326758	82.66100495	171.63036	2.85715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	18	12254880	chr18:12254880	C	A	.	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	13099601	13099601	-	T	intronic	CEP192	.	.	.	7.44E-10	0.999999897	1.02E-07	.	0.09044	0.10852	1.493675397	95.37037037	4911.21175	14.29193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	76	18	13099601	chr18:13099601	G	GT	92	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
18	14144670	14144670	G	T	intergenic	ZNF519;ANKRD20A5P	dist=12181;dist=34426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	18	14144670	chr18:14144670	G	T	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	14173952	14173952	A	G	intergenic	ZNF519;ANKRD20A5P	dist=41463;dist=5144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	135	18	14173952	chr18:14173952	A	G	110	PASS	DP=135;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	14225787	14225787	C	-	ncRNA_exonic	ANKRD20A5P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	124	18	14225786	chr18:14225786	GC	G	78	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	14542791	14542791	C	T	exonic	POTEC	.	nonsynonymous SNV	POTEC:NM_001137671:exon1:c.G355A:p.A119T	0.161704414	0.835123744	0.003171842	.	0.10352	0.06565	.	.	920.22285	5.89584	0.353	0.122	T	0.005	0.119	B	0.002	0.063	B	.	.	.	1	0.090	N	0.895	0.225	L	1.66	0.275	T	-0.93	0.249	N	0.076	0.095	-1.004	0.289	T	0.040	0.174	T	.	.	.	-0.064	0.088	2.011	0.827	0.139	0.005	0.023	N	c	-1.512	-1.612	0.000	0.012	0.487	0.133	0	-0.375	0.118	-1.381	0.026	-1.965	0.005	0.000	0.063	0.001	0.043	.	.	Ankyrin repeat-containing domain	.	.	0.5	130	479	18	14542791	chr18:14542791	C	T	130	PASS	DP=479;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
18	14799099	14799099	G	C	splicing	ANKRD30B	NM_001145029:exon21:c.2030-1G>C	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	0.998	0.449	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.766	0.167	9.250	0.826	0.138	0.370	0.254	N	c	0.384	0.010	0.000	0.012	0.061	0.009	0	0.968	0.187	2.105	0.412	0.372	0.274	0.997	0.399	0.258	0.229	5.318	0.151	.	.	.	0.5	101	97	18	14799099	chr18:14799099	G	C	101	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	14808654	14808654	T	C	intronic	ANKRD30B	.	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	50	18	14808654	chr18:14808654	T	C	51	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	14837168	14837168	-	T	intronic	ANKRD30B	.	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	26	18	14837168	chr18:14837168	G	GT	40	PASS	DP=26;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
18	18531365	18531365	A	-	intronic	ROCK1	.	.	.	0.999996548	3.45E-06	1.48E-19	.	.	0.55483	-0.574945567	18.90186365	77.81309	1.85951	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	35	18	18531364	chr18:18531364	GA	G	44	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	19109914	19109914	G	A	UTR3	ESCO1	NM_052911:c.*390C>T	.	.	0.998809461	0.001190536	3.28E-09	.	0.87705	0.10278	-0.242430445	36.22906346	103.25615	2.19516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	18	19109914	chr18:19109914	G	A	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	22642715	22642715	A	C	intronic	ZNF521	.	.	.	0.999979351	2.06E-05	8.30E-13	DISEASE: Note=A chromosomal aberration involving ZNF521 is found in acute lymphoblastic leukemia. Translocation t(9;18)(p13;q11.2) with PAX5. The translocation generates the PAX5-ZNF521 oncogene consisting of the N-terminus part of PAX5 and the C-terminus part of ZNF521. {ECO:0000269|PubMed:17344859}.; 	0.71744	0.1082	-1.767443354	2.317763623	91.92438	2.06319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	83	18	22642715	chr18:22642715	A	C	51	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	28979237	28979237	G	T	exonic	DSG4	.	nonsynonymous SNV	DSG4:NM_001134453:exon9:c.G1008T:p.M336I,DSG4:NM_177986:exon9:c.G1008T:p.M336I	6.32E-05	0.999718181	0.000218611	DISEASE: Hypotrichosis 6 (HYPT6) [MIM:607903]: A condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The disorder affects the trunk and extremities as well as the scalp, and the eyebrows and eyelashes may also be involved, whereas beard, pubic, and axillary hairs are largely spared. In addition, patients can develop hyperkeratotic follicular papules, erythema, and pruritus in affected areas. In some patients with congenital hypotrichosis, monilethrix-like hairs showing elliptical nodes have been observed. {ECO:0000269|PubMed:15191570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Autoantibodies against DSG4 are found in patients with pemphigus vulgaris. Pemphigus vulgaris is a potentially lethal skin disease in which epidermal blisters occur as the result of the loss of cell-cell adhesion.; 	0.30616	0.1655	1.833561474	97.05119132	578.83724	4.87526	0.354	0.121	T	0.074	0.226	B	0.06	0.256	B	0.001	0.419	D	0.896	0.278	N	0.865	0.215	L	0.73	0.507	T	-1.15	0.295	N	0.227	0.319	-1.048	0.149	T	0.061	0.255	T	0.006	0.145	T	1.575	0.251	13.71	0.944	0.242	0.270	0.229	N	c	-0.462	-0.318	0.998	0.364	0.487	0.133	0	3.57	0.399	-0.173	0.098	1.048	0.713	0.001	0.137	1.000	0.888	1.997	0.032	Cadherin|Cadherin-like	.	.	0.5	71	68	18	28979237	chr18:28979237	G	T	71	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	29480910	29480910	G	A	exonic	TRAPPC8	.	stopgain	TRAPPC8:NM_014939:exon10:c.C1468T:p.Q490X	0.999999744	2.56E-07	1.56E-19	.	0.1499	0.09632	0.721954055	85.86341118	3775.56161	12.03543	.	.	.	.	.	.	.	.	.	0.000	0.537	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.924	0.987	40	0.999	0.931	0.998	0.993	D	c	1.128	1.008	1.000	0.747	0.732	0.924	0	5.5	0.813	9.454	0.968	0.953	0.551	1.000	0.715	1.000	0.888	19.819	0.966	Tetratricopeptide-like helical domain	.	.	0.5	.	38	18	29480910	chr18:29480910	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	29522914	29522914	C	-	UTR5	TRAPPC8	NM_014939:c.-187delG	.	.	0.999999744	2.56E-07	1.56E-19	.	0.1499	0.09632	0.721954055	85.86341118	3775.56161	12.03543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	640	18	29522913	chr18:29522913	AC	A	82	PASS	DP=640;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
18	30908006	30908006	A	G	intronic	CCDC178	.	.	.	4.11E-29	4.49E-06	0.999995511	.	0.71144	.	1.449540683	95.14626091	1397.05643	6.99037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	340	18	30908006	chr18:30908006	A	G	83	PASS	DP=340;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
18	31323178	31323178	G	A	exonic	ASXL3	.	synonymous SNV	ASXL3:NM_030632:exon12:c.G3366A:p.Q1122Q	0.999977048	2.30E-05	8.90E-15	.	0.10816	.	-0.66524926	15.87048832	636.60276	5.07564	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	18	31323178	chr18:31323178	G	A	.	PASS	DP=41;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
18	34340634	34340634	G	A	exonic	FHOD3	.	nonsynonymous SNV	FHOD3:NM_001281739:exon22:c.G3913A:p.E1305K,FHOD3:NM_025135:exon23:c.G3964A:p.E1322K,FHOD3:NM_001281740:exon27:c.G4513A:p.E1505K	0.997517123	0.002482877	1.35E-12	.	0.22803	0.10389	-0.514518236	21.21962727	7901.72753	19.20257	0.098	0.308	T	0.592	0.372	P	0.254	0.374	B	0.000	0.843	D	1.000	0.588	D	1.895	0.505	L	1.44	0.369	T	-2.44	0.534	N	0.439	0.568	-1.102	0.039	T	0.071	0.288	T	0.018	0.396	T	3.289	0.454	22.8	0.998	0.874	0.995	0.962	D	c	0.117	0.227	1.000	0.747	0.758	0.990	0	5.16	0.704	9.443	0.967	1.048	0.713	1.000	0.715	0.324	0.241	15.386	0.743	Formin, FH2 domain	.	.	0.5	.	248	18	34340634	chr18:34340634	G	A	.	PASS	DP=248;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
18	34424156	34424156	T	-	intronic	KIAA1328	.	.	.	6.07E-05	0.894567113	0.105372162	.	0.32449	.	0.040529541	57.15380986	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	35	18	34424155	chr18:34424155	AT	A	59	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	42643480	42643480	A	G	exonic	SETBP1	.	synonymous SNV	SETBP1:NM_015559:exon6:c.A4608G:p.P1536P	0.999002929	0.00099707	4.30E-10	DISEASE: Note=SETBP1 somatic mutations are frequently found in myeloid malignancies. They cause gain of function associated with myeloid leukemic transformation (PubMed:23832012). Myeloid malignancies are separated into three main categories: myeloproliferative neoplasms (MPN) characterized by cellular proliferation of one or more hematologic cell lines in the peripheral blood, myelodysplastic syndromes (MDS) and MDS/MPN. The MDS/MPN category shows overlapping characteristics of both MDS and MPN and includes chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia, atypical chronic myeloid leukemia (ACML) and unclassified MDS/MPN (PubMed:23628959). {ECO:0000269|PubMed:23628959, ECO:0000269|PubMed:23832012}.; DISEASE: Myelodysplastic syndrome (MDS) [MIM:614286]: A heterogeneous group of closely related clonal hematopoietic disorders. All are characterized by a hypercellular or hypocellular bone marrow with impaired morphology and maturation, dysplasia of the myeloid, megakaryocytic and/or erythroid lineages, and peripheral blood cytopenias resulting from ineffective blood cell production. Included diseases are: refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), refractory anemia with excess blasts (RAEB), refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS); chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative disease. MDS is considered a premalignant condition in a subgroup of patients that often progresses to acute myeloid leukemia (AML). {ECO:0000269|PubMed:23648668, ECO:0000269|PubMed:23889083}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Mental retardation, autosomal dominant 29 (MRD29) [MIM:616078]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD29 patients manifest severe intellectual disability, behavioral difficulties, speech and motor delays, and dysmorphic facial features. {ECO:0000269|PubMed:25217958}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269|PubMed:23648668, ECO:0000269|PubMed:23889083}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Leukemia, chronic myeloid, atypical (ACML) [MIM:608232]: A myeloproliferative disorder that shares clinical and laboratory features with chronic myeloid leukemia but lacks the pathognomonic Philadelphia chromosome and the corresponding BCR/ABL1 fusion transcript. Features include myeloid predominance in the bone marrow, myeloid proliferation and low leukocyte alkaline phosphatase value, splenomegaly, hepatomegaly, elevated white blood cell count. Enlarged spleen may also be associated with a hypermetabolic state, fever, weight loss, and chronic fatigue. The enlarged liver may contribute to the patient's weight loss. {ECO:0000269|PubMed:23222956}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:23832011}. Note=The gene represented in this entry is involved in disease pathogenesis.; 	0.7551	0.29962	-1.118903529	6.611229063	3394.47384	11.15813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	28	18	42643480	chr18:42643480	A	G	61	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	43577691	43577691	T	A	intronic	PSTPIP2	.	.	.	0.107611557	0.892114743	0.0002737	.	0.08446	0.08464	0.060756528	58.52795471	1683.83562	7.56284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	18	43577691	chr18:43577691	T	A	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	43577726	43577726	T	A	exonic	PSTPIP2	.	stopgain	PSTPIP2:NM_024430:exon9:c.A631T:p.K211X	0.107611557	0.892114743	0.0002737	.	0.08446	0.08464	0.060756528	58.52795471	1683.83562	7.56284	.	.	.	.	.	.	.	.	.	0.028	0.257	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.132	0.989	41	0.996	0.766	0.950	0.627	D	c	0.800	0.676	1.000	0.747	0.706	0.609	0	5.5	0.813	5.053	0.639	1.061	0.807	1.000	0.715	1.000	0.888	14.880	0.700	F-BAR domain	.	.	0.5	.	69	18	43577726	chr18:43577726	T	A	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	44424035	44424035	C	T	exonic	PIAS2	.	synonymous SNV	PIAS2:NM_001324058:exon8:c.G1023A:p.R341R,PIAS2:NM_001324060:exon8:c.G1035A:p.R345R,PIAS2:NM_004671:exon8:c.G1023A:p.R341R,PIAS2:NM_173206:exon8:c.G1023A:p.R341R,PIAS2:NM_001324047:exon9:c.G996A:p.R332R,PIAS2:NM_001324051:exon9:c.G996A:p.R332R,PIAS2:NM_001324054:exon9:c.G996A:p.R332R,PIAS2:NM_001324046:exon10:c.G996A:p.R332R,PIAS2:NM_001324048:exon10:c.G996A:p.R332R,PIAS2:NM_001324055:exon10:c.G996A:p.R332R,PIAS2:NM_001324059:exon10:c.G996A:p.R332R,PIAS2:NM_001324049:exon11:c.G996A:p.R332R,PIAS2:NM_001324052:exon11:c.G996A:p.R332R,PIAS2:NM_001324053:exon11:c.G996A:p.R332R,PIAS2:NM_001324057:exon11:c.G996A:p.R332R	0.997942261	0.002057727	1.24E-08	.	0.98247	0.28737	-0.426079032	25.36565228	52.72409	1.43865	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	18	44424035	chr18:44424035	C	T	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	47014912	47014920	GTTTCTTCA	-	exonic	RPL17	.	nonframeshift deletion	RPL17:NM_001199345:exon6:c.410_418del:p.L137_K139del,RPL17:NM_000985:exon7:c.524_532del:p.L175_K177del,RPL17:NM_001035006:exon7:c.524_532del:p.L175_K177del,RPL17:NM_001199341:exon7:c.524_532del:p.L175_K177del,RPL17:NM_001199344:exon7:c.524_532del:p.L175_K177del,RPL17:NM_001199340:exon8:c.524_532del:p.L175_K177del,RPL17:NM_001199342:exon8:c.524_532del:p.L175_K177del,RPL17:NM_001199343:exon8:c.524_532del:p.L175_K177del	0.494059426	0.501442148	0.004498425	.	0.33905	0.0819	-0.09720619	46.20193442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	14	18	47014911	chr18:47014911	TGTTTCTTCA	T	41	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	48584781	48584781	C	G	exonic	SMAD4	.	nonsynonymous SNV	SMAD4:NM_005359:exon7:c.C859G:p.H287D	0.967432536	0.032565268	2.20E-06	DISEASE: Pancreatic cancer (PNCA) [MIM:260350]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:8553070}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Juvenile polyposis syndrome (JPS) [MIM:174900]: Autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers. The lesions are typified by a smooth histological appearance, predominant stroma, cystic spaces and lack of a smooth muscle core. Multiple juvenile polyps usually occur in a number of Mendelian disorders. Sometimes, these polyps occur without associated features as in JPS; here, polyps tend to occur in the large bowel and are associated with an increased risk of colon and other gastrointestinal cancers. {ECO:0000269|PubMed:12417513, ECO:0000269|PubMed:9811934}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050]: JP/HHT syndrome phenotype consists of the coexistence of juvenile polyposis (JIP) and hereditary hemorrhagic telangiectasia (HHT) [MIM:187300] in a single individual. JIP and HHT are autosomal dominant disorders with distinct and non-overlapping clinical features. The former, an inherited gastrointestinal malignancy predisposition, is caused by mutations in SMAD4 or BMPR1A, and the latter is a vascular malformation disorder caused by mutations in ENG or ACVRL1. All four genes encode proteins involved in the transforming-growth- factor-signaling pathway. Although there are reports of patients and families with phenotypes of both disorders combined, the genetic etiology of this association is unknown. {ECO:0000269|PubMed:15031030}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:16959974}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=SMAD4 variants may be associated with susceptibility to pulmonary hypertension, a disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs. {ECO:0000269|PubMed:21898662}.; DISEASE: Myhre syndrome (MYHRS) [MIM:139210]: A syndrome characterized by pre- and postnatal growth deficiency, mental retardation, generalized muscle hypertrophy and striking muscular build, decreased joint mobility, cryptorchidism, and unusual facies. Dysmorphic facial features include microcephaly, midface hypoplasia, prognathism, and blepharophimosis. Typical skeletal anomalies are short stature, square body shape, broad ribs, iliac hypoplasia, brachydactyly, flattened vertebrae, and thickened calvaria. Other features, such as congenital heart disease, may also occur. {ECO:0000269|PubMed:22158539, ECO:0000269|PubMed:22243968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99992	0.79641	-0.315847836	31.68789809	15.10025	0.54284	0.429	0.096	T	0.613	0.378	P	0.256	0.375	B	0.000	0.843	D	1.000	0.810	D	2.22	0.631	M	-4.11	0.967	D	-1.96	0.454	N	0.778	0.770	0.660	0.927	D	0.834	0.944	D	0.204	0.870	D	2.699	0.385	20.8	0.982	0.386	0.991	0.919	D	c	0.460	0.594	1.000	0.747	0.707	0.730	0	6.17	0.997	7.777	0.841	0.935	0.490	1.000	0.715	1.000	0.888	19.651	0.958	SMAD/FHA domain	.	.	0.5	54	93	18	48584781	chr18:48584781	C	G	54	PASS	DP=93;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
18	52892720	52892720	C	T	UTR3	TCF4	NM_001306207:c.*2546G>A;NM_001306208:c.*2546G>A;NM_001243234:c.*2546G>A;NM_001348217:c.*2546G>A;NM_001243226:c.*2546G>A;NM_001348218:c.*2546G>A;NM_001348220:c.*2546G>A;NM_001243236:c.*2546G>A;NM_003199:c.*2546G>A;NM_001243230:c.*2546G>A;NM_001243233:c.*2546G>A;NM_001243235:c.*2546G>A;NM_001243227:c.*2546G>A;NM_001243228:c.*2546G>A;NM_001243231:c.*2546G>A;NM_001243232:c.*2546G>A;NM_001348219:c.*2546G>A;NM_001083962:c.*2546G>A;NM_001330605:c.*2546G>A;NM_001330604:c.*2546G>A;NM_001348216:c.*2546G>A;NM_001348213:c.*2546G>A;NM_001348211:c.*2546G>A;NM_001348214:c.*2546G>A;NM_001348212:c.*2546G>A;NM_001348215:c.*2546G>A	.	.	0.999866544	0.000133455	1.58E-11	DISEASE: Pitt-Hopkins syndrome (PTHS) [MIM:610954]: A syndrome characterized by mental retardation, wide mouth and distinctive facial features, and intermittent hyperventilation followed by apnea. Features include intellectual disability with severe speech impairment, normal growth parameters at birth, postnatal microcephaly, breathing anomalies, severe motor developmental delay, motor incoordination, ocular anomalies, constipation, seizures, typical behavior and subtle brain abnormalities. {ECO:0000269|PubMed:17436254, ECO:0000269|PubMed:17436255, ECO:0000269|PubMed:18728071, ECO:0000269|PubMed:19235238, ECO:0000269|PubMed:20184619, ECO:0000269|PubMed:22045651}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, Fuchs endothelial, 3 (FECD3) [MIM:613267]: A late-onset form of Fuchs endothelial corneal dystrophy, a disease caused by loss of endothelium of the central cornea. It is characterized by focal wart-like guttata that arise from Descemet membrane and develop in the central cornea, epithelial blisters, reduced vision and pain. Descemet membrane is thickened by abnormal collagenous deposition. {ECO:0000269|PubMed:24255041, ECO:0000269|PubMed:25168903, ECO:0000269|PubMed:25593321}. Note=The disease is caused by mutations affecting the gene represented in this entry. Causative mutations are heterozygous TCF4 intronic trinucleotide repeat expansions (CTG)n. {ECO:0000269|PubMed:24255041, ECO:0000269|PubMed:25168903, ECO:0000269|PubMed:25593321}.; 	0.97117	0.2956	-0.558357437	19.54470394	19.31829	0.66532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	48	18	52892720	chr18:52892720	C	T	59	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	56204489	56204489	C	G	exonic	ALPK2	.	nonsynonymous SNV	ALPK2:NM_052947:exon5:c.G2930C:p.S977T	3.56E-13	0.89022526	0.10977474	.	0.03572	0.07481	4.926038688	99.79948101	17557.68576	27.86174	0.03	0.453	D	0.013	0.163	B	0.021	0.181	B	0.004	0.010	N	1	0.090	P	1.795	0.474	L	0.74	0.505	T	-1.32	0.330	N	0.029	0.010	-1.084	0.066	T	0.002	0.006	T	.	.	.	2.119	0.316	16.98	0.901	0.188	0.039	0.092	N	c	-0.903	-0.946	1.000	0.747	0.628	0.401	0	0.184	0.143	-0.352	0.077	-0.384	0.065	0.000	0.063	0.000	0.016	2.033	0.033	.	.	.	0.5	60	51	18	56204489	chr18:56204489	C	G	60	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	57013193	57013193	-	T	exonic	LMAN1	.	frameshift insertion	LMAN1:NM_005570:exon8:c.912dupA:p.E305Rfs*19	0.486069839	0.513889663	4.05E-05	DISEASE: Factor V and factor VIII combined deficiency 1 (F5F8D1) [MIM:227300]: A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:10090935, ECO:0000269|PubMed:19787799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1019	0.17526	-0.045835247	50.34206181	760.68404	5.46719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	359	18	57013193	chr18:57013193	C	CT	68	PASS	DP=359;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
18	59878413	59878413	A	G	exonic	KIAA1468	.	nonsynonymous SNV	KIAA1468:NM_001346229:exon2:c.A554G:p.D185G,KIAA1468:NM_001346230:exon2:c.A554G:p.D185G,KIAA1468:NM_001346231:exon2:c.A554G:p.D185G,KIAA1468:NM_001346232:exon2:c.A554G:p.D185G,KIAA1468:NM_001346233:exon2:c.A554G:p.D185G,KIAA1468:NM_001346234:exon2:c.A554G:p.D185G,KIAA1468:NM_020854:exon2:c.A554G:p.D185G	0.99999956	4.40E-07	2.89E-18	.	0.18204	0.12098	-1.285933373	5.083746167	74.67048	1.80768	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.41	0.699	M	0.86	0.468	T	-5.46	0.855	D	0.91	0.900	-0.408	0.718	T	0.316	0.686	T	0.148	0.831	D	6.326	0.874	29.3	0.999	0.940	0.987	0.851	D	c	0.778	0.744	1.000	0.747	0.706	0.609	0	5.21	0.719	8.718	0.911	1.199	0.960	1.000	0.715	0.999	0.750	15.078	0.716	.	.	.	0.5	.	40	18	59878413	chr18:59878413	A	G	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	60015409	60015409	G	A	exonic	TNFRSF11A	.	synonymous SNV	TNFRSF11A:NM_001270949:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001270950:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001270951:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001278268:exon2:c.G84A:p.L28L,TNFRSF11A:NM_003839:exon2:c.G84A:p.L28L	0.879917354	0.120022306	6.03E-05	DISEASE: Paget disease of bone 2, early-onset (PDB2) [MIM:602080]: A form of Paget disease, a disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone. {ECO:0000269|PubMed:10615125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB7 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development. OPTB7 is associated with hypogammaglobulinemia. {ECO:0000269|PubMed:18606301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0838	.	0.665103516	84.6131163	577.42674	4.87253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	18	60015409	chr18:60015409	G	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	60017126	60017126	G	A	exonic	TNFRSF11A	.	stopgain	TNFRSF11A:NM_001270949:exon3:c.G239A:p.W80X,TNFRSF11A:NM_001270950:exon3:c.G239A:p.W80X,TNFRSF11A:NM_001270951:exon3:c.G239A:p.W80X,TNFRSF11A:NM_001278268:exon3:c.G239A:p.W80X,TNFRSF11A:NM_003839:exon3:c.G239A:p.W80X	0.879917354	0.120022306	6.03E-05	DISEASE: Paget disease of bone 2, early-onset (PDB2) [MIM:602080]: A form of Paget disease, a disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone. {ECO:0000269|PubMed:10615125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB7 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development. OPTB7 is associated with hypogammaglobulinemia. {ECO:0000269|PubMed:18606301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0838	.	0.665103516	84.6131163	577.42674	4.87253	.	.	.	.	.	.	.	.	.	0.000	0.481	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.200	0.973	37	0.995	0.693	0.935	0.580	D	c	1.079	0.924	1.000	0.747	0.706	0.609	0	5.33	0.756	6.345	0.728	0.953	0.551	1.000	0.715	0.999	0.750	16.290	0.825	TNFR/NGFR cysteine-rich region	.	.	0.5	50	41	18	60017126	chr18:60017126	G	A	50	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	66358515	66358516	AA	-	exonic	TMX3	.	stopgain	TMX3:NM_001350513:exon8:c.572_573del:p.F191fs*0	0.191322508	0.808583205	9.43E-05	.	0.25561	0.11004	0.240763792	69.36777542	113.00046	2.31345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	17	18	66358514	chr18:66358514	TAA	T	60	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
18	67802446	67802502	AAATAATAGAAGACAAAATAGTGCTCCAACTTCAGTCACGACACTACAATCTTCATG	-	exonic	RTTN	.	nonframeshift deletion	RTTN:NM_001318520:exon21:c.67_123del:p.H23_F41del,RTTN:NM_173630:exon22:c.2803_2859del:p.H935_F953del	2.40E-13	0.999999994	5.97E-09	DISEASE: Polymicrogyria with seizures (PMGYS) [MIM:614833]: A disease characterized by many irregular small gyri in the brain surface and fusion of the molecular layer over multiple small gyri, which gives a festooned appearance to the cortical surface, without abnormal neuronal migration. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization. PMGYS patients have moderate to severe mental retardation, poor speech, dysarthria and seizures. {ECO:0000269|PubMed:22939636}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25498	0.10307	0.18719002	66.27742392	829.75241	5.64516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.33	20	18	67802445	chr18:67802445	CAAATAATAGAAGACAAAATAGTGCTCCAACTTCAGTCACGACACTACAATCTTCATG	C	25.33	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
18	72223645	72223645	G	T	exonic	CNDP1	.	nonsynonymous SNV	CNDP1:NM_032649:exon2:c.G97T:p.A33S	1.91E-05	0.97216589	0.027815013	.	0.11983	0.24162	1.247448154	93.43595188	1273.96612	6.72127	0.784	0.032	T	0.0	0.026	B	0.0	0.013	B	0.447	0.125	N	1	0.090	N	-0.11	0.046	N	2.55	0.138	T	0.5	0.030	N	0.094	0.137	-0.973	0.365	T	0.014	0.056	T	0.005	0.119	T	-0.699	0.045	0.072	0.477	0.039	0.089	0.146	N	c	-1.093	-0.995	1.000	0.436	0.516	0.203	0	4.1	0.470	0.407	0.206	1.048	0.713	0.000	0.063	0.001	0.043	10.045	0.412	.	.	.	0.5	83	81	18	72223645	chr18:72223645	G	T	83	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
18	74637067	74637067	T	C	intronic	ZNF236	.	.	.	0.999998364	1.64E-06	5.86E-19	.	0.17316	0.10239	-1.532514394	3.349846662	617.34905	5.01532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	15	18	74637067	chr18:74637067	T	C	44	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
18	76758049	76758049	A	T	UTR3	SALL3	NM_171999:c.*727A>T	.	.	0.090193129	0.90098293	0.008823941	.	0.53411	0.12093	.	.	660.65433	5.1535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	72	18	76758049	chr18:76758049	A	T	58	PASS	DP=72;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
18	77227476	77227476	A	G	exonic	NFATC1	.	synonymous SNV	NFATC1:NM_001278673:exon7:c.A570G:p.P190P,NFATC1:NM_172388:exon7:c.A570G:p.P190P,NFATC1:NM_001278669:exon8:c.A1986G:p.P662P,NFATC1:NM_001278670:exon8:c.A1986G:p.P662P,NFATC1:NM_001278672:exon8:c.A1947G:p.P649P,NFATC1:NM_001278675:exon8:c.A1947G:p.P649P,NFATC1:NM_006162:exon8:c.A1986G:p.P662P,NFATC1:NM_172387:exon8:c.A1947G:p.P649P,NFATC1:NM_172389:exon8:c.A1947G:p.P649P,NFATC1:NM_172390:exon8:c.A1986G:p.P662P	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.588	P	.	.	.	2.5	0.144	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.835	0.039	0.036	0.251	0.011	0.012	0.043	N	n	-0.140	2.150	1.000	0.747	0.707	0.730	0	-9.38	0.005	-4.079	0.003	-6.217	0.000	0.000	0.063	0.044	0.160	5.332	0.151	.	.	.	0.5	51	41	18	77227476	chr18:77227476	A	G	51	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
18	77254233	77254233	C	G	intronic	NFATC1	.	.	.	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	164	18	77254233	chr18:77254233	C	G	103	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	77254927	77254927	A	T	intronic	NFATC1	.	.	.	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	18	77254927	chr18:77254927	A	T	.	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	464129	464129	C	G	exonic	ODF3L2	.	synonymous SNV	ODF3L2:NM_182577:exon4:c.G585C:p.P195P	0.003142588	0.596423811	0.400433601	.	0.10249	0.1069	.	.	1099.14153	6.3446	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	20	19	464129	chr19:464129	C	G	45	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	507444	507444	-	GG	upstream	TPGS1	dist=53	.	.	0.003467495	0.389170042	0.607362463	.	0.17391	0.10865	.	.	357.58608	4.0068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	13	19	507444	chr19:507444	T	TGG	81	PASS	DP=13;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.
19	757412	757412	A	G	exonic	MISP	.	nonsynonymous SNV	MISP:NM_173481:exon2:c.A466G:p.S156G	1.95E-10	0.034098173	0.965901827	.	0.13168	.	-0.031281682	50.5779665	693.62656	5.25135	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.904	0.086	N	1	0.090	P	-0.82	0.015	N	0.75	0.502	T	0.42	0.034	N	0.015	0.002	-0.951	0.408	T	0.000	0.000	T	.	.	.	-1.729	0.012	0.002	0.144	0.003	0.019	0.058	N	c	-1.589	-1.521	0.002	0.092	0.581	0.326	0	-0.862	0.101	-1.156	0.032	-0.535	0.048	0.000	0.063	0.675	0.304	5.825	0.177	.	.	.	0.5	139	89	19	757412	chr19:757412	A	G	139	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	811918	811920	CTC	-	UTR3	PTBP1	NM_031990:c.*1092_*1094delCTC;NM_031991:c.*1092_*1094delCTC;NM_002819:c.*1092_*1094delCTC	.	.	0.9987392	0.001260782	1.86E-08	.	0.88766	0.24759	-1.217968826	5.638122199	29.53361	0.94402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	27	19	811917	chr19:811917	GCTC	G	44	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	811931	811933	CTC	-	UTR3	PTBP1	NM_031990:c.*1105_*1107delCTC;NM_031991:c.*1105_*1107delCTC;NM_002819:c.*1105_*1107delCTC	.	.	0.9987392	0.001260782	1.86E-08	.	0.88766	0.24759	-1.217968826	5.638122199	29.53361	0.94402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	25	19	811930	chr19:811930	TCTC	T	39	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	900809	900809	C	T	intronic	R3HDM4	.	.	.	0.019345311	0.900324136	0.080330553	.	0.14605	0.10939	0.262810045	70.43524416	922.19623	5.89756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	19	900809	chr19:900809	C	T	.	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	900838	900838	G	A	exonic	R3HDM4	.	nonsynonymous SNV	R3HDM4:NM_138774:exon4:c.C466T:p.R156W	0.019345311	0.900324136	0.080330553	.	0.14605	0.10939	0.262810045	70.43524416	922.19623	5.89756	0.004	0.654	D	0.999	0.764	D	0.89	0.614	P	0.859	0.089	U	1	0.090	N	1.5	0.380	L	.	.	.	-2.74	0.582	D	0.248	0.303	-0.961	0.390	T	0.150	0.477	T	0.013	0.319	T	4.698	0.630	24.6	0.997	0.776	0.215	0.212	N	c	-0.391	-0.634	1.000	0.747	0.840	1.000	0	0.328	0.151	-0.142	0.102	0.824	0.337	0.064	0.217	0.119	0.196	7.657	0.274	R3H-associated N-terminal domain	.	.	0.5	.	110	19	900838	chr19:900838	G	A	.	PASS	DP=110;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	984533	984533	T	C	exonic	WDR18	.	synonymous SNV	WDR18:NM_024100:exon1:c.T180C:p.N60N	0.90160756	0.09821575	0.00017669	.	0.10939	0.1084	-0.001743238	53.85114414	2052.48581	8.34958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	24	19	984533	chr19:984533	T	C	55	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	984554	984554	C	G	exonic	WDR18	.	synonymous SNV	WDR18:NM_024100:exon1:c.C201G:p.L67L	0.90160756	0.09821575	0.00017669	.	0.10939	0.1084	-0.001743238	53.85114414	2052.48581	8.34958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	11	19	984554	chr19:984554	C	G	41	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	1008218	1008218	C	T	exonic	GRIN3B	.	synonymous SNV	GRIN3B:NM_138690:exon6:c.C2394T:p.G798G	0.001113712	0.952832628	0.04605366	.	0.05632	.	.	.	14513.3031	26.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	19	1008218	chr19:1008218	C	T	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	1036468	1036468	A	G	exonic	CNN2	.	synonymous SNV	CNN2:NM_201277:exon5:c.A444G:p.R148R,CNN2:NM_001303499:exon6:c.A528G:p.R176R,CNN2:NM_001303501:exon6:c.A624G:p.R208R,CNN2:NM_004368:exon6:c.A561G:p.R187R	0.212309401	0.778747265	0.008943334	.	0.15623	0.1447	-0.780646273	12.77423921	27.26201	0.87829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	49	19	1036468	chr19:1036468	A	G	54	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	1041352	1041352	A	G	UTR5	ABCA7	NM_019112:c.-9A>G	.	.	1.89E-36	0.000203957	0.999796043	.	0.05554	0.15483	-2.151227095	1.462609106	5319.06822	15.08136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	50	19	1041352	chr19:1041352	A	G	53	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	1111964	1111964	C	T	intronic	SBNO2	.	.	.	0.024423765	0.975552528	2.37E-05	.	0.41647	0.11239	-2.2729502	1.250294881	880.95739	5.7817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	115	19	1111964	chr19:1111964	C	T	.	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	1111965	1111965	C	T	intronic	SBNO2	.	.	.	0.024423765	0.975552528	2.37E-05	.	0.41647	0.11239	-2.2729502	1.250294881	880.95739	5.7817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	276	19	1111965	chr19:1111965	C	T	.	PASS	DP=276;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	1371193	1371193	C	A	intronic	MUM1	.	.	.	0.032092633	0.967523954	0.000383414	.	0.0715	0.13329	-0.661316159	16.02382637	285.13749	3.61395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	169	358	19	1371193	chr19:1371193	C	A	169	PASS	DP=358;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	1430298	1430298	C	A	exonic	DAZAP1	.	nonsynonymous SNV	DAZAP1:NM_018959:exon10:c.C808A:p.P270T,DAZAP1:NM_170711:exon10:c.C808A:p.P270T	0.999571004	0.000428995	1.35E-09	.	0.16252	0.11134	-0.538132194	20.26421326	275.74527	3.55666	0.262	0.189	T	0.003	0.192	B	0.002	0.154	B	0.000	0.843	D	1.000	0.588	D	0.345	0.112	N	1.26	0.363	T	-0.86	0.234	N	0.425	0.481	-1.059	0.119	T	0.041	0.177	T	0.022	0.447	T	1.801	0.277	14.99	0.831	0.141	0.928	0.562	D	c	-0.425	-0.256	1.000	0.747	0.672	0.522	0	5.0	0.661	5.422	0.660	0.848	0.348	1.000	0.715	0.679	0.305	12.011	0.524	.	.	.	0.5	75	363	19	1430298	chr19:1430298	C	A	75	PASS	DP=363;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	1483042	1483044	GGT	-	intronic	PCSK4	.	.	.	6.59E-13	0.113546769	0.886453231	.	0.09952	0.1291	0.606246644	82.93229535	734.41331	5.37512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	105	19	1483041	chr19:1483041	GGGT	G	78	PASS	DP=105;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	1496263	1496263	A	G	intronic	REEP6	.	.	.	0.000463082	0.66517966	0.334357258	.	0.06456	0.03846	-0.427900189	25.14744043	125.42377	2.43777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	29	19	1496263	chr19:1496263	A	G	55	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	1506040	1506040	G	A	exonic	ADAMTSL5	.	synonymous SNV	ADAMTSL5:NM_213604:exon12:c.C1390T:p.L464L	3.22E-10	0.086390501	0.913609499	.	0.15136	0.10435	0.442818085	77.8544468	191.46176	3.00098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	149	19	1506040	chr19:1506040	G	A	131	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	1611803	1611803	T	C	exonic	TCF3	.	nonsynonymous SNV	TCF3:NM_001136139:exon18:c.A1859G:p.E620G,TCF3:NM_003200:exon19:c.A1868G:p.E623G	0.185647144	0.813858528	0.000494328	DISEASE: Note=Chromosomal aberrations involving TCF3 are cause of forms of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation t(1;19)(q23;p13.3) with PBX1. TCF3-PBX1 transforms cells by constitutively activating transcription of genes regulated by PBX1 or by other members of the PBX protein family (PubMed:1967983, PubMed:1671560). Translocation t(17;19)(q22;p13.3) with HLF (PubMed:1386162). Inversion inv(19)(p13;q13) with TFPT (PubMed:10086727). {ECO:0000269|PubMed:10086727, ECO:0000269|PubMed:1386162, ECO:0000269|PubMed:1671560, ECO:0000269|PubMed:1967983}.; 	0.8525	0.49369	-0.075375604	47.26350554	1035.94021	6.18027	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	2.72	0.798	M	1.75	0.571	T	-6.23	0.905	D	0.631	0.794	-0.251	0.763	T	0.351	0.715	T	0.112	0.791	D	5.419	0.735	26.0	0.999	0.976	0.963	0.681	D	c	0.626	0.524	1.000	0.517	0.707	0.730	0	4.69	0.584	7.862	0.853	0.888	0.391	1.000	0.715	0.699	0.309	13.637	0.615	.	.	.	0.5	81	134	19	1611803	chr19:1611803	T	C	81	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	1789344	1789344	C	A	intronic	ATP8B3	.	.	.	9.19E-22	0.003624404	0.996375596	.	0.07662	.	-0.44655933	24.21561689	4172.41798	12.8315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	19	1789344	chr19:1789344	C	A	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	1827080	1827080	G	A	exonic	REXO1	.	nonsynonymous SNV	REXO1:NM_020695:exon2:c.C1708T:p.L570F	0.567927564	0.432051209	2.12E-05	.	0.22306	0.10566	-1.357871407	4.535267752	6405.25153	16.73276	0.01	0.564	D	0.995	0.657	D	0.854	0.591	P	0.994	0.080	N	1	0.090	N	2.125	0.592	M	1.7	0.269	T	-1.59	0.383	N	0.197	0.241	-1.038	0.181	T	0.083	0.327	T	0.044	0.614	D	4.867	0.654	24.9	0.997	0.833	0.439	0.270	N	c	0.274	0.246	1.000	0.747	0.646	0.450	0	3.93	0.445	1.853	0.388	0.877	0.384	0.884	0.308	0.907	0.385	6.698	0.223	.	.	.	0.5	.	23	19	1827080	chr19:1827080	G	A	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	1987472	1987472	C	G	intronic	BTBD2	.	.	.	0.987678942	0.012316184	4.87E-06	.	0.16014	0.11161	-0.622676946	17.30950696	3774.01478	12.02834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	340	19	1987472	chr19:1987472	C	G	100	PASS	DP=340;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	2037757	2037757	G	A	exonic	MKNK2	.	nonsynonymous SNV	MKNK2:NM_017572:exon14:c.C1226T:p.T409I	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	0.0	0.912	D	0.062	0.235	B	0.035	0.214	B	.	.	.	1	0.090	N	.	.	.	0.72	0.670	T	-0.85	0.232	N	0.089	0.086	-0.946	0.417	T	0.130	0.440	T	0.030	0.528	D	0.775	0.168	9.312	0.965	0.293	0.391	0.259	N	c	-0.990	-0.972	1.000	0.458	0.732	0.924	0	-0.258	0.123	1.189	0.315	-0.009	0.132	0.870	0.305	0.753	0.322	9.716	0.393	.	.	.	0.5	.	23	19	2037757	chr19:2037757	G	A	.	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	2038031	2038031	C	-	UTR3	MKNK2	NM_199054:c.*1581delG	.	.	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	354	19	2038030	chr19:2038030	AC	A	60	PASS	DP=354;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	2038185	2038185	C	T	UTR3	MKNK2	NM_199054:c.*1427G>A	.	.	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	113	19	2038185	chr19:2038185	C	T	.	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	2344338	2344338	C	G	intronic	SPPL2B	.	.	.	.	.	.	.	0.13874	0.12165	-0.135838822	43.77211607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	127	19	2344338	chr19:2344338	C	G	76	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	2399234	2399234	G	A	intronic	TMPRSS9	.	.	.	1.77E-18	0.011731011	0.988268989	.	0.07122	.	1.646179058	96.19013918	6013.59996	16.19227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	172	19	2399234	chr19:2399234	G	A	77	PASS	DP=172;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	2401897	2401897	C	T	intronic	TMPRSS9	.	.	.	1.77E-18	0.011731011	0.988268989	.	0.07122	.	1.646179058	96.19013918	6013.59996	16.19227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	116	19	2401897	chr19:2401897	C	T	54	PASS	DP=116;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	2939331	2939331	C	T	exonic	ZNF77	.	synonymous SNV	ZNF77:NM_021217:exon2:c.G78A:p.R26R	4.31E-13	0.012914198	0.987085802	.	0.1856	0.18198	1.537740199	95.57088936	321.29502	3.807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	19	2939331	chr19:2939331	C	T	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	3155902	3155902	G	A	exonic	GNA15	.	synonymous SNV	GNA15:NM_002068:exon5:c.G696A:p.L232L	0.306963812	0.689125446	0.003910742	.	0.06813	.	-0.490397599	22.50530786	101.86504	2.18376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	148	19	3155902	chr19:3155902	G	A	92	PASS	DP=148;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	3620937	3620937	C	A	intronic	CACTIN	.	.	.	0.999345096	0.0006549	3.77E-09	.	0.11116	.	-0.753139731	13.67067705	1251.44006	6.67662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	19	3620937	chr19:3620937	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	3834740	3834740	G	A	ncRNA_intronic	MIR1268A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	196	19	3834740	chr19:3834740	G	A	121	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	3920799	3920799	G	A	ncRNA_intronic	MIR1268A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	19	3920799	chr19:3920799	G	A	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	3941159	3941159	C	T	exonic	NMRK2	.	synonymous SNV	NMRK2:NM_001289117:exon7:c.C501T:p.A167A,NMRK2:NM_170678:exon7:c.C486T:p.A162A	1.17E-07	0.103948737	0.896051146	.	0.471	0.14229	0.240763792	69.36777542	244.945	3.37613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	19	3941159	chr19:3941159	C	T	.	PASS	DP=112;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	4097335	4097335	C	T	exonic	MAP2K2	.	nonsynonymous SNV	MAP2K2:NM_030662:exon8:c.G926A:p.G309E	0.863261159	0.136320885	0.000417956	DISEASE: Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. {ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:20358587}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88489	0.51187	-0.800872469	12.33191791	40.94266	1.19949	0.09	0.319	T	0.975	0.561	D	0.909	0.628	D	0.000	0.843	D	1.000	0.548	D	1.56	0.396	L	-2.99	0.921	D	-2.76	0.585	D	0.574	0.610	0.438	0.897	D	0.770	0.922	D	0.308	0.911	D	1.979	0.299	16.08	0.948	0.250	0.975	0.753	D	c	0.176	0.073	1.000	0.411	0.672	0.522	0	3.38	0.376	4.995	0.634	0.844	0.344	1.000	0.715	0.090	0.185	13.778	0.624	Protein kinase domain|Protein kinase-like domain;Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	.	17	19	4097335	chr19:4097335	C	T	.	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	4097342	4097342	C	T	splicing	MAP2K2	NM_030662:exon8:c.920-1G>A	.	.	0.863261159	0.136320885	0.000417956	DISEASE: Cardiofaciocutaneous syndrome 4 (CFC4) [MIM:615280]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. {ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:20358587}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88489	0.51187	-0.800872469	12.33191791	40.94266	1.19949	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.324	0.458	22.9	0.984	0.407	0.996	0.982	D	c	0.832	0.564	1.000	0.747	0.257	0.036	0	3.38	0.376	7.857	0.852	0.844	0.344	1.000	0.715	0.199	0.217	13.778	0.624	.	.	.	0.5	.	17	19	4097342	chr19:4097342	C	T	.	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	4294807	4294807	G	A	exonic	TMIGD2	.	nonsynonymous SNV	TMIGD2:NM_001308232:exon2:c.C53T:p.P18L,TMIGD2:NM_001169126:exon3:c.C413T:p.P138L,TMIGD2:NM_144615:exon3:c.C413T:p.P138L	0.01525187	0.878338597	0.106409533	.	0.08093	.	1.931026376	97.46992215	710.71198	5.29848	0.118	0.281	T	0.032	0.189	B	0.015	0.162	B	.	.	.	1	0.090	P	0.345	0.112	N	1.62	0.317	T	-2.87	0.603	D	0.021	0.005	-0.996	0.309	T	0.000	0.000	T	.	.	.	-0.525	0.054	0.191	0.781	0.117	0.008	0.032	N	c	-1.298	-1.427	0.000	0.042	0.516	0.203	0	-4.98	0.028	-0.450	0.068	-0.094	0.117	0.000	0.063	0.022	0.137	0.988	0.013	.	.	.	0.5	124	58	19	4294807	chr19:4294807	G	A	124	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	4472401	4472401	C	A	exonic	HDGFL2	.	stopgain	HDGFL2:NM_001001520:exon1:c.C54A:p.Y18X,HDGFL2:NM_032631:exon1:c.C54A:p.Y18X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.023	0.265	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.291	0.967	36	0.993	0.581	0.893	0.494	D	c	0.498	0.303	1.000	0.747	0.733	0.969	0	1.91	0.247	0.262	0.181	-0.627	0.042	0.990	0.367	0.853	0.356	9.381	0.373	PWWP domain	.	.	0.5	.	189	19	4472401	chr19:4472401	C	A	.	PASS	DP=189;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	4502145	4502145	-	T	UTR3	HDGFL2	NM_032631:c.*123_*124insT;NM_001001520:c.*123_*124insT;NM_001348169:c.*123_*124insT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	172	19	4502145	chr19:4502145	G	GT	74	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	4508855	4508855	G	T	exonic	PLIN4	.	nonsynonymous SNV	PLIN4:NM_001080400:exon4:c.C3585A:p.H1195Q	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	0.01	0.564	D	1.0	0.899	D	0.983	0.742	D	0.000	0.473	D	1.000	0.191	N	3.06	0.872	M	2.22	0.182	T	-6.83	0.930	D	0.705	0.708	-1.075	0.083	T	0.075	0.301	T	0.045	0.617	D	4.476	0.599	24.2	0.990	0.492	0.078	0.136	N	c	-0.392	-0.605	0.001	0.078	0.581	0.326	0	-1.18	0.091	-1.209	0.031	-1.161	0.017	0.004	0.165	0.040	0.157	7.974	0.291	.	.	.	0.5	119	182	19	4508855	chr19:4508855	G	T	119	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	4510389	4510389	C	-	intronic	PLIN4	.	.	.	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.22	142	19	4510388	chr19:4510388	AC	A	15.22	PASS	DP=142;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	4945914	4945914	A	C	exonic	UHRF1	.	unknown	UNKNOWN	.	.	.	DISEASE: Note=Defects in UHRF1 may be a cause of cancers. Overexpressed in many different forms of human cancers, including bladder, breast, cervical, colorectal and prostate cancers, as well as pancreatic adenocarcinomas, rhabdomyosarcomas and gliomas. Plays an important role in the correlation of histone modification and gene silencing in cancer progression. Expression is associated with a poor prognosis in patients with various cancers, suggesting that it participates in cancer progression.; 	0.23883	0.15269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	189	203	19	4945914	chr19:4945914	A	C	189	PASS	DP=203;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	5144222	5144222	G	A	intronic	KDM4B	.	.	.	0.999934757	6.52E-05	2.77E-12	.	0.43365	0.11421	-2.565119811	0.837461665	40.68188	1.19189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	125	19	5144222	chr19:5144222	G	A	.	PASS	DP=125;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	5787234	5787234	C	T	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	298	19	5787234	chr19:5787234	C	T	105	PASS	DP=298;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.
19	5787245	5787245	G	A	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	172	19	5787245	chr19:5787245	G	A	87	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	6414075	6414075	-	A	UTR3	KHSRP	NM_003685:c.*47_*48insT	.	.	0.999711222	0.000288778	5.13E-10	.	0.45176	0.15486	-0.690637458	15.12149092	19.12445	0.65912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	250	19	6414075	chr19:6414075	G	GA	68	PASS	DP=250;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	6709644	6709644	C	T	intronic	C3	.	.	.	0.999590151	0.000409849	2.80E-17	DISEASE: Complement component 3 deficiency (C3D) [MIM:613779]: A rare defect of the complement classical pathway. Patients develop recurrent, severe, pyogenic infections because of ineffective opsonization of pathogens. Some patients may also develop autoimmune disorders, such as arthralgia and vasculitic rashes, lupus-like syndrome and membranoproliferative glomerulonephritis. {ECO:0000269|PubMed:7961791}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, age-related, 9 (ARMD9) [MIM:611378]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:17634448, ECO:0000269|PubMed:24036952}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Hemolytic uremic syndrome atypical 5 (AHUS5) [MIM:612925]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269|PubMed:18796626, ECO:0000269|PubMed:20513133}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype.; DISEASE: Note=Increased levels of C3 and its cleavage product ASP, are associated with obesity, diabetes and coronary heart disease. Short-term endurance training reduces baseline ASP levels and subsequently fat storage.; 	.	.	-1.688698506	2.618542109	457.09361	4.43999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	19	6709644	chr19:6709644	C	T	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	6731560	6731560	C	A	intronic	GPR108	.	.	.	1.69E-08	0.840489879	0.159510104	.	0.1498	0.10366	0.268267497	70.64166077	318.67096	3.79102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	65	19	6731560	chr19:6731560	C	A	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	7076418	7076418	C	A	exonic	ZNF557	.	synonymous SNV	ZNF557:NM_001044387:exon5:c.C147A:p.A49A,ZNF557:NM_001044388:exon5:c.C126A:p.A42A,ZNF557:NM_024341:exon5:c.C147A:p.A49A	1.51E-06	0.398872299	0.601126193	.	0.06637	0.06391	-0.179930907	40.35739561	78.21487	1.8653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	163	19	7076418	chr19:7076418	C	A	80	PASS	DP=163;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	7116823	7116823	G	A	UTR3	INSR	NM_001079817:c.*244C>T;NM_000208:c.*244C>T	.	.	0.186547844	0.813452149	6.81E-09	DISEASE: Rabson-Mendenhall syndrome (RMS) [MIM:262190]: Severe insulin resistance syndrome characterized by insulin-resistant diabetes mellitus with pineal hyperplasia and somatic abnormalities. Typical features include coarse, senile-appearing facies, dental and skin abnormalities, abdominal distension, and phallic enlargement. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10443650, ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:17201797, ECO:0000269|PubMed:2365819, ECO:0000269|PubMed:8314008}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leprechaunism (LEPRCH) [MIM:246200]: Represents the most severe form of insulin resistance syndrome, characterized by intrauterine and postnatal growth retardation and death in early infancy. Inheritance is autosomal recessive. {ECO:0000269|PubMed:12538626, ECO:0000269|PubMed:12970295, ECO:0000269|PubMed:1607067, ECO:0000269|PubMed:1730625, ECO:0000269|PubMed:2365819, ECO:0000269|PubMed:2479553, ECO:0000269|PubMed:2834824, ECO:0000269|PubMed:7538143, ECO:0000269|PubMed:7815442, ECO:0000269|PubMed:8188715, ECO:0000269|PubMed:8326490, ECO:0000269|PubMed:8419945, ECO:0000269|PubMed:8636294, ECO:0000269|PubMed:9249867, ECO:0000269|PubMed:9703342}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:1470163, ECO:0000269|PubMed:1607076, ECO:0000269|PubMed:7657032}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Familial hyperinsulinemic hypoglycemia 5 (HHF5) [MIM:609968]: Familial hyperinsulinemic hypoglycemia [MIM:256450], also referred to as congenital hyperinsulinism, nesidioblastosis, or persistent hyperinsulinemic hypoglycemia of infancy (PPHI), is the most common cause of persistent hypoglycemia in infancy and is due to defective negative feedback regulation of insulin secretion by low glucose levels. {ECO:0000269|PubMed:15161766}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]: Characterized by the association of severe insulin resistance (manifested by marked hyperinsulinemia and a failure to respond to exogenous insulin) with the skin lesion acanthosis nigricans and ovarian hyperandrogenism in adolescent female subjects. Women frequently present with hirsutism, acne, amenorrhea or oligomenorrhea, and virilization. This syndrome is different from the type B that has been demonstrated to be secondary to the presence of circulating autoantibodies against the insulin receptor. {ECO:0000269|PubMed:10733238, ECO:0000269|PubMed:11260230, ECO:0000269|PubMed:12107746, ECO:0000269|PubMed:12970295, ECO:0000269|PubMed:1563582, ECO:0000269|PubMed:1963473, ECO:0000269|PubMed:2002058, ECO:0000269|PubMed:2168397, ECO:0000269|PubMed:2365819, ECO:0000269|PubMed:2544998, ECO:0000269|PubMed:3283938, ECO:0000269|PubMed:8243830, ECO:0000269|PubMed:8288049, ECO:0000269|PubMed:8314008, ECO:0000269|PubMed:8388389, ECO:0000269|PubMed:9175790}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99973	0.94105	-2.140595475	1.492097193	141.47735	2.59553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	19	7116823	chr19:7116823	G	A	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	7529415	7529415	C	T	intronic	ARHGEF18	.	.	.	0.908367516	0.091632236	2.47E-07	.	0.10895	0.10442	0.655813101	84.18848785	444.31169	4.38418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	112	19	7529415	chr19:7529415	C	T	135	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	7688678	7688678	T	-	exonic	XAB2	.	frameshift deletion	XAB2:NM_020196:exon8:c.1058delA:p.N353Tfs*71	0.99707026	0.00292974	2.44E-10	.	0.68409	0.19221	-1.368693559	4.482189196	119.33169	2.37747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	33	19	7688677	chr19:7688677	GT	G	40	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	7912579	7912579	G	A	intronic	EVI5L	.	.	.	0.989107013	0.01089284	1.48E-07	.	0.53412	0.10843	-0.824740496	11.67728238	14.85019	0.53429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	19	7912579	chr19:7912579	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	7974758	7974758	G	A	exonic	MAP2K7	.	synonymous SNV	MAP2K7:NM_001297556:exon2:c.G243A:p.L81L,MAP2K7:NM_145185:exon2:c.G243A:p.L81L,MAP2K7:NM_001297555:exon3:c.G291A:p.L97L	0.985719994	0.014273006	7.00E-06	.	0.81541	.	-0.514264485	21.41424864	25.26477	0.82588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	19	7974758	chr19:7974758	G	A	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	7977931	7977934	CTCT	-	UTR3	MAP2K7	NM_145185:c.*615_*618delCTCT;NM_001297556:c.*615_*618delCTCT;NM_001297555:c.*615_*618delCTCT	.	.	0.985719994	0.014273006	7.00E-06	.	0.81541	.	-0.514264485	21.41424864	25.26477	0.82588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.12	60	19	7977928	chr19:7977928	GCTCTCT	GCT,G	12.12	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	7977929	7977934	CTCTCT	-	UTR3	MAP2K7	NM_145185:c.*613_*618delCTCTCT;NM_001297556:c.*613_*618delCTCTCT;NM_001297555:c.*613_*618delCTCTCT	.	.	0.985719994	0.014273006	7.00E-06	.	0.81541	.	-0.514264485	21.41424864	25.26477	0.82588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.12	60	19	7977928	chr19:7977928	GCTCTCT	GCT,G	12.12	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	8027207	8027207	C	A	UTR3	ELAVL1	NM_001419:c.*1160G>T	.	.	0.959986604	0.039924327	8.91E-05	.	0.41503	0.49283	-0.317668748	31.45789101	12.81067	0.46627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	55	19	8027207	chr19:8027207	C	A	70	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	8200817	8200817	C	T	intronic	FBN3	.	.	.	1.35E-27	0.999811749	0.000188251	.	0.09923	0.13532	7.067302466	99.89384289	18901.16442	29.48902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	58	19	8200817	chr19:8200817	C	T	69	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	8200926	8200926	G	T	exonic	FBN3	.	nonsynonymous SNV	FBN3:NM_001321431:exon13:c.C1510A:p.R504S,FBN3:NM_032447:exon13:c.C1510A:p.R504S	1.35E-27	0.999811749	0.000188251	.	0.09923	0.13532	7.067302466	99.89384289	18901.16442	29.48902	0.004	0.654	D	0.998	0.715	D	0.97	0.706	D	0.000	0.629	U	0.987	0.406	D	1	0.253	L	-2.86	0.914	D	-5.04	0.826	D	0.767	0.760	0.324	0.879	D	0.677	0.888	D	0.124	0.806	D	6.588	0.906	31	0.998	0.861	0.780	0.381	D	c	0.361	0.367	1.000	0.747	0.650	0.456	0	4.35	0.513	5.247	0.650	0.884	0.388	1.000	0.715	0.216	0.221	16.882	0.859	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|Growth factor receptor cysteine-rich domain	.	.	0.5	60	122	19	8200926	chr19:8200926	G	T	60	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	8567371	8567371	G	A	intronic	PRAM1	.	.	.	0.007624896	0.977092731	0.015282373	.	0.07212	0.09413	0.780798785	87.24345364	1485.44258	7.17177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	19	8567371	chr19:8567371	G	A	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	9003565	9003565	C	A	splicing	MUC16	NM_024690:exon49:c.40074+1G>T	.	.	.	.	.	.	0.05884	.	29.75317221	100	23894.83454	31.77381	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.826	0.400	21.5	0.962	0.284	0.914	0.533	D	c	0.666	0.383	0.008	0.116	0.061	0.009	0	3.24	0.361	3.457	0.525	0.764	0.310	0.991	0.370	0.016	0.126	10.646	0.446	.	.	.	0.5	115	153	19	9003565	chr19:9003565	C	A	115	PASS	DP=153;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	9582037	9582037	G	T	exonic	ZNF560	.	nonsynonymous SNV	ZNF560:NM_152476:exon6:c.C256A:p.Q86K	7.36E-10	0.665805223	0.334194776	.	0.15343	.	-0.462894052	23.62585515	110.60062	2.29006	0.313	0.139	T	0.069	0.223	B	0.005	0.104	B	.	.	.	1	0.090	N	-0.895	0.014	N	3.53	0.049	T	0.2	0.049	N	0.097	0.098	-0.914	0.464	T	0.009	0.030	T	0.001	0.018	T	-1.789	0.011	0.002	0.382	0.026	0.004	0.019	N	c	-1.364	-1.438	0.000	0.012	0.554	0.246	0	-2.46	0.061	-1.236	0.030	-0.670	0.040	0.000	0.063	0.001	0.043	8.133	0.300	.	.	.	0.5	.	26	19	9582037	chr19:9582037	G	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	9873897	9873897	C	G	intronic	ZNF846	.	.	.	3.75E-16	0.000756524	0.999243476	.	.	.	0.466683681	78.73908941	1291.14567	6.76427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	62	19	9873897	chr19:9873897	C	G	64	PASS	DP=62;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	9931194	9931194	A	-	intergenic	FBXL12;UBL5	dist=1415;dist=7362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	389	19	9931193	chr19:9931193	CA	C	109	PASS	DP=389;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	10078107	10078107	C	G	intronic	COL5A3	.	.	.	7.12E-07	0.999999288	2.65E-11	.	0.45391	.	0.135796279	63.57631517	15615.64674	27.11541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	55	19	10078107	chr19:10078107	C	G	53	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	10084813	10084813	C	A	intronic	COL5A3	.	.	.	7.12E-07	0.999999288	2.65E-11	.	0.45391	.	0.135796279	63.57631517	15615.64674	27.11541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	19	10084813	chr19:10084813	C	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	10369847	10369847	G	A	UTR3	MRPL4	NM_146388:c.*433G>A	.	.	1.13E-07	0.335436284	0.664563603	.	0.05217	0.10832	0.198490371	67.30360934	1535.10751	7.28081	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.240	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.057	0.099	3.156	0.686	0.085	0.021	0.062	N	n	0.593	2.945	1.000	0.747	0.205	0.033	1	1.35	0.210	0.370	0.200	0.944	0.532	0.001	0.137	0.019	0.132	7.217	0.250	.	.	.	0.5	.	30	19	10369847	chr19:10369847	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	10599904	10599904	C	T	exonic	KEAP1	.	nonsynonymous SNV	KEAP1:NM_012289:exon5:c.G1672A:p.G558R,KEAP1:NM_203500:exon5:c.G1672A:p.G558R	0.251629058	0.748110764	0.000260179	.	0.23809	0.20935	-1.133409319	6.434300543	28.06422	0.90037	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	3.04	0.868	M	-1.64	0.825	D	-2.86	0.601	D	0.957	0.955	0.795	0.944	D	0.792	0.929	D	0.291	0.906	D	7.438	0.951	34	0.999	0.995	0.996	0.982	D	c	0.935	0.862	1.000	0.747	0.672	0.522	0	5.56	0.836	7.701	0.834	0.887	0.390	1.000	0.715	0.977	0.480	17.087	0.864	Galactose oxidase, beta-propeller	.	.	0.5	155	210	19	10599904	chr19:10599904	C	T	155	PASS	DP=210;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
19	10662733	10662734	TG	-	exonic	ATG4D	.	frameshift deletion	ATG4D:NM_001281504:exon8:c.869_870del:p.Y291Pfs*51,ATG4D:NM_032885:exon8:c.1058_1059del:p.Y354Pfs*51	0.000323904	0.945773923	0.053902174	.	0.15091	0.10598	-0.578583623	18.71903751	85.56652	1.97238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	237	19	10662732	chr19:10662732	CTG	C	82	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	10969014	10969014	G	A	exonic	C19orf38	.	synonymous SNV	C19orf38:NM_001136482:exon4:c.G456A:p.K152K	.	.	.	.	.	.	0.591694063	82.45458835	366.41714	4.04947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	19	10969014	chr19:10969014	G	A	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	11234008	11234008	A	G	exonic	LDLR	.	nonsynonymous SNV	LDLR:NM_001195800:exon13:c.A1795G:p.M599V,LDLR:NM_001195803:exon13:c.A1765G:p.M589V,LDLR:NM_001195799:exon14:c.A2176G:p.M726V,LDLR:NM_000527:exon15:c.A2299G:p.M767V,LDLR:NM_001195798:exon15:c.A2299G:p.M767V	2.59E-16	0.058594457	0.941405543	DISEASE: Familial hypercholesterolemia (FH) [MIM:143890]: Common autosomal semi-dominant disease that affects about 1 in 500 individuals. The receptor defect impairs the catabolism of LDL, and the resultant elevation in plasma LDL-cholesterol promotes deposition of cholesterol in the skin (xanthelasma), tendons (xanthomas), and coronary arteries (atherosclerosis). {ECO:0000269|PubMed:10090484, ECO:0000269|PubMed:10206683, ECO:0000269|PubMed:10422803, ECO:0000269|PubMed:10447263, ECO:0000269|PubMed:10532689, ECO:0000269|PubMed:10660340, ECO:0000269|PubMed:10882754, ECO:0000269|PubMed:10978268, ECO:0000269|PubMed:10980548, ECO:0000269|PubMed:11298688, ECO:0000269|PubMed:11462246, ECO:0000269|PubMed:1446662, ECO:0000269|PubMed:1464748, ECO:0000269|PubMed:17142622, ECO:0000269|PubMed:17347910, ECO:0000269|PubMed:1867200, ECO:0000269|PubMed:19318025, ECO:0000269|PubMed:19319977, ECO:0000269|PubMed:22160468, ECO:0000269|PubMed:2318961, ECO:0000269|PubMed:24529145, ECO:0000269|PubMed:2569482, ECO:0000269|PubMed:2726768, ECO:0000269|PubMed:3263645, ECO:0000269|PubMed:3955657, ECO:0000269|PubMed:7550239, ECO:0000269|PubMed:7573037, ECO:0000269|PubMed:7583548, ECO:0000269|PubMed:7635461, ECO:0000269|PubMed:7635482, ECO:0000269|PubMed:7649546, ECO:0000269|PubMed:7649549, ECO:0000269|PubMed:8168830, ECO:0000269|PubMed:8347689, ECO:0000269|PubMed:8462973, ECO:0000269|PubMed:8664907, ECO:0000269|PubMed:8740918, ECO:0000269|PubMed:9026534, ECO:0000269|PubMed:9104431, ECO:0000269|PubMed:9143924, ECO:0000269|PubMed:9254862, ECO:0000269|PubMed:9259195, ECO:0000269|PubMed:9452094, ECO:0000269|PubMed:9452095, ECO:0000269|PubMed:9452118, ECO:0000269|PubMed:9654205, ECO:0000269|PubMed:9678702, ECO:0000269|PubMed:9852677, ECO:0000269|Ref.70}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42568	0.94311	-1.853858183	2.028780373	654.09994	5.13173	0.982	0.132	T	0.0	0.026	B	0.0	0.013	B	0.090	0.024	N	1	0.090	N	1.055	0.270	L	-2.49	0.894	D	-0.17	0.096	N	0.176	0.469	-0.493	0.689	T	0.455	0.788	T	0.407	0.935	D	-1.779	0.011	0.002	0.334	0.020	0.146	0.183	N	c	-1.541	-1.601	0.431	0.204	0.672	0.522	0	-3.53	0.043	-0.261	0.086	-0.698	0.038	0.000	0.063	0.001	0.043	8.513	0.322	Six-bladed beta-propeller, TolB-like	.	.	0.5	97	125	19	11234008	chr19:11234008	A	G	97	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	11258044	11258044	T	-	intronic	SPC24	.	.	.	0.006275544	0.741565201	0.252159254	.	0.08605	0.11889	0.413500896	76.67492333	270.60416	3.52755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	31	19	11258043	chr19:11258043	CT	C	44	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	11363664	11363664	A	G	intronic	DOCK6	.	.	.	2.83E-19	0.984497718	0.015502282	DISEASE: Adams-Oliver syndrome 2 (AOS2) [MIM:614219]: A disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins. {ECO:0000269|PubMed:21820096}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15719	0.10035	-0.941152229	9.418494928	1944.2298	8.11461	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	25	19	11363664	chr19:11363664	A	G	61	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	11409676	11409676	A	C	intronic	TSPAN16	.	.	.	0.000252238	0.533132847	0.466614915	.	0.04912	0.08574	0.373041938	75.29488087	212.54112	3.14654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	35	19	11409676	chr19:11409676	A	C	53	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	11564674	11564674	-	T	UTR3	ELAVL3	NM_001420:c.*666_*667insA;NM_032281:c.*666_*667insA	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	279	19	11564674	chr19:11564674	G	GT	134	PASS	DP=279;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	11591325	11591325	C	-	intronic	ELAVL3	.	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	231	19	11591324	chr19:11591324	AC	A	84	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	11591394	11591394	C	A	intronic	ELAVL3	.	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	237	19	11591394	chr19:11591394	C	A	65	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	11725682	11725682	A	G	exonic	ZNF627	.	synonymous SNV	ZNF627:NM_145295:exon3:c.A171G:p.K57K,ZNF627:NM_001290083:exon4:c.A75G:p.K25K	0.005644146	0.989445166	0.004910688	.	0.20136	0.10503	-0.424258538	25.56027365	57.87877	1.53812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	146	19	11725682	chr19:11725682	A	G	62	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	11917481	11917481	C	G	exonic	ZNF491	.	nonsynonymous SNV	ZNF491:NM_152356:exon3:c.C713G:p.T238R	5.13E-07	0.405347903	0.594651584	.	0.19959	.	0.88921411	89.24274593	196.96831	3.03569	0.0	0.912	D	0.999	0.764	D	0.967	0.699	D	.	.	.	0.943	0.374	D	1.53	0.389	L	1.78	0.257	T	-4.81	0.807	D	0.171	0.214	-0.860	0.513	T	0.130	0.439	T	0.001	0.010	T	4.157	0.557	23.8	0.979	0.360	0.001	0.004	N	c	-0.249	-0.575	0.249	0.187	0.554	0.246	0	0.981	0.188	0.146	0.159	0.643	0.292	0.000	0.063	0.007	0.100	9.569	0.384	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	86	13	19	11917481	chr19:11917481	C	G	86	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
19	12639557	12639557	G	A	intronic	ZNF564	.	.	.	8.59E-05	0.929602645	0.070311445	.	0.18832	.	-0.47017169	23.25430526	61.90992	1.60412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	19	12639557	chr19:12639557	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	12760173	12760173	G	C	exonic	MAN2B1	.	nonsynonymous SNV	MAN2B1:NM_000528:exon19:c.C2337G:p.N779K,MAN2B1:NM_001173498:exon19:c.C2334G:p.N778K	1.56E-12	0.928196832	0.071803168	DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A lysosomal storage disease characterized by accumulation of unbranched oligosaccharide chains. This accumulation is expressed histologically as cytoplasmic vacuolation predominantly in the CNS and parenchymatous organs. Depending on the clinical findings at the age of onset, a severe infantile (type I) and a mild juvenile (type II) form of alpha-mannosidosis are recognized. There is considerable variation in the clinical expression with mental retardation, recurrent infections, impaired hearing and Hurler- like skeletal changes being the most consistent abnormalities. {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269, ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146, ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06035	0.22441	0.121225147	62.22576079	2735.34889	9.86188	0.014	0.531	D	1.0	0.899	D	0.995	0.875	D	0.000	0.449	D	1.000	0.537	D	3.56	0.935	H	-1.23	0.789	T	-4.04	0.757	D	0.445	0.499	0.567	0.915	D	0.689	0.893	D	0.097	0.769	D	6.555	0.902	31	0.998	0.855	0.982	0.803	D	c	0.821	0.722	1.000	0.467	0.706	0.609	0	4.66	0.577	7.068	0.763	1.045	0.669	1.000	0.715	0.972	0.466	15.081	0.717	Galactose mutarotase-like domain|Glycosyl hydrolase family 38, C-terminal	.	.	0.5	.	28	19	12760173	chr19:12760173	G	C	.	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	12760222	12760222	C	T	exonic	MAN2B1	.	stopgain	MAN2B1:NM_000528:exon19:c.G2288A:p.W763X,MAN2B1:NM_001173498:exon19:c.G2285A:p.W762X	1.56E-12	0.928196832	0.071803168	DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A lysosomal storage disease characterized by accumulation of unbranched oligosaccharide chains. This accumulation is expressed histologically as cytoplasmic vacuolation predominantly in the CNS and parenchymatous organs. Depending on the clinical findings at the age of onset, a severe infantile (type I) and a mild juvenile (type II) form of alpha-mannosidosis are recognized. There is considerable variation in the clinical expression with mental retardation, recurrent infections, impaired hearing and Hurler- like skeletal changes being the most consistent abnormalities. {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269, ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146, ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06035	0.22441	0.121225147	62.22576079	2735.34889	9.86188	.	.	.	.	.	.	.	.	.	0.002	0.382	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.678	0.993	43	0.996	0.744	0.981	0.798	D	c	0.777	0.604	1.000	0.747	0.706	0.609	0	4.55	0.553	7.077	0.763	0.932	0.445	1.000	0.715	0.919	0.394	14.846	0.698	Galactose mutarotase-like domain|Glycosyl hydrolase family 38, C-terminal	.	.	0.5	.	51	19	12760222	chr19:12760222	C	T	.	PASS	DP=51;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	12768821	12768821	G	A	intronic	MAN2B1	.	.	.	1.56E-12	0.928196832	0.071803168	DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A lysosomal storage disease characterized by accumulation of unbranched oligosaccharide chains. This accumulation is expressed histologically as cytoplasmic vacuolation predominantly in the CNS and parenchymatous organs. Depending on the clinical findings at the age of onset, a severe infantile (type I) and a mild juvenile (type II) form of alpha-mannosidosis are recognized. There is considerable variation in the clinical expression with mental retardation, recurrent infections, impaired hearing and Hurler- like skeletal changes being the most consistent abnormalities. {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269, ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146, ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06035	0.22441	0.121225147	62.22576079	2735.34889	9.86188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	277	19	12768821	chr19:12768821	G	A	75	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	13049577	13049577	G	A	exonic	CALR	.	synonymous SNV	CALR:NM_004343:exon1:c.G84A:p.L28L	0.938728555	0.061218724	5.27E-05	.	0.8981	0.86884	-0.624497208	17.16206653	79.72032	1.88685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	151	19	13049577	chr19:13049577	G	A	.	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	13049578	13049578	G	A	exonic	CALR	.	nonsynonymous SNV	CALR:NM_004343:exon1:c.G85A:p.D29N	0.938728555	0.061218724	5.27E-05	.	0.8981	0.86884	-0.624497208	17.16206653	79.72032	1.88685	0.081	0.334	T	0.139	0.259	B	0.112	0.300	B	0.000	0.843	D	1	0.810	D	2.795	0.818	M	0.71	0.512	T	-3.96	0.735	D	0.122	0.137	-0.843	0.525	T	0.192	0.545	T	0.021	0.434	T	4.183	0.561	23.8	0.998	0.867	0.982	0.806	D	c	0.307	0.442	1.0	0.983	0.442	0.072	0	5.82	0.927	6.327	0.727	1.048	0.713	1.000	0.715	0.997	0.653	18.849	0.922	Concanavalin A-like lectin/glucanase domain	.	.	0.5	.	152	19	13049578	chr19:13049578	G	A	.	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	13085229	13085229	C	T	UTR3	DAND5	NM_152654:c.*781C>T	.	.	1.68E-05	0.252738096	0.74724507	.	0.10745	0.20281	-0.029247611	51.40363293	16.50617	0.58379	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	19	13085229	chr19:13085229	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	13879622	13879622	T	C	intronic	MRI1	.	.	.	0.000533201	0.695290836	0.304175963	.	.	.	0.50895761	80.20169851	295.74482	3.672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	196	19	13879622	chr19:13879622	T	C	96	PASS	DP=196;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	13898936	13898936	G	T	intergenic	C19orf53;ZSWIM4	dist=9350;dist=7338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	19	13898936	chr19:13898936	G	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	13941567	13941567	C	T	exonic	ZSWIM4	.	synonymous SNV	ZSWIM4:NM_023072:exon13:c.C2673T:p.P891P	0.165803304	0.834071799	0.000124897	.	0.24652	.	-1.322782544	4.759377212	1113.90385	6.3763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	606	19	13941567	chr19:13941567	C	T	74	PASS	DP=606;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	14003635	14003635	C	T	exonic	C19orf57	.	nonsynonymous SNV	C19orf57:NM_001345846:exon4:c.G3A:p.M1I,C19orf57:NM_001345847:exon4:c.G3A:p.M1I,C19orf57:NM_001345843:exon5:c.G774A:p.M258I,C19orf57:NM_001345844:exon5:c.G774A:p.M258I,C19orf57:NM_001345848:exon5:c.G774A:p.M258I,C19orf57:NM_024323:exon5:c.G357A:p.M119I	7.18E-05	0.91292763	0.087000543	.	0.06931	0.07027	2.050415361	97.77070064	3198.91219	10.78072	0.471	0.084	T	0.0	0.026	B	0.001	0.040	B	0.106	0.026	N	1	0.090	N	0.69	0.170	N	1.61	0.284	T	-1.43	0.352	N	0.063	0.048	-1.050	0.143	T	0.037	0.161	T	0.002	0.043	T	-3.350	0.001	0.001	0.339	0.020	0.003	0.016	N	c	-2.509	-2.585	1.000	0.747	0.615	0.372	0	-9.22	0.006	-3.186	0.006	-1.722	0.007	0.000	0.063	0.000	0.016	9.940	0.406	.	.	.	0.5	.	57	19	14003635	chr19:14003635	C	T	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	14083681	14083681	G	C	exonic	RFX1	.	synonymous SNV	RFX1:NM_002918:exon9:c.C1188G:p.G396G	0.998752687	0.001247312	7.42E-10	.	0.65257	0.19379	-0.08446956	47.15145081	531.54502	4.70401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	16	19	14083681	chr19:14083681	G	C	58	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	14237026	14237026	C	T	exonic	ASF1B	.	nonsynonymous SNV	ASF1B:NM_018154:exon2:c.G133A:p.V45I	0.565696011	0.422261192	0.012042797	.	0.90878	0.12386	-0.427900189	25.14744043	14.36535	0.51875	0.001	0.784	D	0.948	0.516	P	0.984	0.745	D	0.000	0.843	D	1	0.810	D	1.985	0.540	M	.	.	.	-0.96	0.255	N	0.478	0.527	-0.067	0.809	T	0.514	0.818	D	0.009	0.250	T	6.561	0.903	31	0.999	0.936	0.934	0.579	D	c	0.848	0.831	1.000	0.747	0.732	0.924	0	5.95	0.964	7.905	0.864	0.932	0.445	1.000	0.715	0.978	0.483	17.887	0.887	.	.	.	0.5	.	34	19	14237026	chr19:14237026	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	14530029	14530029	C	T	intronic	DDX39A	.	.	.	0.843485807	0.15639202	0.000122173	.	0.1929	0.12971	-0.580403979	18.58928993	124.14286	2.42456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	252	19	14530029	chr19:14530029	C	T	.	PASS	DP=252;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	14749076	14749076	A	G	exonic	ADGRE3	.	nonsynonymous SNV	ADGRE3:NM_001289159:exon8:c.T947C:p.V316A,ADGRE3:NM_001289158:exon10:c.T1169C:p.V390A,ADGRE3:NM_032571:exon11:c.T1325C:p.V442A	.	.	.	.	0.07768	.	1.223576934	93.23543289	.	.	0.002	0.721	D	0.263	0.423	B	0.314	0.586	B	.	.	.	1.000	0.182	N	2.56	0.750	M	0.96	0.429	T	-1.93	0.448	N	0.163	0.196	-0.926	0.447	T	0.194	0.547	T	0.009	0.240	T	1.901	0.289	15.59	0.893	0.181	0.971	0.726	D	c	-0.195	-0.236	0.017	0.129	0.500	0.196	0	3.43	0.382	6.097	0.709	0.093	0.196	1.000	0.715	0.661	0.301	9.507	0.380	GPCR, family 2-like	.	.	0.5	85	108	19	14749076	chr19:14749076	A	G	85	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	14952262	14952262	A	C	exonic	OR7A10	.	nonsynonymous SNV	OR7A10:NM_001005190:exon1:c.T428G:p.L143R	0.007992982	0.555798032	0.436208986	.	0.06006	.	1.241986644	93.38877094	2606.77431	9.55666	0.002	0.721	D	0.985	0.592	D	0.937	0.655	D	0.008	0.311	U	1	0.090	N	1.885	0.502	L	8.62	0.002	T	-4.62	0.791	D	0.459	0.511	-0.890	0.490	T	0.001	0.003	T	0.001	0.003	T	2.801	0.398	21.4	0.993	0.576	0.044	0.098	N	c	-0.424	-0.705	0.000	0.029	0.487	0.133	0	0.373	0.153	-1.952	0.016	-0.001	0.135	0.000	0.063	0.006	0.095	6.265	0.200	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	39	19	14952262	chr19:14952262	A	C	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	15083485	15083485	T	C	intronic	SLC1A6	.	.	.	0.928911024	0.071012147	7.68E-05	.	0.26103	.	-0.800872469	12.33191791	38.46571	1.14105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	122	19	15083485	chr19:15083485	T	C	64	PASS	DP=122;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	15367816	15367816	C	G	exonic	BRD4	.	nonsynonymous SNV	BRD4:NM_001330384:exon8:c.G1510C:p.E504Q,BRD4:NM_014299:exon8:c.G1510C:p.E504Q,BRD4:NM_058243:exon8:c.G1510C:p.E504Q	0.999993446	6.55E-06	1.03E-14	DISEASE: Note=A chromosomal aberration involving BRD4 is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;19)(q14;p13) with NUT which produces a BRD4-NUT fusion protein. {ECO:0000269|PubMed:11733348, ECO:0000269|PubMed:12543779}.; 	0.42814	0.18694	-1.480759435	3.686010852	185.92351	2.96128	0.002	0.721	D	0.999	0.764	D	0.994	0.807	D	0.000	0.629	D	1	0.810	D	3.41	0.920	M	2.33	0.187	T	-2.94	0.614	D	0.559	0.621	-0.579	0.657	T	0.201	0.557	T	0.030	0.528	D	2.780	0.395	21.3	0.999	0.949	0.981	0.798	D	c	0.896	0.848	1.000	0.747	0.672	0.522	0	5.36	0.765	7.905	0.864	0.935	0.490	1.000	0.715	0.997	0.653	17.898	0.888	.	.	.	0.5	127	215	19	15367816	chr19:15367816	C	G	127	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	15376233	15376233	G	A	exonic	BRD4	.	nonsynonymous SNV	BRD4:NM_001330384:exon5:c.C781T:p.P261S,BRD4:NM_014299:exon5:c.C781T:p.P261S,BRD4:NM_058243:exon5:c.C781T:p.P261S	0.999993446	6.55E-06	1.03E-14	DISEASE: Note=A chromosomal aberration involving BRD4 is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;19)(q14;p13) with NUT which produces a BRD4-NUT fusion protein. {ECO:0000269|PubMed:11733348, ECO:0000269|PubMed:12543779}.; 	0.42814	0.18694	-1.480759435	3.686010852	185.92351	2.96128	0.116	0.284	T	0.19	0.397	B	0.081	0.314	B	0.002	0.374	N	0.994	0.420	D	1.79	0.469	L	1.4	0.336	T	-1.95	0.456	N	0.473	0.523	-1.093	0.051	T	0.059	0.248	T	0.013	0.317	T	0.809	0.171	9.517	0.998	0.904	0.952	0.635	D	c	-0.333	-0.292	1.000	0.454	0.672	0.522	0	3.54	0.395	4.223	0.581	1.048	0.713	1.000	0.715	0.516	0.274	11.923	0.519	.	.	.	0.5	.	22	19	15376233	chr19:15376233	G	A	.	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	15511150	15511150	C	T	exonic	AKAP8L	.	nonsynonymous SNV	AKAP8L:NM_001291478:exon8:c.G821A:p.G274E,AKAP8L:NM_014371:exon8:c.G1004A:p.G335E	0.542386261	0.457587658	2.61E-05	.	0.09475	.	-0.336073593	30.55555556	45.99788	1.30586	0.256	0.168	T	0.917	0.488	P	0.446	0.481	B	0.283	0.149	N	0.999	0.220	N	1.5	0.380	L	0.93	0.441	T	-1.71	0.406	N	0.419	0.476	-1.073	0.088	T	0.058	0.244	T	0.007	0.173	T	2.544	0.367	19.75	0.990	0.487	0.945	0.611	D	c	-0.044	0.057	0.779	0.238	0.707	0.730	0	3.48	0.388	2.702	0.465	0.935	0.490	0.972	0.342	1.000	0.888	9.941	0.406	.	.	.	0.5	.	68	19	15511150	chr19:15511150	C	T	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	15543290	15543290	C	T	UTR5	WIZ	NM_001330395:c.-1320G>A	.	.	0.998940437	0.00105955	1.22E-08	.	0.34714	.	-0.799052816	12.45576787	321.62309	3.8086	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	19	15543290	chr19:15543290	C	T	.	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	15905468	15905468	T	G	exonic	OR10H5	.	nonsynonymous SNV	OR10H5:NM_001004466:exon1:c.T610G:p.C204G	0.043953004	0.666138751	0.289908245	.	0.05526	0.09533	1.910792163	97.4168436	5294.08243	15.03864	0.122	0.276	T	0.998	0.715	D	0.984	0.745	D	0.000	0.537	D	1	0.090	P	-1.72	0.003	N	1.29	0.358	T	-1.9	0.443	N	0.451	0.504	-1.088	0.058	T	0.002	0.008	T	.	.	.	0.506	0.142	7.473	0.698	0.088	0.110	0.161	N	c	-0.380	-0.506	0.000	0.060	0.487	0.133	0	3.36	0.374	1.173	0.313	0.719	0.303	0.001	0.137	0.003	0.074	6.761	0.226	GPCR, rhodopsin-like, 7TM	ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267453.2|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Frontal_Cortex_BA9|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Thyroid|Thyroid	0.5	158	162	19	15905468	chr19:15905468	T	G	158	PASS	DP=162;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	15905505	15905505	T	C	exonic	OR10H5	.	nonsynonymous SNV	OR10H5:NM_001004466:exon1:c.T647C:p.L216P	0.043953004	0.666138751	0.289908245	.	0.05526	0.09533	1.910792163	97.4168436	5294.08243	15.03864	0.006	0.614	D	0.997	0.689	D	0.976	0.719	D	0.012	0.295	N	0.001	0.452	P	2.91	0.844	M	8.34	0.003	T	-4.57	0.787	D	0.262	0.350	-0.887	0.492	T	0.000	0.000	T	.	.	.	4.084	0.548	23.7	0.998	0.921	0.768	0.374	D	c	0.407	0.224	0.022	0.135	0.487	0.133	0	3.88	0.438	2.676	0.463	0.719	0.303	0.038	0.207	0.022	0.137	10.953	0.464	GPCR, rhodopsin-like, 7TM	ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267453.2|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Frontal_Cortex_BA9|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Thyroid|Thyroid	0.5	159	169	19	15905505	chr19:15905505	T	C	159	PASS	DP=169;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	15918201	15918201	A	G	exonic	OR10H1	.	nonsynonymous SNV	OR10H1:NM_013940:exon1:c.T647C:p.L216P	0.637065116	0.334487775	0.028447109	.	0.15432	0.095	0.575097644	82.1656051	2707.23222	9.78935	0.008	0.586	D	0.997	0.689	D	0.976	0.719	D	0.012	0.295	N	0.937	0.372	D	3.125	0.882	M	8.34	0.003	T	-4.7	0.798	D	0.67	0.680	-0.686	0.611	T	0.002	0.006	T	0.005	0.127	T	4.839	0.650	24.8	0.999	0.930	0.163	0.191	N	c	0.497	0.355	0.001	0.086	0.487	0.133	0	4.96	0.650	2.769	0.471	0.897	0.411	0.014	0.188	0.989	0.536	12.564	0.555	GPCR, rhodopsin-like, 7TM	.	.	0.5	126	185	19	15918201	chr19:15918201	A	G	126	PASS	DP=185;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	16222677	16222677	G	T	UTR5	RAB8A	NM_005370:c.-35G>T	.	.	0.962128955	0.037793365	7.77E-05	.	0.20304	0.31462	-0.251530012	35.42108988	1.07555	0.02762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	201	933	19	16222677	chr19:16222677	G	T	201	PASS	DP=933;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	16472812	16472812	A	-	intronic	EPS15L1	.	.	.	0.970002535	0.029997462	3.00E-09	.	0.14632	0.12662	-2.125742609	1.509790045	75.39978	1.81746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	105	19	16472811	chr19:16472811	GA	G	56	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	16653215	16653215	C	G	UTR5	CHERP	NM_006387:c.-26G>C	.	.	0.999988396	1.16E-05	2.04E-13	.	0.24899	0.1174	-1.087493118	7.106628922	30.28923	0.96588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	83	19	16653215	chr19:16653215	C	G	90	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	17370190	17370190	T	G	exonic	USHBP1	.	synonymous SNV	USHBP1:NM_001297703:exon6:c.A762C:p.L254L,USHBP1:NM_001321417:exon7:c.A954C:p.L318L,USHBP1:NM_031941:exon7:c.A954C:p.L318L	3.28E-13	0.259438278	0.740561722	.	0.05039	0.10302	-0.391302095	27.06416608	2829.1436	10.03299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	11	19	17370190	chr19:17370190	T	G	43	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	17395055	17395055	C	G	exonic	ANKLE1	.	synonymous SNV	ANKLE1:NM_001278443:exon6:c.C1407G:p.T469T,ANKLE1:NM_001278444:exon6:c.C1440G:p.T480T,ANKLE1:NM_001278445:exon6:c.C1344G:p.T448T,ANKLE1:NM_152363:exon6:c.C1518G:p.T506T	8.12E-14	0.004843148	0.995156852	.	0.06468	0.09439	2.804006769	99.0504836	7647.36009	18.79705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	43	19	17395055	chr19:17395055	C	G	65	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	17531872	17531933	TCCTCTTCTGGGCCCACAACCCTAGTGCAGCCCTCCCAGCCCCACCTGAACTTTCCCACCCT	-	intronic	MVB12A	.	.	.	0.000679169	0.914542667	0.084778163	.	0.09158	.	0.350995466	74.37485256	188.19304	2.97888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	57	19	17531871	chr19:17531871	CTCCTCTTCTGGGCCCACAACCCTAGTGCAGCCCTCCCAGCCCCACCTGAACTTTCCCACCCT	C	43	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	17531926	17531929	CCCA	-	intronic	MVB12A	.	.	.	0.000679169	0.914542667	0.084778163	.	0.09158	.	0.350995466	74.37485256	188.19304	2.97888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	78	19	17531925	chr19:17531925	TCCCA	T	65	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	17734350	17734350	C	T	intronic	UNC13A	.	.	.	0.999986711	1.33E-05	3.94E-18	.	0.20708	.	-1.697674421	2.583156405	1626.22937	7.45646	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.908	0.660	25.0	0.990	0.487	0.783	0.383	D	c	0.887	0.682	0.022	0.134	0.091	0.019	0	3.75	0.421	3.361	0.518	0.780	0.314	1.000	0.715	0.999	0.750	11.462	0.493	.	.	.	0.5	.	98	19	17734350	chr19:17734350	C	T	.	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	18276930	18276930	G	T	intronic	PIK3R2	.	.	.	0.939626884	0.060371032	2.08E-06	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47036	0.41833	-0.534490515	20.70063694	216.25734	3.17643	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	0.055	0.037	.	.	.	.	.	.	.	.	.	-0.137	0.081	1.468	0.187	0.006	0.089	0.146	N	n	-0.268	-0.222	0.290	0.191	0.563	0.310	0	-6.35	0.018	-0.578	0.059	-0.982	0.023	0.000	0.063	0.001	0.043	2.325	0.039	.	.	.	0.5	.	53	19	18276930	chr19:18276930	G	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	18305695	18305695	C	T	intronic	MPV17L2	.	.	.	1.67E-07	0.127199435	0.872800397	.	.	.	0.03689118	56.64071715	1728.0677	7.67188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	19	18305695	chr19:18305695	C	T	.	PASS	DP=58;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	18305711	18305711	C	T	intronic	MPV17L2	.	.	.	1.67E-07	0.127199435	0.872800397	.	.	.	0.03689118	56.64071715	1728.0677	7.67188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	160	19	18305711	chr19:18305711	C	T	65	PASS	DP=160;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	18375846	18375846	G	A	exonic	KIAA1683	.	nonsynonymous SNV	KIAA1683:NM_001145304:exon3:c.C2504T:p.P835L,KIAA1683:NM_001145305:exon3:c.C2366T:p.P789L,KIAA1683:NM_025249:exon3:c.C2504T:p.P835L	8.28E-06	0.980911152	0.019080563	.	0.07923	0.08035	3.760579722	99.61075725	2365.24197	9.02868	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.012	0.293	N	1	0.090	P	-2.11	0.002	N	4.42	0.024	T	2.5	0.002	N	0.026	0.064	-1.012	0.262	T	0.000	0.000	T	.	.	.	0.036	0.097	2.942	0.209	0.008	0.000	0.002	N	c	-1.263	-1.171	0.939	0.273	0.421	0.056	0	4.29	0.502	1.498	0.350	0.202	0.252	0.004	0.165	0.002	0.062	6.905	0.233	.	.	.	0.5	83	244	19	18375846	chr19:18375846	G	A	83	PASS	DP=244;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	18544469	18544469	G	A	intronic	SSBP4	.	.	.	0.961658882	0.038337822	3.30E-06	.	0.20604	0.10821	-0.293801652	32.93819297	37.43039	1.11514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	102	19	18544469	chr19:18544469	G	A	66	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	18700047	18700047	A	G	intronic	C19orf60	.	.	.	0.249879078	0.642082143	0.10803878	.	0.11766	.	.	.	32.748	1.01722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	48	19	18700047	chr19:18700047	A	G	84	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	18887993	18887993	C	-	exonic	CRTC1	.	frameshift deletion	CRTC1:NM_015321:exon14:c.1706delC:p.S572Afs*5,CRTC1:NM_001098482:exon15:c.1754delC:p.S588Afs*5	0.980548236	0.01945115	6.14E-07	DISEASE: Note=A chromosomal aberration involving CRTC1 is found in mucoepidermoid carcinomas, benign Warthin tumors and clear cell hidradenomas. Translocation t(11;19)(q21;p13) with MAML2. The fusion protein consists of the N-terminus of CRTC1 joined to the C-terminus of MAML2. The reciprocal fusion protein consisting of the N-terminus of MAML2 joined to the C-terminus of CRTC1 has been detected in a small number of mucoepidermoid carcinomas.; 	0.23783	0.22982	-0.400392389	26.85185185	1186.85367	6.53335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	682	19	18887992	chr19:18887992	TC	T	103	PASS	DP=682;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	19650454	19650454	A	T	intronic	CILP2	.	.	.	0.000278936	0.999088514	0.000632549	.	0.16316	0.11129	-1.082044518	7.242274121	113.50816	2.31988	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	19	19650454	chr19:19650454	A	T	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	21116959	21116959	G	A	intronic	ZNF85	.	.	.	2.28E-10	0.03733675	0.962663249	.	0.16722	0.10724	2.577929865	98.74970512	348.08165	3.9535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	105	19	21116959	chr19:21116959	G	A	.	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	21608502	21608502	A	G	UTR3	ZNF493	NM_175910:c.*716A>G;NM_001076678:c.*716A>G	.	.	3.19E-08	0.517403821	0.482596148	.	0.19726	.	-0.372889896	28.20240623	184.42675	2.94725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	43	19	21608502	chr19:21608502	A	G	59	PASS	DP=43;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	22940859	22940859	T	C	exonic	ZNF99	.	nonsynonymous SNV	ZNF99:NM_001080409:exon4:c.A1852G:p.K618E	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	1.0	0.010	T	0.006	0.126	B	0.013	0.154	B	.	.	.	1.000	0.206	N	-0.515	0.026	N	2.66	0.126	T	2.7	0.002	N	0.196	0.269	-0.943	0.422	T	0.009	0.032	T	0.001	0.008	T	-1.031	0.031	0.014	0.791	0.122	0.001	0.007	N	c	-1.539	-1.541	0.000	0.038	0.487	0.133	0	-0.667	0.108	-0.093	0.110	-1.414	0.012	0.000	0.063	0.000	0.016	6.213	0.197	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	65	41	19	22940859	chr19:22940859	T	C	65	PASS	DP=41;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	22942325	22942325	G	C	exonic	ZNF99	.	nonsynonymous SNV	ZNF99:NM_001080409:exon4:c.C386G:p.A129G	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.115	0.002	N	3.24	0.069	T	1.63	0.006	N	0.112	0.121	-0.995	0.313	T	0.000	0.000	T	.	.	.	-1.238	0.024	0.006	0.266	0.013	0.001	0.006	N	c	-2.131	-2.096	0.000	0.012	0.487	0.133	0	-0.806	0.103	-1.663	0.021	-1.836	0.006	0.000	0.063	0.000	0.016	4.388	0.107	.	ENSG00000229676.2|ENSG00000229676.2|ENSG00000261558.1|ENSG00000229676.2	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Testis|Testis	0.5	64	14	19	22942325	chr19:22942325	G	C	64	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	23158703	23158703	A	G	exonic	ZNF728	.	nonsynonymous SNV	ZNF728:NM_001267716:exon4:c.T1436C:p.L479P	1.36E-07	0.208328597	0.791671267	.	.	.	.	.	3188.19789	10.75687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.405	0.006	N	2.85	0.106	T	.	.	.	0.1	0.103	.	.	.	.	.	.	0.030	0.525	D	-1.224	0.024	0.006	0.643	0.072	0.000	0.002	N	n	-0.199	0.121	0.000	0.012	0.487	0.133	0	.	.	0.907	0.280	-5.111	0.000	0.021	0.196	0.000	0.016	6.153	0.194	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	56	20	19	23158703	chr19:23158703	A	G	56	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	23158708	23158708	C	G	exonic	ZNF728	.	nonsynonymous SNV	ZNF728:NM_001267716:exon4:c.G1431C:p.E477D	1.36E-07	0.208328597	0.791671267	.	.	.	.	.	3188.19789	10.75687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.04	0.081	N	1.71	0.267	T	.	.	.	0.113	0.123	.	.	.	.	.	.	0.005	0.130	T	3.615	0.492	23.2	0.584	0.059	0.011	0.040	N	n	0.002	0.153	0.000	0.038	0.487	0.133	0	.	.	-0.149	0.101	0.275	0.269	0.044	0.210	0.008	0.104	8.825	0.340	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	64	24	19	23158708	chr19:23158708	C	G	64	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	33490500	33490500	C	T	exonic	RHPN2	.	nonsynonymous SNV	RHPN2:NM_033103:exon10:c.G1217A:p.R406Q	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	0.33	0.131	T	0.046	0.205	B	0.011	0.145	B	0.546	0.053	N	1	0.090	N	0.72	0.188	N	1.92	0.231	T	-1.58	0.381	N	0.045	0.025	-1.048	0.150	T	0.066	0.274	T	0.014	0.345	T	2.284	0.336	18.06	0.984	0.411	0.008	0.031	N	c	-1.114	-1.210	1.000	0.425	0.672	0.522	0	-6.97	0.015	-0.603	0.057	-0.079	0.119	0.000	0.063	0.088	0.184	3.396	0.068	BRO1 domain	.	.	0.5	98	174	19	33490500	chr19:33490500	C	T	98	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	33490585	33490585	G	A	exonic	RHPN2	.	stopgain	RHPN2:NM_033103:exon10:c.C1132T:p.Q378X	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.292	0.982	39	0.998	0.910	0.991	0.907	D	c	1.043	0.881	1.000	0.747	0.672	0.522	0	4.72	0.591	9.105	0.935	0.889	0.393	1.000	0.715	0.979	0.486	17.685	0.881	BRO1 domain	.	.	0.5	138	193	19	33490585	chr19:33490585	G	A	138	PASS	DP=193;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	33602761	33602761	A	T	exonic	GPATCH1	.	stopgain	GPATCH1:NM_018025:exon12:c.A1717T:p.K573X	3.44E-05	0.999944147	2.14E-05	.	0.12487	.	-0.211293113	37.76244397	310.91302	3.75292	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.329	0.990	41	0.996	0.722	0.905	0.514	D	c	0.669	0.530	0.999	0.388	0.732	0.924	0	4.49	0.540	3.281	0.511	1.193	0.911	1.000	0.715	0.999	0.750	11.972	0.522	.	.	.	0.5	.	57	19	33602761	chr19:33602761	A	T	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	35836418	35836418	T	A	ncRNA_exonic	MIR5196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	14	19	35836418	chr19:35836418	T	A	.	PASS	DP=14;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	36122319	36122319	G	T	intronic	RBM42	.	.	.	0.759889531	0.239708836	0.000401633	.	0.204	0.11141	-0.293801652	32.93819297	28.6708	0.91789	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	142	19	36122319	chr19:36122319	G	T	118	PASS	DP=142;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	36278877	36278877	G	A	exonic	ARHGAP33	.	nonsynonymous SNV	ARHGAP33:NM_001172630:exon21:c.G2918A:p.S973N,ARHGAP33:NM_052948:exon21:c.G2927A:p.S976N	0.21224841	0.787750958	6.32E-07	.	0.40232	0.13342	-1.456898556	3.862939372	201.41522	3.06572	0.179	0.564	T	0.0	0.026	B	0.002	0.063	B	0.518	0.118	N	1.000	0.588	D	0.805	0.203	L	3.11	0.122	T	-0.33	0.162	N	0.019	0.005	-0.985	0.339	T	0.017	0.069	T	0.010	0.254	T	-0.936	0.034	0.022	0.886	0.175	0.181	0.199	N	c	-0.995	-0.929	0.000	0.029	0.706	0.609	0	-1.75	0.076	-0.037	0.120	-0.375	0.066	0.000	0.063	0.902	0.382	5.235	0.147	.	.	.	0.5	.	70	19	36278877	chr19:36278877	G	A	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	36278929	36278929	C	T	exonic	ARHGAP33	.	synonymous SNV	ARHGAP33:NM_001172630:exon21:c.C2970T:p.A990A,ARHGAP33:NM_052948:exon21:c.C2979T:p.A993A	0.21224841	0.787750958	6.32E-07	.	0.40232	0.13342	-1.456898556	3.862939372	201.41522	3.06572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	19	36278929	chr19:36278929	C	T	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	36487002	36487002	G	T	UTR3	SDHAF1	NM_001042631:c.*478G>T	.	.	0.106593834	0.5920706	0.301335566	.	.	.	.	.	13.08923	0.47642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	108	19	36487002	chr19:36487002	G	T	133	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	36564438	36564438	-	C	intronic	WDR62	.	.	.	3.70E-13	0.994431562	0.005568438	.	0.44098	.	0.576763804	82.17740033	516.14972	4.64667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	202	19	36564438	chr19:36564438	G	GC	97	PASS	DP=202;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	36606592	36606592	C	G	intronic	TBCB	.	.	.	0.405521803	0.585756254	0.008721944	.	0.08922	0.10539	-0.383807564	27.41802312	11.3524	0.40856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	33	19	36606592	chr19:36606592	C	G	67	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	36821265	36821265	-	T	ncRNA_exonic	LINC00665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	1308	19	36821265	chr19:36821265	A	AT	95	PASS	DP=1308;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
19	37063218	37063218	-	A	intronic	ZNF529	.	.	.	0.001067137	0.827361965	0.171570898	.	0.14576	.	-0.26993514	34.59542345	37.91119	1.12549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	17	19	37063218	chr19:37063218	C	CA	52	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	37240210	37240210	G	C	exonic	ZNF850	.	nonsynonymous SNV	ZNF850:NM_001267779:exon4:c.C1636G:p.Q546E,ZNF850:NM_001193552:exon5:c.C1732G:p.Q578E	0.188901355	0.810621156	0.000477489	.	.	.	.	.	250.53864	3.41057	.	.	.	0.013	0.154	B	0.026	0.195	B	.	.	.	1	0.090	N	0.51	0.135	N	2.35	0.162	T	.	.	.	0.121	0.135	.	.	.	.	.	.	0.003	0.074	T	-2.385	0.004	0.001	0.425	0.031	0.000	0.001	N	n	-0.138	0.315	0.002	0.089	0.563	0.310	0	-2.22	0.065	-2.693	0.009	0.579	0.285	0.000	0.063	0.003	0.074	4.475	0.111	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	91	170	19	37240210	chr19:37240210	G	C	91	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	37966783	37966783	G	A	exonic	ZNF570	.	nonsynonymous SNV	ZNF570:NM_001321991:exon3:c.G34A:p.E12K,ZNF570:NM_144694:exon3:c.G34A:p.E12K,ZNF570:NM_001300993:exon4:c.G202A:p.E68K	0.001232864	0.958398443	0.040368693	.	0.21459	.	-0.093566408	46.7386176	63.63192	1.63442	0.172	0.226	T	0.435	0.339	B	0.078	0.271	B	.	.	.	1	0.810	D	2.125	0.592	M	5.59	0.009	T	-2.02	0.465	N	0.286	0.345	-0.588	0.653	T	0.003	0.011	T	0.059	0.678	D	2.370	0.346	18.62	0.994	0.614	0.687	0.336	D	c	-0.082	-0.027	0.001	0.082	0.615	0.372	0	3.01	0.337	0.869	0.275	-0.227	0.095	0.953	0.330	0.448	0.262	6.155	0.194	Krueppel-associated box	.	.	0.5	70	72	19	37966783	chr19:37966783	G	A	70	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	38164602	38164602	C	G	intronic	ZNF781	.	.	.	7.22E-06	0.160947174	0.839045605	.	0.19433	.	0.084621747	60.31493277	330.24448	3.86285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	15	19	38164602	chr19:38164602	C	G	52	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	38385614	38385616	GGA	-	exonic	WDR87	.	nonframeshift deletion	WDR87:NM_001291088:exon4:c.727_729del:p.S243del,WDR87:NM_031951:exon4:c.610_612del:p.S204del	.	.	.	.	0.06224	.	4.142836195	99.6933239	2359.54264	9.01627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	16	19	38385613	chr19:38385613	TGGA	T	53	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	38708053	38708053	C	A	intronic	DPF1	.	.	.	0.98898605	0.011013201	7.50E-07	.	0.28964	0.10376	-0.315847836	31.68789809	13.71775	0.49728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	121	19	38708053	chr19:38708053	C	A	67	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	38956803	38956803	G	A	exonic	RYR1	.	synonymous SNV	RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	280	19	38956803	chr19:38956803	G	A	88	PASS	DP=280;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	39019153	39019153	A	G	intronic	RYR1	.	.	.	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	40	19	39019153	chr19:39019153	A	G	77	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	39025341	39025341	T	G	intronic	RYR1	.	.	.	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	16	19	39025341	chr19:39025341	T	G	55	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	39025366	39025366	C	G	exonic	RYR1	.	nonsynonymous SNV	RYR1:NM_001042723:exon78:c.C11251G:p.Q3751E,RYR1:NM_000540:exon79:c.C11266G:p.Q3756E	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.629	N	0.999	0.218	N	-2.49	0.001	N	-1.58	0.820	D	2.36	0.003	N	0.016	0.003	-0.980	0.351	T	0.011	0.043	T	.	.	.	1.140	0.204	11.43	0.963	0.286	0.062	0.121	N	c	-0.821	-0.476	1.000	0.473	0.707	0.730	0	4.82	0.615	8.161	0.895	0.073	0.181	1.000	0.715	0.984	0.507	14.259	0.655	.	.	.	0.5	56	23	19	39025366	chr19:39025366	C	G	56	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	39034301	39034302	GT	-	splicing	RYR1	NM_000540:exon86:r.spl;NM_001042723:exon85:r.spl	.	.	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	16	19	39034300	chr19:39034300	GGT	G	60	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	39227901	39227901	G	C	exonic	CAPN12	.	synonymous SNV	CAPN12:NM_144691:exon10:c.C1257G:p.G419G	7.48E-20	0.000491944	0.999508056	.	0.38998	0.11824	-0.523584927	20.93654164	2537.68423	9.40302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	716	19	39227901	chr19:39227901	G	C	123	PASS	DP=716;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	39948920	39948920	C	A	intronic	SUPT5H	.	.	.	0.999999735	2.65E-07	4.16E-18	.	0.64202	0.11134	-1.42004951	4.104741684	80.77096	1.89887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	19	39948920	chr19:39948920	C	A	.	PASS	DP=87;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	39978801	39978801	C	G	exonic	TIMM50	.	nonsynonymous SNV	TIMM50:NM_001329559:exon8:c.C458G:p.P153R,TIMM50:NM_001001563:exon9:c.C1106G:p.P369R	0.442656937	0.557064432	0.000278631	.	0.15447	0.10784	-0.045835247	50.34206181	685.25632	5.2276	0.236	0.179	T	0.002	0.156	B	0.005	0.121	B	0.001	0.409	D	0.795	0.344	D	0.015	0.080	N	2.23	0.181	T	3.42	0.001	N	0.227	0.278	-1.018	0.242	T	0.024	0.101	T	0.005	0.137	T	2.418	0.352	18.94	0.225	0.009	0.912	0.527	D	c	-0.128	0.081	0.857	0.251	0.707	0.730	0	4.96	0.650	2.818	0.475	0.852	0.362	0.999	0.424	0.997	0.653	10.696	0.449	FCP1 homology domain|HAD-like domain	.	.	0.5	62	76	19	39978801	chr19:39978801	C	G	62	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	40322456	40322456	C	T	exonic	DYRK1B	.	nonsynonymous SNV	DYRK1B:NM_004714:exon2:c.G52A:p.E18K,DYRK1B:NM_006483:exon2:c.G52A:p.E18K,DYRK1B:NM_006484:exon2:c.G52A:p.E18K	0.915927122	0.084048961	2.39E-05	DISEASE: Abdominal obesity-metabolic syndrome 3 (AOMS3) [MIM:615812]: A form of abdominal obesity-metabolic syndrome, a disorder characterized by abdominal obesity, high triglycerides, low levels of high density lipoprotein cholesterol, high blood pressure, and elevated fasting glucose levels. AOMS3 is characterized by early-onset coronary artery disease, central obesity, hypertension, and diabetes. {ECO:0000269|PubMed:24827035}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65474	0.16753	-0.844966979	11.1759849	75.91525	1.8259	0.039	0.440	D	0.88	0.464	P	0.899	0.620	P	0.000	0.466	D	0.749	0.339	D	1.04	0.263	L	0.46	0.563	T	-0.93	0.253	N	0.674	0.684	-0.876	0.501	T	0.140	0.460	T	0.023	0.460	T	6.639	0.911	32	0.999	0.986	0.957	0.657	D	c	0.126	0.208	1.000	0.747	0.646	0.450	0	4.06	0.464	4.015	0.566	0.935	0.490	1.000	0.715	1.000	0.888	11.950	0.520	.	.	.	0.5	120	264	19	40322456	chr19:40322456	C	T	120	PASS	DP=264;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	40368733	40368733	G	C	exonic	FCGBP	.	synonymous SNV	FCGBP:NM_003890:exon28:c.C12615G:p.L4205L	.	.	.	.	0.54275	.	.	.	18359.5916	28.93384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	753	19	40368733	chr19:40368733	G	C	153	PASS	DP=753;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	40392585	40392585	T	G	exonic	FCGBP	.	nonsynonymous SNV	FCGBP:NM_003890:exon16:c.A7919C:p.E2640A	.	.	.	.	0.54275	.	.	.	18359.5916	28.93384	.	.	.	0.057	0.214	B	0.074	0.267	B	0.524	0.052	U	1	0.090	P	1.33	0.334	L	.	.	.	.	.	.	0.217	0.266	-0.964	0.383	T	0.038	0.164	T	.	.	.	-1.631	0.014	0.002	0.275	0.014	0.008	0.032	N	c	-1.238	-1.359	0.001	0.078	0.554	0.246	0	-1.62	0.079	0.274	0.183	1.058	0.762	0.001	0.137	0.001	0.043	7.861	0.285	von Willebrand factor, type D domain	.	.	0.5	60	47	19	40392585	chr19:40392585	T	G	60	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	40877780	40877780	G	T	exonic	PLD3	.	synonymous SNV	PLD3:NM_001031696:exon9:c.G879T:p.A293A,PLD3:NM_001291311:exon9:c.G879T:p.A293A,PLD3:NM_012268:exon9:c.G879T:p.A293A	0.015972164	0.97872065	0.005307186	DISEASE: Alzheimer disease 19 (AD19) [MIM:615711]: A late-onset form of Alzheimer disease, a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituent of these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide (s), derived proteolytically from the transmembrane precursor protein APP by sequential secretase processing. The cytotoxic C- terminal fragments (CTFs) and the caspase-cleaved products such as C31 derived from APP, are also implicated in neuronal death. {ECO:0000269|PubMed:24336208, ECO:0000269|PubMed:25832409, ECO:0000269|PubMed:25832410}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry. Disease association is, however, under debate. Some studies support PLD3 involvement in Alzheimer disease (PubMed:24336208, PubMed:25832410 and PubMed:25832409), while others do not (Ref.8, Ref.11 and Ref.12). {ECO:0000269|PubMed:24336208, ECO:0000269|PubMed:25832408, ECO:0000269|PubMed:25832409, ECO:0000269|PubMed:25832410, ECO:0000269|PubMed:25832411, ECO:0000269|PubMed:25832413}.; 	0.2945	0.12854	-0.512444034	21.55579146	50.17338	1.39128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	19	40877780	chr19:40877780	G	T	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	41074106	41074106	C	T	exonic	SPTBN4	.	nonsynonymous SNV	SPTBN4:NM_020971:exon31:c.C6874T:p.R2292W	.	.	.	.	0.16131	0.15197	-1.824619408	2.129039868	5101.64368	14.64602	0.0	0.912	D	0.997	0.764	D	0.551	0.575	P	0.000	0.473	U	0.965	0.385	D	0	0.065	N	-1.43	0.807	T	-1.74	0.412	N	0.457	0.509	-0.090	0.803	T	0.452	0.786	T	0.271	0.899	D	7.746	0.955	35	0.999	0.951	0.825	0.414	D	c	0.066	0.080	1.000	0.747	0.598	0.340	0	3.64	0.407	1.957	0.398	0.004	0.136	1.000	0.715	0.117	0.195	13.106	0.585	.	.	.	0.5	87	229	19	41074106	chr19:41074106	C	T	87	PASS	DP=229;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	41332171	41332171	C	T	intergenic	CYP2T1P;CYP2A6	dist=15166;dist=17272	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	136	19	41332171	chr19:41332171	C	T	98	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	41354661	41354661	T	C	exonic	CYP2A6	.	synonymous SNV	CYP2A6:NM_000762:exon3:c.A351G:p.V117V	2.18E-06	0.708893749	0.291104073	.	0.23228	0.52146	0.295774947	71.64425572	375.34434	4.08402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	274	19	41354661	chr19:41354661	T	C	146	PASS	DP=274;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	41415923	41415923	G	A	intergenic	CYP2G1P;CYP2B7P	dist=9510;dist=14247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	149	19	41415923	chr19:41415923	G	A	68	PASS	DP=149;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	41450754	41450755	TT	-	ncRNA_exonic	CYP2B7P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.88	22	19	41450753	chr19:41450753	CTT	C	12.88	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	41533087	41533087	T	C	intergenic	CYP2B6;CYP2A13	dist=8786;dist=61269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	367	19	41533087	chr19:41533087	T	C	128	PASS	DP=367;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	41759632	41759632	C	-	intronic	AXL	.	.	.	0.766301151	0.233698224	6.25E-07	DISEASE: Note=AXL and its ligand GAS6 are highly expressed in thyroid carcinoma tissues, and might thus be involved in thyroid tumorigenesis. Overexpression of AXL and its ligand was also detected in many other cancers such as myeloproliferative disorders, prostatic carcinoma cells, or breast cancer.; 	0.31627	0.23288	-0.949752638	9.32413305	128.32814	2.46902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	23	19	41759631	chr19:41759631	AC	A	95	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	42401291	42401291	C	A	intronic	ARHGEF1	.	.	.	0.909497464	0.090502526	9.81E-09	.	0.10869	0.1503	-1.837219906	2.070063694	124.73358	2.42844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	19	42401291	chr19:42401291	C	A	.	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	42595481	42595483	GGA	-	UTR3	POU2F2	NM_001247994:c.*276_*274delTCC;NM_002698:c.*223_*221delTCC;NM_001207025:c.*223_*221delTCC	.	.	0.97379428	0.026199392	6.33E-06	.	0.49246	0.27788	-0.538132194	20.26421326	113.2753	2.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	79	19	42595480	chr19:42595480	TGGA	T	57	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	42620946	42620946	C	-	intronic	POU2F2	.	.	.	0.97379428	0.026199392	6.33E-06	.	0.49246	0.27788	-0.538132194	20.26421326	113.2753	2.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	140	19	42620945	chr19:42620945	AC	A	56	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	43411230	43411230	C	G	exonic	PSG6	.	nonsynonymous SNV	PSG6:NM_001031850:exon5:c.G1084C:p.E362Q,PSG6:NM_002782:exon5:c.G1084C:p.E362Q	2.97E-09	0.16039048	0.839609517	.	0.26273	.	2.166192036	98.0301958	170.30147	2.8473	0.566	0.063	T	0.05	0.211	B	0.124	0.310	B	.	.	.	1	0.090	N	-1.23	0.008	N	2.73	0.119	T	0.02	0.073	N	0.157	0.188	-0.913	0.465	T	0.002	0.007	T	.	.	.	-1.458	0.018	0.003	0.091	0.001	0.000	0.001	N	c	-1.638	-1.675	0.000	0.029	0.487	0.133	0	0.383	0.154	0.193	0.168	-3.193	0.001	0.004	0.165	0.002	0.062	5.830	0.177	Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	95	88	19	43411230	chr19:43411230	C	G	95	PASS	DP=88;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	43586637	43586637	C	T	intronic	PSG2	.	.	.	6.19E-07	0.441195774	0.558803607	.	0.07772	.	1.401792296	94.75112055	126.24057	2.44595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	144	19	43586637	chr19:43586637	C	T	67	PASS	DP=144;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	43763019	43763019	T	C	exonic	PSG9	.	synonymous SNV	PSG9:NM_001301707:exon3:c.A699G:p.L233L,PSG9:NM_002784:exon4:c.A978G:p.L326L	2.75E-14	0.004925661	0.995074339	.	0.24972	.	1.607548084	95.91884879	1896.34765	8.00804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	10	19	43763019	chr19:43763019	T	C	55	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	43883057	43883057	C	T	intergenic	CD177;TEX101	dist=15733;dist=9706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	237	19	43883057	chr19:43883057	C	T	127	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	44098881	44098881	G	-	intronic	IRGQ	.	.	.	0.001197228	0.956861915	0.041940857	.	0.11132	0.10002	0.174625237	65.9648502	46.00143	1.30616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	202	505	19	44098880	chr19:44098880	AG	A	202	PASS	DP=505;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	44768383	44768383	A	G	intronic	ZNF233	.	.	.	3.27E-17	0.000346158	0.999653842	.	0.09894	.	0.97558591	90.37508846	4670.83871	13.76453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	157	19	44768383	chr19:44768383	A	G	45	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	45033485	45033485	A	G	exonic	CEACAM20	.	synonymous SNV	CEACAM20:NM_001102597:exon1:c.T48C:p.L16L,CEACAM20:NM_001102598:exon1:c.T48C:p.L16L,CEACAM20:NM_001102599:exon1:c.T48C:p.L16L,CEACAM20:NM_001102600:exon1:c.T48C:p.L16L	.	.	.	.	0.0885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	49	19	45033485	chr19:45033485	A	G	79	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	45262625	45262625	C	T	intronic	BCL3	.	.	.	0.862172685	0.137400478	0.000426837	DISEASE: Note=A chromosomal aberration involving BCL3 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(14;19)(q32;q13.1) with immunoglobulin gene regions. {ECO:0000269|PubMed:2180580, ECO:0000269|PubMed:7896265}.; 	0.52579	0.28802	.	.	48.07549	1.34896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	101	19	45262625	chr19:45262625	C	T	58	PASS	DP=101;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	45263023	45263023	C	T	UTR3	BCL3	NM_005178:c.*151C>T	.	.	0.862172685	0.137400478	0.000426837	DISEASE: Note=A chromosomal aberration involving BCL3 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(14;19)(q32;q13.1) with immunoglobulin gene regions. {ECO:0000269|PubMed:2180580, ECO:0000269|PubMed:7896265}.; 	0.52579	0.28802	.	.	48.07549	1.34896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	19	45263023	chr19:45263023	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	45317499	45317499	G	-	exonic	BCAM	.	frameshift deletion	BCAM:NM_001013257:exon7:c.875delG:p.D294Tfs*20,BCAM:NM_005581:exon7:c.875delG:p.D294Tfs*19	0.036851184	0.962838134	0.000310682	.	0.1514	0.15985	1.252926935	93.48313281	349.93518	3.9651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	127	19	45317498	chr19:45317498	CG	C	70	PASS	DP=127;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	46025606	46025606	C	T	exonic	VASP	.	nonsynonymous SNV	VASP:NM_003370:exon6:c.C487T:p.P163S	0.583670616	0.415875146	0.000454238	.	0.493	0.35835	-0.137658575	43.57159707	79.23731	1.88068	0.058	0.377	T	0.018	0.165	B	0.016	0.166	B	0.006	0.327	N	0.953	0.264	N	2.895	0.841	M	-0.7	0.728	T	-2.46	0.537	N	0.18	0.219	-0.928	0.444	T	0.225	0.590	T	0.043	0.608	D	2.278	0.335	18.02	0.947	0.248	0.218	0.213	N	c	-0.551	-0.502	1.000	0.416	0.707	0.730	0	0.954	0.186	0.530	0.226	0.930	0.439	0.018	0.193	0.998	0.697	8.921	0.346	.	.	.	0.5	58	68	19	46025606	chr19:46025606	C	T	58	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	46029812	46029812	A	-	UTR3	VASP	NM_003370:c.*377delA	.	.	0.583670616	0.415875146	0.000454238	.	0.493	0.35835	-0.137658575	43.57159707	79.23731	1.88068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	25	19	46029811	chr19:46029811	GA	G	42	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	46124695	46124695	G	-	intronic	EML2	.	.	.	7.58E-10	0.671944659	0.32805534	.	0.17207	0.11401	0.224175308	68.48903043	3227.53207	10.82078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	476	19	46124694	chr19:46124694	CG	C	84	PASS	DP=476;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	46299138	46299138	-	CTCCTCGCCCTCCTCCTC	exonic	RSPH6A	.	nonframeshift insertion	RSPH6A:NM_030785:exon6:c.2142_2143insGAGGAGGAGGGCGAGGAG:p.E714_T715insEEEGEE	2.55E-08	0.471013996	0.528985978	.	0.0719	.	-1.056370776	7.578438311	752.26224	5.4399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	82	19	46299138	chr19:46299138	T	TCTCCTCGCCCTCCTCCTC	117	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	46299147	46299149	CCT	-	exonic	RSPH6A	.	nonframeshift deletion	RSPH6A:NM_030785:exon6:c.2132_2134del:p.E711del	2.55E-08	0.471013996	0.528985978	.	0.0719	.	-1.056370776	7.578438311	752.26224	5.4399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	26	19	46299146	chr19:46299146	CCCT	C	58	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	47342645	47342645	G	A	intronic	AP2S1	.	.	.	0.919495985	0.079989124	0.000514891	DISEASE: Hypocalciuric hypercalcemia, familial 3 (HHC3) [MIM:600740]: A form of hypocalciuric hypercalcemia, a disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. It is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone level. Hypermagnesemia is typically present. Affected individuals are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults. {ECO:0000269|PubMed:23222959, ECO:0000269|PubMed:24081735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21863	0.16306	0.013025609	54.62962963	1.16568	0.03254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	19	47342645	chr19:47342645	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	47575634	47575634	G	C	exonic	ZC3H4	.	nonsynonymous SNV	ZC3H4:NM_015168:exon12:c.C1777G:p.Q593E	0.999999772	2.28E-07	1.41E-17	.	0.40007	.	-1.320975027	4.777070064	637.42325	5.07993	0.018	0.506	D	0.824	0.439	P	0.35	0.410	B	0.229	0.160	U	1.000	0.548	D	1.11	0.288	L	2.22	0.182	T	-0.55	0.168	N	0.346	0.407	-1.110	0.031	T	0.044	0.190	T	0.013	0.325	T	2.615	0.375	20.3	0.988	0.462	0.946	0.616	D	c	0.310	0.370	1.000	0.747	0.713	0.817	0	4.98	0.655	5.545	0.667	0.864	0.376	1.000	0.715	0.724	0.315	17.023	0.863	.	.	.	0.5	75	107	19	47575634	chr19:47575634	G	C	75	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	47603195	47603195	G	A	intronic	ZC3H4	.	.	.	0.999999772	2.28E-07	1.41E-17	.	0.40007	.	-1.320975027	4.777070064	637.42325	5.07993	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	19	47603195	chr19:47603195	G	A	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	48197673	48197673	T	C	exonic	BICRA	.	nonsynonymous SNV	BICRA:NM_015711:exon8:c.T2585C:p.L862P	.	.	.	.	.	.	.	.	.	.	0.003	0.682	D	0.032	0.189	B	0.015	0.162	B	.	.	.	1.000	0.090	N	1.59	0.404	L	1.33	0.350	T	-1.34	0.334	N	0.383	0.443	-1.042	0.166	T	0.054	0.230	T	0.362	0.926	D	0.673	0.158	8.649	0.817	0.133	0.002	0.014	N	c	-0.756	-0.748	0.047	0.147	0.646	0.450	0	1.48	0.218	0.936	0.283	0.835	0.340	0.001	0.137	0.055	0.167	5.257	0.148	.	.	.	0.5	69	130	19	48197673	chr19:48197673	T	C	69	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	48197686	48197686	C	T	exonic	BICRA	.	synonymous SNV	BICRA:NM_015711:exon8:c.C2598T:p.S866S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	19	48197686	chr19:48197686	C	T	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	48229340	48229340	G	A	exonic	EHD2	.	stopgain	EHD2:NM_014601:exon4:c.G774A:p.W258X	0.531641412	0.464989568	0.00336902	.	0.14909	0.13604	-1.041578376	7.773059684	254.81204	3.43303	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.895	0.979	38	0.997	0.796	0.974	0.741	D	c	0.831	0.661	1.0	0.983	0.672	0.522	0	3.66	0.409	9.801	0.982	0.939	0.529	1.000	0.715	0.985	0.512	13.284	0.595	Dynamin-type guanine nucleotide-binding (G) domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	128	406	19	48229340	chr19:48229340	G	A	128	PASS	DP=406;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	48306724	48306724	G	T	intronic	TPRX1	.	.	.	0.000613268	0.485833234	0.513553498	.	0.23746	.	-0.115612493	45.12856806	2120.83171	8.47905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	252	19	48306724	chr19:48306724	G	T	80	PASS	DP=252;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	48607900	48607900	C	A	exonic	PLA2G4C	.	stopgain	PLA2G4C:NM_001159322:exon4:c.G232T:p.E78X,PLA2G4C:NM_001159323:exon4:c.G202T:p.E68X,PLA2G4C:NM_003706:exon4:c.G202T:p.E68X	4.42E-08	0.946243911	0.053756045	.	0.06112	0.06901	2.447407799	98.56687898	2845.06491	10.08702	.	.	.	.	.	.	.	.	.	0.459	0.124	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6.566	0.903	31	0.993	0.566	0.005	0.025	N	c	-0.068	-0.446	0.001	0.079	0.707	0.730	0	-1.58	0.080	-0.567	0.060	0.679	0.295	0.000	0.063	0.981	0.494	5.502	0.160	Acyl transferase/acyl hydrolase/lysophospholipase|Lysophospholipase, catalytic domain	.	.	0.5	.	15	19	48607900	chr19:48607900	C	A	.	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	49184178	49184178	C	G	ncRNA_exonic	SEC1P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	32	19	49184178	chr19:49184178	C	G	50	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	49384368	49384368	A	T	exonic	TULP2	.	nonsynonymous SNV	TULP2:NM_003323:exon13:c.T1463A:p.L488H	1.83E-07	0.963783935	0.036215882	.	0.07447	.	1.646168225	96.17834395	1047.80804	6.21357	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	0.995	0.425	D	3.565	0.936	H	-2.83	0.913	D	-5.41	0.902	D	0.807	0.806	0.964	0.966	D	0.875	0.959	D	0.142	0.825	D	5.621	0.765	26.6	0.979	0.363	0.955	0.648	D	c	0.767	0.629	1.000	0.747	0.615	0.372	0	4.67	0.579	8.984	0.930	1.113	0.880	1.000	0.715	0.924	0.398	12.382	0.545	Tubby C-terminal-like domain|Tubby, C-terminal	.	.	0.5	.	63	19	49384368	chr19:49384368	A	T	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	49468728	49468728	A	T	UTR5	FTL	NM_000146:c.-37A>T	.	.	0.000458653	0.427809813	0.571731534	DISEASE: Hereditary hyperferritinemia-cataract syndrome (HHCS) [MIM:600886]: An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. {ECO:0000269|PubMed:19176363}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild non-progressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels. {ECO:0000269|PubMed:16116125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: L-ferritin deficiency (LFTD) [MIM:615604]: A condition characterized by low levels of ferritin in serum and tissues in the absence of other hematological symptoms. Seizures and mild neuropsychologic impairment may manifest in individuals with complete ferritin deficiency. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08288	0.64843	-0.163345027	41.24793583	10.88019	0.39394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	178	481	19	49468728	chr19:49468728	A	T	178	PASS	DP=481;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	49507487	49507487	A	T	UTR5	RUVBL2	NM_001321190:c.-26A>T	.	.	0.99911008	0.000889912	7.96E-09	.	0.60957	0.54626	-1.023168368	7.944090587	19.53697	0.67025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	19	49507487	chr19:49507487	A	T	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	49558211	49558211	T	G	exonic	CGB7	.	nonsynonymous SNV	CGB7:NM_033142:exon2:c.A70C:p.M24L	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	0.731	0.038	T	.	.	.	.	.	.	0.985	0.079	N	1	0.090	N	.	.	.	1.18	0.377	T	-0.25	0.110	N	0.162	0.195	-1.021	0.234	T	0.000	0.000	T	.	.	.	-1.685	0.013	0.002	0.447	0.034	0.000	0.003	N	c	-0.919	-1.061	0.226	0.184	0.677	0.550	0	0.946	0.186	2.839	0.477	-0.104	0.116	0.727	0.287	0.001	0.043	5.899	0.181	.	ENSG00000196337.6|ENSG00000196337.6|ENSG00000196337.6|ENSG00000196337.6|ENSG00000104827.12|ENSG00000189052.6|ENSG00000196337.6|ENSG00000189052.6|ENSG00000213030.4|ENSG00000189052.6|ENSG00000196337.6|ENSG00000213030.4|ENSG00000196337.6	Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Pancreas|Prostate|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis	0.5	141	367	19	49558211	chr19:49558211	T	G	141	PASS	DP=367;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	49606750	49606750	C	-	intronic	SNRNP70	.	.	.	0.993095086	0.006904675	2.39E-07	.	0.54826	0.24974	.	.	34.51837	1.05414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	996	19	49606749	chr19:49606749	TC	T	129	PASS	DP=996;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
19	49863041	49863041	C	G	intronic	TEAD2	.	.	.	0.002047317	0.993646682	0.004306002	.	0.60613	0.38068	0.020302773	55.60863411	147.32359	2.64505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	13	19	49863041	chr19:49863041	C	G	42	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	49865065	49865065	-	G	intronic	TEAD2	.	.	.	0.002047317	0.993646682	0.004306002	.	0.60613	0.38068	0.020302773	55.60863411	147.32359	2.64505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	94	19	49865065	chr19:49865065	A	AG	55	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	49897776	49897776	G	C	exonic	CCDC155	.	synonymous SNV	CCDC155:NM_144688:exon3:c.G87C:p.P29P	7.22E-07	0.896888585	0.103110692	.	.	0.07875	-0.176292081	40.56381222	104.6039	2.21065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	19	49897776	chr19:49897776	G	C	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	49978960	49978962	CTG	-	exonic	FLT3LG	.	nonframeshift deletion	FLT3LG:NM_001204503:exon2:c.46_48del:p.L20del,FLT3LG:NM_001204502:exon3:c.46_48del:p.L20del,FLT3LG:NM_001459:exon3:c.46_48del:p.L20del	0.950828698	0.049022409	0.000148893	.	0.24328	0.14299	-0.560178693	19.30879925	10.2966	0.3755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	94	19	49978959	chr19:49978959	CCTG	C	61	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	49982166	49982166	C	-	exonic	FLT3LG	.	frameshift deletion	FLT3LG:NM_001204503:exon5:c.343delC:p.S118Afs*23,FLT3LG:NM_001204502:exon6:c.343delC:p.S118Afs*23,FLT3LG:NM_001278637:exon6:c.97delC:p.S36Afs*23,FLT3LG:NM_001278638:exon6:c.97delC:p.S36Afs*23,FLT3LG:NM_001459:exon6:c.343delC:p.S118Afs*23	0.950828698	0.049022409	0.000148893	.	0.24328	0.14299	-0.560178693	19.30879925	10.2966	0.3755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	738	19	49982165	chr19:49982165	GC	G	86	PASS	DP=738;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
19	50155916	50155918	CCT	-	exonic	SCAF1	.	nonframeshift deletion	SCAF1:NM_021228:exon7:c.2270_2272del:p.S763del	0.998787539	0.001212458	3.42E-09	.	0.19731	0.14899	.	.	621.53803	5.02803	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	61	19	50155915	chr19:50155915	GCCT	G	55	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	50358233	50358233	C	G	exonic	PTOV1	.	nonsynonymous SNV	PTOV1:NM_001305105:exon5:c.C457G:p.L153V,PTOV1:NM_001305108:exon5:c.C361G:p.L121V,PTOV1:NM_017432:exon5:c.C457G:p.L153V	0.358456527	0.641012483	0.00053099	.	0.3692	0.11188	-0.821100135	11.88369899	836.58972	5.66639	0.006	0.614	D	0.976	0.585	D	0.851	0.659	P	0.143	0.182	N	0.998	0.445	D	1.935	0.520	L	-1.37	0.802	T	-1.01	0.266	N	0.622	0.674	-0.586	0.654	T	0.283	0.655	T	0.168	0.847	D	5.326	0.721	25.8	0.974	0.334	0.589	0.305	D	c	0.123	0.072	0.996	0.341	0.672	0.522	0	2.39	0.284	2.550	0.452	0.932	0.445	0.982	0.353	0.667	0.302	10.451	0.435	Mediator complex, subunit Med25, PTOV activation and synapsin 2	.	.	0.5	67	235	19	50358233	chr19:50358233	C	G	67	PASS	DP=235;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	50364584	50364584	G	A	exonic	PNKP	.	nonsynonymous SNV	PNKP:NM_007254:exon17:c.C1487T:p.S496F	2.88E-07	0.750458365	0.249541347	DISEASE: Microcephaly, seizures, and developmental delay (MCSZ) [MIM:613402]: A disease characterized by infantile-onset seizures, microcephaly, severe intellectual disability and delayed motor milestones with absent speech or only achieving a few words. Most patients also have behavioral problems with hyperactivity. Microcephaly is progressive and without neuronal migration or structural abnormalities, consistent with primary microcephaly. {ECO:0000269|PubMed:20118933}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ataxia-oculomotor apraxia 4 (AOA4) [MIM:616267]: An autosomal recessive disease characterized by cerebellar ataxia, oculomotor apraxia, areflexia and peripheral neuropathy. {ECO:0000269|PubMed:25728773}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3405	0.1816	-0.529034136	20.85987261	306.43839	3.7256	0.02	0.496	D	0.04	0.227	B	0.04	0.342	B	0.360	0.137	U	0.987	0.245	N	2.275	0.649	M	0.97	0.425	T	-3.59	0.692	D	0.266	0.323	-0.998	0.306	T	0.061	0.255	T	0.039	0.589	D	2.956	0.416	22.1	0.988	0.467	0.441	0.270	N	c	-0.737	-0.691	1.000	0.747	0.742	0.980	0	2.46	0.289	2.298	0.430	-0.363	0.068	0.267	0.248	0.005	0.090	5.644	0.167	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	123	272	19	50364584	chr19:50364584	G	A	123	PASS	DP=272;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	50462298	50462298	G	C	exonic	SIGLEC11	.	nonsynonymous SNV	SIGLEC11:NM_001135163:exon6:c.C1094G:p.A365G,SIGLEC11:NM_052884:exon6:c.C1094G:p.A365G	2.64E-08	0.478412852	0.521587121	.	0.07542	0.08273	0.846940207	88.47605567	1686.30736	7.57044	0.194	0.208	T	0.166	0.269	B	0.169	0.336	B	0.818	0.092	N	1	0.090	P	-0.13	0.045	N	0.54	0.549	T	-1.88	0.439	N	0.052	0.068	-0.957	0.398	T	0.000	0.000	T	.	.	.	0.740	0.165	9.088	0.912	0.199	0.001	0.008	N	c	-0.723	-0.853	0.000	0.052	0.554	0.283	0	-1.51	0.082	-0.502	0.064	-0.143	0.109	0.000	0.063	0.051	0.165	2.921	0.054	Immunoglobulin-like domain	ENSG00000161640.11|ENSG00000161640.11|ENSG00000161640.11|ENSG00000161640.11|ENSG00000105053.6|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11	Breast_Mammary_Tissue|Colon_Transverse|Lung|Nerve_Tibial|Testis|Testis|Testis|Whole_Blood	0.5	83	104	19	50462298	chr19:50462298	G	C	83	PASS	DP=104;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	50463670	50463670	T	G	exonic	SIGLEC11	.	nonsynonymous SNV	SIGLEC11:NM_001135163:exon3:c.A469C:p.K157Q,SIGLEC11:NM_052884:exon3:c.A469C:p.K157Q	2.64E-08	0.478412852	0.521587121	.	0.07542	0.08273	0.846940207	88.47605567	1686.30736	7.57044	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.069	0.216	N	1	0.090	P	-3.23	0.000	N	4.04	0.032	T	2.48	0.002	N	0.021	0.005	-0.964	0.385	T	0.000	0.000	T	.	.	.	-1.721	0.012	0.002	0.118	0.002	0.000	0.002	N	c	-1.667	-1.590	0.001	0.075	0.487	0.133	0	-0.577	0.111	-0.136	0.103	-0.590	0.045	0.000	0.063	0.001	0.043	1.928	0.031	Immunoglobulin-like domain|Immunoglobulin-like fold	ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161643.8|ENSG00000105053.6|ENSG00000105053.6|ENSG00000221125.1|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11	Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adrenal_Gland|Artery_Aorta|Artery_Tibial|Breast_Mammary_Tissue|Colon_Transverse|Esophagus_Mucosa|Lung|Lung|Skin_Sun_Exposed_Lower_leg|Spleen|Testis|Testis|Testis|Testis|Thyroid|Thyroid|Whole_Blood	0.5	181	494	19	50463670	chr19:50463670	T	G	181	PASS	DP=494;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	50764701	50764701	T	-	intronic	MYH14	.	.	.	0.999847921	0.000152079	6.12E-17	DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:15015131, ECO:0000269|PubMed:16222661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]: A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22477	0.14506	-2.236665977	1.309271054	1826.33006	7.88079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	205	19	50764700	chr19:50764700	CT	C	78	PASS	DP=205;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	50764716	50764716	C	T	intronic	MYH14	.	.	.	0.999847921	0.000152079	6.12E-17	DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:15015131, ECO:0000269|PubMed:16222661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]: A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22477	0.14506	-2.236665977	1.309271054	1826.33006	7.88079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	19	50764716	chr19:50764716	C	T	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	50795557	50795557	C	A	exonic	MYH14	.	nonsynonymous SNV	MYH14:NM_024729:exon35:c.C5044A:p.R1682S,MYH14:NM_001077186:exon36:c.C5068A:p.R1690S,MYH14:NM_001145809:exon37:c.C5167A:p.R1723S	0.999847921	0.000152079	6.12E-17	DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:15015131, ECO:0000269|PubMed:16222661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]: A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22477	0.14506	-2.236665977	1.309271054	1826.33006	7.88079	0.003	0.682	D	0.988	0.637	D	0.804	0.633	P	.	.	.	0.892	0.278	N	2.475	0.721	M	-1.29	0.795	T	-5.25	0.840	D	0.631	0.670	-0.173	0.784	T	0.598	0.857	D	0.336	0.919	D	6.375	0.880	29.5	0.997	0.801	0.924	0.554	D	c	0.191	0.047	0.762	0.235	0.742	0.980	0	2.93	0.329	4.460	0.596	0.798	0.323	1.000	0.715	0.036	0.153	11.278	0.482	Myosin tail	.	.	0.5	130	170	19	50795557	chr19:50795557	C	A	130	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	50912139	50912139	G	A	exonic	POLD1	.	nonsynonymous SNV	POLD1:NM_001308632:exon14:c.G1951A:p.G651R,POLD1:NM_001256849:exon15:c.G1873A:p.G625R,POLD1:NM_002691:exon15:c.G1873A:p.G625R	0.001807011	0.998149838	4.32E-05	DISEASE: Colorectal cancer 10 (CRCS10) [MIM:612591]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:23263490, ECO:0000269|PubMed:24501277}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL) [MIM:615381]: An autosomal dominant systemic disorder characterized by prominent loss of subcutaneous fat, metabolic abnormalities including insulin resistance and diabetes mellitus, sclerodermatous skin, and a facial appearance characterized by mandibular hypoplasia. Sensorineural deafness occurs late in the first or second decades of life. {ECO:0000269|PubMed:23770608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96379	0.4561	-0.828637633	11.54163718	551.71434	4.7781	0.226	0.185	T	0.177	0.273	B	0.052	0.241	B	0.016	0.281	N	1.000	0.548	D	2.18	0.615	M	2.36	0.161	T	-2.45	0.535	N	0.663	0.674	-1.111	0.030	T	0.047	0.200	T	0.023	0.464	T	4.438	0.594	24.2	0.898	0.185	0.940	0.596	D	c	-0.075	0.005	0.923	0.267	0.707	0.730	0	4.69	0.584	5.751	0.681	1.048	0.713	1.000	0.715	0.011	0.114	16.771	0.853	DNA-directed DNA polymerase, family B, multifunctional domain	.	.	0.5	84	51	19	50912139	chr19:50912139	G	A	84	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	50978722	50978722	G	T	exonic	FAM71E1	.	synonymous SNV	FAM71E1:NM_001308429:exon3:c.C399A:p.L133L	0.006132393	0.737056923	0.256810684	.	0.18198	.	0.194852702	67.03231894	119.58351	2.38015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	19	50978722	chr19:50978722	G	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	51128360	51128360	A	G	intronic	SYT3	.	.	.	0.225605579	0.772766785	0.001627636	.	0.20106	0.09277	-1.243653018	5.372729417	44.09263	1.26585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	19	51128360	chr19:51128360	A	G	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	51274851	51274851	A	C	exonic	GPR32	.	nonsynonymous SNV	GPR32:NM_001506:exon1:c.A994C:p.T332P	7.91E-05	0.315038766	0.68488214	.	0.0893	.	0.108486928	61.90728946	99.68741	2.16289	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.72	0.003	N	1.24	0.367	T	3.88	0.001	N	0.074	0.064	-0.995	0.312	T	0.030	0.131	T	.	.	.	-1.311	0.022	0.004	0.827	0.139	0.001	0.005	N	c	-1.513	-1.493	0.002	0.089	0.497	0.185	0	-0.781	0.104	0.074	0.144	-0.869	0.028	0.000	0.063	0.757	0.323	3.651	0.077	.	.	.	0.5	102	251	19	51274851	chr19:51274851	A	C	102	PASS	DP=251;AN=4	GT	./.	0/1	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	51567777	51567777	C	G	intronic	KLK13	.	.	.	0.755462838	0.242478739	0.002058424	.	0.04775	0.09971	-0.159704656	41.90846898	120.56718	2.39208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	139	19	51567777	chr19:51567777	C	G	67	PASS	DP=139;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	51567793	51567793	G	A	intronic	KLK13	.	.	.	0.755462838	0.242478739	0.002058424	.	0.04775	0.09971	-0.159704656	41.90846898	120.56718	2.39208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	19	51567793	chr19:51567793	G	A	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	51919120	51919120	A	G	UTR5	LOC100129083	NM_001256795:c.-159A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	234	19	51919120	chr19:51919120	A	G	145	PASS	DP=234;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	52380575	52380575	T	C	exonic	ZNF577	.	synonymous SNV	ZNF577:NM_001135590:exon6:c.A243G:p.P81P,ZNF577:NM_032679:exon6:c.A243G:p.P81P	0.012941322	0.953743723	0.033314955	.	0.10716	.	1.489991751	95.35857514	3127.20421	10.63952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	19	52380575	chr19:52380575	T	C	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	52472295	52472295	A	G	exonic	ZNF350	.	synonymous SNV	ZNF350:NM_021632:exon3:c.T105C:p.D35D	0.000264162	0.930339407	0.069396431	.	0.21884	0.16743	0.843299698	88.37579618	1379.50737	6.95828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	191	19	52472295	chr19:52472295	A	G	91	PASS	DP=191;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	52716628	52716628	A	G	intronic	PPP2R1A	.	.	.	0.719603753	0.280370202	2.60E-05	DISEASE: Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:25533962, ECO:0000269|PubMed:26168268}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6443	0.28104	-0.183570861	39.95046001	14.15057	0.51225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	19	52716628	chr19:52716628	A	G	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	52716637	52716637	G	-	intronic	PPP2R1A	.	.	.	0.719603753	0.280370202	2.60E-05	DISEASE: Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:25533962, ECO:0000269|PubMed:26168268}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6443	0.28104	-0.183570861	39.95046001	14.15057	0.51225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	106	19	52716636	chr19:52716636	TG	T	62	PASS	DP=106;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	52825329	52825329	C	T	exonic	ZNF480	.	stopgain	ZNF480:NM_001297624:exon4:c.C697T:p.R233X,ZNF480:NM_001297625:exon4:c.C595T:p.R199X,ZNF480:NM_144684:exon5:c.C826T:p.R276X	2.36E-07	0.709297411	0.290702353	.	0.16427	.	-0.710864321	14.5730125	759.20608	5.46015	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.770	0.640	24.7	0.794	0.123	0.001	0.004	N	c	-0.931	-1.423	0.987	0.312	0.563	0.310	0	-4.51	0.032	-5.225	0.002	-1.307	0.013	0.000	0.063	0.000	0.016	2.255	0.038	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	51	50	19	52825329	chr19:52825329	C	T	51	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	53014793	53014793	G	T	exonic	ZNF578	.	nonsynonymous SNV	ZNF578:NM_001099694:exon6:c.G1159T:p.V387L	8.81E-14	0.002639121	0.997360879	.	.	.	1.047190339	91.34229771	336.42783	3.89648	.	.	.	0.002	0.090	B	0.001	0.040	B	.	.	.	1	0.090	N	0.01	0.080	N	2.49	0.145	T	.	.	.	0.078	0.097	-1.016	0.249	T	0.036	0.157	T	0.001	0.004	T	-0.021	0.092	2.389	0.760	0.109	0.014	0.047	N	c	-1.326	-1.434	0.000	0.029	0.487	0.133	0	-2.57	0.059	-3.182	0.006	-2.389	0.003	0.000	0.063	0.000	0.016	3.497	0.072	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	148	237	19	53014793	chr19:53014793	G	T	148	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	53209576	53209576	T	C	exonic	ZNF611	.	synonymous SNV	ZNF611:NM_001161500:exon5:c.A732G:p.S244S,ZNF611:NM_001161501:exon5:c.A525G:p.S175S,ZNF611:NM_001161499:exon6:c.A732G:p.S244S,ZNF611:NM_030972:exon7:c.A732G:p.S244S	1.16E-17	0.000188316	0.999811684	.	0.14705	.	0.806491657	87.72705827	2377.17021	9.04647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	19	53209576	chr19:53209576	T	C	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	53393473	53393473	C	G	intronic	ZNF320	.	.	.	0.018449658	0.961147618	0.020402724	.	0.12591	0.09845	-0.291981272	33.20358575	51.19238	1.41059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	95	19	53393473	chr19:53393473	C	G	75	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	53418644	53418644	-	GG	intronic	ZNF888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	52	19	53418644	chr19:53418644	A	AGG	108	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	53643736	53643736	C	G	exonic	ZNF347	.	nonsynonymous SNV	ZNF347:NM_001172674:exon5:c.G2348C:p.R783T,ZNF347:NM_001172675:exon5:c.G2348C:p.R783T,ZNF347:NM_032584:exon5:c.G2345C:p.R782T	1.26E-17	0.000733205	0.999266795	.	0.06109	.	-0.551080959	19.93394669	53.4466	1.45289	0.766	0.035	T	0.0	0.026	B	0.001	0.040	B	.	.	.	1	0.090	N	1.25	0.319	L	1.75	0.262	T	-0.46	0.150	N	0.161	0.193	-0.975	0.362	T	0.025	0.109	T	0.001	0.013	T	-1.541	0.016	0.002	0.101	0.001	0.003	0.017	N	c	-2.158	-2.276	0.067	0.154	0.635	0.413	0	-4.58	0.032	-5.699	0.001	-1.831	0.006	0.000	0.063	0.000	0.016	0.457	0.005	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	105	188	19	53643736	chr19:53643736	C	G	105	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	53644952	53644952	C	G	exonic	ZNF347	.	nonsynonymous SNV	ZNF347:NM_001172674:exon5:c.G1132C:p.E378Q,ZNF347:NM_001172675:exon5:c.G1132C:p.E378Q,ZNF347:NM_032584:exon5:c.G1129C:p.E377Q	1.26E-17	0.000733205	0.999266795	.	0.06109	.	-0.551080959	19.93394669	53.4466	1.45289	0.087	0.324	T	0.843	0.446	P	0.397	0.426	B	.	.	.	1	0.090	N	0.585	0.154	N	3.19	0.074	T	-2.38	0.524	N	0.101	0.104	-0.963	0.386	T	0.012	0.048	T	0.002	0.039	T	0.270	0.120	5.403	0.989	0.478	0.044	0.099	N	c	-0.870	-0.970	0.000	0.038	0.563	0.310	0	0.361	0.153	-0.603	0.057	0.552	0.283	0.000	0.063	0.128	0.199	5.721	0.171	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	136	167	19	53644952	chr19:53644952	C	G	136	PASS	DP=167;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	53805222	53805222	T	G	intergenic	BIRC8;ZNF845	dist=10347;dist=31750	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	117	19	53805222	chr19:53805222	T	G	146	PASS	DP=117;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	53875494	53875494	A	T	UTR5	ZNF525	NM_001348156:c.-41A>T	.	.	0.001291108	0.856656613	0.142052279	.	.	.	.	.	19.03117	0.65731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	69	19	53875494	chr19:53875494	A	T	69	PASS	DP=69;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	53875523	53875523	G	A	UTR5	ZNF525	NM_001348156:c.-12G>A	.	.	0.001291108	0.856656613	0.142052279	.	.	.	.	.	19.03117	0.65731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	85	19	53875523	chr19:53875523	G	A	72	PASS	DP=85;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	53875569	53875569	G	A	intronic	ZNF525	.	.	.	0.001291108	0.856656613	0.142052279	.	.	.	.	.	19.03117	0.65731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	105	19	53875569	chr19:53875569	G	A	88	PASS	DP=105;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	53905388	53905388	A	T	exonic	ZNF765	.	nonsynonymous SNV	ZNF765:NM_001040185:exon3:c.A86T:p.Q29L	9.05E-10	0.043562588	0.956437411	.	0.09639	.	0.733063566	86.27034678	339.26241	3.9063	0.001	0.784	D	0.992	0.629	D	0.932	0.650	D	.	.	.	1	0.090	N	4.51	0.990	H	2.98	0.094	T	-5.24	0.839	D	0.662	0.674	-0.922	0.454	T	0.152	0.482	T	0.002	0.030	T	3.246	0.449	22.8	0.982	0.388	0.643	0.321	D	c	0.301	-0.045	0.001	0.082	0.672	0.522	0	1.63	0.228	2.134	0.415	0.585	0.286	0.882	0.308	0.007	0.100	6.588	0.217	Krueppel-associated box	.	.	0.5	.	60	19	53905388	chr19:53905388	A	T	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	53990021	53990021	A	G	intronic	ZNF813	.	.	.	8.50E-10	0.079646859	0.92035314	.	0.08121	.	1.35769336	94.43854683	2208.34827	8.65139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	176	208	19	53990021	chr19:53990021	A	G	176	PASS	DP=208;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	54721260	54721260	G	A	exonic	LILRB3	.	synonymous SNV	LILRB3:NM_001081450:exon12:c.C1680T:p.P560P,LILRB3:NM_006864:exon12:c.C1677T:p.P559P,LILRB3:NM_001320960:exon13:c.C1728T:p.P576P	0.027760685	0.969891931	0.002347384	.	0.07088	.	1.756425229	96.70912951	1162.94093	6.49058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	190	19	54721260	chr19:54721260	G	A	86	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	54745682	54745682	C	T	exonic	LILRA6;LILRB3	.	nonsynonymous SNV	LILRB3:NM_001081450:exon4:c.G428A:p.R143Q,LILRB3:NM_001320960:exon4:c.G428A:p.R143Q,LILRB3:NM_006864:exon4:c.G428A:p.R143Q,LILRA6:NM_024318:exon4:c.G419A:p.R140Q	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	19	54745682	chr19:54745682	C	T	.	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	54778505	54778505	C	G	UTR3	LILRB2	NM_001278403:c.*32G>C;NM_001278404:c.*32G>C;NM_005874:c.*32G>C;NM_001080978:c.*32G>C;NM_001278405:c.*220G>C	.	.	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	108	19	54778505	chr19:54778505	C	G	140	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	54782405	54782405	C	G	exonic	LILRB2	.	nonsynonymous SNV	LILRB2:NM_001278404:exon6:c.G619C:p.G207R,LILRB2:NM_001278405:exon6:c.G967C:p.G323R,LILRB2:NM_001278406:exon6:c.G967C:p.G323R,LILRB2:NM_001080978:exon7:c.G967C:p.G323R,LILRB2:NM_001278403:exon7:c.G967C:p.G323R,LILRB2:NM_005874:exon7:c.G967C:p.G323R	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	0.254	0.203	T	0.709	0.401	P	0.439	0.439	B	0.114	0.027	N	1	0.090	N	0.08	0.083	N	5.79	0.007	T	-1.54	0.373	N	0.152	0.276	-0.988	0.331	T	0.003	0.009	T	0.003	0.057	T	-0.286	0.069	0.714	0.677	0.082	0.002	0.010	N	c	-1.095	-1.318	0.999	0.381	0.447	0.083	0	-3.77	0.040	-1.813	0.018	-1.204	0.016	0.000	0.063	0.000	0.016	0.771	0.009	Immunoglobulin-like domain;Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	109	19	54782405	chr19:54782405	C	G	.	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	54802461	54802461	C	A	intronic	LILRA3	.	.	.	0.002925351	0.941785239	0.055289411	.	0.06888	.	3.561548721	99.50460014	1102.81114	6.34939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	126	19	54802461	chr19:54802461	C	A	.	PASS	DP=126;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	54822670	54822670	T	A	exonic	LILRA5	.	synonymous SNV	LILRA5:NM_181986:exon4:c.A690T:p.T230T,LILRA5:NM_181879:exon5:c.A726T:p.T242T	4.63E-08	0.115503403	0.88449655	.	0.07382	0.07049	-0.846787714	11.05803255	17.69999	0.61899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	17	19	54822670	chr19:54822670	T	A	87	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
19	54972918	54972918	T	C	UTR3	LENG8	NM_052925:c.*810T>C	.	.	0.998395296	0.001604704	5.62E-11	.	0.14592	0.10396	-1.080231599	7.277659825	678.50553	5.2062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	44	19	54972918	chr19:54972918	T	C	71	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	55009497	55009497	A	C	intergenic	CDC42EP5;LAIR2	dist=25060;dist=4516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	29	19	55009497	chr19:55009497	A	C	65	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	55098667	55098667	G	A	splicing	LILRA2	NM_001290271:exon9:c.1515-1G>A;NM_001290271:exon9:UTR3;NM_006866:exon8:c.1256-1G>A;NM_001290270:exon6:c.1220-1G>A;NM_001130917:exon8:c.1307-1G>A	.	.	6.89E-12	0.017769701	0.982230299	.	0.21687	.	3.228703513	99.37485256	778.15005	5.5191	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.191	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.617	0.014	0.002	0.498	0.042	0.002	0.013	N	c	-0.406	-0.904	0.016	0.128	0.075	0.014	0	-2.44	0.061	-4.641	0.002	-0.714	0.037	0.000	0.063	0.000	0.016	0.509	0.005	.	.	.	0.5	86	170	19	55098667	chr19:55098667	G	A	86	PASS	DP=170;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	55106288	55106288	A	C	exonic	LILRA1	.	nonsynonymous SNV	LILRA1:NM_001278319:exon3:c.A229C:p.I77L,LILRA1:NM_001278318:exon4:c.A229C:p.I77L,LILRA1:NM_006863:exon4:c.A229C:p.I77L	1.54E-16	0.000861763	0.999138237	.	0.03809	.	2.539299607	98.72021703	2966.18722	10.32448	0.384	0.165	T	0.0	0.026	B	0.0	0.063	B	0.222	0.035	N	1	0.090	N	-2.02	0.002	N	5.83	0.007	T	0.68	0.022	N	0.035	0.202	-0.917	0.459	T	0.001	0.003	T	.	.	.	-1.537	0.016	0.002	0.802	0.126	0.000	0.002	N	c	-1.960	-1.968	1.000	0.517	0.610	0.352	0	-1.94	0.071	-3.526	0.005	-1.428	0.011	0.000	0.063	0.000	0.016	4.396	0.107	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	109	97	19	55106288	chr19:55106288	A	C	109	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	55106317	55106317	A	G	exonic	LILRA1	.	synonymous SNV	LILRA1:NM_001278319:exon3:c.A258G:p.P86P,LILRA1:NM_001278318:exon4:c.A258G:p.P86P,LILRA1:NM_006863:exon4:c.A258G:p.P86P	1.54E-16	0.000861763	0.999138237	.	0.03809	.	2.539299607	98.72021703	2966.18722	10.32448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	139	19	55106317	chr19:55106317	A	G	69	PASS	DP=139;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	55179336	55179336	G	A	exonic	LILRB4	.	nonsynonymous SNV	LILRB4:NM_001278429:exon11:c.G1303A:p.E435K,LILRB4:NM_001278426:exon12:c.G1213A:p.E405K,LILRB4:NM_001278427:exon12:c.G1210A:p.E404K,LILRB4:NM_001278428:exon12:c.G1213A:p.E405K	4.67E-08	0.374227412	0.625772542	.	0.07232	.	4.538441647	99.74640245	2838.35258	10.07119	0.023	0.491	D	0.86	0.485	P	0.118	0.367	B	.	.	.	1	0.090	N	2.165	0.608	M	6.83	0.005	T	-2.24	0.501	N	0.548	0.584	-0.896	0.484	T	0.002	0.006	T	0.001	0.006	T	1.309	0.222	12.32	0.986	0.427	0.027	0.072	N	c	-0.458	-0.659	0.001	0.073	0.624	0.395	0	1.12	0.196	1.049	0.298	-0.113	0.115	0.002	0.151	0.344	0.245	4.724	0.122	.	.	.	0.5	58	183	19	55179336	chr19:55179336	G	A	58	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	55209143	55209143	C	A	intergenic	LILRB4;LILRP2	dist=27333;dist=10557	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	224	19	55209143	chr19:55209143	C	A	91	PASS	DP=224;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	55452786	55452786	C	-	intronic	NLRP7	.	.	.	1.10E-12	0.150540999	0.849459001	DISEASE: Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]: A disorder characterized by excessive trophoblast development that produces a growing mass of tissue inside the uterus at the beginning of a pregnancy. It leads to abnormal pregnancies with no embryo, and cystic degeneration of the chorionic villi. {ECO:0000269|PubMed:16462743, ECO:0000269|PubMed:19246479}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06942	0.12139	0.326933865	73.11866006	142.92313	2.60603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	37	19	55452785	chr19:55452785	AC	A	56	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	55494881	55494881	C	G	exonic	NLRP2	.	synonymous SNV	NLRP2:NM_001174082:exon5:c.C1749G:p.L583L,NLRP2:NM_001174081:exon6:c.C1815G:p.L605L,NLRP2:NM_001348003:exon6:c.C1806G:p.L602L,NLRP2:NM_017852:exon6:c.C1815G:p.L605L,NLRP2:NM_001174083:exon7:c.C1746G:p.L582L	1.88E-20	0.002997681	0.997002319	.	0.84299	0.12808	1.199631139	92.95824487	1690.10482	7.58061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	11	19	55494881	chr19:55494881	C	G	42	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	55715319	55715319	C	G	exonic	PTPRH	.	synonymous SNV	PTPRH:NM_002842:exon5:c.G717C:p.S239S	5.10E-29	7.03E-05	0.999929729	.	0.0771	.	1.111434312	92.06770465	5182.51875	14.81765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	31	19	55715319	chr19:55715319	C	G	62	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	55742053	55742053	C	T	splicing	PPP6R1	NM_014931:exon23:c.2571-1G>A	.	.	0.997854506	0.002145492	2.79E-09	.	0.16523	0.11824	0.121225147	62.22576079	190.13458	2.99301	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.463	0.474	23.0	0.983	0.391	0.777	0.380	D	c	0.755	0.502	0.988	0.313	0.257	0.036	0	3.6	0.402	1.627	0.364	0.852	0.362	0.998	0.411	0.762	0.325	11.021	0.467	.	.	.	0.5	58	23	19	55742053	chr19:55742053	C	T	58	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	55795388	55795388	A	C	upstream	BRSK1	dist=146	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	0.017	0.163	B	0.005	0.104	B	.	.	.	0.999	0.211	N	.	.	.	-0.59	0.716	T	.	.	.	.	.	.	.	.	.	.	.	0.815	0.986	D	1.436	0.235	12.97	0.754	0.107	0.391	0.259	N	n	1.546	1.824	1.000	0.747	0.598	0.340	0	2.46	0.289	0.302	0.188	0.875	0.382	0.936	0.322	0.999	0.750	6.084	0.191	.	.	.	0.5	81	252	19	55795388	chr19:55795388	A	C	81	PASS	DP=252;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	55795425	55795425	G	A	upstream	BRSK1	dist=109	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	1124	19	55795425	chr19:55795425	G	A	88	PASS	DP=1124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	55795450	55795450	G	A	upstream	BRSK1	dist=84	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.964	0.297	15.99	0.967	0.301	0.647	0.322	D	n	1.646	1.800	1.000	0.747	0.199	0.033	0	3.47	0.387	0.665	0.246	0.758	0.310	0.998	0.411	1.000	0.888	9.250	0.365	.	.	.	0.5	84	319	19	55795450	chr19:55795450	G	A	84	PASS	DP=319;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	55795451	55795451	-	G	upstream	BRSK1	dist=83	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	309	19	55795451	chr19:55795451	T	TG	78	PASS	DP=309;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	55795468	55795468	C	A	upstream	BRSK1	dist=66	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	19	55795468	chr19:55795468	C	A	.	PASS	DP=104;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	55815036	55815036	C	-	exonic	BRSK1	.	frameshift deletion	BRSK1:NM_032430:exon12:c.1128delC:p.R379Gfs*8	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	580	19	55815035	chr19:55815035	AC	A	111	PASS	DP=580;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	56029168	56029168	C	T	exonic	SSC5D	.	synonymous SNV	SSC5D:NM_001144950:exon14:c.C3525T:p.F1175F	0.346968714	0.48487348	0.168157806	.	.	.	3.778595825	99.61665487	7583.62392	18.68079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	35	19	56029168	chr19:56029168	C	T	62	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	56029175	56029192	ACCCCTCACCCCACCACG	-	exonic	SSC5D	.	nonframeshift deletion	SSC5D:NM_001144950:exon14:c.3532_3549del:p.T1184_T1189del	0.346968714	0.48487348	0.168157806	.	.	.	3.778595825	99.61665487	7583.62392	18.68079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	84	19	56029174	chr19:56029174	CACCCCTCACCCCACCACG	C	76	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	56056943	56056943	C	T	upstream	SBK3	dist=34	.	.	.	.	.	.	.	.	.	.	322.31624	3.81234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	107	19	56056943	chr19:56056943	C	T	.	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	56572875	56572875	G	A	exonic	NLRP5	.	nonsynonymous SNV	NLRP5:NM_153447:exon15:c.G3584A:p.R1195Q	1.24E-07	0.997190144	0.002809732	.	0.05999	.	0.179893931	66.1358811	2994.59421	10.38714	0.224	0.187	T	0.994	0.647	D	0.537	0.469	P	.	.	.	1	0.090	P	1.645	0.421	L	-0.65	0.722	T	-1.08	0.281	N	0.047	0.028	-1.059	0.119	T	0.000	0.000	T	.	.	.	2.129	0.317	17.04	0.998	0.902	0.017	0.054	N	c	-0.327	-0.511	0.000	0.012	0.487	0.133	0	-0.022	0.132	0.536	0.227	0.784	0.316	0.022	0.197	0.745	0.320	3.739	0.080	.	.	.	0.5	69	78	19	56572875	chr19:56572875	G	A	69	PASS	DP=78;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	57950046	57950047	CA	-	intronic	ZNF749	.	.	.	1.63E-06	0.413190579	0.586807793	.	0.27413	0.1155	0.20394914	67.45694739	989.24767	6.06389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	45	19	57950045	chr19:57950045	CCA	C	74	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	58118572	58118572	A	G	exonic	ZNF530	.	nonsynonymous SNV	ZNF530:NM_020880:exon3:c.A1679G:p.N560S,ZNF530:NM_001321981:exon4:c.A1580G:p.N527S	1.74E-10	0.114407016	0.885592984	.	0.08489	.	1.820761234	97.009908	298.54254	3.68443	1.0	0.010	T	0.006	0.126	B	0.002	0.063	B	.	.	.	1	0.090	N	-1.34	0.007	N	3.21	0.071	T	2.18	0.003	N	0.01	0.001	-0.935	0.434	T	0.004	0.013	T	0.001	0.011	T	-2.277	0.005	0.001	0.157	0.004	0.041	0.094	N	c	-1.774	-1.775	0.003	0.100	0.563	0.310	0	-2.9	0.053	-2.862	0.008	-1.267	0.014	0.000	0.063	0.000	0.016	2.216	0.037	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	79	36	19	58118572	chr19:58118572	A	G	79	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	58420660	58420660	T	C	exonic	ZNF417	.	nonsynonymous SNV	ZNF417:NM_001297734:exon3:c.A983G:p.Y328C,ZNF417:NM_152475:exon3:c.A986G:p.Y329C	1.13E-06	0.566466254	0.433532618	.	0.098	0.07895	0.887394731	89.18966737	527.71827	4.68764	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	0.973	0.265	N	-3.59	0.000	N	6.56	0.006	T	10.24	0.000	N	0.185	0.232	-0.966	0.381	T	0.000	0.001	T	0.001	0.017	T	-1.318	0.022	0.004	0.051	0.000	0.007	0.030	N	c	-1.699	-1.547	0.632	0.220	0.707	0.730	0	1.12	0.196	2.653	0.461	-0.256	0.089	0.993	0.376	0.017	0.128	7.822	0.283	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	81	74	19	58420660	chr19:58420660	T	C	81	PASS	DP=74;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	59093550	59093550	G	C	ncRNA_exonic	CENPBD1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	71	19	59093550	chr19:59093550	G	C	70	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	59093579	59093579	G	-	ncRNA_exonic	CENPBD1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	108	19	59093578	chr19:59093578	TG	T	42	PASS	DP=108;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	271135	271135	-	C	intronic	C20orf96	.	.	.	7.45E-13	0.017792517	0.982207483	.	0.02739	.	-0.314027422	31.9297004	25.57746	0.83421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	166	20	271135	chr20:271135	G	GC	81	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	2124496	2124496	G	T	UTR3	STK35	NM_080836:c.*104G>T	.	.	0.918199526	0.081264275	0.000536199	.	0.19968	0.11306	.	.	1408.18303	7.0104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	213	20	2124496	chr20:2124496	G	T	126	PASS	DP=213;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	2290399	2290399	G	A	exonic	TGM3	.	nonsynonymous SNV	TGM3:NM_003245:exon2:c.G104A:p.G35D	9.87E-06	0.984994274	0.014995859	.	0.35958	0.21918	-0.211293113	37.76244397	1529.88306	7.26777	0.001	0.784	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1.000	0.588	D	3.65	0.943	H	-1.12	0.776	T	-6.22	0.904	D	0.927	0.919	0.538	0.911	D	0.683	0.890	D	0.157	0.838	D	4.558	0.610	24.4	0.998	0.874	0.980	0.785	D	c	0.592	0.451	0.991	0.321	0.497	0.185	0	4.56	0.555	6.635	0.740	1.044	0.665	1.000	0.715	0.351	0.246	13.386	0.601	Immunoglobulin E-set|Immunoglobulin-like fold|Transglutaminase, N-terminal	.	.	0.5	.	37	20	2290399	chr20:2290399	G	A	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	2320599	2320599	G	A	exonic	TGM3	.	nonsynonymous SNV	TGM3:NM_003245:exon12:c.G1900A:p.G634R	9.87E-06	0.984994274	0.014995859	.	0.35958	0.21918	-0.211293113	37.76244397	1529.88306	7.26777	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.520	D	3.32	0.909	M	0.12	0.611	T	-7.58	0.953	D	0.93	0.923	-0.039	0.815	T	0.433	0.774	T	0.147	0.830	D	6.132	0.845	28.4	0.999	0.987	0.911	0.525	D	c	0.756	0.678	0.151	0.174	0.516	0.203	0	5.26	0.734	5.717	0.679	1.044	0.665	1.000	0.715	0.995	0.604	14.381	0.663	Immunoglobulin-like fold|Transglutaminase, C-terminal	.	.	0.5	.	80	20	2320599	chr20:2320599	G	A	.	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	2636266	2636266	G	C	exonic	NOP56	.	nonsynonymous SNV	NOP56:NM_006392:exon7:c.G783C:p.L261F	0.97325682	0.026742908	2.73E-07	DISEASE: Spinocerebellar ataxia 36 (SCA36) [MIM:614153]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA36 is characterized by complicated clinical features, with ataxia as the first symptom, followed by characteristic late-onset involvement of the motor neuron system. Ataxic symptoms, such as gait and truncal instability, ataxic dysarthria, and uncoordinated limbs, start in late forties to fifties. Characteristically, affected individuals exhibit tongue atrophy with fasciculation. Progression of motor neuron involvement is typically limited to the tongue and main proximal skeletal muscles in both upper and lower extremities. {ECO:0000269|PubMed:21683323}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by large hexanucleotide CGCCTG repeat expansions within intron 1. These expansions induce RNA foci and sequester the RNA-binding protein SRSF2. In addition, the transcription of MIR1292, a microRNA gene located just 19 bp 3' of the GGCCTG repeat, is significantly decreased.; 	0.99035	0.37745	-0.442665927	24.53408823	2441.81313	9.18965	0.042	0.416	D	0.229	0.689	B	0.202	0.672	B	0.000	0.629	D	1	0.810	D	3.365	0.914	M	-1.26	0.792	T	-3.76	0.712	D	0.823	0.811	0.458	0.900	D	0.604	0.859	D	0.083	0.742	D	4.962	0.667	25.1	0.999	0.960	0.961	0.674	D	c	0.547	0.532	1.000	0.747	0.722	0.854	0	4.9	0.635	3.981	0.564	1.048	0.713	1.000	0.715	1.000	0.888	15.613	0.764	Nop domain	.	.	0.5	65	69	20	2636266	chr20:2636266	G	C	65	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	3462384	3462384	G	T	intronic	ATRN	.	.	.	0.999999976	2.42E-08	2.46E-21	.	0.27789	0.17365	0.117584698	62.19037509	3379.60468	11.13499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	20	3462384	chr20:3462384	G	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	3462432	3462432	A	G	intronic	ATRN	.	.	.	0.999999976	2.42E-08	2.46E-21	.	0.27789	0.17365	0.117584698	62.19037509	3379.60468	11.13499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	92	20	3462432	chr20:3462432	A	G	59	PASS	DP=92;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	4201344	4201344	-	T	UTR3	ADRA1D	NM_000678:c.*825_*826insA	.	.	.	.	.	.	0.14449	0.11771	0.156217551	64.82071243	229.7736	3.27584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	26	20	4201344	chr20:4201344	A	AT	51	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	4228872	4228872	A	G	exonic	ADRA1D	.	nonsynonymous SNV	ADRA1D:NM_000678:exon1:c.T733C:p.F245L	.	.	.	.	0.14449	0.11771	0.156217551	64.82071243	229.7736	3.27584	0.7	0.042	T	0.153	0.265	B	0.27	0.381	B	0.002	0.380	U	0.979	0.252	N	-0.105	0.046	N	1.12	0.387	T	-0.32	0.123	N	0.374	0.435	-0.981	0.347	T	0.055	0.232	T	0.008	0.202	T	1.435	0.235	12.97	0.968	0.304	0.827	0.416	D	c	-0.323	-0.139	1.000	0.747	0.765	0.991	0	4.25	0.495	2.090	0.411	1.197	0.919	1.000	0.715	1.000	0.888	7.069	0.242	GPCR, rhodopsin-like, 7TM	.	.	0.5	159	230	20	4228872	chr20:4228872	A	G	159	PASS	DP=230;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	5155828	5155828	G	T	splicing	CDS2	NM_003818:exon3:c.195-1G>T	.	.	6.78E-05	0.977355656	0.022576536	.	0.08157	0.08152	-0.315847836	31.68789809	624.29254	5.04006	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.201	0.702	25.5	0.995	0.686	0.998	0.992	D	c	1.213	1.054	1.000	0.747	0.140	0.025	0	5.1	0.688	9.972	0.991	1.048	0.713	1.000	0.715	0.880	0.369	17.433	0.874	.	.	.	0.5	.	28	20	5155828	chr20:5155828	G	T	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	5296578	5296578	C	T	intronic	PROKR2	.	.	.	0.000669053	0.503920664	0.495410283	.	0.16785	0.13372	-0.222203495	37.54423213	340.77102	3.91723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	98	20	5296578	chr20:5296578	C	T	90	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	5974276	5974276	A	G	exonic	MCM8	.	nonsynonymous SNV	MCM8:NM_001281522:exon17:c.A2224G:p.R742G,MCM8:NM_001281520:exon18:c.A2365G:p.R789G,MCM8:NM_001281521:exon18:c.A2485G:p.R829G,MCM8:NM_032485:exon18:c.A2365G:p.R789G,MCM8:NM_182802:exon18:c.A2317G:p.R773G	1.93E-10	0.954436717	0.045563282	DISEASE: Premature ovarian failure 10 (POF10) [MIM:612885]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:25437880}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24617	0.19778	1.407269618	94.78650625	3710.46351	11.88891	0.022	0.486	D	0.214	0.305	B	0.139	0.319	B	0.000	0.843	D	0.999	0.466	D	2.395	0.694	M	4.08	0.030	T	-3.62	0.695	D	0.857	0.872	-0.994	0.315	T	0.017	0.069	T	0.017	0.384	T	4.539	0.608	24.3	0.994	0.619	0.941	0.599	D	c	0.118	0.272	0.701	0.227	0.732	0.924	0	5.82	0.927	4.299	0.586	1.199	0.960	1.000	0.715	1.000	0.888	12.092	0.528	MCM domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	78	51	20	5974276	chr20:5974276	A	G	78	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	7976721	7976721	-	A	intronic	TMX4	.	.	.	0.010662181	0.946183863	0.043153956	.	0.16188	.	-0.0274281	51.65723048	79.9201	1.88959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	221	20	7976721	chr20:7976721	T	TA	75	PASS	DP=221;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	9416190	9416190	-	T	intronic	PLCB4	.	.	.	0.272263498	0.727736501	6.10E-10	.	0.12302	0.14602	-0.907472583	10.07313046	4614.82682	13.64468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	16	20	9416190	chr20:9416190	G	GT	42	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
20	9498657	9498657	-	CTGCCAGCAGGAGGGGC	intronic	LAMP5	.	.	.	3.84E-08	0.10400326	0.895996702	.	0.42339	.	0.260991686	70.25831564	2514.20203	9.34534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	22	20	9498657	chr20:9498657	T	TCTGCCAGCAGGAGGGGC	52	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	13936733	13936733	C	A	exonic	SEL1L2	.	nonsynonymous SNV	SEL1L2:NM_001271539:exon2:c.G103T:p.V35F	2.69E-11	0.43582028	0.56417972	.	0.14689	0.0744	0.42259095	77.22929936	615.74121	5.0111	0.105	0.443	T	0.622	0.381	P	0.157	0.329	B	0.027	0.258	N	0.958	0.262	N	.	.	.	2.0	0.280	T	-1.29	0.328	N	0.363	0.458	-1.064	0.108	T	0.038	0.164	T	0.005	0.125	T	4.003	0.538	23.6	0.989	0.483	0.635	0.319	D	c	-0.217	-0.126	0.000	0.012	0.487	0.133	0	2.54	0.295	0.345	0.196	0.069	0.176	0.999	0.424	0.996	0.625	6.196	0.196	.	.	.	0.5	.	34	20	13936733	chr20:13936733	C	A	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	20373844	20373844	C	T	UTR3	RALGAPA2	NM_020343:c.*89G>A	.	.	8.49E-06	0.999991501	1.10E-08	.	0.21358	0.10195	-2.30816515	1.203113942	547.52089	4.75813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	95	20	20373844	chr20:20373844	C	T	88	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	21695452	21695452	C	A	UTR3	PAX1	NM_006192:c.*11C>A;NM_001257096:c.*252C>A	.	.	0.616084026	0.382224632	0.001691342	DISEASE: Otofaciocervical syndrome 2 (OFC2) [MIM:615560]: A disorder characterized by facial dysmorphism, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies including vertebral defects, low-set clavicles, winged scapulae, sloping shoulders, and mild intellectual disability. {ECO:0000269|PubMed:23851939}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.80187	0.30248	0.350995466	74.37485256	224.51285	3.24104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	20	21695452	chr20:21695452	C	A	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	23066469	23066469	C	-	exonic	CD93	.	frameshift deletion	CD93:NM_012072:exon1:c.361delG:p.E121Rfs*78	7.82E-10	0.075948416	0.924051584	.	0.15486	0.28768	-0.148789446	42.29771172	256.90385	3.44823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	164	20	23066468	chr20:23066468	TC	T	67	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	23584198	23584198	A	T	exonic	CST9	.	synonymous SNV	CST9:NM_001008693:exon2:c.T429A:p.G143G	0.095109295	0.769080073	0.135810632	.	0.08285	0.10564	0.505321956	80.00707714	973.5092	6.03439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	63	20	23584198	chr20:23584198	A	T	101	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
20	23667683	23667683	C	G	intronic	CST4	.	.	.	7.30E-06	0.161904959	0.838087741	.	0.09154	0.1077	0.262810045	70.43524416	20.08609	0.68634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	59	20	23667683	chr20:23667683	C	G	51	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	24930259	24930259	A	G	intronic	CST7	.	.	.	9.92E-07	0.099089026	0.900909982	.	0.09739	0.21451	-0.007201372	53.19061099	163.63628	2.79416	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	20	20	24930259	chr20:24930259	A	G	42	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	29449597	29449597	G	A	intergenic	NONE;LINC01597	dist=NONE;dist=63987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	496	20	29449597	chr20:29449597	G	A	147	PASS	DP=496;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29516584	29516584	G	T	ncRNA_exonic	LINC01597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	270	20	29516584	chr20:29516584	G	T	120	PASS	DP=270;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29589699	29589699	G	A	intergenic	LINC01598;FRG1BP	dist=19336;dist=22141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	207	20	29589699	chr20:29589699	G	A	105	PASS	DP=207;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	29612200	29612200	C	T	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	294	20	29612200	chr20:29612200	C	T	126	PASS	DP=294;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29614343	29614343	G	A	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	222	20	29614343	chr20:29614343	G	A	109	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29624020	29624020	-	T	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	96	20	29624020	chr20:29624020	G	GT	80	PASS	DP=96;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
20	29625873	29625873	A	C	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.002	0.721	D	0.837	0.444	P	0.783	0.556	P	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	-2.77	0.587	D	0.799	0.789	-0.879	0.499	T	0.181	0.529	T	.	.	.	3.765	0.509	23.4	0.993	0.591	0.844	0.432	D	c	0.345	0.056	0.999	0.397	0.675	0.547	0	1.68	0.231	1.417	0.342	0.675	0.295	1.000	0.715	0.098	0.188	7.376	0.258	Actin cross-linking	.	.	0.5	142	166	20	29625873	chr20:29625873	A	C	142	PASS	DP=166;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29628185	29628185	A	G	ncRNA_intronic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	297	20	29628185	chr20:29628185	A	G	102	PASS	DP=297;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29628263	29628263	A	G	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.307	0.141	T	0.0	0.067	B	0.018	0.206	B	0.000	0.843	D	0.634	0.328	D	.	.	.	.	.	.	-0.57	0.172	N	0.489	0.536	-1.056	0.127	T	0.055	0.231	T	0.001	0.003	T	1.583	0.252	13.76	0.942	0.239	0.631	0.317	D	c	-0.318	-0.243	1.000	0.489	0.752	0.988	0	2.08	0.260	4.712	0.613	0.666	0.294	1.000	0.715	0.993	0.574	3.866	0.085	Actin cross-linking	.	.	0.5	153	842	20	29628263	chr20:29628263	A	G	153	PASS	DP=842;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29628335	29628335	A	T	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	196	316	20	29628335	chr20:29628335	A	T	196	PASS	DP=316;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29632570	29632571	AG	-	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	421	20	29632569	chr20:29632569	CAG	C	96	PASS	DP=421;AN=4	GT	./.	0/1	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	29632612	29632614	AAG	-	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	226	20	29632611	chr20:29632611	AAAG	A	83	PASS	DP=226;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29632632	29632632	A	G	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	270	20	29632632	chr20:29632632	A	G	132	PASS	DP=270;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29632643	29632643	T	C	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	0.027	0.465	D	0.481	0.349	P	0.317	0.399	B	0.000	0.843	U	1	0.810	D	.	.	.	.	.	.	-4.78	0.805	D	0.829	0.817	-0.847	0.522	T	0.162	0.498	T	.	.	.	4.063	0.546	23.7	0.990	0.494	0.869	0.460	D	c	0.008	-0.014	1.000	0.747	0.675	0.547	0	1.44	0.215	6.853	0.751	0.574	0.285	1.000	0.715	0.999	0.750	6.983	0.237	.	.	.	0.5	141	286	20	29632643	chr20:29632643	T	C	141	PASS	DP=286;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29637851	29637851	C	G	ncRNA_exonic	MLLT10P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	148	20	29637851	chr20:29637851	C	G	106	PASS	DP=148;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29638007	29638007	T	A	ncRNA_exonic	MLLT10P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	128	20	29638007	chr20:29638007	T	A	92	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	30584271	30584271	T	A	intronic	XKR7	.	.	.	0.923951243	0.075603056	0.000445701	.	0.35248	.	-0.359940251	28.93371078	645.89854	5.10288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	20	30584271	chr20:30584271	T	A	.	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	30745722	30745722	G	C	exonic	TM9SF4	.	nonsynonymous SNV	TM9SF4:NM_014742:exon14:c.G1455C:p.Q485H	0.999970772	2.92E-05	1.94E-12	.	0.27945	0.11262	-0.514264485	21.41424864	53.66935	1.45942	0.008	0.586	D	0.781	0.899	P	0.668	0.850	P	0.000	0.629	D	1	0.810	D	2.47	0.719	M	0.83	0.478	T	-3.66	0.700	D	0.618	0.641	-0.194	0.778	T	0.365	0.726	T	0.020	0.421	T	6.528	0.899	31	0.997	0.836	0.992	0.926	D	c	0.817	0.780	1.000	0.747	0.707	0.730	0	4.96	0.650	7.700	0.834	1.048	0.713	1.000	0.715	1.000	0.888	18.422	0.905	.	.	.	0.5	135	206	20	30745722	chr20:30745722	G	C	135	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	31035304	31035304	C	A	UTR3	NOL4L	NM_001256798:c.*95G>T;NM_001351680:c.*295G>T;NM_080616:c.*95G>T	.	.	.	.	.	.	0.66654	0.11152	-1.045216355	7.661004954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	20	31035304	chr20:31035304	C	A	.	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	31292194	31292198	AACCA	-	intronic	COMMD7	.	.	.	6.05E-06	0.451906293	0.54808766	.	0.07383	0.09741	-0.163345027	41.24793583	8.41662	0.30752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.89	33	20	31292193	chr20:31292193	TAACCA	T	14.89	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	31658991	31658991	C	A	intronic	BPIFB3	.	.	.	1.27E-05	0.952461122	0.047526177	.	0.14497	0.08786	1.137205722	92.32719981	8881.73483	20.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	20	31658991	chr20:31658991	C	A	.	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	32298349	32298349	G	A	intronic	PXMP4	.	.	.	0.604956427	0.38624188	0.008801693	.	0.1038	0.10278	0.527368849	80.73248408	67.7056	1.70224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	20	32298349	chr20:32298349	G	A	.	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	32664877	32664877	C	T	exonic	RALY	.	synonymous SNV	RALY:NM_007367:exon7:c.C654T:p.G218G,RALY:NM_016732:exon8:c.C702T:p.G234G	0.55457384	0.442614262	0.002811898	.	0.18001	0.13451	-0.093566408	46.7386176	666.56385	5.16662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	328	20	32664877	chr20:32664877	C	T	75	PASS	DP=328;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	32972827	32972827	T	-	intronic	ITCH	.	.	.	0.999990177	9.82E-06	5.57E-15	DISEASE: Autoimmune disease, multisystem, with facial dysmorphism (ADMFD) [MIM:613385]: A disorder characterized by organomegaly, failure to thrive, developmental delay, dysmorphic features and autoimmune inflammatory cell infiltration of the lungs, liver and gut. {ECO:0000269|PubMed:20170897}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59377	0.08471	-1.089312628	7.047652748	40.17092	1.18051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	57	20	32972826	chr20:32972826	AT	A	50	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	33147070	33147070	G	T	intronic	MAP1LC3A	.	.	.	0.739731535	0.249075138	0.011193327	.	0.09841	0.09617	-0.009020804	52.8544468	1.17647	0.03321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	20	33147070	chr20:33147070	G	T	.	PASS	DP=71;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	33147172	33147172	G	A	exonic	MAP1LC3A	.	nonsynonymous SNV	MAP1LC3A:NM_032514:exon3:c.G118A:p.G40S,MAP1LC3A:NM_181509:exon4:c.G130A:p.G44S	0.739731535	0.249075138	0.011193327	.	0.09841	0.09617	-0.009020804	52.8544468	1.17647	0.03321	0.063	0.367	T	0.001	0.200	B	0.015	0.277	B	0.000	0.843	D	1	0.810	D	2.11	0.588	M	0.96	0.429	T	-4.22	0.758	D	0.52	0.567	-1.008	0.276	T	0.113	0.403	T	0.020	0.432	T	3.667	0.498	23.2	0.996	0.755	0.948	0.620	D	c	0.075	0.251	1.0	0.983	0.726	0.872	0	5.08	0.682	8.052	0.891	0.923	0.433	1.000	0.715	1.000	0.888	18.058	0.892	Ubiquitin-related domain	.	.	0.5	.	113	20	33147172	chr20:33147172	G	A	.	PASS	DP=113;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	33147196	33147196	G	A	exonic	MAP1LC3A	.	nonsynonymous SNV	MAP1LC3A:NM_032514:exon3:c.G142A:p.D48N,MAP1LC3A:NM_181509:exon4:c.G154A:p.D52N	0.739731535	0.249075138	0.011193327	.	0.09841	0.09617	-0.009020804	52.8544468	1.17647	0.03321	0.004	0.912	D	0.001	0.131	B	0.04	0.225	B	0.000	0.843	D	1	0.810	D	2.965	0.855	M	0.52	0.553	T	-4.66	0.794	D	0.117	0.130	-0.626	0.638	T	0.239	0.607	T	0.085	0.745	D	4.796	0.644	24.8	0.998	0.906	0.965	0.692	D	c	0.285	0.409	1.0	0.983	0.726	0.872	0	5.08	0.682	9.908	0.986	0.923	0.433	1.000	0.715	0.998	0.697	18.058	0.892	Ubiquitin-related domain	.	.	0.5	.	74	20	33147196	chr20:33147196	G	A	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	33555031	33555031	A	-	intronic	MYH7B	.	.	.	1.33E-23	0.792349353	0.207650647	.	0.15291	0.32389	-0.893455413	10.17338995	2287.01575	8.85125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	19	20	33555030	chr20:33555030	TA	T	60	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
20	33665776	33665776	-	A	intronic	TRPC4AP	.	.	.	0.999538656	0.000461344	1.33E-11	.	0.44984	0.11627	-1.263883952	5.260674687	88.3574	2.01455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	301	20	33665775	chr20:33665775	GA	GAA,G	111	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	33665776	33665776	A	-	intronic	TRPC4AP	.	.	.	0.999538656	0.000461344	1.33E-11	.	0.44984	0.11627	-1.263883952	5.260674687	88.3574	2.01455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	301	20	33665775	chr20:33665775	GA	GAA,G	111	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	33747721	33747721	G	A	intergenic	EDEM2;PROCR	dist=12560;dist=12019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	103	20	33747721	chr20:33747721	G	A	.	PASS	DP=103;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	33972884	33972884	G	A	intronic	UQCC1	.	.	.	0.004854425	0.989054215	0.00609136	.	0.54483	0.10131	0.483275131	79.25218212	117.95061	2.36137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	20	33972884	chr20:33972884	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	34134710	34134739	AGCCGGTGCAGAGGGAGAGGTGTGAGGAGA	-	intronic	ERGIC3	.	.	.	0.003859077	0.994404724	0.001736199	.	0.29981	0.10239	-0.404032746	26.53338051	12.39957	0.44974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.8	24	20	34134709	chr20:34134709	GAGCCGGTGCAGAGGGAGAGGTGTGAGGAGA	G	12.8	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	34186928	34186928	C	T	ncRNA_intronic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	20	34186928	chr20:34186928	C	T	.	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34188547	34188547	C	A	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	20	34188547	chr20:34188547	C	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34188688	34188688	C	A	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	20	34188688	chr20:34188688	C	A	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34190005	34190005	C	A	ncRNA_intronic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	107	20	34190005	chr20:34190005	C	A	.	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34191771	34191771	C	T	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	92	20	34191771	chr20:34191771	C	T	84	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34191777	34191777	C	T	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	94	20	34191777	chr20:34191777	C	T	94	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34191816	34191816	C	T	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	98	20	34191816	chr20:34191816	C	T	90	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34194189	34194189	C	A	ncRNA_intronic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	20	34194189	chr20:34194189	C	A	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34205387	34205387	G	A	intronic	SPAG4	.	.	.	0.110567923	0.888145117	0.00128696	.	0.14706	0.11092	0.551232944	81.48148148	141.82474	2.59876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	20	34205387	chr20:34205387	G	A	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34207681	34207681	G	A	intronic	SPAG4	.	.	.	0.110567923	0.888145117	0.00128696	.	0.14706	0.11092	0.551232944	81.48148148	141.82474	2.59876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	20	34207681	chr20:34207681	G	A	.	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34214751	34214751	G	C	intronic	CPNE1	.	.	.	3.87E-07	0.942364799	0.057634814	.	0.11193	0.18648	1.001272896	90.72304789	5735.67228	15.69514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	163	20	34214751	chr20:34214751	G	C	115	PASS	DP=163;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	34295072	34295072	A	G	exonic	RBM39	.	nonsynonymous SNV	RBM39:NM_001242599:exon13:c.T1211C:p.F404S,RBM39:NM_001242600:exon13:c.T1193C:p.F398S,RBM39:NM_001323422:exon13:c.T1181C:p.F394S,RBM39:NM_001323424:exon14:c.T1274C:p.F425S,RBM39:NM_004902:exon14:c.T1259C:p.F420S,RBM39:NM_184234:exon14:c.T1277C:p.F426S,RBM39:NM_001323423:exon16:c.T806C:p.F269S	0.999996915	3.08E-06	8.09E-15	.	0.85822	0.14229	-0.207437529	38.2814343	7.60928	0.28162	0.0	0.912	D	1.0	0.899	D	0.98	0.749	D	0.000	0.843	D	1	0.810	D	2.315	0.665	M	0.66	0.524	T	-7.48	0.954	D	0.711	0.732	-0.316	0.746	T	0.316	0.686	T	0.150	0.833	D	5.973	0.821	27.7	0.999	0.944	0.995	0.973	D	c	0.620	0.546	1.000	0.747	0.672	0.522	0	4.65	0.575	8.297	0.898	1.140	0.893	1.000	0.715	0.967	0.454	14.228	0.653	Nucleotide-binding alpha-beta plait domain|RNA recognition motif domain|Splicing factor RBM39, linker;Splicing factor RBM39, linker	.	.	0.5	58	60	20	34295072	chr20:34295072	A	G	58	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	34855890	34855890	G	T	intergenic	AAR2;DLGAP4	dist=11027;dist=38355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	91	20	34855890	chr20:34855890	G	T	.	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	37146163	37146163	C	T	exonic	RALGAPB	.	stopgain	RALGAPB:NM_001282917:exon8:c.C1066T:p.R356X,RALGAPB:NM_001282918:exon8:c.C1066T:p.R356X,RALGAPB:NM_020336:exon8:c.C1066T:p.R356X	0.999999956	4.44E-08	5.33E-20	.	0.64391	0.10552	-0.949752638	9.32413305	208.99718	3.12049	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.749	0.970	36	0.995	0.696	0.897	0.500	D	c	0.495	0.308	0.078	0.158	0.732	0.924	0	0.856	0.181	0.335	0.194	0.935	0.490	0.929	0.320	1.000	0.888	14.989	0.709	.	.	.	0.5	.	20	20	37146163	chr20:37146163	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	37216665	37216665	A	G	intronic	ADIG	.	.	.	.	.	.	.	0.22628	.	0.080983847	59.76055674	11.12436	0.40271	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	209	20	37216665	chr20:37216665	A	G	60	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	37590929	37590929	T	C	upstream	DHX35	dist=52	.	.	9.69E-11	0.973981761	0.026018239	.	0.27324	0.09942	-0.328796968	30.86223166	2233.3121	8.70874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	128	20	37590929	chr20:37590929	T	C	107	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	42165027	42165027	G	T	intronic	L3MBTL1	.	.	.	2.08E-07	0.993446403	0.006553389	.	0.41701	0.10262	0.025760883	55.78556263	239.20304	3.34244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	141	20	42165027	chr20:42165027	G	T	86	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	42281780	42281780	C	T	intergenic	IFT52;MYBL2	dist=5844;dist=13879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	214	20	42281780	chr20:42281780	C	T	64	PASS	DP=214;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	43530234	43530234	A	C	exonic	YWHAB	.	synonymous SNV	YWHAB:NM_139323:exon2:c.A60C:p.R20R,YWHAB:NM_003404:exon3:c.A60C:p.R20R	0.938360894	0.061376766	0.00026234	.	0.98107	0.70722	0.103030231	61.2762444	18.29907	0.63541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	10	20	43530234	chr20:43530234	A	C	44	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	43961750	43961750	C	A	intronic	SDC4	.	.	.	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	20	43961750	chr20:43961750	C	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	43976991	43976991	A	G	exonic	SDC4	.	nonsynonymous SNV	SDC4:NM_002999:exon1:c.T34C:p.F12L	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.354	0.043	N	1	0.588	P	-1.905	0.002	N	1.72	0.266	T	1.24	0.010	N	0.044	0.024	-0.934	0.436	T	0.000	0.000	T	.	.	.	1.585	0.252	13.77	0.784	0.119	0.065	0.124	N	c	-1.092	-0.869	1.000	0.747	0.564	0.319	0	1.9	0.247	0.261	0.181	0.088	0.194	0.995	0.385	0.796	0.335	5.835	0.177	.	.	.	0.5	165	182	20	43976991	chr20:43976991	A	G	165	PASS	DP=182;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	44528543	44528543	G	A	intronic	PLTP	.	.	.	0.000142042	0.962665909	0.037192049	.	0.36337	0.21599	-0.440847477	24.59896202	193.00501	3.01119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	53	20	44528543	chr20:44528543	G	A	72	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	44756862	44756862	C	T	exonic	CD40	.	stopgain	CD40:NM_152854:exon6:c.C583T:p.Q195X,CD40:NM_001302753:exon7:c.C685T:p.Q229X	0.658237504	0.340601066	0.001161431	.	0.16893	0.72844	0.327131069	73.27199811	32.77151	1.0175	.	.	.	.	.	.	.	.	.	.	.	.	0.913	0.364	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.934	0.183	10.28	0.972	0.323	0.130	0.174	N	c	0.305	0.012	0.996	0.342	0.744	0.983	0	1.48	0.218	1.222	0.319	0.892	0.403	0.283	0.249	0.497	0.270	2.712	0.048	.	.	.	0.5	.	27	20	44756862	chr20:44756862	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	46264671	46264671	G	A	exonic	NCOA3	.	nonsynonymous SNV	NCOA3:NM_001174087:exon12:c.G1541A:p.G514E,NCOA3:NM_001174088:exon12:c.G1571A:p.G524E,NCOA3:NM_006534:exon12:c.G1541A:p.G514E,NCOA3:NM_181659:exon12:c.G1541A:p.G514E	0.999916718	8.33E-05	1.70E-15	.	0.74944	0.1263	-1.232771118	5.537862703	2649.41599	9.66014	0.004	0.654	D	0.716	0.528	P	0.493	0.535	P	0.000	0.445	D	0.988	0.407	D	2.54	0.743	M	2.3	0.170	T	-4.57	0.787	D	0.317	0.378	-1.013	0.260	T	0.088	0.340	T	0.018	0.403	T	3.905	0.526	23.5	0.995	0.687	0.981	0.791	D	c	0.256	0.241	0.927	0.268	0.707	0.730	0	4.42	0.526	4.118	0.574	1.048	0.713	1.000	0.715	0.983	0.502	15.432	0.747	.	.	.	0.5	40	34	20	46264671	chr20:46264671	G	A	40	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	46294828	46294828	T	C	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	408	20	46294828	chr20:46294828	T	C	132	PASS	DP=408;AN=4	GT	0/1	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	46294864	46294864	A	G	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	204	20	46294864	chr20:46294864	A	G	139	PASS	DP=204;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	47838071	47838127	AGAAGGAGGGGACGTACGATGGCAGCTGGGCCCTGGCTGATGTCATGAGCCAACTCA	-	exonic	DDX27	.	nonframeshift deletion	DDX27:NM_001348187:exon2:c.269_325del:p.E92_K110del,DDX27:NM_017895:exon2:c.269_325del:p.E92_K110del	0.250170092	0.749829465	4.42E-07	.	0.17829	0.10926	-0.062423436	48.86765747	4157.56288	12.79754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	53	20	47838070	chr20:47838070	GAGAAGGAGGGGACGTACGATGGCAGCTGGGCCCTGGCTGATGTCATGAGCCAACTCA	G	41	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	48146780	48146780	C	A	intronic	PTGIS	.	.	.	2.42E-05	0.915593898	0.08438187	.	0.36541	0.27749	-0.352661697	29.48808681	184.44683	2.94813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	20	48146780	chr20:48146780	C	A	.	PASS	DP=67;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	49225796	49225796	A	G	intronic	RIPOR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	46	20	49225796	chr20:49225796	A	G	56	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	50241868	50241868	C	G	exonic	ATP9A	.	nonsynonymous SNV	ATP9A:NM_006045:exon18:c.G1879C:p.D627H	0.999980637	1.94E-05	1.19E-15	.	0.13853	0.11774	-1.638744339	2.801368247	81.80933	1.91713	0.023	0.481	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	3.075	0.874	M	-1.53	0.816	D	-4.64	0.806	D	0.844	0.861	0.606	0.920	D	0.716	0.902	D	0.273	0.900	D	6.805	0.925	32	0.996	0.715	0.943	0.604	D	c	0.817	0.746	1.000	0.747	0.706	0.609	0	4.7	0.586	7.494	0.802	0.920	0.431	1.000	0.715	0.988	0.529	17.651	0.880	HAD-like domain|P-type ATPase, cytoplasmic domain N	.	.	0.5	87	147	20	50241868	chr20:50241868	C	G	87	PASS	DP=147;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	51588866	51588868	GAG	-	upstream	TSHZ2	dist=78	.	.	0.406843773	0.5927903	0.000365927	.	0.13647	0.11806	-0.916836882	9.831328143	361.35552	4.02303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	189	20	51588865	chr20:51588865	AGAG	A	113	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	55099658	55099658	G	T	intronic	GCNT7	.	.	.	.	.	.	.	0.03282	.	.	.	752.86612	5.44146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	20	55099658	chr20:55099658	G	T	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	56089870	56089870	T	-	intronic	CTCFL	.	.	.	0.783031842	0.216955804	1.24E-05	.	0.11608	0.09123	1.181302384	92.80490682	316.39761	3.77775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	14	20	56089869	chr20:56089869	GT	G	50	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	56834807	56834807	C	T	ncRNA_intronic	PPP4R1L	.	.	.	.	.	.	.	.	.	.	.	1076.00834	6.28755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	140	20	56834807	chr20:56834807	C	T	84	PASS	DP=140;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	57276230	57276230	G	A	ncRNA_intronic	STX16-NPEPL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	99	20	57276230	chr20:57276230	G	A	70	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	57276241	57276241	G	C	ncRNA_intronic	STX16-NPEPL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	208	20	57276241	chr20:57276241	G	C	65	PASS	DP=208;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	57523229	57523229	C	T	intergenic	GNAS;NELFCD	dist=36978;dist=33034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	99	20	57523229	chr20:57523229	C	T	67	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
20	57613653	57613653	C	T	exonic	PRELID3B	.	synonymous SNV	PRELID3B:NM_001256403:exon2:c.G69A:p.Q23Q,PRELID3B:NM_016045:exon2:c.G69A:p.Q23Q	.	.	.	.	0.48576	.	0.281220278	71.07808445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	20	57613653	chr20:57613653	C	T	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
20	57766219	57766219	-	C	exonic	ZNF831	.	frameshift insertion	ZNF831:NM_178457:exon1:c.146dupC:p.T52Hfs*46	7.65E-09	0.970919494	0.029080499	.	0.07141	.	1.328244615	94.10828025	431.43682	4.3351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	476	20	57766219	chr20:57766219	G	GC	75	PASS	DP=476;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
20	60892812	60892812	C	A	exonic	LAMA5	.	nonsynonymous SNV	LAMA5:NM_005560:exon54:c.G7262T:p.R2421L	0.943037981	0.056962019	9.75E-22	.	0.70971	.	3.125188892	99.28049068	9086.1435	20.60876	0.247	0.173	T	0.08	0.230	B	0.051	0.240	B	0.986	0.079	U	1	0.090	N	2.125	0.592	M	2.9	0.101	T	-2.57	0.555	D	0.1	0.103	-0.969	0.374	T	0.021	0.091	T	0.028	0.505	D	3.729	0.505	23.3	0.950	0.253	0.146	0.183	N	c	-1.149	-1.191	1.000	0.454	0.707	0.730	0	-3.58	0.043	-1.086	0.035	-1.185	0.016	0.000	0.063	0.370	0.249	10.203	0.421	Laminin alpha, domain I	.	.	0.5	108	113	20	60892812	chr20:60892812	C	A	108	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	61460243	61460243	C	-	intronic	COL9A3	.	.	.	3.25E-05	0.999944225	2.33E-05	DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.; 	0.4977	.	0.611719262	82.96768106	2646.06911	9.64989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	145	20	61460242	chr20:61460242	TC	T	86	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	62203414	62203414	T	C	intronic	HELZ2	.	.	.	1.26E-09	0.999300381	0.000699618	.	.	.	-0.147490202	42.30360934	4463.72358	13.40473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	20	62203414	chr20:62203414	T	C	.	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	62319558	62319618	TGCCCATCCTGGATCCTGGACCCCTGCTCCCAAGAGCTGGTAGGGAACCCTGCAGACATCC	-	ncRNA_intronic	RTEL1-TNFRSF6B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.34	39	20	62319557	chr20:62319557	GTGCCCATCCTGGATCCTGGACCCCTGCTCCCAAGAGCTGGTAGGGAACCCTGCAGACATCC	G	10.34	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	10906989	10906989	C	T	exonic	TPTE	.	synonymous SNV	TPTE:NM_001290224:exon19:c.G1158A:p.R386R,TPTE:NM_199260:exon22:c.G1458A:p.R486R,TPTE:NM_199259:exon23:c.G1518A:p.R506R,TPTE:NM_199261:exon24:c.G1572A:p.R524R	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	21	10906989	chr21:10906989	C	T	.	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	10909694	10909698	GCGAA	-	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	187	21	10909693	chr21:10909693	TGCGAA	T	94	PASS	DP=187;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
21	11021097	11021097	G	T	intronic	BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	798	21	11021097	chr21:11021097	G	T	123	PASS	DP=798;AN=4	GT	0/1	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	11038998	11038998	G	A	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*668C>T;NM_182481:c.*668C>T;NM_181704:c.*883C>T;NM_182484:c.*883C>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	408	21	11038998	chr21:11038998	G	A	129	PASS	DP=408;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	11049461	11049461	G	T	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*110C>A;NM_182481:c.*110C>A;NM_181704:c.*325C>A;NM_182484:c.*325C>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	499	21	11049461	chr21:11049461	G	T	117	PASS	DP=499;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	11049596	11049596	C	T	exonic	BAGE2;BAGE3	.	nonsynonymous SNV	BAGE3:NM_182481:exon4:c.G305A:p.C102Y,BAGE2:NM_182482:exon4:c.G305A:p.C102Y	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	226	21	11049596	chr21:11049596	C	T	97	PASS	DP=226;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	11049617	11049617	C	G	exonic	BAGE2;BAGE3	.	nonsynonymous SNV	BAGE3:NM_182481:exon4:c.G284C:p.R95T,BAGE2:NM_182482:exon4:c.G284C:p.R95T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	178	21	11049617	chr21:11049617	C	G	126	PASS	DP=178;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	11049623	11049623	T	C	splicing	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:exon4:c.280-2A>G;NM_182481:exon4:c.280-2A>G;NM_181704:exon4:c.285-2A>G;NM_181704:exon4:UTR3;NM_182484:exon4:c.284-2A>G;NM_182484:exon4:UTR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	332	21	11049623	chr21:11049623	T	C	137	PASS	DP=332;AN=4	GT	0/1	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	11058353	11058353	T	C	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	401	21	11058353	chr21:11058353	T	C	115	PASS	DP=401;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.
21	11058377	11058377	C	T	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	184	21	11058377	chr21:11058377	C	T	86	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	14439357	14439357	C	G	ncRNA_exonic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	46	21	14439357	chr21:14439357	C	G	82	PASS	DP=46;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	14469814	14469814	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	21	14469814	chr21:14469814	C	T	.	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	14485395	14485395	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	163	441	21	14485395	chr21:14485395	C	T	163	PASS	DP=441;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	14721685	14721685	C	G	intergenic	ANKRD30BP2;MIR3156-3	dist=231114;dist=57020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	21	14721685	chr21:14721685	C	G	.	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	14722780	14722780	A	G	intergenic	ANKRD30BP2;MIR3156-3	dist=232209;dist=55925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	118	21	14722780	chr21:14722780	A	G	71	PASS	DP=118;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	14756846	14756846	C	A	intergenic	ANKRD30BP2;MIR3156-3	dist=266275;dist=21859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	21	14756846	chr21:14756846	C	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	15311637	15311637	G	T	intergenic	LOC110091776;ANKRD20A11P	dist=5437;dist=4459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	21	15311637	chr21:15311637	G	T	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
21	15311638	15311638	C	T	intergenic	LOC110091776;ANKRD20A11P	dist=5438;dist=4458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	21	15311638	chr21:15311638	C	T	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
21	15352253	15352253	A	C	ncRNA_exonic	ANKRD20A11P	.	.	.	.	.	.	.	0.00688	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	53	21	15352253	chr21:15352253	A	C	71	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
21	15988212	15988212	-	G	intronic	LOC388813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	98	21	15988212	chr21:15988212	A	AG	90	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	17236606	17236606	C	T	exonic	USP25	.	nonsynonymous SNV	USP25:NM_013396:exon19:c.C2357T:p.A786V,USP25:NM_001283042:exon20:c.C2453T:p.A818V,USP25:NM_001283041:exon21:c.C2567T:p.A856V	0.990130458	0.009869542	7.96E-12	.	0.1656	0.10985	-0.905656269	10.12031139	259.94554	3.46398	0.007	0.614	D	0.078	0.286	B	0.087	0.343	B	0.004	0.343	N	0.979	0.810	D	1.995	0.543	M	1.86	0.245	T	-2.41	0.545	N	0.194	0.238	-0.694	0.607	T	0.291	0.663	T	0.010	0.265	T	4.288	0.574	24.0	0.998	0.873	0.968	0.708	D	c	0.368	0.469	1.000	0.747	0.732	0.924	0	5.62	0.857	4.625	0.607	0.935	0.490	1.000	0.715	0.993	0.574	20.011	0.974	.	.	.	0.5	.	24	21	17236606	chr21:17236606	C	T	.	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	18924237	18924237	T	G	exonic	CXADR	.	synonymous SNV	CXADR:NM_001207063:exon3:c.T381G:p.G127G,CXADR:NM_001207064:exon3:c.T381G:p.G127G,CXADR:NM_001207066:exon3:c.T381G:p.G127G,CXADR:NM_001338:exon3:c.T381G:p.G127G	0.342891275	0.654169916	0.00293881	.	.	0.2281	-0.005381972	53.50908233	105.35884	2.22286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	67	21	18924237	chr21:18924237	T	G	58	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	30255396	30255396	-	A	intronic	N6AMT1	.	.	.	0.009871785	0.821358578	0.168769637	.	0.48968	0.09594	0.72761005	86.08162302	1301.02352	6.78541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.15	37	21	30255396	chr21:30255396	G	GA	16.15	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	30257560	30257560	C	G	exonic	N6AMT1	.	synonymous SNV	N6AMT1:NM_013240:exon1:c.G108C:p.L36L,N6AMT1:NM_182749:exon1:c.G108C:p.L36L	0.009871785	0.821358578	0.168769637	.	0.48968	0.09594	0.72761005	86.08162302	1301.02352	6.78541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	285	21	30257560	chr21:30257560	C	G	95	PASS	DP=285;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	30338207	30338207	G	A	exonic	LTN1	.	nonsynonymous SNV	LTN1:NM_015565:exon11:c.C2281T:p.L761F	0.83271401	0.16728599	1.69E-11	.	0.63029	0.09925	0.26079244	70.06369427	4364.96083	13.18197	0.229	0.183	T	0.0	0.026	B	0.0	0.013	B	0.933	0.075	N	0.954	0.264	N	0.985	0.251	L	2.18	0.679	T	-1.3	0.326	N	0.047	0.028	-1.029	0.207	T	0.111	0.398	T	0.016	0.377	T	1.278	0.218	12.15	0.963	0.289	0.462	0.275	N	c	-0.739	-0.632	0.781	0.238	0.707	0.730	0	-1.52	0.081	0.204	0.170	0.031	0.150	0.993	0.376	0.991	0.552	1.593	0.025	Armadillo-type fold	.	.	0.5	.	74	21	30338207	chr21:30338207	G	A	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	32253409	32253409	A	T	exonic	KRTAP11-1	.	stopgain	KRTAP11-1:NM_175858:exon1:c.T435A:p.C145X	0.00426873	0.662516423	0.333214847	.	0.22409	0.09008	0.659651797	84.35362114	3007.85811	10.41393	.	.	.	.	.	.	.	.	.	0.012	0.291	N	1.000	0.548	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.303	0.962	35	0.989	0.474	0.164	0.192	N	c	0.137	-0.081	0.000	0.029	0.487	0.133	0	0.372	0.153	0.081	0.146	-0.546	0.048	0.645	0.279	0.981	0.494	8.509	0.322	.	.	.	0.5	119	94	21	32253409	chr21:32253409	A	T	119	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
21	32508223	32508223	C	A	intronic	TIAM1	.	.	.	0.999932006	6.80E-05	1.04E-15	.	0.48136	0.33272	-0.913225292	9.843123378	5001.55165	14.43752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	108	21	32508223	chr21:32508223	C	A	80	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	33069024	33069024	-	TTCTGGCTCATCATCATAGTCAAATCTATCAAGCAACTTCTTTTTTAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAATTCTGGAATAATTATGTCAATATTTCATTTTAAAATTTAGACTGA	exonic	SCAF4	.	stopgain	SCAF4:NM_001145444:exon7:c.771_772insTCAGTCTAAATTTTAAAATGAAATATTGACATAATTATTCCAGAATTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATTAAAAAAGAAGTTGCTTGATAGATTTGACTATGATGATGAGCCAGAA:p.A258_R1132delinsSV,SCAF4:NM_001145445:exon8:c.816_817insTCAGTCTAAATTTTAAAATGAAATATTGACATAATTATTCCAGAATTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATTAAAAAAGAAGTTGCTTGATAGATTTGACTATGATGATGAGCCAGAA:p.A273_R1125delinsSV,SCAF4:NM_020706:exon8:c.816_817insTCAGTCTAAATTTTAAAATGAAATATTGACATAATTATTCCAGAATTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATTAAAAAAGAAGTTGCTTGATAGATTTGACTATGATGATGAGCCAGAA:p.A273_R1147delinsSV	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	154	21	33069024	chr21:33069024	C	CTTCTGGCTCATCATCATAGTCAAATCTATCAAGCAACTTCTTTTTTAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAATTCTGGAATAATTATGTCAATATTTCATTTTAAAATTTAGACTGA,CACCATTGTTAGTTTTTTTT	43	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	33069024	33069024	-	ACCATTGTTAGTTTTTTTT	exonic	SCAF4	.	stopgain	SCAF4:NM_001145444:exon7:c.771_772insAAAAAAAACTAACAATGGT:p.A258Kfs*3,SCAF4:NM_001145445:exon8:c.816_817insAAAAAAAACTAACAATGGT:p.A273Kfs*3,SCAF4:NM_020706:exon8:c.816_817insAAAAAAAACTAACAATGGT:p.A273Kfs*3	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	154	21	33069024	chr21:33069024	C	CTTCTGGCTCATCATCATAGTCAAATCTATCAAGCAACTTCTTTTTTAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAATTCTGGAATAATTATGTCAATATTTCATTTTAAAATTTAGACTGA,CACCATTGTTAGTTTTTTTT	43	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	33078562	33078562	T	A	intronic	SCAF4	.	.	.	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	39	21	33078562	chr21:33078562	T	A	50	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	33078569	33078569	G	A	intronic	SCAF4	.	.	.	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	21	33078569	chr21:33078569	G	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	33725043	33725043	G	A	exonic	URB1	.	synonymous SNV	URB1:NM_014825:exon19:c.C2589T:p.I863I	.	.	.	.	0.19883	0.09434	2.699225953	98.89124794	843.19169	5.68362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	21	33725043	chr21:33725043	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	33867280	33867280	A	G	intronic	EVA1C	.	.	.	0.325814898	0.670822939	0.003362163	.	0.15987	.	0.174625237	65.9648502	244.83382	3.37468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	6	21	33867280	chr21:33867280	A	G	41	PASS	DP=6;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
21	33993852	33993852	-	T	intergenic	C21orf59-TCP10L;SYNJ1	dist=8671;dist=7217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	294	21	33993852	chr21:33993852	C	CT	71	PASS	DP=294;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
21	34017906	34017906	T	C	intronic	SYNJ1	.	.	.	0.214295146	0.785704854	2.10E-10	DISEASE: Parkinson disease 20, early-onset (PARK20) [MIM:615530]: An early-onset form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK20 is characterized by young adult-onset of parkinsonism. Additional features may include seizures, cognitive decline, abnormal eye movements, and dystonia. {ECO:0000269|PubMed:23804563, ECO:0000269|PubMed:23804577}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72364	0.1212	0.499660491	79.67091295	3892.53157	12.30627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	38	21	34017906	chr21:34017906	T	C	69	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
21	35467710	35467720	TGGAGCTGCAA	-	exonic	SLC5A3	.	frameshift deletion	SLC5A3:NM_006933:exon2:c.213_223del:p.G72Wfs*35	0.84946475	0.149995365	0.000539885	.	0.47678	0.38085	-0.666770504	15.86459071	50.54376	1.39893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	137	21	35467709	chr21:35467709	CTGGAGCTGCAA	C	88	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	36265324	36265324	T	-	intronic	RUNX1	.	.	.	0.449323607	0.549373498	0.001302896	DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of M2 type acute myeloid leukemia (AML-M2). Translocation t(8;21)(q22;q22) with RUNX1T1.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of therapy-related myelodysplastic syndrome (T-MDS). Translocation t(3;21)(q26;q22) with EAP or MECOM.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.; DISEASE: Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.; DISEASE: Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]: Autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia. {ECO:0000269|PubMed:10508512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.; 	0.71814	0.72461	-0.227663163	37.11370606	85.67689	1.97553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	22	21	36265323	chr21:36265323	CT	C	43	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	37664460	37664460	G	T	exonic	DOPEY2	.	nonsynonymous SNV	DOPEY2:NM_001320714:exon36:c.G6574T:p.V2192L,DOPEY2:NM_005128:exon36:c.G6574T:p.V2192L	9.61E-08	0.999999892	1.15E-08	.	0.29781	0.10131	-3.64623945	0.277188016	3301.99985	10.96533	0.626	0.052	T	0.0	0.026	B	0.0	0.013	B	0.304	0.145	N	1	0.090	N	-1.98	0.002	N	1.09	0.392	T	0.4	0.035	N	0.026	0.008	-0.982	0.346	T	0.018	0.077	T	0.006	0.159	T	-0.920	0.035	0.023	0.655	0.076	0.037	0.089	N	c	-1.866	-1.738	0.985	0.308	0.706	0.609	0	-0.309	0.121	-0.508	0.064	-0.442	0.057	0.000	0.063	0.822	0.344	2.821	0.051	.	.	.	0.5	.	37	21	37664460	chr21:37664460	G	T	.	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
21	38092248	38092248	A	-	intronic	SIM2	.	.	.	0.178825369	0.820642349	0.000532282	.	0.36242	0.24747	-0.198338176	39.17197452	2208.64464	8.65301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	57	21	38092247	chr21:38092247	GA	G	74	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	38132055	38132055	T	C	exonic	HLCS	.	nonsynonymous SNV	HLCS:NM_000411:exon10:c.A1768G:p.M590V,HLCS:NM_001242784:exon10:c.A1768G:p.M590V,HLCS:NM_001242785:exon10:c.A1768G:p.M590V	0.486548324	0.513252415	0.000199261	.	0.07149	0.25106	-0.591542347	18.24722812	151.46286	2.69061	0.348	0.124	T	0.002	0.090	B	0.007	0.121	B	0.112	0.194	N	1.000	0.192	N	0.735	0.189	N	-3.32	0.939	D	-1.09	0.283	N	0.178	0.218	-0.471	0.697	T	0.400	0.751	T	0.042	0.603	D	0.448	0.137	7.021	0.640	0.072	0.097	0.152	N	c	-1.260	-1.285	1.000	0.747	0.638	0.428	0	-8.42	0.008	0.029	0.134	0.008	0.138	0.007	0.175	0.987	0.523	2.446	0.042	Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain	.	.	0.5	.	77	21	38132055	chr21:38132055	T	C	.	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
21	38459601	38459601	C	T	exonic	TTC3	.	nonsynonymous SNV	TTC3:NM_001001894:exon2:c.C44T:p.A15V,TTC3:NM_001320703:exon2:c.C110T:p.A37V,TTC3:NM_001320704:exon2:c.C44T:p.A15V,TTC3:NM_001330683:exon2:c.C44T:p.A15V,TTC3:NM_003316:exon2:c.C44T:p.A15V	5.39E-20	0.999708412	0.000291588	.	0.33574	0.08857	-0.972178525	8.911299835	2405.24665	9.10751	0.077	0.437	T	0.595	0.373	P	0.123	0.309	B	0.216	0.163	N	1	0.810	D	1.845	0.488	L	2.69	0.460	T	-0.81	0.245	N	0.273	0.455	-1.095	0.048	T	0.073	0.297	T	0.011	0.280	T	2.851	0.403	21.6	0.995	0.664	0.241	0.221	N	c	-0.344	-0.364	1.0	0.983	0.744	0.983	0	2.96	0.332	0.099	0.149	0.024	0.147	0.010	0.182	0.616	0.292	7.207	0.249	.	.	.	0.5	39	30	21	38459601	chr21:38459601	C	T	39	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
21	38639638	38639638	C	-	UTR5	DSCR3	NM_001331018:c.-43delG;NM_001331021:c.-43delG;NM_001331022:c.-43delG;NM_006052:c.-43delG	.	.	0.505918972	0.489971529	0.004109499	.	0.14303	0.12016	-0.26993514	34.59542345	28.95913	0.9253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	120	21	38639637	chr21:38639637	AC	A	80	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	40684799	40684799	C	T	exonic	BRWD1	.	nonsynonymous SNV	BRWD1:NM_001007246:exon4:c.G166A:p.G56S,BRWD1:NM_018963:exon4:c.G166A:p.G56S,BRWD1:NM_033656:exon4:c.G166A:p.G56S	0.999999462	5.38E-07	6.53E-23	.	0.64569	0.10719	-0.821412236	11.77164426	5050.46205	14.54368	0.004	0.654	D	0.737	0.899	P	0.215	0.971	B	0.000	0.629	D	1.000	0.588	D	3.095	0.878	M	1.14	0.384	T	-5.16	0.869	D	0.549	0.585	-0.464	0.699	T	0.263	0.634	T	0.718	0.977	D	6.777	0.923	32	0.997	0.796	0.808	0.401	D	c	0.507	0.423	1.000	0.747	0.658	0.486	0	3.06	0.342	6.150	0.714	0.028	0.149	1.000	0.715	0.999	0.750	12.682	0.561	.	.	.	0.5	.	124	21	40684799	chr21:40684799	C	T	.	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	40759799	40759799	G	-	intronic	WRB;WRB-SH3BGR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	19	21	40759798	chr21:40759798	AG	A	53	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
21	43299197	43299197	G	A	exonic	PRDM15	.	nonsynonymous SNV	PRDM15:NM_022115:exon2:c.C155T:p.A52V	0.753744615	0.246255384	1.22E-09	.	0.0747	0.10154	-2.001084103	1.733899505	875.44322	5.75655	0.069	0.355	T	0.099	0.241	B	0.01	0.139	B	.	.	.	1	0.810	D	0	0.065	N	2.89	0.102	T	-0.21	0.103	N	0.088	0.084	-0.985	0.337	T	0.014	0.056	T	0.270	0.899	D	3.673	0.498	23.3	0.996	0.732	0.002	0.010	N	c	-0.654	-0.578	1.000	0.747	0.623	0.393	0	1.37	0.211	0.388	0.203	-0.175	0.105	0.643	0.279	0.996	0.625	8.310	0.310	.	.	.	0.5	.	38	21	43299197	chr21:43299197	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	43829538	43829538	G	A	exonic	UBASH3A	.	nonsynonymous SNV	UBASH3A:NM_001001895:exon3:c.G175A:p.D59N,UBASH3A:NM_001243467:exon3:c.G175A:p.D59N,UBASH3A:NM_018961:exon3:c.G175A:p.D59N	3.97E-07	0.944205183	0.055794419	.	0.15909	0.14549	-0.87816671	10.58032555	520.99741	4.66093	0.269	0.496	T	0.118	0.251	B	0.031	0.206	B	0.376	0.134	N	1	0.090	N	0	0.065	N	2.0	0.215	T	0.2	0.049	N	0.082	0.092	-1.013	0.259	T	0.024	0.101	T	0.007	0.188	T	-0.269	0.071	0.778	0.956	0.269	0.611	0.311	D	c	-0.925	-0.871	0.994	0.333	0.447	0.083	0	0.446	0.157	2.291	0.430	-0.312	0.078	0.967	0.338	0.001	0.043	7.201	0.249	UBA-like|Ubiquitin-associated domain	.	.	0.5	.	48	21	43829538	chr21:43829538	G	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	45094558	45094558	G	A	exonic	RRP1B	.	synonymous SNV	RRP1B:NM_015056:exon5:c.G399A:p.K133K	0.036818435	0.963118575	6.30E-05	.	0.43897	0.12441	-0.354480518	29.42911064	196.09453	3.03033	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	21	45094558	chr21:45094558	G	A	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
21	45970993	45970993	C	G	exonic	KRTAP10-2	.	nonsynonymous SNV	KRTAP10-2:NM_198693:exon1:c.G349C:p.A117P	0.017072106	0.71341424	0.269513654	.	0.10939	.	0.971952656	90.26893135	2694.09373	9.76825	0.684	0.044	T	0.89	0.470	P	0.293	0.390	B	.	.	.	1.000	0.090	P	1.495	0.376	L	5.85	0.007	T	0.12	0.056	N	0.05	0.034	-1.108	0.032	T	0.000	0.000	T	.	.	.	-0.654	0.047	0.093	0.611	0.065	0.017	0.053	N	c	-1.156	-1.281	1.000	0.473	0.609	0.351	0	0.117	0.139	-4.321	0.003	-3.150	0.001	0.000	0.063	0.000	0.016	6.221	0.198	.	.	.	0.5	103	135	21	45970993	chr21:45970993	C	G	103	PASS	DP=135;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	45999772	45999772	T	C	exonic	KRTAP10-5	.	nonsynonymous SNV	KRTAP10-5:NM_198694:exon1:c.A684G:p.I228M	8.25E-05	0.321633815	0.678283707	.	.	.	1.953079981	97.54659118	4100.88283	12.70549	0.047	0.403	D	0.256	0.296	B	0.262	0.378	B	.	.	.	1	0.810	D	-0.05	0.049	N	5.78	0.007	T	-1.45	0.356	N	0.116	0.130	-0.887	0.492	T	0.002	0.007	T	0.008	0.201	T	1.241	0.214	11.96	0.938	0.232	0.035	0.086	N	c	-0.684	-0.626	0.000	0.070	0.487	0.133	0	1.72	0.234	-0.098	0.109	-0.366	0.067	0.049	0.212	0.062	0.172	3.773	0.081	.	.	.	0.5	63	100	21	45999772	chr21:45999772	T	C	63	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	46011687	46011687	C	T	exonic	KRTAP10-6	.	nonsynonymous SNV	KRTAP10-6:NM_198688:exon1:c.G679A:p.A227T	1.55E-05	0.242389557	0.757594911	.	.	.	3.24344868	99.38664779	6418.15237	16.78541	0.5	0.077	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	P	1.085	0.274	L	5.04	0.013	T	-1.74	0.412	N	0.023	0.006	-0.929	0.443	T	0.000	0.000	T	.	.	.	-0.650	0.047	0.094	0.752	0.106	0.010	0.037	N	c	-2.148	-2.281	0.515	0.210	0.526	0.212	0	-5.22	0.026	-5.836	0.001	-3.543	0.001	0.000	0.063	0.000	0.016	1.403	0.021	.	ENSG00000188155.8	Testis	0.5	81	211	21	46011687	chr21:46011687	C	T	81	PASS	DP=211;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	46554675	46554675	G	A	intronic	ADARB1	.	.	.	0.843939347	0.155939433	0.00012122	.	0.28156	0.13431	-0.800872469	12.33191791	35.57047	1.07201	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	-0.956	0.399	T	0.097	0.365	T	.	.	.	-0.082	0.086	1.868	0.596	0.061	0.001	0.005	N	c	-0.937	-1.185	1.000	0.489	0.322	0.047	0	-1.4	0.085	-0.357	0.076	-0.551	0.047	0.000	0.063	0.001	0.043	4.253	0.101	.	.	.	0.5	.	45	21	46554675	chr21:46554675	G	A	.	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
21	46554688	46554688	C	A	intronic	ADARB1	.	.	.	0.843939347	0.155939433	0.00012122	.	0.28156	0.13431	-0.800872469	12.33191791	35.57047	1.07201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	21	46554688	chr21:46554688	C	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	46913477	46913477	G	C	exonic	COL18A1	.	nonsynonymous SNV	COL18A1:NM_030582:exon25:c.G2880C:p.Q960H,COL18A1:NM_130444:exon25:c.G3585C:p.Q1195H,COL18A1:NM_130445:exon26:c.G2340C:p.Q780H	1.24E-05	0.999986852	7.71E-07	DISEASE: Knobloch syndrome 1 (KNO1) [MIM:267750]: A developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia. {ECO:0000269|PubMed:10942434, ECO:0000269|PubMed:23667181}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35149	.	0.743953846	86.36470866	5515.49068	15.31657	0.25	0.285	T	0.011	0.147	B	0.012	0.149	B	0.621	0.108	N	1.000	0.197	P	1.88	0.501	L	-3.22	0.934	D	-1.79	0.488	N	0.063	0.091	-0.854	0.517	T	0.011	0.044	T	.	.	.	0.508	0.143	7.491	0.993	0.576	0.061	0.120	N	c	-0.944	-0.958	0.739	0.232	0.707	0.730	0	0.37	0.153	0.360	0.198	0.998	0.613	0.013	0.187	0.959	0.439	6.075	0.190	.	.	.	0.5	98	256	21	46913477	chr21:46913477	G	C	98	PASS	DP=256;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	46925161	46925161	G	C	exonic	COL18A1	.	synonymous SNV	COL18A1:NM_030582:exon35:c.G3513C:p.G1171G,COL18A1:NM_130444:exon35:c.G4218C:p.G1406G,COL18A1:NM_130445:exon36:c.G2973C:p.G991G	1.24E-05	0.999986852	7.71E-07	DISEASE: Knobloch syndrome 1 (KNO1) [MIM:267750]: A developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia. {ECO:0000269|PubMed:10942434, ECO:0000269|PubMed:23667181}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35149	.	0.743953846	86.36470866	5515.49068	15.31657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	198	21	46925161	chr21:46925161	G	C	91	PASS	DP=198;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	46945700	46945700	C	-	intronic	SLC19A1	.	.	.	0.0123881	0.952273227	0.035338672	.	0.0749	.	-0.286522835	33.47487615	1149.843	6.46099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	72	21	46945699	chr21:46945699	TC	T	65	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	47545823	47545823	G	A	exonic	COL6A2	.	synonymous SNV	COL6A2:NM_001849:exon26:c.G2094A:p.A698A,COL6A2:NM_058174:exon26:c.G2094A:p.A698A,COL6A2:NM_058175:exon26:c.G2094A:p.A698A	0.002133757	0.99785937	6.87E-06	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:11865138, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:8782832}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15563506, ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myosclerosis autosomal recessive (MYOSAR) [MIM:255600]: A condition characterized by chronic inflammation of skeletal muscle with hyperplasia of the interstitial connective tissue. The clinical picture includes slender muscles with firm 'woody' consistency and restriction of movement of many joints because of muscle contractures. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.50744	0.37851	-1.001964775	8.221278603	5707.29483	15.65413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	274	21	47545823	chr21:47545823	G	A	103	PASS	DP=274;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	47614405	47614405	C	A	exonic	LSS	.	nonsynonymous SNV	LSS:NM_001145437:exon19:c.G1748T:p.R583L,LSS:NM_001001438:exon20:c.G1988T:p.R663L,LSS:NM_001145436:exon20:c.G1955T:p.R652L,LSS:NM_002340:exon20:c.G1988T:p.R663L	0.000604838	0.999353008	4.22E-05	.	0.09964	0.38626	0.540106923	81.09813635	1845.09003	7.92325	0.152	0.327	T	0.995	0.670	D	0.805	0.566	P	0.000	0.843	D	1	0.810	D	2.755	0.808	M	1.97	0.221	T	-4.99	0.829	D	0.796	0.824	-1.141	0.013	T	0.078	0.312	T	0.045	0.620	D	5.650	0.770	26.7	0.996	0.740	0.965	0.692	D	c	0.480	0.465	1.000	0.747	0.707	0.730	0	5.07	0.680	7.647	0.825	0.935	0.490	1.000	0.715	0.289	0.235	18.434	0.905	Squalene cyclase, C-terminal|Terpene synthase, conserved site|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid;Squalene cyclase, C-terminal|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid	.	.	0.5	116	102	21	47614405	chr21:47614405	C	A	116	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
21	47845915	47845915	C	-	intronic	PCNT	.	.	.	4.18E-38	0.557429948	0.442570052	DISEASE: Microcephalic osteodysplastic primordial dwarfism 2 (MOPD2) [MIM:210720]: Adults with this rare inherited condition have an average height of 100 centimeters and a brain size comparable to that of a 3-month-old baby, but are of near-normal intelligence. {ECO:0000269|PubMed:18157127, ECO:0000269|PubMed:18174396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12195	0.21397	3.571342941	99.52229299	12581.30373	24.04834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.57	42	21	47845914	chr21:47845914	TC	T	23.57	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
21	47976820	47976820	T	-	intronic	DIP2A	.	.	.	0.726099074	0.273900925	1.67E-09	.	0.20513	0.09801	-2.776863601	0.678225997	1074.58254	6.28283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	15	21	47976819	chr21:47976819	CT	C	43	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	16255875	16255875	G	T	downstream	POTEH	dist=457	.	.	.	.	.	.	0.04666	0.08864	.	.	531.82086	4.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	250	22	16255875	chr22:16255875	G	T	109	PASS	DP=250;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	16267032	16267032	C	A	exonic	POTEH	.	nonsynonymous SNV	POTEH:NM_001136213:exon9:c.G1417T:p.G473C	.	.	.	.	0.04666	0.08864	.	.	531.82086	4.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	551	22	16267032	chr22:16267032	C	A	127	PASS	DP=551;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	18910451	18910451	A	-	intronic	PRODH	.	.	.	4.75E-06	0.851614667	0.14838058	DISEASE: Hyperprolinemia 1 (HYRPRO1) [MIM:239500]: An inborn error of proline metabolism resulting in elevated levels of proline in the plasma and urine. The disorder is generally benign and most affected individuals are clinically asymptomatic. Some patients, however, have neurologic manifestations, including epilepsy and mental retardation. Association with certain forms of schizophrenia have been reported. {ECO:0000269|PubMed:12217952, ECO:0000269|PubMed:15662599, ECO:0000269|PubMed:17135275}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schizophrenia 4 (SCZD4) [MIM:600850]: A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder. {ECO:0000269|PubMed:11891283, ECO:0000269|PubMed:15662599}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.66122	.	1.73619725	96.62656287	2500.61703	9.31868	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	47	22	18910450	chr22:18910450	CA	C	82	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	18973471	18973471	T	C	ncRNA_intronic	DGCR5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	142	22	18973471	chr22:18973471	T	C	77	PASS	DP=142;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	20132980	20132980	C	-	UTR3	ZDHHC8	NM_013373:c.*57delC	.	.	0.988991096	0.011008753	1.52E-07	.	0.15989	.	-1.168429872	6.062750649	606.91004	4.98443	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	12	22	20132979	chr22:20132979	AC	A	55	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	20137169	20137169	G	A	intronic	CCDC188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	128	22	20137169	chr22:20137169	G	A	116	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	20137322	20137322	A	G	UTR5	CCDC188	NM_001243537:c.-61T>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	83	22	20137322	chr22:20137322	A	G	84	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	20295384	20295384	C	-	intergenic	RTN4R;DGCR6L	dist=39568;dist=6377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	125	22	20295383	chr22:20295383	GC	G	88	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	20457177	20457247	GAAGTCAGATGCATACTGTTGGCTGGCGCCCAGCTGGGGAGGTGTGAACCCTTGGGCATCTTGCTTTTGCC	-	exonic	RIMBP3	.	frameshift deletion	RIMBP3:NM_015672:exon1:c.4055_4125del:p.R1352Pfs*1	.	.	.	.	.	0.08391	.	.	1804.88297	7.84008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	61	22	20457176	chr22:20457176	GGAAGTCAGATGCATACTGTTGGCTGGCGCCCAGCTGGGGAGGTGTGAACCCTTGGGCATCTTGCTTTTGCC	G	41	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	20847401	20847401	C	A	intronic	KLHL22	.	.	.	0.702611047	0.297235373	0.00015358	.	0.52594	0.11209	-1.199555187	5.761972163	26.86408	0.8677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	22	20847401	chr22:20847401	C	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	21057025	21057025	G	A	ncRNA_intronic	TMEM191A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	193	22	21057025	chr22:21057025	G	A	.	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	21057318	21057318	G	A	ncRNA_exonic	TMEM191A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	129	22	21057318	chr22:21057318	G	A	92	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	21354970	21354970	C	G	exonic	THAP7	.	nonsynonymous SNV	THAP7:NM_030573:exon3:c.G343C:p.A115P,THAP7:NM_001008695:exon4:c.G343C:p.A115P	0.029327855	0.923633046	0.047039099	.	0.37131	0.10994	.	.	76.37465	1.83233	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.888	0.087	N	1	0.090	P	-0.345	0.033	N	-3.75	0.955	D	0.94	0.015	N	0.024	0.007	-0.977	0.357	T	0.000	0.000	T	.	.	.	-0.669	0.046	0.085	0.483	0.040	0.009	0.036	N	c	-1.868	-1.808	1.000	0.747	0.628	0.401	0	0.539	0.163	0.097	0.149	-0.760	0.034	0.004	0.165	0.000	0.016	3.205	0.062	.	.	.	0.5	160	92	22	21354970	chr22:21354970	C	G	160	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
22	21363782	21363782	G	A	ncRNA_exonic	THAP7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	189	22	21363782	chr22:21363782	G	A	.	PASS	DP=189;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	21470329	21470329	C	A	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	174	22	21470329	chr22:21470329	C	A	.	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	21470406	21470406	C	T	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	143	22	21470406	chr22:21470406	C	T	.	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	21537822	21537822	C	A	ncRNA_intronic	FAM230B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	247	22	21537822	chr22:21537822	C	A	102	PASS	DP=247;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	21583596	21583597	CT	-	intronic	GGT2	.	.	.	0.80481651	0.190051731	0.005131759	.	.	0.11718	.	.	1425.85016	7.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	34	22	21583595	chr22:21583595	ACT	A	69	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	23735649	23735649	C	A	ncRNA_intronic	ZDHHC8P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	93	22	23735649	chr22:23735649	C	A	129	PASS	DP=93;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	24180781	24180781	C	T	exonic	DERL3	.	nonsynonymous SNV	DERL3:NM_001002862:exon3:c.G203A:p.G68E,DERL3:NM_001135751:exon3:c.G203A:p.G68E,DERL3:NM_198440:exon3:c.G203A:p.G68E	0.000238218	0.52095039	0.478811391	.	0.23259	0.12763	0.595326758	82.66100495	1232.36532	6.63447	0.004	0.654	D	1.0	0.899	D	0.99	0.774	D	0.000	0.843	D	1	0.810	D	3.98	0.967	H	1.45	0.325	T	-6.63	0.922	D	0.869	0.856	-0.502	0.686	T	0.248	0.618	T	0.206	0.871	D	6.210	0.857	28.7	0.998	0.902	0.971	0.725	D	c	0.806	0.699	1.000	0.747	0.726	0.872	0	4.21	0.488	7.526	0.807	0.932	0.445	1.000	0.715	1.000	0.888	8.335	0.312	.	.	.	0.5	.	88	22	24180781	chr22:24180781	C	T	.	PASS	DP=88;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	24658397	24658397	C	T	ncRNA_exonic	POM121L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	22	24658397	chr22:24658397	C	T	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	24665292	24665292	T	C	intergenic	POM121L9P;SPECC1L-ADORA2A	dist=3800;dist=1493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	22	24665292	chr22:24665292	T	C	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	25574407	25574407	A	G	intronic	KIAA1671	.	.	.	.	.	.	.	.	.	.	.	239.04669	3.34052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	55	22	25574407	chr22:25574407	A	G	74	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	25715733	25715733	G	C	ncRNA_splicing	IGLL3P	NR_029395:exon3:c.216-1G>C	.	.	.	.	.	.	0.05956	0.07001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	22	25715733	chr22:25715733	G	C	.	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	25771874	25771874	C	A	UTR5	LRP5L	NM_001135772:c.-15815G>T	.	.	3.87E-11	0.00690637	0.99309363	.	0.09203	.	0.756930627	86.79523473	937.76875	5.93572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	298	22	25771874	chr22:25771874	C	A	75	PASS	DP=298;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	26422845	26422845	C	A	exonic	MYO18B	.	stopgain	MYO18B:NM_001318245:exon43:c.C6908A:p.S2303X,MYO18B:NM_032608:exon43:c.C6905A:p.S2302X	2.61E-15	0.99999606	3.94E-06	.	0.16167	0.10792	1.205427351	93.02311866	5231.65918	14.90607	.	.	.	.	.	.	.	.	.	0.005	0.329	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.780	0.978	38	0.991	0.513	0.308	0.240	N	c	0.235	-0.047	0.697	0.226	0.554	0.246	0	3.57	0.399	2.155	0.417	0.935	0.490	0.057	0.215	0.282	0.234	8.680	0.332	.	.	.	0.5	90	85	22	26422845	chr22:26422845	C	A	90	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	26897791	26897794	AAAA	-	intronic	TFIP11	.	.	.	1.97E-06	0.993647861	0.006350171	.	0.17486	0.11762	-1.524862616	3.42061807	160.57464	2.76594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	40	22	26897790	chr22:26897790	CAAAA	C	56	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	27019121	27019121	C	A	intronic	CRYBA4	.	.	.	6.69E-08	0.257581927	0.742418006	DISEASE: Cataract 23 (CTRCT23) [MIM:610425]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT23 is a zonular cataract. Zonular or lamellar cataracts are opacities, broad or narrow, usually consisting of powdery white dots affecting only certain layers or zones between the cortex and nucleus of an otherwise clear lens. The opacity may be so dense as to render the entire central region of the lens completely opaque, or so translucent that vision is hardly if at all impeded. Zonular cataracts generally do not involve the embryonic nucleus, though sometimes they involve the fetal nucleus. Usually sharply separated from a clear cortex outside them, they may have projections from their outer edges known as riders or spokes. {ECO:0000269|PubMed:16960806}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20946	0.13306	0.21689899	68.12927577	150.50912	2.67784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	22	27019121	chr22:27019121	C	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	29130347	29130347	-	T	intronic	CHEK2	.	.	.	1.18E-15	0.005518936	0.994481064	DISEASE: Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]: A highly penetrant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:11719428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:12533788}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating in bone-forming cells, affecting the ends of long bones. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:12094328, ECO:0000269|PubMed:21618645, ECO:0000269|PubMed:25619829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:12094328}.; 	0.98514	0.65565	-0.134019284	43.90776126	138.54243	2.56375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	20	22	29130347	chr22:29130347	G	GT	72	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	29683091	29683091	A	G	exonic	EWSR1	.	nonsynonymous SNV	EWSR1:NM_001163286:exon6:c.A593G:p.Y198C,EWSR1:NM_001163285:exon7:c.A761G:p.Y254C,EWSR1:NM_001163287:exon7:c.A761G:p.Y254C,EWSR1:NM_005243:exon7:c.A761G:p.Y254C,EWSR1:NM_013986:exon8:c.A779G:p.Y260C	0.998559249	0.00144075	2.13E-10	DISEASE: Ewing sarcoma (ES) [MIM:612219]: A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. {ECO:0000269|PubMed:15044653, ECO:0000269|PubMed:1522903, ECO:0000269|PubMed:7700648, ECO:0000269|PubMed:9121764}. Note=The protein represented in this entry is involved in disease pathogenesis. Chromosomal aberrations involving EWSR1 are found in patients with Ewing sarcoma. Translocation t(11;22)(q24;q12) with FLI1 (PubMed:1522903, PubMed:15044653). Translocation t(7;22)(p22;q12) with ETV1 (PubMed:7700648). Translocation t(21;22)(q22;q21) with ERG (PubMed:15044653). Translocation t(2;21;22)(q23;q22;q12) that forms a EWSR1-FEV fusion protein with potential oncogenic activity (PubMed:9121764). {ECO:0000269|PubMed:15044653, ECO:0000269|PubMed:1522903, ECO:0000269|PubMed:7700648, ECO:0000269|PubMed:9121764}.; DISEASE: Note=A chromosomal aberration involving EWSR1 has been found in extraskeletal myxoid chondrosarcoma. Translocation t(9;22)(q22-31;q11-12) with NR4A3. {ECO:0000269|PubMed:7539287}.; DISEASE: Note=A chromosomal aberration involving EWSR1 is associated with desmoplastic small round cell tumor (DSRCT). Translocation t(11;22)(p13;q12) with WT1. {ECO:0000269|PubMed:7862627}.; DISEASE: Note=A chromosomal aberration involving EWSR1 is associated with malignant melanoma of soft parts (MMSP). Translocation t(12;22)(q13;q12) with ATF1. Malignant melanoma of soft parts, also known as soft tissue clear cell sarcoma, is a rare tumor developing in tendons and aponeuroses. {ECO:0000269|PubMed:8401579}.; DISEASE: Note=A chromosomal aberration involving EWSR1 is associated with small round cell sarcoma. Translocation t(11;22)(p36.1;q12) with PATZ1. {ECO:0000269|PubMed:10949935}.; DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. {ECO:0000269|PubMed:15884099, ECO:0000269|PubMed:17724745}. Note=The gene represented in this entry is involved in disease pathogenesis. Chromosomal aberrations involving EWSR1 are found in patients with angiomatoid fibrous histiocytoma. Translocation t(12;22)(q13;q12) with ATF1 generates a chimeric EWSR1/ATF1 protein (PubMed:15884099). Translocation t(2;22)(q33;q12) with CREB1 generates a EWSR1/CREB1 fusion gene that is most common genetic abnormality in this tumor type (PubMed:17724745). {ECO:0000269|PubMed:15884099, ECO:0000269|PubMed:17724745}.; DISEASE: Note=EFPS arise due to chromosomal translocations in which EWSR1 is fused to a variety of cellular transcription factors. EFPS are very potent transcriptional activators dependent on the EAD and a C-terminal DNA-binding domain contributed by the fusion partner. The spectrum of malignancies associated with EFPS are thought to arise via EFP-induced transcriptional deregulation, with the tumor phenotype specified by the EWSR1 fusion partner and cell type. Transcriptional repression of the transforming growth factor beta type II receptor (TGF beta RII) is an important target of the EWS-FLI1, EWS-ERG, or EWS-ETV1 oncogene. {ECO:0000305}.; 	0.95588	0.43129	-0.778825328	12.88039632	40.05548	1.1773	0.023	0.912	D	0.999	0.764	D	0.867	0.671	P	0.000	0.629	U	1.000	0.810	D	2.88	0.837	M	1.48	0.317	T	-4.85	0.965	D	0.757	0.872	-0.916	0.461	T	0.168	0.508	T	0.022	0.455	T	2.856	0.404	21.7	0.990	0.494	0.967	0.704	D	c	0.721	0.731	1.000	0.517	0.672	0.522	0	5.7	0.886	6.451	0.732	1.194	0.916	1.000	0.715	1.000	0.888	15.966	0.797	.	.	.	0.5	65	71	22	29683091	chr22:29683091	A	G	65	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	29837537	29837537	T	C	exonic	RFPL1	.	nonsynonymous SNV	RFPL1:NM_021026:exon2:c.T380C:p.M127T	0.00732601	0.770811708	0.221862282	.	0.09815	.	1.396334339	94.70393961	6338.15844	16.66012	0.034	0.440	D	0.982	0.581	D	0.998	0.875	D	.	.	.	0.990	0.242	P	2.89	0.840	M	2.87	0.104	T	-3.43	0.673	D	0.123	0.138	-0.959	0.394	T	0.000	0.000	T	.	.	.	3.716	0.504	23.3	0.980	0.369	0.816	0.407	D	c	0.162	-0.104	0.020	0.132	0.554	0.246	0	1.1	0.195	4.972	0.632	0.443	0.277	0.996	0.391	0.326	0.242	6.312	0.202	B30.2/SPRY domain|Butyrophylin-like|Concanavalin A-like lectin/glucanase domain|SPRY-associated	ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9|ENSG00000100296.9	Adipose_Subcutaneous|Artery_Tibial|Breast_Mammary_Tissue|Esophagus_Muscularis|Lung|Muscle_Skeletal|Skin_Sun_Exposed_Lower_leg|Thyroid	0.5	68	82	22	29837537	chr22:29837537	T	C	68	PASS	DP=82;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	30517869	30517869	G	T	intronic	HORMAD2	.	.	.	3.45E-05	0.584244147	0.415721368	.	0.14701	0.09455	0.927856124	89.70276008	116.45113	2.34686	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	34	22	30517869	chr22:30517869	G	T	51	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	30772228	30772228	-	T	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.73	84	22	30772228	chr22:30772228	C	CT,CTT	21.73	PASS	DP=84;AN=2	GT	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.	././.
22	30772228	30772228	-	TT	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.73	84	22	30772228	chr22:30772228	C	CT,CTT	21.73	PASS	DP=84;AN=2	GT	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.	././.
22	30795595	30795595	C	T	intronic	SEC14L2	.	.	.	4.31E-05	0.958730605	0.041226246	.	0.27976	0.12613	0.238945317	69.20853975	3585.08728	11.58105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	22	30795595	chr22:30795595	C	T	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	31019042	31019042	C	G	exonic	TCN2	.	synonymous SNV	TCN2:NM_000355:exon8:c.C1194G:p.L398L,TCN2:NM_001184726:exon8:c.C1113G:p.L371L	0.022289553	0.974456378	0.003254069	DISEASE: Transcobalamin II deficiency (TCN2 deficiency) [MIM:275350]: Results in various forms of anemia. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21133	0.56503	1.934667198	97.487615	1919.33765	8.06455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	89	22	31019042	chr22:31019042	C	G	107	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	31322631	31322631	G	A	ncRNA_exonic	MORC2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	22	31322631	chr22:31322631	G	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	31672777	31672777	C	-	exonic	LIMK2	.	frameshift deletion	LIMK2:NM_001031801:exon15:c.1712delC:p.A575Pfs*14	0.008440401	0.99099989	0.000559709	.	0.26618	0.2057	0.113945049	62.14319415	767.32501	5.48678	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	66	22	31672776	chr22:31672776	GC	G	51	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	32650200	32650200	C	T	exonic	SLC5A4	.	nonsynonymous SNV	SLC5A4:NM_014227:exon2:c.G136A:p.A46T	2.60E-13	0.125757351	0.874242649	.	0.08441	0.1124	0.736704836	86.32932295	914.47301	5.88119	0.017	0.512	D	0.228	0.288	B	0.206	0.354	B	0.000	0.843	D	0.000	0.588	P	2.89	0.840	M	-2.33	0.879	D	-1.68	0.401	N	0.167	0.207	-0.909	0.470	T	0.003	0.009	T	.	.	.	4.996	0.672	25.1	0.995	0.702	0.940	0.597	D	c	-0.113	-0.109	0.000	0.064	0.554	0.246	0	3.19	0.356	0.590	0.235	0.038	0.153	0.998	0.411	0.133	0.200	12.082	0.528	.	.	.	0.5	114	50	22	32650200	chr22:32650200	C	T	114	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	32756652	32756652	A	G	exonic	RFPL3	.	nonsynonymous SNV	RFPL3:NM_001098535:exon2:c.A787G:p.S263G,RFPL3:NM_006604:exon3:c.A700G:p.S234G	0.000158443	0.437571789	0.562269768	.	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	0.219	0.190	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0.935	0.237	L	0.12	0.611	T	-0.28	0.116	N	0.056	0.078	-1.028	0.211	T	0.108	0.392	T	.	.	.	-1.537	0.016	0.002	0.517	0.045	0.000	0.002	N	c	-1.461	-1.545	0.003	0.100	0.549	0.223	0	0.115	0.139	-0.551	0.061	-1.073	0.019	0.000	0.063	0.004	0.083	6.122	0.193	B30.2/SPRY domain|Concanavalin A-like lectin/glucanase domain|SPRY domain	.	.	0.5	110	390	22	32756652	chr22:32756652	A	G	110	PASS	DP=390;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	35719556	35719556	G	A	exonic	TOM1	.	nonsynonymous SNV	TOM1:NM_001135729:exon5:c.G335A:p.R112Q,TOM1:NM_001135732:exon5:c.G434A:p.R145Q,TOM1:NM_005488:exon5:c.G434A:p.R145Q	6.78E-06	0.974913137	0.025080085	.	0.25337	0.13124	-0.554717505	19.79830149	1589.92055	7.37684	0.007	0.599	D	1.0	0.899	D	0.962	0.708	D	0.000	0.843	D	1.000	0.810	D	1.435	0.361	L	1.97	0.221	T	-2.48	0.567	N	0.31	0.576	-1.037	0.181	T	0.104	0.381	T	0.032	0.538	D	6.875	0.930	33	0.999	0.978	0.922	0.548	D	c	0.454	0.461	1.000	0.446	0.732	0.924	0	4.74	0.596	3.962	0.562	0.953	0.551	1.000	0.715	0.998	0.697	17.725	0.882	ENTH/VHS|VHS domain|VHS subgroup	.	.	0.5	64	255	22	35719556	chr22:35719556	G	A	64	PASS	DP=255;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	35742925	35742925	T	G	exonic	TOM1	.	synonymous SNV	TOM1:NM_001135730:exon13:c.T1152G:p.G384G,TOM1:NM_001135729:exon14:c.T1188G:p.G396G,TOM1:NM_001135732:exon14:c.T1287G:p.G429G,TOM1:NM_005488:exon14:c.T1287G:p.G429G	6.78E-06	0.974913137	0.025080085	.	0.25337	0.13124	-0.554717505	19.79830149	1589.92055	7.37684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	50	22	35742925	chr22:35742925	T	G	71	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	36218875	36218877	TTT	-	intronic	RBFOX2	.	.	.	0.993206875	0.006792895	2.30E-07	.	0.46697	0.0922	-0.427900189	25.14744043	30.95685	0.97922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.99	64	22	36218874	chr22:36218874	CTTT	C	23.99	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	37455498	37455498	C	T	intronic	KCTD17	.	.	.	0.051116993	0.860718465	0.088164542	.	0.12828	0.10832	0.082802743	60.09082331	544.15613	4.74685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	100	22	37455498	chr22:37455498	C	T	64	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	37771139	37771139	C	A	exonic	ELFN2	.	nonsynonymous SNV	ELFN2:NM_052906:exon3:c.G436T:p.A146S	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	0.111	0.290	T	0.989	0.609	D	0.907	0.627	P	0.000	0.843	D	1	0.810	D	1.09	0.274	L	0.56	0.546	T	-1.05	0.275	N	0.457	0.509	-0.628	0.637	T	0.269	0.641	T	0.035	0.560	D	4.486	0.601	24.3	0.994	0.648	0.993	0.939	D	c	0.605	0.586	1.000	0.747	0.701	0.575	0	4.66	0.577	7.796	0.843	0.823	0.336	1.000	0.715	1.000	0.888	17.923	0.888	Leucine-rich repeat domain, L domain-like	.	.	0.5	71	70	22	37771139	chr22:37771139	C	A	71	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	38380439	38380439	C	T	UTR5	SOX10	NM_006941:c.-648G>A	.	.	0.913097851	0.086276806	0.000625343	DISEASE: Waardenburg syndrome 4C (WS4C) [MIM:613266]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). {ECO:0000269|PubMed:18348274, ECO:0000269|PubMed:21898658, ECO:0000269|PubMed:9462749}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]: A complex neurocristopathy that includes features of 4 distinct syndromes: peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease. {ECO:0000269|PubMed:10762540, ECO:0000269|PubMed:15004559, ECO:0000269|PubMed:19208381, ECO:0000269|PubMed:21898658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.98629	0.45051	-0.471992905	23.03609342	24.56042	0.80765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	454	22	38380439	chr22:38380439	C	T	.	PASS	DP=454;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	38523469	38523469	C	A	intronic	PLA2G6	.	.	.	2.66E-08	0.901102432	0.098897542	DISEASE: Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]: A neurodegenerative disease characterized by pathologic axonal swelling and spheroid bodies in the central nervous system. Onset is within the first 2 years of life with death by age 10 years. {ECO:0000269|PubMed:16783378, ECO:0000269|PubMed:17033970, ECO:0000269|PubMed:23749988}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkinson disease 14 (PARK14) [MIM:612953]: An adult- onset progressive neurodegenerative disorder characterized by parkinsonism, dystonia, severe cognitive decline, cerebral and cerebellar atrophy and absent iron in the basal ganglia on magnetic resonance imaging. {ECO:0000269|PubMed:18570303}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16881	0.17642	-1.591018721	3.084453881	148.63297	2.65978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	22	38523469	chr22:38523469	C	A	.	PASS	DP=161;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	38641968	38641968	A	T	exonic	TMEM184B	.	nonsynonymous SNV	TMEM184B:NM_001195071:exon3:c.T331A:p.F111I,TMEM184B:NM_012264:exon3:c.T331A:p.F111I,TMEM184B:NM_001195072:exon4:c.T133A:p.F45I	0.878340976	0.121351922	0.000307103	.	0.33713	.	-0.53631094	20.53550366	24.77878	0.81381	0.001	0.784	D	0.792	0.427	P	0.714	0.528	P	0.000	0.843	D	1	0.810	D	2.05	0.567	M	0.98	0.421	T	-5.53	0.892	D	0.793	0.783	-0.887	0.492	T	0.155	0.487	T	0.048	0.634	D	6.083	0.838	28.2	0.991	0.534	0.993	0.934	D	c	0.491	0.515	1.000	0.747	0.732	0.924	0	4.53	0.548	9.198	0.941	1.183	0.905	1.000	0.715	1.000	0.888	13.892	0.631	.	.	.	0.5	58	80	22	38641968	chr22:38641968	A	T	58	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	38880098	38880098	A	-	UTR3	DDX17	NM_006386:c.*1842delT;NM_001098504:c.*1842delT	.	.	.	.	.	.	0.95209	0.27727	-0.516085732	21.20193442	42.19846	1.22768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	16	22	38880097	chr22:38880097	GA	G	44	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	38901929	38901929	G	A	intronic	DDX17	.	.	.	.	.	.	.	0.95209	0.27727	-0.516085732	21.20193442	42.19846	1.22768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	22	38901929	chr22:38901929	G	A	.	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	39418780	39418780	-	C	intronic	APOBEC3D	.	.	.	2.36E-05	0.912736699	0.087239749	.	.	0.04922	-0.157884861	42.05590941	49.3236	1.37327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	73	22	39418780	chr22:39418780	T	TC	119	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	39421052	39421052	C	T	intronic	APOBEC3D	.	.	.	2.36E-05	0.912736699	0.087239749	.	.	0.04922	-0.157884861	42.05590941	49.3236	1.37327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	22	39421052	chr22:39421052	C	T	.	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	39421059	39421059	C	T	intronic	APOBEC3D	.	.	.	2.36E-05	0.912736699	0.087239749	.	.	0.04922	-0.157884861	42.05590941	49.3236	1.37327	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	122	22	39421059	chr22:39421059	C	T	86	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	39496336	39496336	G	T	exonic	APOBEC3H	.	nonsynonymous SNV	APOBEC3H:NM_001166002:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166003:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166004:exon2:c.G53T:p.R18L,APOBEC3H:NM_181773:exon2:c.G53T:p.R18L	0.637623187	0.355699123	0.00667769	.	0.03807	0.11857	0.705562627	85.52724699	3553.79975	11.52391	0.142	0.270	T	0.989	0.609	D	0.925	0.643	D	.	.	.	1	0.090	P	1.845	0.488	L	0.04	0.634	T	-2.22	0.501	N	0.173	0.210	-1.017	0.247	T	0.000	0.000	T	.	.	.	2.007	0.302	16.25	0.986	0.437	0.019	0.058	N	c	-0.661	-0.923	1.000	0.517	0.560	0.301	0	-0.212	0.125	-0.116	0.106	-0.317	0.077	0.000	0.063	0.000	0.016	5.159	0.143	Cytidine and deoxycytidylate deaminases, zinc-binding	ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000239713.3|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000128394.12|ENSG00000239713.3|ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000226024.1|ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Tibial|Artery_Tibial|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Thyroid|Vagina	0.5	95	36	22	39496336	chr22:39496336	G	T	95	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	39802424	39802424	G	A	intronic	TAB1	.	.	.	0.003995811	0.987970242	0.008033946	.	0.35773	0.30319	-1.217968826	5.638122199	305.94322	3.72456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	31	22	39802424	chr22:39802424	G	A	60	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	40364389	40364389	C	-	intronic	GRAP2	.	.	.	0.101871595	0.896646827	0.001481577	.	0.87215	0.37468	0.283038099	71.26680821	81.93324	1.91955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.64	27	22	40364388	chr22:40364388	AC	A	19.64	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	40666253	40666253	G	C	exonic	TNRC6B	.	synonymous SNV	TNRC6B:NM_001162501:exon6:c.G2934C:p.T978T,TNRC6B:NM_001024843:exon8:c.G693C:p.T231T	0.999999803	1.97E-07	4.09E-19	.	0.5184	0.11889	-1.807947733	2.199811276	2219.15225	8.67424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	73	22	40666253	chr22:40666253	G	C	65	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	41575925	41575925	C	A	UTR3	EP300	NM_001429:c.*965C>A	.	.	1	5.16E-13	1.03E-32	DISEASE: Note=Defects in EP300 may play a role in epithelial cancer.; DISEASE: Note=Chromosomal aberrations involving EP300 may be a cause of acute myeloid leukemias. Translocation t(8;22)(p11;q13) with KAT6A.; DISEASE: Rubinstein-Taybi syndrome 2 (RSTS2) [MIM:613684]: A disorder characterized by craniofacial abnormalities, postnatal growth deficiency, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies. Some individuals with RSTS2 have less severe mental impairment, more severe microcephaly, and a greater degree of changes in facial bone structure than RSTS1 patients. {ECO:0000269|PubMed:15706485}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99999	0.91015	-3.681999375	0.259495164	1174.22905	6.51042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	150	22	41575925	chr22:41575925	C	A	.	PASS	DP=150;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	42276742	42276742	G	C	exonic	SREBF2	.	nonsynonymous SNV	SREBF2:NM_004599:exon10:c.G1784C:p.G595A	0.996271601	0.003728398	4.39E-10	.	0.65981	0.47389	-1.831803113	2.093654164	3329.62947	11.03522	0.873	0.026	T	0.0	0.026	B	0.0	0.013	B	0.058	0.225	N	1	0.090	P	-0.49	0.026	N	2.24	0.179	T	1.32	0.009	N	0.023	0.006	-0.968	0.376	T	0.000	0.000	T	.	.	.	0.476	0.140	7.244	0.797	0.124	0.108	0.160	N	c	-0.836	-0.599	0.548	0.213	0.707	0.730	0	4.95	0.648	1.073	0.301	0.032	0.150	0.742	0.288	0.867	0.362	6.559	0.215	.	ENSG00000183172.8|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000183172.8|ENSG00000100417.7|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000184983.5|ENSG00000183172.8|ENSG00000183172.8|ENSG00000100147.9|ENSG00000183172.8	Adipose_Subcutaneous|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Colon_Transverse|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Lung|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Skin_Sun_Exposed_Lower_leg|Thyroid|Thyroid|Whole_Blood	0.5	89	217	22	42276742	chr22:42276742	G	C	89	PASS	DP=217;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	42993761	42993761	C	T	intronic	POLDIP3	.	.	.	0.832319947	0.167650206	2.98E-05	.	0.12164	.	0.264628794	70.5178108	852.50931	5.70421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	22	42993761	chr22:42993761	C	T	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	43267336	43267336	-	C	UTR3	PACSIN2	NM_001184971:c.*26_*27insG;NM_007229:c.*26_*27insG;NM_001184970:c.*26_*27insG;NM_001349968:c.*26_*27insG;NM_001349969:c.*26_*27insG;NM_001349970:c.*26_*27insG;NM_001349971:c.*26_*27insG;NM_001349974:c.*26_*27insG;NM_001349973:c.*26_*27insG;NM_001349972:c.*26_*27insG	.	.	0.270395757	0.729383646	0.000220597	.	0.24823	0.20703	0.044168103	57.40740741	250.49463	3.41008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	41	22	43267336	chr22:43267336	T	TC	59	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	43274977	43274977	C	T	intronic	PACSIN2	.	.	.	0.270395757	0.729383646	0.000220597	.	0.24823	0.20703	0.044168103	57.40740741	250.49463	3.41008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	143	22	43274977	chr22:43274977	C	T	145	PASS	DP=143;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	44276728	44276728	G	A	exonic	PNPLA5	.	stopgain	PNPLA5:NM_001177675:exon7:c.C895T:p.Q299X,PNPLA5:NM_138814:exon9:c.C1237T:p.Q413X	9.38E-07	0.317699047	0.682300015	.	0.17953	0.09445	0.576916344	82.25406936	1541.98025	7.28556	.	.	.	.	.	.	.	.	.	.	.	.	0.810	0.346	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.992	0.961	35	0.967	0.301	0.113	0.163	N	c	0.037	-0.331	0.035	0.142	0.615	0.352	0	2.1	0.261	1.248	0.322	1.048	0.713	0.057	0.215	0.008	0.104	8.910	0.345	.	.	.	0.5	.	51	22	44276728	chr22:44276728	G	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	44287062	44287062	A	G	exonic	PNPLA5	.	synonymous SNV	PNPLA5:NM_138814:exon2:c.T306C:p.D102D	9.38E-07	0.317699047	0.682300015	.	0.17953	0.09445	0.576916344	82.25406936	1541.98025	7.28556	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	34	22	44287062	chr22:44287062	A	G	60	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	45601764	45601764	C	T	exonic	KIAA0930	.	synonymous SNV	KIAA0930:NM_001009880:exon3:c.G246A:p.V82V,KIAA0930:NM_015264:exon3:c.G261A:p.V87V	0.815289887	0.18451819	0.000191924	.	0.16326	0.09256	-0.977252525	8.799245105	22.55837	0.75396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	22	45601764	chr22:45601764	C	T	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	45601767	45601767	C	T	exonic	KIAA0930	.	synonymous SNV	KIAA0930:NM_001009880:exon3:c.G243A:p.E81E,KIAA0930:NM_015264:exon3:c.G258A:p.E86E	0.815289887	0.18451819	0.000191924	.	0.16326	0.09256	-0.977252525	8.799245105	22.55837	0.75396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	22	45601767	chr22:45601767	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	45749842	45749842	G	A	intronic	SMC1B	.	.	.	0.986578246	0.013421754	3.42E-12	.	0.51288	0.08472	0.271907863	70.73012503	4981.23034	14.38844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	22	45749842	chr22:45749842	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	46709700	46709700	A	G	intronic	GTSE1	.	.	.	6.90E-06	0.900506171	0.099486926	.	0.10167	0.0686	0.854236942	88.51144138	773.1469	5.50331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	65	22	46709700	chr22:46709700	A	G	45	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	49147663	49147663	-	T	UTR3	FAM19A5	NM_001082967:c.*2004_*2005insT;NM_015381:c.*2004_*2005insT	.	.	0.310031382	0.617806909	0.07216171	.	0.13152	.	0.347360312	73.97381458	13.36073	0.48609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	409	22	49147663	chr22:49147663	A	AT	92	PASS	DP=409;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	50312802	50312818	CCCTCGACCTGGGCTCG	-	intronic	CRELD2	.	.	.	4.96E-08	0.220198053	0.779801898	.	0.23727	0.10908	0.801024817	87.65628686	1620.87519	7.44658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	166	126	22	50312801	chr22:50312801	ACCCTCGACCTGGGCTCG	A	166	PASS	DP=126;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	50488632	50488632	C	T	exonic	TTLL8	.	synonymous SNV	TTLL8:NM_001350317:exon4:c.G204A:p.R68R	.	.	.	.	0.72788	0.09578	.	.	3618.46748	11.65843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	89	22	50488632	chr22:50488632	C	T	53	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	50552226	50552226	G	C	intronic	MOV10L1	.	.	.	5.75E-10	0.999564705	0.000435294	.	0.0863	0.12601	-0.694532205	14.83840528	7325.51336	18.41075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	48	22	50552226	chr22:50552226	G	C	57	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	50552242	50552242	C	T	intronic	MOV10L1	.	.	.	5.75E-10	0.999564705	0.000435294	.	0.0863	0.12601	-0.694532205	14.83840528	7325.51336	18.41075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	22	50552242	chr22:50552242	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	50646919	50646919	G	T	intronic	SELENOO	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	72	22	50646919	chr22:50646919	G	T	58	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
22	50687619	50687619	C	T	intronic	HDAC10	.	.	.	3.28E-12	0.149158506	0.850841494	.	0.10737	0.15425	-0.172654315	40.63458363	807.74818	5.59736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	111	22	50687619	chr22:50687619	C	T	.	PASS	DP=111;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	50696648	50696648	C	T	intronic	MAPK12	.	.	.	0.013620058	0.979692625	0.006687317	DISEASE: Note=MAPK is overexpressed in highly metastatic breast cancer cell lines and its expression is preferentially associated with basal-like and metastatic phenotypes of breast tumor samples.; 	0.4586	0.43657	-0.354480518	29.42911064	776.33339	5.51752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	265	22	50696648	chr22:50696648	C	T	88	PASS	DP=265;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	50720031	50720031	C	T	exonic	PLXNB2	.	synonymous SNV	PLXNB2:NM_012401:exon21:c.G3486A:p.Q1162Q	0.992862471	0.007137529	1.47E-13	.	0.21876	0.12373	-3.297942414	0.418730833	992.83256	6.07108	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	22	50720031	chr22:50720031	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	50752070	50752070	G	A	exonic	DENND6B	.	synonymous SNV	DENND6B:NM_001001794:exon15:c.C1287T:p.I429I	0.031020348	0.966992704	0.001986948	.	0.18579	.	-0.951568548	9.271054494	2114.67479	8.46343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	60	22	50752070	chr22:50752070	G	A	58	PASS	DP=60;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	50942133	50942136	GGGA	-	intronic	LMF2	.	.	.	.	.	.	.	0.14313	.	-1.293511806	5.001179523	2091.17234	8.42309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	52	22	50942132	chr22:50942132	TGGGA	T	43	PASS	DP=52;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	51193209	51193209	T	G	intergenic	ACR;RPL23AP82	dist=9482;dist=2305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	135	22	51193209	chr22:51193209	T	G	117	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	51193798	51193798	G	A	intergenic	ACR;RPL23AP82	dist=10071;dist=1716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	496	22	51193798	chr22:51193798	G	A	138	PASS	DP=496;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	13775823	13775823	C	T	exonic	OFD1	.	synonymous SNV	OFD1:NM_001330209:exon13:c.C1336T:p.L446L,OFD1:NM_003611:exon14:c.C1456T:p.L486L,OFD1:NM_001330210:exon15:c.C1036T:p.L346L	0.982887662	0.01711232	1.83E-08	DISEASE: Simpson-Golabi-Behmel syndrome 2 (SGBS2) [MIM:300209]: A severe variant of Simpson-Golabi-Behmel syndrome, a condition characterized by pre- and postnatal overgrowth (gigantism), facial dysmorphism and a variety of inconstant visceral and skeletal malformations. {ECO:0000269|PubMed:16783569}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 10 (JBTS10) [MIM:300804]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:19800048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 23 (RP23) [MIM:300424]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:22619378}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.1103	0.17799	-0.176292081	40.56381222	82.1386	1.92266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	32	X	13775823	chrX:13775823	C	T	64	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	17439191	17439191	T	-	intronic	NHS	.	.	.	0.999461889	0.000538109	2.34E-09	DISEASE: Cataract 40 (CTRCT40) [MIM:302200]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT40 manifests as a congenital nuclear opacity with severe visual impairment in affected males. Heterozygous females have suture cataracts and only slight reduction in vision. In some cases, cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. {ECO:0000269|PubMed:19414485}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by copy number variations predicted to result in altered transcriptional regulation of the NHS gene: a 0.8 Mb segmental duplication-triplication encompassing the NHS, SCML1 and RAI2 genes, and an 4.8 kb intragenic deletion in NHS intron 1.; 	0.17736	0.14772	-0.725642751	14.24274593	725.51652	5.34764	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	32	X	17439190	chrX:17439190	CT	C	56	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	19363864	19363866	CCC	-	intronic	PDHA1	.	.	.	0.992090139	0.007908215	1.65E-06	DISEASE: Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]: An enzymatic defect causing primary lactic acidosis in children. It is associated with a broad clinical spectrum ranging from fatal lactic acidosis in the newborn to chronic neurologic dysfunction with structural abnormalities in the central nervous system without systemic acidosis. {ECO:0000269|PubMed:1293379, ECO:0000269|PubMed:1338114, ECO:0000269|PubMed:1551669, ECO:0000269|PubMed:1909401, ECO:0000269|PubMed:7545958, ECO:0000269|PubMed:7573035, ECO:0000269|PubMed:7757088, ECO:0000269|PubMed:7887409, ECO:0000269|PubMed:7967473, ECO:0000269|PubMed:8032855, ECO:0000269|PubMed:8504306, ECO:0000269|PubMed:8664900, ECO:0000269|PubMed:8844217, ECO:0000269|PubMed:9671272}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27813	0.5595	0.170987912	65.5579146	381.13932	4.11483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	33	X	19363863	chrX:19363863	TCCC	T	44	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	24760277	24760277	C	-	intronic	POLA1	.	.	.	0.999999525	4.75E-07	1.72E-17	.	0.99571	0.30271	-0.795417163	12.5324369	61.5917	1.59962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	54	X	24760276	chrX:24760276	AC	A	98	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	24807159	24807159	C	T	intronic	POLA1	.	.	.	0.999999525	4.75E-07	1.72E-17	.	0.99571	0.30271	-0.795417163	12.5324369	61.5917	1.59962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	238	X	24807159	chrX:24807159	C	T	107	PASS	DP=238;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	29974743	29974743	C	T	downstream	IL1RAPL1	dist=726	.	.	0.996893678	0.003106154	1.68E-07	.	0.7883	0.22741	-0.60427181	17.74593064	15.07771	0.54108	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	X	29974743	chrX:29974743	C	T	.	PASS	DP=83;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	31200833	31200833	T	-	intronic	DMD	.	.	.	1	1.96E-10	2.29E-33	DISEASE: Duchenne muscular dystrophy (DMD) [MIM:310200]: Most common form of muscular dystrophy; a sex-linked recessive disorder. It typically presents in boys aged 3 to 7 year as proximal muscle weakness causing waddling gait, toe-walking, lordosis, frequent falls, and difficulty in standing up and climbing up stairs. The pelvic girdle is affected first, then the shoulder girdle. Progression is steady and most patients are confined to a wheelchair by age of 10 or 12. Flexion contractures and scoliosis ultimately occur. About 50% of patients have a lower IQ than their genetic expectations would suggest. There is no treatment. {ECO:0000269|PubMed:12632325, ECO:0000269|PubMed:7981690, ECO:0000269|PubMed:8401582, ECO:0000269|PubMed:8817332, ECO:0000269|PubMed:9851445}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Becker muscular dystrophy (BMD) [MIM:300376]: A neuromuscular disorder characterized by dystrophin deficiency. It appears between the age of 5 and 15 years with a proximal motor deficiency of variable progression. Heart involvement can be the initial sign. Becker muscular dystrophy has a more benign course than Duchenne muscular dystrophy. {ECO:0000269|PubMed:10573008}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated, X-linked 3B (CMD3B) [MIM:302045]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:12354438, ECO:0000269|PubMed:12359139, ECO:0000269|PubMed:25340340, ECO:0000269|PubMed:9170407}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3401	0.7637	-0.842180844	11.28214201	7684.36218	18.86491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	36	X	31200832	chrX:31200832	AT	A	39	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	31432049	31432049	G	A	intronic	DMD	.	.	.	1	1.96E-10	2.29E-33	DISEASE: Duchenne muscular dystrophy (DMD) [MIM:310200]: Most common form of muscular dystrophy; a sex-linked recessive disorder. It typically presents in boys aged 3 to 7 year as proximal muscle weakness causing waddling gait, toe-walking, lordosis, frequent falls, and difficulty in standing up and climbing up stairs. The pelvic girdle is affected first, then the shoulder girdle. Progression is steady and most patients are confined to a wheelchair by age of 10 or 12. Flexion contractures and scoliosis ultimately occur. About 50% of patients have a lower IQ than their genetic expectations would suggest. There is no treatment. {ECO:0000269|PubMed:12632325, ECO:0000269|PubMed:7981690, ECO:0000269|PubMed:8401582, ECO:0000269|PubMed:8817332, ECO:0000269|PubMed:9851445}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Becker muscular dystrophy (BMD) [MIM:300376]: A neuromuscular disorder characterized by dystrophin deficiency. It appears between the age of 5 and 15 years with a proximal motor deficiency of variable progression. Heart involvement can be the initial sign. Becker muscular dystrophy has a more benign course than Duchenne muscular dystrophy. {ECO:0000269|PubMed:10573008}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated, X-linked 3B (CMD3B) [MIM:302045]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:12354438, ECO:0000269|PubMed:12359139, ECO:0000269|PubMed:25340340, ECO:0000269|PubMed:9170407}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3401	0.7637	-0.842180844	11.28214201	7684.36218	18.86491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	X	31432049	chrX:31432049	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	36178819	36178819	C	A	exonic	CFAP47	.	nonsynonymous SNV	CFAP47:NM_001304548:exon39:c.C5959A:p.P1987T	.	.	.	.	0.06402	.	0.371224249	75.12384996	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.282	0.121	5.518	0.584	0.058	0.735	0.357	D	.	.	.	0.000	0.064	.	.	.	2.99	0.335	3.862	0.555	-0.046	0.123	0.992	0.373	0.035	0.152	9.479	0.379	.	.	.	0.5	.	36	X	36178819	chrX:36178819	C	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	37028770	37028770	C	A	exonic	FAM47C	.	nonsynonymous SNV	FAM47C:NM_001013736:exon1:c.C2287A:p.R763S	0.057797311	0.86697678	0.075225909	.	0.03714	.	1.76190403	96.75041283	797.36508	5.56605	0.602	0.056	T	0.048	0.207	B	0.011	0.145	B	.	.	.	1	0.090	N	1.32	0.331	L	2.06	0.205	T	-1.64	0.393	N	0.058	0.041	-0.957	0.398	T	0.029	0.123	T	0.001	0.005	T	-1.075	0.029	0.011	0.164	0.004	0.004	0.020	N	.	.	.	0.001	0.077	.	.	.	-1.85	0.073	0.201	0.169	-3.068	0.001	0.000	0.063	0.000	0.016	6.232	0.198	.	.	.	0.5	.	104	X	37028770	chrX:37028770	C	A	.	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	38169858	38169858	C	-	intronic	RPGR	.	.	.	0.997857546	0.00214244	1.37E-08	DISEASE: Retinitis pigmentosa 3 (RP3) [MIM:300029]: A X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex. {ECO:0000269|PubMed:10482958, ECO:0000269|PubMed:10737996, ECO:0000269|PubMed:10932196, ECO:0000269|PubMed:10937588, ECO:0000269|PubMed:10970770, ECO:0000269|PubMed:11180598, ECO:0000269|PubMed:11992260, ECO:0000269|PubMed:12657579, ECO:0000269|PubMed:14564670, ECO:0000269|PubMed:8673101, ECO:0000269|PubMed:8817343, ECO:0000269|PubMed:9399904, ECO:0000269|PubMed:9855162}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa and sinorespiratory infections with or without deafness (RPDSI) [MIM:300455]: A disease characterized by the association primary ciliary dyskinesia features with retinitis pigmentosa. Some patients also manifest deafness. {ECO:0000269|PubMed:12920075, ECO:0000269|PubMed:14627685}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy, X-linked 1 (CORDX1) [MIM:304020]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. In cone-rod dystrophy X-linked type 1 the degree of rod-photoreceptor involvement can be variable, with degeneration increasing as the disease progresses. Affected individuals (essentially all of whom are males) present with decreased visual acuity, myopia, photophobia, abnormal color vision, full peripheral visual fields, decreased photopic electroretinographic responses, and granularity of the macular retinal pigment epithelium. Although penetrance appears to be nearly 100%, there is variable expressivity with respect to age at onset and severity of symptoms. {ECO:0000269|PubMed:11857109}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, X-linked, atrophic (MDXLA) [MIM:300834]: An ocular disorder characterized by macular atrophy causing progressive loss of visual acuity with minimal peripheral visual impairment. Some patients manifest extensive macular degeneration plus peripheral loss of retinal pigment epithelium and choriocapillaries. Full-field electroretinograms (ERGs) show normal cone and rod responses in some affected males despite advanced macular degeneration. {ECO:0000269|PubMed:12160730}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.5423	.	2.802177104	99.03868837	2307.37975	8.90096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	33	X	38169857	chrX:38169857	TC	T	65	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	38240578	38240578	T	-	intronic	OTC	.	.	.	0.9810179	0.01896801	1.41E-05	DISEASE: Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]: An X-linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. {ECO:0000269|PubMed:10070627, ECO:0000269|PubMed:10502831, ECO:0000269|PubMed:10737985, ECO:0000269|PubMed:11793483, ECO:0000269|PubMed:1480464, ECO:0000269|PubMed:1671317, ECO:0000269|PubMed:1721894, ECO:0000269|PubMed:2347583, ECO:0000269|PubMed:2474822, ECO:0000269|PubMed:3170748, ECO:0000269|PubMed:7474905, ECO:0000269|PubMed:7951259, ECO:0000269|PubMed:8019569, ECO:0000269|PubMed:8081373, ECO:0000269|PubMed:8081398, ECO:0000269|PubMed:8099056, ECO:0000269|PubMed:8530002, ECO:0000269|PubMed:8807340, ECO:0000269|PubMed:8830175, ECO:0000269|PubMed:8956038, ECO:0000269|PubMed:8956045, ECO:0000269|PubMed:9143919, ECO:0000269|PubMed:9266388, ECO:0000269|PubMed:9286441, ECO:0000269|PubMed:9452024, ECO:0000269|PubMed:9452049, ECO:0000269|PubMed:9452065, ECO:0000269|Ref.32, ECO:0000269|Ref.43}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22278	0.85665	0.082802743	60.09082331	1072.1412	6.27812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	25	X	38240577	chrX:38240577	CT	C	57	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	38420774	38420774	C	A	UTR5	TSPAN7	NM_004615:c.-26C>A	.	.	0.869950131	0.128287984	0.001761884	.	0.27156	0.17096	-0.075159878	47.78839349	0.88041	0.01802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	120	X	38420774	chrX:38420774	C	A	72	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	41092075	41092075	G	T	UTR3	USP9X	NM_001039591:c.*298G>T;NM_001039590:c.*298G>T	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	X	41092075	chrX:41092075	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	41093160	41093160	C	T	UTR3	USP9X	NM_001039591:c.*1383C>T;NM_001039590:c.*1383C>T	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	X	41093160	chrX:41093160	C	T	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	41094954	41094954	-	T	UTR3	USP9X	NM_001039591:c.*3177_*3178insT;NM_001039590:c.*3177_*3178insT	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	17	X	41094954	chrX:41094954	G	GT	42	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	44494322	44494322	C	T	intergenic	FUNDC1;DUSP21	dist=92101;dist=208927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	140	X	44494322	chrX:44494322	C	T	82	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	44920619	44920619	A	T	exonic	KDM6A	.	synonymous SNV	KDM6A:NM_001291421:exon12:c.A492T:p.V164V,KDM6A:NM_001291417:exon13:c.A1245T:p.V415V,KDM6A:NM_001291418:exon13:c.A1245T:p.V415V,KDM6A:NM_001291416:exon14:c.A1401T:p.V467V,KDM6A:NM_021140:exon14:c.A1380T:p.V460V,KDM6A:NM_001291415:exon15:c.A1536T:p.V512V	0.999987121	1.29E-05	1.08E-14	DISEASE: Kabuki syndrome 2 (KABUK2) [MIM:300867]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:22197486}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9827	0.16837	-0.066061882	48.77919321	855.17792	5.70917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	X	44920619	chrX:44920619	A	T	.	PASS	DP=47;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	47034512	47034512	C	-	intronic	RBM10	.	.	.	0.999912181	8.78E-05	2.82E-11	DISEASE: TARP syndrome (TARPS) [MIM:311900]: A disorder characterized by the Robin sequence (micrognathia, glossoptosis and cleft palate), talipes equinovarus and cardiac defects. {ECO:0000269|PubMed:20451169}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17567	0.15702	-0.66859065	15.76433121	77.16708	1.84454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49	50	X	47034511	chrX:47034511	AC	A	49	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	47039756	47039756	C	T	intronic	RBM10	.	.	.	0.999912181	8.78E-05	2.82E-11	DISEASE: TARP syndrome (TARPS) [MIM:311900]: A disorder characterized by the Robin sequence (micrognathia, glossoptosis and cleft palate), talipes equinovarus and cardiac defects. {ECO:0000269|PubMed:20451169}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17567	0.15702	-0.66859065	15.76433121	77.16708	1.84454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	110	X	47039756	chrX:47039756	C	T	.	PASS	DP=110;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	47488911	47488911	G	T	intronic	CFP	.	.	.	0.944168669	0.05578963	4.17E-05	DISEASE: Properdin deficiency (PFD) [MIM:312060]: Results in higher susceptibility to bacterial infections; especially to meningococcal infections. Three phenotypes have been reported: complete deficiency (type I), incomplete deficiency (type II), and dysfunction of properdin (type III). {ECO:0000269|PubMed:10909851, ECO:0000269|PubMed:8871668, ECO:0000269|PubMed:9710744}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14504	0.26817	0.350995466	74.37485256	78.28928	1.86633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	X	47488911	chrX:47488911	G	T	.	PASS	DP=99;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	47969530	47969530	C	G	ncRNA_intronic	SSX6	.	.	.	.	.	.	.	0.01464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	22	X	47969530	chrX:47969530	C	G	61	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	48136516	48136516	A	-	intergenic	SSX1;SSX9	dist=9637;dist=24469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	27	X	48136515	chrX:48136515	CA	C	54	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	48163734	48163734	C	-	ncRNA_exonic	SSX9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	75	X	48163733	chrX:48163733	TC	T	48	PASS	DP=75;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	48324646	48324646	G	C	exonic	SLC38A5	.	nonsynonymous SNV	SLC38A5:NM_033518:exon7:c.C383G:p.A128G	0.976708482	0.023268194	2.33E-05	.	0.07584	0.24156	-0.359940251	28.93371078	343.94842	3.93203	0.287	0.176	T	0.056	0.214	B	0.101	0.292	B	0.000	0.629	D	1.000	0.588	D	1.215	0.307	L	4.32	0.024	T	-1.4	0.372	N	0.348	0.409	-0.840	0.527	T	0.008	0.030	T	0.013	0.316	T	0.455	0.138	7.080	0.959	0.275	0.927	0.560	D	.	.	.	1.000	0.747	.	.	.	3.83	0.431	4.515	0.600	0.055	0.163	1.000	0.715	0.179	0.212	9.913	0.404	Amino acid transporter, transmembrane domain	.	.	0.5	70	131	X	48324646	chrX:48324646	G	C	70	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	53113896	53113896	G	-	intronic	TSPYL2	.	.	.	0.874635828	0.125031878	0.000332294	.	0.13703	0.27669	-0.712684326	14.49634348	93.79731	2.08252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	108	X	53113895	chrX:53113895	TG	T	69	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	53246267	53246267	G	A	intronic	KDM5C	.	.	.	0.997842569	0.002157431	1.16E-10	DISEASE: Mental retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSCJ patients manifest mental retardation associated with variable features such as slowly progressive spastic paraplegia, seizures, facial dysmorphism. {ECO:0000269|PubMed:15586325, ECO:0000269|PubMed:16538222, ECO:0000269|PubMed:16541399, ECO:0000269|PubMed:23356856, ECO:0000269|PubMed:25666439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23488	0.19342	-1.50825116	3.503184713	16.80604	0.59116	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	35	X	53246267	chrX:53246267	G	A	39	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	57620213	57620213	C	G	exonic	ZXDB	.	nonsynonymous SNV	ZXDB:NM_007157:exon1:c.C1732G:p.L578V	0.842955569	0.154160523	0.002883908	.	0.06264	0.09943	.	.	96.86419	2.12723	0.126	0.272	T	0.997	0.689	D	0.978	0.725	D	0.000	0.481	D	0.950	0.377	D	2.73	0.801	M	3.01	0.091	T	-1.43	0.352	N	0.35	0.411	-1.122	0.022	T	0.048	0.205	T	0.020	0.426	T	0.986	0.188	10.58	0.978	0.353	0.940	0.595	D	.	.	.	1.000	0.747	.	.	.	2.96	0.332	3.684	0.542	0.887	0.390	1.000	0.715	0.997	0.653	8.628	0.329	.	.	.	0.5	126	193	X	57620213	chrX:57620213	C	G	126	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	63409495	63409495	G	A	UTR3	AMER1	NM_152424:c.*264C>T	.	.	0.953441253	0.046553393	5.35E-06	.	.	0.08523	-0.394936437	27.02878037	88.95926	2.02444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	61	X	63409495	chrX:63409495	G	A	58	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	70586333	70586333	G	A	exonic	TAF1	.	nonsynonymous SNV	TAF1:NM_001286074:exon1:c.G169A:p.V57I,TAF1:NM_004606:exon1:c.G169A:p.V57I,TAF1:NM_138923:exon1:c.G169A:p.V57I	0.999999756	2.44E-07	6.88E-19	DISEASE: Dystonia 3, torsion, X-linked (DYT3) [MIM:314250]: A X- linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. It has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease. {ECO:0000269|PubMed:12928496, ECO:0000269|PubMed:17273961}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65141	0.18046	-0.420619508	25.72540694	384.74802	4.1332	0.709	0.040	T	0.004	0.131	B	0.005	0.121	B	0.000	0.629	D	0.932	0.370	D	1.345	0.336	L	3.13	0.092	T	0.31	0.042	N	0.139	0.163	-1.075	0.084	T	0.020	0.085	T	0.014	0.335	T	2.240	0.330	17.77	0.967	0.301	0.840	0.428	D	.	.	.	1.000	0.747	.	.	.	4.99	0.658	3.993	0.565	1.035	0.655	1.000	0.715	1.000	0.888	12.257	0.538	TAFII-230 TBP-binding	.	.	0.5	.	94	X	70586333	chrX:70586333	G	A	.	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	70794640	70794640	C	T	ncRNA_intronic	BCYRN1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	X	70794640	chrX:70794640	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	75393057	75393057	T	-	intronic	PBDC1	.	.	.	0.845464415	0.151771167	0.002764418	.	0.05536	0.07658	-0.053113545	49.38664779	6.77226	0.24999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	19	X	75393056	chrX:75393056	CT	C	42	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	96684735	96684735	A	C	exonic	DIAPH2	.	synonymous SNV	DIAPH2:NM_006729:exon26:c.A3232C:p.R1078R,DIAPH2:NM_007309:exon26:c.A3232C:p.R1078R	0.9991191	0.0008809	6.44E-11	DISEASE: Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56881	0.27299	-0.999300439	8.368719038	38.85136	1.15117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	X	96684735	chrX:96684735	A	C	.	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	104707604	104707604	A	G	intronic	IL1RAPL2	.	.	.	0.973379476	0.026613945	6.58E-06	.	0.30056	0.12272	-0.337894035	30.37272942	9.79385	0.35811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	52	X	104707604	chrX:104707604	A	G	53	PASS	DP=52;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	106296453	106296453	A	T	intergenic	MORC4;RBM41	dist=52979;dist=8665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	171	X	106296453	chrX:106296453	A	T	124	PASS	DP=171;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	107433688	107433688	A	G	exonic	COL4A6	.	nonsynonymous SNV	COL4A6:NM_001287758:exon20:c.T1360C:p.S454P,COL4A6:NM_001287759:exon20:c.T1360C:p.S454P,COL4A6:NM_001287760:exon20:c.T1360C:p.S454P,COL4A6:NM_001847:exon20:c.T1363C:p.S455P,COL4A6:NM_033641:exon20:c.T1360C:p.S454P	0.990988266	0.009011734	6.37E-12	DISEASE: Note=Deletions covering the N-terminal regions of COL4A5 and COL4A6, which are localized in a head-to-head manner, are found in the chromosome Xq22.3 centromeric deletion syndrome. This results in a phenotype with features of diffuse leiomyomatosis and Alport syndrome (DL-ATS).; DISEASE: Deafness, X-linked, 6 (DFNX6) [MIM:300914]: A non- syndromic form of sensorineural hearing loss with prelingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:23714752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14684	0.07461	0.36555769	74.7287096	361.2174	4.02247	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.031	0.252	N	1.000	0.090	P	-2.35	0.001	N	-3.28	0.937	D	2.56	0.002	N	0.016	0.069	-0.958	0.395	T	0.000	0.000	T	.	.	.	1.193	0.209	11.71	0.838	0.144	0.002	0.013	N	.	.	.	0.989	0.316	.	.	.	0.71	0.172	0.077	0.145	-0.282	0.084	0.133	0.232	0.643	0.297	3.877	0.085	.	.	.	0.5	43	12	X	107433688	chrX:107433688	A	G	43	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	107917970	107917970	C	T	intronic	COL4A5	.	.	.	0.999918348	8.17E-05	8.02E-15	DISEASE: Alport syndrome, X-linked (APSX) [MIM:301050]: A syndrome that is characterized by progressive glomerulonephritis, renal failure, sensorineural deafness, specific eye abnormalities (lenticonous and macular flecks), and glomerular basement membrane defects. The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness. {ECO:0000269|PubMed:10094548, ECO:0000269|PubMed:10561141, ECO:0000269|PubMed:10563487, ECO:0000269|PubMed:10684360, ECO:0000269|PubMed:10862091, ECO:0000269|PubMed:11004279, ECO:0000269|PubMed:11223851, ECO:0000269|PubMed:1352287, ECO:0000269|PubMed:1363780, ECO:0000269|PubMed:1376965, ECO:0000269|PubMed:1672282, ECO:0000269|PubMed:24522658, ECO:0000269|PubMed:7599631, ECO:0000269|PubMed:7853788, ECO:0000269|PubMed:8406498, ECO:0000269|PubMed:8651292, ECO:0000269|PubMed:8651296, ECO:0000269|PubMed:8829632, ECO:0000269|PubMed:8940267, ECO:0000269|PubMed:9150741, ECO:0000269|PubMed:9452056, ECO:0000269|PubMed:9848783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Deletions covering the N-terminal regions of COL4A5 and COL4A6, which are localized in a head-to-head manner, are found in the chromosome Xq22.3 centromeric deletion syndrome. This results in a phenotype with features of diffuse leiomyomatosis and Alport syndrome (DL-ATS).; 	0.87803	.	-1.148192153	6.316348195	776.06095	5.51594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	68	X	107917970	chrX:107917970	C	T	50	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	109561058	109561060	CCG	-	exonic	AMMECR1	.	nonframeshift deletion	AMMECR1:NM_001025580:exon1:c.240_242del:p.G82del,AMMECR1:NM_015365:exon1:c.240_242del:p.G82del	0.910792997	0.088538552	0.00066845	DISEASE: Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]: A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis. {ECO:0000269|PubMed:10049589}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.89609	0.33817	-0.09720619	46.20193442	15.37972	0.5519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	68	X	109561057	chrX:109561057	CCCG	C	64	PASS	DP=68;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	0/1	./.	./.	./.
X	110988039	110988039	C	T	exonic	ALG13	.	nonsynonymous SNV	ALG13:NM_001099922:exon24:c.C2839T:p.L947F,ALG13:NM_001257231:exon24:c.C2605T:p.L869F	0.99758296	0.002417037	3.73E-09	DISEASE: Congenital disorder of glycosylation 1S (CDG1S) [MIM:300884]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:22492991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	-0.999300439	8.368719038	48.1604	1.35199	0.125	0.273	T	0.019	0.167	B	0.022	0.184	B	0.103	0.026	U	1	0.200	N	0	0.065	N	0.4	0.573	T	0.12	0.056	N	0.07	0.089	-1.032	0.197	T	0.097	0.364	T	0.012	0.306	T	-0.456	0.058	0.282	0.991	0.532	0.084	0.141	N	.	.	.	0.003	0.101	.	.	.	1.69	0.232	0.421	0.208	0.874	0.381	0.668	0.281	0.162	0.208	3.250	0.064	.	.	.	0.5	120	288	X	110988039	chrX:110988039	C	T	120	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	114468474	114468476	CCG	-	exonic	LRCH2	.	nonframeshift deletion	LRCH2:NM_001243963:exon1:c.129_131del:p.G44del,LRCH2:NM_020871:exon1:c.129_131del:p.G44del	0.915538079	0.08443772	2.42E-05	.	0.16063	0.09365	-0.007201372	53.19061099	42.20239	1.22827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	82	X	114468473	chrX:114468473	CCCG	C	120	PASS	DP=82;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	114953359	114953359	C	T	intergenic	PLS3;DANT2	dist=68180;dist=3370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	174	X	114953359	chrX:114953359	C	T	65	PASS	DP=174;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	118758031	118758031	A	T	intronic	SEPT6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	X	118758031	chrX:118758031	A	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	119658624	119658624	-	T	UTR3	CUL4B	NM_003588:c.*1991_*1992insA;NM_001330624:c.*1991_*1992insA;NM_001079872:c.*1991_*1992insA	.	.	0.999846678	0.000153322	1.10E-10	DISEASE: Mental retardation, X-linked, syndromic, 15 (MRXS15) [MIM:300354]: A syndromic form of X-linked mental retardation characterized by severe intellectual deficit associated with short stature, craniofacial dysmorphism, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, pes cavus, small feet, and abnormalities of the toes. Additional neurologic manifestations include speech delay and impairment, tremor, seizures, gait ataxia, hyperactivity and decreased attention span. {ECO:0000269|PubMed:17236139, ECO:0000269|PubMed:17273978, ECO:0000269|PubMed:19377476, ECO:0000269|PubMed:20002452}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87445	0.12121	-0.361761279	28.6329323	9.19638	0.33598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	35	X	119658624	chrX:119658624	C	CT	53	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	128650420	128650420	C	T	exonic	SMARCA1	.	nonsynonymous SNV	SMARCA1:NM_001282874:exon3:c.G316A:p.A106T,SMARCA1:NM_001282875:exon3:c.G316A:p.A106T,SMARCA1:NM_003069:exon3:c.G316A:p.A106T	0.999946646	5.34E-05	3.43E-13	.	0.99248	0.11262	-0.380166007	27.88393489	111.24798	2.29759	0.208	0.214	T	0.08	0.230	B	0.074	0.267	B	0.000	0.629	D	1	0.810	D	1.31	0.329	L	-2.84	0.914	D	-0.94	0.251	N	0.716	0.722	-0.075	0.807	T	0.585	0.851	D	0.763	0.981	D	3.836	0.518	23.4	0.997	0.781	0.983	0.813	D	.	.	.	1.000	0.747	.	.	.	5.37	0.769	7.905	0.864	0.935	0.490	1.000	0.715	1.000	0.888	18.167	0.896	DBINO domain	.	.	0.5	.	29	X	128650420	chrX:128650420	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	128876167	128876167	C	T	intronic	XPNPEP2	.	.	.	1.69E-06	0.963806586	0.036191722	DISEASE: Angioedema induced by ACE inhibitors (AEACEI) [MIM:300909]: A potentially life-threatening side effect of ACE inhibitors that appears in a subset of patients taking these drugs for hypertension and cardiovascular disease treatment. AEACEI is characterized by swelling of the face, lips, tongue, and airway that can lead to suffocation and death if severe. {ECO:0000269|PubMed:16175507, ECO:0000269|PubMed:20625347, ECO:0000269|PubMed:21898657}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.44594	0.13793	-0.376526807	28.10804435	570.24498	4.84534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	X	128876167	chrX:128876167	C	T	.	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	128927042	128927042	T	C	exonic	SASH3	.	synonymous SNV	SASH3:NM_018990:exon7:c.T879C:p.N293N	0.891377605	0.108394024	0.000228371	.	0.3591	0.26327	-0.448125345	24.19202642	28.8003	0.92063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	X	128927042	chrX:128927042	T	C	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	129354266	129354266	C	A	intronic	ZNF280C	.	.	.	0.992273042	0.007726643	3.15E-07	.	0.1424	.	-0.492218069	22.35786742	14.15249	0.5125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	87	X	129354266	chrX:129354266	C	A	64	PASS	DP=87;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	131352206	131352206	G	A	intronic	RAP2C	.	.	.	0.212765647	0.648042038	0.139192315	.	0.61236	0.13588	-0.009020804	52.8544468	1.19806	0.035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	X	131352206	chrX:131352206	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	132351041	132351046	CTGAAG	-	UTR3	TFDP3	NM_016521:c.*29_*24delCTTCAG	.	.	2.30E-06	0.085066935	0.91493076	.	0.05413	0.05691	0.729426781	86.17008728	225.71159	3.2476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.93	26	X	132351040	chrX:132351040	CCTGAAG	C	11.93	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	133119384	133119386	CGG	-	exonic	GPC3	.	nonframeshift deletion	GPC3:NM_001164617:exon1:c.91_93del:p.P31del,GPC3:NM_001164618:exon1:c.91_93del:p.P31del,GPC3:NM_001164619:exon1:c.91_93del:p.P31del,GPC3:NM_004484:exon1:c.91_93del:p.P31del	0.987985909	0.01200951	4.58E-06	.	0.78059	0.36196	-0.448125345	24.19202642	61.55096	1.59866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49	39	X	133119383	chrX:133119383	CCGG	C	49	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	135960119	135960119	C	T	exonic	RBMX	.	nonsynonymous SNV	RBMX:NM_002139:exon4:c.G343A:p.G115R	0.948299697	0.051665932	3.44E-05	DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26116	.	0.325313577	73.11276244	16.97983	0.59829	0.089	0.342	T	0.991	0.899	D	0.86	0.832	P	0.000	0.559	U	0.000	0.810	P	2.015	0.552	M	-1.02	0.763	T	-3.62	0.703	D	0.791	0.782	0.130	0.847	D	0.585	0.851	D	.	.	.	5.659	0.771	26.7	0.999	0.995	0.968	0.710	D	.	.	.	1.000	0.747	.	.	.	5.65	0.868	5.492	0.664	0.931	0.441	1.000	0.715	1.000	0.888	16.982	0.861	Nucleotide-binding alpha-beta plait domain	.	.	0.5	118	99	X	135960119	chrX:135960119	C	T	118	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	140785696	140785696	T	C	exonic	SPANXC;SPANXD	.	nonsynonymous SNV	SPANXC:NM_022661:exon2:c.A220G:p.K74E,SPANXD:NM_032417:exon2:c.A220G:p.K74E	.	.	.	.	.	.	.	.	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	.	.	.	3.77	0.039	T	2.67	0.002	N	0.056	0.188	-0.945	0.419	T	0.004	0.015	T	.	.	.	-0.855	0.038	0.032	0.115	0.002	0.000	0.002	N	.	.	.	0.000	0.035	.	.	.	.	.	-2.052	0.015	-1.826	0.006	0.005	0.169	0.004	0.083	.	.	.	.	.	0.5	83	144	X	140785696	chrX:140785696	T	C	83	PASS	DP=144;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	140785714	140785714	C	G	exonic	SPANXC;SPANXD	.	nonsynonymous SNV	SPANXC:NM_022661:exon2:c.G202C:p.V68L,SPANXD:NM_032417:exon2:c.G202C:p.V68L	.	.	.	.	.	.	.	.	.	.	0.991	0.020	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	N	.	.	.	3.23	0.070	T	-1.26	0.318	N	0.082	0.230	-0.921	0.454	T	0.009	0.031	T	.	.	.	-0.583	0.051	0.137	0.204	0.007	0.002	0.011	N	.	.	.	0.000	0.012	.	.	.	.	.	0.064	0.142	0.079	0.188	0.016	0.191	0.017	0.128	.	.	.	.	.	0.5	83	145	X	140785714	chrX:140785714	C	G	83	PASS	DP=145;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	140993912	140993912	C	T	exonic	MAGEC1	.	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C722T:p.S241F	.	.	.	.	0.03644	.	6.421180534	99.87025242	4106.66315	12.72208	0.935	0.022	T	0.001	0.067	B	0.0	0.013	B	.	.	.	0.999	0.588	P	0.345	0.112	N	4.3	0.025	T	-0.38	0.134	N	0.184	0.323	-0.929	0.443	T	0.000	0.000	T	.	.	.	0.015	0.095	2.732	0.175	0.005	0.007	0.030	N	.	.	.	0.000	0.029	.	.	.	.	.	-0.253	0.087	-2.027	0.005	0.000	0.063	0.000	0.016	2.669	0.047	.	.	.	0.5	78	116	X	140993912	chrX:140993912	C	T	78	PASS	DP=116;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	150347552	150347552	C	-	intronic	GPR50	.	.	.	0.445210115	0.525810593	0.028979292	.	0.08612	0.10006	-0.378346116	28.01368247	1098.54685	6.34364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	401	X	150347551	chrX:150347551	TC	T	116	PASS	DP=401;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	150347647	150347647	G	A	intronic	GPR50	.	.	.	0.445210115	0.525810593	0.028979292	.	0.08612	0.10006	-0.378346116	28.01368247	1098.54685	6.34364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	X	150347647	chrX:150347647	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	151909156	151909156	A	G	exonic	CSAG1	.	nonsynonymous SNV	CSAG1:NM_001102576:exon4:c.A185G:p.K62R,CSAG1:NM_153478:exon5:c.A185G:p.K62R	0.000227012	0.30598978	0.693783208	.	0.01704	.	0.924227736	89.61429582	714.31094	5.30676	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.000	0.070	.	.	.	0.837	0.180	1.014	0.293	0.296	0.270	0.001	0.137	0.003	0.074	.	.	.	.	.	0.5	87	47	X	151909156	chrX:151909156	A	G	87	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	152935352	152935352	-	G	UTR3	PNCK	NM_001135740:c.*240_*241insC;NM_001039582:c.*240_*241insC	.	.	0.00047919	0.874195492	0.125325319	.	0.13631	0.11128	-0.494039303	22.09247464	30.66195	0.9756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	57	X	152935352	chrX:152935352	C	CG	53	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	153049525	153049525	C	-	exonic	SRPK3	.	frameshift deletion	SRPK3:NM_001170760:exon10:c.1001delC:p.A336Pfs*55,SRPK3:NM_014370:exon10:c.1004delC:p.A337Pfs*55	0.179643538	0.817765333	0.002591129	.	0.22866	0.11172	-0.33061537	30.82094834	46.03612	1.30706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	63	X	153049524	chrX:153049524	TC	T	43	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
X	153068235	153068235	C	G	UTR3	PDZD4	NM_001303515:c.*573G>C;NM_001303516:c.*573G>C;NM_001303512:c.*573G>C;NM_001303513:c.*573G>C;NM_001303514:c.*573G>C;NM_032512:c.*573G>C	.	.	0.930873832	0.069054613	7.16E-05	.	0.4676	0.11257	-0.380166007	27.88393489	54.5917	1.47872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	98	X	153068235	chrX:153068235	C	G	81	PASS	DP=98;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
X	153282349	153282349	C	-	intronic	IRAK1	.	.	.	0.994301924	0.005697338	7.38E-07	.	0.17579	0.59389	0.687150476	85.17928757	144.97421	2.62306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	38	X	153282348	chrX:153282348	GC	G	44	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	153695719	153695720	CG	-	exonic	PLXNA3	.	frameshift deletion	PLXNA3:NM_017514:exon19:c.3346_3347del:p.R1116Lfs*7	0.983112793	0.016887207	1.47E-10	.	0.13437	0.14072	-2.494487417	0.937721161	2064.44297	8.3709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	467	X	153695718	chrX:153695718	CCG	C	84	PASS	DP=467;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
Y	27535800	27535800	G	A	intergenic	TTTY17A;GOLGA2P3Y	dist=204880;dist=65658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	Y	27535800	chrY:27535800	G	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
